Citrus Sinensis ID: 011486
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGF4 | 591 | LRR receptor-like serine/ | yes | no | 0.927 | 0.759 | 0.778 | 0.0 | |
| C0LGL9 | 589 | LRR receptor-like serine/ | no | no | 0.973 | 0.799 | 0.753 | 0.0 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.787 | 0.394 | 0.398 | 1e-73 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.787 | 0.390 | 0.370 | 7e-71 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.919 | 0.723 | 0.354 | 9e-71 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.801 | 0.352 | 0.393 | 2e-70 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.787 | 0.319 | 0.380 | 2e-70 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.890 | 0.695 | 0.368 | 6e-70 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.785 | 0.393 | 0.379 | 6e-70 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.921 | 0.703 | 0.345 | 5e-67 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/455 (77%), Positives = 397/455 (87%), Gaps = 6/455 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 380 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 439
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 440 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 474
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/478 (75%), Positives = 404/478 (84%), Gaps = 7/478 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +K W L I L + N++ AI+ DGEALLSFR V++SDG + WRPEDPDP
Sbjct: 1 MGICLMKRCCSWFLLISFLSALTNENEAISPDGEALLSFRNGVLASDGVIGLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNWKGV CD K KRVI LSLT HKL GP+ +LGKLDQL+ L LH+N Y IP+ LGNC
Sbjct: 61 CNWKGVTCDAKTKRVIALSLTYHKLRGPLPPELGKLDQLRLLMLHNNALYQSIPASLGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
T L+G+ LQ+NY++G+IPSE+GNLS L NLD+S+N+L+ IP SLG+L+RL FNVSNNF
Sbjct: 121 TALEGIYLQNNYITGTIPSEIGNLSGLKNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDG+L + S SF GNR LCGKQI++ C NDSG ST S SP QGG N
Sbjct: 181 LVGKIPSDGLLARLSRDSFNGNRNLCGKQIDIVC-NDSGNSTA-SGSPT---GQGGN-NP 234
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
RLLISASATVG LLLVALMCFWGCFLYKKLG+ ESK L DVGGGASIVMFHGDLPY+S
Sbjct: 235 KRLLISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLVIDVGGGASIVMFHGDLPYAS 294
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE+L+++HIIG GGFGTVYKL+MDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH+R EQLDWD+R+NII+GAAKGLAY
Sbjct: 355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAY 414
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 415 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 472
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 171/429 (39%), Positives = 233/429 (54%), Gaps = 48/429 (11%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L+++ G I A+LG + L L+L NNF G IP LG+ L L+L N+L+G++
Sbjct: 413 LNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTL 472
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ------------------------RLIT 172
P+E GNL ++ +D+S N L+ IP LG+LQ L
Sbjct: 473 PAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLAN 532
Query: 173 FNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQN 232
N+S N L G IP T+FS +SFFGN LCG + C G S SQ
Sbjct: 533 LNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSIC----GPSLPKSQ------- 581
Query: 233 QGGKKNSGRLLISASATVGALLLVALMCFWGCFLYK-KLGKNESKGLARDVGGGASIVMF 291
+ + L + L+C +YK K K KG ++ G +V+
Sbjct: 582 ---------VFTRVAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVIL 632
Query: 292 HGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFF 350
H D+ ++ DI++ E LD+ +IIG G TVYK A+KRI R F
Sbjct: 633 HMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREF 692
Query: 351 ERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLN 408
E ELE +GSI+HR +V+L GY SP LL YD++ GSL + LH + +LDW+ RL
Sbjct: 693 ETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLK 752
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I +GAA+GLAYLHHDC+PRIIHRDIKSSNILLDGN EAR+SDFG+AK + +++ +T V
Sbjct: 753 IAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYV 812
Query: 469 AGTFGYLAP 477
GT GY+ P
Sbjct: 813 LGTIGYIDP 821
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 165/445 (37%), Positives = 243/445 (54%), Gaps = 64/445 (14%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
K + + L+L+++ + GPI +L ++ L L+L +N G IPS LG+ L ++L
Sbjct: 401 KLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSR 460
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI------------------ 171
N+++G +P + GNL +++ +D+S+N +S IP L +LQ +I
Sbjct: 461 NHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLAN 520
Query: 172 -----TFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQS 226
NVS+N LVG IP + ++FS SF GN GLCG +N C +
Sbjct: 521 CLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPCHD----------- 569
Query: 227 PNSAQNQGGKKNSGRLLISASA----TVGALLLVALMCFWGC-------FLYKKLGKNES 275
+ + R+ IS +A +G L+++ ++ C FL L K +
Sbjct: 570 ---------SRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSLDKPVT 620
Query: 276 KGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVF 334
+ +V+ H ++ + +DI++ E L + +IIG G TVYK + +
Sbjct: 621 YSTPK-------LVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPV 673
Query: 335 ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL 394
A+KR+ N + FE ELE+L SIKHR LV+L+ Y S LL YD+L GSL + L
Sbjct: 674 AIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLL 733
Query: 395 H--ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452
H + + LDWD RL I GAA+GLAYLHHDCSPRIIHRD+KSSNILLD +LEAR++DFG
Sbjct: 734 HGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFG 793
Query: 453 LAKLLEDEESHITTIVAGTFGYLAP 477
+AK L +SH +T V GT GY+ P
Sbjct: 794 IAKSLCVSKSHTSTYVMGTIGYIDP 818
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 9e-71, Method: Compositional matrix adjust.
Identities = 167/471 (35%), Positives = 252/471 (53%), Gaps = 26/471 (5%)
Query: 12 WLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKN 71
WL+ +L L + ++ N++G+AL + + ++ + L W PC W V C+ +
Sbjct: 12 WLILVLDLVLRVSG----NAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSD 67
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
V + L N LSG + LG+L L++L L+SNN G IP +LGN TEL L L N
Sbjct: 68 NSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNN 127
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
LSG IPS LG L L L +++NSLS IP SL + L ++SNN L G IP +G +
Sbjct: 128 LSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFS 187
Query: 192 KFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG 251
F+ SF + + + S S + GG LL + A
Sbjct: 188 LFTPISFANTKLTPLPASPPPPISPTPPSPAGSNR-ITGAIAGGVAAGAALLFAVPAIA- 245
Query: 252 ALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLD 310
+ +W + + + DV + G L +S +++ +
Sbjct: 246 -------LAWW--------RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFS 290
Query: 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+ +I+G GGFG VYK + DG + A+KR+ ++ +G + F+ E+E++ HR L+ LR
Sbjct: 291 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 350
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
G+C +PT +LL+Y ++ GS+ L ER E LDW R I +G+A+GLAYLH C P
Sbjct: 351 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 410
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+IIHRD+K++NILLD EA V DFGLAKL++ +++H+TT V GT G++AP
Sbjct: 411 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 461
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 161/409 (39%), Positives = 233/409 (56%), Gaps = 21/409 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ-GLSLQSNYLSGS 135
L L+N+ LSG I LG L +L L + N F G IP ELG+ T LQ L+L N L+G
Sbjct: 582 LKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
IP EL NL L L +++N+LS IP S L L+ +N S N L G IP +L S
Sbjct: 642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISM 698
Query: 196 SSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG--AL 253
SSF GN GLCG +N + T +P+ + + G S +++ +A +G +L
Sbjct: 699 SSFIGNEGLCGPPLNQCIQ-------TQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSL 751
Query: 254 LLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDH 313
+L+AL+ + + + + G ++ + + F ++ +D++ + D+
Sbjct: 752 MLIALIVYLMRRPVRTVASSAQDGQPSEM---SLDIYFPPKEGFTFQDLVAATDNFDESF 808
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-----FDRFFERELEILGSIKHRYLVNL 368
++G G GTVYK + G A+K++ +EG D F E+ LG+I+HR +V L
Sbjct: 809 VVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKL 868
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G+CN S LL+Y+++P GSL E LH+ S LDW R I +GAA+GLAYLHHDC PRI
Sbjct: 869 HGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRI 928
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIKS+NILLD EA V DFGLAK+++ S + +AG++GY+AP
Sbjct: 929 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP 977
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 165/434 (38%), Positives = 233/434 (53%), Gaps = 53/434 (12%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
++ L+LT +KL GP+ A LG L +L ++L NN GE+ SEL +L GL ++ N +
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFT 737
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF 193
G IPSELGNL+ L LD+S N LS IP + L L N++ N L G +PSDGV
Sbjct: 738 GEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDP 797
Query: 194 SESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGAL 253
S++ GN+ LCG+ + CK + G L SA G +
Sbjct: 798 SKALLSGNKELCGRVVGSDCKIE-----------------------GTKLRSAWGIAGLM 834
Query: 254 LLVALMCFWGCFLYKK---------------LGKNESKGLARD----VGGGAS------- 287
L ++ F F ++ + ++ KG + G S
Sbjct: 835 LGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSIN 894
Query: 288 IVMFHGDL-PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF 346
I MF L DI++ + +IIG GGFGTVYK + A+K++ +
Sbjct: 895 IAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQG 954
Query: 347 DRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDW 403
+R F E+E LG +KH LV+L GYC+ KLL+Y+++ GSLD L ++ E LDW
Sbjct: 955 NREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDW 1014
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
RL I +GAA+GLA+LHH P IIHRDIK+SNILLDG+ E +V+DFGLA+L+ ESH
Sbjct: 1015 SKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESH 1074
Query: 464 ITTIVAGTFGYLAP 477
++T++AGTFGY+ P
Sbjct: 1075 VSTVIAGTFGYIPP 1088
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 169/458 (36%), Positives = 250/458 (54%), Gaps = 27/458 (5%)
Query: 28 AINSDGEALLSFRTAVVSSD---GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKL 84
A N++G+AL + ++ S D L W PC W V C+ +V + L N KL
Sbjct: 28 AGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKL 87
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144
SG + +LG+L L++L L+SNN GEIP ELG+ EL L L +N +SG IPS LG L
Sbjct: 88 SGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLG 147
Query: 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
L L +++NSLS IP +L +Q L ++SNN L G IP +G + F+ SF N
Sbjct: 148 KLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN--- 203
Query: 205 CGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGC 264
D S SP GG+ + A+ + A+ W
Sbjct: 204 --------SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAW-- 253
Query: 265 FLYKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTV 323
+L +K + DV + G L ++ ++++ + + +++G GGFG V
Sbjct: 254 WLRRK-----PQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308
Query: 324 YKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
YK + DGN+ A+KR+ ++ +G + F+ E+E++ HR L+ LRG+C +PT +LL+Y
Sbjct: 309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368
Query: 383 DFLPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439
++ GS+ L ER E LDW R +I +G+A+GLAYLH C +IIHRD+K++NIL
Sbjct: 369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428
Query: 440 LDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LD EA V DFGLAKL+ +SH+TT V GT G++AP
Sbjct: 429 LDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAP 466
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 163/429 (37%), Positives = 231/429 (53%), Gaps = 49/429 (11%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L+++ G I +LG + L L+L NNF G IP LG+ L L+L N+LSG +
Sbjct: 411 LNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQL 470
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ------------------------RLIT 172
P+E GNL ++ +D+S N LS IP LG+LQ L+
Sbjct: 471 PAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVN 530
Query: 173 FNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQN 232
NVS N L G +P ++F+ +SF GN LCG + C
Sbjct: 531 LNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSIC------------------- 571
Query: 233 QGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKNES-KGLARDVGGGASIVMF 291
G R+ + L ++ L+C +YK + + + +G ++ G +V+
Sbjct: 572 --GPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVIL 629
Query: 292 HGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFF 350
H D+ ++ DI++ E L++ IIG G TVYK A+ A+KR+ R F
Sbjct: 630 HMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREF 689
Query: 351 ERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLN 408
E ELE +GSI+HR +V+L GY SPT LL YD++ GSL + LH + +LDW+ RL
Sbjct: 690 ETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLK 749
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I +GAA+GLAYLHHDC+PRIIHRDIKSSNILLD N EA +SDFG+AK + ++H +T V
Sbjct: 750 IAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYV 809
Query: 469 AGTFGYLAP 477
GT GY+ P
Sbjct: 810 LGTIGYIDP 818
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 162/469 (34%), Positives = 248/469 (52%), Gaps = 23/469 (4%)
Query: 16 ILLLCIIIN---KSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNK 72
+LLLC + S N + EAL++ + + G W DPC+W + C +
Sbjct: 15 LLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSDN 74
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
VI L + LSG +S +G L L+ ++L +NN G+IP E+ + +LQ L L +N
Sbjct: 75 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRF 134
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
SG IP + LSNL L +++NSLS P SL ++ L ++S N L G +P K
Sbjct: 135 SGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP------K 188
Query: 193 FSESSF--FGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATV 250
F +F GN +C + C GS + S S ++ G++ + +++ + V
Sbjct: 189 FPARTFNVAGNPLICKNSLPEICS----GSISASPLSVSLRSSSGRRTN---ILAVALGV 241
Query: 251 GALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDL-PYSSKDIIKKLETL 309
V+++ G Y+K K + R ++ G+L ++ +++ +
Sbjct: 242 SLGFAVSVILSLGFIWYRK--KQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGF 299
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNL 368
I+G+GGFG VY+ DG V A+KR+ +N + F ELE++ HR L+ L
Sbjct: 300 SSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRL 359
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
GYC S + +LL+Y ++ GS+ L + LDW+ R I +GAA+GL YLH C P+I
Sbjct: 360 IGYCASSSERLLVYPYMSNGSVASRLKAK-PALDWNTRKKIAIGAARGLFYLHEQCDPKI 418
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IHRD+K++NILLD EA V DFGLAKLL E+SH+TT V GT G++AP
Sbjct: 419 IHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAP 467
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | ||||||
| 255557731 | 596 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.985 | 0.800 | 0.828 | 0.0 | |
| 359474742 | 596 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.800 | 0.812 | 0.0 | |
| 358248000 | 590 | LRR receptor-like serine/threonine-prote | 0.975 | 0.8 | 0.797 | 0.0 | |
| 359474744 | 592 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.800 | 0.805 | 0.0 | |
| 449462503 | 595 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.801 | 0.767 | 0.0 | |
| 449455673 | 599 | PREDICTED: LRR receptor-like serine/thre | 0.983 | 0.794 | 0.769 | 0.0 | |
| 12322537 | 590 | protein kinase, putative [Arabidopsis th | 0.927 | 0.761 | 0.778 | 0.0 | |
| 334182976 | 591 | leucine-rich repeat protein kinase-like | 0.927 | 0.759 | 0.778 | 0.0 | |
| 297851928 | 592 | hypothetical protein ARALYDRAFT_891122 [ | 0.927 | 0.758 | 0.778 | 0.0 | |
| 42562442 | 592 | leucine-rich repeat protein kinase-like | 0.927 | 0.758 | 0.776 | 0.0 |
| >gi|255557731|ref|XP_002519895.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540941|gb|EEF42499.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/479 (82%), Positives = 426/479 (88%), Gaps = 2/479 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M +Y +C+G WL +IL+L I + KS AINSDGEALL+F+ A+VSSDG L WRPEDPDP
Sbjct: 1 MAIYLRRCQGTWLFYILVLYIFVQKSGAINSDGEALLNFKNAIVSSDGILPLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW+GV CD K KRVI LSL NHKLSG IS D+GKL L+ L L++NNFYG IPSELGNC
Sbjct: 61 CNWRGVTCDQKTKRVIYLSLKNHKLSGSISPDIGKLQHLRILALYNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQGL LQ NYLSG IPSELG LS L LDISSNSLS IPPSLGKL +LITFNVSNNF
Sbjct: 121 TELQGLYLQGNYLSGLIPSELGKLSELQYLDISSNSLSGSIPPSLGKLNKLITFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKN- 238
LVG IPSDGVL FS+SSF GNRGLCG QIN+ CK+++GG +++S SP SAQNQGGKK
Sbjct: 181 LVGPIPSDGVLFNFSQSSFTGNRGLCGNQINMNCKDETGGPSSNSGSPTSAQNQGGKKKY 240
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS 298
SGRLLISASATVGALLLVALMCFWGCFLYKK GKNES +A DV GGASIVMFHGDLPYS
Sbjct: 241 SGRLLISASATVGALLLVALMCFWGCFLYKKFGKNESNSIAMDVSGGASIVMFHGDLPYS 300
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
SKDIIKKLETL+++HIIG GGFGTVYKLAMDDG+VFALKRI KLNEGFDRFFERELEILG
Sbjct: 301 SKDIIKKLETLNEEHIIGCGGFGTVYKLAMDDGSVFALKRIVKLNEGFDRFFERELEILG 360
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA
Sbjct: 361 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 420
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLHHDC+PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 421 YLHHDCAPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 479
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474742|ref|XP_002266702.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like isoform 1 [Vitis vinifera] gi|296085503|emb|CBI29235.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/479 (81%), Positives = 421/479 (87%), Gaps = 2/479 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M + I+C ++LLL I++N+S+A++ DGEALLSFR ++VSSDG L QWRPEDPDP
Sbjct: 1 MSTFLIRCLVPLPFYLLLLYILMNQSKALSPDGEALLSFRNSIVSSDGVLRQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGV CD + KRVI L+L +HKLSG IS D+GKL+ LK L L +NNFYG IPSELGNC
Sbjct: 61 CGWKGVTCDLETKRVIYLNLPHHKLSGSISPDIGKLELLKLLALQNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQ L LQ NYLSG IPSELG+L L +LDISSNSLS YIPPSLGKL +L TFNVS NF
Sbjct: 121 TELQALYLQGNYLSGLIPSELGSLLELKDLDISSNSLSGYIPPSLGKLDKLSTFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKN- 238
LVG IPSDGVLT FS +SF GNRGLCGKQIN+TCK+DSGG+ T SQ P QNQ GKK
Sbjct: 181 LVGPIPSDGVLTNFSGNSFVGNRGLCGKQINITCKDDSGGAGTKSQPPILDQNQVGKKKY 240
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS 298
SGRLLISASATVGALLLVALMCFWGCFLYKK GKN+ + LA DV GGASIVMFHGDLPYS
Sbjct: 241 SGRLLISASATVGALLLVALMCFWGCFLYKKCGKNDGRSLAMDVSGGASIVMFHGDLPYS 300
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
SKDIIKKLETL+++HIIGSGGFGTVYKLAMDDGNVFALKRI K+NE FDRFFERELEILG
Sbjct: 301 SKDIIKKLETLNEEHIIGSGGFGTVYKLAMDDGNVFALKRIVKMNECFDRFFERELEILG 360
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
SIKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA
Sbjct: 361 SIKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 420
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 421 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 479
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248000|ref|NP_001239788.1| LRR receptor-like serine/threonine-protein kinase FEI 1 precursor [Glycine max] gi|223452450|gb|ACM89552.1| leucine-rich repeat transmembrane protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/478 (79%), Positives = 412/478 (86%), Gaps = 6/478 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ K + WLL++LL+ ++I KS AI DGE LLSFRT+VVSSDG L QWRPEDPDP
Sbjct: 1 MGICLWKWQWPWLLYVLLIHVVIYKSGAITPDGEVLLSFRTSVVSSDGILLQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGVKCD K KRV LSL++HKLSG IS DLGKL+ L+ L LH+NNFYG IPSELGNC
Sbjct: 61 CKWKGVKCDPKTKRVTHLSLSHHKLSGSISPDLGKLENLRVLALHNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TEL+G+ LQ NYLSG IP E+GNLS L NLDISSNSLS IP SLGKL L FNVS NF
Sbjct: 121 TELEGIFLQGNYLSGVIPIEIGNLSQLQNLDISSNSLSGNIPASLGKLYNLKNFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IP+DGVL F+ SSF GNRGLCG +IN TC++D G T+ QS +S G KK S
Sbjct: 181 LVGPIPADGVLANFTGSSFVGNRGLCGVKINSTCRDD-GSPDTNGQSTSS----GKKKYS 235
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYKK GKN+ LA DVG GASIVMFHGDLPYSS
Sbjct: 236 GRLLISASATVGALLLVALMCFWGCFLYKKFGKNDRISLAMDVGSGASIVMFHGDLPYSS 295
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLETL+++HIIG GGFGTVYKLAMDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 296 KDIIKKLETLNEEHIIGIGGFGTVYKLAMDDGNVFALKRIVKLNEGFDRFFERELEILGS 355
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHER++QLDWD+RLNIIMGAAKGLAY
Sbjct: 356 IKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERADQLDWDSRLNIIMGAAKGLAY 415
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 416 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 473
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474744|ref|XP_003631527.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/478 (80%), Positives = 419/478 (87%), Gaps = 4/478 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M + I+C ++LLL I++N+S+A++ DGEALLSFR ++VSSDG L QWRPEDPDP
Sbjct: 1 MSTFLIRCLVPLPFYLLLLYILMNQSKALSPDGEALLSFRNSIVSSDGVLRQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGV CD + KRVI L+L +HKLSG IS D+GKL+ LK L L +NNFYG IPSELGNC
Sbjct: 61 CGWKGVTCDLETKRVIYLNLPHHKLSGSISPDIGKLELLKLLALQNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQ L LQ NYLSG IPSELG+L L +LDISSNSLS YIPPSLGKL +L TFNVS NF
Sbjct: 121 TELQALYLQGNYLSGLIPSELGSLLELKDLDISSNSLSGYIPPSLGKLDKLSTFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDGVLT FS +SF GNRGLCGKQIN+TCK+DSGG+ T SQ P ++ KK S
Sbjct: 181 LVGPIPSDGVLTNFSGNSFVGNRGLCGKQINITCKDDSGGAGTKSQPPILGRS---KKYS 237
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYKK GKN+ + LA DV GGASIVMFHGDLPYSS
Sbjct: 238 GRLLISASATVGALLLVALMCFWGCFLYKKCGKNDGRSLAMDVSGGASIVMFHGDLPYSS 297
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLETL+++HIIGSGGFGTVYKLAMDDGNVFALKRI K+NE FDRFFERELEILGS
Sbjct: 298 KDIIKKLETLNEEHIIGSGGFGTVYKLAMDDGNVFALKRIVKMNECFDRFFERELEILGS 357
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY
Sbjct: 358 IKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 417
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 418 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 475
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462503|ref|XP_004148980.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] gi|449515017|ref|XP_004164546.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/478 (76%), Positives = 414/478 (86%), Gaps = 1/478 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +KC G +L +LLLC+ +NKS + DG ALLSFR AV SSDG + QWRPEDP+P
Sbjct: 1 MGICLVKCSGLLILHVLLLCMAMNKSTGLTPDGAALLSFRMAVASSDGVIFQWRPEDPNP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW GV CD K KRVI+L L +HKLSG I+ +LGKLDQLK L L NN YG IPSELGNC
Sbjct: 61 CNWTGVVCDPKTKRVISLKLASHKLSGFIAPELGKLDQLKTLILSDNNLYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++LQG+ LQ NYLSG IP ELGNL L LD+SSNSLS IP SLG L +L NVS+NF
Sbjct: 121 SQLQGMFLQRNYLSGVIPYELGNLLELEMLDVSSNSLSGNIPTSLGNLDKLAILNVSSNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
L+G +PSDGVL+KFSE+SF GNRGLCGKQ+NV CK+D+ S T+S+S +S QNQ +K S
Sbjct: 181 LIGPVPSDGVLSKFSETSFVGNRGLCGKQVNVVCKDDNNESGTNSESTSSGQNQMRRKYS 240
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYK+ GKN+ KGLA+DVGGGAS+VMFHGDLPYSS
Sbjct: 241 GRLLISASATVGALLLVALMCFWGCFLYKRFGKNDKKGLAKDVGGGASVVMFHGDLPYSS 300
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDI+KKLETL+++HIIGSGGFGTVY+LAMDDGNVFALK I K+NEGFD FFERELEILGS
Sbjct: 301 KDIMKKLETLNEEHIIGSGGFGTVYRLAMDDGNVFALKNIVKINEGFDHFFERELEILGS 360
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
+KHRYLVNLRGYCNSPTSKLLIYD+L GGSLDEALHERSEQLDWD RLNII+GAAKGLAY
Sbjct: 361 LKHRYLVNLRGYCNSPTSKLLIYDYLSGGSLDEALHERSEQLDWDTRLNIILGAAKGLAY 420
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LHHDCSPRIIHRDIKSSNILLDGNL+ARVSDFGLAKLL+D++SHITTIVAGTFGYLAP
Sbjct: 421 LHHDCSPRIIHRDIKSSNILLDGNLDARVSDFGLAKLLDDDKSHITTIVAGTFGYLAP 478
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455673|ref|XP_004145576.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] gi|449485054|ref|XP_004157058.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/485 (76%), Positives = 406/485 (83%), Gaps = 9/485 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG Y +K + +L I+ LC+I+++S I SDGEALLSFR +++ SDG L QW+PE+P P
Sbjct: 1 MGFYTVKWQWLLILHIVPLCMIMSRSSGITSDGEALLSFRASILDSDGVLLQWKPEEPHP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKG+ CD K KRVI LSL HKLSG +S +LGKLD LK L LH NNFYG IPSELGNC
Sbjct: 61 CKWKGITCDPKTKRVIYLSLPYHKLSGSLSPELGKLDHLKILALHDNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++LQG+ LQ NY SGSIP+ELGNL L NLDISSNSL IP SLGKL L++ NVS NF
Sbjct: 121 SQLQGMFLQGNYFSGSIPNELGNLWALKNLDISSNSLGGNIPISLGKLSNLVSLNVSANF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQ-GGKKN 238
LVG IP+ G+L FSESSF GNRGLCGKQINV CK+D T+ +SP S QNQ G KK
Sbjct: 181 LVGTIPNVGMLLNFSESSFLGNRGLCGKQINVMCKDDKKEPETN-ESPFSVQNQIGKKKY 239
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGG--ASIVMFHGDLP 296
SGRLLISASATVGALLLVALMCFWGCFLYKK GKN+SKGL + GG AS VMFHGDLP
Sbjct: 240 SGRLLISASATVGALLLVALMCFWGCFLYKKFGKNDSKGLVLNGCGGARASGVMFHGDLP 299
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI 356
Y SKDIIKK ETL+++HIIG GGFGTVYKLAMDDGNVFALKRI KLNEGFDRFFERELEI
Sbjct: 300 YMSKDIIKKFETLNEEHIIGCGGFGTVYKLAMDDGNVFALKRIIKLNEGFDRFFERELEI 359
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH----ERSEQLDWDARLNIIMG 412
LGSIKHR+LVNLRGYCNSPTSKLLIYDFLPGGSLDEALH E SEQLDWDARLNIIMG
Sbjct: 360 LGSIKHRFLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHGLRTEGSEQLDWDARLNIIMG 419
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
AAKGLAYLHHDCSPRIIHRDIKSSNILLD NLEARVSDFGLAKLLEDEESHITTIVAGTF
Sbjct: 420 AAKGLAYLHHDCSPRIIHRDIKSSNILLDANLEARVSDFGLAKLLEDEESHITTIVAGTF 479
Query: 473 GYLAP 477
GYLAP
Sbjct: 480 GYLAP 484
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12322537|gb|AAG51266.1|AC027135_7 protein kinase, putative [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/455 (77%), Positives = 397/455 (87%), Gaps = 6/455 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 24 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 83
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 84 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 143
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 144 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 203
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 204 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 258
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 259 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 318
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 319 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 378
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 379 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 438
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 439 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 473
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182976|ref|NP_001185122.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|263419027|sp|C0LGF4.1|FEI1_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase FEI 1; Flags: Precursor gi|224589410|gb|ACN59239.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332193233|gb|AEE31354.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/455 (77%), Positives = 397/455 (87%), Gaps = 6/455 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 380 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 439
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 440 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 474
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297851928|ref|XP_002893845.1| hypothetical protein ARALYDRAFT_891122 [Arabidopsis lyrata subsp. lyrata] gi|297339687|gb|EFH70104.1| hypothetical protein ARALYDRAFT_891122 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/456 (77%), Positives = 398/456 (87%), Gaps = 7/456 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVSRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ ++GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+GN
Sbjct: 85 KIMGPLPPEIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGN 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LHGLQKLDMSSNTLSGAIPASLGQLKKLTNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK I+V C++DSG +++SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHIDVVCQDDSGNPSSNSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
D+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLD
Sbjct: 380 DYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLD 439
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 440 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 475
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42562442|ref|NP_174427.3| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|332193232|gb|AEE31353.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/456 (77%), Positives = 397/456 (87%), Gaps = 7/456 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
D+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLD
Sbjct: 380 DYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLD 439
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 440 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 475
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | ||||||
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.975 | 0.797 | 0.724 | 4.7e-183 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.973 | 0.799 | 0.719 | 2.1e-180 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.931 | 0.746 | 0.474 | 1.6e-109 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.762 | 0.366 | 0.380 | 1.1e-72 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.909 | 0.704 | 0.361 | 4.4e-68 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.913 | 0.703 | 0.352 | 1.2e-67 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.764 | 0.317 | 0.370 | 4.4e-66 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.886 | 0.691 | 0.355 | 3.2e-65 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.785 | 0.392 | 0.397 | 8.3e-65 | |
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.745 | 0.329 | 0.377 | 8.3e-65 |
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1776 (630.2 bits), Expect = 4.7e-183, P = 4.7e-183
Identities = 347/479 (72%), Positives = 388/479 (81%)
Query: 1 MGMYQIKCRGQWXXXXXXXXXXXNKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ ++K W N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDP
Sbjct: 2 MGICEMKSCCSWLLLISLLCSLSNESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDP 61
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW GV CD K KRVITL+LT HK+ GP+ D+GKLD L+ L LH+N YG IP+ LGNC
Sbjct: 62 CNWNGVTCDAKTKRVITLNLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNC 121
Query: 120 TELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNF 179
T L+ + LQSNY +G IP IP SLG+L++L FNVSNNF
Sbjct: 122 TALEEIHLQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNF 181
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDGVL+ FS++SF GN LCGK ++V C++DSG ++ SQS QNQ KKNS
Sbjct: 182 LVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNS 236
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
G+LLISASATVGALLLVALMCFWGCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSS
Sbjct: 237 GKLLISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSS 296
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE L+++HIIG GGFGTVYKLAMDDG VFALKRI KLNEGFDRFFERELEILGS
Sbjct: 297 KDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGS 356
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLA 418
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+
Sbjct: 357 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLS 416
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 417 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 475
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1751 (621.4 bits), Expect = 2.1e-180, P = 2.1e-180
Identities = 344/478 (71%), Positives = 382/478 (79%)
Query: 1 MGMYQIKCRGQWXXXXXXXXXXXNKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +K W N++ AI+ DGEALLSFR V++SDG + WRPEDPDP
Sbjct: 1 MGICLMKRCCSWFLLISFLSALTNENEAISPDGEALLSFRNGVLASDGVIGLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNWKGV CD K KRVI LSLT HKL GP+ +LGKLDQL+ L LH+N Y IP+ LGNC
Sbjct: 61 CNWKGVTCDAKTKRVIALSLTYHKLRGPLPPELGKLDQLRLLMLHNNALYQSIPASLGNC 120
Query: 120 TELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNF 179
T L+G+ LQ+NY++G+IP IP SLG+L+RL FNVSNNF
Sbjct: 121 TALEGIYLQNNYITGTIPSEIGNLSGLKNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDG+L + S SF GNR LCGKQI++ C NDSG ST S SP QGG N
Sbjct: 181 LVGKIPSDGLLARLSRDSFNGNRNLCGKQIDIVC-NDSGNSTA-SGSPTG---QGGN-NP 234
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
RLLISASATVG LLLVALMCFWGCFLYKKLG+ ESK L DVGGGASIVMFHGDLPY+S
Sbjct: 235 KRLLISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLVIDVGGGASIVMFHGDLPYAS 294
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE+L+++HIIG GGFGTVYKL+MDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH+R EQLDWD+R+NII+GAAKGLAY
Sbjct: 355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAY 414
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP
Sbjct: 415 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 472
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 220/464 (47%), Positives = 299/464 (64%)
Query: 26 SRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNHKL 84
S A+ DG ALL ++ + L W+ D PC+W GV C+ +++RV++++L +L
Sbjct: 21 SFALTLDGFALLELKSGFNDTRNSLENWKDSDESPCSWTGVSCNPQDQRVVSINLPYMQL 80
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXX 144
G IS +GKL +L+ L LH N+ +G IP+E+ NCTEL+ + L++N+L G IP
Sbjct: 81 GGIISPSIGKLSRLQRLALHQNSLHGNIPNEITNCTELRAMYLRANFLQGGIPPDLGNLT 140
Query: 145 XXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
IP S+ +L RL + N+S NF G IP GVL++F +F GN L
Sbjct: 141 FLTILDLSSNTLKGAIPSSISRLTRLRSLNLSTNFFSGEIPDIGVLSRFGVETFTGNLDL 200
Query: 205 CGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRL----LISASATVGALLLVALMC 260
CG+QI C++ G + SA K S RL LI A +T+ +V +
Sbjct: 201 CGRQIRKPCRSSMGFPVVLPHA-ESADESDSPKRSSRLIKGILIGAMSTMALAFIVIFVF 259
Query: 261 FWGCFLYKKLGK----NESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIG 316
W L KK K E K ++ FHGDLPYSS ++I+KLE+LD++ I+G
Sbjct: 260 LWIWMLSKKERKVKKYTEVKKQKDPSETSKKLITFHGDLPYSSTELIEKLESLDEEDIVG 319
Query: 317 SGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376
SGGFGTVY++ M+D FA+K+ID+ +G DR FERE+EILGS+KH LVNLRGYC P+
Sbjct: 320 SGGFGTVYRMVMNDLGTFAVKKIDRSRQGSDRVFEREVEILGSVKHINLVNLRGYCRLPS 379
Query: 377 SKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
S+LLIYD+L GSLD+ LHER+++ L+W+ARL I +G+A+GLAYLHHDCSP+I+HRDI
Sbjct: 380 SRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLKIALGSARGLAYLHHDCSPKIVHRDI 439
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
KSSNILL+ LE RVSDFGLAKLL DE++H+TT+VAGTFGYLAP
Sbjct: 440 KSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAP 483
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
Identities = 147/386 (38%), Positives = 200/386 (51%)
Query: 101 LNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYI 160
+ L NN G I E GN +L L+ N LSGSIP I
Sbjct: 528 IELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSI 587
Query: 161 PPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGS 220
P SL +L L F+V+ N L G IPS G F SSF N LCG+ C S G
Sbjct: 588 PVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEH-RFPC---SEG- 641
Query: 221 TTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKN--ESKGL 278
T + S +++GG + G + A +V L L++L+ ++ ES+ +
Sbjct: 642 TESALIKRSRRSRGG--DIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESM 699
Query: 279 AR-DVG--GGASIVMFHG-DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVF 334
R ++G G +V+F D S D++ + D +IIG GGFG VYK + DG
Sbjct: 700 NRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKV 759
Query: 335 ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL 394
A+K++ +R FE E+E L +H LV LRG+C +LLIY ++ GSLD L
Sbjct: 760 AIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWL 819
Query: 395 HERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451
HER++ L W RL I GAAKGL YLH C P I+HRDIKSSNILLD N + ++DF
Sbjct: 820 HERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADF 879
Query: 452 GLAKLLEDEESHITTIVAGTFGYLAP 477
GLA+L+ E+H++T + GT GY+ P
Sbjct: 880 GLARLMSPYETHVSTDLVGTLGYIPP 905
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
Identities = 165/456 (36%), Positives = 238/456 (52%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPIS 89
N +G+AL + R +V + L W P +PC W V C+ VI + L N +LSG +
Sbjct: 27 NLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNAELSGHLV 86
Query: 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXX 149
+LG L L++L L+SNN G IPS LGN T L L L N SG IP
Sbjct: 87 PELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFL 146
Query: 150 XXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
IP SL + L ++SNN L G++P +G + F+ SF N LCG
Sbjct: 147 RLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 206
Query: 210 NVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASA---TVGALLLVALMCFWGCFL 266
+ C GS S P Q SG + A A GA LL A F
Sbjct: 207 SHPCP----GSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAI--AFA 260
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK 325
+ + + + + DV + G L +S +++ + + +I+G GGFG VYK
Sbjct: 261 WWR--RRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYK 318
Query: 326 LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384
+ DG + A+KR+ ++ G + F+ E+E++ HR L+ LRG+C +PT +LL+Y +
Sbjct: 319 GRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 378
Query: 385 LPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
+ GS+ L ER LDW R I +G+A+GL+YLH C P+IIHRD+K++NILLD
Sbjct: 379 MANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 438
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
EA V DFGLAKL++ +++H+TT V GT G++AP
Sbjct: 439 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 474
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
Identities = 160/454 (35%), Positives = 235/454 (51%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPIS 89
N +G+AL S R +V + L W P +PC W V C+ VI + L N LSG +
Sbjct: 30 NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQLV 89
Query: 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXX 149
LG+L L++L L+SNN G +PS+LGN T L L L N +G IP
Sbjct: 90 PQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFL 149
Query: 150 XXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
IP SL + L ++SNN L G++P +G + F+ SF N LCG
Sbjct: 150 RLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 209
Query: 210 NVTCKNDSGGSTTDSQSPNS-AQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYK 268
+ C S P GG +G I+ GA LL A F +
Sbjct: 210 SRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGA--IAGGVAAGAALLFAAPAL--AFAWW 265
Query: 269 KLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLA 327
+ K + DV + G L +S +++ ++ + +I+G GGFG VYK
Sbjct: 266 RRRKPQE--FFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 328 MDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386
+ DG + A+KR+ ++ G + F+ E+E++ HR L+ LRG+C +PT +LL+Y ++
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 387 GGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443
GS+ L ER L W R I +G+A+GL+YLH C P+IIHRD+K++NILLD
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 444 LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
EA V DFGLA+L++ +++H+TT V GT G++AP
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAP 477
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 4.4e-66, Sum P(2) = 4.4e-66
Identities = 147/397 (37%), Positives = 210/397 (52%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDY 159
+L+L N G IP G LQ L+L N L+G+IP +
Sbjct: 643 YLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGF 702
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGG 219
+P SLG L L +VSNN L G IP G LT F + + N GLCG + C SG
Sbjct: 703 LPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLP-PCS--SGS 759
Query: 220 STTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLA 279
T S + Q+ ++G ++ S V +L++AL + + KK + E +
Sbjct: 760 RPTRSHAHPKKQSIATGMSAG-IVFSFMCIV--MLIMAL--YRARKVQKKEKQREKYIES 814
Query: 280 RDVGGGAS--IVMFHGDLPYSSKDIIKKLETLDDDHI------------IGSGGFGTVYK 325
G +S + H L + K L L H+ IGSGGFG VYK
Sbjct: 815 LPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYK 874
Query: 326 LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385
+ DG+V A+K++ ++ DR F E+E +G IKHR LV L GYC +LL+Y+++
Sbjct: 875 AKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 934
Query: 386 PGGSLDEALHERSEQ----LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
GSL+ LHE++++ LDW AR I +GAA+GLA+LHH C P IIHRD+KSSN+LLD
Sbjct: 935 KYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLD 994
Query: 442 GNLEARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAP 477
+ ARVSDFG+A+L+ ++H++ + +AGT GY+ P
Sbjct: 995 QDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPP 1031
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
Identities = 162/456 (35%), Positives = 240/456 (52%)
Query: 30 NSDGEALLSFRTAVVSSD---GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSG 86
N++G+AL + ++ S D L W PC W V C+ +V + L N KLSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 87 PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXX 146
+ +LG+L L++L L+SNN GEIP ELG+ EL L L +N +SG IP
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 147 XXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206
IP +L +Q L ++SNN L G IP +G + F+ SF N
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN----- 203
Query: 207 KQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFL 266
++T D S SP GG+ + I+ GA LL A+ F
Sbjct: 204 ---SLT---DLPEPPPTSTSPTPPPPSGGQMTAA---IAGGVAAGAALLFAVPAI--AFA 252
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK 325
+ K + DV + G L ++ ++++ + + +++G GGFG VYK
Sbjct: 253 WWLRRKPQDHFF--DVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYK 310
Query: 326 LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384
+ DGN+ A+KR+ ++ +G + F+ E+E++ HR L+ LRG+C +PT +LL+Y +
Sbjct: 311 GRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 370
Query: 385 LPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
+ GS+ L ER E LDW R +I +G+A+GLAYLH C +IIHRD+K++NILLD
Sbjct: 371 MANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLD 430
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
EA V DFGLAKL+ +SH+TT V GT G++AP
Sbjct: 431 EEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAP 466
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 8.3e-65, P = 8.3e-65
Identities = 162/408 (39%), Positives = 219/408 (53%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L+ + SG I LG L+ L LNL N+ G +P+E GN +Q + + N+L+G
Sbjct: 436 TLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGV 495
Query: 136 IPXXXXXXXXXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
IP IP L L N+S N L G IP T+FS
Sbjct: 496 IPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSP 555
Query: 196 SSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALL- 254
+SFFGN LCG + C G S SQ + + A + +L
Sbjct: 556 ASFFGNPFLCGNWVGSIC----GPSLPKSQ-----------------VFTRVAVICMVLG 594
Query: 255 LVALMCFWGCFLYK-KLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDD 312
+ L+C +YK K K KG ++ G +V+ H D+ ++ DI++ E LD+
Sbjct: 595 FITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEK 654
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+IIG G TVYK A+KRI ++ F R FE ELE +GSI+HR +V+L GY
Sbjct: 655 YIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNF-REFETELETIGSIRHRNIVSLHGY 713
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
SP LL YD++ GSL + LH + +LDW+ RL I +GAA+GLAYLHHDC+PRII
Sbjct: 714 ALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRII 773
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIKSSNILLDGN EAR+SDFG+AK + +++ +T V GT GY+ P
Sbjct: 774 HRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVLGTIGYIDP 821
|
|
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 8.3e-65, Sum P(2) = 8.3e-65
Identities = 149/395 (37%), Positives = 204/395 (51%)
Query: 106 NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLG 165
NN G IP E+G L L L N SGSIP IP SL
Sbjct: 591 NNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLT 650
Query: 166 KLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQ 225
L L FNV+NN L G IP+ F +++F GN LCG + +C + + STT
Sbjct: 651 GLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPLLCGGVLLTSC-DPTQHSTTKMG 709
Query: 226 SPNSAQNQGGKKNSGRLL-ISASATVGALLLVALMCFWGCFLYKKL---GKNE------- 274
GK N +L + G L++ L+ L K+ G +E
Sbjct: 710 K--------GKVNRTLVLGLVLGLFFGVSLILVLLAL--LVLSKRRVNPGDSENAELEIN 759
Query: 275 SKGLARDVGGGA----SIVMFHGDLPYSSKDI-----IKKLETLDDDHIIGSGGFGTVYK 325
S G +V G+ S+V+ G+ Y KD+ +K + +IIG GGFG VYK
Sbjct: 760 SNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQANIIGCGGFGLVYK 819
Query: 326 LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385
+D+G A+K++ ++ F+ E+E+L KH LV L+GYC ++++LIY F+
Sbjct: 820 ATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFM 879
Query: 386 PGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
GSLD LHE E QLDW RLNI+ GA+ GLAY+H C P I+HRDIKSSNILLDG
Sbjct: 880 ENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDG 939
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
N +A V+DFGL++L+ +H+TT + GT GY+ P
Sbjct: 940 NFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPP 974
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGF4 | FEI1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7780 | 0.9276 | 0.7597 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00007621001 | SubName- Full=Chromosome chr2 scaffold_196, whole genome shotgun sequence; (598 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 484 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 67/166 (40%), Positives = 91/166 (54%), Gaps = 7/166 (4%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDR-FFERELEILGSIKHRYLVNLRGYC 372
+G GGFGTVY G A+K I K + RE+EIL + H +V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
L+ ++ GGSL + L E +L D L I++ +GL YLH S IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 433 IKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+K NILLD N + +++DFGL+KLL ++S + TIV GT Y+AP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 116/380 (30%), Positives = 177/380 (46%), Gaps = 33/380 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
KR+ L L+ ++ SG + LG L +L L L N GEIP EL +C +L L L N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
LSG IP+ + L LD+S N LS IP +LG ++ L+ N+S+N L G++PS G
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 192 KFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG 251
+ S+ GN LC GG TT P +K T+G
Sbjct: 595 AINASAVAGNIDLC------------GGDTTSGLPPCKRV----RKTPSWWFYITC-TLG 637
Query: 252 ALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS--SKDIIKKLETL 309
A L++AL+ F F++ + N + G + F + S DI L +L
Sbjct: 638 AFLVLALVAF--GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSL 692
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
++++I G G YK + F +K I+ +N E+ +G ++H +V L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKL 748
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C S LI++++ G +L E L L W+ R I +G AK L +LH CSP +
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 429 IHRDIKSSNILLDGNLEARV 448
+ ++ I++DG E +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 63/168 (37%), Positives = 83/168 (49%), Gaps = 10/168 (5%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+GSG FGTVYK A G + A+K + K D+ RE+ IL + H +V L
Sbjct: 6 KLGSGSFGTVYK-AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+ ++ GG L + L R L D I + +GL YLH S II
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRD+K NILLD N +++DFGLAK L + S T GT Y+AP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 59/167 (35%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG VY A D G + A+K I K + RE++IL +KH +V L
Sbjct: 6 KLGEGSFGKVYL-ARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L+ ++ GG L + L +R + +AR + L YLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-FYLRQILSALEYLH---SKGIVH 120
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K NILLD + +++DFGLA+ L+ E +TT V GT Y+AP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHR 363
+G G FG VYK L G V LK + + F RE I+ + H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+V L G C ++ +++ GG L L + +L L+ + A+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S IHRD+ + N L+ NL ++SDFGL++ L D++
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYL 365
+G G FG VYK L + L E F RE I+ + H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDC 424
V L G C +++ +++PGG L + L + + L L+ + A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S IHRD+ + N L+ NL ++SDFGL++ L D++
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGFD----RFFERELEILGSIKH 362
+G G FG VYK L D A+K L EG F E I+ + H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREEFLEEASIMKKLSH 60
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L G C ++ +++PGG L + L + E+L L + + AKG+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S +HRD+ + N L+ NL ++SDFGL++ + +++
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 4e-29
Identities = 61/178 (34%), Positives = 91/178 (51%), Gaps = 24/178 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
++G G FG+VY LA+D G + A+K ++ +E ERE+ IL S++H +V
Sbjct: 6 ELLGRGSFGSVY-LALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 369 RGYCNSPTSK-LLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAA------KGLAYL 420
G L I+ +++ GGSL L + +L + +GLAYL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-------KLPEPVIRKYTRQILEGLAYL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHITTIVAGTFGYLAP 477
H S I+HRDIK +NIL+D + +++DFG AK L D E T V GT ++AP
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 58/167 (34%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG-- 370
IG GGFG VYK A G A+K I ++ E++IL KH +V G
Sbjct: 8 IGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ +F GGSL + L ++ L + KGL YLH S IIH
Sbjct: 67 LKKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RDIK++NILL + E ++ DFGL+ L D ++ T + GT ++AP
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 314 IIGSGGFGTVYK--LAMDDGNVF--ALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG VYK L DG A+K + + +E + F +E ++ + H +V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--------LDWDARLNIIMGAAKGLAYL 420
G C L+ +++ GG L + L + L L+ + AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
S + +HRD+ + N L+ +L ++SDFGL++ + D++ +
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG VY + DG ++ LK ID ++E E++IL + H ++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ---------LDWDARLNIIMGAAKGLAYLHH 422
++ ++ GG L + + ++ ++ LDW +L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH- 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S +I+HRDIK NI L N ++ DFG++K+L T+V GT YL+P
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 53/152 (34%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V D N + LN E FERE+EIL ++ H +V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 369 RGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G C P + LI ++LP GSL + L +Q++ L KG+ YL S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
R IHRD+ + NIL++ ++SDFGLAK+L
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 33/171 (19%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNL 368
IG G +G VYK A + G + ALK+I NE GF RE+++L ++H +V L
Sbjct: 5 AQIGEGTYGQVYK-ARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 369 RGYCNSPTSK--LLIYDFLP---GGSLDEALHERSE--------QLDWDARLNIIMGAAK 415
+ S ++++++ G LD + +E QL +
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------LE 111
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
GL YLH + I+HRDIK SNIL++ + +++DFGLA+ S T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 57/168 (33%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + D +FA+K ++K + +G R E IL + H +LVNL
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ L+ D L GG L L ++ + + + I L YLH S II
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH---SKGII 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK NILLD ++DF +A + + +TT +GT GY+AP
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 9e-24
Identities = 61/173 (35%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK----LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V L D G ++A+K + K + + E IL I H ++V L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKL 58
Query: 369 RGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDC 424
Y KL L+ ++ PGG L L + + AR I++ L YLH
Sbjct: 59 H-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH--- 110
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S II+RD+K NILLD + +++DFGLAK L E S T GT YLAP
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 60/188 (31%), Positives = 101/188 (53%), Gaps = 6/188 (3%)
Query: 13 LLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNK 72
L +L + +N S + E LLSF++++ +L+ W D C W+G+ C+ +
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSA-DVCLWQGITCNNSS 69
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNY 131
RV+++ L+ +SG IS+ + +L ++ +NL +N G IP ++ + L+ L+L +N
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
+GSIP G++ NL LD+S+N LS IP +G L ++ N LVG IP LT
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP--NSLT 185
Query: 192 KFSESSFF 199
+ F
Sbjct: 186 NLTSLEFL 193
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 52/109 (47%), Positives = 70/109 (64%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L +++L G I +LG++ LK++ L NN GEIP E+G T L L L N L+G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
PS LGNL NL L + N LS IPPS+ LQ+LI+ ++S+N L G IP
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 20/174 (11%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
++G G G VYK G ++ALK+I +E F + REL+ L S + Y+V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAA----KGLAYLHHD 423
++ +++ GGSL + L + E ++ A KGL YLH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP--------VLAYIARQILKGLDYLHTK 118
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IIHRDIK SN+L++ E +++DFG++K+LE+ T V GT Y++P
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 58/170 (34%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V+K+ D V+A+K+ID K+N E +L + Y++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR---Y 64
Query: 372 CNSPTSKLLIY---DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
S K + ++ G L + L +R L D + GLA+LH S +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRDIKS N+ LD ++ D G+AKLL D + TIV GT YL+P
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.8 bits (234), Expect = 3e-21
Identities = 66/175 (37%), Positives = 88/175 (50%), Gaps = 17/175 (9%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKH-RYLVNLRG 370
+G G FG VY LA D V ALK + K F RE++IL S+ H +V L
Sbjct: 8 LGEGSFGEVY-LARDRKLV-ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ S L+ +++ GGSL++ L + + L L I+ L YLH S I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 429 IHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESH-----ITTIVAGTFGYLAP 477
IHRDIK NILLD + ++ DFGLAKLL D S + + GT GY+AP
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 14/170 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVNL 368
+GSG FG+VY+ L +DDG+ FA+K + ++G + E+E+ +L ++H +V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 369 RGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G L I+ + +PGGSL L ++ GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK +NIL+D N +++DFG+AK + E G+ ++AP
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 56/172 (32%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G +G VYK A D G + ALK R+D EG RE+ +L +KH +V L
Sbjct: 6 KLGEGTYGVVYK-ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----KGLAYLHHDCS 425
++ L++++ L + L +R L N+I +GLAY H S
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKSIMYQLLRGLAYCH---S 116
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RI+HRD+K NIL++ + +++DFGLA+ T V T Y AP
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 53/138 (38%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 59 DPC-----NWKGVKC--DKNKR---VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF 108
DPC W G C D K + L L N L G I D+ KL L+ +NL N+
Sbjct: 395 DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI 454
Query: 109 YGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLG-KL 167
G IP LG+ T L+ L L N +GSIP LG L++L L+++ NSLS +P +LG +L
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
Query: 168 QRLITFNVSNNFLVGAIP 185
+FN ++N + IP
Sbjct: 515 LHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 7/172 (4%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
E D +G G +G+VYK + + G V A+K + + E +E+ IL Y+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEI-IKEISILKQCDSPYI 60
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
V G T ++ ++ GS+ + + ++ L + I+ KGL YLH S
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ IHRDIK+ NILL+ +A+++DFG++ L D + T V GT ++AP
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 55/155 (35%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 315 IGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG+V D G V A+K++ R FERE+EIL S++H +V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 370 GYCNSP--TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C S + L+ ++LP GSL + L + E+LD L KG+ YL S R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKR 128
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEE 461
+HRD+ + NIL++ ++ DFGL K+L +D+E
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDG-NVFALKRIDKLNEGFDRF----FERELE 355
I K L+ ++GSG FGTVYK + + +G V I L E E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ S+ H ++V L G C S LI +P G L + + + + LN + AK
Sbjct: 62 VMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
G++YL R++HRD+ + N+L+ +++DFGLAKLL+ +E
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 59/166 (35%), Positives = 91/166 (54%), Gaps = 11/166 (6%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALK-RIDKLNEGF----DRFFERELE 355
I+K+ E L ++GSG FGTVYK + + +G + I LNE + F E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
I+ S+ H +LV L G C SPT +L + +P G L + +HE + + LN + AK
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
G+ YL R++HRD+ + N+L+ +++DFGLA+LLE +E
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 52/167 (31%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+IG G FG VYK L ++ G+ A+K+I K+ E + +E+++L ++KH +V G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ S +I ++ GSL + + + + +GLAYLH +IH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLH---EQGVIH 122
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RDIK++NIL + +++DFG+A L D ++V GT ++AP
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+ IG G FG VY + +D G + A+K RI + + E+++L +KH LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 370 GYCNSPTSKLLIY-DFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAK----GLAYLHHD 423
G K+ I+ ++ GG+L+E L R ++I GLAYLH
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHGRILDE------HVIRVYTLQLLEGLAYLH-- 116
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG---YLAP 477
S I+HRDIK +NI LD N ++ DFG A L++ + + V G Y+AP
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 10/174 (5%)
Query: 306 LETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHR 363
LE L + +G+G G V K L G + A+K I ++NE + REL+IL
Sbjct: 3 LEYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
Y+V G + + +++ GGSLD+ L E ++ I + KGL YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IIHRD+K SNIL++ + ++ DFG++ L + + GT Y+AP
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G G V+K A D G ALK++ +L G RE++ L + +H Y+V L
Sbjct: 8 IGEGAHGIVFK-AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ +L+ +++P L E L + L + + + M KG+AY+H + I+
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM-LLKGVAYMH---ANGIM 121
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRD+K +N+L+ + +++DFGLA+L +EE + + T Y AP
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 50/116 (43%), Positives = 65/116 (56%), Gaps = 2/116 (1%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
K+ + I L N LSG I ++G L L L+L NN G IPS LGN LQ L L
Sbjct: 212 KSLKWIYLGYNN--LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
N LSG IP + +L L++LD+S NSLS IP + +LQ L ++ +N G IP
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 312 DHIIGSGGFGTVY----KLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLV 366
+ +IG G FG V KL A+K + ++ F E I+G H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L G ++I +++ GSLD+ L E + + ++ G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+HRD+ + NIL++ NL +VSDFGL++ LED E+ TT
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 48/111 (43%), Positives = 64/111 (57%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L+N+ LSG I D+G LK L+L N G+IP+ L N T L+ L+L SN L G
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
IP ELG + +L + + N+LS IP +G L L ++ N L G IPS
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 51/119 (42%), Positives = 71/119 (59%), Gaps = 6/119 (5%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+++I+L L+++ LSG I + +L L+ L+L SNNF G+IP L + LQ L L SN
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL---GKLQRLITFNVSNNFLVGAIPSD 187
SG IP LG +NL LD+S+N+L+ IP L G L +LI F +N L G IP
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF---SNSLEGEIPKS 399
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 315 IGSGGFGTVYKLAMDDGNVF-ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL-RGYC 372
+G G FG VYK + +F A K I +E F E++IL KH +V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 373 NSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
KL I +F GG+LD + E L + + L +LH S ++IHR
Sbjct: 73 YEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 432 DIKSSNILLDGNLEARVSDFGL-AKLLEDEESHITTIVAGTFGYLAP 477
D+K+ NILL + + +++DFG+ AK + T I GT ++AP
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 8/166 (4%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK G + A+K+I +EG + RE+++L + H ++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
L+++F+ L + + +R L + + +GLA+ H S I+HR
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K N+L++ +++DFGLA+ T V T Y AP
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAP 167
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 17/177 (9%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FGTV K+ DG + K ID + E + E+ IL +KH +V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---R 63
Query: 371 YC----NSPTSKLLIY-DFLPGGSLDEAL---HERSEQLDWDARLNIIMGAAKGLAYLHH 422
Y + L I ++ GG L + + + + ++ + I+ L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 423 --DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D ++HRD+K +NI LD N ++ DFGLAK+L + S T V GT Y++P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 25/196 (12%)
Query: 294 DLPYSSKDIIKK---LETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR 348
+L + KDI+ + E + IG G G VYK A D G A+K++ + +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYK-ATDRATGKEVAIKKMRLRKQNKEL 61
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLD 402
E+ I+ KH +V+ S L ++ +++ GGSL + + + +++
Sbjct: 62 II-NEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN 114
Query: 403 WDARLNIIMGAA-KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ ++ + +GL YLH S +IHRDIKS NILL + +++DFG A L E+
Sbjct: 115 -EPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170
Query: 462 SHITTIVAGTFGYLAP 477
S ++V GT ++AP
Sbjct: 171 SKRNSVV-GTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 9/158 (5%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIK-HRYLVNL 368
IIG G F TV + +A+K +DK + E ++ + E E+L + H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ + ++ P G L + + + LD L YLH S I
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
IHRD+K NILLD ++ +++DFG AK+L+ S +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 42/146 (28%), Positives = 80/146 (54%), Gaps = 4/146 (2%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+GSG FG V++ + A+K + + + F++E++ L ++H++L++L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+I + + GSL L Q L + +++ A+G+AYL IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 434 KSSNILLDGNLEARVSDFGLAKLLED 459
+ NIL+ +L +V+DFGLA+L+++
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 52/167 (31%), Positives = 74/167 (44%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGFG V + FALK + K + G E EIL H ++V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ ++ GG L L +R ++ AR I YLH+ II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAFEYLHNR---GIIY 116
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K N+LLD N ++ DFG AK L+ + T GT Y+AP
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF--DRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG V+ + A+K I EG + F E +++ + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+ L+++F+ G L + L + + + L + + +G+AYL +IHRD
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ + N L+ N +VSDFG+ + + D++
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVN 367
++G G FG VY +D G A+K++ + + E E+++L +++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC 424
G + + +++PGGS+ + L +E + I+ +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH--- 121
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAP 477
S I+HRDIK +NIL D ++ DFG +K L+ S T + V GT +++P
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF----ALKRIDKLN--EGFDRFFERELE 355
I K L ++GSG FGTV+K + + +G+ A+K I + + F + L
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA 414
+ GS+ H Y+V L G C P + L L+ P GSL + + + + LD LN + A
Sbjct: 63 M-GSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
KG+ YL ++HR++ + NILL + +++DFG+A LL
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 57/168 (33%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNLRG- 370
IGSG +G VYK A D G + A+K I KL G D ++E+ +L +H +V G
Sbjct: 11 IGSGTYGDVYK-ARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 371 YCNSPTSKLLI-YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
Y KL I ++ GGSL + L + KGLAYLH I
Sbjct: 69 YLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKI 123
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK +NILL + + +++DFG++ L + + + GT ++AP
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 61/178 (34%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G G+V K + + G +FALK I N + RELEI S K Y+V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------IIMGAAKGLAYLHHD 423
S +S + ++ GGSLD + ++ R+ I KGL+YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLH-- 122
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG----YLAP 477
S +IIHRDIK SNILL + ++ DFG++ L +AGTF Y+AP
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSFYMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 59/176 (33%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIK 361
K L L+ + IGSG GTVYK + G ++ALK I + R RE+EIL +
Sbjct: 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN 130
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H +V + ++ +F+ GGSL E H EQ D I+ G+AYLH
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLADVARQIL----SGIAYLH 185
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRDIK SN+L++ +++DFG++++L + V GT Y++P
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 13/168 (7%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + G + A K I+ +E + E+EIL + H Y+V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ +F PGG++D + E L I + L YLH S +IIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136
Query: 434 KSSNILLDGNLEARVSDFGLA----KLLEDEESHITTIVAGTFGYLAP 477
K+ N+LL + + +++DFG++ K L+ +S I GT ++AP
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDG-NVFALKRIDKLNEGFDRFFEREL----E 355
I+K+ E ++GSG FGTVYK L + +G V I +L E +E+
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ S+ + ++ L G C + T +L I +P G L + + E + + LN + AK
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
G+ YL R++HRD+ + N+L+ +++DFGLAKLL +E
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 312 DHIIGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHR 363
+ +IG+G FG V KL A+K L G+ R F E I+G H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIK---TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+++L G ++I +F+ G+LD L + Q + ++ G A G+ YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+HRD+ + NIL++ NL +VSDFGL++ LED+ S T
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRI---------DKLNEGFDRFFERELEILGSIKH 362
+IGSG FG+VY L M+ G + A+K++ RE+ +L ++H
Sbjct: 7 LIGSGSFGSVY-LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 363 RYLVNLRGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
+V G + L I+ +++PGGS+ AL + N + KGL YLH
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
+ IIHRDIK +NIL+D ++SDFG++K LE
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLVNL 368
+IG+G FG V++ + G I L G+ F E I+G H ++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G ++I +++ G+LD+ L + + + ++ G A G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
+HRD+ + NIL++ NLE +VSDFGL+++LED+ T G
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 44/111 (39%), Positives = 58/111 (52%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L ++ +G I L L +L+ L L SN F GEIP LG L L L +N L+G I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P L + NL L + SNSL IP SLG + L + +N G +PS+
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGSIK 361
K E L ++G G +G V K G + A+K + + +E + RE+++L ++
Sbjct: 2 KYEVL---GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H +VNL+ L+++++ L+ L L DA + I + +AY H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
S IIHRDIK NIL+ + ++ DFG A+ L S +T VA T Y AP
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 315 IGSGGFGTVYKLAMDD--GNVF--ALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V + G V A+K + DKL++ D F +E I+ S+ H L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-------WDARLNIIMGAAKGLAYLH 421
G + + + + P GSL + L R + L D + I A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQI----ANGMRYLE 114
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
S R IHRD+ + NILL + + ++ DFGL + L E H
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 315 IGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRYL 365
+G GGFG V + G ++A K++DK R +R E +IL + R++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK-----KRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLHH 422
V+L + L+ + GG L ++ E +AR I AA+ GL +LH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR--AIFYAAQIICGLEHLHQ 113
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RI++RD+K N+LLD + R+SD GLA L+ + AGT GY+AP
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 61/177 (34%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFER---ELEILGSIKHRYLVNLR 369
I G +G V+ LA G+++A+K I K + ++ E +IL + Y+V L
Sbjct: 1 ISKGAYGRVF-LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y L L+ ++LPGG L L LD D I L YLH S I
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKL--------LEDEESHITTIVAGTFGYLAP 477
IHRD+K NIL+D N +++DFGL+K+ L D+E IV GT Y+AP
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 8e-15
Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 40/181 (22%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK------------LNEGFDRFFERELEILGSI 360
+G+G FG V L G +ALK + K LNE IL SI
Sbjct: 9 LGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE---------KRILQSI 58
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKG 416
+H +LVNL G ++ L+ +++PGG L + +S + AR +++
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH I++RD+K N+LLD + +++DFG AK ++ T+ GT YLA
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLC-GTPEYLA 166
Query: 477 P 477
P
Sbjct: 167 P 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 312 DHIIGSGGFGTVY--KLAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHRYL 365
+ +IG+G FG V +L + + I L G+ R F E I+G H +
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVA-IKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
++L G +++ +++ GSLD L + Q + ++ G A G+ YL D
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS-DMG 126
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
+HRD+ + NIL++ NL +VSDFGL+++LED+ T G
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 51/178 (28%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---------RELEILGSIK 361
IGSG +G V A+D G A+K+I F+ RE+++L ++
Sbjct: 6 KPIGSGAYGVVC-SAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLR 57
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE-------------ALHE--RSEQLDWDAR 406
H ++ L D L S ++ LH+ +S Q D
Sbjct: 58 HENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH 104
Query: 407 LNIIM-GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ + +GL YLH S +IHRD+K SNIL++ N + ++ DFGLA+ ++ +E
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER----------ELEILGSIK 361
+IG G +G VY LA+ G + A+K+++ R R E+E L +
Sbjct: 8 LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQLDWDARLNIIMGAAKGLAY 419
H +V G+ + + +++PGGS+ L + R E+ ++ +GLAY
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLAY 123
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
LH S I+HRD+K+ N+L+D + ++SDFG++K +D ++ + G+ ++AP
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 59/168 (35%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFE--RELEILGSIKHRYLVNLRG 370
IG G FG VYK A+D V A+K ID L E D + +E++ L + Y+ G
Sbjct: 9 IGKGSFGEVYK-AIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 371 YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
SKL +I ++ GGS + L + +LD I+ GL YLH + I
Sbjct: 67 -SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK++NILL + +++DFG++ L S T V GT ++AP
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 26/180 (14%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLN--EGFDRFFERELEILGSIK---HRYLVN 367
IG G +GTVYK ++ G ALK++ EG RE+ +L ++ H +V
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 368 LRGYCNSPTSK-----LLIYDFLPGGSLDEALH---ERSEQ--LDWDARLNIIMGAAKGL 417
L C+ P + L+++ + D+ L + + L + +++ +G+
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+LH S RI+HRD+K NIL+ + + +++DFGLA++ E +T++V T Y AP
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVV-TLWYRAP 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +GTV+K + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----KGLAYLHHDCSPR 427
+S L++++ D+ L + + + D I+ KGLA+ H S
Sbjct: 68 LHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAK 455
++HRD+K N+L++ N E +++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 55/193 (28%), Positives = 83/193 (43%), Gaps = 39/193 (20%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGS 359
+ + E L + IG G +G VY+ G + ALK R+D +G RE+ +L +
Sbjct: 6 VTEFEKL---NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 360 IKHRYLVNLR---------------GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD 404
++H +V L+ YC + LL D +P + + QL
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKCLMLQL--- 117
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
+GL YLH + IIHRD+K SN+LL +++DFGLA+ +
Sbjct: 118 ---------LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 465 TTIVAGTFGYLAP 477
T V T Y AP
Sbjct: 166 TPKVV-TLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 50/136 (36%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
R+ L L ++K SG I +LGK + L L+L +NN GEIP L + L L L SN L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI-------P 185
G IP LG +L + + NS S +P KL + ++SNN L G I P
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
Query: 186 SDGVLTKFSESSFFGN 201
S +L+ + + FFG
Sbjct: 453 SLQMLS-LARNKFFGG 467
|
Length = 968 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 54/168 (32%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGFG V + + + G ++A K++DK + ++ E EIL + ++VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S T L+ + GG L ++ E+ L+ + ++ G+ +LH S I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+RD+K N+LLD R+SD GLA L+D ++ T AGT GY+AP
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+SK++ IG G FG V L G A+K + K + + F E ++
Sbjct: 4 NSKELKLG-------ATIGKGEFGDVM-LGDYRGQKVAVKCL-KDDSTAAQAFLAEASVM 54
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKG 416
+++H LV L G ++ +++ GSL + L R + +L + +G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ YL +HRD+ + N+L+ +L A+VSDFGLAK
Sbjct: 115 MEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 51/175 (29%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI-----DKLN-EGFDRFFERELEILGSIKHRYLVN 367
++G G +GTVY + G + A+K++ + L E + E+++L S+KH +V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C + + +F+PGGS+ L R L G+AYLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLL-----EDEESHITTIVAGTFGYLAP 477
++HRDIK +N++L N ++ DFG A+ L S++ + GT ++AP
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 64/173 (36%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG V LA DG +A+K I K E ER + +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 367 NLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L Y KL + D++ GG L L + AR A L YLH S
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
II+RD+K NILLD ++DFGL K E E S T+ GT YLAP
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 39/191 (20%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFER-----E 353
++KKL G G +G+VYK+ + D +ALK +D +++ ER E
Sbjct: 4 VLKKL---------GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-----EREDAVNE 49
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-------EQLDWDAR 406
+ IL S+ H +++ + ++ ++ P G L +A+ +R EQ W
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--- 106
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
I + +GL LH +I+HRD+KS+NILL N ++ D G++K+L + ++
Sbjct: 107 -RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAK 159
Query: 467 IVAGTFGYLAP 477
GT Y+AP
Sbjct: 160 TQIGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRFFEREL----E 355
I+K+ E L ++GSG FGTVYK D NV I L E +E+
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ + Y+ L G C + T +L + +P G L + + E +++ LN + AK
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
G++YL R++HRD+ + N+L+ +++DFGLA+LL+ +E+
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 41/111 (36%), Positives = 58/111 (52%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L + L+GPI + LG L L++L L+ N G IP + + +L L L N LSG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P + L NL L + SN+ + IP +L L RL + +N G IP +
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 64/184 (34%), Positives = 82/184 (44%), Gaps = 31/184 (16%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
IG G +G VYK A D G + ALK R+D EGF RE++IL + HR +VNL
Sbjct: 14 QIGEGTYGQVYK-ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL- 71
Query: 370 GYCNSPTSKLLIYDFLPG----------------GSLDEALHERSEQLDWDARLNIIMGA 413
T K DF G L+ L SE D + +
Sbjct: 72 --KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE----DHIKSFMKQL 125
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
+GL Y H +HRDIK SNILL+ + +++DFGLA+L EES T T
Sbjct: 126 LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 474 YLAP 477
Y P
Sbjct: 183 YRPP 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNE--GFDRFFERELEILGSIK 361
L D I +G G FG VYK + G V ALK+I NE GF RE++IL +K
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 362 HRYLVNL--RGYCNSPTS---KLLIYDFLPGGSLDEA--LHERSEQLDWDARLNIIMGAA 414
H +V L S + +Y P D + L S +L ++
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460
+G+ YLH I+HRDIK++NIL+D +++DFGLA+ +
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG VYK + A+K R L R F +E EIL H +V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + +PGGSL L ++ +L L + + AA G+ YL IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHRD 118
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
+ + N L+ N ++SDFG+++ +EE I T+ G
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGL 154
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 21/165 (12%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTV----YKLAMDD-GNVFALKRIDKLNEGFDRF-FERE 353
K +KK+ L G G FG V Y A D G + A+K + + + +++E
Sbjct: 3 KRYLKKIRVL------GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKE 56
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
+ IL ++ H +V +G C+ K LI +++P GSL + L + L A+L +
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFA 113
Query: 412 GA-AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+G+AYLH S IHRD+ + N+LLD + ++ DFGLAK
Sbjct: 114 QQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 35/181 (19%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLV 366
+G G + VYK A D G + A+K+I KL E G + RE+++L +KH ++
Sbjct: 8 LGEGTYAVVYK-ARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----------KG 416
L ++ L+++F+ L++ + ++S I++ A +G
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKDKS----------IVLTPADIKSYMLMTLRG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH S I+HRD+K +N+L+ + +++DFGLA+ +T V T Y A
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 477 P 477
P
Sbjct: 171 P 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 27/184 (14%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSIK 361
++LE +IG G +G VY+ + G V ALK I+ D +RE+ +L ++
Sbjct: 4 QRLE------LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR 57
Query: 362 HRYLVNLRGYCNS---PTSKLLIYDFLPGGSL-----DEALHERSEQLDWDARLNIIMGA 413
N+ Y S +I ++ GGS+ + E+ + II
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREV 110
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
L Y+H +IHRDIK++NIL+ ++ DFG+A LL S +T V GT
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPY 166
Query: 474 YLAP 477
++AP
Sbjct: 167 WMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 57/166 (34%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRGY 371
IG G FG VYK + V A+K ID L E D ++E+ +L Y+ G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
T +I ++L GGS + L + L+ I+ KGL YLH S R IHR
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SERKIHR 125
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
DIK++N+LL + +++DFG+A L D + T V F ++AP
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 57/181 (31%), Positives = 87/181 (48%), Gaps = 29/181 (16%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
IGSG +G V A+D G A+K+I FD R REL+IL KH +
Sbjct: 12 NIGSGAYGVVCS-AIDTRSGKKVAIKKIPH---AFDVPTLAKRTL-RELKILRHFKHDNI 66
Query: 366 VNLRGYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA-KGLAYL 420
+ +R P + ++ D L L +H S+Q + + + +GL Y+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEESHITTIVAGTFGYLA 476
H S +IHRD+K SN+L++ + E R+ DFG+A+ L + + +T VA T Y A
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRA 179
Query: 477 P 477
P
Sbjct: 180 P 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G VY + + + A+KRID K D +E++ + H +V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+ +L GGSL + + + LD ++ KGL YLH S I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLE---DEESHITTIVAGTFGYLAP 477
HRDIK+ NILL + +++DFG++ L D + GT ++AP
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFER 352
++P S + +KL G+G FG V+ +G A+K + + F +
Sbjct: 2 EIPRESLKLERKL---------GAGQFGEVWM-GTWNGTTKVAVKTLKPGTMSPEAFLQ- 50
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--II 410
E +I+ ++H LV L C+ ++ +++ GSL + L + RL +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVD 107
Query: 411 MGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
M A A+G+AYL S IHRD+ + NIL+ NL +++DFGLA+L+ED+E
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G V A D G A+K KL+ F R + REL +L + H ++
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIK---KLSRPFQSAIHAKRTY-RELRLLKHMDHENVI 77
Query: 367 NLRGYCNSPTSKLLIYDF-----LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
L +S D L G L+ + + ++L D ++ +GL Y+H
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S IIHRD+K SNI ++ + E ++ DFGLA+ +DE +T VA T Y AP
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVA-TRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/173 (34%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG V LA DG+ +A+K I K E ER + +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG-AAKGLAYLHHDCS 425
L + + D++ GG L H + E+ + R A + YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAP 477
II+RD+K NILLD ++DFGL K +E EE+ T+ GT YLAP
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 315 IGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNL 368
+G G FG V D G A+K + + G ++E+EIL ++ H +V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 369 RGYCNSP--TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G C LI +FLP GSL E L +++ +L + KG+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+ +HRD+ + N+L++ + ++ DFGL K +E ++ + T
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLVN 367
+G G FG V+ ++ N L + L E FERE E+L + +H +V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEAL-----------HERSE--QLDWDARLNIIMGAA 414
G C +++++++ G L++ L S +L L I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
G+ YL S +HRD+ + N L+ +L ++ DFG+++
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 4/147 (2%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G FG V+K + D A+K + L + F E IL H +V L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + +PGG L ++ ++L + + AA G+AYL S IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLED 459
+ + N L+ N ++SDFG+++ +D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDD 145
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
IG G FG V+K +D+ V A+K ID L E D ++E+ +L Y+ G
Sbjct: 12 IGKGSFGEVFK-GIDNRTQQVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
T +I ++L GGS + L R+ D ++ KGL YLH S + IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLH---SEKKIH 124
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RDIK++N+LL + +++DFG+A L D + T V F ++AP
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLN--EGFDRFFERE 353
+ D + K E L IG G FG V+K + ALK++ N EGF RE
Sbjct: 5 FPFCDEVSKYEKLA---KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK--------LLIYDFLPGGSLDEALHERSEQLDWDA 405
++IL +KH +VNL C + + L+++F + L +
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVKF 116
Query: 406 RLNIIMGAAK----GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
L+ I K GL Y+H +I+HRD+K++NIL+ + +++DFGLA+
Sbjct: 117 TLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
H +G G +G VY+ + A+K + + + F +E ++ IKH LV L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLVQLLGV 70
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C +I +F+ G+L + L E + Q ++ L + + + YL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDE 460
RD+ + N L+ N +V+DFGL++L+ +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 11/170 (6%)
Query: 314 IIGSGGFGTVY----KLAMDDGNVFALKRIDKLN-EGFDRFFER-ELEILGSIKHRYLVN 367
++G G FG V+ D G ++A+K + K + DR + E +IL + H ++V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L + LI DFL GG L L + + D + + A L +LH S
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH---SLG 118
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
II+RD+K NILLD +++DFGL+K D E GT Y+AP
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 61/182 (33%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRF--FERELE 355
+++ KLE IG G FG V+K +D+ V A+K ID L E D ++E+
Sbjct: 3 EELFTKLEK------IGKGSFGEVFK-GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEIT 54
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
+L Y+ G T +I ++L GGS + L LD I+ K
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILK 112
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GL YLH S + IHRDIK++N+LL + E +++DFG+A L D + T V F ++
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WM 168
Query: 476 AP 477
AP
Sbjct: 169 AP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 34/178 (19%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLVN 367
+G+G FG V+ L D + +ALK + +L + ++ E +L + H +++
Sbjct: 9 VGTGTFGRVH-LVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIR 65
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMG---AAK---GLAY 419
L + + L + +++PGG L L R + G A++ L Y
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEY 116
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH S I++RD+K NILLD +++DFG AK L D T + GT YLAP
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/173 (36%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEIL-GSIKHRYLVN 367
+IG G FG V LA DG +A+K + K LN + E +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNI-IMGAAKGLAYLHHDCS 425
L Y T KL + DF+ GG L H + E+ + R A L YLH S
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
I++RD+K NILLD ++DFGL K E +S TT GT YLAP
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 314 IIGSGGFGTVYKLAM----DDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYL 365
++G GG+G V+++ D G +FA+K + K N+ + E IL ++KH ++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 366 VNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
V+L Y KL LI ++L GG L L ++ A I + L +LH
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLH 117
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
II+RD+K NILLD +++DFGL K E +T GT Y+AP
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 312 DHIIGSGGFGTVYKLAMDDG--NVFALKRIDKLNEGFDRFFERELEILGSI--------- 360
+H+ GSG FG VYK+ + N+ ALK I+ N F + + +G I
Sbjct: 6 EHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 361 --KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE---ALHERSEQLDWDARLNIIMGAAK 415
+H +V ++ D + G L E +L E+ ++ + NI +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
L YLH + RI+HRD+ +NI+L + + ++DFGLAK + ES +T+ V GT Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTS-VVGTILYS 180
Query: 476 AP 477
P
Sbjct: 181 CP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 51/127 (40%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L +KLSGPI + L +L L+L N+ GEIP + L+ L L SN +G I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTK 192
P L +L L L + SN S IP +LGK L ++S N L G IP S G L K
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 193 ---FSES 196
FS S
Sbjct: 385 LILFSNS 391
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 315 IGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G+G FG V K G A+K I + + D F E E +++ + H LV L G C
Sbjct: 12 LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVCT 69
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ +++ G L L E ++ L + +G+AYL S + IHRD+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ N L+D +VSDFGL++ + D+E
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 5/167 (2%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER---ELEILGSIKHRYLVNLRG 370
+G GGFG V M G ++A K+++K + +E E IL + R++V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ T L+ + GG L ++ E+ A+ ++ L H RII+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K N+LLD + R+SD GLA L+D +S T AGT G++AP
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 51/176 (28%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 315 IGSGGFGTV----YKLAMDDGNVFALKRIDKLNEGFDR-FFERELEILGSIKHRYLVNLR 369
+GSG FG V YK+ +V A+K + NE R RE EI+ + + Y+V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C + + +L+ + GG L++ L + +++ + ++ + G+ YL +
Sbjct: 62 GVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPGKDCTN 483
HRD+ + N+LL A++SDFGL+K L ++S+ AG + + AP +C N
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP--ECIN 171
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 32/180 (17%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL--RG 370
IIG GGFG VY D G ++A+K +DK R ++ E L ++ R +++L G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNERIMLSLVSTG 54
Query: 371 YC----------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGL 417
C ++P I D + GG L L + + + R II+G
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----- 109
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+AP
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 32/180 (17%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL--RG 370
IIG GGFG VY D G ++A+K +DK R ++ E L ++ R +++L G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNERIMLSLVSTG 54
Query: 371 YC----------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGL 417
C ++P I D + GG L L + + + R II+G
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----- 109
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+AP
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 315 IGSGGFGTVYK--LAMDDGNVF--ALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG+V K M G A+K + + + G F RE ++ + H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C +L+ + P G L + L +R E D + A G+AYL S
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLE---SKHF 116
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLL 457
+HRD+ + N+LL +A++SDFG+++ L
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+IG G FG V+ L D G V+A+K + K + E +IL ++V L
Sbjct: 8 VIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 369 RGYCN-SPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARLNII-MGAAKGLAYLHHDC 424
Y + L L+ +++PGG L L R + + AR I + A L +H
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARFYIAELVLA--LDSVH--- 118
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
IHRDIK NIL+D + +++DFGL K
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 50/173 (28%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G +G VYK DG +A+K+ + G + RE+ +L +KH +V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 369 RGYCNSPTSKL--LIYDF-------------------LPGGSLDEALHERSEQLDWDARL 407
K L++D+ +P + L Q+ L
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QI-----L 118
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLEARV--SDFGLAKL 456
N G+ YLH S ++HRD+K +NIL+ +G V D GLA+L
Sbjct: 119 N-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 29/166 (17%)
Query: 315 IGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VYK A+K + + E + F +E E++ ++H +V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMG 412
L G C +++++L G L E L S LD L+I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 413 AAKGLAYL--HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
A G+ YL HH +HRD+ + N L+ L ++SDFGL++
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 315 IGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNLRG 370
+GSG FG V L G + A+K I EG D F E E +++ + H LV L G
Sbjct: 12 LGSGQFGVV-HLGKWRGKIDVAIKMI---REGAMSEDDFIE-EAKVMMKLSHPNLVQLYG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C ++ +++ G L L ER +L + L++ + + YL + IH
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
RD+ + N L+ + +VSDFGLA+ + D++
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 16/172 (9%)
Query: 314 IIGSGGFG--TVYKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG T+Y+ DD V K ++ +L+E R E+ IL ++H N+
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDALNEIVILSLLQHP---NII 62
Query: 370 GYCNS---PTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNIIMGAAKGLAYLHHDCS 425
Y N + L+ ++ GG+L + + + QL + + L + ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRDIK+ NI L ++ DFG++K+L E S T+V GT Y++P
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 18/150 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A D G + ALK+I + +EG RE+ +L + H +V L
Sbjct: 7 IGEGTYGVVYK-ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPR 427
+S L+++FL LD + + S D L + + +G+AY H S R
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHR 119
Query: 428 IIHRDIKSSNILLD--GNLEARVSDFGLAK 455
++HRD+K N+L+D G L +++DFGLA+
Sbjct: 120 VLHRDLKPQNLLIDREGAL--KLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
++ L IG G FG V L GN A+K I N+ + F E ++ ++H
Sbjct: 4 NMKELKLLQTIGKGEFGDVM-LGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSN 60
Query: 365 LVNLRGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHH 422
LV L G L I +++ GSL + L R L D L + + + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ +HRD+ + N+L+ + A+VSDFGL K
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G G FG V+ + A+K + + F + E +++ ++H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLV 64
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +++ GSL + L E + L +++ A G+AY+
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--- 120
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+HRD++++NIL+ NL +V+DFGLA+L+ED E
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 30/176 (17%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRFFERE 353
+DI+ K E +G G FG V+ L D + A+K + + +E + F+RE
Sbjct: 5 RDIVLKWE-------LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 57
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL---------DEALHERSE----- 399
E+L ++H+++V G C L++++++ G L D + E
Sbjct: 58 AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG 117
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
QL L I A G+ YL S +HRD+ + N L+ L ++ DFG+++
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFE------------RELEILGSIK 361
IG G +G V+K + G + A+K+ F E RE+ +L +K
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK----------FVESEDDPVIKKIALREIRMLKQLK 58
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H LVNL L++++ L+E L + + II + + + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 422 -HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H+C IHRD+K NIL+ + ++ DFG A++L T VA T Y AP
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 315 IGSGGFGTV--------YKLAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHR 363
+GSG FG V K+A I +NEG + F E E +++ + H
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVA-----------IKAINEGAMSEEDFIE-EAKVMMKLSHP 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
LV L G C ++ +F+ G L L +R +L D L++ +G+ YL +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
IHRD+ + N L+ +VSDFG+ + + D+E
Sbjct: 120 ---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P S +IKKL G+G FG V+ + A+K + + F E E
Sbjct: 2 EIPRESLQLIKKL---------GNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMG 412
+I+ ++H LV L S ++ +++ GSL + L + L +++
Sbjct: 52 AQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
A G+AY+ IHRD++S+NIL+ L +++DFGLA+L+ED E
Sbjct: 111 VAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 291 FHGDLPYSSKDIIKKLETLDDD-------HIIGSGGFGTVYKLA-MDDGNVFALKRIDKL 342
+G PY+S + LE+L D IG G +G VYK+ DG++ A+K +D +
Sbjct: 1 LYGLFPYNSSML--GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI 58
Query: 343 NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL-----LIYDFLPGGSLDE---A 393
++ D E E IL S+ H +V G + L+ + GGS+ E
Sbjct: 59 SD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG 117
Query: 394 LHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
L ++LD I+ GA GL +LH++ RIIHRD+K +NILL ++ DFG+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 454 AKLLEDEESHITTIVAGTFGYLAP 477
+ L T V GT ++AP
Sbjct: 175 SAQLTSTRLRRNTSV-GTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 45/167 (26%), Positives = 89/167 (53%), Gaps = 28/167 (16%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G+G FG V+ + A+K + + + F E ++ +++H LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLV 64
Query: 367 NLRGYCNSPTSKLLIY---DFLPGGSLDEALHERSEQ---------LDWDARLNIIMGAA 414
L ++ +K IY +F+ GSL + L +S++ +D+ A++ A
Sbjct: 65 KL----HAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQI------A 112
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+G+A++ IHRD++++NIL+ +L +++DFGLA+++ED E
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN-LRGY 371
IG G GTVY A+D G A+K+++ + E+ ++ KH +VN L Y
Sbjct: 27 IGQGASGTVY-TAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ ++L GGSL + + E +D + + L +LH S ++IHR
Sbjct: 86 LVG-DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
DIKS NILL + +++DFG + E+S +T+V GT ++AP
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 12/177 (6%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
++E LD+ +G G +G+VYK L G A+K I +L+E EL+IL
Sbjct: 2 EIEVLDE---LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS 58
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
Y+V+ G + + +++ GSLD+ + D I KGL +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ + IIHRD+K +N+L++GN + ++ DFG++ L + T I G Y+AP
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNI--GCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN------------EGFDRF 349
I ++ TL IG G FG VY+ V+ +K+ ++F
Sbjct: 3 IQREDITLGR--CIGEGQFGDVYQ------GVYMSPENEKIAVAVKTCKNCTSPSVREKF 54
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
+ E I+ H ++V L G ++ + P G L L LD + +
Sbjct: 55 LQ-EAYIMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ LAYL S R +HRDI + N+L+ ++ DFGL++ LEDE + +
Sbjct: 113 SYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169
Query: 470 GTFGYLAP 477
++AP
Sbjct: 170 LPIKWMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 31/177 (17%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTV-----YKLA-MDDGNVFALKRIDKLNEGFDRFFERE 353
+DI+ K E +G G FG V Y L+ D + A+K + + F+RE
Sbjct: 5 RDIVLKRE-------LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 57
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH---------------ERS 398
E+L +++H ++V G C +++++++ G L++ L +
Sbjct: 58 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 117
Query: 399 EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+L L+I A G+ YL S +HRD+ + N L+ NL ++ DFG+++
Sbjct: 118 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 30/156 (19%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A + G V ALK R+D EG RE+ +L + H +V L
Sbjct: 8 IGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 371 YCNSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++ L+++FL P + L + + + +GLA+
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-----------SYLFQLLQGLAF 115
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
H S R++HRD+K N+L++ +++DFGLA+
Sbjct: 116 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L D +G G FG V+ + A+K + + F + E +I+ ++H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ-EAQIMKKLRHDKLV 64
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +F+ GSL + L E + L +++ A G+AY+
Sbjct: 65 PLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--- 120
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
IHRD++++NIL+ NL +++DFGLA+L+ED E
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 38/186 (20%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+IG G +G VYK G + A+K +D + + E E IK Y + LR Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEE-----EIKEEYNI-LRKYS 60
Query: 373 NSPT-----------------SKL-LIYDFLPGGS---LDEALHERSEQLDWDARLNIIM 411
N P +L L+ + GGS L + L ++ ++L + I+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
+GLAYLH ++IHRDIK NILL N E ++ DFG++ L+ T + GT
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 472 FGYLAP 477
++AP
Sbjct: 177 PYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P S ++KKL G+G FG V+ ++ A+K + F E E
Sbjct: 2 EIPRESIKLVKKL---------GAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-------EQLDWDAR 406
++ +++H LV L +I +++ GSL + L + +D+ A+
Sbjct: 52 ANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ A+G+AY+ IHRD++++N+L+ +L +++DFGLA+++ED E
Sbjct: 112 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 25/179 (13%)
Query: 314 IIGSGGFGTVY---KLA-MDDGNVFALKRIDKLNEGFDRFFER---------ELEILGSI 360
++G+G +G V+ K+ D G ++A+K + K ++ E ++L ++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA-----TIVQKAKTAEHTRTERQVLEAV 61
Query: 361 KHR-YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ +LV L Y +KL LI D++ GG L L++R + + R+ I A+ +
Sbjct: 62 RRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI----AEIVL 116
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L H II+RDIK NILLD ++DFGL+K EE GT Y+AP
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 49/149 (32%), Positives = 79/149 (53%), Gaps = 15/149 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A D ALK R+++ +EG RE+ +L ++H +V L+
Sbjct: 10 IGEGTYGVVYK-ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPR 427
+S L++++L LD H + S + RL + +G+AY H S R
Sbjct: 69 VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHR 122
Query: 428 IIHRDIKSSNILLDGNLEA-RVSDFGLAK 455
++HRD+K N+L+D A +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 55/171 (32%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 313 HIIGSGGFGTVYKLAMDDGN-VFALKRID----KLNEGFDRFFERELEILGSIKHRYLVN 367
H IG G FG VY N V A+K++ + NE + +E++ L +KH +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII-KEVKFLQQLKHPNTIE 85
Query: 368 LRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G Y T+ L++ L GS + L + L I GA +GLAYLH
Sbjct: 86 YKGCYLKEHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+IHRDIK+ NILL + +++DFG A S + GT ++AP
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 5/150 (3%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGL 125
+ + + +L L N+ ++ I +G L LK L+L N +PS L N L+ L
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNL 168
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L N LS +P L NLSNL NLD+S N +SD +PP + L L ++SNN ++ +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLS 226
Query: 186 SDGVLTKFSESSFFGNRGLCGKQINVTCKN 215
S L S N+ + N
Sbjct: 227 SLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 315 IGSGGFGTV-----YKLAMDDGNVF-ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V Y L + + A+K + ++ + F RE E+L +++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS------------EQLDWDARLNIIMGAAKG 416
G C +++++++ G L++ L +L L+I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ YL S +HRD+ + N L+ NL ++ DFG+++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E +IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGESMALNEKQILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+V+L + + L+ + GG L ++ E + R + AA+ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGR--AVFYAAEICCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ RI++RD+K NILLD + R+SD GLA + E GT GY+AP
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 315 IGSGGFGTVYKLAMDDGNVFAL-KRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + V A K ID +E + E++IL S H +V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+ ++ +F GG++D + E L + + L YLH + +IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 434 KSSNILLDGNLEARVSDFGLA----KLLEDEESHITTIVAGTFGYLAP 477
K+ NIL + + +++DFG++ + ++ +S I GT ++AP
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
I+G G GTVYK + + A+K I + + ELEIL Y++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+ +F+ GGSLD L I + KGL YL S +I+HR
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHR 119
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K SN+L++ + ++ DFG++ L + I GT Y+AP
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
++G G FG V ++ + G+++A+K + K L + FFE E +IL ++ L
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD------ARLNIIMGAAKGLAYLHH 422
+ + L+ ++ PGG L L+ +Q D D A L + + + + Y
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY--- 123
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK N+L+D +++DFG A L + + + GT Y+AP
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD----------RFFERELEILGSIKH 362
++G G FG VY D G A+K++ FD E E+++L +++H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVP-----FDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 363 RYLVNLRGYCNSPTS-KLLIY-DFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGL 417
+V G P KL I+ +++PGGS+ + L +E + I+ +G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGV 119
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYL 475
+YLH S I+HRDIK +NIL D ++ DFG +K ++ T I V GT ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 476 AP 477
+P
Sbjct: 177 SP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 44/139 (31%), Positives = 58/139 (41%), Gaps = 25/139 (17%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE----------------- 115
+ L L ++ L G I LG L+ + L N+F GE+PSE
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 116 LGNC-------TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ 168
G LQ LSL N G +P G+ L NLD+S N S +P LG L
Sbjct: 441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499
Query: 169 RLITFNVSNNFLVGAIPSD 187
L+ +S N L G IP +
Sbjct: 500 ELMQLKLSENKLSGEIPDE 518
|
Length = 968 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 17/179 (9%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD-----RFFERELEILG 358
K E L ++G G +G V K + G + A+K K E D + RE+ +L
Sbjct: 2 KYENLG---LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLK 55
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
++H LVNL L+++F+ LD+ L + LD + +G+
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ H S IIHRDIK NIL+ + ++ DFG A+ L T VA T Y AP
Sbjct: 115 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E +IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+V+L + + L+ + GG L ++ + R + AA+ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEER--AVFYAAEITCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RI++RD+K NILLD R+SD GLA + + E+ I V GT GY+AP
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/172 (33%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEIL-GSIKHRYLVN 367
+IG G FG V LA + +A+K + K L + ++ E +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L + KL + D++ GG L L L+ AR A L YLH S
Sbjct: 61 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
I++RD+K NILLD ++DFGL K E+ E + T+ GT YLAP
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 15/172 (8%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + + + + VFA+K ++K L F E ++L + ++++ L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNI--IMGAAKGLAYLHHDCSP 426
+ L+ D+ GG L L + ++L D AR + ++ A + LH+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFG-LAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK NIL+D N R++DFG KL+ED +++ GT Y++P
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/191 (30%), Positives = 83/191 (43%), Gaps = 47/191 (24%)
Query: 312 DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHR 363
D IG G FG V+ + D DG ALK K+ F R F REL++L KH
Sbjct: 5 DRPIGYGAFGVVWSVT-DPRDGKRVALK---KMPNVFQNLVSCKRVF-RELKMLCFFKHD 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLD--EALHERSEQLDWDARLNIIMGAA------- 414
+++ D L +D E ++ +E + D II+
Sbjct: 60 NVLSA-------------LDILQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHV 105
Query: 415 --------KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+GL YLH S I+HRDIK N+L++ N ++ DFGLA++ E +ES T
Sbjct: 106 KVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
Query: 467 IVAGTFGYLAP 477
T Y AP
Sbjct: 163 QEVVTQYYRAP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G+G G V K+ G + A K I ++ REL++L Y+V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
S + + + GGSLD+ L E ++++ + + + +GLAYL +I+HRD
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRD 129
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+K SNIL++ E ++ DFG++ L D + GT Y++P
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+G+G FG V++ ++ A+K + K + F E +I+ ++H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 375 PTSKLLIYDFLPGGSLDEALHER-------SEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
++ + + GSL E L + +D A++ A G+AYL +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV------ASGMAYLE---AQN 123
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
IHRD+ + N+L+ N +V+DFGLA++++++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHR---------- 363
IG G FG VY++ D ++A+K + K + + E+ +I R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 364 --YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
++V L+ + + L+ D++ GG L L + + A+ I A+ + L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI----AELVLALE 110
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAP 477
H I++RD+K NILLD + DFGL+K L D ++ T GT YLAP
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 314 IIGSGGFGTVYKL----AMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ + D G ++A+K + K E +L ++ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 365 LVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYL 420
LV L Y +KL LI D++ GG + L++R + + R II+ L +L
Sbjct: 67 LVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHL 121
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H I++RDIK NILLD ++DFGL+K EE T GT Y+AP
Sbjct: 122 H---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G +G VY + A+K I + + + + E+ + +KHR +V G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA--KGLAYLHHDCSPRIIH 430
+ + + +PGGSL L + L + + I +GL YLH + +I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 431 RDIKSSNILLD---GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RDIK N+L++ G + ++SDFG +K L T GT Y+AP
Sbjct: 132 RDIKGDNVLVNTYSGVV--KISDFGTSKRLAGINP-CTETFTGTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 48/172 (27%), Positives = 91/172 (52%), Gaps = 16/172 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
++G G FG V+ D + +K+I +++ + + E ++L + H N+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP---NIIE 63
Query: 371 YCNS---PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
Y + + +++ ++ PGG+L E + +R + LD D L+ + + L LHH +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---QILLALHHVHTK 120
Query: 427 RIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRD+K+ NILLD + + ++ DFG++K+L + T V GT Y++P
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 57/174 (32%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 311 DDHIIGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRY 364
D IG G FG VY A D V A+K++ + NE + +E+ L ++H
Sbjct: 19 DLREIGHGSFGAVY-FARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVRFLQQLRHPN 76
Query: 365 LVNLRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+ +G Y T+ L++ L GS + L + L I GA +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL--GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-- 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S IHRDIK+ NILL +++DFG A L+ S + GT ++AP
Sbjct: 133 -SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 30/191 (15%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRI--DKLNEGFDRFFEREL 354
S D +KL +++ G +G VY+ A D G + ALK++ +K EGF RE+
Sbjct: 3 SVDEYEKLNRIEE------GTYGVVYR-ARDKKTGEIVALKKLKMEKEKEGFPITSLREI 55
Query: 355 EILGSIKHRYLVNLR----GYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDAR 406
IL ++H +V ++ G S L ++ +++ L + +
Sbjct: 56 NILLKLQHPNIVTVKEVVVG------SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+++ G+A+LH + I+HRD+K+SN+LL+ ++ DFGLA+ T
Sbjct: 109 KCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ 165
Query: 467 IVAGTFGYLAP 477
+V T Y AP
Sbjct: 166 LVV-TLWYRAP 175
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 60/190 (31%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 301 DIIKKLETLDDDHI--IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFD-RFFERELEIL 357
DI+++ D + I +GSG +G VYK A +I KL G D ++E+ ++
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH---ERSE-QLDWDARLNIIMGA 413
KH +V G S + ++ GGSL + H SE Q+ + R +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---- 116
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA---- 469
+GLAYLH S +HRDIK +NILL N + +++DFG+A + IT +A
Sbjct: 117 -QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKS 165
Query: 470 --GTFGYLAP 477
GT ++AP
Sbjct: 166 FIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 57/170 (33%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG VY A D V A+K++ + NE + +E++ L IKH +
Sbjct: 33 IGHGSFGAVY-FARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVKFLQRIKHPNSIEY 90
Query: 369 RG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+G Y T+ L++ L GS + L + L I GA +GLAYLH S
Sbjct: 91 KGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHN 145
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+IHRDIK+ NILL + +++DFG A + S + GT ++AP
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 16/168 (9%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V A D G A+K+I K + REL++L ++H +++L
Sbjct: 18 VGMGAFGLVCS-ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
SP + L G L L R E+ L I+ +GL Y+H S ++
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL---RGLKYVH---SAGVV 130
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRD+K SNIL++ N + ++ DFGLA++ ++ +T V+ + Y AP
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRY-YRAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 59/184 (32%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-RFFERELE-ILGSIKHR 363
E L D IG G FGTV K L G + A+KRI + + + +L+ ++ S
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 364 YLVNL------RGYCNSPTSKLLIYDFLPGGSLD---EALHERSEQ-LDWDARLNIIMGA 413
Y+V G C I L SLD + ++E + + + I +
Sbjct: 64 YIVKFYGALFREGDC-------WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
K L YL + +IIHRD+K SNILLD N ++ DFG++ L D S T AG
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRP 172
Query: 474 YLAP 477
Y+AP
Sbjct: 173 YMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 314 IIGSGGFGTVYKL----AMDDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ + D G ++A+K + K E ++L I+ +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
LV L + T LI D++ GG L L +R + + ++ I++ L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA----LEHLH 122
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
II+RDIK NILLD N ++DFGL+K ++E GT Y+AP
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG VY A D + V A+K++ + NE + +E+ L ++H +
Sbjct: 23 IGHGSFGAVY-FARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFLQKLRHPNTIQY 80
Query: 369 RG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
RG Y T+ L++ L GS + L + L + GA +GLAYLH S
Sbjct: 81 RGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+IHRD+K+ NILL ++ DFG A ++ + GT ++AP
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVF--ALKRIDKL-NEGFDRFFERELEILGSI-K 361
E + + +IG G FG V + + DG A+K + + +E R F ELE+L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDAR 406
H ++NL G C + + ++ P G+L + L H + L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
L A G+ YL + IHRD+ + N+L+ NL ++++DFGL++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 44/172 (25%), Positives = 87/172 (50%), Gaps = 21/172 (12%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P + ++KKL G+G FG V+ + A+K + + + + F E
Sbjct: 2 EVPRETLKLVKKL---------GAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIY---DFLPGGSLDEALH-ERSEQLDWDARLNI 409
++ ++H LV L + ++ IY +++ GSL + L +L + +++
Sbjct: 52 ANLMKQLQHPRLVRL----YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
A+G+A++ IHRD++++NIL+ L +++DFGLA+L+ED E
Sbjct: 108 AAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNV--FALKRIDKL----NEGFDRFFERELEILG 358
K E + +G+G FG V + + A+KR +K + D F E +IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILN 86
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
I H + VNL G + L+ +F+ GG L R+++ D AA+ +
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG---CFYAAQIVL 142
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ S I++RD+K N+LLD + +++DFG AK+++ T + GT Y+AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-10
Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 29 INSDGEALLSFRTAVVS-SDGFLNQWRPEDPDPCNWKGVKCD 69
+N D +ALL+F++++ G L+ W P DPC+W GV CD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRG 370
++G G +G V + DG + +K+++ N + E+E ++L +KH +V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 371 YCNSPTSKL-LIYDFLPGGSLDEALHERSEQL-------DWDARLNIIMGAAKGLAYLHH 422
L ++ F GG L L E+ +L +W ++ A L YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRD+K+ N+ L +V D G+A++LE++ +T++ GT Y++P
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 18/180 (10%)
Query: 307 ETLDDD----HIIGSGGFGTVYKLAMD-DGNVFALKRID-KLNEGFDRFFERELEILGSI 360
E DDD +G+G G V+K++ G + A K I ++ REL++L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGL 417
Y+V G S + + + GGSLD+ L + EQ+ + +I KGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGL 116
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YL +I+HRD+K SNIL++ E ++ DFG++ L D + GT Y++P
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 47/189 (24%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR--FFER---ELEILGSIKHRYLV 366
IG G +G V A G A+K+I F+ F +R E++IL KH ++
Sbjct: 12 YIGEGAYGMVC-SATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEA-------------LHE--RSEQLDWDARLNIIM 411
I D + S + L++ +++ L D +
Sbjct: 67 G-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY 113
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIV 468
+GL Y+H S ++HRD+K SN+LL+ N + ++ DFGLA++ + E H +T V
Sbjct: 114 QILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 469 AGTFGYLAP 477
A T Y AP
Sbjct: 171 A-TRWYRAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 314 IIGSGGFGTVY--KLAMDDGN-----VFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG VY L DG V +L RI L E ++F +E I+ H ++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFL-KEGIIMKDFSHPNVL 59
Query: 367 NLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG--AAKGLAYLHHD 423
+L G C S S L++ ++ G L + RSE + + I G AKG+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL--- 114
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S + +HRD+ + N +LD + +V+DFGLA+ + D+E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 7/164 (4%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
IG G GTVY + + G A+K+++ + E+ ++ K+ +VN
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ ++L GGSL + + E +D + + L +LH S ++IHRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
KS NILL + +++DFG + E+S +T+V GT ++AP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVN 367
++G G FG VY D G A+K++ E + E E+++L ++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHH 422
G P + L + +PGGS+ + L +E + I+ +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLH- 123
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
S I+HRDIK +NIL D ++ DFG +K L+
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 31/166 (18%)
Query: 314 IIGSGGFGTVYK-------LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSI-KHRY 364
+IG G FG V K L MD A+KR+ + D R F ELE+L + H
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDA----AIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDARLNI 409
++NL G C L ++ P G+L + L + + L L+
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 51/160 (31%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 315 IGSGGFGTVYKLAMDDGN--VFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+G G G V+ L G +FALK +DK N+ E+E IL ++ H +L
Sbjct: 9 LGKGDVGRVF-LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPT 65
Query: 368 LRGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQL--DWDARLNIIMGAAK---GLAYL 420
L Y + T L D+ PGG L L + + + AR AA+ L YL
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY----AAEVLLALEYL 119
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460
H I++RD+K NILL + +SDF L+K + E
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A KR++K R +R E +IL + ++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEK-----KRIKKRKGESMALNEKQILEKVNSQF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+VNL + + L+ + GG L ++ + R + AA+ GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER--ALFYAAEILCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ ++RD+K NILLD R+SD GLA + + ES + GT GY+AP
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 48/175 (27%), Positives = 88/175 (50%), Gaps = 13/175 (7%)
Query: 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHR 363
LET+ D +G+G G+V K+ K++ + + REL+I+ +
Sbjct: 7 LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 364 YLVNLRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
Y+V+ G + N + + +F+ GSLD ++++ + + I + +GL YL++
Sbjct: 64 YIVSFYGAFLNENNICMCM-EFMDCGSLD-RIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RI+HRDIK SNIL++ + ++ DFG++ L + I GT Y++P
Sbjct: 122 --VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEG----FDRFFERELEILGSIKHRYLVN 367
IG G FG V++ + F + + L E F+RE ++ H +V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSE---------------------QLDWDAR 406
L G C L+++++ G L+E L RS L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
L I A G+AYL + +HRD+ + N L+ N+ +++DFGL++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIK 361
KLET +G G + TVYK + G + ALK I +L EG RE +L +K
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLK 61
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK------ 415
H +V L ++ + L++++L D L + +D + M +
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYL-----DTDL---KQYMDDCGGG-LSMHNVRLFLFQL 112
Query: 416 --GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
GLAY H R++HRD+K N+L+ E +++DFGLA+
Sbjct: 113 LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 28/154 (18%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G G + TVYK ++ +G + ALK I K EG RE +L +KH +V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 373 NSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
++ + +++++ PGG LH + +L + +GLAY+H
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRL-------FMFQLLRGLAYIH 120
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
I+HRD+K N+L+ E +++DFGLA+
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
+IG G FG V + D G+++A+K++ K E+ E +IL + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRK-----SEMLEKEQVAHVRAERDILAEADNPW 62
Query: 365 LVNLRGYCN--SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L Y + LI ++LPGG + L + + + I + +H
Sbjct: 63 VVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIH- 118
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
IHRDIK N+LLD ++SDFGL L ++SH T
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 9/165 (5%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G GTV+ A+D G A+K+I+ + E+ ++ +K+ +VN
Sbjct: 27 IGQGASGTVFT-AIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ ++L GGSL + + E +D + + L +LH + ++IHRD
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IKS N+LL + +++DFG + E+S +T+V GT ++AP
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK G + A+K R++ EG RE+ +L ++H +V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERS----EQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+ LI++FL S+D + S + +D + + + +G+ + H S R
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAK 455
++HRD+K N+L+D +++DFGLA+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLR 369
IG G FG +Y LA D +K ID K+ ++E+ +L +KH +V
Sbjct: 7 KIGEGSFGKIY-LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
++ ++ GG L + ++ +R D L+ + + GL ++H +I
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKI 122
Query: 429 IHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483
+HRDIKS NI L N + A++ DFG+A+ L D T V GT YL+P + C N
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSP-EICQN 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 314 IIGSGGFGTVYKLAMDD-GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + M + G V+A+K ++K L F E ++L + R++ NL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNI--IMGAAKGLAYLHHDCSP 426
+ L+ D+ GG L L + ++L D AR + ++ A + L +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---- 123
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK N+LLD N R++DFG L + + + + GT Y++P
Sbjct: 124 --VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGSIK---HRYLVNL 368
IG G +GTVYK G+ ALK R+ +G RE+ +L ++ H +V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-----LDWDARLNIIMGAAKGLAYLHHD 423
C + + L +D+ L ++ L + +++ +GL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
C I+HRD+K NIL+ + +++DFGLA++ + + +V T Y AP
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+ + L + +LI D++ G L + L + +L II + L L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDL 125
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAK 455
H IIH DIK N+L D + + D+GL K
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 28/155 (18%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+G GG+G V+ LA D G + ALKR+ K LNE R E +IL + K +LV
Sbjct: 9 VGQGGYGQVF-LAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKSEWLVK 65
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDE------ALHERSEQLDWDARLNII-MGAAKGLAYL 420
L L +++PGG L E AR + M A + L
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYMAEMFEA--VDAL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
H IHRD+K N L+D + +++DFGL+K
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 23/180 (12%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
LD+ IG G G V +A D G A+K++D + E+ I+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIV-CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 365 LVNLRGYCNSPTSKL------LIYDFLPGGSL-DEALHERSEQLDWDARLNIIMGAAKGL 417
+V + S L ++ +FL GG+L D H R ++ + + + K L
Sbjct: 78 IVEMYS------SYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKAL 128
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++LH + +IHRDIKS +ILL + ++SDFG + E ++V GT ++AP
Sbjct: 129 SFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 5/147 (3%)
Query: 315 IGSGGFGTVY--KLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V+ +L D+ V + L F +E IL H +V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + + GG L +L + ++ AA G+ YL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLED 459
+ + N L+ ++SDFG+++ ED
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 45/196 (22%)
Query: 311 DDHI---------IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF---------F 350
D HI +G G +G V+K A+D V ALK+I FD F F
Sbjct: 2 DKHILRKYEILQKLGKGAYGIVWK-AIDRRTKEVVALKKI------FDAFRNATDAQRTF 54
Query: 351 ERELEILGSIK-HRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHE--RSEQLDWDA 405
RE+ L + H +V L + K L+++++ + LH R+ L+
Sbjct: 55 -REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVH 108
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEE 461
+ I+ K L Y+H S +IHRD+K SNILL+ + +++DFGLA+ L E+ E
Sbjct: 109 KRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 462 SHITTIVAGTFGYLAP 477
+ + T T Y AP
Sbjct: 166 NPVLTDYVATRWYRAP 181
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSI 360
K+LE L G G + TVYK G + ALK I L+ EG RE+ ++ +
Sbjct: 3 KQLEKL------GEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKEL 55
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLA 418
KH +V L ++ +L+++++ L + + + LD + + KG+A
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ H + R++HRD+K N+L++ E +++DFGLA+
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+GSG +GTV L G A+K++ + +E F + REL +L +KH ++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 372 CNSPTSKLLIYDF---LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S +DF +P D + E+L D ++ KGL Y+H + I
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGI 139
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460
IHRD+K N+ ++ + E ++ DFGLA+ + E
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
KLET +G G + TV+K + N+ ALK I + EG RE+ +L ++KH
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ L++++L L + L + + +GL+Y H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+I+HRD+K N+L++ E +++DFGLA+
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNLR 369
+GSG +G+V + D + + KL+ F REL +L +KH ++ L
Sbjct: 23 VGSGAYGSV--CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 370 GYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
TS ++ + L G L+ + + ++L + +I +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIH--- 135
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S IIHRD+K SN+ ++ + E R+ DFGLA+ +DE +T VA T Y AP
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVA-TRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGF---DRFFE---RELEILGSIKHRYL 365
+G+G F + Y+ A D G + A+K++ + + E +E+ ++ + H ++
Sbjct: 7 QLGTGAFSSCYQ-ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ + G + L +++ GGS+ L + +N +GL+YLH +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 426 PRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTI------VAGTFGYLAP 477
+IIHRD+K +N+L+D R++DFG A L + T + GT ++AP
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 22/158 (13%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD----------RFFERELEILGSIKH 362
++G G FG VY +D G A K++ FD E E+++L +++H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQ-----FDPESPETSKEVSALECEIQLLKNLQH 63
Query: 363 RYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+V G K L +++PGGS+ + L + R +G++YL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYL 122
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
H S I+HRDIK +NIL D ++ DFG +K L+
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 9/165 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G GTVY AMD G A+++++ + E+ ++ K+ +VN
Sbjct: 28 IGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ ++L GGSL + + E +D + + L +LH S ++IHRD
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IKS NILL + +++DFG + E+S +T+V GT ++AP
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNLR 369
+GSG +G+V A D + + KL+ F REL +L +KH ++ L
Sbjct: 25 VGSGAYGSVCA-AFDTKTGLRVA-VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 370 GYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S + + L G L+ + + ++L D +I +GL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S IIHRD+K SN+ ++ + E ++ DFGLA+ +DE +T VA T Y AP
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVA-TRWYRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 33/181 (18%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-----------RELEILGSIKH 362
IG G F VYK + + DG V ALK++ + FE +E+++L + H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV--------QIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 363 RYLVNLRGYCNS--PTSKLLI-YDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKG 416
N+ Y S ++L I + G L + +Q + +
Sbjct: 62 ---PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L ++H S RI+HRDIK +N+ + ++ D GL + + + ++V GT Y++
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 477 P 477
P
Sbjct: 175 P 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
KLET +G G + TVYK + N+ ALK I + EG RE+ +L +KH
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ S L++++L L + L + ++ + +GL Y H
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+++HRD+K N+L++ E +++DFGLA+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFG-----TVYKLAMDDGNVFALKRIDKLNEGFDRF 349
LPY K + L +G+G FG T Y L+ D +K K+ +
Sbjct: 24 LPYDLKWEFPR-NNLSFGKTLGAGAFGKVVEATAYGLSKSDA---VMKVAVKMLKPTAHS 79
Query: 350 FER-----ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LD 402
ER EL+I+ + H +VNL G C L+I ++ G L L + E L
Sbjct: 80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLT 139
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ L+ AKG+A+L S IHRD+ + N+LL ++ DFGLA+
Sbjct: 140 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK--GLAYLHH 422
+V+L + + L+ + GG L ++ +D + I A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQR 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ RI++RD+K NILLD R+SD GLA ++ E GT GY+AP
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG + + +DG + +K I+ K++ +E+ +L ++KH +V +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHER-------SEQLDWDARLNIIMGAAKGLAYLH-HD 423
+ ++ D+ GG L + ++ + + LDW ++ LA H HD
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI--------CLALKHVHD 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+I+HRDIKS NI L + ++ DFG+A++L T + GT YL+P
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 28/175 (16%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNLRGYC 372
IGSG +G VYK ++ G + A+K I KL G D ++E+ ++ KH +V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 373 NSPTSKLLIYDFLPGGSLDEALH---ERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ +F GGSL + H SE Q+ + +R + +GL YLH S
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SKGK 127
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA------GTFGYLAP 477
+HRDIK +NILL N +++DFG++ + IT +A GT ++AP
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 9/169 (5%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + M ++A+K ++K L F E +L + +++ L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNIIMGAAKGLAYLHHDCSPRI 428
L+ D+ GG L L + ++L D AR I A+ + +H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----AEMVLAIHSIHQLHY 123
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK N+LLD N R++DFG + + + +++ GT Y++P
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 27/178 (15%)
Query: 314 IIGSGGFGTV----YKLAMDDGNVFALKRIDK----LNEGFDRFF--ERELEILGSIKHR 363
++G G FG V YK G ++A+K + K + + +R E S +H
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYL 420
+LVNL + + ++ GG L +H ++ + AA GL YL
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFS---EPRAVFYAACVVLGLQYL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAP 477
H + +I++RD+K N+LLD +++DFGL K E T+ GT +LAP
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAP 170
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 13/179 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDR----FFERELEILGS 359
K E D +IG G FG V + V+A+K + K E R FF E +I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWEERDIMAH 99
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++V L ++ +++PGG L + W AR L
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARF-YTAEVVLALDA 157
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-KLLEDEESHITTIVAGTFGYLAP 477
+H S IHRD+K N+LLD + +++DFG K+ + T V GT Y++P
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISP 212
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 53/169 (31%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG V ++ D ++ALK I K +E ER +L + ++V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT--VLAQVNCPFIVPL 58
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ SP L+ F+ GG L L AR A+ L L + +
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT----AELLCALENLHKFNV 114
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+RD+K NILLD + DFGL K L ++ T GT YLAP
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
I G FG+VY LA G+ FA+K + K N+ + ER + ++ Y+
Sbjct: 4 ISKGAFGSVY-LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-YVAK 61
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L S L+ ++L GG +L + L D I G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---G 117
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IIHRDIK N+L+D +++DFGL++ + + + GT YLAP
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 41/128 (32%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 352 RELEILGSIKHRYLVNLRG--YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
REL++L Y+V G Y + S + + + GGSLD+ L +++ ++ + I
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEH--MDGGSLDQVL-KKAGRIPENILGKI 104
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ +GL YL I+HRD+K SNIL++ E ++ DFG++ L D S + V
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV- 159
Query: 470 GTFGYLAP 477
GT Y++P
Sbjct: 160 GTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/196 (27%), Positives = 79/196 (40%), Gaps = 36/196 (18%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+IG GG G VY LA D ALK+I + N + F RE +I + H +V +
Sbjct: 9 LIGKGGMGEVY-LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALH----------ERSEQLDWDARLNIIMGAAKGLA 418
C+ ++ G +L L E +E+ A L+I +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE--------------SHI 464
Y+H S ++HRD+K NILL E + D+G A + EE
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 465 TTI---VAGTFGYLAP 477
TI + GT Y+AP
Sbjct: 185 MTIPGKIVGTPDYMAP 200
|
Length = 932 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNL 368
IG G +G V + A+K+I FD + RE+++L + H ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI---ANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 369 RGYCNSPTSK------LLIYDFLPGGSLDEALHE--RSEQ-LDWDARLNIIMGAAKGLAY 419
+ P + ++Y+ + D LH+ RS Q L D + +GL Y
Sbjct: 70 KD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+H S ++HRD+K SN+LL+ N + ++ DFGLA+ ++ +T V T Y AP
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 313 HIIGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
+GSG +G+V A+D G A+K++ + +E F + REL +L ++H ++ L
Sbjct: 21 KQVGSGAYGSVCS-AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 369 RGYCNSPTSKLLIYDF---LPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S S DF +P D L + L D ++ GL Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
S IIHRD+K N+ ++ + E ++ DFGLA+
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 19/123 (15%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
EQL + ++ A+G+ YL S R IHRD+ + N+L+ + +++DFGLA+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 457 LED 459
+ D
Sbjct: 184 VHD 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 314 IIGSGGFGTVYKLAMDDGNVF----ALKRIDKLNEGFD---RFFERELEILGSIKHRYLV 366
++G G FG V + N F ALK+ D + E D ER + L +H +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 367 NLRGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQLDWDARLNIIMGAA--KGLAYLHH 422
+L +C T + L + ++L GG L + +D A GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH- 113
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
II+RD+K N+LLD + +++DFG+ K + E +T GT Y+AP
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 18/175 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G+G +G VYK + G + A+K +D + E + + E+ +L H N+ Y
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHR--NIATYY 79
Query: 373 NSPTSK---------LLIYDFLPGGSL-DEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ K L+ +F GS+ D + + L D I +GLA+LH
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH- 138
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ ++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++AP
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
K+ET +G G + TV+K + N+ ALK I + EG RE+ +L +KH
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ S L++++L L + + + + + +GLAY H
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+++HRD+K N+L++ E +++DFGLA+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 314 IIGSGGFGTVYK--LAMDDGNV--FALKRIDKLNEGFDRF--FERELEILGSIKHRYLVN 367
I+G G FG+V + L+ DDG+ A+K + + F E + H ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 368 LRGYC------NSPTSKLLIYDFLPGGSLDEAL-----HERSEQLDWDARLNIIMGAAKG 416
L G C ++I F+ G L L E+L L ++ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ YL + IHRD+ + N +L ++ V+DFGL+K
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVF--ALKRIDKL-NEGFDRFFERELEILGSIKHR-YLVNL 368
+IG G FG V K DG A+KR+ + ++ R F ELE+L + H ++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDARLNIIMGA 413
G C L ++ P G+L + L + + L L+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 34/172 (19%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-REL 354
+ D +KLE L G G + TVYK + +G + ALK I E F RE
Sbjct: 1 FGKADSYEKLEKL------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREA 54
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDW 403
+L +KH +V L ++ + L+++++ PGG LH + +L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKL-- 107
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ +GL+Y+H I+HRD+K N+L+ E +++DFGLA+
Sbjct: 108 -----FLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
++G G FG + + + +A+K I +L + +E +L +KH +V +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ ++ ++ GG L + + +R + D L + G+ ++H R++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIKS NI L N + ++ DFG A+LL ++ T V GT Y+ P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPP 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 29/181 (16%)
Query: 315 IGSGGFGTVYKLAMD---DGNVFALKRI--DKLNEGFDRFFERELEIL---GSIKHRYLV 366
IG G +G V+K A D G ALKR+ EG RE+ +L + +H +V
Sbjct: 9 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 367 NLRGYC-----NSPTSKLLIYDFLPGGSLDEALHERSEQ-----LDWDARLNIIMGAAKG 416
L C + T L+++ +D+ L ++ + + +++ +G
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L +LH S R++HRD+K NIL+ + + +++DFGLA++ + T V T Y A
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRA 177
Query: 477 P 477
P
Sbjct: 178 P 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 13/175 (7%)
Query: 307 ETLDDDHIIGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
E LD IG G G V G A+K++D + E+ I+ H +
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSL-DEALHER--SEQLDWDARLNIIMGAAKGLAYLHH 422
V++ ++ +FL GG+L D H R EQ+ + + + L+YLH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH- 135
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ +IHRDIKS +ILL + ++SDFG + E ++V GT ++AP
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 45/157 (28%), Positives = 62/157 (39%), Gaps = 19/157 (12%)
Query: 315 IGSGGFGTVYK---LAMDDGNV---FALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ D V A+K + + D F E I+ H+ +V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHE------RSEQLDWDARLNIIMGAAKGLAYLH 421
L G + ++ + + GG L L E R L L AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAK 455
IHRDI + N LL RV +DFG+A+
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 25/163 (15%)
Query: 315 IGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNL 368
+G FG +YK MD + A+K + +N F++E ++ + H +V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS----------------EQLDWDARLNIIMG 412
G +++++L G L E L RS LD L+I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
A G+ YL S +H+D+ + NIL+ L ++SD GL++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 18/157 (11%)
Query: 314 IIGSGGFGTVYKLAM---DDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLV 366
+G G FG V+ ++ L + L + D F REL++ + H+ +V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEAL--------HERSEQLDWDARLNIIMGAAKGLA 418
L G C +I ++ G L + L + L ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+L + R +HRD+ + N L+ E +VS L+K
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 295 LPYSSKDII-----KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDR 348
P S K II +T + IG G +G V+K L +G+ A+K +D +++ D
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDE 59
Query: 349 FFERELEILGSIK-HRYLVNLRGYCNSPTSK-----LLIYDFLPGGS---LDEALHERSE 399
E E IL ++ H +V G K L+ + GGS L + +R E
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
+++ I+ A GL +LH + + IHRD+K +NILL ++ DFG++ L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 460 EESHITTIVAGTFGYLAP 477
T V GT ++AP
Sbjct: 177 TRLRRNTSV-GTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 26/178 (14%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FGTVY K A+ + + LK I +LN +E ++L + H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHE---------RSEQLDWDARLNIIMGAAKGLAY 419
+ +I ++ G LD L E ++ +W +L + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+H RI+HRD+K+ NI L NL ++ DFG+++LL + T GT Y++P
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 29/69 (42%), Positives = 41/69 (59%), Gaps = 4/69 (5%)
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I + K L YLH S +IHRD+K SN+L++ N + ++ DFG++ L D S TI
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTID 163
Query: 469 AGTFGYLAP 477
AG Y+AP
Sbjct: 164 AGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 13/173 (7%)
Query: 309 LDDDHIIGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN 367
LD+ IG G G V G + A+K++D + E+ I+ +H +V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 368 LRGYCNSPTSKLLIYDFLPGGSL-DEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ ++ +FL GG+L D H R EQ+ + + K L+ LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH--- 133
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ +IHRDIKS +ILL + ++SDFG + E ++V GT ++AP
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
EQ+ + ++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 18/175 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G+G +G VYK + G + A+K +D + + ++E+ +L H N+ Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-KQEINMLKKYSHHR--NIATYY 69
Query: 373 NSPTSK---------LLIYDFLPGGSLDEAL-HERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ K L+ +F GS+ + + + + L + I +GL++LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++AP
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGS 359
KL + +G+G FG V ++A G +A+K + K L + +E IL
Sbjct: 16 KLSDFEMGETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 360 IKHRYLVN-LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAK 415
+ H ++VN + + + L+ +F+ GG L L + + A+ +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--- 130
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
YLH S II+RD+K N+LLD +V+DFG AK + D T + GT YL
Sbjct: 131 -FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYL 182
Query: 476 AP 477
AP
Sbjct: 183 AP 184
|
Length = 329 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
L+ L IIG G FG V + G A+K I K + F E E ++ + H+ L
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQ-GEYTGQKVAVKNI-KCDVTAQAFLE-ETAVMTKLHHKNL 61
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL-NIIMGAAKGLAYLHHDC 424
V L G ++ + + G+L L R L +L + A+G+ YL
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--- 117
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
S +++HRD+ + NIL+ + A+VSDFGLA+
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 312 DHIIGSGGFGTV-YKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVN- 367
++GSG GTV + DG FA+K +D ++E + E+ L + +V
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 368 ----LRGYCNSPTSKL---LIYDFLPGGSLDEALHERSEQ----LDWDARLNIIMGAAKG 416
+ +P + L L+ D+ G L + + R++ + +A L I +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI----QV 152
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYL 475
L +HH S +IHRDIKS+NILL N ++ DFG +K+ S + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 476 AP 477
AP
Sbjct: 213 AP 214
|
Length = 496 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
I G FG VY L ++ ++A+K + K +N+ + E + L K ++V+L
Sbjct: 12 ISRGAFGKVY-LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S + L+ ++L GG + LH D + + I A L YLH II
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GII 126
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
HRD+K N+L+ +++DFGL+K+ + E ++ I+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDIL 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 13/145 (8%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV--NLRGY 371
++ G VY L + LK +G DR ERE+ IL + + L +
Sbjct: 5 LLKGGLTNRVYLL-GTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLAS 61
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
S L+ +++ G +LDE E E + A A+ LA LH + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDI---AEQ-----LAELLAKLHQLPLLVLCHG 113
Query: 432 DIKSSNILLDGNLEARVSDFGLAKL 456
D+ NIL+D + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 22/175 (12%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILG-SIKHRYLVNL 368
++G G FG V + + G ++A+K + K L + E IL + H +L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 369 RGYC--NSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
YC +P + +F+ GG L H ++S + D L +LH
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH---D 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIVAGTFGYLAP 477
II+RD+K N+LLD +++DFG+ K E T+ GT Y+AP
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 43/188 (22%)
Query: 312 DHIIGSGGFGTVYKLAMDDGNVFALK--------RIDKLNEGFD----RFFERELEILGS 359
+G G FG V K F LK + L E R E +L
Sbjct: 5 GKTLGEGEFGKVVK-----ATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE---------------RSEQLDWD 404
+ H +++ L G C+ LLI ++ GSL L E S LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 405 ARLNIIMG--------AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
+ MG ++G+ YL +++HRD+ + N+L+ + ++SDFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 457 LEDEESHI 464
+ +E+S++
Sbjct: 177 VYEEDSYV 184
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 305 KLETLDDDHIIGSGGFGTVYK---LAMDDGN---VFALKRI-DKLNEGFDRFFERELEIL 357
+ L +G G FG V K + +D+ N A+K + D E E+E++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 358 GSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQL 401
I KH+ ++NL G C ++ ++ G+L + L R E L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
++ A+G+ +L S + IHRD+ + N+L+ + +++DFGLA+
Sbjct: 130 TQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 13/179 (7%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEI-LGS 359
+ LE L + IGSG G VYK+ G+V A+K++ + N+ ++ +L++ L S
Sbjct: 14 LNDLENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL-NIIMGAAKGLA 418
Y+V GY + + + + + + + L +R + + L + + K L
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YL +IHRD+K SNILLD + ++ DFG++ L D ++ T AG Y+AP
Sbjct: 129 YLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALK---RIDKLNEGFDRFFERELEILGSIKH 362
E + +IG G FG V + D G+V+A+K + D L + E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V + + LI +FLPGG + L ++ + L + I + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
IHRDIK N+LLD ++SDFGL
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 315 IGSGGFGTVYK--LAMDDG-NVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+GSG FGTV K M A+K + D + RE ++ + + Y+V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C + S +L+ + G L++ L + + + ++ + G+ YL +
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEET---NFV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
HRD+ + N+LL A++SDFGL+K L +E++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 36/159 (22%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALKRIDKLNEGFDR----FFERELEILGSIKHRYLVN 367
+IG G FG V +L D G ++A+K + K +E F + + E ++L ++V+
Sbjct: 8 VIGKGAFGEV-RLVQKKDTGKIYAMKTLLK-SEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-----------ARLNIIMGAAK 415
L Y L LI +FLPGG L L + +D A + + A
Sbjct: 66 LY-YSFQDAQYLYLIMEFLPGGDLMTML------IKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
L + IHRDIK NIL+D ++SDFGL+
Sbjct: 119 KLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNLR 369
++G G +G V K + + A+K+ K +E + E REL++L ++K +V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+++++ L E L E + + + I K + + H + I+
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIV 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAK-LLEDEESHITTIVAGTFGYLAP 477
HRDIK N+L+ N ++ DFG A+ L E ++ T VA T Y +P
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
EQL + ++ A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 28/119 (23%), Positives = 61/119 (51%), Gaps = 14/119 (11%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER--------SEQL 401
F +E++I+ +K+ ++ L G C S +I +++ G L++ L +R + +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 402 DWDARLNIIMGAAK---GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
+ N++ A + G+ YL S +HRD+ + N L+ + +++DFG+++ L
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 312 DHIIGSGGFGTV----YKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLV 366
+ I+G+G FG + KL A+ + ++ R F E LG H +V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L G + +++ +++ G+LD L + QL + ++ G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
+H+ + + +L++ +L ++S F +L ED+ I T ++G
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSG 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 3/62 (4%)
Query: 394 LHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
L +RS L D L I +GL YLH + RIIHRD+K+ NI ++ + + D G
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 454 AK 455
A+
Sbjct: 204 AQ 205
|
Length = 357 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C ++ ++ G+L E L R
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
EQL + ++ A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 314 IIGSGGFGTVYKLAMDD-GNVFALK---RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + D G+++A+K + D L + E +IL ++V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ LI +FLPGG + L ++ + L +A I + +H I
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFI 123
Query: 430 HRDIKSSNILLDGNLEARVSDFGL 453
HRDIK N+LLD ++SDFGL
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEG---FDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ + G I +NE +R F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNII-------MGA--AKGLA 418
L G ++ L++ + + G L L R + + + L M A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
YL + + +HRD+ + N ++ +L ++ DFG+ + +
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 9/106 (8%)
Query: 351 ERELEILGSIKHRYLVNL-RGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLN 408
RE++IL +I HR ++NL Y T ++ +P D + +RS L + +
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMV----MPKYKCDLFTYVDRSGPLPLEQAIT 189
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
I + LAYLH IIHRD+K+ NI LD A + DFG A
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----DRFFERELEILGSIKHRYLVNLRG 370
IG+G FG V ++ G A + +L F E + S++H L+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGA--AKGLAYLHHDCSP 426
C T LL+ +F P G L L ++E + D M A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
IH D+ N LL +L ++ D+GL+ E+ ++T
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 24/169 (14%)
Query: 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEI 356
D +KLE IG G +G VYK A D G + ALK R++ EG RE+ +
Sbjct: 1 DAYEKLE------KIGEGTYGKVYK-ARDKNTGKLVALKKTRLEMDEEGIPPTALREISL 53
Query: 357 LGSIKHR-YLVNLRGY----CNSPTSKL-LIYDFLPG---GSLDEALHERSEQLDWDARL 407
L + Y+V L + L L++++L +D L
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAK 455
+ + KG+A+ H ++HRD+K N+L+D +++D GL +
Sbjct: 114 SFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 24/162 (14%)
Query: 314 IIGSGGFGTVYK------LAMDDGNV-FALKRIDK--LNEGFDRFFERELEILGSIKHRY 364
+GSG FG VY+ L G + A+K + K ++ F +E ++ + H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFL-KEAHLMSNFNHPN 60
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------LDWDARLNIIMGAAKGLA 418
+V L G C + +I + + GG L L + + L L+I + AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 419 YLHHDCSPRIIHRDIKSSNILL-----DGNLEARVSDFGLAK 455
YL IHRD+ + N L+ D + ++ DFGLA+
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 10/173 (5%)
Query: 308 TLDDDHI-IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+L +++I IG G G V +A + G A+K +D + E+ I+ +H+
Sbjct: 21 SLLENYIKIGEGSTGIVC-IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+V + ++ +FL GG+L + + + +L+ + + + L YLH
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--- 134
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S +IHRDIKS +ILL + ++SDFG + + ++V GT ++AP
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 24/179 (13%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK-HRYLVNL 368
+G G +G V + A+K+I + + + REL++L + H+ + L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 369 RGYCN---SPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLN-IIMGAAKGLAYLHH 422
++L +Y+ L ++ LH+ RS Q DA I GL Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEEL----MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH- 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEESHITTIVAGTFGYLAP 477
S ++HRD+K N+L++ + E ++ DFGLA+ + +T VA T Y AP
Sbjct: 123 --SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 15/180 (8%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSI 360
K E D +IG G FG V + V+A+K + K + FF E +I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 361 KHRYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
++V L +C K L + +++PGG L + W A+ +
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVL 153
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-KLLEDEESHITTIVAGTFGYLAP 477
L S +IHRD+K N+LLD + +++DFG K+ E T V GT Y++P
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 5/174 (2%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRI---DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G F VY+ + DG ALK++ D ++ +E+++L + H ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ + G L + +Q + + + L H S R++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTNG 484
RDIK +N+ + ++ D GL + + + ++V GT Y++P + NG
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 38/183 (20%)
Query: 314 IIGSGGFGTVYKLAMDDG--NVFALKRIDK------------LNEGFDRFFERELEILGS 359
++G G FG V LA G ++A+K + K + E +R L + G
Sbjct: 2 VLGKGSFGKVL-LAELKGTDELYAVKVLKKDVILQDDDVECTMTE------KRVLALAG- 53
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKG 416
KH +L L + + +++ GG L + + AR I++G
Sbjct: 54 -KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGY 474
L +LH II+RD+K N+LLD +++DFG+ K +L T+ GT Y
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDY 162
Query: 475 LAP 477
+AP
Sbjct: 163 IAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 314 IIGSGGFGTVYKLAMDDGN--VFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVN 367
++G G FG V LA G V+A+K + K D + E IL + KH +L
Sbjct: 2 VLGKGSFGKVM-LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH-HD 423
L + + +++ GG L + +RS + D + R AA+ L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFD-EPRSRFY--AAEVTLALMFLHRHG 116
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGYLAP 477
+I+RD+K NILLD +++DFG+ K +L TT GT Y+AP
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVNL 368
++G G FG V+ + N FA+K + K D E E +L + +H +L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 369 RGYCNSPTSKLLIY--DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCS 425
YC T + L + ++L GG L H +S + D GL +LH S
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGYLAP 477
I++RD+K NILLD + +++DFG+ K +L D + T GT Y+AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 88 ISADLGKLDQLKFLN--LHSNNFYGEIPSELGNCT-ELQGLSLQSNYLSGSIPSELGNLS 144
+ +++ +L +L L NN +IP +G L+ L L N + S+PS L NL
Sbjct: 105 LRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLP 163
Query: 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
NL NLD+S N LSD +P L L L ++S N
Sbjct: 164 NLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGN 196
|
Length = 394 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
E +L + +H +L L+ Y +L + ++ GG L H E++ + R
Sbjct: 45 ESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-Y 100
Query: 412 GA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIV 468
GA L YLH S +++RD+K N++LD + +++DFGL K E +
Sbjct: 101 GAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 155
Query: 469 AGTFGYLAP 477
GT YLAP
Sbjct: 156 CGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG V + G +A+K + K + + E +L + +H +L +L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA--AKGLAYLHHDCSPR 427
+ + +++ GG L H E++ + R GA L YLH S +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGK 115
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I++RD+K N++LD + +++DFGL K + + + T GT YLAP
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-CGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 23/181 (12%)
Query: 315 IGSGGFGTVYKLAMDDGN---VFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK DG +ALK+I+ G RE+ +L +KH ++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 372 CNSPTSK--LLIYDF-------LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
S + + L++D+ + +++ QL +++ G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 423 DCSPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEESHITTI--VAGTFGYLA 476
+ ++HRD+K +NIL+ G R ++D G A+L + + V TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 477 P 477
P
Sbjct: 184 P 184
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 19/179 (10%)
Query: 315 IGSGGFGTVYKLAMDDGNV---FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK DG +ALK+I+ G RE+ +L +KH +++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66
Query: 372 CNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY-----LHHDC 424
S + L++D+ R+ + + + + G K L Y +H+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 425 SPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEESHITTI--VAGTFGYLAP 477
+ ++HRD+K +NIL+ G R ++D G A+L + + V TF Y AP
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE----RELEILGSIK-HRYLVNL 368
+G G FG+VY + G + A+K K+ + F + E RE++ L + H +V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK---KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 369 RGYCNSPTSKLLIYD----FLPGGSLDEALHERSEQL--DWDARL-------NIIMGAAK 415
K + + + ++ L+ QL D + +II +
Sbjct: 64 ---------KEVFRENDELYFVFEYMEGNLY----QLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
GLA++H HRD+K N+L+ G +++DFGLA+
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 25/128 (19%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD------- 402
F +E++IL +K ++ L G C +I +++ G L++ L LD
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH--HLDDKEENGN 123
Query: 403 -------------WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
+ + L++ + A G+ YL S +HRD+ + N L+ NL +++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 450 DFGLAKLL 457
DFG+++ L
Sbjct: 181 DFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 8/116 (6%)
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLI---YDF-LPGGSLDEALHERSEQLDWD 404
E E+ LG + H ++ + S + +I YDF L DEA + L
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460
R I+ + Y+H ++IHRDIK NI L+ + + + DFG A E E
Sbjct: 269 TR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
|
Length = 501 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 9/127 (7%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E +L + +H +L L+ + + ++ GG L H E++ + R G
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-YG 101
Query: 413 A--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
A L YLH S +++RDIK N++LD + +++DFGL K + + + T G
Sbjct: 102 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CG 157
Query: 471 TFGYLAP 477
T YLAP
Sbjct: 158 TPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 9/182 (4%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK---LNEGFDRFFERELE 355
+D+ K E + +IG G FG V + V+A+K + K + FF E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
I+ ++V L ++ +++PGG L + W AR A+
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFY----TAE 150
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
+ L S IHRD+K N+LLD + +++DFG + E GT Y+
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 476 AP 477
+P
Sbjct: 211 SP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 20/149 (13%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRI---DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V +D ++A+K + D LN + E +IL + ++V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 371 YCNSPTSKLLIYDFLPGGSLD------EALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ + D++PGG + E E + + A L + + + + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHKMGF----- 122
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGL 453
IHRDIK NIL+D + +++DFGL
Sbjct: 123 ----IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF-----DRFFERELEILGSIKHRYLVNLR 369
IG+G FG V G A + +L F + E++ + H ++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQCL 61
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQ----LDWDARLNIIMG--AAKGLAYLHHD 423
G C LL+ +F P G L L RS + + M A GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
IH D+ N L +L ++ D+GLA E+ +IT
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 329 DDGNVFALK--RIDKLNEGFDRF-FERELEILGSIKHRYLVNL--RGYCNSPTSKLLIYD 383
G+ A+K R D E R F RE + + H +V L G P +++
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--- 440
++PG +L E L L +++ LA H+ I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 441 DGNLEARVSDFGLAKLLED-EESHITTI-----VAGTFGYLAP 477
A+V DFG+ LL ++ + T+ V GT Y AP
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 39/168 (23%)
Query: 315 IGSGGFGTVYKLAMDDGNVF-----------ALKRI-DKLNEGFDRFFERELEILGSIKH 362
+G FG VYK G++F A+K + DK F+ E + ++H
Sbjct: 13 LGEDRFGKVYK-----GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------L 407
+V L G +I+ + L E L RS D + +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 408 NIIMGAAKGLAYL--HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
+I+ A G+ +L HH ++H+D+ + N+L+ L ++SD GL
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 18/50 (36%), Positives = 34/50 (68%), Gaps = 4/50 (8%)
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESH 463
+GL Y+H S ++HRD+K +N+ ++ +L ++ DFGLA++++ SH
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 48/170 (28%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---------------RELEIL 357
+G G +G V K A D G + A+K++ K+ E + + REL+I+
Sbjct: 17 LGEGTYGKVEK-AYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 358 GSIKHRYLVNLR------GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--- 408
IKH ++ L + N L+ D + + + +D RL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFIN------LVMDIMAS--------DLKKVVDRKIRLTESQ 120
Query: 409 ---IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
I++ GL LH +HRD+ +NI ++ +++DFGLA+
Sbjct: 121 VKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDD---GNVFALKRIDKLNEGFD------RFFER 352
++K+ + L IGSG G V A D G A+K KL+ F R + R
Sbjct: 14 VLKRYQNL---KPIGSGAQGIV--CAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAY-R 64
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF----LPGGSLDEALHERSEQLDWD-ARL 407
EL ++ + H+ N+ G N T + + +F L +D L + Q+D D R+
Sbjct: 65 ELVLMKLVNHK---NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMDLDHERM 120
Query: 408 N-IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ ++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+
Sbjct: 121 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 32/135 (23%), Positives = 61/135 (45%), Gaps = 13/135 (9%)
Query: 315 IGSGGFGTVYK----LAMDDGNVFA----LKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+G G F ++K D G + LK +DK + + F ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY-LHHDCS 425
G C +++ +++ GSLD L + ++ +L + AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFLED 118
Query: 426 PRIIHRDIKSSNILL 440
+ H ++ + N+LL
Sbjct: 119 KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKL--AMDDGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A+ D NV A+K++ + N+ + RE
Sbjct: 11 STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRE 66
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYD--FLPGGSLDEALHERSE-QLDWDARLNII 410
L ++ + H+ +++L +P L + +L +D L + + +LD + ++
Sbjct: 67 LVLMKCVNHKNIISLLNVF-TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
G+ +LH S IIHRD+K SNI++ + ++ DFGLA+
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 18/173 (10%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVNL 368
++G G FG V + G FA+K + K D E E +L + ++ +L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 369 RGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQLDWDARLNIIMGAAK--GLAYLHHDC 424
YC T + L + +FL GG L + ++ +D A GL +LH
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH--- 113
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S II+RD+K N++LD + +++DFG+ K ++ +T GT Y+AP
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
FFE ++ + H+++V L G C +++ +F+ G LD +H +S+ L +
Sbjct: 51 FFETA-SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440
+ A L+YL ++H ++ + NILL
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 32/120 (26%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
H +LV L + + + +F+ GG L + + + + AR I + L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 110
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAP 477
+LH II+RD+K N+LLD +++D+G+ K + ++ T+ GT Y+AP
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 25/170 (14%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A D G A+K++ + N+ + RE
Sbjct: 15 STFTVLKRYQQL---KPIGSGAQGIVCA-AFDTVLGINVAVKKLSRPFQNQTHAKRAYRE 70
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDF--------LPGGSLDEALHERSEQLDWDA 405
L +L + H+ +++L N T + + +F L +L + +H +LD +
Sbjct: 71 LVLLKCVNHKNIISL---LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHER 124
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-SEQL---DWDARLN 408
EL L + H +V S LLI ++ GG L++ + +R E L +++ L
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL- 173
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTI 467
+ L +H S +++HRD+KS+NI L ++ DFG +K D S + +
Sbjct: 174 LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 468 VAGTFGYLAP 477
GT YLAP
Sbjct: 231 FCGTPYYLAP 240
|
Length = 478 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 15/114 (13%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN- 408
F +E++IL + + L G C +I +++ G L++ L + N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETSGLACNS 124
Query: 409 --------IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452
+ M A G+ YL S +HRD+ + N L+ N +++DFG
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 35/165 (21%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+IIG+G FG VY+ + +D A+K++ L + ++ REL I+ ++ H ++ L+ Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV--LQD--PQYKNRELLIMKNLNHINIIFLKDY 127
Query: 372 CNSPTSKL--------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM----------GA 413
+ K ++ +F+P + +H+ + AR N +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-----QTVHK---YMKHYARNNHALPLFLVKLYSYQL 179
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAKLL 457
+ LAY+H S I HRD+K N+L+D N ++ DFG AK L
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 25/105 (23%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 336 LKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH 395
LK + + FFE ++ + H++LV L G C + +++ +++ G LD LH
Sbjct: 35 LKVLGSDHRDSLAFFE-TASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH 92
Query: 396 ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440
+ +L++ A L YL +++H ++ NIL+
Sbjct: 93 REKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 19/65 (29%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGK 479
+ H S R++HRDIK +N+ + ++ D GL + + + ++V GT Y++P +
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 480 DCTNG 484
NG
Sbjct: 178 IHENG 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 26/66 (39%), Positives = 38/66 (57%), Gaps = 6/66 (9%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTF 472
A GL +LH S II+RD+K N++LD +++DFG+ K E+ +TT GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 473 GYLAPG 478
Y+AP
Sbjct: 166 DYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 26/77 (33%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447
S DE E S LD D L A+G+ +L S IHRD+ + N+LL A+
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAK 252
Query: 448 VSDFGLAKLLEDEESHI 464
+ DFGLA+ + ++ +++
Sbjct: 253 ICDFGLARDIMNDSNYV 269
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 8/66 (12%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGT 471
A GL +LH S II+RD+K N++LD +++DFG+ K + + T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGT 164
Query: 472 FGYLAP 477
Y+AP
Sbjct: 165 PDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 32/187 (17%)
Query: 314 IIGSGGFGTVYKLAMDDGNV-FALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+I +G +G VY + + FA+K+I+K N+ F ER+ IL ++ ++V+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERD--ILTFAENPFVVS 65
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWD-ARLNIIMGAAKGLAYLHHDC 424
+ +C+ T + L + +++ GG L + L D AR+ L YLH
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARM-YFAETVLALEYLH--- 118
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK---------LLE-----DEESHITTIVAG 470
+ I+HRD+K N+L+ +++DFGL+K L E D + V G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 471 TFGYLAP 477
T Y+AP
Sbjct: 179 TPEYIAP 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 7/66 (10%)
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHI--TTIVAGT 471
+ L Y+H + + HRD+K NIL + + + ++ DFGLA++ D + I T VA T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-T 169
Query: 472 FGYLAP 477
Y AP
Sbjct: 170 RWYRAP 175
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK--LNEGFD-RFFERELEIL-GSIKHRYLVNL 368
+IG G + V + + ++A+K + K +N+ D + + E + + H +LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ + + +++ GG L + + + + AR + L YLH I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER---GI 117
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
I+RD+K N+LLD +++D+G+ K E T+ GT Y+AP
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 3/73 (4%)
Query: 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451
E L E LD + L+ AKG+++L S IHRD+ + NILL ++ DF
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDF 258
Query: 452 GLAKLLEDEESHI 464
GLA+ + ++ +++
Sbjct: 259 GLARDIRNDSNYV 271
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
A G+ YL S IHRD+ + N +L+ N+ V+DFGL+K
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 25/115 (21%), Positives = 54/115 (46%), Gaps = 9/115 (7%)
Query: 348 RFFERELEILGSIKHRYLVNLRGY----CNSPTSKLLIYDFLPGGSLDEALHERSEQLDW 403
E E++ L I ++ + G+ + LI ++ G L E L ++ + L +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSF 121
Query: 404 DARLNIIMGAAKGLAYLH-HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
+L++ + KGL L+ + P ++++ S + L+ N + ++ GL K+L
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL 173
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 30/143 (20%), Positives = 53/143 (37%), Gaps = 15/143 (10%)
Query: 316 GSGGFGTVYKLAMDDGNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+ K + A+K+I+ E + E+ ++H N+ Y
Sbjct: 11 EDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQ-EIITSRQLQHP---NILPYV 65
Query: 373 NSPTSK---LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S ++ + GS ++ L E L A I+ L Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 429 IHRDIKSSNILLDGNLEARVSDF 451
IHR +K+S+ILL G+ + +S
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 20/159 (12%)
Query: 314 IIGSGGFGTVYK--LAMDDGNV--FALK--RIDKLNEGFDRFFERELEILGSIKHRYLVN 367
++G G FG+V + L +DG+ A+K + D + F RE + H ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 368 LRGYCNSPTSK------LLIYDFLPGGSLDEAL-----HERSEQLDWDARLNIIMGAAKG 416
L G +K ++I F+ G L L E L + ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ YL S IHRD+ + N +L+ N+ V+DFGL+K
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 8/127 (6%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E +L + +H +L L+ + + ++ GG L H E++ + R G
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YG 101
Query: 413 A--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
A L YLH + +++RD+K N++LD + +++DFGL K + + + T G
Sbjct: 102 AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CG 158
Query: 471 TFGYLAP 477
T YLAP
Sbjct: 159 TPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 25/170 (14%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKL--AMDDGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A+ + NV A+K++ + N+ + RE
Sbjct: 18 STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNV-AIKKLSRPFQNQTHAKRAYRE 73
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDF--------LPGGSLDEALHERSEQLDWDA 405
L ++ + H+ N+ G N T + + +F L +L + + +LD +
Sbjct: 74 LVLMKCVNHK---NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHER 127
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 315 IGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG V + D N ++A+K + K L + E +IL + ++V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLA--YLHHDCS 425
+ + D++PGG + L E L AR I A A +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYI---AELTCAIESVH---K 119
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGL 453
IHRDIK NIL+D + +++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+N+ + + + L L L L L +N ++P +GN + L+ L L +N +S
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-- 268
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL 164
S LG+L+NL LD+S NSLS+ +P
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.002
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 24/153 (15%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IG G F V K + G +A+K + K + ++ RE++ L L +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRR--------LSPHP 58
Query: 373 NSPTSKLLIYDFLPG----------GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
N +++D G +L E + R L + + K L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ I HRDIK NIL+ ++ +++DFG +
Sbjct: 119 N---GIFHRDIKPENILIKDDI-LKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
NI+ GA +GL YLH + IHR+IK+S+IL+ G + VS GL+ L
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHL 148
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 22/175 (12%)
Query: 314 IIGSGGFGTVY--KLAMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYLVN 367
+IG G + V +L +D ++A+K + K +E D + + + +LV
Sbjct: 2 VIGRGSYAKVLLVRLKKND-QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLHHD 423
L C TS+L L+ +++ GG L + + + + AR AA+ L +LH
Sbjct: 61 LHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY----AAEICIALNFLHER 115
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
II+RD+K N+LLD + +++D+G+ K E T+ GT Y+AP
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTF 472
+ GL +LH II+RD+K N++LD +++DFG+ K E +TT GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 473 GYLAP 477
Y+AP
Sbjct: 166 DYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 29/119 (24%), Positives = 51/119 (42%), Gaps = 11/119 (9%)
Query: 344 EGFDRFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E F + E+ + G + + + + +L F P S + ++ L
Sbjct: 108 EFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL- 166
Query: 403 WDARLNI------IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
W + L + A+G+ +L S + IHRD+ + NILL N ++ DFGLA+
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 34/157 (21%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 315 IGSGGFGTVYK-----LAMDDGNV-FALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ + D+ A+K +++ +R F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN-------IIMGA--AKGLA 418
L G + L+I + + G L L +++ + I M A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
YL+ + + +HRD+ + N ++ + ++ DFG+ +
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
L I + + YLH + RIIHRDIK+ NI ++ + + DFG A
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 31/118 (26%), Positives = 57/118 (48%), Gaps = 13/118 (11%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQL-DWDAR 406
F +E++I+ +K ++ L C + +I +++ G L++ L HE E D
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 407 L----NIIMGA---AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
+I A A G+ YL S +HRD+ + N L+ N +++DFG+++ L
Sbjct: 126 TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.92 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.92 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.91 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.91 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.91 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.91 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.9 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.9 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.9 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.87 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.49 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.48 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.47 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.45 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.4 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.32 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.32 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.28 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.27 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.21 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.1 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.1 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.97 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.93 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.92 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.92 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.88 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.87 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.87 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.67 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.42 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.36 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=445.42 Aligned_cols=376 Identities=30% Similarity=0.514 Sum_probs=253.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|.++|.+|..+..+++|+.|||
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 45677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcccccccCCCCCCCCCCCCCCccc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQ 231 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~~~~c~~~~~~~~~~~~s~~s~~ 231 (484)
++|+++|.+|..+..+++|+.|++++|+++|.+|..+.+..+....+.||+.+|+.+.... .+.+
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---------------~~~c 619 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---------------LPPC 619 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---------------CCCC
Confidence 7777777777777777777777777777777777656666666667777777776432100 0000
Q ss_pred ccCCCCCCCceEeeeehhhhHHHHHHHHhhhhhheeccccccccCCCccccCCCcceEEecCC--CCCCHHHHHHHhcCC
Q 011486 232 NQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGD--LPYSSKDIIKKLETL 309 (484)
Q Consensus 232 ~~~~~~~~~~~ii~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~el~~~~~~~ 309 (484)
.. ..+...+.+++++++++++++++++++++++++|+..+.++ ...+ .+......+... ..++.+++ ...+
T Consensus 620 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~ 692 (968)
T PLN00113 620 KR-VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR--VENE-DGTWELQFFDSKVSKSITINDI---LSSL 692 (968)
T ss_pred cc-ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccc--cccc-cccccccccccccchhhhHHHH---HhhC
Confidence 00 11111122222222222222222222222222222111111 0000 000111111111 11333333 3457
Q ss_pred CccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 310 DDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+..+.||+|+||.||+|.. .++..||+|+++..... ..+|++.+++++||||++++++|.+++..|+||||+++|
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 7788999999999999987 47899999998754322 235688999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecc
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
+|.++++. ++|..+.+|+.||++||+|||+.++++|+||||||+||+++.++.+++. ||.+...... ...
T Consensus 769 ~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~ 838 (968)
T PLN00113 769 NLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC 838 (968)
T ss_pred cHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence 99999953 8999999999999999999997777899999999999999999988876 6665543221 123
Q ss_pred cccccccCCcccCCC
Q 011486 469 AGTFGYLAPGKDCTN 483 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~~ 483 (484)
.||+.|||||++.++
T Consensus 839 ~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 839 FISSAYVAPETRETK 853 (968)
T ss_pred cccccccCcccccCC
Confidence 589999999998753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=332.49 Aligned_cols=188 Identities=49% Similarity=0.861 Sum_probs=167.5
Q ss_pred CCCCHHHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 295 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
..|+++++.+++++|...+.||+|+||.||+|...++..||||++........++|.+|++++.+++|||+|+++|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 34899999999999999999999999999999999999999998876543214569999999999999999999999999
Q ss_pred CCc-eEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 375 PTS-KLLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 375 ~~~-~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
.+. .++|||||++|+|.++++.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 995 9999999999999999998766 89999999999999999999999888899999999999999999999999999
Q ss_pred CCcccCC-CCcceeecccccccccCCcccCCC
Q 011486 453 LAKLLED-EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 453 la~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+|+.... .....+.. .||.+|+|||++.+|
T Consensus 223 La~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 223 LAKLGPEGDTSVSTTV-MGTFGYLAPEYASTG 253 (361)
T ss_pred CcccCCccccceeeec-CCCCccCChhhhccC
Confidence 9976654 22221111 799999999999765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.39 Aligned_cols=172 Identities=29% Similarity=0.464 Sum_probs=153.2
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
...+|...+.||+|+|++||+|+.+ ++..||||.+.+. .....+.+..|+++|+.++|||||+++++++.++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888888999999999999876 5889999999865 566677889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC------CcEEEEecCCCc
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN------LEARVSDFGLAK 455 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~------~~~kl~DFGla~ 455 (484)
||||+||+|.+|++.+ +.+++.++..++.|+|.||++||+ ++||||||||+||||+.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999875 579999999999999999999994 599999999999999864 469999999999
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+.++. .....+|++.|||||+++.
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHh
Confidence 987643 3456789999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=281.63 Aligned_cols=170 Identities=34% Similarity=0.547 Sum_probs=151.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-eEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-KLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 384 (484)
+++....||+|..|+||++.++ +++.+|+|.+... ++...+++.+|++++++.+||+||.++|.|+.++. ..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444678999999999999876 6888999999543 45667899999999999999999999999999995 9999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
|++|||++++... +++++....+|+.+|++||.|||+ .++||||||||+|||++..|++||+|||.++.+... .
T Consensus 160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999999754 679999999999999999999996 369999999999999999999999999999987654 3
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
...++||..|||||.++++
T Consensus 234 a~tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGE 252 (364)
T ss_pred cccccccccccChhhhcCC
Confidence 4568899999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=284.02 Aligned_cols=173 Identities=29% Similarity=0.464 Sum_probs=149.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
.+.|.+.+.||+|+||.|-+|..+ +++.||||++++... ......++|+++|++++|||||++.+++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356778899999999999998654 799999999975321 123346799999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC---CcEEEEecCCC
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFGLA 454 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~---~~~kl~DFGla 454 (484)
.||||||++||+|.+.+-.+ +.+.+..-..+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999764 568888889999999999999995 599999999999999765 78999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
+..+.. ......+|||.|.|||++.+.|
T Consensus 327 K~~g~~--sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 327 KVSGEG--SFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred hccccc--eehhhhcCCccccChhheecCC
Confidence 988632 3456689999999999998765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=279.02 Aligned_cols=175 Identities=31% Similarity=0.450 Sum_probs=154.0
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.++||+|+||+||.++.+ +++.||+|++++.. ....+....|..++.+++||+||++.-.|++++..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999766 58899999998643 3345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|+||+.||.|..+|.+. +.+++..+.-++..|+.||.||| +++||||||||+|||+|.+|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999653 67999999999999999999999 569999999999999999999999999999965433
Q ss_pred CcceeecccccccccCCcccCCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
.. .+..++||+.|||||++...|
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred CC-ccccccCCccccChHHHhcCC
Confidence 22 345589999999999988654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=289.99 Aligned_cols=172 Identities=30% Similarity=0.479 Sum_probs=155.1
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
..|...+.||+|+|+.+|+++. ..|+.||+|++.+. .....+...+||++.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999988 78999999999863 3456778999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+|+.++|.++++ +...+++.++..+.+||+.||.||| +.+|+|||||..|++++++.++||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999997 5577999999999999999999999 55999999999999999999999999999999875432
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ....+|||.|+|||++..-
T Consensus 174 r-k~TlCGTPNYIAPEVl~k~ 193 (592)
T KOG0575|consen 174 R-KKTLCGTPNYIAPEVLNKS 193 (592)
T ss_pred c-cceecCCCcccChhHhccC
Confidence 2 3457899999999998743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.51 Aligned_cols=171 Identities=37% Similarity=0.629 Sum_probs=147.7
Q ss_pred CCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-ceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 384 (484)
++...+.+|+|+||+||++.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.++. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 334456699999999999999866669999998643 222568999999999999999999999999987 78999999
Q ss_pred CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR-IIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~ 461 (484)
+++|+|.++++. +...+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999988 467799999999999999999999965 5 99999999999999998 99999999998765432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...+...||+.|||||++++
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred -ccccCCCCCccccChhhhcC
Confidence 11233679999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=283.69 Aligned_cols=173 Identities=30% Similarity=0.437 Sum_probs=151.3
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
.+.|+.++.||+|.||.||+|+. .+|+.||+|++.... ++......+||.+|++|+||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34566778999999999999975 479999999997544 55667788999999999999999999998887 67999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|+|||++ +|.-++....-.+++.++..++.|++.||+|+| +++|+|||||.+|||||.+|.+||+|||+|+.+...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999977 999999876667999999999999999999999 669999999999999999999999999999988765
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+..+-|++|+|||.+.+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred CCcccccceEEeeccChHHhcC
Confidence 5443344445999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=277.06 Aligned_cols=171 Identities=33% Similarity=0.504 Sum_probs=146.4
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhc--CCCCceeeeEEEEEcCC----ceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSPT----SKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 379 (484)
....+..++||+|+||.||+|++. ++.||||++... ..+.|++|-++++. ++|+||++++++-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 455666789999999999999996 589999999753 35678888888765 58999999999876655 789
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC------SPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
+|+||.+.|+|.+||.. ..++|....+|+.-+++||+|||+.. +++|+|||||++|||+..|+++.|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999976 45999999999999999999999763 57899999999999999999999999999
Q ss_pred CcccCCCCcce-eecccccccccCCcccCC
Q 011486 454 AKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 454 a~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|..+.+..... +...+||.+|||||++.+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 99887644322 234689999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.57 Aligned_cols=177 Identities=25% Similarity=0.437 Sum_probs=151.0
Q ss_pred hcCCCccceeeeccceeEEEEE-ecCCCEEEEEEecc--cChhHHHHHHHHHHHHhcCCCCceeeeEE-EEEcCCc-eEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG-YCNSPTS-KLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 380 (484)
..+|++.+.||+|.||.||++. ..+|..+|.|.++- .+...++....|+.+|++++|||||++++ -+.++.+ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4567888999999999999986 45899999999873 34556788999999999999999999998 4445555 789
Q ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 381 IYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
||||+++|+|..+++. ....+++..+++++.|++.||.++|... +. |+||||||.||+|+.+|.+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999974 3455999999999999999999999532 34 8999999999999999999999999999
Q ss_pred ccCCCCcceeecccccccccCCcccCCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
.+..... .....+|||.||+||.+...|
T Consensus 177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~ 204 (375)
T KOG0591|consen 177 FLSSKTT-FAHSLVGTPYYMSPERIHESG 204 (375)
T ss_pred HhcchhH-HHHhhcCCCcccCHHHHhcCC
Confidence 9876543 345678999999999988654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=258.22 Aligned_cols=171 Identities=30% Similarity=0.470 Sum_probs=152.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||.|+||.|..++.+ +|..||+|++++.. ....+...+|..+|+.+.||+++++.+.+.+.+..|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456778899999999999999866 68899999998643 23345678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||.+||.|..+++.. +++++..+..+|.||+.||+||| +.+|++||+||+|||+|++|.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999764 67999999999999999999999 669999999999999999999999999999988653
Q ss_pred cceeecccccccccCCcccCCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
+...+|||.|+|||++++-|
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ 217 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKG 217 (355)
T ss_pred ---EEEecCCccccChHHhhcCC
Confidence 45678999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=255.81 Aligned_cols=171 Identities=28% Similarity=0.463 Sum_probs=151.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|...+.+|+|.||.||+|+.. +|+.||||+++..+ ++......+|++.++.++|+||+.+++.|...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777899999999999999754 79999999998543 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
||+. +|+..++++...++..++..++.++++|++|+| ++.|+||||||.|+||+.+|.+||+|||+|+.+.+....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9965 999999988888999999999999999999999 559999999999999999999999999999999876554
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+.. +-|.+|+|||.+.+
T Consensus 158 ~~~~-V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFG 175 (318)
T ss_pred cccc-eeeeeccChHHhcc
Confidence 4444 46999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=262.78 Aligned_cols=171 Identities=25% Similarity=0.351 Sum_probs=148.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+.|+....+|+|+||.||+|+.+ +|+.||||++.... +...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46777889999999999999877 58999999997643 4456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++. ++.+-+......++.+...++..|++.|+.|+|. .+++||||||+||||+.+|.+||+|||+|+.+......
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9987 5555565555679999999999999999999994 59999999999999999999999999999988743333
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
. +..+.|.+|+|||.+.+
T Consensus 158 Y-TDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 158 Y-TDYVATRWYRAPELLVG 175 (396)
T ss_pred h-hhhhhhhhccChhhhcc
Confidence 2 34567999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=258.31 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=149.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
.++|+..+.|++|.||.||+|+++ +++.||+|+++... .+..-.-.+||.++.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456777899999999999999876 68899999997543 33445578999999999999999999987654 56899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|||||+. +|..+++....++...++..++.|+++|++|||++ .|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999976 99999988777899999999999999999999954 8999999999999999999999999999999877
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....+..+ -|.+|+|||.+.+
T Consensus 231 ~k~~T~lV-VTLWYRaPELLLG 251 (419)
T KOG0663|consen 231 LKPYTPLV-VTLWYRAPELLLG 251 (419)
T ss_pred cccCcceE-EEeeecCHHHhcC
Confidence 65555444 5999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=274.12 Aligned_cols=171 Identities=25% Similarity=0.416 Sum_probs=149.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHH-HHHHHHHHHHhcCC-CCceeeeEEEEEcCC-ceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFD-RFFERELEILGSIK-HRYLVNLRGYCNSPT-SKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 381 (484)
.++|...+.||.|.||.||+|+.. ++..||||++++.-.... -.-.||++.|++++ |||||++.+.+.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 467888999999999999999754 689999999986543322 23468999999998 999999999999888 89999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
||||+. +|.+++++++..+++.++..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999955 99999999988899999999999999999999955 99999999999999988899999999999887644
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. -+..+.|.+|+|||++..
T Consensus 165 P--YTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred C--cchhhhcccccchHHhhh
Confidence 3 345678999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=260.83 Aligned_cols=174 Identities=33% Similarity=0.511 Sum_probs=149.4
Q ss_pred cCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--ceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 383 (484)
.+|...+.||+|.||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456678899999999999998764 8999999987654333677899999999999999999999855555 5889999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccCC--C
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLED--E 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~--~ 460 (484)
|+++|+|.+++......+++..+.++.+||++||+||| +++||||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999876557999999999999999999999 569999999999999999 79999999999987763 1
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.........||+.|||||++..|
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g 196 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNG 196 (313)
T ss_pred cccccccccCCccccCchhhcCC
Confidence 12223457899999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=260.04 Aligned_cols=170 Identities=29% Similarity=0.423 Sum_probs=144.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhc--CCCCceeeeEEEEEcCC----ceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSPT----SKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 380 (484)
.+....+.||+|+||.||+|+++ |+.||||++...+ ++.+.+|.++++. |+|+||+.+++.-..++ +.|+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45677899999999999999996 7789999997644 4668889999886 59999999998865443 4799
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
|+||.+.|||.|||.. ..++.+..++++..+|.||+|||.+ .++.|+|||||+.|||+.+++...|+|+|+|-
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999965 5699999999999999999999964 36889999999999999999999999999998
Q ss_pred ccCCCCcc---eeecccccccccCCcccCC
Q 011486 456 LLEDEESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
........ ..+..+||.+|||||++..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhh
Confidence 76544322 2345689999999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=270.08 Aligned_cols=175 Identities=29% Similarity=0.476 Sum_probs=152.5
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc----Ch-hHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCC
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL----NE-GFDRFFERELEILGSIK-HRYLVNLRGYCNSPT 376 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 376 (484)
.....|...+.||+|.||+|+.|... ++..||+|.+++. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568889999999999999999654 6899999977653 11 23556778999999999 999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAK 455 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~ 455 (484)
..|+||||+.+|+|.+++.. .+++.+..+.++++|++.|++|+| +++|+||||||+|||++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999988 678999999999999999999999 5699999999999999999 999999999999
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .........+||+.|+|||++.+.
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCC
Confidence 874 122234567899999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=270.20 Aligned_cols=171 Identities=32% Similarity=0.433 Sum_probs=153.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. +...+.+.+|++++++++||||+.++++|++..+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999766 58899999998644 4456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+.| +|..++... +.++++.+..++.|++.||.||| +.+|.|||+||.|||++..|.+|++|||+|+.+..+. .
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 9976 999999654 67999999999999999999999 5599999999999999999999999999999887643 4
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..+.+.|||.|||||.+.++
T Consensus 156 vltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred eeeeccCcccccCHHHHcCC
Confidence 55677899999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=266.76 Aligned_cols=177 Identities=28% Similarity=0.402 Sum_probs=153.4
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
.+...+|...+.||+|+|++|++|+.. .++.||||++.+.- +...+.+.+|-++|.+| .||.|++++-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344568888999999999999999765 68999999997532 33345678899999999 79999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+|+||+++|+|.++|++. +.+++..+..++.+|+.||+||| +.|||||||||+|||+|+||++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999875 67999999999999999999999 569999999999999999999999999999988
Q ss_pred CCCCcc--------e----eecccccccccCCcccCCC
Q 011486 458 EDEESH--------I----TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~--------~----~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+.... . ...++||..|.+||++..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~ 262 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS 262 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCC
Confidence 642211 1 1348999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=257.87 Aligned_cols=170 Identities=26% Similarity=0.429 Sum_probs=152.3
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+|++.+.||+|.||+|-++.. ..|+.||||.+++.. ++..-.+.+||++|+.++||||+.++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577788999999999999876 579999999997643 444567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||..+|.|.+|+.++ +.+++.++..+++||+.|+.|+|.+ ++||||||.+|||+|+++++||+|||++..+.+..
T Consensus 133 EYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 999999999999765 6799999999999999999999954 99999999999999999999999999999887643
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....++|+|-|.+||++.+
T Consensus 208 -fLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred -HHHHhcCCcccCCccccCC
Confidence 3456899999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=266.58 Aligned_cols=171 Identities=31% Similarity=0.462 Sum_probs=148.9
Q ss_pred CCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+...+.||+|.||.||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++..|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34467899999999999999988899999998753 34678999999999999999999999999999999999999999
Q ss_pred CHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 389 SLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 389 sL~~~l~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
+|.++|+. ....+...+.+.++.|||+||+||+ ++++|||||.++|||++++..+||+|||+|+.+.++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999987 4556899999999999999999999 5699999999999999999999999999999666554433332
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..-...|.|||.+..+
T Consensus 364 ~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYG 379 (468)
T ss_pred CCCCceecCHHHHhhC
Confidence 2235689999998754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=261.28 Aligned_cols=148 Identities=28% Similarity=0.432 Sum_probs=134.3
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh---hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|+...+||+|+||.||.|+.+ +|..+|+|++++... ...+....|-.+|....+|+||+++-.|++.++.||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4678999999999999999999876 599999999987652 234567889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
||||++||++..+|... ..+++..+..++.+++-|++-||+ .|+|||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999654 679999999999999999999995 5999999999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=266.56 Aligned_cols=170 Identities=26% Similarity=0.414 Sum_probs=152.7
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
..|+..+.||+|..|.||.+.. .+++.||||++....+..++-+.+|+.+|+..+|+|||.+++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999865 468899999999877777888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++|+|.|.+... .+++.++..|+++++.||+||| ..+|+|||||.+|||++.+|.+||+|||++..+.......
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR- 426 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR- 426 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc-
Confidence 999999999653 4999999999999999999999 5599999999999999999999999999999887665433
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
...+|||+|||||++..
T Consensus 427 ~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTR 443 (550)
T ss_pred ccccCCCCccchhhhhh
Confidence 44679999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=249.70 Aligned_cols=172 Identities=27% Similarity=0.396 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCc-eeeeEEEEEcCC-----
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRY-LVNLRGYCNSPT----- 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 376 (484)
...|+..+.||+|.||+||+|+.. +|+.||+|++.-.. ++......+|+.++++++|+| |+.+.+++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999765 68899999997543 345566789999999999999 999999998877
Q ss_pred -ceEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 377 -SKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
..++|+||++. +|.+++.... ..++...+..+++||++||+|||+ .+|+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 78899999954 9999998755 358888999999999999999994 599999999999999999999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|+.+.-..... +..++|.+|+|||++.+
T Consensus 166 lAra~~ip~~~y-t~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 166 LARAFSIPMRTY-TPEVVTLWYRAPEVLLG 194 (323)
T ss_pred hHHHhcCCcccc-cccEEEeeccCHHHhcC
Confidence 999776433333 34558999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=254.48 Aligned_cols=177 Identities=27% Similarity=0.400 Sum_probs=144.7
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---------hh-----HHHHHHHHHHHHhcCCCCceee
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---------EG-----FDRFFERELEILGSIKHRYLVN 367 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~-----~~~~~~~E~~~l~~l~h~niv~ 367 (484)
.+..++|+..+.||+|.||.|-+|+.. +++.||||++.+.. +. ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 455788999999999999999999876 68999999996421 11 1247889999999999999999
Q ss_pred eEEEEEcC--CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 368 LRGYCNSP--TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 368 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
++++..++ +..|||+|||..|.+...= .....+++.++++|+++++.||+|||- .+||||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 99998776 5689999999988775432 222228999999999999999999995 59999999999999999999
Q ss_pred EEEEecCCCcccCCCCc----ceeecccccccccCCcccCCC
Q 011486 446 ARVSDFGLAKLLEDEES----HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+||+|||.+........ ......+|||.|||||...+|
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 99999999987733211 112236799999999987653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=248.03 Aligned_cols=173 Identities=25% Similarity=0.368 Sum_probs=149.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.+.|+..+.||.|..++||+|+.. .+..||||+++-.. ....+.+.+|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467889999999999999999754 57999999997533 3336889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||.+||+.++++.. ...+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||....+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999863 33499999999999999999999955 999999999999999999999999998776654332
Q ss_pred ce--e-ecccccccccCCcccC
Q 011486 463 HI--T-TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~--~-~~~~Gt~~Y~APE~~~ 481 (484)
.. . ..++||+.|||||++.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred eeeEeeccccCcccccChHHhh
Confidence 21 1 4568999999999954
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=260.52 Aligned_cols=180 Identities=29% Similarity=0.434 Sum_probs=154.2
Q ss_pred CCHHHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 297 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
.+.+++....+++...+.||+|+||+||+|++. ..||||.++... +...+.|++|+..+++-+|.||+-+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344666677777888999999999999999986 358999998644 4467889999999999999999999999998
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+.. .||+.+|+|-+|+.++|.....++..+.+.||+||++||.||| .++|||||||+.||++++++.|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 887 9999999999999999987778999999999999999999999 679999999999999999999999999999
Q ss_pred cccCCC-CcceeecccccccccCCcccCC
Q 011486 455 KLLEDE-ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~-~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..-..- .........|...|||||+++.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhh
Confidence 754321 1111223458899999999863
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=258.15 Aligned_cols=173 Identities=24% Similarity=0.370 Sum_probs=148.6
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.+.||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999876 57899999986421 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999653 48899999999999999999994 59999999999999999999999999999877543
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.........||+.|+|||++..
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred CceecccCCCCcccCCHHHHhc
Confidence 3222334579999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=256.28 Aligned_cols=173 Identities=28% Similarity=0.428 Sum_probs=147.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|+||+||++... +++.||+|+++... ......+.+|++++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999765 58899999997532 223456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999754 56899999999999999999999 45999999999999999999999999999976532110
Q ss_pred ----------------------------------ceeecccccccccCCcccCCC
Q 011486 463 ----------------------------------HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ----------------------------------~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......+||+.|+|||++.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 211 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence 001235799999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=250.94 Aligned_cols=173 Identities=24% Similarity=0.379 Sum_probs=149.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+++.. +++.||+|.+.+.. ......+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999875 57889999987532 233456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875567899999999999999999999 45999999999999999999999999999987755433
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......||+.|+|||++.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred eeeccccCCcccCCHHHHhc
Confidence 33334569999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=251.26 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=149.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||++... +++.||+|.+.+.. ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999865 58899999987522 233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999765567999999999999999999999 45999999999999999999999999999987654333
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
.......||+.|+|||++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred ccccceeccccccCHHHHh
Confidence 2233356999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=232.73 Aligned_cols=173 Identities=29% Similarity=0.466 Sum_probs=151.7
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. ....+++.+|+++-+.|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3568899999999999999999865 67889999997643 3346789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
++||..+|++...+.+. ..++++.....++.|+|.|+.|+| .++|+||||||+|+|++.++..||+|||-+..-..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999999853 345999999999999999999999 67999999999999999999999999998875542
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .....+||..|.|||...+.
T Consensus 177 ~---kR~tlcgt~dyl~pEmv~~~ 197 (281)
T KOG0580|consen 177 N---KRKTLCGTLDYLPPEMVEGR 197 (281)
T ss_pred C---CceeeecccccCCHhhcCCC
Confidence 2 23457899999999998764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=255.63 Aligned_cols=148 Identities=27% Similarity=0.460 Sum_probs=132.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999875 58899999997532 233456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999754 468999999999999999999995 599999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=263.05 Aligned_cols=171 Identities=29% Similarity=0.502 Sum_probs=150.5
Q ss_pred CCccceeeeccceeEEEEEec----CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
..++++||.|.||.||+|+++ ....||||.++... +..+.+|..|..||.++.||||+++.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456889999999999999876 24579999998644 5667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
||++|+|+.+|+.+.+++++.+...+.++||.||.||-+ .++|||||.++|||++.+..+|++|||+++.++++...
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 999999999999999999999999999999999999995 59999999999999999999999999999988765433
Q ss_pred eeecccc--cccccCCcccCC
Q 011486 464 ITTIVAG--TFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~G--t~~Y~APE~~~~ 482 (484)
..+...| ..+|.|||.+..
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~ 808 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAY 808 (996)
T ss_pred cccccCCccceeecChhHhhh
Confidence 2222223 569999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=250.07 Aligned_cols=172 Identities=26% Similarity=0.420 Sum_probs=150.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999765 68899999997532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999998765679999999999999999999994 5999999999999999999999999999987765443
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
.......||+.|+|||++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred eeeecccCCccccCHHHhc
Confidence 3333456999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=253.95 Aligned_cols=147 Identities=28% Similarity=0.431 Sum_probs=131.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999998765 68899999986532 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999754 56899999999999999999999 459999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=251.26 Aligned_cols=170 Identities=27% Similarity=0.377 Sum_probs=146.8
Q ss_pred HhcCCCccceeeeccceeEEEEEecC--CCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
..++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34678889999999999999997653 3689999986432 233567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999754 468999999999999999999994 5999999999999999999999999999987643
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ....||+.|||||++.+
T Consensus 184 ~~----~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 184 RT----YTLCGTPEYIAPEILLN 202 (340)
T ss_pred Cc----ceecCChhhcCHHHHhC
Confidence 21 23569999999999764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=250.12 Aligned_cols=170 Identities=28% Similarity=0.419 Sum_probs=148.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467888999999999999999876 58899999987532 23346788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999754 568899999999999999999995 599999999999999999999999999998765432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....||+.|+|||++.+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~ 190 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSK 190 (329)
T ss_pred ----ceecCChhhcCHHHHcCC
Confidence 234699999999998653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=263.35 Aligned_cols=175 Identities=26% Similarity=0.432 Sum_probs=147.8
Q ss_pred hcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
..+.+..+.||+|.||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|.|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556788999999999998743 4567999999876644 789999999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 379 LLIYDFLPGGSLDEALHERS-------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
++|+|||..|||.++|+.+. .+++..+.+.||.|||.||+||- +..+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 99999999999999997421 22788999999999999999999 459999999999999999999
Q ss_pred EEEEecCCCcccCCCCcceee-cccccccccCCcccCCC
Q 011486 446 ARVSDFGLAKLLEDEESHITT-IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~-~~~Gt~~Y~APE~~~~~ 483 (484)
|||+|||+++.+-..+.+... ...=..+|||||.+.-|
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~ 680 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG 680 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence 999999999987654443221 11125799999998644
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=233.37 Aligned_cols=176 Identities=31% Similarity=0.487 Sum_probs=151.7
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--------hhHHHHHHHHHHHHhcC-CCCceeeeE
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--------EGFDRFFERELEILGSI-KHRYLVNLR 369 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~ 369 (484)
++-..-.+.|...+.+|+|..+.|.++.. ++++++|+|++.... ....+.-.+|+.+++++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 33445567888899999999999998754 478999999986421 12345567899999998 599999999
Q ss_pred EEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 370 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
++|+++...++|+|.|+.|.|.|++.+. -.++++...+|++|+.+|++||| .+.||||||||+|||+|++.++||+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEe
Confidence 9999999999999999999999999654 56999999999999999999999 5699999999999999999999999
Q ss_pred ecCCCcccCCCCcceeecccccccccCCcccC
Q 011486 450 DFGLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 450 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
|||+|..+++++. ....+|||+|.|||.+.
T Consensus 166 DFGFa~~l~~Gek--LrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 166 DFGFACQLEPGEK--LRELCGTPGYLAPETIK 195 (411)
T ss_pred ccceeeccCCchh--HHHhcCCCcccChhhee
Confidence 9999999987654 34578999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=242.97 Aligned_cols=165 Identities=30% Similarity=0.458 Sum_probs=136.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-----eEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-----KLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 381 (484)
.|...+++|+|+||.||+|... +++.||||++-.... .-.+|+++|+.++|||||++.-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999876 468999999876432 23469999999999999999988865422 3489
Q ss_pred EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCccc
Q 011486 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLL 457 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~ 457 (484)
||||+. +|.+.++. .+..++.-.+.-+..||.+||+||| +.+|+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99999974 2456888888889999999999999 4699999999999999965 99999999999998
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..++.... ..-|..|+|||.+.+
T Consensus 177 ~~~epniS--YicSRyYRaPELifg 199 (364)
T KOG0658|consen 177 VKGEPNIS--YICSRYYRAPELIFG 199 (364)
T ss_pred ccCCCcee--EEEeccccCHHHHcC
Confidence 87665433 334899999999865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=253.48 Aligned_cols=146 Identities=24% Similarity=0.350 Sum_probs=130.1
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999765 57899999997532 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999999754 458999999999999999999994 59999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=246.42 Aligned_cols=168 Identities=27% Similarity=0.408 Sum_probs=146.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999876 68899999986432 233566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999999754 468999999999999999999994 599999999999999999999999999998765422
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|+|||++.+
T Consensus 156 ---~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQS 172 (291)
T ss_pred ---ccccCChhhcCHHHHcC
Confidence 23468999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=248.38 Aligned_cols=172 Identities=26% Similarity=0.395 Sum_probs=148.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||++... +++.+|+|.+.+.. ......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999876 47889999986432 223455888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875567899999999999999999999 45999999999999999999999999999986644333
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
.......||+.|+|||++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred ceecccccCccccCHHHHh
Confidence 3333456999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=253.61 Aligned_cols=178 Identities=24% Similarity=0.363 Sum_probs=151.3
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 375 (484)
.++....++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999876 57899999986422 22345678899999999999999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
+..++||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999998653 4888999999999999999999 4599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..............||+.|||||++..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhc
Confidence 775433322334679999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=256.39 Aligned_cols=175 Identities=25% Similarity=0.369 Sum_probs=149.5
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
....++|....+||+|.||+|+.+..+ +++.||||.+++.. ....+....|.+++... +||++++++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999876 57899999998754 34456677888887776 49999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|.||||+.||++..+. +...+++..+..|+..|+.||+|||++ +||+||||.+|||+|.+|.+||+|||+++.-
T Consensus 444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999954433 335699999999999999999999965 9999999999999999999999999999965
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
-.... .+.+++|||.|||||++...
T Consensus 519 m~~g~-~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred CCCCC-ccccccCChhhcChhhhccC
Confidence 42222 46678999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=246.34 Aligned_cols=165 Identities=24% Similarity=0.339 Sum_probs=141.2
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.||+|+||.||++... +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 68899999997532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecc
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccce
Confidence 999998654 568999999999999999999994 5999999999999999999999999999986432221 12345
Q ss_pred cccccccCCcccCC
Q 011486 469 AGTFGYLAPGKDCT 482 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~ 482 (484)
.||+.|+|||++.+
T Consensus 156 ~gt~~y~aPE~~~~ 169 (323)
T cd05571 156 CGTPEYLAPEVLED 169 (323)
T ss_pred ecCccccChhhhcC
Confidence 69999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=243.65 Aligned_cols=172 Identities=27% Similarity=0.393 Sum_probs=146.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467899999999999999999765 68899999987533 2334567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ +|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9975 9999987665668999999999999999999994 59999999999999999999999999999865432221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 160 -~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred -ccCceecccccChHHhcC
Confidence 223458999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.22 Aligned_cols=173 Identities=24% Similarity=0.379 Sum_probs=147.8
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999875 58899999996432 2234557889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999998653 47888999999999999999994 59999999999999999999999999999876543
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.........||+.|+|||++.+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred CcccCCCCCCCcCeECHHHhcc
Confidence 3222234569999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=248.54 Aligned_cols=169 Identities=27% Similarity=0.386 Sum_probs=147.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 58899999997532 223467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999999654 468999999999999999999995 5999999999999999999999999999986643
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++.+.
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~ 173 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGK 173 (333)
T ss_pred -ccCCcccCccccChhHhcCC
Confidence 12345699999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=252.60 Aligned_cols=145 Identities=25% Similarity=0.386 Sum_probs=129.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999865 58899999986532 2234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 99999999999754 468899999999999999999995 5999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=240.94 Aligned_cols=171 Identities=28% Similarity=0.429 Sum_probs=145.4
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+++++.++|+||+++.+++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999764 68999999987532 2233467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999998886432 35899999999999999999999 45999999999999999999999999999987643322
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 158 --~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNE 176 (285)
T ss_pred --ecCCCCCCCccCHhhhcCC
Confidence 2345689999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=252.89 Aligned_cols=145 Identities=24% Similarity=0.355 Sum_probs=129.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999865 58899999987532 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999999654 468899999999999999999994 5999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=252.85 Aligned_cols=179 Identities=27% Similarity=0.391 Sum_probs=148.7
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEecC--C--CE-EEEEEecc---cChhHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDD--G--NV-FALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYC 372 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 372 (484)
.++-.-++....++||+|+||.||+|.++. + .. ||+|..+. .......+|.+|.++|+.++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344444555667899999999999998753 2 23 89999885 2355678899999999999999999999999
Q ss_pred EcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 373 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
..+...|+|||+|+||+|.++|++....++..++.+++.++|.||+||| +++++||||.++|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999987777999999999999999999999 5699999999999999999999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+++.-...... .....-..+|+|||.+.++
T Consensus 308 Ls~~~~~~~~~-~~~~klPirWLAPEtl~~~ 337 (474)
T KOG0194|consen 308 LSRAGSQYVMK-KFLKKLPIRWLAPETLNTG 337 (474)
T ss_pred cccCCcceeec-cccccCcceecChhhhccC
Confidence 98754311110 0011125789999998865
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=248.45 Aligned_cols=174 Identities=27% Similarity=0.437 Sum_probs=142.2
Q ss_pred hcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC-
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT- 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 376 (484)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999964 235689999997543 33456789999999999 8999999999987654
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC----------------------------------------------------------
Q 011486 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (484)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999997431
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce-eecccccccc
Q 011486 399 ---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGY 474 (484)
Q Consensus 399 ---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y 474 (484)
..+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23778889999999999999999 4599999999999999999999999999998764332211 1233467899
Q ss_pred cCCcccCC
Q 011486 475 LAPGKDCT 482 (484)
Q Consensus 475 ~APE~~~~ 482 (484)
+|||++.+
T Consensus 243 ~aPE~~~~ 250 (338)
T cd05102 243 MAPESIFD 250 (338)
T ss_pred cCcHHhhc
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=246.21 Aligned_cols=171 Identities=27% Similarity=0.388 Sum_probs=146.0
Q ss_pred CCCccceeeeccceeEEEEEec----CCCEEEEEEecccC----hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCce
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN----EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 378 (484)
+|++.+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|++++..++ ||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998753 57899999986532 223456888999999995 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999999754 458999999999999999999994 599999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...........||+.|+|||++.+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC
Confidence 443333344679999999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=243.27 Aligned_cols=172 Identities=25% Similarity=0.380 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 68899999987543 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++ ++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 995 68888887666678999999999999999999994 5999999999999999999999999999976543221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLG 177 (303)
T ss_pred cCCCCcccCCCCChHHHcC
Confidence 1223458999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=249.22 Aligned_cols=173 Identities=27% Similarity=0.435 Sum_probs=146.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|++++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 58899999997532 233567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999999754 56899999999999999999999 56999999999999999999999999999875532110
Q ss_pred ----------------------------------ceeecccccccccCCcccCCC
Q 011486 463 ----------------------------------HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ----------------------------------~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......+||+.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 211 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 211 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC
Confidence 001234699999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=244.94 Aligned_cols=166 Identities=25% Similarity=0.344 Sum_probs=141.2
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.||+|+||.||++... +++.||+|.++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999997532 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecc
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 999988654 468999999999999999999994 5999999999999999999999999999876432221 12335
Q ss_pred cccccccCCcccCCC
Q 011486 469 AGTFGYLAPGKDCTN 483 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~~ 483 (484)
.||+.|+|||++.++
T Consensus 156 ~gt~~y~aPE~~~~~ 170 (323)
T cd05595 156 CGTPEYLAPEVLEDN 170 (323)
T ss_pred cCCcCcCCcccccCC
Confidence 699999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=242.15 Aligned_cols=174 Identities=22% Similarity=0.357 Sum_probs=144.5
Q ss_pred cCCCccceeeeccceeEEEEEecC-----------------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeee
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-----------------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNL 368 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 368 (484)
++|+..+.||+|+||.||+|...+ +..||+|.+.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 3369999987643 3345679999999999999999999
Q ss_pred EEEEEcCCceEEEEEcCCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 011486 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (484)
Q Consensus 369 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH 430 (484)
++++.+.+..++||||+++++|.+++.... ..+++..+.+++.||+.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999986421 236788899999999999999995 59999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 431 rDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++..+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence 999999999999999999999999876543321 12233468899999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=244.30 Aligned_cols=166 Identities=26% Similarity=0.370 Sum_probs=141.7
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 68999999997532 234567888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecc
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 999988654 56899999999999999999999 45999999999999999999999999999986433221 12345
Q ss_pred cccccccCCcccCCC
Q 011486 469 AGTFGYLAPGKDCTN 483 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~~ 483 (484)
.||+.|+|||++.++
T Consensus 156 ~gt~~y~aPE~~~~~ 170 (328)
T cd05593 156 CGTPEYLAPEVLEDN 170 (328)
T ss_pred cCCcCccChhhhcCC
Confidence 699999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=252.36 Aligned_cols=170 Identities=26% Similarity=0.378 Sum_probs=149.5
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.-|+..+.||+|+.|.|..|+. .+|+.+|||.+.+.. +.....+++|+-+|+-+.||||+++++.+++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577789999999999999875 479999999998752 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|-|.+++..+ +.+++.++.++++||+.|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-.++.
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999999999765 67899999999999999999999 5699999999999999999999999999998654432
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....-+|+|.|.|||++.+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred -cccccCCCcccCCchhhcC
Confidence 2334579999999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=242.83 Aligned_cols=164 Identities=30% Similarity=0.402 Sum_probs=140.7
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||.||++... +++.||+|.++.. .......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 5789999998753 233456788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 9999754 56899999999999999999999 45999999999999999999999999999986433222 2334569
Q ss_pred cccccCCcccCCC
Q 011486 471 TFGYLAPGKDCTN 483 (484)
Q Consensus 471 t~~Y~APE~~~~~ 483 (484)
|+.|+|||++.+.
T Consensus 156 t~~y~aPE~~~~~ 168 (312)
T cd05585 156 TPEYLAPELLLGH 168 (312)
T ss_pred CcccCCHHHHcCC
Confidence 9999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=242.76 Aligned_cols=167 Identities=25% Similarity=0.348 Sum_probs=141.0
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.||+|+||.||++... +++.||+|.++... ......+.+|+++++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68899999997532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecc
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
+|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~ 156 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTF 156 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cccc
Confidence 999988654 4689999999999999999999941 59999999999999999999999999998754322221 2335
Q ss_pred cccccccCCcccCCC
Q 011486 469 AGTFGYLAPGKDCTN 483 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~~ 483 (484)
.||+.|+|||++.++
T Consensus 157 ~gt~~y~aPE~~~~~ 171 (325)
T cd05594 157 CGTPEYLAPEVLEDN 171 (325)
T ss_pred cCCcccCCHHHHccC
Confidence 699999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=248.91 Aligned_cols=173 Identities=26% Similarity=0.417 Sum_probs=149.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999876 68999999997532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC-
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE- 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~- 461 (484)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999765 568999999999999999999994 599999999999999999999999999998765432
Q ss_pred ---------------------------cceeecccccccccCCcccCCC
Q 011486 462 ---------------------------SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ---------------------------~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
........||+.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 0112335699999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=245.50 Aligned_cols=170 Identities=29% Similarity=0.421 Sum_probs=149.7
Q ss_pred hcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccCh---hHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE---GFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 380 (484)
.+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||.+.+.|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3467778999999999999998775 99999999976442 23468999999999998 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC----CCcEEEEecCCCcc
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSDFGLAKL 456 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~----~~~~kl~DFGla~~ 456 (484)
|||+++||.|.+.+... .+++..+..++.|++.|++||| +.+|+||||||+|+|+.. ++.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999776 3999999999999999999999 569999999999999963 35799999999998
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .......+||+.|+|||++..
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcC
Confidence 876 233456789999999999873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=236.09 Aligned_cols=173 Identities=20% Similarity=0.334 Sum_probs=146.1
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999753 35689999988643 33456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999998765678999999999999999999995 599999999999999999999999999877543322
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
........++..|+|||++..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~ 182 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQY 182 (266)
T ss_pred hhcccCCCCceeecCHHHHhh
Confidence 111222345678999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=242.09 Aligned_cols=166 Identities=31% Similarity=0.480 Sum_probs=140.7
Q ss_pred ceeeeccceeEEEEEe----cCCCEEEEEEecccC----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999875 357899999987532 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 9999999999654 557888999999999999999994 5999999999999999999999999999975433222 2
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~ 175 (323)
T cd05584 157 THTFCGTIEYMAPEILMRS 175 (323)
T ss_pred ccccCCCccccChhhccCC
Confidence 2345699999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=247.62 Aligned_cols=173 Identities=25% Similarity=0.469 Sum_probs=153.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-eEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-KLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 381 (484)
.+.|...+.+|+|+||.++.++.+ ++..|++|.+.... ...++...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367888999999999999998655 67899999987543 4455678999999999999999999999999988 8999
Q ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 382 YDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|+|++||++.+.+.+.+ ..++++.+..|+.|++.|+.|||+ ..|+|||||++||+++.++.|||+|||+|+.+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998765 559999999999999999999994 59999999999999999999999999999999876
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ....++||+.||.||.+.+
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSD 180 (426)
T ss_pred hh-hhheecCCCcccCHHHhCC
Confidence 53 3455789999999999864
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=251.51 Aligned_cols=165 Identities=29% Similarity=0.399 Sum_probs=145.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|...+.||.|+||.||-++.. +..+||||++.-.. ...-.++.+|+.++.+++|||+|.+.|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555678999999999999764 68899999997433 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|| -||-.|++.-...++.+..+..|..+.+.||+||| +.+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 99 56999998877778999999999999999999999 569999999999999999999999999999887653
Q ss_pred eeecccccccccCCcccC
Q 011486 464 ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~ 481 (484)
..++|||.|||||++.
T Consensus 180 --nsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVIL 195 (948)
T ss_pred --hcccCCccccchhHhe
Confidence 4578999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=238.76 Aligned_cols=173 Identities=23% Similarity=0.338 Sum_probs=146.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|++.+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999876 57889999987532 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++++.+..+. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987666554 334568999999999999999999994 59999999999999999999999999999877543332
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~ 176 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGA 176 (287)
T ss_pred cccccccccccCCcHHHcCC
Confidence 23345689999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=232.85 Aligned_cols=172 Identities=25% Similarity=0.351 Sum_probs=147.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|+..+.||+|+||.||++..+++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4677889999999999999999888899999887543 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+|+|.++++.....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 999999997655568999999999999999999995 59999999999999999999999999999876443322222
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...++..|+|||++..
T Consensus 160 ~~~~~~~y~aPE~~~~ 175 (256)
T cd05114 160 GAKFPVKWSPPEVFNF 175 (256)
T ss_pred CCCCchhhCChhhccc
Confidence 2345678999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=249.68 Aligned_cols=167 Identities=29% Similarity=0.493 Sum_probs=145.1
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++..++.+...+-||.|+.|.||+|+++ ++.||||+++... +.+|+-|++|+||||+.+.|+|.....++||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 3344445556788999999999999996 6788999986543 3578899999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
||||..|-|.+.|+.. ..+.......|..+||.||.|||.+ .|||||||+-||||..+..|||+|||.++...+..
T Consensus 191 MEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred eeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 9999999999999764 5588888999999999999999955 99999999999999999999999999999876542
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....++||..|||||++++
T Consensus 267 --TkMSFaGTVaWMAPEvIrn 285 (904)
T KOG4721|consen 267 --TKMSFAGTVAWMAPEVIRN 285 (904)
T ss_pred --hhhhhhhhHhhhCHHHhhc
Confidence 2346889999999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=252.63 Aligned_cols=173 Identities=23% Similarity=0.265 Sum_probs=147.2
Q ss_pred CCCccceeeeccceeEEEEEec-C-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-D-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.|...+.||+|++|.||+|... + +..||+|.+..........+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999998754 3 5778888776555555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 386 PGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 386 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
++|+|.++++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 345889999999999999999999 45999999999999999999999999999987654322
Q ss_pred -ceeecccccccccCCcccCCC
Q 011486 463 -HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 -~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.......||+.|+|||++.++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~ 246 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK 246 (478)
T ss_pred cccccccCCCccccCHhHhCCC
Confidence 123345699999999988653
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=238.20 Aligned_cols=168 Identities=29% Similarity=0.439 Sum_probs=150.2
Q ss_pred CCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
|++.+.||+|+||.||++.. +.|+++|+|.+.... ..+++.+|+.+|++.+.|+||+++|.|......|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55678899999999999855 469999999997644 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+..+.++.++..+++.++..+.+..++||+|||. ..-+|||||+.|||++.+|.+||+|||.|..+.+.... ...
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCc
Confidence 99999999988999999999999999999999995 47899999999999999999999999999887654332 345
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
+.|||-|||||+++.
T Consensus 189 VIGTPFWMAPEVI~E 203 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEE 203 (502)
T ss_pred cccCcccccHHHHHH
Confidence 779999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=239.16 Aligned_cols=170 Identities=22% Similarity=0.310 Sum_probs=142.9
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCCceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 382 (484)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 47789999987532 2345667889999999976 46888999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999998654 468999999999999999999994 5999999999999999999999999999875432221
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
......||+.|+|||++.+
T Consensus 157 -~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred -ceeeecCCccccChhhhcC
Confidence 2234569999999999865
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=239.52 Aligned_cols=171 Identities=28% Similarity=0.425 Sum_probs=148.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999876 57889999987542 3445779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999999999754 4589999999999999999999952 369999999999999999999999999998664322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 159 -~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQG 176 (331)
T ss_pred -cccCCCCcCcCCHhHhcC
Confidence 233568999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=239.35 Aligned_cols=165 Identities=31% Similarity=0.431 Sum_probs=141.4
Q ss_pred ceeeeccceeEEEEEe----cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 313 HIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
+.||+|+||.||+++. .+++.+|+|+++... ......+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997533 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999999654 468999999999999999999994 5999999999999999999999999999986644322 223
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...||+.|+|||++..
T Consensus 157 ~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 157 SFCGTVEYMAPEVVNR 172 (318)
T ss_pred cccCChhhcCHHHHcC
Confidence 4569999999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=233.20 Aligned_cols=147 Identities=27% Similarity=0.377 Sum_probs=130.9
Q ss_pred cCCCccceeeeccceeEEEEEecC-CCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+.|+..+.||+|.-|+||.++..+ +..+|+|++.+.. .....+.+.|-+||+.+.||.++.+++.++.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345567889999999999999875 5889999998754 233467888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 383 DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
|||+||+|..+.+.+. +.+++..+..++.+|+-||+|||. .|||.|||||+||||.+||++-|+||.++..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999987653 459999999999999999999994 5999999999999999999999999998764
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=239.33 Aligned_cols=166 Identities=23% Similarity=0.393 Sum_probs=140.7
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||++... +++.||+|.++... ....+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 58899999997532 23345688899999988 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence 9999988654 569999999999999999999994 5999999999999999999999999999975322211 1234
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 156 ~~gt~~y~aPE~~~~~ 171 (329)
T cd05588 156 FCGTPNYIAPEILRGE 171 (329)
T ss_pred ccCCccccCHHHHcCC
Confidence 5699999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=238.81 Aligned_cols=166 Identities=23% Similarity=0.397 Sum_probs=140.0
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||++... +++.+|+|.+++. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5789999999753 223445678899888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 9999988654 568999999999999999999994 5999999999999999999999999999975432221 1234
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 156 ~~gt~~y~aPE~~~~~ 171 (329)
T cd05618 156 FCGTPNYIAPEILRGE 171 (329)
T ss_pred ccCCccccCHHHHcCC
Confidence 5699999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-30 Score=229.59 Aligned_cols=171 Identities=30% Similarity=0.404 Sum_probs=146.4
Q ss_pred hcCCCccceeeeccceeEEEEE-ecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.|++.+.||+|.|+.||++. ..+|+.+|+|.++.. .....+.+.+|+++-+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3567888999999999999974 457999999988642 3445778999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~~~~~ 459 (484)
|+|+|++|..-+-.+ ..+++..+-.+++||++||.|+|. .+|||||+||+|+++. ..-.+||+|||+|..+.+
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999998777655 458889999999999999999995 4999999999999995 344699999999999884
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+ ......+|||+|||||++..
T Consensus 166 g--~~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 166 G--EAWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred c--cccccccCCCcccCHHHhhc
Confidence 3 23455789999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=238.64 Aligned_cols=171 Identities=27% Similarity=0.438 Sum_probs=147.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368899999999999999999876 5788999988754 23445679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 99999999999754 4589999999999999999999952 379999999999999999999999999997664321
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||..|+|||++.+
T Consensus 159 -~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQG 176 (333)
T ss_pred -cccCCCCccccCHHHhcC
Confidence 223468999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=265.77 Aligned_cols=179 Identities=26% Similarity=0.379 Sum_probs=159.6
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 375 (484)
.++.-..++|.+.++||+|+||.|..++.+ ++++||+|+++++. ......|..|-.+|..-+.+-|+.+.-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455556789999999999999999999876 58899999998743 33456788999999999999999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
.+.|+|||||+||+|-.++.... +++++.+..++..|+-||.-|| +.|+|||||||+|||||.+|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999998765 7999999999999999999999 6699999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+..+..-.....+|||.|++||++++
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHh
Confidence 887665555566789999999999975
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=244.70 Aligned_cols=165 Identities=24% Similarity=0.234 Sum_probs=141.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|++.+.||+|+||.||++... +++.||+|... .+.+.+|++++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999765 68899999653 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
. ++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+..........
T Consensus 166 ~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 166 K-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 5 6898888654 468999999999999999999995 5999999999999999999999999999975433222222
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|+|||++..
T Consensus 241 ~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 241 YGWAGTIATNAPELLAR 257 (391)
T ss_pred ccccCccCCCChhhhcC
Confidence 34579999999999864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=239.01 Aligned_cols=168 Identities=27% Similarity=0.381 Sum_probs=140.4
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHH---hcCCCCceeeeEEEEEcCCceEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEIL---GSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999765 68899999997532 22345566676655 567899999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|..+++. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988854 458999999999999999999994 599999999999999999999999999987543322
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. ......||+.|+|||++.+
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred C-cccccccCccccCHhHhcC
Confidence 2 2234569999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=237.63 Aligned_cols=165 Identities=25% Similarity=0.371 Sum_probs=137.6
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhc-CCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57889999987532 2233455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999998754 468999999999999999999995 599999999999999999999999999998654322 22334
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05592 156 FCGTPDYIAPEILKG 170 (316)
T ss_pred ccCCccccCHHHHcC
Confidence 569999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=244.28 Aligned_cols=175 Identities=26% Similarity=0.380 Sum_probs=144.7
Q ss_pred HhcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
..++|++.+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|++++..+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999863 245689999997543 33456788999999999 8999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC----------------------------------------------------------
Q 011486 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (484)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 399 ----------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 399 ----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
..+++..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 137888999999999999999994 5999999999999999999999999999987654322
Q ss_pred ce-eecccccccccCCcccCC
Q 011486 463 HI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....++..|+|||++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred ccccCCCCCCcceeChhHhcC
Confidence 11 112335678999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=238.28 Aligned_cols=167 Identities=31% Similarity=0.487 Sum_probs=144.0
Q ss_pred cceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 312 DHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
.++||+|.||+||-|.. ++|+.||||.+.+.. .....++++|+.+++.+.||.||.+...|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 68999999999999865 479999999998643 334578999999999999999999999999999999999999 55
Q ss_pred CHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCcccCCCCcce
Q 011486 389 SLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 389 sL~~~l~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++.+++- ...+++++.....+..||+.||.|||. ++|||.||||+|||+.+ --++||+|||+|+.++... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 6666654 456779999999999999999999994 59999999999999964 3479999999999987643 3
Q ss_pred eecccccccccCCcccCCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~~ 484 (484)
...++|||.|.|||++++-|
T Consensus 723 RrsVVGTPAYLaPEVLrnkG 742 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKG 742 (888)
T ss_pred hhhhcCCccccCHHHHhhcc
Confidence 45688999999999998644
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=238.05 Aligned_cols=166 Identities=31% Similarity=0.421 Sum_probs=137.6
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH-HHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||++... +++.+|+|++.... ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999765 68899999986532 223345555655 46779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 9999988653 568999999999999999999994 5999999999999999999999999999875432221 2234
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 156 ~~gt~~y~aPE~~~~~ 171 (325)
T cd05604 156 FCGTPEYLAPEVIRKQ 171 (325)
T ss_pred ccCChhhCCHHHHcCC
Confidence 5699999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=237.20 Aligned_cols=166 Identities=30% Similarity=0.428 Sum_probs=137.3
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH-HHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 68999999987532 122334455544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST 155 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence 9999998654 568999999999999999999995 5999999999999999999999999999976432221 2234
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 156 ~~gt~~y~aPE~~~~~ 171 (323)
T cd05575 156 FCGTPEYLAPEVLRKQ 171 (323)
T ss_pred ccCChhhcChhhhcCC
Confidence 5699999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=237.50 Aligned_cols=171 Identities=23% Similarity=0.322 Sum_probs=143.1
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+|++.+.||+|+||.||+|... +++.||+|.+.+.. ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 57899999987532 22334567788888777 5899999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999998654 468999999999999999999994 5999999999999999999999999999986432221
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++..+
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred -ccccCCCChhhcCHHHhcCC
Confidence 22345699999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=237.92 Aligned_cols=165 Identities=26% Similarity=0.390 Sum_probs=139.5
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.+.+.. ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999987532 23345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 9999998654 468999999999999999999994 5999999999999999999999999999876432221 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (320)
T cd05590 156 FCGTPDYIAPEILQE 170 (320)
T ss_pred cccCccccCHHHHcC
Confidence 569999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=243.51 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=144.6
Q ss_pred HHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
-..++|++.+.||+|+||.||+|... ++..||+|+++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457889999999999999998642 34579999997543 33456788999999999 899999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------------------------------------------------
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS--------------------------------------------------------- 398 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 398 (484)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999986421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce-e
Q 011486 399 ------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-T 465 (484)
Q Consensus 399 ------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 465 (484)
..+++..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 237888899999999999999994 599999999999999999999999999998764432211 1
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....+++.|||||++.+
T Consensus 272 ~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 272 GNARLPVKWMAPESIFD 288 (374)
T ss_pred cCCCCccceeCHHHhcC
Confidence 12335678999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=237.45 Aligned_cols=165 Identities=26% Similarity=0.371 Sum_probs=139.3
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 47899999987532 23345677888988866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 9999998654 568999999999999999999995 5999999999999999999999999999986433222 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (321)
T cd05591 156 FCGTPDYIAPEILQE 170 (321)
T ss_pred cccCccccCHHHHcC
Confidence 569999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=249.04 Aligned_cols=168 Identities=29% Similarity=0.447 Sum_probs=143.8
Q ss_pred CCccceeeeccceeEEEEE-ecCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------ceEE
Q 011486 309 LDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------SKLL 380 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 380 (484)
|.-.+.||+|+||.||+++ .+.|+.||||.++... ....+...+|++++++++|||||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999998 4579999999998643 445678899999999999999999998865543 4689
Q ss_pred EEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCC--cEEEEecCCC
Q 011486 381 IYDFLPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNL--EARVSDFGLA 454 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~--~~kl~DFGla 454 (484)
|||||.+|||...+.... ..+++.+.+.+..+++.||.|||++ +||||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998643 3499999999999999999999976 999999999999984 334 4899999999
Q ss_pred cccCCCCcceeecccccccccCCcccC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+.+.++. ....++||+.|.+||.+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHh
Confidence 9988765 456678999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=232.37 Aligned_cols=165 Identities=32% Similarity=0.417 Sum_probs=139.8
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccCh---hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||+||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999998765 688999999875321 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 391 DEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 391 ~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++..+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988753 23458999999999999999999994 59999999999999999999999999999876543322 233
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 157 ~~g~~~y~aPE~~~~~ 172 (280)
T cd05608 157 YAGTPGFMAPELLQGE 172 (280)
T ss_pred cCCCcCccCHHHhcCC
Confidence 5689999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=228.33 Aligned_cols=172 Identities=24% Similarity=0.325 Sum_probs=146.0
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
.+|+..+.||+|+||.||++..+++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999888788899999875432 34568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||+++...+.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999998765678999999999999999999995 59999999999999999999999999999876543222112
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...++..|+|||++..
T Consensus 160 ~~~~~~~y~~Pe~~~~ 175 (256)
T cd05059 160 GTKFPVKWAPPEVFDY 175 (256)
T ss_pred CCCCCccccCHHHhcc
Confidence 2224568999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=228.45 Aligned_cols=172 Identities=24% Similarity=0.347 Sum_probs=147.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|+..+.||+|+||.||++...++..+|+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677889999999999999988877789999987543 234678999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++......+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999997655578999999999999999999994 59999999999999999999999999999876543322222
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...++..|+|||++..
T Consensus 160 ~~~~~~~y~~pe~~~~ 175 (256)
T cd05113 160 GSKFPVRWSPPEVLLY 175 (256)
T ss_pred CCccChhhCCHHHHhc
Confidence 2335678999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=240.96 Aligned_cols=166 Identities=31% Similarity=0.521 Sum_probs=140.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44556788999999999999865 68999999986543 34457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+. ...++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 224 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP- 224 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-
Confidence 999998653 235677888999999999999995 59999999999999999999999999999876543221
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
.....||..|+|||++.
T Consensus 225 ~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 CNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccccccCccccCccccc
Confidence 23356999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=235.63 Aligned_cols=165 Identities=30% Similarity=0.419 Sum_probs=136.6
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH-HHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|+.. +++.||+|.+.+.. ......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999987532 222344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 9999888653 568889999999999999999994 5999999999999999999999999999876432221 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (321)
T cd05603 156 FCGTPEYLAPEVLRK 170 (321)
T ss_pred ccCCcccCCHHHhcC
Confidence 569999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=235.14 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=145.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|.+.+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367888999999999999999865 57889999987533 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9975 8988887665668999999999999999999995 59999999999999999999999999999865432221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 161 -~~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLG 178 (309)
T ss_pred -cccccccccccCCHHHhC
Confidence 123457999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=228.50 Aligned_cols=173 Identities=23% Similarity=0.374 Sum_probs=148.7
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 457888999999999999999988888999999875432 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.++++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999754 3458899999999999999999995 599999999999999999999999999998765433222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++..
T Consensus 161 ~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05072 161 REGAKFPIKWTAPEAINF 178 (261)
T ss_pred cCCCccceecCCHHHhcc
Confidence 223346778999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=227.62 Aligned_cols=173 Identities=28% Similarity=0.444 Sum_probs=147.3
Q ss_pred cCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|+..+.||+|+||.||+|.... ...+|+|.++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998752 4578999987543 33456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++......+++..+.+++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999998766679999999999999999999994 599999999999999999999999999999875222
Q ss_pred cc-eeecccccccccCCcccCC
Q 011486 462 SH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ......+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~ 182 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY 182 (266)
T ss_pred cceeccCCCCCccccChhhhcc
Confidence 21 1222335678999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=230.81 Aligned_cols=170 Identities=29% Similarity=0.442 Sum_probs=144.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999865 68899999987532 2223557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988653 2458999999999999999999995 5999999999999999999999999999987643322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++.+
T Consensus 158 --~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred --cccccCCCCccCcHHhcC
Confidence 123468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=235.44 Aligned_cols=165 Identities=25% Similarity=0.383 Sum_probs=138.6
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999997532 22345567788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence 9999998654 568999999999999999999995 5999999999999999999999999999875432222 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05620 156 FCGTPDYIAPEILQG 170 (316)
T ss_pred cCCCcCccCHHHHcC
Confidence 569999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.24 Aligned_cols=171 Identities=22% Similarity=0.323 Sum_probs=142.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667889999999999999865 68899999987532 223456778889988886 577888999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999998654 568999999999999999999994 5999999999999999999999999999986533221
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++.++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred -cccCccCCccccCHHHHcCC
Confidence 22345699999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=234.48 Aligned_cols=165 Identities=25% Similarity=0.384 Sum_probs=138.4
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhc-CCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 47889999997532 2234556678888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999999753 458999999999999999999994 5999999999999999999999999999975432221 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (316)
T cd05619 156 FCGTPDYIAPEILLG 170 (316)
T ss_pred ecCCccccCHHHHcC
Confidence 569999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=235.93 Aligned_cols=165 Identities=28% Similarity=0.408 Sum_probs=135.5
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH-HHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57789999987532 122234444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 9999999754 457888888999999999999994 5999999999999999999999999999976433221 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (325)
T cd05602 156 FCGTPEYLAPEVLHK 170 (325)
T ss_pred ccCCccccCHHHHcC
Confidence 569999999998765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=240.91 Aligned_cols=179 Identities=25% Similarity=0.320 Sum_probs=146.8
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEE
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCN 373 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 373 (484)
.....++|++.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3444678889999999999999998753 23469999997543 334567999999999996 999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcC-------------------------------------------------------
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERS------------------------------------------------------- 398 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 398 (484)
+.+..|+||||+++|+|.++++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999986421
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcE
Q 011486 399 ----------------------------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNI 438 (484)
Q Consensus 399 ----------------------------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NI 438 (484)
..+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhE
Confidence 237788889999999999999994 5999999999999
Q ss_pred EEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 439 LLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 439 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|+++++.+||+|||+++........ ......+++.|+|||++.++
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 314 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN 314 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC
Confidence 9999999999999999876433221 12233467899999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=209.56 Aligned_cols=171 Identities=27% Similarity=0.427 Sum_probs=148.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecc--cChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.+|+..+.||+|.||+||+++.+ +++.||+|+++- .+++......+|+-+++.++|.|||++++....+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35667789999999999999866 478899998864 335556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
||+. +|..+...-++.++.+....++.|+++||.|+| +.++.|||+||.|.||+.+|+.|++|||+++.++-....
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9954 999999887788999999999999999999999 569999999999999999999999999999988765444
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... +-|.+|++|.++.+
T Consensus 158 ysae-vvtlwyrppdvlfg 175 (292)
T KOG0662|consen 158 YSAE-VVTLWYRPPDVLFG 175 (292)
T ss_pred eece-eeeeeccCcceeee
Confidence 3333 35999999998754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=235.53 Aligned_cols=166 Identities=22% Similarity=0.386 Sum_probs=140.5
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.+|+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999997532 23345688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 9999988653 469999999999999999999994 5999999999999999999999999999975432221 2234
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|+|||++.++
T Consensus 156 ~~gt~~y~aPE~~~~~ 171 (327)
T cd05617 156 FCGTPNYIAPEILRGE 171 (327)
T ss_pred ccCCcccCCHHHHCCC
Confidence 5699999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=234.37 Aligned_cols=172 Identities=27% Similarity=0.428 Sum_probs=144.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.+|+..+.||+|+||.||+|.+. ++. .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 38999987543 34567899999999999999999999998765 5679
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
++||+++|+|.++++.....+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999876667899999999999999999999 459999999999999999999999999999977543
Q ss_pred Cccee-ecccccccccCCcccCC
Q 011486 461 ESHIT-TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~-~~~~Gt~~Y~APE~~~~ 482 (484)
..... ....++..|+|||++..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~ 185 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH 185 (316)
T ss_pred CcceeccCCccceeecChHHhcc
Confidence 32221 12234678999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=229.24 Aligned_cols=171 Identities=26% Similarity=0.392 Sum_probs=143.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecc--cChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-----PTSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 378 (484)
..|...+.||+|+||.|.++..+ +|+.||+|++.. .+....++..+|+++++.++|+||+.+.+.+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34555788999999999998765 689999999973 345567888999999999999999999999865 2468
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+|+|+| +.+|...++.. ..++...+..++.|+++||.|+| +-+|+|||+||+|++++.+..+||+|||+|+...
T Consensus 102 YiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred EEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecc
Confidence 9999999 55999999754 44899999999999999999999 5699999999999999999999999999999875
Q ss_pred CCC-cceeecccccccccCCcccCC
Q 011486 459 DEE-SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~-~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ....+..+-|.+|+|||++.+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhc
Confidence 421 112244567999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=239.73 Aligned_cols=171 Identities=30% Similarity=0.385 Sum_probs=150.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..|+..+.||+|.||.||+|... .++.||+|.+.-.. +..-+++++|+.++..++++||.++++.+..+...|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45667789999999999999765 68899999998543 44567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
|.+|++.+.++.. ..+++..+.-|+++++.|+.|||. .+.+|||||+.|||+..+|.+|++|||.+..+.......
T Consensus 93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999643 345888888999999999999995 499999999999999999999999999998887654433
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
..++|||.|||||++..
T Consensus 169 -~tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQ 185 (467)
T ss_pred -ccccccccccchhhhcc
Confidence 56789999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=240.60 Aligned_cols=174 Identities=24% Similarity=0.367 Sum_probs=149.9
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+.+.+.+.||+|.||.|..+....+..||||+++... ...+++|.+|+++|.+++||||++++|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456688999999999999999888999999999765 445689999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++|+|.+++..+..+ .+-....+|+.||+.||+||. +.++|||||.++|+|+|.++++||+|||+++.+-.++.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999865333 355666789999999999999 6699999999999999999999999999999776554432
Q ss_pred -eecccccccccCCcccCCC
Q 011486 465 -TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 -~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+=..+|||||.+..|
T Consensus 695 vqgr~vlpiRwmawEsillg 714 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLG 714 (807)
T ss_pred eecceeeeeeehhHHHHHhc
Confidence 2234447899999988654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=239.42 Aligned_cols=172 Identities=26% Similarity=0.382 Sum_probs=151.5
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
....|.+...||+|.|++|..++.. ++..||+|.+++.. ....+.+.+|+++|+.++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888999999999999998765 68999999998753 33445689999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+.+|.+.+++... ++..+..+..++.|+.+|++|+| ++.|||||||++|||++.+.++||+|||++..+..+.
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999999876 45566888999999999999999 5699999999999999999999999999999887533
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+|++.|.|||++.+
T Consensus 210 --~lqt~cgsppyAaPEl~~g 228 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNG 228 (596)
T ss_pred --cccccCCCCCccChHhhcC
Confidence 3445789999999999875
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=223.93 Aligned_cols=168 Identities=26% Similarity=0.434 Sum_probs=143.3
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHH
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 391 (484)
++||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4689999999999998889999999987643 334557889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeeccccc
Q 011486 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471 (484)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt 471 (484)
+++......+++..+..++.|++.||.|+|+ .+++||||||+||++++++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9997665668999999999999999999994 5999999999999999999999999999976543322222223346
Q ss_pred ccccCCcccCCC
Q 011486 472 FGYLAPGKDCTN 483 (484)
Q Consensus 472 ~~Y~APE~~~~~ 483 (484)
..|+|||++.++
T Consensus 158 ~~y~aPE~~~~~ 169 (250)
T cd05085 158 IKWTAPEALNYG 169 (250)
T ss_pred ccccCHHHhccC
Confidence 789999988654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=226.13 Aligned_cols=173 Identities=23% Similarity=0.363 Sum_probs=146.9
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356888899999999999999988888999999876432 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++.... ..+++..+..++.|++.|+.|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997643 458999999999999999999994 599999999999999999999999999998775332211
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++..
T Consensus 161 ~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05068 161 REGAKFPIKWTAPEAALY 178 (261)
T ss_pred cCCCcCceeccCcccccc
Confidence 111223468999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=250.64 Aligned_cols=174 Identities=27% Similarity=0.360 Sum_probs=144.7
Q ss_pred cCCCccceeeeccceeEEEEEecCC-CEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEE-EEEcC------Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDG-NVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRG-YCNSP------TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~------~~ 377 (484)
.++++.+.|.+|||+.||.|+...+ ..||+|++-..++...+.+.+|+++|+.|+ |+|||.+++ ..... -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3456788999999999999998876 999999998778888899999999999997 999999999 33221 24
Q ss_pred eEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 378 KLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
.+|.||||++|+|-|++..+. ..+++.++++|+.|+++|+++||.. +++|||||||-+||||+.++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 689999999999999998643 3499999999999999999999976 88999999999999999999999999999874
Q ss_pred cCCCC-ccee-------ecccccccccCCcccC
Q 011486 457 LEDEE-SHIT-------TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 457 ~~~~~-~~~~-------~~~~Gt~~Y~APE~~~ 481 (484)
.-... .... ....-|+-|+|||++.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID 228 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence 32211 1100 1123699999999874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=235.97 Aligned_cols=170 Identities=22% Similarity=0.398 Sum_probs=140.4
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----ceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 379 (484)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999865 68999999987432 233456889999999999999999999886432 479
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6899988654 458999999999999999999995 5999999999999999999999999999986533
Q ss_pred CCc--ceeecccccccccCCcccCC
Q 011486 460 EES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .......||+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhc
Confidence 221 11233569999999998753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=228.19 Aligned_cols=174 Identities=31% Similarity=0.507 Sum_probs=145.7
Q ss_pred cCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 379 (484)
+.|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999874 25789999999876666667899999999999999999999987543 4578
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 9999999999999997655668999999999999999999995 5999999999999999999999999999987754
Q ss_pred CCccee--ecccccccccCCcccCCC
Q 011486 460 EESHIT--TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~--~~~~Gt~~Y~APE~~~~~ 483 (484)
...... ....++..|+|||++.++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTES 186 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccC
Confidence 332211 122245569999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=239.55 Aligned_cols=170 Identities=29% Similarity=0.426 Sum_probs=143.4
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----ceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 379 (484)
+|+..+.||+|+||.||++... +++.||+|++... .....+++.+|+++++.++||||+++++++..++ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 6899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 5888887543 568999999999999999999994 5999999999999999999999999999987654
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..........+|+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC
Confidence 33322334468999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=222.96 Aligned_cols=173 Identities=23% Similarity=0.394 Sum_probs=145.8
Q ss_pred HHHHHHHhcCCCccceeeeccceeEEEEE-ecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCC
Q 011486 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPT 376 (484)
Q Consensus 299 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 376 (484)
++|+-+-+ .+.||+|+|+.|.-+. ..++.+||||++.+..-..+.+..+|++++...+ |+||++++++|++++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 45555554 4789999999999864 5689999999999876667788999999999985 999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecCC
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGL 453 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGl 453 (484)
.+|+|||-|.||+|..+|+++ ..+++.++.++.++|+.||.||| .+||.|||+||+|||-.+-. -+||+||.+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999999875 56999999999999999999999 56999999999999986543 499999998
Q ss_pred CcccCCCC------cceeecccccccccCCccc
Q 011486 454 AKLLEDEE------SHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 454 a~~~~~~~------~~~~~~~~Gt~~Y~APE~~ 480 (484)
..-+.... .......+|+..|||||++
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 86543211 1112345799999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=229.58 Aligned_cols=170 Identities=28% Similarity=0.431 Sum_probs=137.9
Q ss_pred cCCCccceeeeccceeEEEEEec--CCCEEEEEEecccC--hhHHHHHHHHHHHHhcC---CCCceeeeEEEEEc-----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNS----- 374 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 374 (484)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999763 46789999886432 22334566777777665 69999999999853
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999996 69999987532 348999999999999999999994 5999999999999999999999999999
Q ss_pred CcccCCCCcceeecccccccccCCcccCC
Q 011486 454 AKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 454 a~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++...... ......||+.|+|||++..
T Consensus 157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred eEeccCCc--ccccccccccccChHHHhC
Confidence 98765432 2234568999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=253.67 Aligned_cols=174 Identities=28% Similarity=0.363 Sum_probs=145.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|++.... +...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 58899999997532 334567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 383 DFLPGGSLDEALHER----------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 383 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
||+++++|.+++... ....++..+++++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998641 1235677889999999999999994 599999999999999999999999999
Q ss_pred CCcccCCCCc-----------------ceeecccccccccCCcccCCC
Q 011486 453 LAKLLEDEES-----------------HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 453 la~~~~~~~~-----------------~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+++....... ......+||+.|||||++.++
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~ 206 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV 206 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence 9987621110 001124699999999998653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=256.70 Aligned_cols=174 Identities=27% Similarity=0.455 Sum_probs=148.3
Q ss_pred cCCCccceeeeccceeEEEEEecC--CC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD--GN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
+..+..+.||+|.||.||+|...+ +. .||+|.+++.. .+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567889999999999998763 33 48999998754 556788999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 380 LIYDFLPGGSLDEALHER------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
|++|||++|+|..+|++. ...++..+.+.++.|||+|+.||+ ++++|||||.++|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 556899999999999999999999 56999999999999999999999999999
Q ss_pred CcccCCCCcceeecc-cccccccCCcccCCC
Q 011486 454 AKLLEDEESHITTIV-AGTFGYLAPGKDCTN 483 (484)
Q Consensus 454 a~~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~ 483 (484)
|+.+...+.+..... .=..+|||||.+..|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhc
Confidence 997655443322211 113589999998764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=227.79 Aligned_cols=173 Identities=25% Similarity=0.415 Sum_probs=150.7
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
..+|+..+.||+|+||.||+|...+++.+|+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688889999999999999999889999999998766555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.++++.. ...+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999763 3458999999999999999999995 59999999999999999999999999999876543222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~PE~~~~ 178 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH 178 (261)
T ss_pred ccCCCCceEecCHHHHcc
Confidence 123346778999998754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=224.77 Aligned_cols=174 Identities=28% Similarity=0.448 Sum_probs=146.3
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999764 23478999987533 33456899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999998766678999999999999999999994 599999999999999999999999999998775433
Q ss_pred cceee--cccccccccCCcccCCC
Q 011486 462 SHITT--IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~--~~~Gt~~Y~APE~~~~~ 483 (484)
..... ...++..|+|||++.++
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~ 184 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYR 184 (267)
T ss_pred ceeeecCCCccceeecCHhHhccC
Confidence 22211 12235689999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=233.90 Aligned_cols=173 Identities=28% Similarity=0.405 Sum_probs=150.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.+.|+.-++||+|+||.||-++.+ +|+.||.|++.+.. ........+|-.++.++..++||.+--.|++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456777889999999999998776 59999999886532 23345577899999999999999999899999999999
Q ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 382 YDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
+..|.||+|.-+|.... ..+++..++.++.+|+.||++|| ..+||.||+||+|||+|++|+++|+|.|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998887654 34999999999999999999999 459999999999999999999999999999998776
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ...+||.+|||||++.++
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne 361 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNE 361 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCC
Confidence 543 234799999999999764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=222.04 Aligned_cols=168 Identities=26% Similarity=0.396 Sum_probs=141.1
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999875 68899999886533 34557799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee-eccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-TIVA 469 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 469 (484)
.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766566899999999999999999999 45999999999999999999999999999986543221111 1112
Q ss_pred ccccccCCcccCCC
Q 011486 470 GTFGYLAPGKDCTN 483 (484)
Q Consensus 470 Gt~~Y~APE~~~~~ 483 (484)
++..|+|||.+.++
T Consensus 158 ~~~~y~aPE~~~~~ 171 (252)
T cd05084 158 IPVKWTAPEALNYG 171 (252)
T ss_pred CceeecCchhhcCC
Confidence 34679999988654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=231.81 Aligned_cols=165 Identities=25% Similarity=0.374 Sum_probs=139.5
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.+++.. ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999997532 23345677899999887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 9999988654 46999999999999999999999 45999999999999999999999999999875432221 1233
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~g~~~y~aPE~~~~ 170 (318)
T cd05570 156 FCGTPDYIAPEILSY 170 (318)
T ss_pred eecCccccCHHHhcC
Confidence 568999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-27 Score=225.70 Aligned_cols=164 Identities=32% Similarity=0.480 Sum_probs=138.8
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||.||++... +++.||+|.+.... ....+.+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeeccc
Q 011486 391 DEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469 (484)
Q Consensus 391 ~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 469 (484)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 98886533 348999999999999999999994 5999999999999999999999999999987654322 23346
Q ss_pred ccccccCCcccCCC
Q 011486 470 GTFGYLAPGKDCTN 483 (484)
Q Consensus 470 Gt~~Y~APE~~~~~ 483 (484)
||+.|+|||++.++
T Consensus 156 ~~~~y~aPE~~~~~ 169 (277)
T cd05607 156 GTNGYMAPEILKEE 169 (277)
T ss_pred CCCCccCHHHHccC
Confidence 89999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=224.01 Aligned_cols=171 Identities=27% Similarity=0.351 Sum_probs=147.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357889999999999999999864 6888999998754444456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.++++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999998654 468999999999999999999995 5999999999999999999999999999987643221 1
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
.....|++.|+|||.+.
T Consensus 163 ~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 163 RKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cCccccCccccCHhHcc
Confidence 22345899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=232.96 Aligned_cols=163 Identities=29% Similarity=0.389 Sum_probs=135.0
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC---CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI---KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
||+|+||+||+|+.. +++.||+|++.... ......+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 58999999986532 11223455666776655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 9999998653 568999999999999999999994 5999999999999999999999999999976433222 2234
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++.+
T Consensus 156 ~~gt~~y~aPE~~~~ 170 (330)
T cd05586 156 FCGTTEYLAPEVLLD 170 (330)
T ss_pred ccCCccccCHHHHcC
Confidence 569999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-27 Score=227.04 Aligned_cols=173 Identities=22% Similarity=0.432 Sum_probs=146.5
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999998742 345689999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 381 IYDFLPGGSLDEALHERS------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999997432 248999999999999999999994 59999999999999999999999
Q ss_pred EecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 449 SDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 449 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|||+++........ ......+++.|+|||++.+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 999999866433221 1122345788999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=225.64 Aligned_cols=171 Identities=29% Similarity=0.395 Sum_probs=149.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+.|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999876 48899999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|..++......+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-R 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-c
Confidence 9999999887655679999999999999999999994 59999999999999999999999999998765332211 1
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....|++.|+|||++.
T Consensus 168 ~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 168 DSFIGTPYWMAPEVVM 183 (292)
T ss_pred ceecCCccccCceeec
Confidence 2345889999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=245.05 Aligned_cols=177 Identities=25% Similarity=0.302 Sum_probs=146.6
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT---- 376 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 376 (484)
...++|++.+.||+|+||+||++... +++.||+|.+... .......+.+|+..+..++|+||+++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999754 6899999998653 2344567889999999999999999988775432
Q ss_pred ----ceEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 377 ----SKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 377 ----~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
..++||||+++|+|.++++.+ ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 257999999999999999753 235899999999999999999999 4599999999999999999999999
Q ss_pred ecCCCcccCCCCc-ceeecccccccccCCcccCCC
Q 011486 450 DFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 450 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|||+++.+..... .......||+.|+|||++..+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence 9999987653221 122345699999999998653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=227.00 Aligned_cols=163 Identities=18% Similarity=0.301 Sum_probs=139.2
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh---HHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEEEEEc
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG---FDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIYDF 384 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 384 (484)
...|++|+++.||+|.. +++.||||.++..... ..+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999988 6889999999764322 24678899999999999999999999876 3467899999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++|+|.+++... ..+++..+.+++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999764 4689999999999999999999952 378899999999999999999999999998664322
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
....||..|+|||++.+
T Consensus 178 -~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLND 194 (283)
T ss_pred -ccccCcccccCHHHhhh
Confidence 22458999999999854
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=239.76 Aligned_cols=167 Identities=28% Similarity=0.415 Sum_probs=149.3
Q ss_pred ceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHH
Q 011486 313 HIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 391 (484)
-+||+|.||+||-|++.+ ...+|||.+...+....+-+..||.+.++++|.|||+++|.+.+++++-|.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999998775 5568999998877777788999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCCCCcceeecc
Q 011486 392 EALHERSEQL--DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIV 468 (484)
Q Consensus 392 ~~l~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 468 (484)
++++..-+++ .+.+.-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||.++.+..- ...+..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 9999887777 7888889999999999999965 999999999999996 6799999999999987643 3445667
Q ss_pred cccccccCCcccCCC
Q 011486 469 AGTFGYLAPGKDCTN 483 (484)
Q Consensus 469 ~Gt~~Y~APE~~~~~ 483 (484)
.||..|||||++..|
T Consensus 737 TGTLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQG 751 (1226)
T ss_pred ccchhhhChHhhccC
Confidence 899999999999776
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=225.97 Aligned_cols=174 Identities=25% Similarity=0.456 Sum_probs=145.5
Q ss_pred cCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
++|++.+.||+|+||.||+|.... ...+|+|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999997643 2579999987543 334567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 380 LIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
++|||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 9999999999999997531 347889999999999999999995 5999999999999999999
Q ss_pred cEEEEecCCCcccCCCCc-ceeecccccccccCCcccCCC
Q 011486 445 EARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+||+|||+++....... .......+++.|+|||++.++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG 201 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence 999999999986643321 122334568899999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=225.45 Aligned_cols=169 Identities=28% Similarity=0.422 Sum_probs=143.7
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+||+.+.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999998765 68899999986532 22234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999999886533 35999999999999999999999 45999999999999999999999999999976543221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++.+
T Consensus 158 -~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred -ccCCCCCcCccChHHhcC
Confidence 123468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=225.46 Aligned_cols=169 Identities=27% Similarity=0.357 Sum_probs=146.5
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999876 4778899998765555567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 99999887655679999999999999999999995 5999999999999999999999999999976543221 1233
Q ss_pred ccccccccCCcccC
Q 011486 468 VAGTFGYLAPGKDC 481 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~ 481 (484)
..|++.|+|||++.
T Consensus 163 ~~~~~~y~aPE~~~ 176 (282)
T cd06643 163 FIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccCHhhcc
Confidence 46899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=224.06 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=144.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|++.+.||+|+||.||+|...+...+|+|+++.... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888999999999999999887777899999975332 3467899999999999999999999874 456799999999
Q ss_pred CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 387 GGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 387 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999753 2348999999999999999999994 5999999999999999999999999999987654332222
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||+...
T Consensus 161 ~~~~~~~~y~~PE~~~~ 177 (262)
T cd05071 161 QGAKFPIKWTAPEAALY 177 (262)
T ss_pred cCCcccceecCHhHhcc
Confidence 23346778999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-28 Score=224.19 Aligned_cols=176 Identities=26% Similarity=0.406 Sum_probs=146.4
Q ss_pred HHHhcCCCccceeeeccceeEEEEEecC-----CCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS- 374 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 374 (484)
.+....|+....||+|.||.||+|..++ .+.+|+|+++... .+......+|+.+++.++||||+.+..++.+
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 4566789999999999999999985432 3378999998643 3345667899999999999999999999877
Q ss_pred CCceEEEEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC----CcE
Q 011486 375 PTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN----LEA 446 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~----~~~ 446 (484)
+...++++||.+. +|.+.++.. ...++......|+.||+.|+.|||++ =|+||||||.|||+..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 6778999999977 899988742 23489999999999999999999965 79999999999999877 899
Q ss_pred EEEecCCCcccCCCCcce--eecccccccccCCcccCC
Q 011486 447 RVSDFGLAKLLEDEESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 447 kl~DFGla~~~~~~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
||+|||+++.+...-... ...++-|.+|+|||.+.+
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 999999999887543322 234566999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=225.57 Aligned_cols=173 Identities=24% Similarity=0.418 Sum_probs=144.4
Q ss_pred cCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5677889999999999999974 246789999997533 3344678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 381 IYDFLPGGSLDEALHERS----------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
||||+++++|.+++..+. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 237889999999999999999995 5999999999999999999
Q ss_pred cEEEEecCCCcccCCCCc-ceeecccccccccCCcccCC
Q 011486 445 EARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+||+|||+++....... .......++..|+|||++.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence 999999999987644321 11223346778999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=223.23 Aligned_cols=176 Identities=26% Similarity=0.396 Sum_probs=148.6
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+.+++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566666789999999999999865 5778999998876655667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccC
Q 011486 382 YDFLPGGSLDEALHERSEQL--DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLE 458 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~ 458 (484)
+||+++++|.+++......+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999998654445 888899999999999999994 59999999999999986 6799999999998664
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......|++.|+|||++..
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred cCCC-ccccCCCCccccChhhhcc
Confidence 3222 1223458999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=224.93 Aligned_cols=173 Identities=26% Similarity=0.469 Sum_probs=145.4
Q ss_pred CCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 379 (484)
.|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999874 357889999987543 34456799999999999999999999998775 5678
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999997655568999999999999999999994 5999999999999999999999999999987654
Q ss_pred CCcc--eeecccccccccCCcccCCC
Q 011486 460 EESH--ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~--~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......|+..|+|||++.++
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~ 187 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQS 187 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccC
Confidence 3321 11234567789999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.73 Aligned_cols=172 Identities=26% Similarity=0.411 Sum_probs=144.7
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999988888999999876433 3467999999999999999999999875 45689999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.++++... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 9999999997642 348999999999999999999995 599999999999999999999999999998765433222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~ 177 (260)
T cd05070 160 RQGAKFPIKWTAPEAALY 177 (260)
T ss_pred ccCCCCCccccChHHHhc
Confidence 222335678999998753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=222.03 Aligned_cols=162 Identities=20% Similarity=0.317 Sum_probs=137.4
Q ss_pred ceeeeccceeEEEEEecC-------------CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 313 HIIGSGGFGTVYKLAMDD-------------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
+.||+|+||.||+|...+ ...+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358889887655555667889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc-------EEEEecC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-------ARVSDFG 452 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~-------~kl~DFG 452 (484)
+||||+++++|..+++.....+++..+.+++.||+.||+||| +++|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766567999999999999999999999 569999999999999987664 8999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++...... ....|+..|+|||++..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVED 182 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcC
Confidence 98765432 12357889999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=226.35 Aligned_cols=172 Identities=27% Similarity=0.341 Sum_probs=150.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|++|.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999875 5889999999866655667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 99999999998766679999999999999999999995 59999999999999999999999999998765433222
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
.....|++.|+|||++.
T Consensus 160 ~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 160 RDTFIGTPYWMAPEVVA 176 (280)
T ss_pred cceeecchhhcCHHHHh
Confidence 22345899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=235.35 Aligned_cols=179 Identities=23% Similarity=0.344 Sum_probs=146.7
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEE
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCN 373 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 373 (484)
.....++|.+.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888999999999999999853 34689999997543 333457889999999997 999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcC-------------------------------------------------------
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERS------------------------------------------------------- 398 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 398 (484)
.++..++||||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999996431
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 011486 399 ------------------------------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (484)
Q Consensus 399 ------------------------------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~ 436 (484)
..+++..+.+++.|++.||+||| +++|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 12577788999999999999999 569999999999
Q ss_pred cEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 437 NILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 437 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|||+++++.+||+|||+++........ ......|++.|+|||++..+
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence 999999999999999999865432211 11223478899999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=225.26 Aligned_cols=174 Identities=18% Similarity=0.313 Sum_probs=143.9
Q ss_pred hcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|+..+.||+|+||.||+|... .+..+|+|++.... .....++.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 467889999999999999998653 35679999986533 33456788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 379 LLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
++||||+++++|.++++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999997532 235788899999999999999994 599999999999999999999999
Q ss_pred ecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++......... .....+++.|+|||++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 195 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence 999998664332211 112345788999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=224.53 Aligned_cols=169 Identities=27% Similarity=0.429 Sum_probs=143.6
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+.+.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999998765 68899999986532 22235577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999986532 35899999999999999999999 459999999999999999999999999999765433221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
....||..|+|||++.+
T Consensus 159 --~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 159 --KGRVGTVGYMAPEVVKN 175 (285)
T ss_pred --cCCCCCccccChHHHcC
Confidence 23468999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=224.17 Aligned_cols=173 Identities=29% Similarity=0.432 Sum_probs=142.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999864 344 47778775432 2344678889999999999999999998754 45788
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
++||+++|+|.+++......+++..+..++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++...+.
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999998766679999999999999999999994 59999999999999999999999999999876443
Q ss_pred Ccce-eecccccccccCCcccCCC
Q 011486 461 ESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....|+..|+|||++.++
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~ 186 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFG 186 (279)
T ss_pred CcccccCCCCCcccccCHHHhccC
Confidence 2221 2234577899999988643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=220.30 Aligned_cols=172 Identities=28% Similarity=0.433 Sum_probs=148.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 6889999998643 344567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.++++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 4568999999999999999999994 59999999999999999999999999999877554322
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....|++.|+|||++.++
T Consensus 158 -~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred -hhccccCccccCHHHhcCC
Confidence 2334689999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=224.55 Aligned_cols=169 Identities=33% Similarity=0.547 Sum_probs=139.5
Q ss_pred ccceeeeccceeEEEEEec-----CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 311 DDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999877 35779999996543 34478899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.++++.. ...+++..+..|+.||++||+|||+ .+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 5669999999999999999999995 48999999999999999999999999999877332221
Q ss_pred -eeecccccccccCCcccCC
Q 011486 464 -ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 -~~~~~~Gt~~Y~APE~~~~ 482 (484)
......+...|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp EESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccc
Confidence 1223446789999998753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=225.05 Aligned_cols=174 Identities=22% Similarity=0.436 Sum_probs=145.9
Q ss_pred cCCCccceeeeccceeEEEEEecC------CCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788999999999999997643 478999999765433 5678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcE
Q 011486 380 LIYDFLPGGSLDEALHERS-------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~ 446 (484)
+||||+++++|.++++... ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997532 237889999999999999999994 599999999999999999999
Q ss_pred EEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 447 RVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 447 kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
||+|||+++........ ......+++.|+|||++.++
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR 199 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccC
Confidence 99999999865432211 11233467899999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=222.65 Aligned_cols=172 Identities=24% Similarity=0.370 Sum_probs=145.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+..+.||+|++|.||+|... .++.+|+|.+.... ...+.+.+|++++++++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999865 48889999987543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999997543 348999999999999999999994 599999999999999999999999999998765433222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~ 179 (263)
T cd05052 162 HAGAKFPIKWTAPESLAY 179 (263)
T ss_pred cCCCCCccccCCHHHhcc
Confidence 222234678999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=240.15 Aligned_cols=167 Identities=21% Similarity=0.194 Sum_probs=142.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
..|.+.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46888999999999999999876 478899996432 23678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-e
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-I 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 464 (484)
. ++|.+++......+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 69999987665679999999999999999999994 59999999999999999999999999999876432211 1
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.+.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~ 337 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGD 337 (461)
T ss_pred ccccCCCcCCcCHHHHcCC
Confidence 2235699999999998653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=226.28 Aligned_cols=170 Identities=28% Similarity=0.420 Sum_probs=146.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||++... ++..+|+|.++... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999765 57888999887542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.++++.. ..+++..+..++.|++.||.|||+. .+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999999754 5689999999999999999999952 489999999999999999999999999987654322
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++.+
T Consensus 155 ~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG 172 (308)
T ss_pred cccCCCCcCccChhHhcC
Confidence 233568999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=222.80 Aligned_cols=165 Identities=25% Similarity=0.343 Sum_probs=134.9
Q ss_pred eeeeccceeEEEEEecC---CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 314 IIGSGGFGTVYKLAMDD---GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3467888776433 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce-
Q 011486 390 LDEALHERSE----QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI- 464 (484)
Q Consensus 390 L~~~l~~~~~----~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 464 (484)
|.+++..... ..++.....++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 25678889999999999999994 599999999999999999999999999987654322111
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
.....+++.|+|||++.
T Consensus 159 ~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 159 KDCHAVPLRWLAPELVE 175 (269)
T ss_pred cCCCCCcccccCHHHHh
Confidence 12234577899999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=221.91 Aligned_cols=173 Identities=18% Similarity=0.356 Sum_probs=146.8
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999865 6899999987642 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998853 23448899999999999999999995 5999999999999999999999999999987654
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....|++.|+|||++.+.
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~ 181 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccC
Confidence 3221 2234588999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.17 Aligned_cols=172 Identities=27% Similarity=0.400 Sum_probs=145.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467889999999999999999775 57899999987433 3334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++ ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 997 5999998776667899999999999999999999 459999999999999999999999999999765432221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+++.|+|||++.+
T Consensus 161 -~~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLG 178 (301)
T ss_pred -ccccceeecccCcHHHhC
Confidence 122357899999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=220.54 Aligned_cols=172 Identities=26% Similarity=0.394 Sum_probs=145.6
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||+|..++++.+|+|.+..... ....+.+|++++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 357888999999999999999988899999999876443 356789999999999999999999986 456789999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998653 345899999999999999999999 4599999999999999999999999999998765333222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++..
T Consensus 160 ~~~~~~~~~y~~pe~~~~ 177 (260)
T cd05067 160 REGAKFPIKWTAPEAINY 177 (260)
T ss_pred ccCCcccccccCHHHhcc
Confidence 223346788999998754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=223.81 Aligned_cols=171 Identities=27% Similarity=0.413 Sum_probs=148.5
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999875 68899999987543 33457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+ +++|.+++......+++.++..++.||+.||+|||+ .+++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999997666679999999999999999999994 599999999999999999999999999998775543222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||++.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 157 YSHQVATRWYRAPELLYG 174 (286)
T ss_pred cccccCcccccCceeeec
Confidence 233468999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=238.59 Aligned_cols=165 Identities=28% Similarity=0.437 Sum_probs=140.2
Q ss_pred cceeeeccceeEEEEEec-CCCEEEEEEec--c--cChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc--eEEEEEc
Q 011486 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRID--K--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS--KLLIYDF 384 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 384 (484)
.++||+|+|-+||+|.+. +|..||--.++ . ..+...++|..|+++|+.|+||||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 578999999999999775 46667633222 1 124445889999999999999999999999988766 6689999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+..|+|..|.++. +.++.+....|++||++||.|||.+ .++|+|||||-+||+|+ ..|.|||+|.|+|.......
T Consensus 125 ~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999999765 5689999999999999999999998 89999999999999998 56899999999999876533
Q ss_pred eeecccccccccCCcccC
Q 011486 464 ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~ 481 (484)
...++|||.|||||++.
T Consensus 201 -aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE 217 (632)
T ss_pred -cceeccCccccChHHHh
Confidence 23478999999999875
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=222.27 Aligned_cols=166 Identities=28% Similarity=0.422 Sum_probs=142.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778899999999999999764 6889999998653 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999997652 36888999999999999999995 599999999999999999999999999998764332
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||..|+|||++.++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 150 AKTYVGTNAYMAPERISGE 168 (279)
T ss_pred ccCCCCChhhcCceeecCC
Confidence 2335689999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=223.43 Aligned_cols=161 Identities=19% Similarity=0.284 Sum_probs=135.2
Q ss_pred eeeeccceeEEEEEecC-------------------------CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeee
Q 011486 314 IIGSGGFGTVYKLAMDD-------------------------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 368 (484)
.||+|+||.||+|.... ...+++|.+..........+.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999986421 13588898876554455678889999999999999999
Q ss_pred EEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----
Q 011486 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---- 444 (484)
Q Consensus 369 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---- 444 (484)
++++......++||||+++|+|.+++....+.+++..+.+++.||++||+||| +++|+||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999766667899999999999999999999 45999999999999997644
Q ss_pred ---cEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 445 ---EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ---~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+|++|||++....... ...++..|+|||++.+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPG 194 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcC
Confidence 48999999986543221 2347888999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=223.04 Aligned_cols=168 Identities=35% Similarity=0.495 Sum_probs=143.3
Q ss_pred CCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHH--HHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
|+..+.||+|+||+||++.... ++.+|+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998775 56899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENF 155 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEB
T ss_pred ccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccc
Confidence 99999999973 35689999999999999999999964 9999999999999999999999999999865222 2233
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....|+..|+|||++.
T Consensus 156 ~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp SSSSSSGGGSCHHHHT
T ss_pred cccccccccccccccc
Confidence 4566899999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=218.93 Aligned_cols=173 Identities=27% Similarity=0.401 Sum_probs=146.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999764 68999999986432 1123568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998754 458899999999999999999995 59999999999999999999999999999866432
Q ss_pred Cccee--ecccccccccCCcccCCC
Q 011486 461 ESHIT--TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~--~~~~Gt~~Y~APE~~~~~ 483 (484)
..... ....|+..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGE 182 (263)
T ss_pred ccccccccCCCcCccccCcceeccC
Confidence 22111 234578999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=223.97 Aligned_cols=169 Identities=30% Similarity=0.457 Sum_probs=147.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999865 58999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999999765 568999999999999999999995 59999999999999999999999999999876543
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....|++.|+|||.+.++
T Consensus 155 --~~~~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSK 173 (290)
T ss_pred --CCCCCCCccccChhhhcCC
Confidence 2234689999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=225.55 Aligned_cols=174 Identities=21% Similarity=0.354 Sum_probs=143.6
Q ss_pred cCCCccceeeeccceeEEEEEecC---------------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD---------------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRG 370 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 370 (484)
++|++.+.||+|+||.||++...+ ...||+|.++... ......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999987542 2358999987542 344567999999999999999999999
Q ss_pred EEEcCCceEEEEEcCCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEE
Q 011486 371 YCNSPTSKLLIYDFLPGGSLDEALHERS-----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 371 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NIL 439 (484)
++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999986432 136889999999999999999995 59999999999999
Q ss_pred EcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 440 LDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+++++.+||+|||+++........ ......++..|+|||++..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 999999999999999866433221 11223457789999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=231.58 Aligned_cols=169 Identities=26% Similarity=0.346 Sum_probs=140.7
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 376 (484)
..++|+..+.||+|+||.||++... ++..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999765 5889999998643 2334567889999999999999999999986543
Q ss_pred -ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 377 -SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
..|+||||+++ ++.+.++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999965 67776643 37889999999999999999995 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... ......||+.|+|||++.+
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccC
Confidence 654322 1233568999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=222.97 Aligned_cols=174 Identities=26% Similarity=0.441 Sum_probs=143.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCC----EEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
.++|+..+.||+|+||+||+|.+. ++. .||+|.+... .....+.+.+|+.+++.+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888899999999999999754 444 4799998753 344567789999999999999999999998754 568
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+++||+++|+|.++++.....+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999 45999999999999999999999999999987754
Q ss_pred CCcce-eecccccccccCCcccCCC
Q 011486 460 EESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... .....+++.|+|||++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHR 186 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccC
Confidence 32211 1122356789999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=220.41 Aligned_cols=173 Identities=27% Similarity=0.444 Sum_probs=148.0
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|++|.||++...++..+|+|.+..... ..+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888999999999999999988888999999876432 3567899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999997643 458999999999999999999995 499999999999999999999999999998765432221
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||.+.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~ 178 (261)
T cd05034 161 REGAKFPIKWTAPEAANY 178 (261)
T ss_pred hhccCCCccccCHHHhcc
Confidence 122234678999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=224.40 Aligned_cols=171 Identities=27% Similarity=0.439 Sum_probs=146.8
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999876 6899999988753 233456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
+++++|.+++... ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998753 2368999999999999999999995 2489999999999999999999999999998664322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++.+
T Consensus 158 --~~~~~~~~~y~aPE~~~~ 175 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKS 175 (286)
T ss_pred --cccCCCccCccCcchhcC
Confidence 223458899999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=220.03 Aligned_cols=161 Identities=20% Similarity=0.345 Sum_probs=136.8
Q ss_pred ceeeeccceeEEEEEecCCC-----------EEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 313 HIIGSGGFGTVYKLAMDDGN-----------VFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876433 4677876654332 6788999999999999999999999988 778999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-------cEEEEecCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-------EARVSDFGLA 454 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-------~~kl~DFGla 454 (484)
|||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765578999999999999999999994 5999999999999999888 7999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... ....++..|+|||++...
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNG 179 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCC
Confidence 876441 123467889999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=232.17 Aligned_cols=167 Identities=24% Similarity=0.246 Sum_probs=142.0
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999876 4678899975432 23568999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+. ++|.+++......+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 994 68999987766779999999999999999999994 599999999999999999999999999997543221
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++..+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~ 231 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARD 231 (357)
T ss_pred ccccccccccccCCeecCCC
Confidence 12235689999999998653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=223.99 Aligned_cols=173 Identities=22% Similarity=0.432 Sum_probs=145.8
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999998743 355689999877665556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
||||+++++|.+++.... ..+++..++.++.||+.|++|||+ .+|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999996532 237899999999999999999994 59999999999999999999
Q ss_pred EEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||+|||++......... ......|+..|+|||++..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence 999999999866443211 1223456889999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=219.48 Aligned_cols=171 Identities=28% Similarity=0.437 Sum_probs=143.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|++.+.||+|++|.||++...++..+|+|.+..... ..+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45788899999999999999988777899998875432 3567889999999999999999998875 456899999999
Q ss_pred CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 387 GGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 387 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
+++|.++++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997643 348999999999999999999995 5999999999999999999999999999987654332222
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||+...
T Consensus 161 ~~~~~~~~y~~Pe~~~~ 177 (260)
T cd05069 161 QGAKFPIKWTAPEAALY 177 (260)
T ss_pred CCCccchhhCCHHHhcc
Confidence 22346778999998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=224.94 Aligned_cols=170 Identities=25% Similarity=0.386 Sum_probs=147.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+..+.||+|++|.||++... +++.+|+|.+........+.+.+|+++++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999754 68899999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......... .
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 99999999864 348899999999999999999994 59999999999999999999999999998876543221 2
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....|++.|+|||++..
T Consensus 174 ~~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 174 STMVGTPYWMAPEVVTR 190 (296)
T ss_pred CcccCCccccCHHHHcC
Confidence 23458999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.75 Aligned_cols=170 Identities=28% Similarity=0.366 Sum_probs=146.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|+..+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999765 58899999987654444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++... +.+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06645 89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence 999999998654 468999999999999999999995 4999999999999999999999999999876643221 12
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....|+..|+|||++.
T Consensus 164 ~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 164 KSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCcccccChhhhc
Confidence 3356899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=220.75 Aligned_cols=172 Identities=26% Similarity=0.358 Sum_probs=143.7
Q ss_pred cCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|+..+.||+|+||.||+|...+ ...+|+|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999997643 3468999887654 4456789999999999999999999998875 557899
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999997755568999999999999999999995 599999999999999999999999999998765443
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
........++..|+|||++..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~ 182 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINF 182 (270)
T ss_pred ceecCCCCccccccChhhhcc
Confidence 222223334678999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=230.13 Aligned_cols=174 Identities=26% Similarity=0.407 Sum_probs=141.8
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC-Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP-TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 377 (484)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999998642 35789999987533 33446688899999999 799999999988755 45
Q ss_pred eEEEEEcCCCCCHHHHHhhcC-----------------------------------------------------------
Q 011486 378 KLLIYDFLPGGSLDEALHERS----------------------------------------------------------- 398 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 398 (484)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999986421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce-eecccccccccC
Q 011486 399 -EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLA 476 (484)
Q Consensus 399 -~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~A 476 (484)
..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+....... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257899999999999999999994 599999999999999999999999999998764332221 223446788999
Q ss_pred CcccCCC
Q 011486 477 PGKDCTN 483 (484)
Q Consensus 477 PE~~~~~ 483 (484)
||++.++
T Consensus 244 PE~~~~~ 250 (337)
T cd05054 244 PESIFDK 250 (337)
T ss_pred cHHhcCC
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=223.83 Aligned_cols=176 Identities=18% Similarity=0.302 Sum_probs=143.8
Q ss_pred HhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
..++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568899999999999999998653 24579999887543 2334568889999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 378 KLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
.++||||+++|+|.++++... ...++..+..++.|++.||.||| +++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997521 22567788999999999999999 459999999999999999999999
Q ss_pred EecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 449 SDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 449 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+|||+++........ ......++..|+|||.+.++
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 196 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccC
Confidence 999999865432211 11223357789999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=220.86 Aligned_cols=174 Identities=30% Similarity=0.519 Sum_probs=145.2
Q ss_pred cCCCccceeeeccceeEEEEEecC-C---CEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
..|++.+.||+|+||.||+|.... + ..||+|.+... .....+.|..|+++++.++||||+++.+++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999998653 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++....+.+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999998766678999999999999999999995 599999999999999999999999999998664322
Q ss_pred cce--eecccc--cccccCCcccCCC
Q 011486 462 SHI--TTIVAG--TFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~--~~~~~G--t~~Y~APE~~~~~ 483 (484)
... .....| +..|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred cccccccccCCCcceeecCHhHhccC
Confidence 211 111112 4579999998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=219.67 Aligned_cols=166 Identities=25% Similarity=0.312 Sum_probs=137.2
Q ss_pred ceeeeccceeEEEEEecC---CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD---GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997643 4578999887543 334457889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 389 SLDEALHERS----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 389 sL~~~l~~~~----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+|.++++... ...++..+..++.|++.|++|||+ .+++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 236778888999999999999994 599999999999999999999999999997654332211
Q ss_pred -eecccccccccCCcccC
Q 011486 465 -TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 -~~~~~Gt~~Y~APE~~~ 481 (484)
.....|+..|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 158 TPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cCCCcCCcccccCHhHhc
Confidence 12345788999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=218.81 Aligned_cols=173 Identities=25% Similarity=0.407 Sum_probs=147.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
.+|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46777899999999999999887788999999875432 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++......++++.+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 999999998765668999999999999999999995 59999999999999999999999999999866443221112
Q ss_pred cccccccccCCcccCCC
Q 011486 467 IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~~ 483 (484)
...++.+|+|||++.++
T Consensus 160 ~~~~~~~~~aPe~~~~~ 176 (256)
T cd05112 160 GTKFPVKWSSPEVFSFS 176 (256)
T ss_pred CCccchhhcCHhHhccC
Confidence 22356789999988643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=217.49 Aligned_cols=169 Identities=25% Similarity=0.401 Sum_probs=146.5
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||++... ++.+|+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999875 78899999986544 5678999999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999999976532 58999999999999999999994 5999999999999999999999999999987643221
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
...++..|+|||++.++
T Consensus 158 --~~~~~~~~~ape~~~~~ 174 (256)
T cd05039 158 --SGKLPVKWTAPEALREK 174 (256)
T ss_pred --cCCCcccccCchhhcCC
Confidence 22346789999988653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=218.05 Aligned_cols=165 Identities=26% Similarity=0.444 Sum_probs=136.6
Q ss_pred eeeeccceeEEEEEec---CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 314 IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.||+|+||.||+|.+. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999998764 35569999987543 334567999999999999999999999875 457899999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee--c
Q 011486 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--I 467 (484)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~--~ 467 (484)
|.+++......+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........... .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999997666679999999999999999999995 59999999999999999999999999999866443322111 1
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..++..|+|||++..
T Consensus 158 ~~~~~~y~aPE~~~~ 172 (257)
T cd05115 158 GKWPLKWYAPECINF 172 (257)
T ss_pred CCCCcccCCHHHHcc
Confidence 223578999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=221.06 Aligned_cols=173 Identities=23% Similarity=0.394 Sum_probs=145.6
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
++|+..+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 3467899988754433 4678999999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 380 LIYDFLPGGSLDEALHERS--------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 158999999999999999999995 59999999999999999999999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++..............++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc
Confidence 9987554322222233456788999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=224.21 Aligned_cols=170 Identities=26% Similarity=0.391 Sum_probs=148.3
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+..+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999986 478999999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 99999999864 348899999999999999999995 59999999999999999999999999999876543322 2
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....|++.|+|||.+.+
T Consensus 173 ~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 173 STMVGTPYWMAPEVVTR 189 (297)
T ss_pred CcccCCccccCHHHHcC
Confidence 23458999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=224.75 Aligned_cols=176 Identities=26% Similarity=0.389 Sum_probs=145.2
Q ss_pred HhcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNS 374 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 374 (484)
..++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999998641 24578999987532 33456789999999999 79999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEE
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NIL 439 (484)
....++||||+++++|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 999999999999999999997532 247888999999999999999995 59999999999999
Q ss_pred EcCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 440 LDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
+++++.+||+|||+++......... .....+++.|+|||++.++
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 214 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence 9999999999999998775432221 2223457789999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=226.22 Aligned_cols=165 Identities=27% Similarity=0.394 Sum_probs=133.5
Q ss_pred cceeeeccceeEEEEEec---CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEEEEcCC
Q 011486 312 DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIYDFLP 386 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 386 (484)
.+.||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++... ...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999987543 234578899999999999999999998653 45789999995
Q ss_pred CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE----cCCCcEEEEecCCC
Q 011486 387 GGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLA 454 (484)
Q Consensus 387 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla 454 (484)
++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888887532 1248899999999999999999994 599999999999999 46679999999999
Q ss_pred cccCCCCcc--eeecccccccccCCcccCC
Q 011486 455 KLLEDEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.+...... ......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcC
Confidence 876543221 1234568999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=221.97 Aligned_cols=170 Identities=27% Similarity=0.399 Sum_probs=143.3
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|++.+.||+|++|.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999875 68899999986432 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988886532 458999999999999999999994 5999999999999999999999999999986643322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....+++.|+|||++.+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 157 V-YTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred c-ccCCcccccccChHHhcC
Confidence 1 123357899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=227.96 Aligned_cols=171 Identities=23% Similarity=0.336 Sum_probs=151.7
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.-|+..+.||+|-|+.|-.++. -+|..||||++.+.. ......+..|++.|+-++|||||++|++..+....|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3577788999999999988864 379999999998643 4456678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE-cCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-DGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl-~~~~~~kl~DFGla~~~~~~~~ 462 (484)
.-++|+|.+||-+....+.++.+.+++.||+.|+.|+| ...+|||||||+||.+ .+-|-+||+|||++-.+.++..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999888888999999999999999999999 4699999999999877 5678999999999999887654
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
- +..+|++.|.|||++.+
T Consensus 175 L--~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 175 L--TTSCGSLAYSAPEILLG 192 (864)
T ss_pred h--hcccchhhccCchhhhc
Confidence 3 45679999999999875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=223.42 Aligned_cols=172 Identities=28% Similarity=0.411 Sum_probs=144.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|+..+.||+|++|.||+|..+ +++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467889999999999999999876 68899999986532 2223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ +|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9975 9999987765678999999999999999999994 59999999999999999999999999998754322111
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 160 -~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred -ccccccccccCCcHHhhc
Confidence 122346889999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=236.76 Aligned_cols=167 Identities=26% Similarity=0.371 Sum_probs=135.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--------C
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--------T 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 376 (484)
..+|+..+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 357899999999999999999875 58899999886532 2345799999999999999999987432 1
Q ss_pred ceEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecC
Q 011486 377 SKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFG 452 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFG 452 (484)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 78777653 3355899999999999999999999 45999999999999999664 79999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|+.+..... .....||+.|+|||++.+
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLG 244 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcC
Confidence 9987654332 223568999999998754
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=221.80 Aligned_cols=173 Identities=25% Similarity=0.344 Sum_probs=144.4
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568899999999999999999765 68899999986533 233446788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||++ +++.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++++||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 68877776555568888999999999999999995 5999999999999999999999999999986543221
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....+++.|+|||++.+
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred C-CCCccccccccCCceeec
Confidence 1 123357899999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=218.53 Aligned_cols=173 Identities=27% Similarity=0.486 Sum_probs=145.1
Q ss_pred cCCCccceeeeccceeEEEEEecC-C---CEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|+..+.||+|+||.||+|.... + ..+|+|.++... ....+.+.+|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778999999999999998752 3 378999987543 34456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999999998766679999999999999999999995 599999999999999999999999999998765332
Q ss_pred ccee--ecccccccccCCcccCC
Q 011486 462 SHIT--TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~--~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....+..|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred ccceeccCCCcCceecCHHHhhc
Confidence 2111 11223567999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=218.21 Aligned_cols=172 Identities=24% Similarity=0.400 Sum_probs=145.9
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999988788889999887543 345678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999763 3447899999999999999999995 599999999999999999999999999998765433222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++..
T Consensus 160 ~~~~~~~~~y~~PE~~~~ 177 (260)
T cd05073 160 REGAKFPIKWTAPEAINF 177 (260)
T ss_pred ccCCcccccccCHhHhcc
Confidence 223346778999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=217.70 Aligned_cols=172 Identities=28% Similarity=0.378 Sum_probs=150.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|+..+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999875 57889999998655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 9999999997765679999999999999999999995 5999999999999999999999999999987654321 12
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....|+..|+|||.+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 159 KSFIGTPYWMAPEVAAV 175 (262)
T ss_pred ccccCCccccCchhhcc
Confidence 23468899999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=216.42 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=146.3
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|++++++++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999765 6889999998643 2345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++++|||.+.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 999999998653 3458899999999999999999994 59999999999999999999999999999876543221
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++..
T Consensus 157 ~~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN 174 (255)
T ss_pred cccccCCccccCHHHHcc
Confidence 233568999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=222.06 Aligned_cols=174 Identities=21% Similarity=0.363 Sum_probs=146.1
Q ss_pred hcCCCccceeeeccceeEEEEEecC-----------------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceee
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-----------------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVN 367 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 367 (484)
.++|++.+.||+|+||.||++...+ +..+|+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987542 2468999987543 345678999999999999999999
Q ss_pred eEEEEEcCCceEEEEEcCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCc
Q 011486 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERS----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (484)
Q Consensus 368 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~N 437 (484)
+++++..++..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999997543 258999999999999999999995 599999999999
Q ss_pred EEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 438 ILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 438 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++.++.++|+|||+++........ ......+++.|+|||++..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 99999999999999999866433221 1223446789999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=217.55 Aligned_cols=172 Identities=20% Similarity=0.378 Sum_probs=147.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|++|.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999877 7899999988642 2334678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++.. ....+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999864 23448999999999999999999994 5999999999999999999999999999986654
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....|++.|+|||++.+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHE 180 (267)
T ss_pred CCcc-cceecCCccccCHHHhcc
Confidence 3221 223458999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=221.22 Aligned_cols=173 Identities=23% Similarity=0.433 Sum_probs=145.8
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.+|+..+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999998642 356889999887666667789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcE
Q 011486 381 IYDFLPGGSLDEALHERS--------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~ 446 (484)
+|||+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999997532 247899999999999999999994 599999999999999999999
Q ss_pred EEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 447 RVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 447 kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+|||+++........ ......+++.|+|||++..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 99999999866432211 1122335788999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=219.76 Aligned_cols=172 Identities=28% Similarity=0.444 Sum_probs=144.3
Q ss_pred cCCCccceeeeccceeEEEEEecC-CC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.+|++.+.||+|+||.||+|...+ +. .+|+|.+.... ......+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998653 32 58999887543 3345778999999999999999999999987 78899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 999999999999998766679999999999999999999995 59999999999999999999999999999877643
Q ss_pred Ccceee-cccccccccCCcccCC
Q 011486 461 ESHITT-IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~-~~~Gt~~Y~APE~~~~ 482 (484)
...... ...++..|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred ccceecCCCcccccccCHHHhhc
Confidence 322211 1223578999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=228.62 Aligned_cols=174 Identities=27% Similarity=0.408 Sum_probs=140.7
Q ss_pred hcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC-C
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP-T 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 376 (484)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999963 357889999997543 33456788999999999 689999999988665 4
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC----------------------------------------------------------
Q 011486 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (484)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce-eeccc
Q 011486 399 --------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVA 469 (484)
Q Consensus 399 --------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 469 (484)
..+++..+.+++.||+.||+|||+ .+|+||||||+||++++++++||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 236788889999999999999994 599999999999999999999999999998754322111 11233
Q ss_pred ccccccCCcccCC
Q 011486 470 GTFGYLAPGKDCT 482 (484)
Q Consensus 470 Gt~~Y~APE~~~~ 482 (484)
++..|+|||++.+
T Consensus 243 ~~~~y~aPE~~~~ 255 (343)
T cd05103 243 LPLKWMAPETIFD 255 (343)
T ss_pred CCcceECcHHhcC
Confidence 5678999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=217.33 Aligned_cols=171 Identities=28% Similarity=0.432 Sum_probs=145.3
Q ss_pred CCCccceeeeccceeEEEEEecCCCEEEEEEecccC------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+|+..+.||+|+||.||+|...+++.+|+|.++... ....+.+.+|++++++++|+||+++.+++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999886422 22345688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999654 458899999999999999999995 589999999999999999999999999988653211
Q ss_pred -----cceeecccccccccCCcccCC
Q 011486 462 -----SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 -----~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
........|+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred ccccccccccccCCCccccChhhhcC
Confidence 111223468999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=223.07 Aligned_cols=174 Identities=21% Similarity=0.323 Sum_probs=143.6
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
.+|++.+.||+|+||.||+|... +++.+|+|+++... ....+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34667788999999999999764 25789999997543 234567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 380 LIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
+++||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998532 124788899999999999999999 45999999999999999999
Q ss_pred cEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 445 EARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+||+|||+++........ ......+++.|+|||++.++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence 9999999999876443221 12233467899999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=229.96 Aligned_cols=170 Identities=24% Similarity=0.333 Sum_probs=141.4
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT---- 376 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 376 (484)
...++|+..+.||+|+||.||++... .++.+|+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34678999999999999999999765 5889999998753 2334567888999999999999999999886442
Q ss_pred --ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 377 --SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 377 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 46899999965 77777643 38899999999999999999994 59999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+...... ......||+.|+|||++.+
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcC
Confidence 8664322 2234568999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=216.76 Aligned_cols=167 Identities=26% Similarity=0.457 Sum_probs=144.7
Q ss_pred ceeeeccceeEEEEEecC----CCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||++.... +..+++|.++..... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998764 788999999865433 367899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 388 GSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 388 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 466999999999999999999999 46999999999999999999999999999987765
Q ss_pred CCc-ceeecccccccccCCcccCC
Q 011486 460 EES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .......+++.|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc
Confidence 331 11233457899999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=215.90 Aligned_cols=171 Identities=27% Similarity=0.454 Sum_probs=145.9
Q ss_pred CCccceeeeccceeEEEEEecC-----CCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+++.+.||+|+||.||+++..+ +..+|+|.+...... ..+.+..|++.+..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998764 478999999765433 5678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
||+++++|.+++...... +++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765444 899999999999999999999 4599999999999999999999999999998776543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
........+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~ 178 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD 178 (258)
T ss_pred ccccccCCCcccccChHHhcc
Confidence 222222336889999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=222.46 Aligned_cols=175 Identities=25% Similarity=0.385 Sum_probs=144.8
Q ss_pred HhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
..++|+..+.||+|+||.||++... +...+|+|.+.... ......+.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999998764 23678999987532 33446788999999999 7999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc
Q 011486 377 SKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~ 441 (484)
..+++|||+++|+|.++++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999999642 2358999999999999999999995 5999999999999999
Q ss_pred CCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 442 GNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 442 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
+++.+||+|||+++.+....... .....++..|+|||++.+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence 99999999999998765432211 112235678999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=222.76 Aligned_cols=175 Identities=25% Similarity=0.366 Sum_probs=145.6
Q ss_pred hcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
.++|...+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999998642 34579999987543 33456789999999999 79999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 378 KLLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
.++||||+++++|.++++.... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+|++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999975433 38999999999999999999994 5999999999999999999999999999987
Q ss_pred cCCCCcc-eeecccccccccCCcccCCC
Q 011486 457 LEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 457 ~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....... ......++..|+|||++.++
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 218 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNC 218 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccC
Confidence 6543221 11223467889999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=233.55 Aligned_cols=167 Identities=25% Similarity=0.285 Sum_probs=141.4
Q ss_pred cCCCccceeeeccceeEEEEEec---CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.+|++.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 47899999999999999998754 3577899988653 235689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+. ++|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 167 ~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 995 68988884 34669999999999999999999994 59999999999999999999999999999876543221
Q ss_pred -eeecccccccccCCcccCCC
Q 011486 464 -ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 -~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++..+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~ 262 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALD 262 (392)
T ss_pred ccccccccccCccCHhHhcCC
Confidence 12345699999999998643
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=221.21 Aligned_cols=162 Identities=20% Similarity=0.339 Sum_probs=138.1
Q ss_pred ceeeeccceeEEEEEecC--------CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999997642 234788887665555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc--------EEEEecCCCcc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--------ARVSDFGLAKL 456 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~--------~kl~DFGla~~ 456 (484)
+++|+|.++++.+...+++..++.++.||+.||+||| +.+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876566899999999999999999999 459999999999999987765 69999999876
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ....|+..|+|||++.+
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIEN 178 (258)
T ss_pred cCCc-----hhccccCCccCchhccC
Confidence 5432 22457889999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=222.04 Aligned_cols=171 Identities=25% Similarity=0.408 Sum_probs=148.2
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999875 468999999997655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 99999999864 358999999999999999999994 59999999999999999999999999998876543322 2
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
....|++.|+|||.+.++
T Consensus 173 ~~~~~~~~y~aPE~~~~~ 190 (296)
T cd06655 173 STMVGTPYWMAPEVVTRK 190 (296)
T ss_pred CCcCCCccccCcchhcCC
Confidence 234589999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=219.25 Aligned_cols=174 Identities=20% Similarity=0.322 Sum_probs=145.2
Q ss_pred hcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||++...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999987642 4689999987543 33456788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 379 LLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999996421 23688899999999999999999 4599999999999999999999999
Q ss_pred ecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++.+...... ......++..|+|||++.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc
Confidence 99999876543221 1223446889999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=222.05 Aligned_cols=177 Identities=27% Similarity=0.415 Sum_probs=146.7
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEE----
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCN---- 373 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 373 (484)
+++....++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 455566789999999999999999999765 57889999886532 2346788899999999 6999999999874
Q ss_pred -cCCceEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 374 -SPTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 374 -~~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
..+..++||||+++++|.++++. ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEc
Confidence 33568999999999999998763 23458899999999999999999994 599999999999999999999999
Q ss_pred ecCCCcccCCCCcceeecccccccccCCcccC
Q 011486 450 DFGLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 450 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
|||+++........ .....|++.|+|||++.
T Consensus 167 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 167 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIA 197 (286)
T ss_pred cCCceeecccCCCc-cccccCCCcccChhhhc
Confidence 99999876543221 22346899999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=222.52 Aligned_cols=170 Identities=25% Similarity=0.426 Sum_probs=144.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-----hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+|+..+.||+|++|.||+|... +++.||+|.+..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999865 688999999975432 2345677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+ +++|.+++......+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999997654469999999999999999999994 599999999999999999999999999998775433
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ....+++.|+|||++.+
T Consensus 157 ~~~-~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 157 RKM-THQVVTRWYRAPELLFG 176 (298)
T ss_pred ccc-cccccceeeeCHHHHhC
Confidence 221 22346889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=219.72 Aligned_cols=173 Identities=19% Similarity=0.368 Sum_probs=147.0
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|++|.||++.. .+++.+|+|.+... ......++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 47899999988643 2334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864 23458999999999999999999994 5999999999999999999999999999887654
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....|+..|+|||++.+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~ 181 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCC
Confidence 3321 2234589999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=223.37 Aligned_cols=175 Identities=26% Similarity=0.368 Sum_probs=143.6
Q ss_pred hcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|.+.+.||+|+||.||++... +...+|+|.++... ......+.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999998753 23569999997542 33456788899999999 799999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..|+||||+++++|.+++.... ..+++.++++++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999997532 248899999999999999999995 599999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
++++.+||+|||.++......... .....+++.|+|||++.++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC
Confidence 999999999999998664322111 1122345789999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=215.93 Aligned_cols=170 Identities=29% Similarity=0.454 Sum_probs=149.7
Q ss_pred cCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|+..+.||+|++|.||++...+ ++.+++|.+..... .+.+.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999998775 78999999876433 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 9999999997766679999999999999999999995 4999999999999999999999999999987754332 12
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....|+..|+|||++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 157 NTVIGTPFWMAPEVIQE 173 (256)
T ss_pred ccccCCccccCHHHHhc
Confidence 33458999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=223.06 Aligned_cols=172 Identities=29% Similarity=0.443 Sum_probs=140.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCC--EEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGN--VFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|... ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888999999999999999865 343 45778776532 34456788999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
||||+++++|.++++... ..+++.+++.++.|++.|++||| +.+|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999997532 24789999999999999999999 459999999999999999999
Q ss_pred EEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||+|||+++...... ......++..|+|||++..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 197 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY 197 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhc
Confidence 9999999987432111 1112234678999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=220.48 Aligned_cols=170 Identities=28% Similarity=0.439 Sum_probs=137.6
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcC---CCCceeeeEEEEEcC-----C
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNSP-----T 376 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 376 (484)
+|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999776 68899999987532 22234566787777665 699999999988643 3
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 377 SKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 47899999974 8988887543 348999999999999999999994 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....... .....||+.|+|||++.++
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQS 182 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCC
Confidence 7653321 2335689999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=215.05 Aligned_cols=171 Identities=23% Similarity=0.367 Sum_probs=147.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999998754 5888999988643 244567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999764 3458999999999999999999995 4999999999999999999999999999987654332
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......|++.|+|||++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG 175 (256)
T ss_pred cccccCCCccccCHhhcCC
Confidence 2234568999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=238.46 Aligned_cols=170 Identities=28% Similarity=0.357 Sum_probs=147.5
Q ss_pred CCCccceeeeccceeEEEEEecCCC-EEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
.|.++..||.|+||.||++..++.. ..|.|.+........++|.-||++|+...||+||++++.|+.++..||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4555677999999999999877544 446788877666778899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
||-++..+-+-...+.+.++.-+++|++.||.||| +..|||||||+.|||++-||.++|+|||.+........ ...
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-kRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-KRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh-hhc
Confidence 99999998887778999999999999999999999 55999999999999999999999999998765433221 124
Q ss_pred cccccccccCCcccC
Q 011486 467 IVAGTFGYLAPGKDC 481 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~ 481 (484)
.+.|||+|||||++.
T Consensus 189 sFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVM 203 (1187)
T ss_pred cccCCcccccchhee
Confidence 578999999999875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=213.65 Aligned_cols=168 Identities=29% Similarity=0.446 Sum_probs=142.6
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEEecccCh-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHH
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 391 (484)
+.||+|++|.||++...+++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999887799999999876443 25678999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee-ecccc
Q 011486 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-TIVAG 470 (484)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~G 470 (484)
+++......+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997665668999999999999999999995 4999999999999999999999999999986643221111 11224
Q ss_pred cccccCCcccCCC
Q 011486 471 TFGYLAPGKDCTN 483 (484)
Q Consensus 471 t~~Y~APE~~~~~ 483 (484)
+..|+|||++.++
T Consensus 158 ~~~y~~PE~~~~~ 170 (251)
T cd05041 158 PIKWTAPEALNYG 170 (251)
T ss_pred eeccCChHhhccC
Confidence 6679999987643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=219.68 Aligned_cols=172 Identities=26% Similarity=0.399 Sum_probs=144.1
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC------C
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP------T 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 376 (484)
+...|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4456788899999999999999865 57889999987543 2346788999999998 699999999998753 3
Q ss_pred ceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 377 SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
..|+||||+++++|.+++... ...+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999999764 3458999999999999999999995 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
....... ......|++.|+|||++.
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhc
Confidence 6643222 123356899999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=227.31 Aligned_cols=168 Identities=28% Similarity=0.383 Sum_probs=141.1
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 375 (484)
..++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999764 67899999987532 22345677899999999999999999887543
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3468999988 7899988753 458999999999999999999995 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... ....||+.|+|||++.+
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLN 189 (343)
T ss_pred ecCCCc----CCccccccccCchHhcC
Confidence 764322 23468999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=219.74 Aligned_cols=171 Identities=30% Similarity=0.433 Sum_probs=145.3
Q ss_pred CCCccceeeeccceeEEEEEe----cCCCEEEEEEecccC----hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCce
Q 011486 308 TLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 378 (484)
+|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999876 368899999987532 23356788999999999 599999999999998899
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999754 458899999999999999999994 599999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...........|+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred cccccccccccCCcccCChhhccC
Confidence 433222334568999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=228.48 Aligned_cols=170 Identities=24% Similarity=0.328 Sum_probs=141.2
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 375 (484)
..++|+..+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999765 5888999998753 233456788999999999999999999987543
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 346999999965 78777743 3788999999999999999999 4599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... ......||+.|+|||++.+.
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~ 200 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGM 200 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCC
Confidence 664322 22345689999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=223.96 Aligned_cols=167 Identities=21% Similarity=0.186 Sum_probs=130.8
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec--CCCEEEEEEeccc-----ChhHHHHHHHHHHHHhcCCCCceee-eEEE
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVN-LRGY 371 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~ 371 (484)
+.+....+.|+..+.||+|+||+||+|... +++.+|||++... .....+.+.+|++++++++|+|++. ++++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344455678999999999999999999765 5777899987532 2234567999999999999999985 4432
Q ss_pred EEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCcEEEcCCCcEEEEe
Q 011486 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI-KSSNILLDGNLEARVSD 450 (484)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDi-kp~NILl~~~~~~kl~D 450 (484)
+..|+||||+++++|... .. .. ...++.|+++||.|||+ .+|+|||| ||+|||++.++.+||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 11 11 14688999999999994 59999999 99999999999999999
Q ss_pred cCCCcccCCCCcce-------eecccccccccCCcccC
Q 011486 451 FGLAKLLEDEESHI-------TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 451 FGla~~~~~~~~~~-------~~~~~Gt~~Y~APE~~~ 481 (484)
||+|+.+....... .....|++.|+|||++.
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999775433111 13456899999999975
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=221.17 Aligned_cols=172 Identities=24% Similarity=0.377 Sum_probs=145.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
.++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 457888999999999999999876 58899999987433 22344677899999999999999999998877 78999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||++ ++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999997 49999987655569999999999999999999995 59999999999999999999999999999877653
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....+++.|+|||++.+
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLG 180 (293)
T ss_pred ccc-cccccccccccCchhhcC
Confidence 222 123457899999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=214.81 Aligned_cols=169 Identities=28% Similarity=0.452 Sum_probs=146.0
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+|+..+.||+|++|.||+|... +++.|++|.+.... +...+.+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 78999999886432 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
+||+++++|.+++... ..+++..+..++.|++.|++|||+ .+|+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999999754 458999999999999999999995 599999999999999999999999999988764432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
......|+..|+|||.+..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred --cccccCCCcceeCHHHhcC
Confidence 2234568999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=215.44 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=142.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 378 (484)
++|+..+.||+|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999865 58899999875321 22346788999999999999999999988764 457
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
+++|||+++++|.+++... ..+++..+.+++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 7999999999999998654 458899999999999999999995 599999999999999999999999999998654
Q ss_pred CCCc--ceeecccccccccCCcccCC
Q 011486 459 DEES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .......|+..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred cccccccccccCCCCccccChhhhcC
Confidence 3211 11223458999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=222.29 Aligned_cols=170 Identities=26% Similarity=0.404 Sum_probs=143.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||+|... +|+.+|+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999875 68899999986432 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++ ++|.+++......+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 96 58888887655679999999999999999999995 59999999999999999999999999999866543222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+++.|+|||++.+
T Consensus 156 ~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred cCCCccccCCcChHHHhC
Confidence 123457899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=219.37 Aligned_cols=172 Identities=24% Similarity=0.365 Sum_probs=141.7
Q ss_pred CCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999998753 23578888887543 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCc
Q 011486 381 IYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~N 437 (484)
++||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999986421 237889999999999999999995 599999999999
Q ss_pred EEEcCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 438 ILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 438 ILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|++++++.+||+|||+++......... .....++..|+|||++.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 999999999999999998664332211 122345778999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=216.28 Aligned_cols=165 Identities=19% Similarity=0.283 Sum_probs=134.1
Q ss_pred eeeeccceeEEEEEecCCC---EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 314 IIGSGGFGTVYKLAMDDGN---VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.||+|+||.||++...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999998765433 45667665433 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC-ccee
Q 011486 390 LDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHIT 465 (484)
Q Consensus 390 L~~~l~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~ 465 (484)
|.++++... ...++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997532 236677788999999999999995 599999999999999999999999999986432211 1112
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....|+..|+|||++.
T Consensus 159 ~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 159 DDKCVPLRWLAPELVG 174 (268)
T ss_pred cCCcCcccccCchhcc
Confidence 2345789999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=215.90 Aligned_cols=166 Identities=28% Similarity=0.430 Sum_probs=141.4
Q ss_pred ceeeeccceeEEEEEecC--C--CEEEEEEecccCh-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD--G--NVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999987654 567789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce--
Q 011486 388 GSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (484)
Q Consensus 388 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 464 (484)
++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998754 46899999999999999999999 4599999999999999999999999999998775432221
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT 174 (257)
T ss_pred ccCCCCCceecCHHHhcc
Confidence 123457889999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=218.99 Aligned_cols=171 Identities=25% Similarity=0.370 Sum_probs=145.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 58899999886432 2234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|..++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9999888877654 3458999999999999999999995 59999999999999999999999999999877543321
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 157 -~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 157 -YTDYVATRWYRAPELLVG 174 (286)
T ss_pred -ccCcccccccCCHHHHhC
Confidence 223457899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=220.35 Aligned_cols=171 Identities=27% Similarity=0.444 Sum_probs=140.0
Q ss_pred cCCCccceeeeccceeEEEEEecC-C--CEEEEEEeccc-ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-G--NVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 381 (484)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 34688888743 233456789999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcE
Q 011486 382 YDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~ 446 (484)
+||+++++|.++++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 247889999999999999999995 599999999999999999999
Q ss_pred EEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 447 RVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 447 kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+|||++........ ......+..|+|||++..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 192 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNY 192 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhcc
Confidence 9999999874322111 111223567999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=229.72 Aligned_cols=167 Identities=25% Similarity=0.322 Sum_probs=143.1
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-C-----CceeeeEEEEEcCCceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-H-----RYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 380 (484)
+|.+.++||+|.||.|-+|.+. +++.||||+++.. ....++-..|+.+|..++ | -|+|+++++|.-.++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999765 5899999999864 345667788999999997 4 499999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC--CCcEEEEecCCCccc
Q 011486 381 IYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLL 457 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~~ 457 (484)
|+|.++ .+|.++++.+. ..++...+..++.||+.||.+||+ .+|||+||||+|||+.+ ...+||+|||.+...
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999995 59999998754 349999999999999999999995 59999999999999974 347999999999876
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... ..+-+..|+|||++.+.
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGl 363 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGL 363 (586)
T ss_pred CCcce----eeeeccccccchhhccC
Confidence 54322 34458899999999874
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=215.16 Aligned_cols=172 Identities=29% Similarity=0.474 Sum_probs=144.1
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh---------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
+|.....||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999764 578999998864321 123568899999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999654 568899999999999999999995 59999999999999999999999999999877
Q ss_pred CCCCcc-----eeecccccccccCCcccCCC
Q 011486 458 EDEESH-----ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~-----~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... ......|+..|+|||++.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 187 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccC
Confidence 532111 11224588999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=217.61 Aligned_cols=174 Identities=24% Similarity=0.330 Sum_probs=142.7
Q ss_pred hcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568888999999999999998753 5678999887543 33456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEE
Q 011486 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVS 449 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~ 449 (484)
++||||+++++|.++++... ..+++..+.+++.||+.||+|||+ .+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997543 248999999999999999999994 5999999999999998654 59999
Q ss_pred ecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++.+....... .....++..|+|||++.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence 999998764322111 112223568999999754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=245.31 Aligned_cols=178 Identities=24% Similarity=0.361 Sum_probs=145.3
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--Cc
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TS 377 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 377 (484)
....++|++.+.||+|+||.||++... ++..+|+|.+... .......+..|+.+++.++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999876 4678899988643 234457789999999999999999999988554 45
Q ss_pred eEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEcCCCCCcEEEcC--------
Q 011486 378 KLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC----SPRIIHRDIKSSNILLDG-------- 442 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~----~~~ivHrDikp~NILl~~-------- 442 (484)
.|+||||+++++|.+++... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 88999999999999999752 245999999999999999999999641 146999999999999964
Q ss_pred ---------CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 443 ---------NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 443 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+.+||+|||++..+.... ......||+.|+|||++..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhc
Confidence 3359999999998765432 1234569999999998753
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=221.60 Aligned_cols=175 Identities=26% Similarity=0.393 Sum_probs=142.9
Q ss_pred hcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|.+.+.||+|+||.||+++.. ....+|+|.++... ......+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357788999999999999998642 24578999987543 33456788999999999 699999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..+++|||+++|+|.+++.... ..+++.++.+++.|++.||.|||+ .+|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 99999999999999999997532 348899999999999999999995 599999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
++++.+||+|||+++......... .....++..|+|||++.++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence 999999999999998765322111 1122345689999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=215.42 Aligned_cols=171 Identities=23% Similarity=0.344 Sum_probs=137.7
Q ss_pred CccceeeeccceeEEEEEecCCC---EEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------Cce
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGN---VFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TSK 378 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 378 (484)
.+.+.||+|+||.||+|+..+.. .+|+|.++.. .....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45788999999999999876432 5899988753 234457789999999999999999999987532 246
Q ss_pred EEEEEcCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 379 LLIYDFLPGGSLDEALHE-----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
+++|||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998742 12348999999999999999999995 5999999999999999999999999999
Q ss_pred CcccCCCCcce-eecccccccccCCcccCCC
Q 011486 454 AKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 454 a~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.+....... .....+++.|+|||++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 189 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR 189 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC
Confidence 98775433211 1223457789999997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=213.74 Aligned_cols=167 Identities=26% Similarity=0.382 Sum_probs=140.8
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN-SPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357888999999999999999765 7788999986533 3467899999999999999999999765 44668999999
Q ss_pred CCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.++++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999999976443 48999999999999999999994 599999999999999999999999999988654322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||++.+
T Consensus 157 --~~~~~~~~y~aPE~~~~ 173 (256)
T cd05082 157 --DTGKLPVKWTAPEALRE 173 (256)
T ss_pred --CCCccceeecCHHHHcc
Confidence 12335678999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=218.97 Aligned_cols=173 Identities=25% Similarity=0.378 Sum_probs=144.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999875 47889999987543 233457889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC-
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE- 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~- 461 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999664 468999999999999999999995 599999999999999999999999999987421100
Q ss_pred -------------cceeecccccccccCCcccCCC
Q 011486 462 -------------SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 -------------~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
........|+..|+|||++..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 191 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCC
Confidence 0011124578899999987643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=213.24 Aligned_cols=172 Identities=26% Similarity=0.440 Sum_probs=144.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-ceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 383 (484)
+|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++.+.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999998865 57889999986432 334567889999999999999999999876544 5789999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999764 3458999999999999999999995 5999999999999999999999999999987654322
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......|++.|+|||++.++
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~ 177 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNK 177 (257)
T ss_pred -ccccccCCcCccChhHhcCC
Confidence 22334589999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=221.10 Aligned_cols=165 Identities=27% Similarity=0.390 Sum_probs=133.0
Q ss_pred cceeeeccceeEEEEEec---CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCceEEEEEcCC
Q 011486 312 DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLLIYDFLP 386 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 386 (484)
...||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999865 357899999875432 3457889999999999999999999854 456789999986
Q ss_pred CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE----cCCCcEEEEecCCC
Q 011486 387 GGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLA 454 (484)
Q Consensus 387 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla 454 (484)
+ +|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 888877521 124889999999999999999999 4599999999999999 56779999999999
Q ss_pred cccCCCCcc--eeecccccccccCCcccCC
Q 011486 455 KLLEDEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
+........ ......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcC
Confidence 876543221 1233568999999998864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=219.43 Aligned_cols=173 Identities=18% Similarity=0.333 Sum_probs=142.5
Q ss_pred cCCCccceeeeccceeEEEEEec-----------------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeee
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-----------------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNL 368 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 368 (484)
++|++.+.||+|+||.||++... +...+|+|.+.... ....+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999997532 23468999987543 3445789999999999999999999
Q ss_pred EEEEEcCCceEEEEEcCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcE
Q 011486 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNI 438 (484)
Q Consensus 369 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NI 438 (484)
++++...+..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999997532 237788999999999999999995 5999999999999
Q ss_pred EEcCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 439 LLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 439 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
++++++.++|+|||+++.+....... .....+++.|+|||+...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 99999999999999998764432211 122334678999997654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=221.12 Aligned_cols=174 Identities=29% Similarity=0.403 Sum_probs=146.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh---hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999876 489999999975432 24567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998753 345899999999999999999999 4599999999999999999999999999987653221
Q ss_pred cc----------------------------eeecccccccccCCcccCCC
Q 011486 462 SH----------------------------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~----------------------------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. ......||..|+|||++.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 207 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence 10 01124689999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=213.83 Aligned_cols=168 Identities=26% Similarity=0.398 Sum_probs=136.9
Q ss_pred ceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCceEEEEEcCC
Q 011486 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYDFLP 386 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 386 (484)
+.||+|+||.||+|...+ ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997542 4578999986432 3445778899999999999999999998764 456789999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce--
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 464 (484)
+++|.+++.......++..+..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997665567888889999999999999995 599999999999999999999999999998664322111
Q ss_pred -eecccccccccCCcccCCC
Q 011486 465 -TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 -~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....++..|+|||++.++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~ 177 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQ 177 (262)
T ss_pred ccccCcCCccccChhHhccC
Confidence 1123467789999987643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=217.14 Aligned_cols=169 Identities=27% Similarity=0.444 Sum_probs=139.7
Q ss_pred CCccceeeeccceeEEEEEe-----cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
|+..+.||+|+||+||++.. .++..+|+|.++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988643 357789999987643 33467788999999999999999999988664 35789
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999653 48999999999999999999995 59999999999999999999999999999876543
Q ss_pred Ccce--eecccccccccCCcccCC
Q 011486 461 ESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc
Confidence 2211 112335678999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=212.89 Aligned_cols=164 Identities=26% Similarity=0.419 Sum_probs=136.4
Q ss_pred eeeeccceeEEEEEec---CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 314 IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
.||+|+||.||+|.++ ++..+|+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999998653 57889999986433 334677999999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee--e
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--T 466 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 466 (484)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......... .
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999654 468999999999999999999994 5999999999999999999999999999987754432211 1
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...++..|+|||.+..
T Consensus 157 ~~~~~~~y~aPE~~~~ 172 (257)
T cd05116 157 HGKWPVKWYAPECMNY 172 (257)
T ss_pred CCCCCccccCHhHhcc
Confidence 2234679999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=218.68 Aligned_cols=179 Identities=31% Similarity=0.451 Sum_probs=148.8
Q ss_pred HHHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC-
Q 011486 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP- 375 (484)
Q Consensus 299 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 375 (484)
..++....++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3555666888999999999999999999875 68899999987543 2346678899999999 799999999998754
Q ss_pred ----CceEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 376 ----TSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 376 ----~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
+..++||||+++++|.++++. ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEE
Confidence 357999999999999998863 33458999999999999999999995 59999999999999999999999
Q ss_pred EecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|||++......... .....|+..|+|||++..
T Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred eecccchhccccccc-ccCccCCccccChhhhcC
Confidence 999999876543221 223458999999998753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=220.74 Aligned_cols=171 Identities=26% Similarity=0.406 Sum_probs=145.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999876 58899999886533 2245678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.++.... ..+++.++..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999888877543 458999999999999999999995 5999999999999999999999999999987654332
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......|+..|+|||++.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 156 VYTDYVATRWYRAPELLVG 174 (286)
T ss_pred ccCcccceeeccCcHHhcc
Confidence 2233458899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=213.48 Aligned_cols=171 Identities=31% Similarity=0.453 Sum_probs=147.4
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh--hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||++... +++.|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999765 688999999875443 3567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999754 458899999999999999999994 599999999999999999999999999998775433222
Q ss_pred ee---cccccccccCCcccCC
Q 011486 465 TT---IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~---~~~Gt~~Y~APE~~~~ 482 (484)
.. ...|+..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred cccccCCcCCcCccChhhccC
Confidence 11 2457899999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=214.15 Aligned_cols=171 Identities=25% Similarity=0.354 Sum_probs=139.8
Q ss_pred CCccceeeeccceeEEEEEecC----CCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-----
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----- 377 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 377 (484)
|++.+.||+|+||.||+|.... +..+|+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999997642 3679999987532 3345678999999999999999999999876554
Q ss_pred -eEEEEEcCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 378 -KLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 378 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
.++++||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999998542 2348999999999999999999995 59999999999999999999999999
Q ss_pred CCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++......... .....++..|+|||++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhccc
Confidence 9998765433221 112235678999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=214.97 Aligned_cols=171 Identities=25% Similarity=0.450 Sum_probs=143.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC----------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN----------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
+|...+.||+|++|.||+|... +++.+|+|.++... ....+.+.+|+++++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999765 68899999885321 112346788999999999999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 568999999999999999999995 5999999999999999999999999999986
Q ss_pred cCCCCcc-eeecccccccccCCcccCC
Q 011486 457 LEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... ......|+..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHS 184 (272)
T ss_pred ccccccccccccccCCccccCHHHhcc
Confidence 5432211 1233458999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.94 Aligned_cols=172 Identities=27% Similarity=0.401 Sum_probs=147.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778899999999999998865 58889999876533 3446789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++... +.+++..+..++.|++.||.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999998654 468999999999999999999995 2489999999999999999999999999987653322
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....|+..|+|||++.++
T Consensus 159 -~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred -cCccccCcccCCHHHHccC
Confidence 2235689999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=215.61 Aligned_cols=173 Identities=32% Similarity=0.497 Sum_probs=145.5
Q ss_pred cCCCccceeeeccceeEEEEEec-----CCCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNS--PTSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 378 (484)
+.|+..+.||+|+||.||++... ++..+|+|.+...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677889999999999999754 3688999999865443 56789999999999999999999999877 5578
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999998765569999999999999999999995 599999999999999999999999999998776
Q ss_pred CCCccee--ecccccccccCCcccCC
Q 011486 459 DEESHIT--TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~--~~~~Gt~~Y~APE~~~~ 482 (484)
....... ....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc
Confidence 3322111 12235667999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=221.14 Aligned_cols=165 Identities=25% Similarity=0.404 Sum_probs=142.5
Q ss_pred cceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
...||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999764 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++......... .....|
T Consensus 107 ~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 180 (292)
T cd06658 107 TDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVG 180 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceeec
Confidence 998854 358999999999999999999994 59999999999999999999999999999765433221 223458
Q ss_pred cccccCCcccCC
Q 011486 471 TFGYLAPGKDCT 482 (484)
Q Consensus 471 t~~Y~APE~~~~ 482 (484)
+..|+|||++.+
T Consensus 181 ~~~y~aPE~~~~ 192 (292)
T cd06658 181 TPYWMAPEVISR 192 (292)
T ss_pred CccccCHHHHcc
Confidence 999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=206.83 Aligned_cols=175 Identities=23% Similarity=0.255 Sum_probs=146.6
Q ss_pred hcCCCccceeeeccceeEEEEE-ecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 379 (484)
-++|++.+.+|+|+|+-||.++ ..+++.||+|++.-......+...+|++..++++||||++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999987 457899999999876666778899999999999999999999887443 3489
Q ss_pred EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 380 LIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
++++|+..|+|.+.+... +..+++.+.+.|+.+|++||++||+. .++++||||||.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999752 33599999999999999999999976 55799999999999999999999999999986
Q ss_pred cCCCCcce--------eecccccccccCCcccC
Q 011486 457 LEDEESHI--------TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 457 ~~~~~~~~--------~~~~~Gt~~Y~APE~~~ 481 (484)
..-.-... .....-|..|+|||.+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 54211100 01123588999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=227.20 Aligned_cols=173 Identities=23% Similarity=0.294 Sum_probs=146.4
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh--------hHHHHHHHHHHHHhcCC---CCceeeeEEE
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--------GFDRFFERELEILGSIK---HRYLVNLRGY 371 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~ 371 (484)
++..+|...+.+|+|+||.|+.|..+ +...|++|.+.+..- ......-.||.+|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 44567888999999999999999766 567889999875321 11223567999999997 9999999999
Q ss_pred EEcCCceEEEEEcC-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEe
Q 011486 372 CNSPTSKLLIYDFL-PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (484)
Q Consensus 372 ~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~D 450 (484)
|++++++|++||-. ++.+|.+++.. ...+++.++..|++||+.|+++||+ .+|||||||-+||.++.+|.+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 99999999999976 45689999964 4669999999999999999999995 5999999999999999999999999
Q ss_pred cCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 451 FGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 451 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
||.|.....+. ...++||..|.|||++.+.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~ 743 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGE 743 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCC
Confidence 99998776543 3457899999999998753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=219.91 Aligned_cols=172 Identities=31% Similarity=0.491 Sum_probs=141.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||.||+|... ++. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46777899999999999999764 343 47888887543 33345788999999999999999999998764 4678
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
++||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence 999999999999998765668999999999999999999994 59999999999999999999999999999876543
Q ss_pred Ccce-eecccccccccCCcccCC
Q 011486 461 ESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....++..|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred ccccccCCCccccccCCHHHhcc
Confidence 2221 122335778999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=237.68 Aligned_cols=174 Identities=21% Similarity=0.272 Sum_probs=136.4
Q ss_pred HhcCCCccceeeeccceeEEEEEecC--CCEEEEE------------------EecccChhHHHHHHHHHHHHhcCCCCc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALK------------------RIDKLNEGFDRFFERELEILGSIKHRY 364 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 364 (484)
..++|++.+.||+|+||+||++..+. +...+.| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999986542 2222222 111 11223556889999999999999
Q ss_pred eeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 365 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
|+++++++...+..|+|+|++. ++|.+++.... .......+..|+.||+.||+|||+ .+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999995 57877775421 123456678899999999999994 599999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+.++.+||+|||+++.+............||+.|+|||++.+.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC
Confidence 9999999999999987765433333345799999999998654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=215.59 Aligned_cols=171 Identities=30% Similarity=0.393 Sum_probs=147.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999866 58899999987543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||+++........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 9999999999754 68999999999999999999994 59999999999999999999999999999887643221
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....|++.|+|||++.+.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~ 173 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS 173 (274)
T ss_pred cccccCCccccChhhhccC
Confidence 2334689999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=215.56 Aligned_cols=174 Identities=18% Similarity=0.309 Sum_probs=145.1
Q ss_pred hcCCCccceeeeccceeEEEEEecC-----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 378 (484)
.++|++.+.||+|+||.||+|...+ +..+++|.+.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999998765 6889999887543 3446778899999999999999999998776 4678
Q ss_pred EEEEEcCCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 379 LLIYDFLPGGSLDEALHERS-------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999996532 348999999999999999999995 59999999999999999999999999
Q ss_pred CCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++.+.+..... .....++..|+|||++..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence 9998765433221 122346778999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=240.25 Aligned_cols=171 Identities=27% Similarity=0.405 Sum_probs=147.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|+++++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467889999999999999999876 68899999987532 33456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..++.|+.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence 9999999999999654 458899999999999999999995 599999999999999999999999999998765433
Q ss_pred cceeecccccccccCCcccC
Q 011486 462 SHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.. .....||+.|+|||...
T Consensus 159 ~~-~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 159 LN-MMDILTTPSMAKPKNDY 177 (669)
T ss_pred cc-ccccccCccccCccccc
Confidence 22 23456899999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=221.05 Aligned_cols=169 Identities=20% Similarity=0.280 Sum_probs=139.0
Q ss_pred ccceeeec--cceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 311 DDHIIGSG--GFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 311 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
..++||+| +|++||++... +++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 67899998764 68999999997542 334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH- 463 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~- 463 (484)
++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999653 2348999999999999999999994 59999999999999999999999999876543221110
Q ss_pred -----eeecccccccccCCcccCC
Q 011486 464 -----ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 -----~~~~~~Gt~~Y~APE~~~~ 482 (484)
......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccceecccChHHhhc
Confidence 0112346788999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=214.18 Aligned_cols=171 Identities=24% Similarity=0.447 Sum_probs=144.2
Q ss_pred CCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999875 468899999986432 1235678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~ 459 (484)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999999754 468999999999999999999995 5999999999999998776 699999999987654
Q ss_pred CCcc---eeecccccccccCCcccCC
Q 011486 460 EESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......|+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~ 182 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRG 182 (268)
T ss_pred ccccCCccccccccccceeCHhHhcc
Confidence 3211 1223468999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=208.88 Aligned_cols=171 Identities=32% Similarity=0.459 Sum_probs=150.9
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++.++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999876 688999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++......+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999999997765679999999999999999999994 5999999999999999999999999999987765432 23
Q ss_pred cccccccccCCcccCCC
Q 011486 467 IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~~ 483 (484)
...|+..|+|||++..+
T Consensus 156 ~~~~~~~~~~PE~~~~~ 172 (253)
T cd05122 156 TMVGTPYWMAPEVINGK 172 (253)
T ss_pred ceecCCcccCHHHHcCC
Confidence 45689999999988653
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=217.37 Aligned_cols=173 Identities=26% Similarity=0.378 Sum_probs=146.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|+..+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999876 57899999987532 3345778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++++.+..+... ...+++..+..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9998766665543 3558999999999999999999995 49999999999999999999999999999877654432
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred cccCcccccCCcCCchhcCC
Confidence 23345689999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.31 Aligned_cols=174 Identities=25% Similarity=0.434 Sum_probs=144.2
Q ss_pred hcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++++.||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999753 46789999987543 33456799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCc
Q 011486 379 LLIYDFLPGGSLDEALHERS---------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~N 437 (484)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997432 237888899999999999999995 599999999999
Q ss_pred EEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 438 ILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 438 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|++++++.+||+|||+++.+...... ......++..|+|||.+.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 99999999999999998865432211 1112234678999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=215.71 Aligned_cols=170 Identities=26% Similarity=0.414 Sum_probs=143.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+|+..+.||+|++|.||+|+.. ++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999876 58899999987543 233466778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 386 PGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 386 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
++ +|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 75 8988886543 458999999999999999999994 59999999999999999999999999999865433221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 157 -~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred -cccccccccccChHHhcC
Confidence 123457899999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=213.48 Aligned_cols=165 Identities=30% Similarity=0.456 Sum_probs=135.0
Q ss_pred ceeeeccceeEEEEEecC-CC--EEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD-GN--VFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|...+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 33 46888887533 34456789999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 388 GSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 388 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
++|.++++... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 237899999999999999999995 599999999999999999999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++....... .......+..|+|||++..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~ 185 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNY 185 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHcc
Confidence 986432111 1111223667999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=211.78 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=142.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 378 (484)
.+|+..+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999765 58899999886421 22345788999999999999999999988753 567
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++++||+++++|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999999754 458999999999999999999994 599999999999999999999999999998654
Q ss_pred CCCc--ceeecccccccccCCcccCC
Q 011486 459 DEES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .......|+..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC
Confidence 3211 11123458999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=215.30 Aligned_cols=174 Identities=27% Similarity=0.351 Sum_probs=147.8
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|+..++||+|.||+|..++-+ +++.||+|++++.. ......-..|-++++..+||.+..+--.|+..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3567888999999999999999765 68999999998643 2233345678899999999999999888999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||..||.|.-++.. ...+++.....+-..|+.||.||| +++||.||||.+|.|+|+||++||+|||+++.--..
T Consensus 246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999888854 355888888899999999999999 569999999999999999999999999999853322
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ..+..++|||.|.|||++..+
T Consensus 322 g-~t~kTFCGTPEYLAPEVleDn 343 (516)
T KOG0690|consen 322 G-DTTKTFCGTPEYLAPEVLEDN 343 (516)
T ss_pred c-ceeccccCChhhcCchhhccc
Confidence 2 234568999999999998653
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=221.47 Aligned_cols=173 Identities=25% Similarity=0.379 Sum_probs=142.3
Q ss_pred cCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
.+|++.+.||+|+||.||++... ....+|+|.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999998642 12368999887533 33457889999999999 7999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc
Q 011486 377 SKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~ 441 (484)
..+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999997532 247889999999999999999994 5999999999999999
Q ss_pred CCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 442 GNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 442 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
+++.+||+|||+++......... .....++..|+|||++..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 99999999999998765422111 122234678999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=216.07 Aligned_cols=171 Identities=30% Similarity=0.471 Sum_probs=147.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999876 58899999987643 34567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++......+++..+..++.|++.|++|||+ ..+++||||||+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999999997655678999999999999999999994 169999999999999999999999999998766432211
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
...|+..|+|||++.+
T Consensus 158 --~~~~~~~y~~PE~~~~ 173 (265)
T cd06605 158 --TFVGTSSYMAPERIQG 173 (265)
T ss_pred --cccCChhccCHHHHcC
Confidence 1568999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=217.11 Aligned_cols=170 Identities=26% Similarity=0.396 Sum_probs=147.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|+..+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999764 67889999987555445677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-c
Confidence 999999998653 47899999999999999999994 59999999999999999999999999998766543322 2
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....|++.|+|||++..
T Consensus 173 ~~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 173 STMVGTPYWMAPEVVTR 189 (293)
T ss_pred ccccCChhhcCchhhcc
Confidence 23458999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=211.37 Aligned_cols=173 Identities=31% Similarity=0.537 Sum_probs=150.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|++|.||+++.. +++.+++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999877 489999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... ..+++..+..++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999999764 568999999999999999999994 1699999999999999999999999999998775433321
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
....|+..|+|||.+.++
T Consensus 158 -~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGE 175 (264)
T ss_pred -cceeecccccCHhhhCCC
Confidence 234588999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.04 Aligned_cols=170 Identities=31% Similarity=0.424 Sum_probs=144.9
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556788999999999999765 57889999987433 344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++......... .
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh-h
Confidence 99999999854 458999999999999999999994 59999999999999999999999999999876543221 2
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
....|+..|+|||++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred hcccCcccccCHHHhCcC
Confidence 234588999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=214.52 Aligned_cols=169 Identities=27% Similarity=0.401 Sum_probs=145.4
Q ss_pred CCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC---CCceeeeEEEEEcCCceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN-EGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 382 (484)
.|+..+.||+|+||.||+|.. .+++.+|+|.++... .....++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999986 468999999987542 334567889999999996 999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.++++. ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999865 368999999999999999999995 5999999999999999999999999999987765432
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....|+..|+|||++.+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITE 175 (277)
T ss_pred c-cccccCCcceeCHHHhcc
Confidence 2 233468999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=243.99 Aligned_cols=177 Identities=27% Similarity=0.416 Sum_probs=141.6
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc------
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS------ 374 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 374 (484)
-+-..+|+..+.||+|+||.||+++.+ ||+.||||++.-. .......+.+|++++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678888999999999999999987 8999999999754 34455678899999999999999988754300
Q ss_pred --------------------------------------------------------------------------------
Q 011486 375 -------------------------------------------------------------------------------- 374 (484)
Q Consensus 375 -------------------------------------------------------------------------------- 374 (484)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011486 375 -------------------------P--------TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421 (484)
Q Consensus 375 -------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH 421 (484)
+ -..||-||||+...+.++++.+.-.-.....++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1247889999998888888664322246778899999999999999
Q ss_pred hCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC----C-------------CCcceeecccccccccCCcccCC
Q 011486 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE----D-------------EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 422 ~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~----~-------------~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+ .+||||||||.||++|++..|||+|||+|.... . ......+..+||.-|+|||++..
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 5 499999999999999999999999999998721 0 01112345689999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=211.72 Aligned_cols=174 Identities=26% Similarity=0.369 Sum_probs=149.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|++|+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 67889999987533 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
+++++|.++++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997642 458999999999999999999994 5999999999999999999999999999987765332
Q ss_pred c---eeecccccccccCCcccCCC
Q 011486 463 H---ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~---~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ......|+..|+|||++..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccccCChhhcChHHHccc
Confidence 2 12335689999999987653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=214.62 Aligned_cols=169 Identities=33% Similarity=0.484 Sum_probs=147.3
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999876 58899999997532 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 99999999999765 568999999999999999999995 4999999999999999999999999999987654321
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||++.+
T Consensus 156 -~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred -ccccCCChhhcCHHHHcc
Confidence 233558899999998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=211.41 Aligned_cols=172 Identities=26% Similarity=0.401 Sum_probs=143.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-----ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 378 (484)
.+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999865 5889999987532 123456789999999999999999999998765 357
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998754 458899999999999999999995 599999999999999999999999999998664
Q ss_pred CCCc--ceeecccccccccCCcccCC
Q 011486 459 DEES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .......|+..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC
Confidence 3111 11123458999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=220.00 Aligned_cols=165 Identities=25% Similarity=0.376 Sum_probs=142.4
Q ss_pred cceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999765 6889999998765544567788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... .....|
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 179 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVG 179 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccceec
Confidence 998754 458999999999999999999995 59999999999999999999999999999765443221 233568
Q ss_pred cccccCCcccCC
Q 011486 471 TFGYLAPGKDCT 482 (484)
Q Consensus 471 t~~Y~APE~~~~ 482 (484)
+..|+|||++.+
T Consensus 180 ~~~y~aPE~~~~ 191 (297)
T cd06659 180 TPYWMAPEVISR 191 (297)
T ss_pred CccccCHHHHcc
Confidence 999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=210.79 Aligned_cols=171 Identities=25% Similarity=0.388 Sum_probs=146.3
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|+||.+|++... +++.+|+|.+... .....+++.+|++++++++||||+++.+++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999998765 6889999998643 234456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++.... ..+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999997643 358899999999999999999995 59999999999999999999999999999876543221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||++.+
T Consensus 158 -~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 158 -ARTCIGTPYYLSPEICEN 175 (256)
T ss_pred -hhhccCCccccCHHHhCC
Confidence 223458899999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-27 Score=248.73 Aligned_cols=172 Identities=30% Similarity=0.417 Sum_probs=146.2
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
-+|+-...||.|.||.||.|.. .+|...|+|.++... ....+.+.+|+.++..++|||+|+++|+-..++..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3566678899999999999764 568889999886432 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
||++|+|.+.+.. ....++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|..+......
T Consensus 1315 yC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999964 34477777888999999999999965 9999999999999999999999999999988764322
Q ss_pred e---eecccccccccCCcccCC
Q 011486 464 I---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~---~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|||||++.+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcc
Confidence 1 234679999999999874
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=213.80 Aligned_cols=171 Identities=28% Similarity=0.425 Sum_probs=140.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHH-HhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|++.+.||+|+||.||++... +++.||+|+++... ......+..|++. ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999876 68999999987543 2234455666665 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|++ ++|.+++.. ....+++..+..++.||+.||+|||++ .+++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 688888764 234589999999999999999999952 38999999999999999999999999999876432
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....|+..|+|||++..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINP 177 (283)
T ss_pred cc--cccccCCccccChhhcCC
Confidence 21 223458999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=209.83 Aligned_cols=166 Identities=25% Similarity=0.384 Sum_probs=137.1
Q ss_pred ceeeeccceeEEEEEecC----CCEEEEEEecccCh-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|.... +..+|+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997542 26899999876443 35677999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee-
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT- 466 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~- 466 (484)
++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999765 368999999999999999999995 59999999999999999999999999999877544332211
Q ss_pred -cccccccccCCcccCCC
Q 011486 467 -IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 467 -~~~Gt~~Y~APE~~~~~ 483 (484)
...++..|+|||.+.++
T Consensus 156 ~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05060 156 TAGRWPLKWYAPECINYG 173 (257)
T ss_pred cCccccccccCHHHhcCC
Confidence 12245689999987643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=214.54 Aligned_cols=170 Identities=30% Similarity=0.430 Sum_probs=144.6
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIYD 383 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 383 (484)
|++.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999876 48899999998653 33456788999999999999999999999888 78999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ +|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 8999987655579999999999999999999995 59999999999999999999999999999877554322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......++..|+|||.+.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 157 DYTNRVITLWYRPPELLLG 175 (287)
T ss_pred cccccccccccCCceeeEc
Confidence 2233457889999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=211.69 Aligned_cols=170 Identities=32% Similarity=0.426 Sum_probs=145.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+-|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34667889999999999999764 68899999986433 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++..+..... .
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999999864 458999999999999999999994 5999999999999999999999999999987654321 1
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hccccCCccccChhhhcc
Confidence 223458899999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=213.83 Aligned_cols=172 Identities=28% Similarity=0.454 Sum_probs=146.0
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC------
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT------ 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 376 (484)
..++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999875 578899999876443 356799999999999 6999999999997654
Q ss_pred ceEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 377 SKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 379999999999999998653 356899999999999999999999 45999999999999999999999999999
Q ss_pred CcccCCCCcceeecccccccccCCcccC
Q 011486 454 AKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 454 a~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+......... .....|+..|+|||++.
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 160 SAQLDSTLGR-RNTFIGTPYWMAPEVIA 186 (275)
T ss_pred ceecccchhh-hcCccccccccCHhHhc
Confidence 9866443221 22345899999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=209.92 Aligned_cols=175 Identities=27% Similarity=0.416 Sum_probs=145.6
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 382 (484)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+++..|++++++++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999998754 6788999998643 344456788999999999999999999987643 4578999
Q ss_pred EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 383 DFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
||+++++|.+++... ...+++..++.++.|++.||+|||..+ +.+++||||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 356899999999999999999999332 358999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... .....|++.|+|||++..+
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~ 185 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHM 185 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCC
Confidence 654321 2234689999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=216.22 Aligned_cols=175 Identities=32% Similarity=0.462 Sum_probs=145.1
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT---- 376 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 376 (484)
...++|++.+.||+|++|.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999876 58899999987532 233456788999999999999999999987655
Q ss_pred ------ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEe
Q 011486 377 ------SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (484)
Q Consensus 377 ------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~D 450 (484)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 7878776655568999999999999999999995 4999999999999999999999999
Q ss_pred cCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||++...............++..|+|||.+.+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcC
Confidence 99998765433222222346889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-25 Score=212.56 Aligned_cols=171 Identities=30% Similarity=0.413 Sum_probs=146.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999875 58899999987543 34467789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 999999999864 458899999999999999999994 59999999999999999999999999999876543321
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....++..|+|||++.++
T Consensus 158 ~~~~~~~~~y~apE~~~~~ 176 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQS 176 (277)
T ss_pred cccccCcccccCHhHhccC
Confidence 2334588999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=230.80 Aligned_cols=172 Identities=18% Similarity=0.264 Sum_probs=137.3
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCC------CceeeeEEEEEcC
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKH------RYLVNLRGYCNSP 375 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~ 375 (484)
....++|++.+.||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++| ++++++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 334578999999999999999999765 57889999996532 234456677777777654 4589999998765
Q ss_pred -CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----------
Q 011486 376 -TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---------- 444 (484)
Q Consensus 376 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---------- 444 (484)
...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||.+ .+||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence 4678999988 77899988654 5689999999999999999999942 4999999999999998765
Q ss_pred ------cEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 445 ------EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 445 ------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+||+|||.+...... ....+||+.|||||++.+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred cCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcC
Confidence 4999999988643221 2346799999999998653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=214.61 Aligned_cols=170 Identities=27% Similarity=0.414 Sum_probs=143.1
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 68899999887432 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
++ ++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 6899888653 3458999999999999999999995 59999999999999999999999999999866543221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+++.|+|||++.+
T Consensus 157 -~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLG 174 (284)
T ss_pred -cccccccccccCCeEEec
Confidence 122347889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=214.54 Aligned_cols=166 Identities=29% Similarity=0.399 Sum_probs=142.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999865 68899999886432 233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||++ |++.+++......+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 9996 58888876555669999999999999999999995 599999999999999999999999999987654322
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
...|++.|+|||++.
T Consensus 170 ----~~~~~~~y~aPE~~~ 184 (307)
T cd06607 170 ----SFVGTPYWMAPEVIL 184 (307)
T ss_pred ----CccCCccccCceeee
Confidence 245889999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=197.33 Aligned_cols=172 Identities=26% Similarity=0.416 Sum_probs=143.3
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEeccc-ChhHHHHHHHHHHHHhc-CCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+++...+.||+|+||.|-+.++ .+|...|+|++... +.+..++..+|+.+..+ ...|++|+++|.+..+...|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4445567899999999987654 47999999999853 35567778889988655 479999999999999999999999
Q ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
.|+ .||+.+.++ +++.+++...-+||..+++||.|||+ +..++|||+||+||||+.+|++|++|||++..+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 994 588877653 55679999999999999999999998 469999999999999999999999999999887653
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
-. .+...|...|||||.+..+
T Consensus 203 iA--kt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPE 223 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcc
Confidence 32 2335689999999988643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=209.80 Aligned_cols=167 Identities=27% Similarity=0.385 Sum_probs=140.2
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 35688899999999999999875 57789999986532 346789999999999999999999998654 579999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999997643 348999999999999999999994 599999999999999999999999999997654321
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....+..|+|||++.++
T Consensus 155 -~~~~~~~~y~~pe~~~~~ 172 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHK 172 (254)
T ss_pred -CCCCCCceecCHHHhccC
Confidence 112346789999987653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=216.76 Aligned_cols=171 Identities=26% Similarity=0.388 Sum_probs=141.1
Q ss_pred CCCccceeeeccceeEEEEEecC---CCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDD---GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 379 (484)
.|++.+.||+|++|.||+|.... ++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999998754 7899999998632 33456678899999999999999999999988 7799
Q ss_pred EEEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC----CCcEEEEec
Q 011486 380 LIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSDF 451 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~----~~~~kl~DF 451 (484)
+||||+++ ++.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777766432 125889999999999999999999 459999999999999999 999999999
Q ss_pred CCCcccCCCCc--ceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++....... .......+|+.|+|||++.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC
Confidence 99987654322 11223467999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=212.08 Aligned_cols=162 Identities=29% Similarity=0.429 Sum_probs=132.2
Q ss_pred eeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHH---hcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEIL---GSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999886532 12223344454433 33479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++... ..+++..+..++.|++.||+|||. .+|+||||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 99999998754 469999999999999999999994 5999999999999999999999999999976543221 2
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...||+.|+|||.+.+
T Consensus 154 ~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 154 ASVGTHGYMAPEVLQK 169 (279)
T ss_pred CcCCCcCccCHHHhcC
Confidence 3458999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.05 Aligned_cols=162 Identities=31% Similarity=0.441 Sum_probs=140.7
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 48899999987532 23457799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...... ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999754 458999999999999999999995 599999999999999999999999999998775532 1223468
Q ss_pred cccccCCcccCC
Q 011486 471 TFGYLAPGKDCT 482 (484)
Q Consensus 471 t~~Y~APE~~~~ 482 (484)
++.|+|||++..
T Consensus 155 ~~~~~~PE~~~~ 166 (262)
T cd05572 155 TPEYVAPEIILN 166 (262)
T ss_pred CcCccChhHhcC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=206.39 Aligned_cols=170 Identities=29% Similarity=0.418 Sum_probs=148.0
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh--hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999765 578999999976543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999754 56899999999999999999999 459999999999999999999999999999877654332
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||....
T Consensus 156 ~~~~~~~~~y~~pe~~~~ 173 (254)
T cd06627 156 DASVVGTPYWMAPEVIEM 173 (254)
T ss_pred ccccccchhhcCHhhhcC
Confidence 233458999999998754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=211.95 Aligned_cols=173 Identities=28% Similarity=0.412 Sum_probs=149.4
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
..+.|+..+.||+|++|.||++... ++..+++|.+..... ..+.+.+|++.+++++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456778889999999999999876 688999999976544 46678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 99999999999876447999999999999999999999 469999999999999999999999999998765443221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||++.+
T Consensus 173 -~~~~~~~~~y~~PE~~~~ 190 (286)
T cd06614 173 -RNSVVGTPYWMAPEVIKR 190 (286)
T ss_pred -hccccCCcccCCHhHhcC
Confidence 123457899999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=215.87 Aligned_cols=172 Identities=27% Similarity=0.404 Sum_probs=143.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
.++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 568899999999999999999875 58999999986432 22234567899999999999999999998765 45799
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||++ ++|.+++......+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 48998887655669999999999999999999995 59999999999999999999999999999877643
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ....+++.|+|||.+.+
T Consensus 162 ~~~~-~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 162 AKPM-TPKVVTLWYRAPELLLG 182 (309)
T ss_pred cCCC-CcccccccccChhhhcC
Confidence 3221 22346889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=207.38 Aligned_cols=170 Identities=25% Similarity=0.432 Sum_probs=144.6
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999998764 6888999998653 233467799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~~~~~~ 462 (484)
+++++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||+++++ +.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 348999999999999999999995 599999999999999854 4689999999987654322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||.+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 158 --AYTVVGTPCYISPELCEG 175 (256)
T ss_pred --ccccccCCcccCchhccC
Confidence 223458999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=209.28 Aligned_cols=172 Identities=28% Similarity=0.428 Sum_probs=143.5
Q ss_pred CCCccceeeeccceeEEEEEecC--CCEEEEEEeccc----------ChhHHHHHHHHHHHHhc-CCCCceeeeEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKL----------NEGFDRFFERELEILGS-IKHRYLVNLRGYCNS 374 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 374 (484)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998765 688999987532 12234557788888865 799999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 375 PTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+. .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998753 344589999999999999999999952 48999999999999999999999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|.+....... ......|+..|+|||++.++
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~ 188 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNE 188 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCC
Confidence 9998765443 22345689999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=211.52 Aligned_cols=168 Identities=26% Similarity=0.402 Sum_probs=144.3
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999764 6889999998765545566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 999999876 458999999999999999999995 5999999999999999999999999999876543322 1223
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..|++.|+|||++.+
T Consensus 175 ~~~~~~y~aPE~~~~ 189 (285)
T cd06648 175 LVGTPYWMAPEVISR 189 (285)
T ss_pred ccCCccccCHHHhcC
Confidence 458999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=211.68 Aligned_cols=164 Identities=29% Similarity=0.432 Sum_probs=138.9
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999998755 68899999986532 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeeccc
Q 011486 391 DEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469 (484)
Q Consensus 391 ~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 469 (484)
.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||.+........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 99997643 358999999999999999999994 5999999999999999999999999999986643221 22345
Q ss_pred ccccccCCcccCCC
Q 011486 470 GTFGYLAPGKDCTN 483 (484)
Q Consensus 470 Gt~~Y~APE~~~~~ 483 (484)
|+..|+|||++.++
T Consensus 156 ~~~~y~~PE~~~~~ 169 (277)
T cd05577 156 GTPGYMAPEVLQGE 169 (277)
T ss_pred CCCCcCCHHHhcCC
Confidence 78899999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=226.04 Aligned_cols=175 Identities=23% Similarity=0.321 Sum_probs=133.8
Q ss_pred HhcCCCccceeeeccceeEEEEEe-----------------cCCCEEEEEEecccChhHHHHH--------------HHH
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAM-----------------DDGNVFALKRIDKLNEGFDRFF--------------ERE 353 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 353 (484)
..++|++.++||+|+||.||+|.. .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999863 2356799999875443333333 346
Q ss_pred HHHHhcCCCCce-----eeeEEEEEc--------CCceEEEEEcCCCCCHHHHHhhcC----------------------
Q 011486 354 LEILGSIKHRYL-----VNLRGYCNS--------PTSKLLIYDFLPGGSLDEALHERS---------------------- 398 (484)
Q Consensus 354 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------- 398 (484)
+..+.+++|.++ ++++++|.. .+..|+||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 677777753 356899999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCC
Q 011486 399 -EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477 (484)
Q Consensus 399 -~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~AP 477 (484)
..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 124677889999999999999995 5999999999999999999999999999976644322222223358999999
Q ss_pred cccCC
Q 011486 478 GKDCT 482 (484)
Q Consensus 478 E~~~~ 482 (484)
|.+..
T Consensus 380 E~l~~ 384 (507)
T PLN03224 380 EELVM 384 (507)
T ss_pred hhhcC
Confidence 98753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=213.06 Aligned_cols=171 Identities=25% Similarity=0.358 Sum_probs=140.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCc-----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTS----- 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 377 (484)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|+++++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999875 68899999886532 223457888999999995 6999999999887665
Q ss_pred eEEEEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecC
Q 011486 378 KLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFG 452 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFG 452 (484)
.|+||||+++ +|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888643 2348999999999999999999994 59999999999999998 8999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+++.+....... ....+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 157 LGRAFSIPVKSY-THEIVTLWYRAPEVLLG 185 (295)
T ss_pred cceecCCCcccc-CCcccccCCCChHHhhC
Confidence 998664322211 22346889999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=212.80 Aligned_cols=171 Identities=26% Similarity=0.406 Sum_probs=141.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|+..+.||+|.+|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999875 68899999986532 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccCCCC
Q 011486 384 FLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~ 461 (484)
|++ ++|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 588888754332 36788888999999999999994 59999999999999985 5679999999998664332
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....|++.|+|||++.+
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 158 RT-FTHEVVTLWYRAPEILLG 177 (294)
T ss_pred cc-cccCceeecccCHHHHhC
Confidence 21 123357899999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=221.51 Aligned_cols=171 Identities=27% Similarity=0.413 Sum_probs=147.3
Q ss_pred cCCCccceeeeccceeEEEEEecC-----CCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+..+..+.||.|.||.||+|.+.+ .-.||||..+.. .....+.|..|..+|+.++||||++++|+|.+. ..||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344557889999999999997643 235889988763 355678899999999999999999999999764 5799
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|||.++.|.|.+|++.+...++......++.||..||+||| ++.+|||||..+|||+.....+||+|||+++.++++
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999988888999999999999999999999 779999999999999999999999999999999877
Q ss_pred CcceeecccccccccCCcccC
Q 011486 461 ESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
..+..+...=...|||||.+.
T Consensus 545 ~yYkaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESIN 565 (974)
T ss_pred chhhccccccceeecCccccc
Confidence 655444333366899999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=211.48 Aligned_cols=169 Identities=29% Similarity=0.424 Sum_probs=142.3
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
|+..+.||+|++|.||+|... ++..||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999765 68999999987533 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||+++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 69999987643 358999999999999999999995 599999999999999999999999999998664332211
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
....+++.|+|||++.+
T Consensus 157 -~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 157 -THEVVTLWYRAPEILLG 173 (283)
T ss_pred -CccccccCCCCCceeec
Confidence 22346899999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=218.67 Aligned_cols=171 Identities=21% Similarity=0.292 Sum_probs=146.9
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecc--cChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
-..|++.+.||+||.+.||++...+.+.||+|++.. .+......|.+|+..|.+++ |.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 346888999999999999999998889999988753 34556778999999999996 999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||= ..+|..+|+++....+-..+..+..|++.|+.++|++ ||||.||||.|+|+- +|.+||+|||+|..+..+..
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 986 5599999988765555337788999999999999976 999999999999998 57999999999998876543
Q ss_pred ce-eecccccccccCCcccC
Q 011486 463 HI-TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~-~~~~~Gt~~Y~APE~~~ 481 (484)
.. ....+||+.|||||.+.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~ 534 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALT 534 (677)
T ss_pred ceeeccccCcccccCHHHHh
Confidence 32 34567999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.12 Aligned_cols=174 Identities=28% Similarity=0.433 Sum_probs=142.6
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc----
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS---- 377 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 377 (484)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3567889999999999999999875 68899999886432 2234456789999999999999999999876543
Q ss_pred ----eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 378 ----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 378 ----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
.++||||+. ++|.+++......+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999996 58888887665568999999999999999999995 4999999999999999999999999999
Q ss_pred CcccCCCCcc---eeecccccccccCCcccCC
Q 011486 454 AKLLEDEESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 454 a~~~~~~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
+......... ......++..|+|||++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcC
Confidence 9876432221 1123457889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=206.24 Aligned_cols=171 Identities=28% Similarity=0.460 Sum_probs=148.5
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|++|.||++... ++..+++|++.... ....+.+.+|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999876 58899999997543 34567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999765 3669999999999999999999995 499999999999999999999999999998765543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......|++.|+|||....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQN 177 (258)
T ss_pred -ceecceeeeecccChhHhcc
Confidence 12333568999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=209.04 Aligned_cols=168 Identities=30% Similarity=0.407 Sum_probs=140.5
Q ss_pred CccceeeeccceeEEEEE-ecCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 310 DDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
+....||.|+||+|+|-. .+.|+..|||+++..+ +...+++..|.++..+- +.||||+++|.+..++..|+-||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 345679999999999964 4579999999998654 46678899999886554 6899999999999999999999999
Q ss_pred CCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 387 GGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 387 ~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
..|++.+.+. ....+++.-.-+|....++||.||-+. ..|+|||+||+|||+|..|.+||+|||++..+.+.-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 4587766542 345689999999999999999999974 699999999999999999999999999998775432
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..+.-+|...|||||.+..
T Consensus 223 -AkT~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 223 -AKTVDAGCRPYMAPERIDP 241 (361)
T ss_pred -HhhhccCCccccChhccCC
Confidence 2345579999999998864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=209.65 Aligned_cols=167 Identities=25% Similarity=0.252 Sum_probs=138.9
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcC--CceEEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSP--TSKLLIYD 383 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 383 (484)
|++.+.||+|+||.||++... +++.+|+|+++... ........+|+..+.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999865 68899999987532 222334457889999885 99999999999887 88999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|++ +++.+.+......+++.++..++.|++.||+|||+ .+++||||||+||++++ +.+||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 58888887655678999999999999999999995 59999999999999999 99999999999876543221
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||++..
T Consensus 156 --~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 156 --TEYISTRWYRAPECLLT 172 (282)
T ss_pred --CCCCCCcccCChhHhhc
Confidence 23457899999998654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=209.58 Aligned_cols=164 Identities=31% Similarity=0.460 Sum_probs=140.2
Q ss_pred eeeccceeEEEEEecC-CCEEEEEEecccCh---hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||.||++...+ ++.+++|.+..... ...+.+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999998874 89999999875432 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc-------c
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-------H 463 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-------~ 463 (484)
.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999764 368999999999999999999995 5999999999999999999999999999876543211 1
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......++..|+|||....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~ 175 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG 175 (265)
T ss_pred cccCcccCccccCHHHhcC
Confidence 1233457899999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=212.48 Aligned_cols=171 Identities=29% Similarity=0.410 Sum_probs=144.2
Q ss_pred CCCccceeeeccceeEEEEEec----CCCEEEEEEecccC----hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCce
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 378 (484)
+|+..+.||+|++|.||+++.. ++..+|+|.++... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999998743 57889999987432 23346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999998654 458899999999999999999994 599999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...........|+..|+|||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred cccccccccccCCccccCHHHhcC
Confidence 443322334568999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=209.47 Aligned_cols=170 Identities=34% Similarity=0.456 Sum_probs=143.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 382 (484)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999875 57889999987543 34567789999999999999999999998654 3679999
Q ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 23458899999999999999999995 5999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ....++..|+|||.+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQG 177 (287)
T ss_pred ccc---ccccCCccccCHHHhcC
Confidence 221 23457889999998764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=208.73 Aligned_cols=163 Identities=28% Similarity=0.421 Sum_probs=132.9
Q ss_pred eeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH---HHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE---ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
.||+|+||.||++... +++.||+|.+.... ......+..|.. .++...||+|+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999998765 58899999986532 111223344433 3445679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 99999988653 569999999999999999999995 5999999999999999999999999999986643221 2
Q ss_pred cccccccccCCcccCCC
Q 011486 467 IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~~ 483 (484)
...|+..|+|||++.++
T Consensus 154 ~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 154 ASVGTHGYMAPEVLQKG 170 (278)
T ss_pred CcCCCcCCcCcHHhcCC
Confidence 34689999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=205.83 Aligned_cols=170 Identities=25% Similarity=0.338 Sum_probs=137.8
Q ss_pred HHHHHHhcCCCcccee--eeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 300 KDIIKKLETLDDDHII--GSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 300 ~el~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++.+..+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455556677777776 99999999998764 68889999986532111 122222222 699999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCC
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLA 454 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla 454 (484)
+..++||||+++++|.+++... ..+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999999765 378999999999999999999994 5899999999999999988 9999999998
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+...... ...|+..|+|||++.++
T Consensus 158 ~~~~~~~-----~~~~~~~y~aPE~~~~~ 181 (267)
T PHA03390 158 KIIGTPS-----CYDGTLDYFSPEKIKGH 181 (267)
T ss_pred eecCCCc-----cCCCCCcccChhhhcCC
Confidence 8664322 23589999999998653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.89 Aligned_cols=168 Identities=26% Similarity=0.409 Sum_probs=137.8
Q ss_pred ceeeeccceeEEEEEecC-------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAMDD-------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2578999886533 33466789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-----cEEEEecCC
Q 011486 385 LPGGSLDEALHER------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-----EARVSDFGL 453 (484)
Q Consensus 385 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-----~~kl~DFGl 453 (484)
+++++|.+++... ...+++.++..++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 233789999999999999999999 45999999999999999877 899999999
Q ss_pred CcccCCCCcce-eecccccccccCCcccCCC
Q 011486 454 AKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 454 a~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
++......... .....++..|+|||++.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccC
Confidence 98664322111 1123457889999988654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=209.84 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=147.3
Q ss_pred CHHHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEc-
Q 011486 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS- 374 (484)
Q Consensus 298 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 374 (484)
+..++......|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556788999999999999999999875 57889999886543 3346688899999998 69999999999853
Q ss_pred -----CCceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 375 -----PTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 375 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
.+..+++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEE
Confidence 356799999999999999997533 448888899999999999999995 59999999999999999999999
Q ss_pred EecCCCcccCCCCcceeecccccccccCCcccC
Q 011486 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+|||++......... .....|++.|+|||.+.
T Consensus 163 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 163 VDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIA 194 (282)
T ss_pred eeCcchhhhhccccC-CCcccccccccCHhhcC
Confidence 999998865432211 22356899999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=220.48 Aligned_cols=146 Identities=25% Similarity=0.364 Sum_probs=127.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChh---HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG---FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
-|..++.||-|+||+|..++.. +...||+|.+++.+.. .......|-+||+....+-||+++-.|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3567888999999999998654 4678999999875422 23346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
|++||++..+|-.. +.++++.+..++.++..|+++.| +.|+|||||||+|||||.||++||+|||++.-+
T Consensus 710 YIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred ccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence 99999999988653 66899999999999999999999 569999999999999999999999999998743
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=216.85 Aligned_cols=169 Identities=25% Similarity=0.333 Sum_probs=141.1
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 376 (484)
..++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3568999999999999999999865 6899999998643 2334456778999999999999999999886442
Q ss_pred -ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 377 -SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
..|+||||++ ++|.+.+... +++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 4699999995 5888887543 8899999999999999999995 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .....|++.|+|||++.+
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILG 191 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhC
Confidence 7654322 233458999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=216.93 Aligned_cols=171 Identities=28% Similarity=0.403 Sum_probs=141.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC--ceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT--SKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~~ 379 (484)
.++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999876 5788999988642 223345677899999999 9999999999986543 579
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999997 5999988653 68899999999999999999994 5999999999999999999999999999987654
Q ss_pred CCcc----eeecccccccccCCcccCC
Q 011486 460 EESH----ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~----~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......||..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred ccccccCcchhcccccccccCceeeec
Confidence 3221 2233568999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=211.33 Aligned_cols=164 Identities=30% Similarity=0.411 Sum_probs=141.0
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999865 68899999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++ |++.+.+......+++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 58888886656679999999999999999999995 59999999999999999999999999998765432
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
....|++.|+|||++.
T Consensus 179 -~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 179 -NSFVGTPYWMAPEVIL 194 (317)
T ss_pred -ccccCCccccChhhhh
Confidence 2345899999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=201.45 Aligned_cols=169 Identities=26% Similarity=0.429 Sum_probs=142.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+++....||.|..|.|++++.+ .|..+|||.+.+.. ....+++...++++..-. .|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3444677999999999999876 58899999998654 555678888888876654 89999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
| ..-++.+++.-.+++++..+-++...+++||.||.+ +.+|+|||+||+|||+|+.|++|++|||++..+.+...+
T Consensus 173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 8 446677776666779999999999999999999987 569999999999999999999999999999887664433
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
+...|.+.|||||.+.
T Consensus 249 -trsAGC~~YMaPERid 264 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERID 264 (391)
T ss_pred -ccccCCccccCccccC
Confidence 3456999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=216.10 Aligned_cols=170 Identities=26% Similarity=0.461 Sum_probs=140.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----ceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 379 (484)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 57889999999999999999764 68899999987532 334567888999999999999999999876543 478
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+|+||++ +++.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 85 IVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9999996 488888754 458999999999999999999995 5999999999999999999999999999987643
Q ss_pred CCcce--eecccccccccCCcccCC
Q 011486 460 EESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhC
Confidence 22211 123468999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=207.18 Aligned_cols=172 Identities=27% Similarity=0.402 Sum_probs=144.9
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999876 57889999986532 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~ 462 (484)
+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999976433 48999999999999999999995 5999999999999999875 579999999987654332
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .....|++.|+|||++.++
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~ 177 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNR 177 (257)
T ss_pred c-ccccCCCccccCHHHHcCC
Confidence 2 2234589999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=221.12 Aligned_cols=179 Identities=23% Similarity=0.337 Sum_probs=150.3
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
++++-...++....+||-|.||.||.|.|+. .-.||||.++... ...++|.+|..+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4444444566667899999999999999875 6789999998754 3568899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 379 LLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
|||+|||.+|+|.+|+++... .++.-..+.+|.||+.||+||. .+++|||||.++|.|+.++..+||+|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999987543 3777778899999999999999 679999999999999999999999999999999
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..+.........-...|.|||.+.-
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAy 440 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAY 440 (1157)
T ss_pred cCCceecccCccCcccccCcccccc
Confidence 7654322111122568999998753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=210.81 Aligned_cols=165 Identities=25% Similarity=0.387 Sum_probs=142.1
Q ss_pred cceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
...||+|+||.||++... +++.+|+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999774 6889999998765555567799999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........ ......|
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 998754 358999999999999999999995 5999999999999999999999999999876644321 1233568
Q ss_pred cccccCCcccCC
Q 011486 471 TFGYLAPGKDCT 482 (484)
Q Consensus 471 t~~Y~APE~~~~ 482 (484)
++.|+|||++.+
T Consensus 179 ~~~y~~pE~~~~ 190 (292)
T cd06657 179 TPYWMAPELISR 190 (292)
T ss_pred CccccCHHHhcC
Confidence 999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=205.84 Aligned_cols=172 Identities=23% Similarity=0.324 Sum_probs=138.0
Q ss_pred CCccceeeeccceeEEEEEec----CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 376 (484)
|.+.+.||+|+||.||+|... +++.+|+|.+... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999754 3678999998753 2334567889999999999999999999886542
Q ss_pred ceEEEEEcCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 377 SKLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 1247889999999999999999994 59999999999999999999999999
Q ss_pred CCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 452 GLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 452 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|+++........ ......+++.|++||.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN 190 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence 999876433211 11223456789999987543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=202.53 Aligned_cols=172 Identities=32% Similarity=0.454 Sum_probs=148.6
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIY 382 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 382 (484)
+|+..+.||+|++|.||+|... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999876 68899999987644 24567899999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997653 78999999999999999999995 5999999999999999999999999999987765432
Q ss_pred c-eeecccccccccCCcccCCC
Q 011486 463 H-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ......++..|+|||.+..+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred cccccCCCCCccccCHhhhcCC
Confidence 1 12234589999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=247.75 Aligned_cols=173 Identities=32% Similarity=0.576 Sum_probs=127.1
Q ss_pred CcchHHHHHHHHHhccCCCCCCCCCCCCCCCCCCcceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcc
Q 011486 29 INSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF 108 (484)
Q Consensus 29 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 108 (484)
.+.|+.||++||+++.+|.+.+.+|+. +.+||.|.||+|+..++|+.|+|++|+++|.+++.|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 457899999999999888888899975 4589999999999778999999999999999999999999999999999999
Q ss_pred cccCCcccC-CccccceecccccccCCCCC----------------------hhhhcccccccccccccccCCCCCCccc
Q 011486 109 YGEIPSELG-NCTELQGLSLQSNYLSGSIP----------------------SELGNLSNLLNLDISSNSLSDYIPPSLG 165 (484)
Q Consensus 109 ~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p----------------------~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 165 (484)
+|.+|..+. ++++|++|+|++|+++|.+| ..++++++|++|+|++|.+.+.+|..+.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 988887754 67777777777776665544 4455555555555555555555555555
Q ss_pred cccccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 166 KLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 166 ~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
++++|++|+|++|++++.+| .++.+.+|+.+++++|.
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 223 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence 55555555555555555544 44555555555555554
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=209.72 Aligned_cols=172 Identities=28% Similarity=0.422 Sum_probs=147.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 381 (484)
++|...+.||+|++|.||++... +++.+|+|.+... .....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999876 6899999998752 2334567889999999998 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999764 469999999999999999999995 599999999999999999999999999998765432
Q ss_pred c-------------------ceeecccccccccCCcccCC
Q 011486 462 S-------------------HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~-------------------~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .......|+..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 1 11223457899999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=210.61 Aligned_cols=173 Identities=28% Similarity=0.469 Sum_probs=143.4
Q ss_pred HhcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 381 (484)
..++|++.+.||+|++|.||+|...+ ++.||+|.++... ......+.+|++++.+.. ||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999998875 8899999997543 234456677887777765 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||++ +++.+++......+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++..+....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99985 578887766556799999999999999999999952 489999999999999999999999999998765432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ....|+..|+|||++..
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~ 188 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDP 188 (296)
T ss_pred cc--cCCCCCccccCHhhcCC
Confidence 21 22347889999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=208.22 Aligned_cols=171 Identities=31% Similarity=0.419 Sum_probs=139.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999998765 58899999987543 334567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHh---h-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 385 LPGGSLDEALH---E-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 385 ~~~gsL~~~l~---~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
++. ++.++.. . ....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 6655432 2 235689999999999999999999952 48999999999999999999999999999866433
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. .....|++.|+|||++..+
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred Cc--cccccCccCccCHHHhccc
Confidence 22 1233589999999998653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=202.69 Aligned_cols=162 Identities=28% Similarity=0.368 Sum_probs=133.9
Q ss_pred ceeeeccceeEEEEEec-CCCEEEEEEecccCh---hHHHHHHHHHHHH-hcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEIL-GSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|... +++.||+|.++.... .....+..|..++ ...+|+|++++++++...+..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 588999999875431 1223344555544 455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999999654 458999999999999999999995 5999999999999999999999999999876543 123
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..|++.|+|||.+.++
T Consensus 153 ~~~~~~y~~pe~~~~~ 168 (260)
T cd05611 153 FVGTPDYLAPETILGV 168 (260)
T ss_pred CCCCcCccChhhhcCC
Confidence 4588999999997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.15 Aligned_cols=178 Identities=26% Similarity=0.409 Sum_probs=149.9
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEc---
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS--- 374 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 374 (484)
+.+....+.|++.++||+|.+|.||+++.. +++..|+|+..... ...++.+.|.++++.. .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344455678889999999999999998754 68888999887644 3467788899999888 59999999999853
Q ss_pred --CCceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 375 --PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 375 --~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
++..|+|||||.+||..|+++.. ..++.|..+..|.+.++.|+.+||.+ .++|||||-.|||++.++.||+.||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 46799999999999999999864 44599999999999999999999954 9999999999999999999999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|.+..+..... .....+|||.|||||++..
T Consensus 168 GvSaQldsT~g-rRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 168 GVSAQLDSTVG-RRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred eeeeeeecccc-cccCcCCCcccccceeeec
Confidence 99987764332 2345679999999999753
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=214.07 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=145.0
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----ceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 379 (484)
+|++.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+++++.++||||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999876 48899999987643 344577999999999999999999999988775 789
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
++|||++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 5899988654 379999999999999999999994 5999999999999999999999999999987765
Q ss_pred CCc--ceeecccccccccCCcccCCC
Q 011486 460 EES--HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~--~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .......+++.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred cccccccccccccccCcCCceeeecc
Confidence 431 112334579999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=214.62 Aligned_cols=171 Identities=27% Similarity=0.438 Sum_probs=141.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC----CceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP----TSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~ 379 (484)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999765 58999999987532 23456778899999999999999999987543 4579
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999995 6899988654 458999999999999999999995 5999999999999999999999999999986643
Q ss_pred CCcc---eeecccccccccCCcccCC
Q 011486 460 EESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......|+..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred cCcCCCcccccccccccccChHHhcC
Confidence 2211 1123468999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=212.01 Aligned_cols=168 Identities=30% Similarity=0.413 Sum_probs=141.1
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 376 (484)
..++|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3567989999999999999999754 68999999986432 334567889999999999999999999987654
Q ss_pred -ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 377 -SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999999 7799988864 458999999999999999999994 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... ....+++.|+|||++.+
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILN 189 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhC
Confidence 664322 23457899999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=226.01 Aligned_cols=169 Identities=30% Similarity=0.448 Sum_probs=142.9
Q ss_pred CCccceeeeccceeEEEEEec-CC----CEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DG----NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+..++||+|+||+||+|.+- ++ -+||+|++... ......++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344689999999999998653 33 46889988653 3556788999999999999999999999998776 78999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
+||+.|+|.++++.++..+-....+.|..|||+||.|||++ ++|||||.++|||+.+-..+||.|||+|+...+++.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999888899999999999999999999954 999999999999999999999999999999887655
Q ss_pred ceeec-ccccccccCCcccC
Q 011486 463 HITTI-VAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~-~~Gt~~Y~APE~~~ 481 (484)
..... ..-.+.|||=|.+.
T Consensus 854 ey~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred cccccccccCcHHHHHHHhh
Confidence 44332 12255788877764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=210.94 Aligned_cols=173 Identities=31% Similarity=0.402 Sum_probs=141.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 376 (484)
.++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 58899999886432 222346778999999999999999999875543
Q ss_pred --ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 377 --SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 377 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
..++|+||+++ ++.+.+......+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35899999965 788877665567999999999999999999999 459999999999999999999999999999
Q ss_pred cccCCCCcc----------eeecccccccccCCcccCC
Q 011486 455 KLLEDEESH----------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~----------~~~~~~Gt~~Y~APE~~~~ 482 (484)
+........ ......|++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 865432211 1123457889999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=203.16 Aligned_cols=166 Identities=25% Similarity=0.326 Sum_probs=134.5
Q ss_pred hcCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEc----CCce
Q 011486 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS----PTSK 378 (484)
Q Consensus 306 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 378 (484)
+++|++. ++||-|-.|.|-.+..+ +++.+|+|++... ...++|+++.-.. .|||||+++++|.. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455543 57999999999997654 6889999998653 2356788876555 59999999999854 3457
Q ss_pred EEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla 454 (484)
.+|||.|+||.|...+.+++. .+++.++..|++||+.|+.||| +.+|.||||||+|+|.. .+..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 899999999999999987643 4999999999999999999999 66999999999999996 4557999999999
Q ss_pred cccCCCCcceeecccccccccCCcccC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+....... ....+-||.|.|||++-
T Consensus 212 K~t~~~~~--L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 212 KETQEPGD--LMTPCFTPYYVAPEVLG 236 (400)
T ss_pred cccCCCcc--ccCCcccccccCHHHhC
Confidence 97654322 23344699999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=206.34 Aligned_cols=169 Identities=26% Similarity=0.387 Sum_probs=144.7
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
|+..+.||+|++|.||++... +++.+++|.++... ......+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999875 68889999987543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++ ++.+++......+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||.+........ ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence 75 8988887765679999999999999999999995 5999999999999999999999999999987755431 12
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||.+.+
T Consensus 156 ~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 156 THYVVTRWYRAPELLLG 172 (283)
T ss_pred cCccCcccccCcHHHhc
Confidence 23457889999998754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=206.47 Aligned_cols=164 Identities=29% Similarity=0.404 Sum_probs=140.0
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
|...+.||+|+||.||+|+.. ++..+++|.+.... ....+.+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999865 58899999986432 23345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+. +++.+++......+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 95 58888887666679999999999999999999995 59999999999999999999999999998654322
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
....|+..|+|||++.
T Consensus 175 -~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 175 -NSFVGTPYWMAPEVIL 190 (313)
T ss_pred -CCccccccccChhhcc
Confidence 2346899999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=206.38 Aligned_cols=168 Identities=25% Similarity=0.392 Sum_probs=141.7
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-hHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEcC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-GFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
|++.+.||+|++|.||+|... +++.+++|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999886 478899999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 468999999999999999999995 4999999999999999999999999999987654322
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|+..|+|||++..
T Consensus 155 ~~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 155 YTDYVSTRWYRAPEILLR 172 (283)
T ss_pred cCCCCCcccccCceeeec
Confidence 123458899999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=203.05 Aligned_cols=169 Identities=27% Similarity=0.428 Sum_probs=145.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+|++.+.||+|++|.||++... +++.+|+|.+.... +.....+.+|++++++++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999998755 67899999987532 34456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998652 245899999999999999999999 4599999999999999999999999999998775542
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||.+.+
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred ---cccccCCccccCHHHHCC
Confidence 223458899999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=211.13 Aligned_cols=165 Identities=27% Similarity=0.398 Sum_probs=137.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------c
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------S 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 377 (484)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 78888999999999999999864 68999999987532 233456889999999999999999999986543 3
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 5899999964 7777652 358999999999999999999995 59999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ....|++.|+|||++.+
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 168 DAEM----TGYVVTRWYRAPEVILN 188 (342)
T ss_pred CCCC----CCceeeecccChhhhcC
Confidence 4321 23457899999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=219.35 Aligned_cols=174 Identities=28% Similarity=0.378 Sum_probs=152.0
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCC-EEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+..+++....||-|+||.|=.++..... .+|+|.+++. +....+.+..|-.+|...+.|+||+++.-|.+..+.|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3455666778999999999998876544 3888888753 34445668889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
+||-|-||.+...++++ +.++..++..++..+++|++||| +++||.|||||+|.++|.+|-+||.|||+|+.+..+
T Consensus 498 LmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999999876 66899999999999999999999 679999999999999999999999999999999876
Q ss_pred CcceeecccccccccCCcccCCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
.. +..++|||.|.|||++.+-|
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred Cc--eeeecCCcccccchhhhccC
Confidence 54 56789999999999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-26 Score=207.75 Aligned_cols=170 Identities=30% Similarity=0.480 Sum_probs=139.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--------C
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--------T 376 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 376 (484)
.|.....||+|.||.||+|+.+ +++.||+|++-.. ..+......+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3455678999999999999766 4677888876432 244556678999999999999999999887442 2
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
.+|+||++|+. +|.-++.....+++..++.+++.++..||.|+|. ..|+|||+||+|+||+.||.+||+|||+|+.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 37999999976 9999998777789999999999999999999994 5999999999999999999999999999987
Q ss_pred cCCCCcc----eeecccccccccCCcccCC
Q 011486 457 LEDEESH----ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~----~~~~~~Gt~~Y~APE~~~~ 482 (484)
+...... .+.. +-|.+|++||.+.+
T Consensus 174 fs~~~n~~kprytnr-vvTLwYrppEllLG 202 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNR-VVTLWYRPPELLLG 202 (376)
T ss_pred eecccccCCCCcccc-eeeeecCCHHHhhc
Confidence 7543222 2223 34999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=205.91 Aligned_cols=169 Identities=30% Similarity=0.433 Sum_probs=144.0
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
|+..+.||+|.+|.||+|... +++.+|+|.+.... ....+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999876 48999999997643 334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
+ ++|.+++......+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||.++........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 7 59999998764569999999999999999999995 49999999999999999999999999999876543321 1
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 156 THEVVTLWYRAPEILLG 172 (282)
T ss_pred CccccCcCcCChHHhcC
Confidence 22346788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=208.62 Aligned_cols=174 Identities=30% Similarity=0.440 Sum_probs=143.0
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecc---cCh----hHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-Cce
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK---LNE----GFDRFFERELEILGSIKHRYLVNLRGYCNSP-TSK 378 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 378 (484)
+|-...+||+|+|+.||++.+- ..+.||||+-.. +.+ ...+...+|-++.+.+.||.||++++|+.-+ +.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 4556778999999999998654 577788886532 111 1234567899999999999999999999655 567
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCc
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAK 455 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~ 455 (484)
+-|+|||+|.+|+-|++.. ..+++.++..|+.||+.||.||.+- +++|||=||||.|||+. .-|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8999999999999999765 5689999999999999999999987 89999999999999995 45789999999999
Q ss_pred ccCCCCcc------eeecccccccccCCcccCCC
Q 011486 456 LLEDEESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+.++... .+....||.+|.+||.+.-|
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg 655 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG 655 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecC
Confidence 98764432 24567899999999997643
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=209.76 Aligned_cols=170 Identities=24% Similarity=0.310 Sum_probs=138.8
Q ss_pred CCC-ccceeeeccceeEEEEEec-CCCEEEEEEecccChhH--------------HHHHHHHHHHHhcCCCCceeeeEEE
Q 011486 308 TLD-DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGF--------------DRFFERELEILGSIKHRYLVNLRGY 371 (484)
Q Consensus 308 ~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~ 371 (484)
+|. +.+.||+|+||.||+|... +++.||+|.+....... ...+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3567999999999999865 68899999986432111 1257789999999999999999999
Q ss_pred EEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
+..++..++||||++ ++|.+++... ..+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence 999999999999996 6999998643 458999999999999999999994 59999999999999999999999999
Q ss_pred CCCcccCCCC-------------cceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEE-------------SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++...... ........+++.|+|||++.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 9998665111 011122346889999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=211.88 Aligned_cols=170 Identities=24% Similarity=0.406 Sum_probs=141.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 378 (484)
++|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46888999999999999999765 6899999998753 222345677899999999999999999987654 347
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999995 6899888654 569999999999999999999994 599999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......|+..|+|||++..
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 160 EKGD-FMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred CCcc-cccccccccCccChHHHhc
Confidence 4322 1233457899999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=209.56 Aligned_cols=173 Identities=28% Similarity=0.395 Sum_probs=142.9
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP- 375 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 375 (484)
.++....++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++.+++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45556678999999999999999999975 468899999987532 22346688899999999999999999987543
Q ss_pred -----CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEe
Q 011486 376 -----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (484)
Q Consensus 376 -----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~D 450 (484)
...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEec
Confidence 3467888877 7899888854 358999999999999999999995 5999999999999999999999999
Q ss_pred cCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+++..... .....|+..|+|||.+.+
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhC
Confidence 9999865432 123458999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=207.05 Aligned_cols=165 Identities=28% Similarity=0.409 Sum_probs=140.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|++|.||+|... ++..+|+|.+... .....+++.+|+++++.++|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999865 5788999988642 23344568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+. |++.+++......+++.++..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 68888886655668999999999999999999994 59999999999999999999999999998765432
Q ss_pred eeecccccccccCCcccC
Q 011486 464 ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~ 481 (484)
....|++.|+|||++.
T Consensus 169 --~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 --NXFVGTPYWMAPEVIL 184 (308)
T ss_pred --ccccCCccccCHHHHh
Confidence 2345889999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=209.07 Aligned_cols=170 Identities=22% Similarity=0.331 Sum_probs=137.5
Q ss_pred CCCccceeeeccceeEEEEEec-C--CCEEEEEEecccC--hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC----Cc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-D--GNVFALKRIDKLN--EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP----TS 377 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 377 (484)
+|+..+.||+|+||.||++... . +..||+|++.... ....+.+.+|+++++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999875 3 6789999987532 22356788899999999 599999999875432 45
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.++++||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 688899885 6899988643 568999999999999999999995 59999999999999999999999999999876
Q ss_pred CCCCcc---eeecccccccccCCcccCC
Q 011486 458 EDEESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... ......||+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhC
Confidence 532211 1123468999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=207.97 Aligned_cols=170 Identities=28% Similarity=0.402 Sum_probs=142.0
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCce
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSK 378 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 378 (484)
....++|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++.+++.. .+..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999765 78999999886422 2345678899999999999999999999876 4578
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++++||+ +++|.++++. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+....
T Consensus 86 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 8999998 5689988864 347888889999999999999994 599999999999999999999999999998654
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ....+++.|+|||++.+
T Consensus 160 ~~~----~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 160 PQM----TGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CCc----CCCcccccccCceeeec
Confidence 321 22457889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=225.03 Aligned_cols=160 Identities=35% Similarity=0.588 Sum_probs=123.1
Q ss_pred CCCcchHHHHHHHHHhccCCCCCCCCCCCCCCCCC-----CcceeeeCCC-----CcEEEEeeCCCccccccCcCcCCCC
Q 011486 27 RAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPC-----NWKGVKCDKN-----KRVITLSLTNHKLSGPISADLGKLD 96 (484)
Q Consensus 27 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c-----~w~gv~C~~~-----~~l~~L~L~~n~l~~~~~~~~~~l~ 96 (484)
.+...|.+||+.+|+.+.++.. .+|++ +|| .|.||.|+.. ..++.|+|++|+++|.+|+.+++++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 4566789999999999976543 47964 455 7999999621 2478888888888888888888888
Q ss_pred CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeecc
Q 011486 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (484)
Q Consensus 97 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls 176 (484)
+|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..+
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~--------- 513 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR--------- 513 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc---------
Confidence 88888888888888888888888888888888888888888888888888888888888888777766432
Q ss_pred CCcccccCCCCCcccccCcccccCCcCCCCCcccccc
Q 011486 177 NNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTC 213 (484)
Q Consensus 177 ~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~~~~c 213 (484)
+.++..+++.+|+.+|+.|....|
T Consensus 514 -------------~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 514 -------------LLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred -------------cccCceEEecCCccccCCCCCCCC
Confidence 123345678899999987654455
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=207.67 Aligned_cols=167 Identities=17% Similarity=0.192 Sum_probs=135.4
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 6899999998754 34455789999999999999999999999999999999999999999
Q ss_pred HHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc------
Q 011486 390 LDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES------ 462 (484)
Q Consensus 390 L~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~------ 462 (484)
|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999764 3458899999999999999999995 5999999999999999999999999999876543211
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......++..|+|||++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred cccccccccccccCHHHhcC
Confidence 11123457889999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=201.93 Aligned_cols=168 Identities=30% Similarity=0.471 Sum_probs=138.5
Q ss_pred CCccceeeeccceeEEEEEecC-CCEEEEEEecccC--hhHHHHHHHHHHHHhcC---CCCceeeeEEEEEcCCc-----
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNSPTS----- 377 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 377 (484)
|++.+.||+|+||.||+|..+. ++.+|+|+++... ......+.+|+++++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999998864 8999999997432 22345566788777665 59999999999988776
Q ss_pred eEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 378 KLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
.+++|||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 48999887543 358999999999999999999995 5999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... ....++..|+|||++..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred ccCCccc--ccccccccccChHHhcc
Confidence 6543221 23347899999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=207.92 Aligned_cols=167 Identities=23% Similarity=0.304 Sum_probs=135.7
Q ss_pred ceeeec--cceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSG--GFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+| +||+||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999865 78999999987432 33457789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce--
Q 011486 388 GSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (484)
Q Consensus 388 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 464 (484)
+++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987542 34899999999999999999999 4599999999999999999999999998654332211100
Q ss_pred ----eecccccccccCCcccCC
Q 011486 465 ----TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ----~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccccCccCccChhhhcC
Confidence 011235677999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=197.06 Aligned_cols=163 Identities=32% Similarity=0.453 Sum_probs=140.4
Q ss_pred eeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
||+|+||.||++... +++.+|+|.+.... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 58899999987543 22456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccc
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G 470 (484)
.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||.+........ ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence 9999754 458999999999999999999995 5999999999999999999999999999987654321 1234568
Q ss_pred cccccCCcccCC
Q 011486 471 TFGYLAPGKDCT 482 (484)
Q Consensus 471 t~~Y~APE~~~~ 482 (484)
+..|+|||...+
T Consensus 156 ~~~~~~Pe~~~~ 167 (250)
T cd05123 156 TPEYLAPEVLLG 167 (250)
T ss_pred CccccChHHhCC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=215.73 Aligned_cols=171 Identities=25% Similarity=0.393 Sum_probs=145.5
Q ss_pred CCccceeeeccceeEEEEEec--CCC--EEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD--DGN--VFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
....+.||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|||+++++|...+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 334678999999999999876 343 5799999865533 67899999999999999999999999887 56789999
Q ss_pred cCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
.++.|||.+.|++ ....+-......++.|||.||+||. ++++|||||..+|+|+.....+||+|||+.+.+...+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999987 4445888899999999999999999 67999999999999999999999999999999987666
Q ss_pred ceeec--ccccccccCCcccCCC
Q 011486 463 HITTI--VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~--~~Gt~~Y~APE~~~~~ 483 (484)
++... ..-...|.|||.+.++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~ 290 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHR 290 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccc
Confidence 55322 1225689999999865
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=202.23 Aligned_cols=171 Identities=24% Similarity=0.292 Sum_probs=125.7
Q ss_pred cCCCccceeeeccceeEEEEEecCC----CEEEEEEecccChhH-----------HHHHHHHHHHHhcCCCCceeeeEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDG----NVFALKRIDKLNEGF-----------DRFFERELEILGSIKHRYLVNLRGY 371 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~ 371 (484)
++|++.+.||+|+||.||+|...++ ..+|+|......... ......+...+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999987643 455666543222110 0112233445567789999999987
Q ss_pred EEcCC----ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEE
Q 011486 372 CNSPT----SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447 (484)
Q Consensus 372 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~k 447 (484)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.||+||| +.+|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 65543 3467888874 4777766542 34678889999999999999999 45999999999999999999999
Q ss_pred EEecCCCcccCCCCcc------eeecccccccccCCcccCC
Q 011486 448 VSDFGLAKLLEDEESH------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 448 l~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+|||+|+.+...... ......||+.|+|||++.+
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 9999999876432211 1123469999999998764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=205.89 Aligned_cols=174 Identities=24% Similarity=0.323 Sum_probs=144.7
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
.....+|....+||+|+||+|..+..+ +.+.||||++++.. ....+--..|-++|+.. +-|.++++...|++.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344557888999999999999998766 46789999998643 22223345577777665 57899999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|.||||+.||+|.-.+++- +.+.+..+..+|..||-||-||| +++|+.||||.+|||+|.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999988764 56888899999999999999999 679999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccCCcccC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
--+. ..+..++|||.|+|||++.
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred ccCC-cceeeecCCCcccccceEE
Confidence 3332 2356789999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=220.79 Aligned_cols=170 Identities=19% Similarity=0.232 Sum_probs=122.4
Q ss_pred HhcCCCccceeeeccceeEEEEEecC-----CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEE------EE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY------CN 373 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 373 (484)
..++|+..+.||+|+||.||+|...+ +..||+|++...... +.+..| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998764 689999998653321 111111 1122222222222211 24
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERSEQ-------------------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDik 434 (484)
.+...++||||+++++|.+++...... ..+..+..++.|++.||+|||+ .+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 556789999999999999998753211 1233456799999999999994 599999999
Q ss_pred CCcEEEcC-CCcEEEEecCCCcccCCCCcceeecccccccccCCcccC
Q 011486 435 SSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 435 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
|+|||+++ ++.+||+|||+|+.+............||+.|||||.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99999985 579999999999876554444445567899999999653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=207.82 Aligned_cols=170 Identities=22% Similarity=0.352 Sum_probs=139.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC----------
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP---------- 375 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 375 (484)
.+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999865 5889999998765555567788999999999999999999876544
Q ss_pred ----CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEe
Q 011486 376 ----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSD 450 (484)
Q Consensus 376 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~D 450 (484)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999997 589888854 358999999999999999999995 5999999999999997 456799999
Q ss_pred cCCCcccCCCCcc--eeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
||.++........ ......|+..|+|||++..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhC
Confidence 9999866432211 1122357899999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-25 Score=201.35 Aligned_cols=170 Identities=26% Similarity=0.400 Sum_probs=140.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----ceE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 379 (484)
+.+..+.||-|+||.||.+.+. +|+.||.|++.... -...+++.+|++++..++|.|++..+++.+... +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455788999999999998764 79999999987543 235678889999999999999999999876553 467
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+++|.|. .+|.+.+-.. ..++.+.+.-+..||++||.||| +.+|.||||||.|.|++.+...||+|||+|+.-+.
T Consensus 134 V~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 8999985 4888887653 56888888999999999999999 45999999999999999999999999999997765
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++....+..+-|..|+|||++.+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc
Confidence 44433344456999999999875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=198.44 Aligned_cols=170 Identities=25% Similarity=0.382 Sum_probs=137.6
Q ss_pred CCCccceeeeccceeEEEEEecC-CCEEEEEEeccc-----ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999987653 344555555431 122345677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 23458999999999999999999995 59999999999999985 569999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......|++.|+|||++..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~ 179 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKH 179 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHcc
Confidence 4322 2233458999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=192.82 Aligned_cols=152 Identities=23% Similarity=0.200 Sum_probs=127.9
Q ss_pred ccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhh
Q 011486 318 GGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE 396 (484)
Q Consensus 318 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 396 (484)
|.+|.||++... +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999765 68899999997643 234455556666799999999999999999999999999999999865
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccC
Q 011486 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476 (484)
Q Consensus 397 ~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~A 476 (484)
. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 4 458999999999999999999994 599999999999999999999999999887665421 12346778999
Q ss_pred CcccCC
Q 011486 477 PGKDCT 482 (484)
Q Consensus 477 PE~~~~ 482 (484)
||+...
T Consensus 151 PE~~~~ 156 (237)
T cd05576 151 PEVGGI 156 (237)
T ss_pred CcccCC
Confidence 998754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=207.09 Aligned_cols=167 Identities=28% Similarity=0.416 Sum_probs=141.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-----
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----- 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 377 (484)
.++|+..+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 467888999999999999999876 5789999998653 22334667889999999999999999998766554
Q ss_pred -eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 378 -KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 378 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799999865 458999999999999999999994 5999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....++..|+|||.+.+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccc----ccCCcccccccCHHHHhC
Confidence 6433 223457899999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=194.19 Aligned_cols=172 Identities=22% Similarity=0.377 Sum_probs=145.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|+...+||+|+|++|-.++.+ +.+.||+|++++. .....+-.+.|-.++.+. +||++|-+...|+++...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 568889999999999999998765 5788999998753 222334466777777766 69999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|.||++||+|.-++... ..++++.+..+...|.-||.||| ++||+.||+|.+|+|+|..|.+||+|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999998777543 45899999999999999999999 579999999999999999999999999999864322
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. ..+..++|||.|+|||++++
T Consensus 405 g-d~tstfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRG 425 (593)
T ss_pred C-cccccccCCCcccchhhhcc
Confidence 2 23567899999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=216.06 Aligned_cols=179 Identities=27% Similarity=0.372 Sum_probs=148.8
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEE
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRG 370 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 370 (484)
.++...++..+.+.+|+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44444555566779999999999998643 14578999998643 45678899999999998 5999999999
Q ss_pred EEEcCCceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 011486 371 YCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (484)
Q Consensus 371 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp 435 (484)
+|...+..++|+||++.|+|.++++... ..++..+.+.++.|||.|++||+ +.++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998765 34888999999999999999999 56999999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccCCCCcceeecccc--cccccCCcccCC
Q 011486 436 SNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG--TFGYLAPGKDCT 482 (484)
Q Consensus 436 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~G--t~~Y~APE~~~~ 482 (484)
+|||+.++..+||+|||+|+............-.| ...|||||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 99999999999999999999876655444332233 345999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-24 Score=215.16 Aligned_cols=171 Identities=26% Similarity=0.358 Sum_probs=149.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|+....+|.|.||.|||++.. .++..|+|.++-.......-.+.|+-+++..+||||+.++|.+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999865 6888999999865544556678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
|.+|+|.+..+-. +.+++.++..+.+..++|++||| +.+-+|||||-.||++++.|.+|++|||.+..+...-..
T Consensus 94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 9999999987654 67999999999999999999999 569999999999999999999999999998877643221
Q ss_pred eecccccccccCCcccC
Q 011486 465 TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~ 481 (484)
...+.||++|||||+..
T Consensus 169 rksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhcccCCccccchhHHH
Confidence 24577999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=184.03 Aligned_cols=169 Identities=31% Similarity=0.479 Sum_probs=146.0
Q ss_pred CCccceeeeccceeEEEEEecC-CCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998875 889999999875544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+++|.+++......+++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999997653338999999999999999999995 49999999999999999999999999999877554211223
Q ss_pred cccccccccCCccc
Q 011486 467 IVAGTFGYLAPGKD 480 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~ 480 (484)
...++..|++||.+
T Consensus 158 ~~~~~~~~~~pe~~ 171 (225)
T smart00221 158 TVKGTPFYLAPEVL 171 (225)
T ss_pred ceeccCCcCCHhHh
Confidence 34578899999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=183.02 Aligned_cols=142 Identities=15% Similarity=0.157 Sum_probs=110.4
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh--H------------------------HHHHHHHHHHHhcCCCCce
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--F------------------------DRFFERELEILGSIKHRYL 365 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 365 (484)
.+.||+|++|.||+|...+|+.||+|+++..... . .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999753211 0 1123459999999988777
Q ss_pred eeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 366 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
.....+.. ...++||||++++++...... ...+++..+..++.|++.+|.|+|+ +.+|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCc
Confidence 55444322 234899999998877655322 3468999999999999999999942 35999999999999998 478
Q ss_pred EEEEecCCCcccCC
Q 011486 446 ARVSDFGLAKLLED 459 (484)
Q Consensus 446 ~kl~DFGla~~~~~ 459 (484)
++|+|||+|.....
T Consensus 156 v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 LYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEccccccCCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-21 Score=175.96 Aligned_cols=164 Identities=38% Similarity=0.618 Sum_probs=141.1
Q ss_pred eeeccceeEEEEEecC-CCEEEEEEecccChh-HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHH
Q 011486 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE 392 (484)
Q Consensus 315 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 392 (484)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 889999999865432 35679999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccCCCCcceeeccccc
Q 011486 393 ALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGT 471 (484)
Q Consensus 393 ~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~Gt 471 (484)
++......+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 997653468999999999999999999995 59999999999999999 89999999999987654321 12234578
Q ss_pred ccccCCcccCC
Q 011486 472 FGYLAPGKDCT 482 (484)
Q Consensus 472 ~~Y~APE~~~~ 482 (484)
..|++||.+..
T Consensus 157 ~~~~~pe~~~~ 167 (215)
T cd00180 157 PAYMAPEVLLG 167 (215)
T ss_pred CCccChhHhcc
Confidence 89999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=176.98 Aligned_cols=142 Identities=16% Similarity=0.191 Sum_probs=113.2
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh--------------------------HHHHHHHHHHHHhcCCCCce
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--------------------------FDRFFERELEILGSIKHRYL 365 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 365 (484)
...||+|++|.||+|...+|+.||||+++..... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753210 01234678999999999988
Q ss_pred eeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 366 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
.....+... ..++||||++++++...... ...++..+..+++.|++.++.++|+ ..+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence 665555433 24899999998865443222 2457888999999999999999995 15999999999999999 889
Q ss_pred EEEEecCCCcccCC
Q 011486 446 ARVSDFGLAKLLED 459 (484)
Q Consensus 446 ~kl~DFGla~~~~~ 459 (484)
++|+|||+++....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=206.72 Aligned_cols=166 Identities=28% Similarity=0.421 Sum_probs=133.2
Q ss_pred CCccceeeeccce-eEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 309 LDDDHIIGSGGFG-TVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 309 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
|...+++|.|..| .||+|..+ ++.||||++-.. .....++|+..++.- +|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4456778999886 56899884 789999998543 345678999999887 59999999999899999999999995
Q ss_pred CCCHHHHHhhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---C--CcEEEEecCCCcccC
Q 011486 387 GGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---N--LEARVSDFGLAKLLE 458 (484)
Q Consensus 387 ~gsL~~~l~~~~~~---l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~--~~~kl~DFGla~~~~ 458 (484)
.+|.++++..... ..-...+.+..|+++||++|| +.+||||||||.||||+. + .+++|+|||+++...
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999763111 111334678999999999999 569999999999999975 3 479999999999987
Q ss_pred CCCcce--eecccccccccCCcccCC
Q 011486 459 DEESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
.+.... .....||-+|+|||+++.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhc
Confidence 654433 234679999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=180.57 Aligned_cols=157 Identities=33% Similarity=0.468 Sum_probs=136.6
Q ss_pred cceeEEEEEecC-CCEEEEEEecccChhH-HHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhh
Q 011486 319 GFGTVYKLAMDD-GNVFALKRIDKLNEGF-DRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE 396 (484)
Q Consensus 319 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 396 (484)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998874 8999999997654333 67899999999999999999999999999999999999999999999976
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccC
Q 011486 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476 (484)
Q Consensus 397 ~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~A 476 (484)
.. .+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......|+..|+|
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 43 38999999999999999999995 499999999999999999999999999998776532 2234558899999
Q ss_pred CcccC
Q 011486 477 PGKDC 481 (484)
Q Consensus 477 PE~~~ 481 (484)
||.+.
T Consensus 155 pE~~~ 159 (244)
T smart00220 155 PEVLL 159 (244)
T ss_pred HHHHc
Confidence 99875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=176.08 Aligned_cols=164 Identities=20% Similarity=0.341 Sum_probs=138.0
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCc--eEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTS--KLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--~~lv 381 (484)
.++|++.+.+|+|.|+.||.|.. .+.+.++||.+++.. .+.+.+|++++..++ ||||+++++...++.. ..+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788899999999999999864 467889999998753 567899999999997 9999999999987754 5799
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~ 460 (484)
+||+++.+...+.. .++...+..++.+++.||.|+| +.||.|||+||.|++||. .-.++|+|+|+|..+.++
T Consensus 114 FE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999988777663 3677788899999999999999 679999999999999995 457999999999988776
Q ss_pred CcceeecccccccccCCcccC
Q 011486 461 ESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
... ...+.+..|--||.+.
T Consensus 187 ~eY--nVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLV 205 (338)
T ss_pred cee--eeeeehhhcCCchhee
Confidence 543 2334578889999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=182.52 Aligned_cols=170 Identities=24% Similarity=0.327 Sum_probs=140.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCC--C----ceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKH--R----YLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~ 378 (484)
..+|.+...+|+|.||.|-++... .+..||+|+++... ...+...-|+++++++.+ | -++++.+||.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 567888999999999999998655 46889999997643 346677889999999942 2 478888999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---------------
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------------- 442 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--------------- 442 (484)
++|+|.+ |-|+.+++..+. .+++...+..++.|++++++|||+ .+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 679999998743 348999999999999999999995 59999999999999932
Q ss_pred -----CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCCC
Q 011486 443 -----NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTNG 484 (484)
Q Consensus 443 -----~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~ 484 (484)
+..+||+|||.|+...... ..++.|..|+|||++.+-|
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG 285 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC
Confidence 2358999999998654332 3466799999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=168.85 Aligned_cols=139 Identities=23% Similarity=0.344 Sum_probs=108.9
Q ss_pred CCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcC-----CCCceeeeEEEEEcCC---ceE-
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-----KHRYLVNLRGYCNSPT---SKL- 379 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 379 (484)
+...+.||+|+||.||. ...++.. +||++........+.+.+|+++++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45578999999999996 4334444 78988765444567899999999999 5799999999998874 333
Q ss_pred EEEEc--CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCcEEEcC----CCcEEEEe-c
Q 011486 380 LIYDF--LPGGSLDEALHERSEQLDWDARLNIIMGAAKGL-AYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSD-F 451 (484)
Q Consensus 380 lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~~ivHrDikp~NILl~~----~~~~kl~D-F 451 (484)
+|+|| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+| |
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999653 36655 35688888888 999954 9999999999999974 34799999 5
Q ss_pred CCCcc
Q 011486 452 GLAKL 456 (484)
Q Consensus 452 Gla~~ 456 (484)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=178.45 Aligned_cols=167 Identities=25% Similarity=0.354 Sum_probs=135.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecc--cChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 377 (484)
.+|.....++.|.. .|..+.+. .++.||+|++.. .+....++..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888888 45544332 578899998753 2244567788999999999999999999998543 35
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||| ..+|...+.. .++-.+...|..|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.-
T Consensus 96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 79999999 4599999873 3788889999999999999999 569999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ...+..+.|..|.|||++.+-
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~ 192 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGM 192 (369)
T ss_pred Ccc--cccCchhheeeccCchheecc
Confidence 443 344567789999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=189.80 Aligned_cols=164 Identities=24% Similarity=0.288 Sum_probs=135.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.+.|.....+|.|+|+.|-++... +++..++|++.+.. .+..+|+.++... .||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 677888888999999999987654 68889999997652 2345677776666 69999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE-cCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-DGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl-~~~~~~kl~DFGla~~~~~~~~ 462 (484)
++.++-+.+.+.... .....+..|+.+|+.|+.|||. .||||||+||+|||+ ++.++++|+|||.++...+.
T Consensus 397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999998888776532 2336777899999999999995 599999999999999 58999999999999988765
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. . ..+=|..|.|||++..
T Consensus 470 ~-~-tp~~t~~y~APEvl~~ 487 (612)
T KOG0603|consen 470 C-D-TPALTLQYVAPEVLAI 487 (612)
T ss_pred h-c-ccchhhcccChhhhcc
Confidence 1 1 1234889999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=170.37 Aligned_cols=166 Identities=18% Similarity=0.310 Sum_probs=133.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEE-EEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGY-CNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 382 (484)
.+.|++.+.+|+|.||.+-.+..+ ....+++|.++.. ....++|.+|...--.| .|.||+.-++. |++.+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 457888999999999999999876 4677888888763 33467899998765556 48999988765 56677778999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCCcEEEEecCCCcccCCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~~~kl~DFGla~~~~~~ 460 (484)
||++.|+|.+-+.. ..+-+....+++.|+++|+.||| ++++||||||.+||||- +..++||+|||+.+..+..
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999998854 34788889999999999999999 67999999999999993 4458999999999876542
Q ss_pred CcceeecccccccccCCcccC
Q 011486 461 ESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
... ..-+..|.|||...
T Consensus 177 V~~----~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCD 193 (378)
T ss_pred ehh----hhhhcccCCcHHHh
Confidence 211 22366789998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=177.93 Aligned_cols=146 Identities=27% Similarity=0.348 Sum_probs=127.4
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec----CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcC
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSP 375 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 375 (484)
++....+.|...++||+|.|++||++... ..+.||+|.+..... ..++.+|++.|..+. +.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445567889999999999999998654 367899999976543 456899999999995 99999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCC
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLA 454 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla 454 (484)
+...+|+||++...-.++... ++...+..+++.+..||+++| ..|||||||||+|+|.+ ..+.-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence 999999999999999998854 678899999999999999999 55999999999999998 4567899999999
Q ss_pred c
Q 011486 455 K 455 (484)
Q Consensus 455 ~ 455 (484)
.
T Consensus 181 ~ 181 (418)
T KOG1167|consen 181 Q 181 (418)
T ss_pred H
Confidence 8
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=162.25 Aligned_cols=167 Identities=25% Similarity=0.328 Sum_probs=137.2
Q ss_pred hcCCCccceeeeccceeEEEEE-ecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 383 (484)
...|.+.+.||+|+||.+|.|. ..+|..||+|.-..... ..++..|.+++..++| ..|..+..|..+..+-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999986 45799999998654322 2356778999999975 678888888888889999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~~~~~~ 460 (484)
.+ |.||++++.-....++..+.+-++.|++.-++|+| .++++||||||+|+|.. ....+.++|||+|+.+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 98 89999999877677999999999999999999999 45999999999999996 3346999999999988653
Q ss_pred Ccce------eecccccccccCCc
Q 011486 461 ESHI------TTIVAGTFGYLAPG 478 (484)
Q Consensus 461 ~~~~------~~~~~Gt~~Y~APE 478 (484)
.... .....||.+|.+--
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred cccccCccccCCccceeeeehhhh
Confidence 3211 23356999998744
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=178.04 Aligned_cols=171 Identities=23% Similarity=0.336 Sum_probs=136.7
Q ss_pred CCCccceeeeccceeEEEEEecCC--CEEEEEEecccChhHHHHHHHHHHHHhcCCC----CceeeeEEEE-EcCCceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDDG--NVFALKRIDKLNEGFDRFFERELEILGSIKH----RYLVNLRGYC-NSPTSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 380 (484)
.|.+.+.||+|+||.||.|..... ..+|+|............+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999987654 4788888765432222268889999988863 6899999998 47778999
Q ss_pred EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-----CcEEEEecCCC
Q 011486 381 IYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-----LEARVSDFGLA 454 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-----~~~kl~DFGla 454 (484)
||+.+ |.+|.++..... +.++..+..+|+.|++.+|++|| +.|++||||||+|+.+... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 889999886554 66999999999999999999999 5699999999999999754 46999999999
Q ss_pred c--ccCCCCc----ce---eecccccccccCCcccCC
Q 011486 455 K--LLEDEES----HI---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~--~~~~~~~----~~---~~~~~Gt~~Y~APE~~~~ 482 (484)
+ .+..... .. .....||.+|++++....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 9 3322111 01 123569999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=165.58 Aligned_cols=167 Identities=20% Similarity=0.306 Sum_probs=138.7
Q ss_pred CCCccceeeeccceeEEEEE-ecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.|.+.++||+|+||.++.|. +-+++.||||.-....+ .-++..|-+.++.|. .+.|...+-+..+..+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999986 45799999998655332 346788888988885 689999887777777888999998
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-----CCcEEEEecCCCcccCCC
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-----~~~~kl~DFGla~~~~~~ 460 (484)
|.||+|++.-....++.++++.+|.|++.-++|+| .+.+|.|||||+|+||.. ...+.|+|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 88999999877778999999999999999999999 459999999999999964 336999999999988765
Q ss_pred Ccce------eecccccccccCCccc
Q 011486 461 ESHI------TTIVAGTFGYLAPGKD 480 (484)
Q Consensus 461 ~~~~------~~~~~Gt~~Y~APE~~ 480 (484)
.... .....||.+||+=...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTH 208 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTH 208 (449)
T ss_pred cccccCccccccccccceeeeEeecc
Confidence 4322 2345799999985443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-19 Score=158.36 Aligned_cols=134 Identities=19% Similarity=0.182 Sum_probs=107.0
Q ss_pred CccceeeeccceeEEEEEecCCCEEEEEEecccCh----hHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEc
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE----GFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.+...|++|+||+||.+.. ++..++.+.+..... .....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997665 677777777765332 12336899999999995 5889999886 456999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI-KSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDi-kp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
++|.+|.+.... . ...++.|++.+|.++|+ .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998754321 1 23578899999999995 49999999 79999999999999999999986554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=165.67 Aligned_cols=144 Identities=15% Similarity=0.182 Sum_probs=112.7
Q ss_pred CCCccceeeeccceeEEEEE--ecCCCEEEEEEecccChh------------------------HHHHHHHHHHHHhcCC
Q 011486 308 TLDDDHIIGSGGFGTVYKLA--MDDGNVFALKRIDKLNEG------------------------FDRFFERELEILGSIK 361 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 361 (484)
.|++.+.||+|++|.||+|. ..+|+.||+|.++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778999999999999998 568999999998743210 1234678999999997
Q ss_pred CC--ceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCcE
Q 011486 362 HR--YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR-IIHRDIKSSNI 438 (484)
Q Consensus 362 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivHrDikp~NI 438 (484)
+. .+++++++ ...++||||++++++....... ...+..+...++.|++.++++||+ .+ |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 53 34444443 2358999999998887665322 345666678899999999999995 48 99999999999
Q ss_pred EEcCCCcEEEEecCCCcccCCC
Q 011486 439 LLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 439 Ll~~~~~~kl~DFGla~~~~~~ 460 (484)
+++ +++++|+|||.+......
T Consensus 181 li~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EEE-CCCEEEEEChhhhccCCc
Confidence 999 889999999999876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.62 Aligned_cols=136 Identities=20% Similarity=0.273 Sum_probs=114.7
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEEecccCh--------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE--------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.||+|++|.||+|.. ++..+++|....... .....+.+|++++..+.|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 567788887653211 1234688899999999999998888888788888999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++|++|.+++... .+ .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||.++...
T Consensus 81 ~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999998643 22 788999999999999994 5999999999999999 7899999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.9e-19 Score=161.50 Aligned_cols=146 Identities=13% Similarity=0.190 Sum_probs=117.5
Q ss_pred HHHHHHH--hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHH---H------HHHHHHHHhcCCCCceee
Q 011486 299 SKDIIKK--LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDR---F------FERELEILGSIKHRYLVN 367 (484)
Q Consensus 299 ~~el~~~--~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~ 367 (484)
+.++... ..+|+..+++|.|+||.||.... ++..+|+|.+.+......+ . +++|++.+.++.||+|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 4455544 36799999999999999999766 5778999999754322222 2 689999999999999999
Q ss_pred eEEEEEcC--------CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEE
Q 011486 368 LRGYCNSP--------TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 368 l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NIL 439 (484)
+.+++... +..++||||++|.+|.++.. +++ ....+++.++..+|+ .+++|||+||+||+
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nil 167 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFI 167 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEE
Confidence 99986543 35789999999999988742 232 245699999999995 59999999999999
Q ss_pred EcCCCcEEEEecCCCcccC
Q 011486 440 LDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~ 458 (484)
++.++ ++|+|||..+...
T Consensus 168 i~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred EeCCC-EEEEECCCccccc
Confidence 99998 9999999887664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=158.33 Aligned_cols=146 Identities=17% Similarity=0.136 Sum_probs=113.3
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccCh----------------------hHHHHHHHHHHHHh
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE----------------------GFDRFFERELEILG 358 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 358 (484)
++...-..|...+.||+|+||.||++...+++.+|||+++.... .....+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333334777899999999999999888899999998754221 01223678899999
Q ss_pred cCCCC--ceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 011486 359 SIKHR--YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (484)
Q Consensus 359 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~ 436 (484)
.+.|+ .+++.++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+|+||||||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcc
Confidence 98877 4445444 2456899999999999776421 3356789999999999995 59999999999
Q ss_pred cEEEcCCCcEEEEecCCCcccCCC
Q 011486 437 NILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 437 NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||++++++.++|+|||.+.....+
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCCc
Confidence 999999999999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6e-19 Score=173.12 Aligned_cols=168 Identities=24% Similarity=0.231 Sum_probs=139.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC------CCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK------HRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~ 379 (484)
..|.+....|+|-|++|.+|... .|+.||||+|.... ...+.=.+|+++|++|+ --|+++++..|...++++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46788888999999999999765 47899999998643 33455678999999995 348999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCcc
Q 011486 380 LIYDFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKL 456 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~ 456 (484)
||+|-+ .-+|.+.++..+. .+....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..+||||||.|..
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccc
Confidence 999988 5699999987533 388889999999999999999954 99999999999999865 5699999999998
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....+- ++..-+.-|.|||++.+
T Consensus 587 ~~enei---tPYLVSRFYRaPEIiLG 609 (752)
T KOG0670|consen 587 ASENEI---TPYLVSRFYRAPEIILG 609 (752)
T ss_pred cccccc---cHHHHHHhccCcceeec
Confidence 765442 23334678999999875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=179.47 Aligned_cols=141 Identities=21% Similarity=0.274 Sum_probs=114.3
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEeccc-C------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL-N------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
...|...+.||+|+||.||++.+.+...++.+++.+. . ....+++.+|+++++.++|++++....++..++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445668899999999999998765544333333221 1 12245688999999999999999988888888888
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++. ....++.|++.+|.|||+ .+++||||||+|||+ +++.++|+|||+++...
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999999885 356799999999999995 599999999999999 57799999999998754
Q ss_pred C
Q 011486 459 D 459 (484)
Q Consensus 459 ~ 459 (484)
.
T Consensus 479 ~ 479 (535)
T PRK09605 479 L 479 (535)
T ss_pred c
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=156.31 Aligned_cols=133 Identities=20% Similarity=0.312 Sum_probs=108.9
Q ss_pred eeeeccceeEEEEEecCCCEEEEEEecccC--------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.||+|++|.||++.. ++..+++|...... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56788999864321 112356788999999999887776666666777789999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
++++|.+++..... .++.+++.+|.++| +.+++|||++|+||+++ ++.++++|||+++....
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 99999998754211 78999999999999 45999999999999999 88999999999887543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-17 Score=162.77 Aligned_cols=169 Identities=37% Similarity=0.516 Sum_probs=142.6
Q ss_pred CCccceeeeccceeEEEEEecCCCEEEEEEecccChh---HHHHHHHHHHHHhcCCCC-ceeeeEEEEEcCCceEEEEEc
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG---FDRFFERELEILGSIKHR-YLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 384 (484)
|...+.||.|.|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78899998754322 477899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~ 461 (484)
+.++++.+++.... ..++......++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543 268899999999999999999995 4899999999999999988 79999999998665433
Q ss_pred cc-----eeecccccccccCCcccCC
Q 011486 462 SH-----ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~-----~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ......||..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccccccCCHHHhcC
Confidence 22 2345679999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-18 Score=163.33 Aligned_cols=180 Identities=16% Similarity=0.212 Sum_probs=143.0
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEE
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYC 372 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 372 (484)
+++.....+++....+.+|.||.||+|.+.+ .+.+-+|.++... +.....+..|-..+..+.|||+..+.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445567777889999999999996553 3455677776543 44456788898899999999999999998
Q ss_pred EcC-CceEEEEEcCCCCCHHHHHhh-----c--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 373 NSP-TSKLLIYDFLPGGSLDEALHE-----R--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 373 ~~~-~~~~lv~e~~~~gsL~~~l~~-----~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
.++ +..+++|.++.-|+|..++.. . .+.++..+...++.|++.|++||| +.+|||.||.++|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 665 567899999999999999982 1 223777888999999999999999 45999999999999999999
Q ss_pred cEEEEecCCCcccCCCCcceee-cccccccccCCcccCC
Q 011486 445 EARVSDFGLAKLLEDEESHITT-IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~~~~~-~~~Gt~~Y~APE~~~~ 482 (484)
++||+|-.+++..-+.+.+... .......||+||.+++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n 472 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN 472 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhh
Confidence 9999999999988776554321 1224678999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=143.84 Aligned_cols=137 Identities=23% Similarity=0.238 Sum_probs=115.9
Q ss_pred ccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCC--CceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH--RYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
+.+.|++|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999998855 7889999876433 5678999999999976 59999999888888899999999887
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.++...
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77544 556677889999999999996533579999999999999998999999999988543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=144.89 Aligned_cols=138 Identities=19% Similarity=0.224 Sum_probs=99.4
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh--HHHH----------------------HHHHHHHHhcCCCC--ce
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--FDRF----------------------FERELEILGSIKHR--YL 365 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 365 (484)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988653211 1111 13566666666443 24
Q ss_pred eeeEEEEEcCCceEEEEEcCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 366 VNLRGYCNSPTSKLLIYDFLPGGSLDE-ALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 366 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
.++++. ...++||||++++++.. .+.... .. ..+..++.+++.++.++|. +.+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 444443 24689999999854321 111110 11 5677899999999999995 16999999999999999 89
Q ss_pred cEEEEecCCCcccCC
Q 011486 445 EARVSDFGLAKLLED 459 (484)
Q Consensus 445 ~~kl~DFGla~~~~~ 459 (484)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-18 Score=146.19 Aligned_cols=132 Identities=25% Similarity=0.388 Sum_probs=118.2
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|.|++|+|+ .+|+.+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 457889999999999 78889999999999999999999 88999999999999999999998 9999999999999999
Q ss_pred ccccccCC-CCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 151 ISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 151 ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
|++|+++. .+|..|..++.|+.|+|++|.|.-.+|..+.+++|+.+.+.+|..+.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~ 164 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLS 164 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhh
Confidence 99999864 57888888999999999999998888888899999888888887543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-17 Score=180.52 Aligned_cols=121 Identities=16% Similarity=0.159 Sum_probs=88.5
Q ss_pred hcCCC-CceeeeEEEE-------EcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011486 358 GSIKH-RYLVNLRGYC-------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429 (484)
Q Consensus 358 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 429 (484)
+.++| +||.++++++ ...+.++.++||+ +++|.+++......+++.+++.++.||++||+||| +.+|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 34455 5888888877 2234567888988 66999999765566999999999999999999999 45999
Q ss_pred EcCCCCCcEEEcCC-------------------CcEEEEecCCCcccCCCCc---------------ceeeccccccccc
Q 011486 430 HRDIKSSNILLDGN-------------------LEARVSDFGLAKLLEDEES---------------HITTIVAGTFGYL 475 (484)
Q Consensus 430 HrDikp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~---------------~~~~~~~Gt~~Y~ 475 (484)
||||||+||||+.. +.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4556666666654221000 0011235899999
Q ss_pred CCcccCC
Q 011486 476 APGKDCT 482 (484)
Q Consensus 476 APE~~~~ 482 (484)
|||++.+
T Consensus 183 APE~~~~ 189 (793)
T PLN00181 183 SPEEDNG 189 (793)
T ss_pred Chhhhcc
Confidence 9999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=143.54 Aligned_cols=137 Identities=19% Similarity=0.210 Sum_probs=107.0
Q ss_pred cceee-eccceeEEEEEecCCCEEEEEEecccC-------------hhHHHHHHHHHHHHhcCCCCce--eeeEEEEEcC
Q 011486 312 DHIIG-SGGFGTVYKLAMDDGNVFALKRIDKLN-------------EGFDRFFERELEILGSIKHRYL--VNLRGYCNSP 375 (484)
Q Consensus 312 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 375 (484)
...|| .|+.|+||.+... +..+++|.+.... .....++.+|++++..++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999998775 6778998885311 1234568889999999998775 7777775443
Q ss_pred Cc----eEEEEEcCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEe
Q 011486 376 TS----KLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (484)
Q Consensus 376 ~~----~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~D 450 (484)
.. .++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+ .||+||||||+|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2599999997 699998854 234543 36789999999995 5999999999999999999999999
Q ss_pred cCCCcccC
Q 011486 451 FGLAKLLE 458 (484)
Q Consensus 451 FGla~~~~ 458 (484)
||.+....
T Consensus 186 fg~~~~~~ 193 (239)
T PRK01723 186 FDRGELRT 193 (239)
T ss_pred CCCcccCC
Confidence 99998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.9e-16 Score=150.25 Aligned_cols=133 Identities=23% Similarity=0.385 Sum_probs=112.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-----C---CceeeeEEEEEcC--
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-----H---RYLVNLRGYCNSP-- 375 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~-- 375 (484)
.+|.+.++||-|-|++||.+.+. +.+.||+|+.+.. +...+....||++|++++ | ..||+++++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 47889999999999999999765 5678899988753 445677888999999884 2 4799999999654
Q ss_pred --CceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC
Q 011486 376 --TSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443 (484)
Q Consensus 376 --~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~ 443 (484)
.+.+||+|++ |.+|..+|.... ..++...+.+|++||+.||.|||..| +|||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 4689999999 779999997643 34999999999999999999999976 99999999999999644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-15 Score=164.01 Aligned_cols=171 Identities=21% Similarity=0.197 Sum_probs=129.0
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC---CCceeeeEEEEEcCCceEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 381 (484)
--+.|.+...||+|+||.||+|...+|+.+|+|+-++.+. .+|.--.+++.+|+ -+-|..+...+.-.+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3456778889999999999999988899999998776442 23333344555555 23445555555666777899
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-------CCCcEEEEecCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-------GNLEARVSDFGLA 454 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-------~~~~~kl~DFGla 454 (484)
+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||.. +|||+||||+|+||. +..-++|+|||.+
T Consensus 773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 99999999999997 446699999999999999999999955 999999999999994 2346999999998
Q ss_pred cccCCCCc-ceeecccccccccCCcccCC
Q 011486 455 KLLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
-.+.--.. .......+|-.+-.+|+..+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~g 877 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREG 877 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcC
Confidence 76642111 12234456777777776654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-17 Score=137.95 Aligned_cols=132 Identities=27% Similarity=0.435 Sum_probs=123.3
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCC-CCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG-SIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L 149 (484)
..+++.|++.+|+++ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|||++|+++. .+|..|..+..|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 357889999999999 89999999999999999999999 999999999999999999999973 689999999999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
+|++|.|. .+|..++++++|+.|.+..|.+-..+..++.+.+|+++.+.||+..-
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeee
Confidence 99999998 79999999999999999999999777789999999999999998654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-15 Score=160.66 Aligned_cols=168 Identities=22% Similarity=0.287 Sum_probs=128.6
Q ss_pred CccceeeeccceeEEEEEec-CCCEEEEEEec----ccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRID----KLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
...+++|.|.+|.|+.+... ..+.++.|.+. ... ......+..|..+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977775433 33434444332 211 111222667777788899999988887777766666669
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++ +|..++... ..+...++..++.|++.|++|+|. .||.|||+|++|++++.+|.+||+|||.+..+.-...
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999998653 458888899999999999999994 5999999999999999999999999999987653222
Q ss_pred ---ceeecccccccccCCcccCC
Q 011486 463 ---HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ---~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....++|+-.|+|||.+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc
Confidence 34456789999999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=147.70 Aligned_cols=142 Identities=18% Similarity=0.234 Sum_probs=101.8
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChhH----------------------------------------HHHHH
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----------------------------------------DRFFE 351 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 351 (484)
.+.||.|++|.||+|++++|+.||||+.++..... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999986532110 01244
Q ss_pred HHHHHHhcC----C-CCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 011486 352 RELEILGSI----K-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK-GLAYLHHDCS 425 (484)
Q Consensus 352 ~E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-aL~~LH~~~~ 425 (484)
+|.+.+.++ + +++|.-..-+....+..++||||++|++|.++........+ +.+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence 555555554 2 34433222222334567999999999999888754322232 3456666666 4678884
Q ss_pred CCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 426 ~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
.|++|+|+||.||++++++.++++|||++..+.+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4999999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.3e-15 Score=151.29 Aligned_cols=159 Identities=30% Similarity=0.378 Sum_probs=131.3
Q ss_pred eeeeccceeEEEEEe----cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEcCC
Q 011486 314 IIGSGGFGTVYKLAM----DDGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|+|.||.|+.++. ..+..||+|..++.. .........|..++...+ ||.++++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998542 347788999887533 112225566888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+|.+...+.+. ..+++.....+...++-|++++| +.+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998888654 34677777778888999999999 569999999999999999999999999999877554322
Q ss_pred cccccccccCCcccC
Q 011486 467 IVAGTFGYLAPGKDC 481 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~ 481 (484)
+||..|||||++.
T Consensus 154 --cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN 166 (612)
T ss_pred --ccchhhhhhHhhh
Confidence 7999999999987
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-15 Score=144.68 Aligned_cols=126 Identities=29% Similarity=0.420 Sum_probs=117.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhh-ccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELG-NLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~ 150 (484)
+++.+||...|-|+ .+|+.++.+.+|..|||..|+|. .+| +|.+++.|++|+++.|+|. .+|+..+ .+++|.+||
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence 46778888888887 89999999999999999999999 788 8999999999999999999 9999876 899999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
|.+|+++ ..|+.+.-+++|+.||+|+|.+++.++.++++ +|+.+.+.|||.
T Consensus 259 LRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 259 LRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred ccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 9999998 59999999999999999999999999999999 999999999985
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.3e-14 Score=149.53 Aligned_cols=89 Identities=36% Similarity=0.604 Sum_probs=87.2
Q ss_pred CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeecc
Q 011486 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (484)
Q Consensus 97 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls 176 (484)
.++.|+|++|.|+|.+|..+.++++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCC
Q 011486 177 NNFLVGAIP 185 (484)
Q Consensus 177 ~N~l~~~~p 185 (484)
+|+|+|.+|
T Consensus 499 ~N~l~g~iP 507 (623)
T PLN03150 499 GNSLSGRVP 507 (623)
T ss_pred CCcccccCC
Confidence 999999999
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-15 Score=149.76 Aligned_cols=137 Identities=22% Similarity=0.293 Sum_probs=99.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChh---hhccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE---LGNLSNLLN 148 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~---~~~l~~L~~ 148 (484)
.++.+|+|++|+|+...+..|..|..|+.|+|++|+++-.-...|..+++|++|||++|.|++.|.+. |..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 46677777777777666666777777777777777776555556777777777777777777666543 666777777
Q ss_pred ccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 149 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|+|.+|+|..+.-..|..+..|++|||.+|.+..+-| .|..+ +|++|.+..-.++|+|++
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL 457 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccH
Confidence 7888888776555677788888888888888877766 56666 778888877788898876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-14 Score=132.28 Aligned_cols=164 Identities=23% Similarity=0.338 Sum_probs=127.3
Q ss_pred ccceeeeccceeEEEEEecCCCEEEEEEecc--cChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
...+|.+...|..|+|++..+ .+++|+++. ......++|..|.-.++-+.||||..++|.|..+....++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345688889999999999744 455676653 33445678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 389 SLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 389 sL~~~l~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
+|...+++..+. ++..++.+++.+|++|++|||.- .+-|.---+.+..++||++.+++|+- +-++..- ....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf-----qe~g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-----QEVG 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee-----eccc
Confidence 999999976443 78899999999999999999975 34444557899999999999988852 1111100 0011
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..-.|.||+||.++.
T Consensus 346 r~y~pawmspealqr 360 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQR 360 (448)
T ss_pred cccCcccCCHHHHhc
Confidence 123789999998863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5e-15 Score=141.86 Aligned_cols=116 Identities=29% Similarity=0.402 Sum_probs=105.0
Q ss_pred ccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCcccc
Q 011486 87 PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK 166 (484)
Q Consensus 87 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 166 (484)
.+|..+..+++|..|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+-.+..|+.+-.++|++....|..+.+
T Consensus 426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 45556788999999999999998 89999999999999999999999 99998888888888888889998766666999
Q ss_pred ccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 167 LQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 167 l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
|.+|..|||.+|.+...+|.++++.+++++.+.|||+.
T Consensus 504 m~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 99999999999999999999999999999999999974
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.3e-15 Score=145.90 Aligned_cols=130 Identities=22% Similarity=0.207 Sum_probs=83.4
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
++.+|+|+.|+++..-...+.+|+.|+.|+||+|.|...-++.+.-..+|++||||+|+|+..-|.+|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 46667777777776666667777777777777777776666667777777777777777774444456666666666666
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCC----CCCcccccCcccccCCc
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~l~~l~~l~l~~N~ 202 (484)
+|.++..-...|..+++|+.|||++|.|++.|. .+..++.|+.|.|.||+
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 666655444555566666666666666665554 23445555555555554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.4e-13 Score=139.93 Aligned_cols=143 Identities=14% Similarity=0.180 Sum_probs=95.8
Q ss_pred hcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccCh----------------------------------hHHHH-
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE----------------------------------GFDRF- 349 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------------------------------~~~~~- 349 (484)
...|+. +.||+|++|.||+|+.++ |+.||||+.++... ...+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445665 789999999999999987 99999999975311 01112
Q ss_pred -----HHHHHHHHhcC----CCCceeeeEEEEEc-CCceEEEEEcCCCCCHHHHHhhcCCCCC-----HHHHHHHHHHHH
Q 011486 350 -----FERELEILGSI----KHRYLVNLRGYCNS-PTSKLLIYDFLPGGSLDEALHERSEQLD-----WDARLNIIMGAA 414 (484)
Q Consensus 350 -----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~l~-----~~~~~~i~~~i~ 414 (484)
+.+|...+.++ .+.+.+.+-.++.+ ....++||||++|+.+.++-.-.....+ ...+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 34444444444 24444444444433 4567899999999999875321112222 22223333333
Q ss_pred HHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCCcccCC
Q 011486 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAKLLED 459 (484)
Q Consensus 415 ~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla~~~~~ 459 (484)
+ ..|++|+|+||.||+++.++ .+++.|||++..+.+
T Consensus 277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 23999999999999999888 999999999987754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-14 Score=136.81 Aligned_cols=140 Identities=19% Similarity=0.255 Sum_probs=127.1
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc-cccCCCCCh-hhhccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS-NYLSGSIPS-ELGNLSNLLN 148 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~-~~~~l~~L~~ 148 (484)
+...+.|+|..|+|+...|.+|+.+++|+.||||+|+|+.+-|..|.++.+|..|-+.+ |+|+ .+|. .|++|.+|+.
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 35789999999999988888999999999999999999999999999999987776655 9999 6665 5899999999
Q ss_pred ccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcccc
Q 011486 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQINV 211 (484)
Q Consensus 149 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~~~ 211 (484)
|.+.-|++.-.....|..+++|..|.+.+|.+..... .+..+..++.+.+.-|++.|.+.++.
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 9999999998888999999999999999999997766 78899999999999999999988754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.1e-13 Score=117.71 Aligned_cols=133 Identities=20% Similarity=0.157 Sum_probs=97.5
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCce-eeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
.+.++.|.++.||++... ++.+++|....... ....+.+|.++++.+.+.++ .+++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999998865 77899998765432 23356789999998865444 4455443 3345899999999887
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
.+.- .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..-.
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 6430 111346789999999999541 12369999999999999 6689999999988543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-14 Score=144.29 Aligned_cols=129 Identities=25% Similarity=0.341 Sum_probs=94.2
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccc-ccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFY-GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
++..|.+++|+|. .+-..++.|+.|+.+++.+|+|. .-||..+..|..|+.||||+|+++ ..|..+..-+++-.|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 4566666777766 45556667777777777777664 246777777888888888888887 77887777778888888
Q ss_pred cccccCCCCCC-ccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
|+|+|.. ||. -|.+|+.|-.||||+|+|...+|.+..+..|+.|.|++||..
T Consensus 134 S~N~Iet-IPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 134 SYNNIET-IPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ccCcccc-CCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhh
Confidence 8888874 444 456777778888888888877777777778888888887753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.1e-14 Score=141.59 Aligned_cols=130 Identities=28% Similarity=0.406 Sum_probs=74.6
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccC------------------
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS------------------ 133 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------------------ 133 (484)
++...|+|++|+|..+..+-|-+|+.|-+||||+|+|. .+|+.+..|.+|+.|+||+|.+.
T Consensus 126 Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 34445555555555222223445555555555555555 45555555555555555555432
Q ss_pred -------CCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 134 -------GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 134 -------g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
.-+|.++..|.+|..+|||.|++. .+|+.+-++++|+.|+||+|+|+..--..+...+++.|+++.|+.
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchh
Confidence 134555556666666666666665 466666666666666666666665554555666677777777764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.7e-11 Score=109.68 Aligned_cols=138 Identities=14% Similarity=0.155 Sum_probs=100.7
Q ss_pred cceeeeccceeEEEEEecC-------CCEEEEEEeccc-------------C---------hhHHHHH----HHHHHHHh
Q 011486 312 DHIIGSGGFGTVYKLAMDD-------GNVFALKRIDKL-------------N---------EGFDRFF----ERELEILG 358 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~ 358 (484)
...||.|.-+.||.|...+ +..+|||..+.. . ....+.+ ++|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997653 478999987421 0 0112233 38999999
Q ss_pred cCC--CCceeeeEEEEEcCCceEEEEEcCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCC
Q 011486 359 SIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE-ALHERSEQLDWDARLNIIMGAAKGLAYL-HHDCSPRIIHRDIK 434 (484)
Q Consensus 359 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivHrDik 434 (484)
++. .-++++++++ ...++||||+.+..+.. .+++ ..++..+...+..+++.+|..| |+ .+||||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 985 3567777765 45689999997654422 2322 2355566778889999999999 63 499999999
Q ss_pred CCcEEEcCCCcEEEEecCCCcccCC
Q 011486 435 SSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 435 p~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+.||+++ ++.++|+|||.+.....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999997 46899999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.3e-13 Score=116.88 Aligned_cols=121 Identities=29% Similarity=0.375 Sum_probs=49.2
Q ss_pred cEEEEeeCCCccccccCcCcC-CCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhh-hccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLD 150 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~ 150 (484)
++++|+|++|+|+ .+. .++ .+.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+ .++..+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 6788999999998 443 465 5889999999999998 454 5888899999999999998 676655 4689999999
Q ss_pred ccccccCCCCC-CccccccccceeeccCCcccccCC----CCCcccccCcccc
Q 011486 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSF 198 (484)
Q Consensus 151 ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p----~~~~l~~l~~l~l 198 (484)
|++|+|...-- ..+..+++|+.|+|.+|+++...- .+..+++|+.||.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 99999975321 346678889999999999886532 2345566666654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-13 Score=144.56 Aligned_cols=170 Identities=21% Similarity=0.175 Sum_probs=125.5
Q ss_pred CCCccceeeeccceeEEEEEecCCCEEEEEEecccC-hhHHHHHHHHHHH--HhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEI--LGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++...+.||++.|=+|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||++.+.-+...+...|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 7888886543 2223334333332 5566899999988877777778899899
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC-CCCcc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-DEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 463 (484)
..+ +|.|.+..+ ..+..-+.+-|+.|++.||.-+|+ .+|+|||||.+||||+.-.=+.|+||..-+..- +++..
T Consensus 103 vkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 854 999998654 346667777899999999999994 599999999999999988889999998765432 11111
Q ss_pred e-----eecccccccccCCcccCCC
Q 011486 464 I-----TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~-----~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ...-..-..|+|||-+..+
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhcc
Confidence 1 0111123469999988653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-13 Score=144.71 Aligned_cols=129 Identities=29% Similarity=0.395 Sum_probs=114.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCc-ccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS-ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..|+.|+|.+|.|+...=+.|.++.+|+.|+|++|+|. .+|. .+.++..|++|+||+|+|+ .+|..+.+++.|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 46888999999999887778999999999999999999 5554 5899999999999999999 9999999999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCccccc-CCCCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA-IPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~l~~l~~l~l~~N~~~ 204 (484)
..+|+|. ..| .+..+++|+.+|+|.|+|+.. +|.-...++|++|+|+||.++
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999998 577 889999999999999999875 342222379999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.6e-12 Score=113.82 Aligned_cols=79 Identities=23% Similarity=0.202 Sum_probs=68.1
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeec
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|+|.++++.+...+++.++..|+.||+.||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999987666799999999999999999999964 4 999999999999999 99998765422
Q ss_pred ccccccccCCcccCCC
Q 011486 468 VAGTFGYLAPGKDCTN 483 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~~ 483 (484)
..||+.|||||++.++
T Consensus 64 ~~g~~~y~aPE~~~~~ 79 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ 79 (176)
T ss_pred CCCcccccChHHhcCC
Confidence 2589999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.2e-11 Score=113.57 Aligned_cols=144 Identities=22% Similarity=0.284 Sum_probs=113.0
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccCh-hHHHHHHHHHHHHhcCCC--CceeeeEEEEEcCC---ceEEEEEcC
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKH--RYLVNLRGYCNSPT---SKLLIYDFL 385 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~ 385 (484)
.+.++.|.++.+|++...+|+.+++|....... .....+.+|.++++.+++ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999887778899998765332 134578899999999975 45677887766542 568999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC----------------------------------------- 424 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~----------------------------------------- 424 (484)
++.++.+.+.. ..+++.++..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888776532 34677888889999999999998521
Q ss_pred ------------CCCeEEcCCCCCcEEEcC--CCcEEEEecCCCccc
Q 011486 425 ------------SPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ------------~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~~ 457 (484)
...++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.7e-11 Score=105.27 Aligned_cols=134 Identities=25% Similarity=0.365 Sum_probs=103.3
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEE-eccc------C-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKR-IDKL------N-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~------~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..+++|+-+.+|.+.+.+.. +++|. +++. + .-..++..+|.+++.+++--.|....=+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998775434 45553 3321 1 12345678899999998766676666677788888999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
.+|..|.+.+... ...++..+-.-+.-||.+ +|||+||.++||++..+. +.++|||++..-..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999888653 245777788888889954 999999999999998765 99999999986543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.3e-12 Score=120.36 Aligned_cols=116 Identities=24% Similarity=0.339 Sum_probs=86.6
Q ss_pred CCCceeeeEEEEEc---------------------------CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 011486 361 KHRYLVNLRGYCNS---------------------------PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413 (484)
Q Consensus 361 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 413 (484)
+|||||++.++|.+ +...|+||.-++. +|.+++..+ ..+...+.-+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 69999999887632 2346899998855 999999764 35667777899999
Q ss_pred HHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCC--cEEEEecCCCcccCCCC---cce--eecccccccccCCcccCC
Q 011486 414 AKGLAYLHHDCSPRIIHRDIKSSNILLD--GNL--EARVSDFGLAKLLEDEE---SHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 414 ~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~--~~kl~DFGla~~~~~~~---~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
++|+.|||.+ +|.|||+|++|||+. +|+ ...|+|||.+-.-+... .+. .-...|...-||||+...
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999965 999999999999994 444 47899999875432211 011 112347888999998764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=114.49 Aligned_cols=164 Identities=21% Similarity=0.276 Sum_probs=103.8
Q ss_pred CCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCC----------CceeeeEEEEE-
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKH----------RYLVNLRGYCN- 373 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~- 373 (484)
+...+.||.|+++.||.+++. +++.+|+|.+.... ....+.+++|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344678999999999999876 48999999875322 2345667777655555332 23333333321
Q ss_pred --------cC---C-----ceEEEEEcCCCCCHHHHHhh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 011486 374 --------SP---T-----SKLLIYDFLPGGSLDEALHE---RSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431 (484)
Q Consensus 374 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~---l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHr 431 (484)
.. + ..+++|+-+ .++|.+++.. .... +....++.+..|+++.+++||. .|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 235678877 5689888652 2222 3345567777999999999995 599999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCCccc
Q 011486 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 432 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~ 480 (484)
||||+|++++++|.++|+||+.....+... .. ...+..|.+||..
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELE 214 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhh
Confidence 999999999999999999999877654321 11 2346789999965
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.7e-13 Score=139.94 Aligned_cols=175 Identities=27% Similarity=0.315 Sum_probs=138.9
Q ss_pred hcCCCccceeeeccceeEEEEEec--CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 380 (484)
...|.+.+.||+|.|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345677788999999999887653 34556667665432 334455566887777776 9999999999999999999
Q ss_pred EEEcCCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccC
Q 011486 381 IYDFLPGGSLDEAL-HERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLE 458 (484)
Q Consensus 381 v~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~ 458 (484)
++||.+++++.+.+ +......+......+..|+..++.|+|. ..++.||||||+|.+++..+ ..|++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 4433256677778899999999999993 24999999999999999999 99999999999876
Q ss_pred C--CCcceeecccc-cccccCCcccCC
Q 011486 459 D--EESHITTIVAG-TFGYLAPGKDCT 482 (484)
Q Consensus 459 ~--~~~~~~~~~~G-t~~Y~APE~~~~ 482 (484)
. +.........| ++.|+|||....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccc
Confidence 5 33333345678 999999998764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-10 Score=101.69 Aligned_cols=144 Identities=19% Similarity=0.240 Sum_probs=108.8
Q ss_pred ccceeeeccceeEEEEEecCCCEEEEEEe-ccc-------ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKL-------NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
..+.+-||+-+.|+++.+. |+.++||.= .+. .+-..++..+|.+.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5688999999999999885 666666643 221 1234567889999999987656666666666777778999
Q ss_pred EcCCC-CCHHHHHhhcCCCCCHHHH-HHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecCCCccc
Q 011486 383 DFLPG-GSLDEALHERSEQLDWDAR-LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~~ 457 (484)
||+++ .++.+++......-..+.. ..++++|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99976 4788888765443333333 68899999999999954 999999999999997665 3589999998754
Q ss_pred C
Q 011486 458 E 458 (484)
Q Consensus 458 ~ 458 (484)
.
T Consensus 167 ~ 167 (229)
T KOG3087|consen 167 R 167 (229)
T ss_pred c
Confidence 3
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.1e-13 Score=127.12 Aligned_cols=70 Identities=21% Similarity=0.302 Sum_probs=55.0
Q ss_pred hhcccccccccccccccCCCCCCc------------------------cccccccceeeccCCcccccCC-CCCcccccC
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPPS------------------------LGKLQRLITFNVSNNFLVGAIP-SDGVLTKFS 194 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~~------------------------~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~ 194 (484)
|..|++|+.|+|++|+|+++-+.+ |.++..|+.|+|.+|+|+...| .|..+..|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 455667777777777776654444 5566788889999999999888 788888999
Q ss_pred cccccCCcCCCCCcc
Q 011486 195 ESSFFGNRGLCGKQI 209 (484)
Q Consensus 195 ~l~l~~N~~~c~~~~ 209 (484)
.+++.+|||.|.+.+
T Consensus 350 ~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 350 TLNLLSNPFNCNCRL 364 (498)
T ss_pred eeehccCcccCccch
Confidence 999999999999876
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.3e-13 Score=122.07 Aligned_cols=127 Identities=22% Similarity=0.261 Sum_probs=110.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.-+++|||++|.|+ .+..+..-++.++.|+||+|.|. .+. .+..|++|+.||||+|.++ .+-..-..|.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45889999999999 78888888999999999999998 454 3888999999999999999 77777678889999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~ 204 (484)
+.|.|.. -..+.++-+|..||+++|++...-. .+++++-|+.+.+.+||..
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9999974 2567889999999999999987533 7899999999999999853
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-11 Score=124.07 Aligned_cols=124 Identities=31% Similarity=0.443 Sum_probs=103.7
Q ss_pred HhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 011486 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (484)
Q Consensus 357 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~ 436 (484)
|+.+.|.|+.+++|.+..+...++|.+|+..|+|.|.+......+++.-...+.++|+.||+|+|.. +--.|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4578899999999999999999999999999999999988777799999999999999999999963 33499999999
Q ss_pred cEEEcCCCcEEEEecCCCcccCCC-CcceeecccccccccCCcccCC
Q 011486 437 NILLDGNLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 437 NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|.++|....+||+|||+....... .........-..-|.|||.++.
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 999999999999999998877431 1111111223567999999876
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.3e-12 Score=113.35 Aligned_cols=108 Identities=30% Similarity=0.353 Sum_probs=42.5
Q ss_pred CcCCCCCCCEEEcccCcccccCCcccC-CccccceecccccccCCCCChhhhcccccccccccccccCCCCCCcc-cccc
Q 011486 91 DLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQ 168 (484)
Q Consensus 91 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~ 168 (484)
.+.+..++++|+|++|.|+ .|. .++ .+.+|+.||||+|.|+ .++ .+..+++|++|++++|+|+. +++.+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCC
Confidence 3566678999999999999 554 566 6899999999999999 665 58889999999999999996 65555 4689
Q ss_pred ccceeeccCCcccccCC--CCCcccccCcccccCCcC
Q 011486 169 RLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 169 ~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~ 203 (484)
+|++|+|++|++...-. .+..+++|+.|++.|||.
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 99999999999987533 567789999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.5e-11 Score=131.12 Aligned_cols=135 Identities=30% Similarity=0.439 Sum_probs=93.8
Q ss_pred cCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+.++.|..|+||.||.++.+. .+.+|+ ++++.+- +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee-------------------
Confidence 577888999999999999997764 667888 4444321 1111 33333444444
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC----
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE---- 461 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~---- 461 (484)
|+-...++.. +.++... +.+++|+| +.+|+|||+||+|.+|+.-|.+|++|||+.+..-...
T Consensus 136 --gDc~tllk~~-g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKNI-GPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhcccC-CCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 5555666432 3333332 77899999 6799999999999999999999999999987542100
Q ss_pred ----------cceeecccccccccCCcccCC
Q 011486 462 ----------SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ----------~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
......++||+.|+|||++.-
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 011245689999999999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-11 Score=123.63 Aligned_cols=100 Identities=26% Similarity=0.423 Sum_probs=83.9
Q ss_pred ceEEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 377 SKLLIYDFLPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+.|+.|++|+..+|.+|+..+ ....++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 2347888899999999999999 38999999999999999999999999999
Q ss_pred cccCCCC-----cceeecccccccccCCcccCC
Q 011486 455 KLLEDEE-----SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~-----~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... ....+..+||..||+||.+.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 8775543 111234579999999999875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.2e-11 Score=126.61 Aligned_cols=56 Identities=25% Similarity=0.189 Sum_probs=34.4
Q ss_pred ccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 145 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+..+..+..+++|..+++++|++.
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 44455555555543 4432 23556677777777644336677788888888888864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-10 Score=121.42 Aligned_cols=97 Identities=26% Similarity=0.381 Sum_probs=55.6
Q ss_pred EEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccc
Q 011486 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153 (484)
Q Consensus 74 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~ 153 (484)
.+.|+|++++|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 566788888887 4565443 46777777777777 4555443 36666666666666 5555443 2455555555
Q ss_pred cccCCCCCCccccccccceeeccCCcccc
Q 011486 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVG 182 (484)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 182 (484)
|+++ .+|..+. ++|+.|+|++|+|+.
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~~ 276 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKISC 276 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccCc
Confidence 5554 2444332 245555555555543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.6e-10 Score=99.21 Aligned_cols=128 Identities=19% Similarity=0.257 Sum_probs=86.4
Q ss_pred eEEEEEecCCCEEEEEEecccC--------------------------hhHHHHHHHHHHHHhcCCCC--ceeeeEEEEE
Q 011486 322 TVYKLAMDDGNVFALKRIDKLN--------------------------EGFDRFFERELEILGSIKHR--YLVNLRGYCN 373 (484)
Q Consensus 322 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 373 (484)
.||.|...++..+|+|..+... .......++|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999874210 11234578899999999755 677777553
Q ss_pred cCCceEEEEEcCC--CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 374 SPTSKLLIYDFLP--GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 374 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
...+||||++ |..+..+.... ++......++.+++..+..+++ ..+|+|+|+.+.||+++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 55555443322 2234456678888886766532 4599999999999999987 9999999
Q ss_pred CCCcccCC
Q 011486 452 GLAKLLED 459 (484)
Q Consensus 452 Gla~~~~~ 459 (484)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 99876653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-10 Score=124.19 Aligned_cols=118 Identities=25% Similarity=0.351 Sum_probs=81.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 46888999999998 5666553 58888888888888 5676553 46888888888887 7777654 46778888
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|+|+. +|..+. ++|+.|+|++|+|++.++.+. .+|+.|++++|..
T Consensus 270 s~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~L 316 (754)
T PRK15370 270 FHNKISC-LPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSL 316 (754)
T ss_pred cCCccCc-cccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcc
Confidence 8888774 666553 467777777777776443221 2455555555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.8e-09 Score=100.28 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=101.8
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh-HH----------HHHHHHHHHHhcCCCC--ceeeeEEEEEc----
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-FD----------RFFERELEILGSIKHR--YLVNLRGYCNS---- 374 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~--niv~l~~~~~~---- 374 (484)
.+.+-+-....|+++.. +|+.|.||........ .. ..+.+|.+.+.++... .++.++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35555555556777655 5778999977543211 01 1478899998888533 33445666543
Q ss_pred -CCceEEEEEcCCCC-CHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-------CC
Q 011486 375 -PTSKLLIYDFLPGG-SLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-------NL 444 (484)
Q Consensus 375 -~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-------~~ 444 (484)
....++|||++++. +|.+++... ....+...+..++.+++..+.-||+. ||+|+|++++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 899998532 23356677788999999999999954 9999999999999985 46
Q ss_pred cEEEEecCCCcc
Q 011486 445 EARVSDFGLAKL 456 (484)
Q Consensus 445 ~~kl~DFGla~~ 456 (484)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-11 Score=120.94 Aligned_cols=108 Identities=32% Similarity=0.559 Sum_probs=81.1
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
-+..|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|+.++++.+|+.|++..|++. .+|..++.| .|..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 3667777777777 67777777777777777777777 67777777777777777777777 777777754 47778888
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
.|+++ .||-.|.+|+.|++|-|.+|.|+..+.
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 88877 477778888888888888888875543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=84.41 Aligned_cols=18 Identities=33% Similarity=0.516 Sum_probs=6.8
Q ss_pred cCCccccceecccccccC
Q 011486 116 LGNCTELQGLSLQSNYLS 133 (484)
Q Consensus 116 ~~~l~~L~~L~Ls~N~l~ 133 (484)
|.++++|++|+|++|+++
T Consensus 21 f~~l~~L~~L~l~~N~l~ 38 (61)
T PF13855_consen 21 FSNLPNLETLDLSNNNLT 38 (61)
T ss_dssp TTTGTTESEEEETSSSES
T ss_pred HcCCCCCCEeEccCCccC
Confidence 333333333333333333
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.2e-10 Score=114.47 Aligned_cols=171 Identities=22% Similarity=0.213 Sum_probs=136.3
Q ss_pred CCCccceeee--ccceeEEEEEe---cCCCEEEEEEec--ccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceE
Q 011486 308 TLDDDHIIGS--GGFGTVYKLAM---DDGNVFALKRID--KLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 308 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 379 (484)
.+.+...+|. |.+|.+|.+.. .++..+|+|+-+ ........+=.+|+...+.++ |+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455678899 99999999766 468889999843 222233344456777777775 999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK----GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLA 454 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla 454 (484)
+-+|++ +.+|.++.+.....++......+..+... ||.++| +..++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 999998 57999999877666888888888999888 999999 5699999999999999999 88999999999
Q ss_pred cccCCCCcce----eecccccccccCCcccCC
Q 011486 455 KLLEDEESHI----TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~----~~~~~Gt~~Y~APE~~~~ 482 (484)
..+.+..... .....|...|++||....
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 9887654211 122357888999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.8e-09 Score=108.69 Aligned_cols=124 Identities=13% Similarity=0.220 Sum_probs=103.4
Q ss_pred EecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHH
Q 011486 327 AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR 406 (484)
Q Consensus 327 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~ 406 (484)
+..++.++.|...+...........+-++.++.++||||+++++.+..++..|+|+|-+. -|..++++. .....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence 344688888888876555445567778889999999999999999999999999999884 577777653 24555
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 407 ~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
.-.+.||+.||.|||+. .+++|++|.-+.|+++..|+.||++|.++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 66789999999999975 499999999999999999999999999886554
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6e-10 Score=74.91 Aligned_cols=40 Identities=45% Similarity=1.111 Sum_probs=30.4
Q ss_pred cchHHHHHHHHHhccC-CCCCCCCCCCCC-CCCCCcceeeeC
Q 011486 30 NSDGEALLSFRTAVVS-SDGFLNQWRPED-PDPCNWKGVKCD 69 (484)
Q Consensus 30 ~~~~~~l~~~k~~~~~-~~~~l~~w~~~~-~~~c~w~gv~C~ 69 (484)
+.|++||++||+++.+ |.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 4789999999999994 678999999764 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.4e-10 Score=81.27 Aligned_cols=61 Identities=30% Similarity=0.404 Sum_probs=56.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 132 (484)
++++.|+|++|+|+...+..|.++++|++|++++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3689999999999977778899999999999999999988888999999999999999986
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-09 Score=124.75 Aligned_cols=128 Identities=17% Similarity=0.248 Sum_probs=105.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 468889999998887899999999999999999875444788776 7899999999997655567653 367899999
Q ss_pred cccccCCCCCCccccccccceeeccC-CcccccCCCCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSN-NFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
++|.++. +|.++..+++|+.|+|++ |+|++.++....+++|+.+++.+++.+
T Consensus 854 s~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L 906 (1153)
T PLN03210 854 SRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGAL 906 (1153)
T ss_pred CCCCCcc-ChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCccc
Confidence 9999984 898999999999999988 677776667788888999888876544
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.6e-10 Score=118.84 Aligned_cols=80 Identities=33% Similarity=0.363 Sum_probs=61.4
Q ss_pred CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeecc
Q 011486 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (484)
Q Consensus 97 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls 176 (484)
+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 4555666666665 34432 246777788888877 56753 246889999999998 589999999999999999
Q ss_pred CCcccccCC
Q 011486 177 NNFLVGAIP 185 (484)
Q Consensus 177 ~N~l~~~~p 185 (484)
+|+|++.+|
T Consensus 454 ~N~Ls~~~~ 462 (788)
T PRK15387 454 GNPLSERTL 462 (788)
T ss_pred CCCCCchHH
Confidence 999999877
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-10 Score=115.51 Aligned_cols=127 Identities=28% Similarity=0.378 Sum_probs=115.8
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 46888999999999 7888777765 899999999999 89999999999999999999999 99999999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
..|++.. +|..+..| .|..||+|.|+++..+-.|..+..|+.|-|.+||..
T Consensus 197 rRn~l~~-lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 197 RRNHLED-LPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhh-CCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence 9999985 88888865 689999999999976668999999999999999963
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.9e-11 Score=115.96 Aligned_cols=134 Identities=22% Similarity=0.229 Sum_probs=99.4
Q ss_pred CCCcEEEEeeCCCccccccCcCcCCCCC---CCEEEcccCcccc----cCCcccCCc-cccceecccccccCCC----CC
Q 011486 70 KNKRVITLSLTNHKLSGPISADLGKLDQ---LKFLNLHSNNFYG----EIPSELGNC-TELQGLSLQSNYLSGS----IP 137 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~g~----~p 137 (484)
...+++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 3568999999999998766666665555 9999999999873 333455666 8899999999999853 33
Q ss_pred hhhhcccccccccccccccCCC----CCCccccccccceeeccCCcccccCC-----CCCcccccCcccccCCcC
Q 011486 138 SELGNLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-----SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 138 ~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p-----~~~~l~~l~~l~l~~N~~ 203 (484)
..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++... .+..+++|+.+++++|+.
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 3456677899999999998852 33345556789999999998875422 345667889999988763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.88 E-value=8.6e-10 Score=112.50 Aligned_cols=130 Identities=35% Similarity=0.485 Sum_probs=91.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCC-CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..++.|++.+|.++ .+++....++ +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 45777777777777 5666666664 7777777777777 66666777777777777777777 7777666777777777
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
+++|+++. +|.....+..|++|++++|++...+..+..+.++..+.+.+|+..+
T Consensus 193 ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 193 LSGNKISD-LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred ccCCcccc-CchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 77777774 6665555566777777777655455556666666666666666544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.5e-09 Score=120.73 Aligned_cols=125 Identities=23% Similarity=0.337 Sum_probs=59.1
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
+++.|+|++|+|. .++..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|..-..+|..+.++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 4445555555544 344444555555555555443333444 24455555555555544333555555555555555555
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCc
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~ 202 (484)
+|..-+.+|..+ ++++|+.|++++|...+.+|. ...+|+.|++.+|.
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~--~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD--ISTNISWLDLDETA 736 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc--ccCCcCeeecCCCc
Confidence 543222344433 455555555555544333332 12344555555554
|
syringae 6; Provisional |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-11 Score=124.03 Aligned_cols=128 Identities=24% Similarity=0.297 Sum_probs=107.2
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChh-hhcccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDI 151 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~l 151 (484)
.+...+.+.|.|. .+..++.-++.|+.|||++|+++.. . .+..|+.|++|||++|+|+ .+|.- ...+. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4666788889998 7778899999999999999999944 3 7889999999999999999 77763 33444 999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCCCCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGLCGK 207 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~c~~ 207 (484)
.+|.++.. ..+.+|++|+.|||++|-|.+--. .++.|..|..|.|.|||.-|..
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999843 467899999999999999987544 4678889999999999987753
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-10 Score=114.04 Aligned_cols=132 Identities=25% Similarity=0.286 Sum_probs=94.5
Q ss_pred CcEEEEeeCCCcccc----ccCcCcCCC-CCCCEEEcccCccccc----CCcccCCccccceecccccccCCC----CCh
Q 011486 72 KRVITLSLTNHKLSG----PISADLGKL-DQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~ 138 (484)
+++++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 458999999998873 334456667 8899999999998843 344566777899999999988842 334
Q ss_pred hhhcccccccccccccccCCC----CCCccccccccceeeccCCcccccCC-CC-C----cccccCcccccCCcC
Q 011486 139 ELGNLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-SD-G----VLTKFSESSFFGNRG 203 (484)
Q Consensus 139 ~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p-~~-~----~l~~l~~l~l~~N~~ 203 (484)
.+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++... .+ . ....|+.+++++|..
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCC
Confidence 455566899999999988743 23445667889999999998886321 11 1 236788888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-10 Score=105.74 Aligned_cols=107 Identities=21% Similarity=0.216 Sum_probs=91.4
Q ss_pred cCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccc
Q 011486 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171 (484)
Q Consensus 92 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 171 (484)
+.-.+.|++||||+|.|+ .+.++..-++.++.|+||+|+|. .+-. +..|++|+.||||+|.++. +-.+-.++.+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHh-hhhhHhhhcCEe
Confidence 334567999999999999 88888999999999999999998 5544 8999999999999999984 667777889999
Q ss_pred eeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 172 TFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 172 ~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
.|.|+.|.+... ..++.+-+|..|++.+|+.
T Consensus 356 tL~La~N~iE~L-SGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 356 TLKLAQNKIETL-SGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred eeehhhhhHhhh-hhhHhhhhheeccccccch
Confidence 999999988743 2456777889999999975
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.5e-08 Score=102.10 Aligned_cols=149 Identities=17% Similarity=0.246 Sum_probs=99.0
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChh----------------------------------HHH---
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG----------------------------------FDR--- 348 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------~~~--- 348 (484)
...|+ .+.|+.++-|.||+|++++|+.||||+.++.-.. ..+
T Consensus 125 F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 34444 3789999999999999999999999987542110 011
Q ss_pred ---HHHHHHHHHhcC----C-CCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011486 349 ---FFERELEILGSI----K-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420 (484)
Q Consensus 349 ---~~~~E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~L 420 (484)
++.+|..-+.++ + .++|.-..=|+.-.+...++|||++|..+.+....+....+.+.......++.--.-+-
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh
Confidence 133444444444 2 34443333333445677999999999999888543334466444332222222212222
Q ss_pred HhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 421 H~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
| |+.|.|..|.||+++.+|++.+.|||+...+.+.
T Consensus 284 d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 D-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred c-----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 4 9999999999999999999999999999887653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-10 Score=118.94 Aligned_cols=109 Identities=31% Similarity=0.433 Sum_probs=94.6
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
+++.|||++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|+|.+|++. .+|.++..+.+|++||+|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3888999999988 78888999999999999999998 78888999999999999999998 899999999999999999
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
.|++. .+|..+..++.++.++.++|......+
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg 154 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG 154 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhc
Confidence 99997 588889999999999999994333333
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.5e-08 Score=91.80 Aligned_cols=137 Identities=20% Similarity=0.150 Sum_probs=100.5
Q ss_pred CccceeeeccceeEEEEEecCCCEEEEEEeccc----------------------ChhHHHHHHHHHHHHhcCCCC--ce
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL----------------------NEGFDRFFERELEILGSIKHR--YL 365 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----------------------~~~~~~~~~~E~~~l~~l~h~--ni 365 (484)
.+.+.||-|.-+.||.|...+|.++|||.=+.. -.......++|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 346889999999999999999999999953210 011344578899999999755 78
Q ss_pred eeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 366 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
++.+++ +...+||||.+|--|...- ++.+..-.++..|+.-+.-.- ..||||+|+++-||++++||.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 887765 5578999999886554332 123333445555555555444 249999999999999999999
Q ss_pred EEEEecCCCcccCC
Q 011486 446 ARVSDFGLAKLLED 459 (484)
Q Consensus 446 ~kl~DFGla~~~~~ 459 (484)
+.++||--+.....
T Consensus 241 ~~vIDwPQ~v~~~h 254 (304)
T COG0478 241 IVVIDWPQAVPISH 254 (304)
T ss_pred EEEEeCcccccCCC
Confidence 99999987766543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-09 Score=109.66 Aligned_cols=127 Identities=31% Similarity=0.432 Sum_probs=105.8
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
+++.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999999 77778999999999999999999 78877778999999999999999 999887777779999999
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
+|.+. .++..+.++.++..+.+++|++...+-.++.++.++.+++++|..
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccc
Confidence 99543 366667778888888888888776544556677777777777764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.7e-08 Score=89.72 Aligned_cols=108 Identities=25% Similarity=0.308 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHhcCC--CCceeeeEEEEEcCC----ceEEEEEcCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Q 011486 347 DRFFERELEILGSIK--HRYLVNLRGYCNSPT----SKLLIYDFLPGG-SLDEALHERSEQLDWDARLNIIMGAAKGLAY 419 (484)
Q Consensus 347 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~ 419 (484)
.....+|.+.+.++. .-.+++++++..... ..++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 346778888887774 334566677765532 347999999874 89999875322 5667788899999999999
Q ss_pred HHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecCCCcccC
Q 011486 420 LHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLLE 458 (484)
Q Consensus 420 LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~~~ 458 (484)
||+. ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9954 999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=94.09 Aligned_cols=139 Identities=21% Similarity=0.298 Sum_probs=108.7
Q ss_pred cceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEEEEEcCCC-CCHHH
Q 011486 319 GFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIYDFLPG-GSLDE 392 (484)
Q Consensus 319 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~ 392 (484)
...+.||+.. .||..|++|+++............-++.++++.|+|||++.+++.. +...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4467888854 4899999999965433333333445788999999999999998863 3457899999986 57777
Q ss_pred HHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 393 ALHER--------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 393 ~l~~~--------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
+.-.. +...++...+.++.|+..||.++|+ .|..-+-|.+++||++.+.+++|+..|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65321 1226789999999999999999995 499999999999999999999999999887665
Q ss_pred CC
Q 011486 459 DE 460 (484)
Q Consensus 459 ~~ 460 (484)
.+
T Consensus 445 ~d 446 (655)
T KOG3741|consen 445 ED 446 (655)
T ss_pred CC
Confidence 43
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.2e-10 Score=92.13 Aligned_cols=111 Identities=25% Similarity=0.388 Sum_probs=81.3
Q ss_pred eCCCCcEEEEeeCCCccccccCcC---cCCCCCCCEEEcccCcccccCCcccC-CccccceecccccccCCCCChhhhcc
Q 011486 68 CDKNKRVITLSLTNHKLSGPISAD---LGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSNYLSGSIPSELGNL 143 (484)
Q Consensus 68 C~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l 143 (484)
|.+...+-.++|+++.|- .+++. +.....|+..+|++|.|. ..|+.|. ..+.++.|+|++|.|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 555556667788888776 45544 444556666688888888 5555554 3457888888888888 888888888
Q ss_pred cccccccccccccCCCCCCccccccccceeeccCCcccc
Q 011486 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG 182 (484)
Q Consensus 144 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 182 (484)
+.|+.|+++.|.|.. .|..+..|.+|..||.-+|.+..
T Consensus 100 ~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds~~na~~e 137 (177)
T KOG4579|consen 100 PALRSLNLRFNPLNA-EPRVIAPLIKLDMLDSPENARAE 137 (177)
T ss_pred HHhhhcccccCcccc-chHHHHHHHhHHHhcCCCCcccc
Confidence 888888888888874 67777778888888888777763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-08 Score=103.46 Aligned_cols=152 Identities=25% Similarity=0.307 Sum_probs=120.3
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEec--CCCEEEEEEecccChhHH--HHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
......+|.....||.|.|+.|+.+..+ ++..|++|.+.+...... ..-..|+.+...+ .|.+++.....+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445667888899999999999997644 678899998865433222 2223466665555 4888998888887777
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAK 455 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~ 455 (484)
..|+--||++++++...+. -...+++..++++..|++.++.++| ++.++|+|+||+||++..+ +.-++.|||.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 8889999999999877763 2345888889999999999999999 6799999999999999876 889999999987
Q ss_pred cc
Q 011486 456 LL 457 (484)
Q Consensus 456 ~~ 457 (484)
.+
T Consensus 416 ~~ 417 (524)
T KOG0601|consen 416 RL 417 (524)
T ss_pred cc
Confidence 53
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.5e-09 Score=85.20 Aligned_cols=111 Identities=23% Similarity=0.259 Sum_probs=92.0
Q ss_pred CCcEEEEeeCCCccccccCcCc-CCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...++.++|++|.+. ..|+.| ..++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 468999999999999 455555 45679999999999999 89999999999999999999999 899999999999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
|..+|.+.. +|-.+-.-+.+-..++.+|.+.+.-+
T Consensus 129 ds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 129 DSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCCCCcccc-CcHHHhccccHHHHHhcCCcccccCc
Confidence 999999974 66554444445555667777776655
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.3e-07 Score=80.49 Aligned_cols=140 Identities=12% Similarity=0.069 Sum_probs=102.5
Q ss_pred eeeeccceeEEEEEecCCCEEEEEEecccC------hhHHHHHHHHHHHHhcCCC--CceeeeEEEEEcC----CceEEE
Q 011486 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLN------EGFDRFFERELEILGSIKH--RYLVNLRGYCNSP----TSKLLI 381 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv 381 (484)
--++|+.+-|++....+ ..+-+|+-...- +.....|.+|+..+.++.. -.++++..+.... -..+||
T Consensus 25 N~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 35778999999977654 467788764211 2345679999999998853 3355555222121 125799
Q ss_pred EEcCCC-CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc--EEEEecCCCccc
Q 011486 382 YDFLPG-GSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKLL 457 (484)
Q Consensus 382 ~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~--~kl~DFGla~~~ 457 (484)
+|-+++ .+|.+++.+.. .+.+...+..+..+++..+.-||+ .++.|+|+.+.||+++.++. ++++||.-++..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 997753 58999885532 346778888999999999999995 59999999999999986666 999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-08 Score=93.08 Aligned_cols=123 Identities=20% Similarity=0.297 Sum_probs=91.5
Q ss_pred HHhcCCCCceeeeEEEEEcC-----CceEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011486 356 ILGSIKHRYLVNLRGYCNSP-----TSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427 (484)
Q Consensus 356 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ 427 (484)
-+-.+-|.||+++..|+.+. .+..+++|||+.|++.++|++. ...+......+|+.||..||.|||.. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34556799999999998654 3467899999999999999863 23478888899999999999999975 899
Q ss_pred eEEcCCCCCcEEEcCCCcEEEEecCCCcccCC----CCcceeecccccccccCCccc
Q 011486 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLED----EESHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 428 ivHrDikp~NILl~~~~~~kl~DFGla~~~~~----~~~~~~~~~~Gt~~Y~APE~~ 480 (484)
|+|+++.-+-|++..+|-+|+.- +.-..... ..........|-++|.|||+=
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 99999999999999999888742 11111110 000111223467899999974
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=81.39 Aligned_cols=133 Identities=17% Similarity=0.155 Sum_probs=85.8
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC--ceeeeEEEEEcCCceEEEEEcCCCCC-
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR--YLVNLRGYCNSPTSKLLIYDFLPGGS- 389 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gs- 389 (484)
..|++|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567888876533 234568899999888633 35677888777777889999998863
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCCeE
Q 011486 390 LDEALHERSEQLDWDARLNIIMGAAKG---------------------------------------LAYLHHD-CSPRII 429 (484)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~i~~a---------------------------------------L~~LH~~-~~~~iv 429 (484)
+.+.+.. +......++.++++. ..+|... ....++
T Consensus 82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 2211110 000111111111111 1222211 134578
Q ss_pred EcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 430 HRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 430 HrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-06 Score=90.56 Aligned_cols=143 Identities=17% Similarity=0.199 Sum_probs=94.6
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChh-------------------------------HHH------HHHHHH
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-------------------------------FDR------FFEREL 354 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------~~~~E~ 354 (484)
.+.|+.-+.|.||+|+.++|+.||||+-++.-+. ..+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4789999999999999999999999986542110 011 233444
Q ss_pred HHHhc----CCCCc---eeeeEEEEEc-CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 011486 355 EILGS----IKHRY---LVNLRGYCNS-PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426 (484)
Q Consensus 355 ~~l~~----l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~ 426 (484)
+-..+ ++|-+ =|.+-.++++ .....++||||+|..+.|.-.-....++...+..-+.++..-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~----- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT----- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc-----
Confidence 33332 34545 1112223322 34678999999998776665434445676655544444333333334
Q ss_pred CeEEcCCCCCcEEEcC----CCcEEEEecCCCcccCC
Q 011486 427 RIIHRDIKSSNILLDG----NLEARVSDFGLAKLLED 459 (484)
Q Consensus 427 ~ivHrDikp~NILl~~----~~~~kl~DFGla~~~~~ 459 (484)
|++|.|=.|.||++.. ++++.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 67899999999987754
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4e-08 Score=100.76 Aligned_cols=128 Identities=28% Similarity=0.303 Sum_probs=88.7
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
.+..++|..|.+.. +-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+ .+. .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~-~i~-~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKIT-KLE-GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccc-ccc-chhhccchhhheec
Confidence 45556677777763 3445777788888888888887 44444777888888888888887 332 25566678888888
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCC-CCcccccCcccccCCcCCCC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~l~~l~~l~l~~N~~~c~ 206 (484)
+|.|+. + ..+..+++|+.+++++|+++..-+. ...+.+++.+.+.+|.....
T Consensus 149 ~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 149 GNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI 201 (414)
T ss_pred cCcchh-c-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc
Confidence 888874 2 3455677888888888888765443 46677777778877765544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.5e-06 Score=78.80 Aligned_cols=152 Identities=17% Similarity=0.231 Sum_probs=102.2
Q ss_pred HHHHHHHhcCCCccc---eeeeccceeEEEEEecCCCEEEEEEecccChhHH------------------------HHHH
Q 011486 299 SKDIIKKLETLDDDH---IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFD------------------------RFFE 351 (484)
Q Consensus 299 ~~el~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~ 351 (484)
.+.+..-.....+.+ .|++|.-+.||+|...++..+|+|+++....... .-..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444444444444 4666777899999888899999999854221110 1134
Q ss_pred HHHHHHhcCC--CCceeeeEEEEEcCCceEEEEEcCCCCC-HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011486 352 RELEILGSIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGS-LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428 (484)
Q Consensus 352 ~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i 428 (484)
+|..-|.++. +-.+++.+++.. -.+||||+.... -.-.|++ -.+...+...+..++++.+.-|-.. -++
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~--a~L 188 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKE--AGL 188 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHh--cCc
Confidence 6777777774 556666666543 469999995431 1111111 1233336777888999999888852 499
Q ss_pred EEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 429 vHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||+||+.=|||+. ++.+.|+|||-|.....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccCC
Confidence 9999999999999 88999999999876653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.8e-06 Score=78.65 Aligned_cols=143 Identities=22% Similarity=0.260 Sum_probs=86.6
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC--ceeeeEEEEEcC---CceEEEEEcCC
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR--YLVNLRGYCNSP---TSKLLIYDFLP 386 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 386 (484)
.+.++.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3678999999999998877 68999997664 3456788899988887532 356777654332 34689999999
Q ss_pred CCCHHH----------------HHh---hc---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 011486 387 GGSLDE----------------ALH---ER---SEQLDWDA---------RLNI------------IMGAAK-GLAYLHH 422 (484)
Q Consensus 387 ~gsL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~~i~~-aL~~LH~ 422 (484)
+..+.. .+. .. ........ .... ...+.. .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 01111100 0000 111222 2333332
Q ss_pred ----CCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCccc
Q 011486 423 ----DCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLL 457 (484)
Q Consensus 423 ----~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~ 457 (484)
.....++|+|+.|.||+++ +++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1246799999999999999 6677789999988654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.2e-08 Score=94.79 Aligned_cols=135 Identities=24% Similarity=0.230 Sum_probs=81.6
Q ss_pred eCCCCcEEEEeeCCCccccccCcC-cCCCCCCCEEEcccCcccc-cCCcccCCccccceecccccccCCCCChhhhcccc
Q 011486 68 CDKNKRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSN 145 (484)
Q Consensus 68 C~~~~~l~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 145 (484)
|+.-++++.|+|+.|++.-..... -..+++|+.|.|+.+.|+- .+-..+..+++|+.|+|..|...+.-......+..
T Consensus 168 ~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~ 247 (505)
T KOG3207|consen 168 AEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQT 247 (505)
T ss_pred HHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhH
Confidence 445677888888888876333222 2356777777777777762 12222445677777777777533233333455567
Q ss_pred cccccccccccCCCCC--CccccccccceeeccCCccccc-CCC------CCcccccCcccccCCcC
Q 011486 146 LLNLDISSNSLSDYIP--PSLGKLQRLITFNVSNNFLVGA-IPS------DGVLTKFSESSFFGNRG 203 (484)
Q Consensus 146 L~~L~ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~-~p~------~~~l~~l~~l~l~~N~~ 203 (484)
|+.|||++|++-. .+ ...+.++.|..|+++.+.++.. .|. ...+++|+.|++..|+.
T Consensus 248 L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 248 LQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred HhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 7777777777754 33 3355667777777777766653 222 24466777777777764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.8e-06 Score=78.86 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=87.7
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHH---------HHHHHHHhcCCCCc---eeeeEEEE--
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFF---------ERELEILGSIKHRY---LVNLRGYC-- 372 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~l~~~~-- 372 (484)
.+|...+++-......|.+-.. +++.+++|..+.......+.| .+++..+.+++... ...++...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 4566667777766666666544 578899998865443222222 23344344443222 22222222
Q ss_pred ---EcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 373 ---NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 373 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
.-....+++|||++|..|.+... +++ .++..++.++.-+|+ .|+.|+|..|.|++++++ .++++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEE
Confidence 22234568999999988876542 222 255667788999995 499999999999999965 49999
Q ss_pred ecCCCccc
Q 011486 450 DFGLAKLL 457 (484)
Q Consensus 450 DFGla~~~ 457 (484)
||+..+..
T Consensus 177 D~~~k~~~ 184 (229)
T PF06176_consen 177 DTQGKRMS 184 (229)
T ss_pred ECcccccc
Confidence 99877643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-08 Score=95.70 Aligned_cols=129 Identities=25% Similarity=0.170 Sum_probs=61.9
Q ss_pred cEEEEeeCCCccccccC--cCcCCCCCCCEEEcccCcccccCCccc-CCccccceecccccccCCC-CChhhhccccccc
Q 011486 73 RVITLSLTNHKLSGPIS--ADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGS-IPSELGNLSNLLN 148 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~ 148 (484)
+++.|||+.|-+....+ .....|++|+.|+|+.|++.-...+.. ..+++|+.|.|+.+.|+-. +-..+..+|+|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 45555555555442221 223445555555555555542222211 2344455555555555410 1111234566666
Q ss_pred ccccccccCCCCCCccccccccceeeccCCcccccC--CCCCcccccCcccccCC
Q 011486 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI--PSDGVLTKFSESSFFGN 201 (484)
Q Consensus 149 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~--p~~~~l~~l~~l~l~~N 201 (484)
|+|..|..-+.-......++.|+.|||++|++-... +..+.|+.|..|+++.+
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 666666432223333445566666666666665543 34555666666655543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.1e-06 Score=78.82 Aligned_cols=140 Identities=22% Similarity=0.179 Sum_probs=87.0
Q ss_pred eeeeccc-eeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEcCCCCCHH
Q 011486 314 IIGSGGF-GTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (484)
Q Consensus 314 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 391 (484)
.|..|.+ ..||+.... +..+.+|...... .....+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 789998764 4678888876542 335677888888774 445667888877766789999999998776
Q ss_pred HHH-------------------hhcC-C--CCCH--HHHHHHHH--------------------HHHHHHHHHHhC----
Q 011486 392 EAL-------------------HERS-E--QLDW--DARLNIIM--------------------GAAKGLAYLHHD---- 423 (484)
Q Consensus 392 ~~l-------------------~~~~-~--~l~~--~~~~~i~~--------------------~i~~aL~~LH~~---- 423 (484)
+.. |.-. . .... ........ .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 442 1000 0 0110 00000000 011112222111
Q ss_pred CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 424 ~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
..+.++|+|+.|.|||++++..+.|+||+.+..-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 1356899999999999999878899999988643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.1e-07 Score=97.50 Aligned_cols=128 Identities=27% Similarity=0.267 Sum_probs=99.0
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
...+..|+|.+|+|. .+...+..+++|++|+|++|.|+... .+..++.|+.|++++|.|+ .++ .+..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheeccCcch-hcc-CCccchhhhccc
Confidence 468999999999999 45444889999999999999999543 4778888999999999998 554 356689999999
Q ss_pred ccccccCCCCC-CccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 151 ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
+++|.++..-+ . ...+.+|+.+++.+|.+...-. ...+..+..+++..|....
T Consensus 169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~-~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 169 LSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG-LDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred CCcchhhhhhhhh-hhhccchHHHhccCCchhcccc-hHHHHHHHHhhccccccee
Confidence 99999986444 2 5788899999999998875432 2334444445666665543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.8e-07 Score=103.05 Aligned_cols=107 Identities=28% Similarity=0.388 Sum_probs=82.5
Q ss_pred CcEEEEeeCCCc--cccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 72 KRVITLSLTNHK--LSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 72 ~~l~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
+.+++|-+..|. +.-..++.|..++.|+.||||+|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|..|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 467788888876 44333345777888888888887655688888888888888888888888 888888888888888
Q ss_pred cccccccCCCCCCccccccccceeeccCCc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNF 179 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 179 (484)
|+..+.-...+|.....|++|++|.+-.-.
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccc
Confidence 888887665667777778888888876554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 484 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-86
Identities = 81/172 (47%), Positives = 119/172 (69%), Gaps = 4/172 (2%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+ +I+G GGFG VYK + DG + A+KR+ ++ +G + F+ E+E++ HR L+ L
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCS 425
RG+C +PT +LL+Y ++ GS+ L ER E LDW R I +G+A+GLAYLH C
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
P+IIHRD+K++NILLD EA V DFGLAKL++ +++H+TT V GT G++AP
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 9e-74
Identities = 70/172 (40%), Positives = 101/172 (58%), Gaps = 7/172 (4%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
D +IG G FG VYK + DG ALKR + FE E+E L +H +LV+L
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
G+C+ +LIY ++ G+L L+ + W+ RL I +GAA+GL YLH
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-- 159
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAP 477
IIHRD+KS NILLD N +++DFG++K E +++H++T+V GT GY+ P
Sbjct: 160 -IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-71
Identities = 62/178 (34%), Positives = 96/178 (53%), Gaps = 17/178 (9%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRF-------FERELEILGSIKH 362
+ +G GGFG VYK +++ V A+K+ L D F++E++++ +H
Sbjct: 34 VGGNKMGEGGFGVVYKGYVNNTTV-AVKK---LAAMVDITTEELKQQFDQEIKVMAKCQH 89
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
LV L G+ + L+Y ++P GSL + L L W R I GAA G+ +L
Sbjct: 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
H + IHRDIKS+NILLD A++SDFGLA+ + ++ +T+ + GT Y+AP
Sbjct: 150 HENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-56
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFER 352
+ ++++ + L + G FG V+K + + V A+K ++ + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW--QNEY 67
Query: 353 ELEILGSIKHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
E+ L +KH ++ G + LI F GSL + L + + W+ +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCH 125
Query: 409 IIMGAAKGLAYLHHD-------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
I A+GLAYLH D P I HRDIKS N+LL NL A ++DFGLA E +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 462 SHI-TTIVAGTFGYLAP 477
S T GT Y+AP
Sbjct: 186 SAGDTHGQVGTRRYMAP 202
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPE-DPDPCNWKGVKCD---KNKRVITLSLTNHKLS 85
D +ALL + + + L+ W P D W GV CD + RV L L+ L
Sbjct: 5 PQDKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 86 G--PISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
PI + L L L FL + NN G IP + T+L L + +SG+IP L
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ L+ LD S N+LS +PPS+ L L+ N + GAIP
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-43
Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 2/130 (1%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
++++ ++L+G I L+ L F++L N G+ G+ Q + L N L+ +
Sbjct: 179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
+G NL LD+ +N + +P L +L+ L + NVS N L G IP G L +F S
Sbjct: 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
Query: 197 SFFGNRGLCG 206
++ N+ LCG
Sbjct: 297 AYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 2/116 (1%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
++ L +T+ +SG I L ++ L L+ N G +P + + L G++ N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 132 LSGSIPSELGNLSNLLN-LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+SG+IP G+ S L + IS N L+ IPP+ L L ++S N L G
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 7e-08
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+++ G + L +L L LN+ NN GEIP GN + +N
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306
Query: 136 IP 137
P
Sbjct: 307 SP 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 7/177 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
L+ IG+G FGTV++ A G+ A+K + + F RE+ I+ ++H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHR-AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYL 420
+V G P + ++ ++L GSL LH EQLD RL++ AKG+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H+ +P I+HR++KS N+L+D +V DFGL++L + AGT ++AP
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS-AAGTPEWMAP 208
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-45
Identities = 51/153 (33%), Positives = 74/153 (48%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
++T+ G S + FL++ N G IP E+G+ L L+L N +S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF 193
GSIP E+G+L L LD+SSN L IP ++ L L ++SNN L G IP G F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 194 SESSFFGNRGLCGKQINVTCKNDSGGSTTDSQS 226
+ F N GLCG + +++ G +S
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 46/117 (39%), Positives = 64/117 (54%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ L L + L G I +L + L+ L L N+ GEIPS L NCT L +SL +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
N L+G IP +G L NL L +S+NS S IP LG + LI +++ N G IP+
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 46/115 (40%), Positives = 66/115 (57%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+++L L+ + LSG I + LG L +L+ L L N GEIP EL L+ L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+G IPS L N +NL + +S+N L+ IP +G+L+ L +SNN G IP+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-32
Identities = 43/118 (36%), Positives = 56/118 (47%), Gaps = 1/118 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+ +G I L +L L+L N G IPS LG+ ++L+ L L N L G
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTK 192
IP EL + L L + N L+ IP L L ++SNN L G IP G L
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-31
Identities = 50/113 (44%), Positives = 67/113 (59%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISADLGK--LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
TL L+++ SGPI +L + + L+ L L +N F G+IP L NC+EL L L NYLS
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
G+IPS LG+LS L +L + N L IP L ++ L T + N L G IPS
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 41/113 (36%), Positives = 54/113 (47%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++ +KLSG S + +LK LN+ SN F G IP LQ LSL N +G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284
Query: 136 IPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
IP L G L LD+S N +PP G L + +S+N G +P D
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 48/223 (21%), Positives = 78/223 (34%), Gaps = 61/223 (27%)
Query: 26 SRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVI---------- 75
S+++ + L+SF+ V+ L W + +PC + GV C + +V
Sbjct: 7 SQSLYREIHQLISFK-DVLPDKNLLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLN 63
Query: 76 ----------------------------------------TLSLTNHKLSGPISAD--LG 93
+L L+ + LSGP++ LG
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 94 KLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSEL---GNLSNLLNL 149
LKFLN+ SN S L+ L L +N +SG+ L +L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
IS N +S + + + L +VS+N IP G +
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSA 224
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-28
Identities = 46/132 (34%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCT-ELQGLSLQSNYLS 133
+L+L+++ SG + D L K+ LK L+L N F GE+P L N + L L L SN S
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 134 GSIPSELGN--LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVL 190
G I L + L L + +N + IPP+L L++ ++S N+L G IPS G L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 191 TKFSESSFFGNR 202
+K + + N
Sbjct: 442 SKLRDLKLWLNM 453
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-28
Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L + L+G I + L L +++L +N GEIP +G L L L +N SG+
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
IP+ELG+ +L+ LD+++N + IP ++ K + ++ NF+ G
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 40/113 (35%), Positives = 63/113 (55%), Gaps = 4/113 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
L++++++ GPI L L++L+L N F GEIP L G C L GL L N+ G
Sbjct: 251 LLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPS 186
++P G+ S L +L +SSN+ S +P +L K++ L ++S N G +P
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ L+++ +K+SG + + + L+FL++ SNNF IP LG+C+ LQ L + N
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LSG + + L L+ISSN IPP L+ L +++ N G IP
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 23/148 (15%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ +SL+N++L+G I +G+L+ L L L +N+F G IP+ELG+C L L L +
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 130 NYLSGSIPSELGNLSNLL----------------------NLDISSNSLSDYIPPSLGKL 167
N +G+IP+ + S + + + L +L
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 168 QRLITFNVSNNFLVGAIPSD-GVLTKFS 194
N+++ G
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMM 635
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-45
Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 23/198 (11%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFD---- 347
+ P S + ++ + IG GGFG V+K L D V A+K + + +
Sbjct: 7 EFPKSRLPTLA-DNEIEYEKQIGKGGFGLVHKGRLVKDKSVV-AIKSLILGDSEGETEMI 64
Query: 348 ---RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD 404
+ F+RE+ I+ ++ H +V L G ++P ++ +F+P G L L +++ + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459
+L +++ A G+ Y+ + +P I+HRD++S NI L E A+V+DFGL++
Sbjct: 123 VKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 460 EESHITTIVAGTFGYLAP 477
+ H + + G F ++AP
Sbjct: 178 QSVHSVSGLLGNFQWMAP 195
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
+ S + L+ L +IG G +G VYK ++D+ V A+K N + F E
Sbjct: 2 EAAASEPSL--DLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANR---QNFINE 55
Query: 354 LEI--LGSIKHRYLVNLRGYC-----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR 406
I + ++H + + LL+ ++ P GSL + L + DW +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 407 LNIIMGAAKGLAYLHHD------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-- 458
+ +GLAYLH + P I HRD+ S N+L+ + +SDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 459 -----DEESHITTIVAGTFGYLAP 477
EE + GT Y+AP
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAP 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
S +I + ++ + ++G G FG V K A A+K+I +E + F EL L
Sbjct: 1 SLHMID-YKEIEVEEVVGRGAFGVVCK-AKWRAKDVAIKQI--ESESERKAFIVELRQLS 56
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKG 416
+ H +V L G C +P L+ ++ GGSL LH E ++ + ++G
Sbjct: 57 RVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
+AYLH +IHRD+K N+LL ++ DFG A + T G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 476 AP 477
AP
Sbjct: 171 AP 172
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 13/178 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
+ L+ + G ++K GN +K + + R F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWK-GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 363 RYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAY 419
++ + G C SP + I ++P GSL LHE + +D + + A+G+A+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH P I + S ++++D ++ AR+S + + ++AP
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAP 177
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 50/196 (25%), Positives = 76/196 (38%), Gaps = 18/196 (9%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
LP + I + + IG G +G V+ V A+K E F E E
Sbjct: 26 GLPLLVQRTI--AKQIQMVKQIGKGRYGEVWMGKWRGEKV-AVKVFFTTEEA-SWFRETE 81
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
+ ++H ++ T LI D+ GSL + L + LD + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL 139
Query: 410 IMGAAKGLAYLH-----HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
+ GL +LH P I HRD+KS NIL+ N ++D GLA + + +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 465 ---TTIVAGTFGYLAP 477
GT Y+ P
Sbjct: 200 DIPPNTRVGTKRYMPP 215
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 12/179 (6%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
E L+ +IG G FG VY G V A++ I ++ NE + F+RE+ +H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYH-GRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V G C SP +I G +L + + LD + I KG+ YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL----LEDEESHITTIVAGTFGYLAP 477
+ I+H+D+KS N+ D N + ++DFGL + I G +LAP
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 16/183 (8%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+ +G G +G V++ + NV A+K +E F E EL ++H ++
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENV-AVKIFSSRDEK-SWFRETELYNTVMLRHENIL 65
Query: 367 NLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ LI + GSL + L + LD + L I++ A GLA+LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 123
Query: 423 D-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI---TTIVAGTFGY 474
+ P I HRD+KS NIL+ N + ++D GLA + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 475 LAP 477
+AP
Sbjct: 184 MAP 186
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-40
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 18/185 (9%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI----DKLNEGFDRFFERELEILGSI 360
L + IIG GGFG VY+ V A+K D+ +E ++ +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
KH ++ LRG C + L+ +F GG L+ L + ++ D +N + A+G+ YL
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYL 121
Query: 421 HHDCSPRIIHRDIKSSNILLD--------GNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
H + IIHRD+KSSNIL+ N +++DFGLA+ AG +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAY 178
Query: 473 GYLAP 477
++AP
Sbjct: 179 AWMAP 183
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
++G G FG K + G V +K + + +E R F +E++++ ++H ++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
I +++ GG+L + Q W R++ A G+AYLH S IIHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-------------TIVAGTFGYLAP 477
D+ S N L+ N V+DFGLA+L+ DE++ V G ++AP
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 22/197 (11%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFEREL 354
LP + I T+ IG G FG V++ V A+K E R + RE
Sbjct: 32 LPLLVQRTI--ARTIVLQESIGKGRFGEVWRGKWRGEEV-AVKIFSSREE---RSWFREA 85
Query: 355 EI--LGSIKHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
EI ++H ++ + T L+ D+ GSL + L+ + + + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIK 143
Query: 409 IIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ + A GLA+LH + P I HRD+KS NIL+ N ++D GLA +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 464 IT---TIVAGTFGYLAP 477
I GT Y+AP
Sbjct: 204 IDIAPNHRVGTKRYMAP 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRY 364
+ IGSG FGTVYK G+V A+K + + F+ E+ +L +H
Sbjct: 24 GQITVGQRIGSGSFGTVYK-GKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
++ GY +P ++ + G SL LH + + ++I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAP 477
+ IIHRD+KS+NI L + ++ DFGLA SH ++G+ ++AP
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 27/182 (14%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY- 371
+IGSGGFG V+K DG + +KR+ NE ERE++ L + H +V+ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHYNGCW 73
Query: 372 --------------CNSPTSKLLIY-DFLPGGSLDEALHER-SEQLDWDARLNIIMGAAK 415
S T L I +F G+L++ + +R E+LD L + K
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
G+ Y+H S ++I+RD+K SNI L + ++ DFGL L+++ + GT Y+
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRYM 188
Query: 476 AP 477
+P
Sbjct: 189 SP 190
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 35/193 (18%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG- 370
++G G FG V K A + D +A+K+I E E+ +L S+ H+Y+V
Sbjct: 13 VLGQGAFGQVVK-ARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 371 ---------YCNSPTSKLLIY---DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ K ++ ++ G+L + +H + D + + L+
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE--------------DEESHI 464
Y+H S IIHRD+K NI +D + ++ DFGLAK + ++
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 465 TTIVAGTFGYLAP 477
T+ + GT Y+A
Sbjct: 188 TSAI-GTAMYVAT 199
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 16/172 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG + +DG + +K I+ +++ RE+ +L ++KH +V R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
S ++ D+ GG L + ++ + E D + I + L ++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA----LKHVH---D 143
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+I+HRDIKS NI L + ++ DFG+A++L + GT YL+P
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSP 194
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 11/174 (6%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG+G +G K DG + K +D + E + E+ +L +KH +V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 371 -YCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLH--HD 423
+ + L I ++ GG L + + +++ LD + L ++ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K +N+ LDG ++ DFGLA++L + S T V GT Y++P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 30/190 (15%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLV------ 366
+G GGFG V++ D +A+KRI N E RE++ L ++H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 367 ---NLRGYCNSPTSKLLIY---DFLPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLA 418
N + K+ +Y +L + ++ R E+ + L+I + A+ +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--------- 469
+LH S ++HRD+K SNI + +V DFGL ++ +E T +
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 470 --GTFGYLAP 477
GT Y++P
Sbjct: 190 QVGTKLYMSP 199
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F VY A + G A+K IDK G + + E++I +KH ++ L
Sbjct: 19 LGKGSFAGVY-RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-WDARLNIIMGAAKGLAYLHHDCSPRI 428
Y L+ + G ++ L R + +AR + + G+ YLH S I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH---SHGI 133
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRD+ SN+LL N+ +++DFGLA L+ T+ GT Y++P
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISP 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 293 GDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGF 346
G+ P + I+K+ E ++GSG FGTVYK + V A+K +L E
Sbjct: 1 GEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT 56
Query: 347 DRF----FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E ++ S+ + ++ L G C + T LI +P G L + + E + +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG 115
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
LN + AKG+ YL R++HRD+ + N+L+ +++DFGLAKLL EE
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 463 HITT 466
Sbjct: 173 EYHA 176
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+S I+ K+ ++G G GT+ M D A+KRI F +RE+++L
Sbjct: 16 TSVVIVGKIS-FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLL 71
Query: 358 -GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
S +H ++ + + + L +L E + ++ + ++ G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 417 LAYLHHDCSPRIIHRDIKSSNILL-----DGNLEARVSDFGLAKLLEDEES--HITTIVA 469
LA+LH S I+HRD+K NIL+ G ++A +SDFGL K L + V
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 470 GTFGYLAP 477
GT G++AP
Sbjct: 188 GTEGWIAP 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGF ++++ D VFA K + K L E+ I S+ H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ ++ + SL E R + +AR + G YLH R+IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K N+ L+ +LE ++ DFGLA +E + + GT Y+AP
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAP 210
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 12/184 (6%)
Query: 301 DIIKKLETLDD---DHIIGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERE 353
+++ + +G GGF ++++ D VFA K + K L E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
+ I S+ H+++V G+ ++ + SL E R + +AR +
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQI 124
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
G YLH R+IHRD+K N+ L+ +LE ++ DFGLA +E + + GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPN 180
Query: 474 YLAP 477
Y+AP
Sbjct: 181 YIAP 184
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
++GSG F V+ L G +FALK I K D E E+ +L IKH +V L
Sbjct: 16 VLGSGAFSEVF-LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S T L+ + GG L + + ER +E+ DA +I + YLH I
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEK---DAS-LVIQQVLSAVKYLH---ENGI 127
Query: 429 IHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRD+K N+L + N + ++DFGL+K+ ++ ++T GT GY+AP
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAP 176
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 292 HGDLPYSSKD--IIKKLETLDDDHIIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNE 344
H Y+ +D I ++ L +G G FG+V L + G + A+K++
Sbjct: 7 HHAQLYACQDPTIFEE-RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65
Query: 345 GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLD 402
R F+RE++IL ++ ++V RG P + L+ ++LP G L + L +LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
L KG+ YL S R +HRD+ + NIL++ +++DFGLAKLL ++
Sbjct: 126 ASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
Query: 463 H 463
+
Sbjct: 183 Y 183
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD---RFFERELEILGSIKHRY 364
+G G FG+V L + G V A+K KL + R FERE+EIL S++H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 365 LVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V +G C S + LI ++LP GSL + L + E++D L KG+ YL
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+ R IHRD+ + NIL++ ++ DFGL K+L ++
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 44/180 (24%), Positives = 69/180 (38%), Gaps = 21/180 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G GGF V L DG+ +ALKRI + +RE ++ H ++ L YC
Sbjct: 37 LGEGGFSYVD-LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 373 NSPTSK----LLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCS 425
L+ F G+L + ++ L D L +++G +GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--------GTFGYLAP 477
HRD+K +NILL + + D G + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 13/173 (7%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNL 368
IG G F VY+ + DG ALK++ + + +E+++L + H ++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 369 RGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDC 424
++L I + G L + +Q + + L ++H
Sbjct: 98 YASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S R++HRDIK +N+ + ++ D GL + + + ++V GT Y++P
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 205
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 312 DHIIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVN 367
D IG G F TVYK +D A + KL + + F+ E E+L ++H +V
Sbjct: 31 DIEIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 368 LRGYCNSPTSK---LLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
S +++ + + G+L L +R + + + KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 424 CSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+P IIHRD+K NI + G ++ D GLA L S ++ GT ++AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVI-GTPEFMAP 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 314 IIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD---RFFERELEILGSIKHRYL 365
+G G FG+V L + G V A+K KL + R FERE+EIL S++H +
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 366 VNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
V +G C S + LI ++LP GSL + L + E++D L KG+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ R IHRD+ + NIL++ ++ DFGL K+L ++ +
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFD 347
+K L +G G FG V + N V +LK N D
Sbjct: 11 TEVDPTHFEK-RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69
Query: 348 RFFERELEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDA 405
++E+EIL ++ H +V +G C LI +FLP GSL E L + +++
Sbjct: 70 --LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+L + KG+ YL S + +HRD+ + N+L++ + ++ DFGL K +E ++ + T
Sbjct: 128 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 466 T 466
Sbjct: 185 V 185
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G +G VY + + A+K I + + + + E+ + +KH+ +V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 373 NSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPRII 429
S + I+ + +PGGSL L + L + + +GL YLH +I+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144
Query: 430 HRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK N+L++ + ++SDFG +K L T GT Y+AP
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAP 192
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 293 GDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGF 346
G+ P + I+K+ E ++GSG FGTVYK + V A+K +L E
Sbjct: 1 GEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT 56
Query: 347 DRF----FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E ++ S+ + ++ L G C + T LI +P G L + + E + +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG 115
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
LN + AKG+ YL R++HRD+ + N+L+ +++DFGLAKLL EE
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 463 HITT 466
Sbjct: 173 EYHA 176
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG VY LA + ALK + K G + RE+EI ++H ++ L
Sbjct: 17 LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
GY + T LI ++ P G++ L + S+ + I A L+Y H S R+I
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVI 131
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK N+LL E +++DFG + GT YL P
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDL--CGTLDYLPP 176
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 292 HGDLPYSSKDIIKKLETLDDDHI---IGSGGFGTVYKLAMDDGNVFALKRIDK------- 341
+ +L Y +K + +K + ++D I + G F + L D +ALK+ +K
Sbjct: 13 YSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKR 71
Query: 342 ----------LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391
+ F+ EL+I+ IK+ Y + G + +IY+++ S+
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131
Query: 392 EALHERSEQLDWDARLNIIMGAAK-------GLAYLHHDCSPRIIHRDIKSSNILLDGNL 444
+ I +Y+H++ I HRD+K SNIL+D N
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNG 189
Query: 445 EARVSDFGLAKLLEDEESHITTIVAGTFGYLAP----GKDCTNG 484
++SDFG ++ + D++ + GT+ ++ P + NG
Sbjct: 190 RVKLSDFGESEYMVDKKIK-GS--RGTYEFMPPEFFSNESSYNG 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFDRF----FE 351
K +K+ L D +G G FG+V + M + A+K L +G ++
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMM 384
Query: 352 RELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
RE +I+ + + Y+V L G C + +L+ + GG L + L + E++ ++
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
+ G+ YL +HR++ + N+LL A++SDFGL+K L ++S+ T AG
Sbjct: 444 QVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 472 F 472
+
Sbjct: 501 W 501
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFEREL 354
S+ L L D I+G G V++ G++FA+K + D RE
Sbjct: 2 GSQSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREF 58
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEAL--HERSEQLDWDARLNII 410
E+L + H+ +V L T++ LI +F P GSL L + L L ++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITT 466
G+ +L I+HR+IK NI+ DG +++DFG A+ LED+E +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 467 IVAGTFGYLAP 477
+ GT YL P
Sbjct: 175 LY-GTEEYLHP 184
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 25/180 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK---------LNEGFDRFFERELEILGSIK 361
I+G G V + +A+K ID + +E++IL +
Sbjct: 23 EILGRGVSSVVR-RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 362 -HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGL 417
H ++ L+ + T L++D + G L + L E+ SE+ + R I+ + +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETR-KIMRALLEVI 137
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH I+HRD+K NILLD ++ +++DFG + L+ E + + GT YLAP
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSYLAP 192
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V++ D G A+K++ + F EL + +V L G
Sbjct: 64 PRVGRGSFGEVHR-MKDKQTGFQCAVKKVR-----LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 371 YCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ I+ + L GGSL + + ++ L D L + A +GL YLH + RI+
Sbjct: 118 -AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLH---TRRIL 172
Query: 430 HRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTI----VAGTFGYLAP 477
H D+K+ N+LL + A + DFG A L+ + + + + GT ++AP
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+ + +K L + I+G G GTV G A+KR+ F E+++L
Sbjct: 8 NFEQSLKNLVVSEK--ILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLL 62
Query: 358 G-SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE------ALHERSEQLDWDARLNII 410
S H ++ + + + L +L + E + ++++
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-------------GNLEARVSDFGLAKLL 457
A G+A+LH S +IIHRD+K NIL+ NL +SDFGL K L
Sbjct: 122 RQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 458 EDEESHITTI---VAGTFGYLAP 477
+ +S T +GT G+ AP
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAP 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 13/168 (7%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG VY LA + + ALK + K EG + RE+EI ++H ++ +
Sbjct: 22 LGKGKFGNVY-LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
Y + L+ +F P G L + L + + + + A L Y H ++I
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH---ERKVI 136
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
HRDIK N+L+ E +++DFG + T GT YL P
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPP 181
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIK- 361
+IG G V + G+ FA+K ++ E RE IL +
Sbjct: 100 DVIGRGVSSVVR-RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLA 418
H +++ L S + L++D + G L + L E+ SE+ + R +I+ + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---ETR-SIMRSLLEAVS 214
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+LH + I+HRD+K NILLD N++ R+SDFG + LE E + + GT GYLAP
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAP 268
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFEREL 354
S+ L L D I+G G V++ G++FA+K + D RE
Sbjct: 2 GSQSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREF 58
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEAL--HERSEQLDWDARLNII 410
E+L + H+ +V L T++ LI +F P GSL L + L L ++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITT 466
G+ +L I+HR+IK NI+ DG +++DFG A+ LED+E +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 467 IVAGTFGYLAP 477
+ GT YL P
Sbjct: 175 LY-GTEEYLHP 184
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSIKHRY 364
D +G G FG+V + M + A+K L +G + RE +I+ + + Y
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+V L G C + +L+ + GG L + L + E++ ++ + G+ YL
Sbjct: 72 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
+HRD+ + N+LL A++SDFGL+K L ++S+ T AG +
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG-Y 371
+G G FG VYK A + G + A K I+ +E + E+EIL + H Y+V L G Y
Sbjct: 27 LGDGAFGKVYK-AKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 372 CNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ KL ++ +F PGG++D + E L + + L +LH S RIIH
Sbjct: 86 YHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIH 140
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
RD+K+ N+L+ + R++DFG++ + + GT
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT 180
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 37/175 (21%), Positives = 68/175 (38%), Gaps = 22/175 (12%)
Query: 312 DHIIGSGGFGTVYKLAMD---DGNVFALKR-IDKLNEGFDRFFERELEILGSIKHRYLVN 367
I GG G +Y LA+D +G LK + + E + L + H +V
Sbjct: 85 KGCIAHGGLGWIY-LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 368 LR--GYCNSPTSKLLIY---DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ + Y +++ G SL + ++ L + ++ L+YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH- 199
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S +++ D+K NI+L + ++ D G + + GT G+ AP
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAP 246
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD--RFFERELEILGSI-KHRYLVNLRG 370
+G G +G V+K + +DG ++A+KR G E+ + +H V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L + L G SL + L + LA+LH S ++H
Sbjct: 125 AWEEG-GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVH 180
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K +NI L ++ DFGL L + G Y+AP
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAP 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 7/152 (4%)
Query: 313 HIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVNLR 369
IG G FG V+ L D+ V A+K + + F +E IL H +V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C ++ + + GG L +L L ++ AA G+ YL S I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
HRD+ + N L+ ++SDFG+++ D
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G G +G+VYK A+ G + A+K++ + +E+ I+ ++V G
Sbjct: 37 LGEGSYGSVYK-AIHKETGQIVAIKQVP-VESDLQEI-IKEISIMQQCDSPHVVKYYG-S 92
Query: 373 NSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+ L ++ ++ GS+ + + R++ L D I+ KGL YLH R IHR
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHR 149
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
DIK+ NILL+ A+++DFG+A L D + T++ GT ++AP
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAP 194
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 19/174 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F V + G +A I+ L+ + ERE I +KH +V L
Sbjct: 18 ELGKGAFSVVR-RCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ LI+D + GG L E + R SE DA + I + + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA---DAS-HCIQQILEAVLHCH---QM 129
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HR++K N+LL +++DFGLA +E E+ GT GYL+P
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 11/187 (5%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF--ALK--RIDKLNEGF 346
G+ P S + + L +G G FG V + G A+K + D L++
Sbjct: 4 GEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 347 DRF-FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDA 405
F RE+ + S+ HR L+ L G +P ++ + P GSL + L +
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+ A+G+ YL S R IHRD+ + N+LL ++ DFGL + L + H
Sbjct: 123 LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 466 TIVAGTF 472
Sbjct: 180 MQEHRKV 186
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 313 HIIGSGGFGTVYKLAMDDGN--------VFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+G G FG V D N V ALK +++E++IL ++ H +
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG--WKQEIDILRTLYHEH 94
Query: 365 LVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++ +G C + L+ +++P GSL + L + L +G+AYLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ IHRD+ + N+LLD + ++ DFGLAK + + +
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 36/172 (20%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 96 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAP 477
+H D+K +N L+ G L ++ DFG+A ++ + + + + V GT Y+ P
Sbjct: 149 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPP 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 283 GGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID 340
GGG + M D+ + + + +IG G F V ++ G FA+K +D
Sbjct: 8 GGGGILDMADDDVLFEDVYELCE--------VIGKGPFSVVR-RCINRETGQQFAVKIVD 58
Query: 341 K----LNEGFDR-FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH 395
+ G +RE I +KH ++V L +S ++++F+ G L +
Sbjct: 59 VAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV 118
Query: 396 ERSEQLDW----DARLNI--IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEA 446
+R++ A + I+ A L Y H IIHRD+K +LL + +
Sbjct: 119 KRADAGFVYSEAVASHYMRQILEA---LRYCH---DNNIIHRDVKPHCVLLASKENSAPV 172
Query: 447 RVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++ FG+A L + V GT ++AP
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILG-SIKHRYLVNLR 369
IG G + + + FA+K IDK E+EIL +H ++ L+
Sbjct: 28 EDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLK 82
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ + + GG L + + + SE+ +A ++ K + YLH +
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSER---EAS-AVLFTITKTVEYLH---AQ 135
Query: 427 RIIHRDIKSSNILL---DGNLEA-RVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K SNIL GN E+ R+ DFG AK L E + T T ++AP
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAP 189
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHR 363
++GSG FGTV+K + + + ++ + +GS+ H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHA 75
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++V L G C + L+ +LP GSL + + + L LN + AKG+ YL
Sbjct: 76 HIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
++HR++ + N+LL + +V+DFG+A LL ++ +
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G F V + G FA K I+ L+ + ERE I ++H +V L
Sbjct: 12 EELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ L++D + GG L E + R SE DA + I + +AY H S
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DAS-HCIQQILESIAYCH---S 123
Query: 426 PRIIHRDIKSSNILLDGNLEA---RVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HR++K N+LL + +++DFGLA + D E+ GT GYL+P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSP 176
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 21/188 (11%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEI 356
+ + D +G G F K + FA+K I K E ++E+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRK-CVHKKSNQAFAVKIISKRME---ANTQKEITA 58
Query: 357 LGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMG 412
L + H +V L + L+ + L GG L E + ++ SE +A I+
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET---EAS-YIMRK 114
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVA 469
++++H ++HRD+K N+L + NLE ++ DFG A+L + + T
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 470 GTFGYLAP 477
T Y AP
Sbjct: 171 FTLHYAAP 178
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 298 SSKDIIKKLETL----------DDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEG 345
S ++I++KL ++ IG G GTVY AMD G A+++++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQP 59
Query: 346 FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD 404
E+ ++ K+ +VN +L ++ ++L GGSL + + E
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
A + + L +LH S ++IHRDIKS NILL + +++DFG + E+S
Sbjct: 119 AA--VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 465 TTIVAGTFGYLAP 477
+T+V GT ++AP
Sbjct: 174 STMV-GTPYWMAP 185
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER 352
+ S++D + ++ +G G VY +ALK + K + +
Sbjct: 43 IDGSNRDALSDFFEVES--ELGRGATSIVY-RCKQKGTQKPYALKVLKKTVD--KKIVRT 97
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNI 409
E+ +L + H ++ L+ +PT L+ + + GG L + + E+ SE+ DA +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER---DAA-DA 153
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITT 466
+ + +AYLH I+HRD+K N+L + +++DFGL+K++E + + T
Sbjct: 154 VKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 467 IVAGTFGYLAP 477
+ GT GY AP
Sbjct: 210 VC-GTPGYCAP 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 60/169 (35%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
IG G FG V+K +D V A+K ID L E D ++E+ +L Y+ G
Sbjct: 30 IGKGSFGEVFK-GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 371 -YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y +KL +I ++L GGS + L A I+ KGL YLH S +
Sbjct: 88 SYLKD--TKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILKGLDYLH---SEKK 140
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IHRDIK++N+LL + E +++DFG+A L D + T V GT ++AP
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 314 IIGSGGFGTVYK--LAMDDGNVF-ALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+GSG FGTV K M A+K + + + E ++ + + Y+V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C + S +L+ + G L++ L + + + ++ + G+ YL
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNF 138
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
+HRD+ + N+LL A++SDFGL+K L +E++ G +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 36/172 (20%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 77 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAP 477
+H D+K +N L+ G L ++ DFG+A ++ + + + + V GT Y+ P
Sbjct: 130 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPP 178
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
LD IG G G V A + G A+K +D + E+ I+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCL-AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 365 LVNLRG-YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V + Y +L ++ +FL GG+L + + + + A + + LAYLH
Sbjct: 104 VVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQVRLNEEQIAT--VCEAVLQALAYLH- 158
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ +IHRDIKS +ILL + ++SDFG + + ++V GT ++AP
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 20/175 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVN---- 367
+G+G +G VYK G + A+K +D + + ++E+ +L HR +
Sbjct: 32 VGNGTYGQVYK-GRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 368 -LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQL---DWDARLNIIMGAAKGLAYLHH 422
++ +L L+ +F GS+ + + +W A I +GL++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH- 146
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++AP
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 198
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 312 DHIIGSGGFGTVYK---LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
+ IIGSG G V +V A+K L G+ R F E I+G H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++ L G +++ +++ GSLD L Q + ++ G G+ YL
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
+HRD+ + N+L+D NL +VSDFGL+++LED+ T G
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG V D +A+K I+K RE+E+L + H ++ L
Sbjct: 29 MLGKGSFGEVL-KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+S ++ + GG L + + +R SE DA II G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAA-RIIKQVFSGITYMH---KH 140
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRD+K NILL + + + ++ DFGL+ + + + GT Y+AP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAP 192
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F V + G FA K I+ L+ + ERE I ++H +V L
Sbjct: 36 ELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ L++D + GG L E + R SE DA + I + +AY H S
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DAS-HCIQQILESIAYCH---SN 147
Query: 427 RIIHRDIKSSNILLDGNLEA---RVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HR++K N+LL + +++DFGLA + D E+ GT GYL+P
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSP 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 28/200 (14%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEG 345
G P+ + + + + +GSG F V K + G +A K I K G
Sbjct: 1 GMEPFKQQKVEDFYDIGE---ELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRG 56
Query: 346 FDR-FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQL 401
R ERE+ IL + H ++ L + T +LI + + GG L + L ++ SE+
Sbjct: 57 VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE- 115
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLL 457
+A + I G+ YLH + +I H D+K NI+L ++ DFGLA +
Sbjct: 116 --EAT-SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 458 EDEESHITTIVAGTFGYLAP 477
ED + GT ++AP
Sbjct: 170 EDGV--EFKNIFGTPEFVAP 187
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+GSG FG V++ ++ G VF K I+ + E+ I+ + H L+NL
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+LI +FL GG L + + ++ +N + A +GL ++H I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 433 IKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IK NI+ + + V DFGLA L +E I + T + AP
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAP 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 18/193 (9%)
Query: 296 PYSSKDIIKKLETLDDD------HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD 347
P+ + + K ++ I+G G FG V+K + G A K I
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDK 130
Query: 348 RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-WDAR 406
+ E+ ++ + H L+ L S +L+ +++ GG L + + + S L D
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
+ +G+ ++H I+H D+K NIL ++ DFGLA+ + E +
Sbjct: 191 -LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-L 245
Query: 465 TTIVAGTFGYLAP 477
GT +LAP
Sbjct: 246 KVNF-GTPEFLAP 257
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 10/176 (5%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEILGSIK 361
K + + +G+G G V+K G V A K I ++ REL++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
Y+V G S + + + GGSLD+ L ++ ++ + + KGL YL
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+I+HRD+K SNIL++ E ++ DFG++ L D S + V GT Y++P
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSP 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN-EGFDRFFEREL 354
S+K I + TL++ IG G +G V +A+ A K+I K E DRF ++E+
Sbjct: 2 STKGDINQYYTLEN--TIGRGSWGEVK-IAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEI 57
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIM 411
EI+ S+ H ++ L T L+ + GG L E + + E DA I+
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES---DAA-RIMK 113
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIV 468
+AY H + HRD+K N L + ++ DFGLA + + + T V
Sbjct: 114 DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV 169
Query: 469 AGTFGYLAP 477
GT Y++P
Sbjct: 170 -GTPYYVSP 177
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 45/188 (23%), Positives = 66/188 (35%), Gaps = 44/188 (23%)
Query: 312 DHIIGSGGFGTVYKLAMDDGNVFALKRID--KL-------NEGFDRFFERELEILGSIKH 362
++G GG G VY A D +RI KL + F +RE G ++
Sbjct: 39 RRLVGRGGMGDVY-EAEDT----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 363 RYLVNLRGYCNSPTSKLLIYD-------------FLPGGSLDEALHERSEQLDWDARLNI 409
++V I+D + G L L + L + I
Sbjct: 94 PHVVP-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAI 139
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ L H HRD+K NIL+ + A + DFG+A DE+
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 470 GTFGYLAP 477
GT Y+AP
Sbjct: 197 GTLYYMAP 204
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 268 KKLGKNESKGLARD----VGGGASIVMFHGDLPYSSKDIIKKLETLDDD----HIIGSGG 319
+ +GK + + L + + + V DL + + K L D+ +GSG
Sbjct: 90 ELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPK--ALRDEYIMSKTLGSGA 147
Query: 320 FGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHRYLVNLR 369
G V LA + A++ I K E E+EIL + H ++ ++
Sbjct: 148 CGEVK-LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ ++ + + GG L + + E + + YLH
Sbjct: 207 NFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYLH---EN 258
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IIHRD+K N+LL + + +++DFG +K+L E S + T+ GT YLAP
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAP 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 291 FHGDLPYSSKDII-KKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-- 341
F GDL + I K L + +GSG +G V L D A+K I K
Sbjct: 16 FQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVL-LCRDKVTHVERAIKIIRKTS 74
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---S 398
++ + E+ +L + H ++ L + + L+ + GG L + + R +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 399 EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAK 455
E DA II G+ YLH I+HRD+K N+LL + + ++ DFGL+
Sbjct: 135 EV---DAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 456 LLEDEESHITTIVAGTFGYLAP 477
+ E+++ + + GT Y+AP
Sbjct: 188 VFENQKK-MKERL-GTAYYIAP 207
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 35/172 (20%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 124 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAP 477
+H D+K +N L+ G L ++ DFG+A ++ + + + + V G Y+ P
Sbjct: 177 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPP 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 7e-23
Identities = 55/178 (30%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K G +A K I K G R ERE+ IL I+H ++
Sbjct: 13 LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L E+ +E +A + G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED---EAT-QFLKQILDGVHYLH-- 125
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S RI H D+K NI+L N ++ DFG+A +E I GT ++AP
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTPEFVAP 180
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-23
Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 17/178 (9%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALKRIDKLNEGFD- 347
G + S++D + E ++ IG G FG V++ + M N A+K
Sbjct: 1 GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSD 57
Query: 348 ---RFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDW 403
F +E + H ++V L G +P +I + G L L R LD
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDL 115
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ + + LAYL S R +HRDI + N+L+ N ++ DFGL++ +ED
Sbjct: 116 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 9/167 (5%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHRYL 365
+IG+G FG VYK L G I L G+ F E I+G H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ L G + ++I +++ G+LD+ L E+ + + ++ G A G+ YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
+HRD+ + NIL++ NL +VSDFGL+++LED+ T G
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNL 368
IGSG FG V+ ++ V A+K + EG + F E E E++ + H LV L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKV-AIK---TIREGAMSEEDFIE-EAEVMMKLSHPKLVQL 68
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C L+ +F+ G L + L + + L + + +G+AYL +
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 125
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
IHRD+ + N L+ N +VSDFG+ + + D++
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 25/188 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLR 369
++ GGF VY A D G +ALKR+ E +R +E+ + + H +V
Sbjct: 34 RVLAEGGFAFVY-EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 370 GYC-------NSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
++ ++ L+ L G L E L + + L D L I + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA----------- 469
H P IIHRD+K N+LL ++ DFG A + + +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 470 GTFGYLAP 477
T Y P
Sbjct: 212 TTPMYRTP 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 33/187 (17%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELE 355
D I IG G FG V + D ++A+K ++K + ER EL+
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQ 67
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLD-WDARL---NII 410
I+ ++H +LVNL Y + ++ D L GG L L +++ +L ++
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELV 125
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
M L YL + RIIHRD+K NILLD + ++DF +A +L E T +AG
Sbjct: 126 MA----LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAG 176
Query: 471 TFGYLAP 477
T Y+AP
Sbjct: 177 TKPYMAP 183
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 25/178 (14%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K + G +A K I K G R ERE+ IL + H ++
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L ++ SE+ +A + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---EAT-SFIKQILDGVNYLH-- 132
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ +I H D+K NI+L ++ DFGLA +ED + GT ++AP
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAP 187
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF--ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
D ++G+G FG V L + A+K L G+ R F E I+G H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++ L G +++ +++ GSLD L + Q + ++ G A G+ YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
+HRD+ + NIL++ NL +VSDFGL ++LED+ T G
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF--ALKRIDKLNEGFDRF----FERELEILGSIKHR 363
+ I+G G FG VY+ G A+K + F E I+ ++ H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 364 YLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V L G PT +I + P G L L L + + K +AYL
Sbjct: 74 HIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S +HRDI NIL+ ++ DFGL++ +EDE+
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 16/191 (8%)
Query: 296 PYSSKDIIKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF 349
Y + + K + + D +G+G FG V++ + GN FA K + +E
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKET 200
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL-DEALHERSEQLDWDARLN 408
+E++ + ++H LVNL ++IY+F+ GG L ++ E ++ + +A
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-E 259
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITT 466
+ KGL ++H +H D+K NI+ + DFGL L+ ++S
Sbjct: 260 YMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VK 314
Query: 467 IVAGTFGYLAP 477
+ GT + AP
Sbjct: 315 VTTGTAEFAAP 325
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 38/182 (20%)
Query: 315 IGSGGFGTVYKLAMD---DGNVFALK--RID-KLNEGFDRFFERELEILGSIKHRYLVNL 368
+G GG TVY A D + V A+K I + E + FERE+ + H+ +V+
Sbjct: 19 LGGGGMSTVYL-AEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 369 RGYCNSPTSKLLIYD-------------FLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
+ D ++ G +L E + L D +N
Sbjct: 76 ------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILD 122
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
G+ + H RI+HRDIK NIL+D N ++ DFG+AK L + T V GT Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 476 AP 477
+P
Sbjct: 180 SP 181
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 27/180 (15%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHR 363
+GSG G V LA + A+K I K E E+EIL + H
Sbjct: 17 TLGSGACGEVK-LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYL 420
++ ++ + ++ ++ + + GG L + + E + + YL
Sbjct: 76 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYL 130
Query: 421 HHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H IIHRD+K N+LL + + +++DFG +K+L + + T+ GT YLAP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAP 185
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 35/191 (18%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEI-LGSI 360
K + L+ +G G +G V K G + A+KRI +N + +L+I + ++
Sbjct: 5 KADDLEPIMELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 361 KHRYLVNLRG-------------YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL 407
+ V G ++ K G ++ E + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI------------L 111
Query: 408 NIIMGAA-KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
I + K L +LH +IHRD+K SN+L++ + ++ DFG++ L D
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKD 167
Query: 467 IVAGTFGYLAP 477
I AG Y+AP
Sbjct: 168 IDAGCKPYMAP 178
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 35/170 (20%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG V++ + + K + ++E+ IL +HR +++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV-KKEISILNIARHRNILHLHESFE 71
Query: 374 SPTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S ++I++F+ G + E ++ +E+ + + + + L +LH S I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNER---EIV-SYVHQVCEALQFLH---SHNIG 124
Query: 430 HRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H DI+ NI+ + + +FG A+ L+ ++ + Y AP
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAP 172
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRF 349
+ +S+ + + ++G G FG V L D G A+K I K +
Sbjct: 17 VQHSTAIFSDRYKG---QRVLGKGSFGEVI-LCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDAR 406
RE+++L + H ++ L + L+ + GG L + + R SE DA
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAA 129
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH 463
II G+ Y+H +I+HRD+K N+LL + R+ DFGL+ E +
Sbjct: 130 -RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184
Query: 464 ITTIVAGTFGYLAP 477
+ + GT Y+AP
Sbjct: 185 MKDKI-GTAYYIAP 197
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 4e-22
Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 17/159 (10%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVF---ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
IG G FG V++ + M N A+K F +E + H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 364 YLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V L G +P +I + G L L R LD + + + LAYL
Sbjct: 452 HIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE- 508
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S R +HRDI + N+L+ N ++ DFGL++ +ED
Sbjct: 509 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 6/150 (4%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V +V A+K I + + D F E E +++ ++ H LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLYGV 87
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
C +I +++ G L L E + L + + + YL S + +HR
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
D+ + N L++ +VSDFGL++ + D+E
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 20/200 (10%), Positives = 40/200 (20%), Gaps = 44/200 (22%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+ G V+ L D FALK + +
Sbjct: 69 PLRVGDRSVVF-LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 369 RGYCN--------------------------SPTSKLLIYDFLPG-----GSLDEALHER 397
R + + LL+ S + ++
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 398 SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
A + + A L S ++H N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 458 EDEESHITTIVAGTFGYLAP 477
+ + Y
Sbjct: 243 --KVGTRGPASSVPVTYAPR 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 312 DHIIGSGGFGTVYKLAMD---DGNVFALK--RID-KLNEGFDRFFERELEILGSIKHRYL 365
I+G GG V+ A D +V A+K R D + F F RE + ++ H +
Sbjct: 17 GEILGFGGMSEVHL-ARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 366 VNLRGYCNSPTSKLLIY----DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
V + + T + +++ G +L + +H + + +I A + L + H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 133
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--IVAGTFGYLAP 477
+ IIHRD+K +NI++ +V DFG+A+ + D + +T V GT YL+P
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+GSG FG V +V A+K I + + D FF+ E + + + H LV G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGV 71
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
C+ ++ +++ G L L + L+ L + +G+A+L S + IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
D+ + N L+D +L +VSDFG+ + + D++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 13/168 (7%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNEGFDRFFEREL 354
I + + +IG G FG VY +D+ V +L RI + E F E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 77
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLL-IYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
I+ H +++L G C L + ++ G L + + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
AKG+ YL S + +HRD+ + N +LD +V+DFGLA+ + D+E
Sbjct: 138 AKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 35/201 (17%)
Query: 302 IIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-------------L 342
+ KK + + +GSG +G V L + + A+K I K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVL-LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 343 NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SE 399
E F E+ +L S+ H ++ L L+ +F GG L E + R E
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE 145
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKL 456
DA NI+ G+ YLH I+HRDIK NILL + L ++ DFGL+
Sbjct: 146 C---DAA-NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 457 LEDEESHITTIVAGTFGYLAP 477
+ + + GT Y+AP
Sbjct: 199 FSKDYK-LRDRL-GTAYYIAP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+ +IG G FG VY +D+ V +L RI + E F E I+ H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPN 151
Query: 365 LVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+++L G C S S L++ ++ G L + + + + AKG+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 209
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
S + +HRD+ + N +LD +V+DFGLA+ + D+E
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 18/183 (9%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEI-LGSI 360
E L D IG G +G+V K + G + A+KRI ++E + +L++ + S
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------IIMGAA 414
Y+V G + + + S D+ LD + I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD--DVIPEEILGKITLATV 135
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
K L +L + +IIHRDIK SNILLD + ++ DFG++ L D S T AG Y
Sbjct: 136 KALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPY 191
Query: 475 LAP 477
+AP
Sbjct: 192 MAP 194
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 294 DLPYSSKD--IIKKLETLDDDHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNE 344
L KD I + D +IG G FG VY +D + +L RI ++ +
Sbjct: 6 ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ 65
Query: 345 GFDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYDFLPGGSLDEALHERSEQLDW 403
F RE ++ + H ++ L G P ++ ++ G L + +
Sbjct: 66 VEA--FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
++ + A+G+ YL + +HRD+ + N +LD + +V+DFGLA+ + D E
Sbjct: 124 KDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFER 352
Y ++ + ++G G FG V D +A+K I+K R
Sbjct: 15 YFQGTFAERYNIVC---MLGKGSFGEVL-KCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNI 409
E+E+L + H ++ L +S ++ + GG L + + +R SE DA I
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAA-RI 126
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITT 466
I G+ Y+H I+HRD+K NILL + + + ++ DFGL+ + +
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182
Query: 467 IVAGTFGYLAP 477
+ GT Y+AP
Sbjct: 183 RI-GTAYYIAP 192
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 18/121 (14%), Positives = 45/121 (37%), Gaps = 10/121 (8%)
Query: 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF--------YGEIPSELGNCTELQGLS 126
+ + N + L L +++ +N+ N + ++ ++Q +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 127 LQSNYL-SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
+ N L + + + L + L L+ N L P+ G +L + N++ N +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPA 370
Query: 186 S 186
+
Sbjct: 371 N 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 28/224 (12%), Positives = 60/224 (26%), Gaps = 46/224 (20%)
Query: 21 IIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWK------------GVKC 68
I ++++ D AL A+ + + NW GV
Sbjct: 20 IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGF--GTQPGANWNFNKELDMWGAQPGVSL 77
Query: 69 DKNKRVITLSLTNHKLSGPISAD----------------------------LGKLDQLKF 100
+ N RV LSL SG + + +
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 101 LNLHSNNFYGEIPSELG--NCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSD 158
++ + ++L + S+ SI + SN+++
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT- 196
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGN 201
++ ++ +L +L F + N+ V + +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 21/118 (17%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ------ 128
++ L +KL+ L L ++L N+F + P++ N + L+G ++
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
N P + +L L I SN + + + + ++ +N + S
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 4/107 (3%)
Query: 81 NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL 140
N+ + P+ L K+ +L L N G++P G+ +L L+L N ++ +
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFC 373
Query: 141 GNLSNLLNLDISSNSLSDYIPPSL--GKLQRLITFNVSNNFLVGAIP 185
G + NL + N L IP + + + S N +
Sbjct: 374 GFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 16/148 (10%), Positives = 43/148 (29%), Gaps = 20/148 (13%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+I + + I + + SNN + + T+L+ + ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPF 218
Query: 133 SG-------------------SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITF 173
+ + NL +L ++++ + +P L L +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 174 NVSNNFLVGAIPSDGVLTKFSESSFFGN 201
NV+ N + +++
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 27/132 (20%), Positives = 46/132 (34%), Gaps = 17/132 (12%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-------YGEIPSELGNCTEL 122
K V +++L+N+++S L +NL N + N L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 123 QGLSLQSNYLSGSIPSEL--GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN--- 177
+ L+ N L+ + + L L+ +D+S NS S P L F + N
Sbjct: 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRD 548
Query: 178 ---NFLVGAIPS 186
N + P
Sbjct: 549 AQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 19/133 (14%), Positives = 42/133 (31%), Gaps = 16/133 (12%)
Query: 77 LSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYG-------EIPSELGNCTELQGLSLQ 128
LS ++KL P D + + ++ N + + ++L
Sbjct: 382 LSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSD-------YIPPSLGKLQRLITFNVSNNFLV 181
+N +S S L ++++ N L++ + L + ++ N L
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 182 GAIPSDGVLTKFS 194
+ D T
Sbjct: 502 K-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 17/109 (15%), Positives = 32/109 (29%), Gaps = 11/109 (10%)
Query: 86 GPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYLSGSIPSELGNL 143
+ + L ++L N ++ + L G+ L N S P++ N
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 144 SNL------LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S L D N P + L + +N + +
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 17/109 (15%), Positives = 32/109 (29%), Gaps = 10/109 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH------SNNFYGEIPSELGNCTELQGLSLQS 129
+ L+ + S LK + N E P + C L L + S
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
N + + ++ N+ LDI N + + + +
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 17/107 (15%), Positives = 31/107 (28%), Gaps = 4/107 (3%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS---- 157
N + + + L + + GLSL+ SG +P +G L+ L L + S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
+ P + FS+
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 8/82 (9%), Positives = 23/82 (28%), Gaps = 3/82 (3%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
++ + L L + SN+ ++ ++ + L ++ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISID 603
Query: 137 PSELGNLSNLLNLDISSNSLSD 158
S + + + D
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQD 625
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K + G +A K I K G R ERE+ IL I+H ++
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L E+ +E+ +A + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE---EAT-EFLKQILNGVYYLH-- 131
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S +I H D+K NI+L ++ DFGLA ++ + GT ++AP
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 20/171 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE--RELEILGSIKHRYLVNLRG 370
IGSG V A A+KRI+ L + E +E++ + H +V+
Sbjct: 23 IGSGATAVVQA-AYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 371 -YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL-------NIIMGAAKGLAYLH 421
+ +L L+ L GGS+ + + + + + + I+ +GL YLH
Sbjct: 81 SFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
IHRD+K+ NILL + +++DFG++ L V TF
Sbjct: 139 ---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G FG V+ V A+K + + F + E +++ ++H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV 247
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P ++ +++ GSL + L + + L +++ A G+AY+ +
Sbjct: 248 VSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
HRD++++NIL+ NL +V+DFGLA+L+ED E
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 22/112 (19%), Positives = 39/112 (34%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L + + L L L N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LS+L L +L+ +G L+ L NV++N + +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 23/113 (20%), Positives = 46/113 (40%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L L+ + + +S++ L+QL+ L+ +N S + L L + +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPS 186
+ LS+L L ++ NS + P +L+ L ++S L P+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 26/116 (22%), Positives = 37/116 (31%), Gaps = 2/116 (1%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ LS G S LK+L+L N + S +L+ L Q + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 133 SGSIP-SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
S +L NL+ LDIS L L ++ N D
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 22/113 (19%), Positives = 36/113 (31%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + + D +L L FL+L P+ + + LQ L++ N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR-LITFNVSNNFLVGAIPS 186
L++L LD S N + L L N++ N
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 3/119 (2%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C + IT I +L K L+L N + ELQ L L
Sbjct: 3 CVEVVPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ +LS+L L ++ N + + L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 26/149 (17%), Positives = 47/149 (31%), Gaps = 10/149 (6%)
Query: 81 NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ----GLSLQSNYLSGSI 136
N S + L L+ L+L SN ++L ++ L L N ++
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
P + L L + +N S + + L L + L KF +
Sbjct: 194 PGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN----LEKFDK 248
Query: 196 SSFFGNRGLCGKQINVTCKNDSGGSTTDS 224
S+ G L ++ + + D
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 22/119 (18%), Positives = 38/119 (31%), Gaps = 9/119 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ SL + + D + L L + F +L + L G
Sbjct: 286 SFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGG 338
Query: 136 IPSELGNLSNLLNLDISSNSLS--DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+L +L LD+S N LS S L ++S N ++ + L +
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 21/121 (17%), Positives = 35/121 (28%), Gaps = 12/121 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGE------IPSELGNCTEL 122
K R+ L+L N+ S + + L L+ L F E S L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 123 QGLSLQSNYLSGS---IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
+ YL I L+N+ + + S ++ + N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 180 L 180
Sbjct: 316 F 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 15/108 (13%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC-TELQGLSLQSN 130
+ L+++++ + L+ L+ L+ N+ EL + + L L+L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 131 YLSGSIPSE--LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176
+ + + L + + L + + P + +++ N++
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK-QGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 9/113 (7%)
Query: 73 RVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNN------FYGEIPSELGNCTELQGL 125
V L L + G + D L+ L L + + +I T +
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
SL S + +L++ + + L L+RL +
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 28/207 (13%), Positives = 52/207 (25%), Gaps = 41/207 (19%)
Query: 308 TLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER------ELEILGS 359
TL ++G A D G F + ++ L +L
Sbjct: 79 TLVRGTVLGQEDPYAYL-EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 360 IKHRYLVNLRGYCNSPTSKL------LIYDFLP--------------------GGSLDEA 393
IK++ + P + + + E
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 394 LHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450
L + L ARL + + + LA LH ++H ++ +I+LD ++
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 451 FGLAKLLEDEESHITTIVAGTFGYLAP 477
F A
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAE 281
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 25/180 (13%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRG 370
++G G V ++ +A+K I+K RE+E+L + HR ++ L
Sbjct: 20 VLGEGAHARVQ-TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+ L+++ + GGS+ +H+R +E +A ++ A L +LH +
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EAS-VVVQDVASALDFLH---NKG 131
Query: 428 IIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH-------ITTIVAGTFGYLAP 477
I HRD+K NIL + ++ DF L ++ + T G+ Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 36/190 (18%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSI-KHRYLVNLRG 370
IGSG FG+V+K + DG ++A+KR K ++ RE+ + +H ++V
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 371 YCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
+ +LI ++ GGSL +A+ E ++++ +GL Y+H S
Sbjct: 79 -AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 427 RIIHRDIKSSNILLDGN-------------------LEARVSDFGLAKLLEDEESHITTI 467
++H DIK SNI + + ++ D G + +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191
Query: 468 VAGTFGYLAP 477
G +LA
Sbjct: 192 --GDSRFLAN 199
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 6e-21
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G FG V+ V A+K + + F + E +++ ++H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV 330
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P ++ +++ GSL + L + L +++ A G+AY+ +
Sbjct: 331 VSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
HRD++++NIL+ NL +V+DFGLA+L+ED E
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 28/194 (14%)
Query: 302 IIKKLETLDD-----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFER 352
+ +E ++ +G G F V + + G +A K + K +
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILH 77
Query: 353 ELEILGSIKHR-YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-----SEQLDWDAR 406
E+ +L K ++NL + + +LI ++ GG + SE D
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN---DVI 134
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH 463
+I +G+ YLH I+H D+K NILL + ++ DFG+++ +
Sbjct: 135 -RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 464 ITTIVAGTFGYLAP 477
+ I+ GT YLAP
Sbjct: 190 LREIM-GTPEYLAP 202
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 7e-21
Identities = 57/176 (32%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALK-----RIDKLNEGFDRFFERE-LEILGSIKHRYL 365
IIG GGFG VY D G ++A+K RI ER L ++ + ++
Sbjct: 196 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 366 VNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
V + Y KL I D + GG L L + + D R II+G L ++H
Sbjct: 255 VCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMH 309
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ +++RD+K +NILLD + R+SD GLA ++ H V GT GY+AP
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAP 359
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 290 MFHGDLPYSSKDIIKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDK-- 341
M H S ++ + T+DD +GSG FG V+ L + G +K I+K
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVH-LVEERSSGLERVIKTINKDR 59
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL 401
++ E E+E+L S+ H ++ + + ++ + GG L E + +
Sbjct: 60 SQVPMEQI-EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG 118
Query: 402 DW----DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLA 454
++ LAY H S ++H+D+K NIL + ++ DFGLA
Sbjct: 119 KALSEGYVA-ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 455 KLLEDEESHITTIVAGTFGYLAP 477
+L + +E H T GT Y+AP
Sbjct: 175 ELFKSDE-HSTNAA-GTALYMAP 195
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 8e-21
Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 20/180 (11%)
Query: 312 DHIIGSGGFGTVYKLA--MDDGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNL 368
+G+GGFG V D G A+K+ + L+ + E++I+ + H +V+
Sbjct: 19 KERLGTGGFGYVL-RWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 369 ------RGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQLDWDARLNIIMGAAKGLAYL 420
LL ++ GG L + L E L ++ + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEAR---VSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H RIIHRD+K NI+L + + D G AK L+ E T V GT YLAP
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV-GTLQYLAP 192
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 34/166 (20%), Positives = 71/166 (42%), Gaps = 19/166 (11%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVF-------ALKRIDKLNEGFDRFFERELEILGSIKHR 363
+ +G G F ++K + + G+ LK +DK + + F ++ + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+LV G C +L+ +F+ GSLD L + ++ +L + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-- 130
Query: 424 CSPRIIHRDIKSSNILLDG--------NLEARVSDFGLAKLLEDEE 461
+IH ++ + NILL ++SD G++ + ++
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
H +G G +G VY+ + A+K + + + F + E ++ IKH LV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGV 284
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C +I +F+ G+L + L E + Q + L + + + YL IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
R++ + N L+ N +V+DFGL++L+ +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 38/183 (20%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+IG+G FG V++ + + + A+K++ DK RF REL+I+ +KH +V+L+ +
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAF 100
Query: 372 CNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----------K 415
S K L+ +++P E ++ A+L M +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVP-----ETVYRA---SRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
LAY+H S I HRDIK N+LLD ++ DFG AK+L E +++ I + Y
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYY 207
Query: 475 LAP 477
AP
Sbjct: 208 RAP 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 28/229 (12%), Positives = 67/229 (29%), Gaps = 47/229 (20%)
Query: 287 SIVMFHGDLPYSSKDII-KKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN 343
S +++ P+ + + ++ TL ++G A D G F +
Sbjct: 52 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL-EATDQETGESFEVHVPYFTE 110
Query: 344 EGFDRFFER----------------------------ELEILGSIKHRYLVNLRGYCNSP 375
++ +++ + + ++ +R
Sbjct: 111 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 170
Query: 376 TSK--LLIYDFLPG--GSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+Y + + E L + L ARL + + + LA LH +
Sbjct: 171 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+H ++ +I+LD ++ F + + G+ P
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSS-VSRGFEPP 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 10/145 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNLR 369
IG G FG VY A D + V A+K++ + + ++ +E+ L ++H + R
Sbjct: 62 IGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G + L+ ++ G + D L + L + GA +GLAYLH S +I
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 176
Query: 430 HRDIKSSNILLDGNLEARVSDFGLA 454
HRD+K+ NILL ++ DFG A
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHR 363
++G GGFG V+ G ++A K+++K R +R E +IL + R
Sbjct: 192 VLGRGGFGEVF-ACQMKATGKLYACKKLNK-----KRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDW----DARL---NIIMGAAK 415
++V+L Y + L L+ + GG + ++ E A I+
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---- 300
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GL +LH II+RD+K N+LLD + R+SD GLA L+ ++ GT G++
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFM 356
Query: 476 AP 477
AP
Sbjct: 357 AP 358
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNL 368
H +G G +G VY+ + A+K L E + F + E ++ IKH LV L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLK-EAAVMKEIKHPNLVQL 74
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C +I +F+ G+L + L E +++ L + + + YL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
IHRD+ + N L+ N +V+DFGL++L+ +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 10/189 (5%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRF 349
G L + ++ L++ +GSG G V+K G+V A+K++ N+ ++
Sbjct: 11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWK-MRFRKTGHVIAVKQMRRSGNKEENKR 69
Query: 350 FERELEIL-GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
+L+++ S Y+V G + T + + + G ++ +
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK 128
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
+ + K L YL +IHRD+K SNILLD + ++ DFG++ L D
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRS 184
Query: 469 AGTFGYLAP 477
AG Y+AP
Sbjct: 185 AGCAAYMAP 193
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V+ V A+K + + + D F E ++ ++H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P +I +++ GSL + L S +L + L++ A+G+A++ I
Sbjct: 77 VTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
HRD++++NIL+ L +++DFGLA+L+ED E
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-20
Identities = 30/113 (26%), Positives = 49/113 (43%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
+ L+LT+++L +A+ + QL L++ N P L+ L+LQ N LS
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+NL L + SNS+ K + LIT ++S+N L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 30/112 (26%), Positives = 44/112 (39%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L + + +S KL LK LNL N CT L L L SN +
Sbjct: 53 SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ NL+ LD+S N LS + +L+ L +SNN + +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 2/114 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L ++ + + K L L+L N LQ L L +N +
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 136 IPSELGNLSN--LLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
EL +N L L++SSN + ++ P + RL ++N L ++
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L+LT +K+S S L L+ L+L N E+ E + + L N
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 135 SIPSELGNLSNLLNLDISSNSLS--DYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ + +L L + +L D P L+ L ++SNN +
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 8/119 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNN--------FYGEIPSELGNCTELQGLSL 127
L L+N+ ++ L L++L+ L+L NN G L + L L+L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+SN +L L +D+ N+L+ L + N+ N +
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 2/114 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L +++LS L L+L SN+ + L L L N LS +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLG--KLQRLITFNVSNNFLVGAIPSD 187
L NL L +S+N + L L +S+N + P
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 9/137 (6%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
K + L L+ + L+ + L QL++ L NN L ++ L+L+
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 130 NYLSGSI---------PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ SI L L +L++ N + L L ++SN+F
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 181 VGAIPSDGVLTKFSESS 197
++ + S
Sbjct: 366 SLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 28/137 (20%), Positives = 44/137 (32%), Gaps = 4/137 (2%)
Query: 78 SLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP 137
L H G L L L LNL SN F + EL+ + L N L+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 138 SELGNLSNLLNLDISSNSLSDYIPPSLGK-LQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
S N +L +L++ N ++ G + L ++ N S +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 197 SFFGNRGLCGKQINVTC 213
+ L + C
Sbjct: 638 THTNIPELSS---HYLC 651
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 23/120 (19%), Positives = 36/120 (30%), Gaps = 10/120 (8%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSG 134
+ L+ +K + L+ L L PS L L L +N ++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 135 SIPSELGNLSNLLNLDISSNSLSD--------YIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L L L LD+ N+L+ L L L N+ +N
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 26/122 (21%), Positives = 51/122 (41%), Gaps = 5/122 (4%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG---NCTELQGLS 126
N + L L+++++ + +L L L++ + +L T ++ LS
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 127 LQSNYLSGSIPSELGNL--SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI 184
L ++ LS + + L +NL LD+S N+L+ S L +L F + N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 185 PS 186
Sbjct: 289 SH 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 28/128 (21%), Positives = 43/128 (33%), Gaps = 11/128 (8%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
N + LSL+N +LS + L L L+L NN +L+ L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 128 QSNYLSGSIPSELGNLS---------NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N + L L + IS SL S L+ L N+ +N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339
Query: 179 FLVGAIPS 186
+ G +
Sbjct: 340 DIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 76 TLSLTNHKLSGPISADLG--KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
L L+N+K+ S +L LK L L SN P L GL L + L
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208
Query: 134 GSIPSELG---NLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVGAIPS 186
S+ +L +++ NL +S++ LS + L+ L ++S N L
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 28/122 (22%), Positives = 42/122 (34%), Gaps = 8/122 (6%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ + L K + L L L+L +NN L +L+ L LQ N L
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 133 S--------GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI 184
+ G L LS+L L++ SN + L L ++ N L
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLP 576
Query: 185 PS 186
S
Sbjct: 577 AS 578
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 18/99 (18%), Positives = 26/99 (26%), Gaps = 1/99 (1%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP-SELGNLSNLLNLDISSNS 155
L LNL N L+ L L N + + E L N+ + +S N
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 156 LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFS 194
S + L + L S
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-----YGEIPSELGNCTELQGLSLQSN 130
L++ ++ + G S L LK+L+L ++ E L + + L L+L N
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKN 391
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
+S L +L LD+ N + + L+ + +S N + +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 22/149 (14%), Positives = 42/149 (28%), Gaps = 37/149 (24%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---------PSELGNCTELQGLS 126
L + + S L L +++LNL + I L+ L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISS----------------------------NSLSD 158
++ N + G + L NL L +S+ N +S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ L L ++ N + +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 13/69 (18%), Positives = 28/69 (40%), Gaps = 4/69 (5%)
Query: 119 CT-ELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177
CT + L+ +P +L +N+ L+++ N L + + +L + +V
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 178 NFLVGAIPS 186
N + P
Sbjct: 59 NTISKLEPE 67
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 8/112 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSN 130
+ + L + L+ ++ LK LNL N G L L ++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 131 YLSGSIPSELG-----NLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177
+ S N ++ ++SS+ L + PP + F+ S+
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHY-HGFPVRLFDTSS 669
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V+ V A+K + + + F E ++ +++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 251
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P +I +F+ GSL + L + ++ A+G+A++ I
Sbjct: 252 VTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
HRD++++NIL+ +L +++DFGLA+++ED E
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 37/175 (21%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+IG+G FG VY+ D G + A+K++ DK RF REL+I+ + H +V LR
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRY 114
Query: 371 YCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA---------- 414
+ S K L+ D++P E ++ +R +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP-----ETVYRV---ARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAKLLEDEESHITTIV 468
+ LAY+H S I HRDIK N+LLD + ++ DFG AK L E +++ I
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + + + VFA+K ++K L F E ++L + +++ L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
Y + L L+ D+ GG L L + ++L + AR +++ + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH--- 192
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK NIL+D N R++DFG L ++ + +++ GT Y++P
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 33/188 (17%), Positives = 60/188 (31%), Gaps = 25/188 (13%)
Query: 312 DHIIGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
H++G G F VY+ + F LK N + +E L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLH 421
+ +L+ + G+L A++ + + ++ M + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 422 HDCSPRIIHRDIKSSNILL-----------DGNLEARVSDFGLAKLLE-DEESHITTIVA 469
IIH DIK N +L D + + D G + ++ + I T
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 470 GTFGYLAP 477
T G+
Sbjct: 247 ETSGFQCV 254
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 32/197 (16%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERE 353
P K + L ++G G G V + G ALK + + +E
Sbjct: 19 PEPKKYAVTDDYQLSKQ-VLGLGVNGKVLE-CFHRRTGQKCALKLLYDSPK-----ARQE 71
Query: 354 LEILGSI-KHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHER-----SEQLDW 403
++ ++V + + L+I + + GG L + ER +E+
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER--- 128
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460
+A I+ + +LH S I HRD+K N+L + + +++DFG AK
Sbjct: 129 EAA-EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 461 ESHITTIVAGTFGYLAP 477
+ T T Y+AP
Sbjct: 185 A--LQTPC-YTPYYVAP 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G F V + M G V+A+K ++K L G F E ++L + R++ L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
+ + L L+ ++ GG L L + E++ + AR I+M + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH--- 179
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRDIK NILLD R++DFG L + + + + GT YL+P
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 9e-20
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +GTV+K A + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 10 IGEGTYGTVFK-AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+S L+++F L + + LD + + + KGL + H ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K N+L++ N E ++++FGLA+ + V T Y P
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 28/178 (15%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHR 363
++G GGFG V G ++A K+++K R +R E +IL + R
Sbjct: 191 VLGKGGFGEVC-ACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSR 244
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAY 419
++V+L Y L L+ + GG L ++ + +AR + AA+ GL
Sbjct: 245 FVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAEICCGLED 301
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH RI++RD+K NILLD + R+SD GLA + + ++ GT GY+AP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAP 354
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G V+K + G + A+K+ + + + RE+ +L +KH LVNL
Sbjct: 11 IGEGSYGVVFK-CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L++++ ++ L + +I + + + H IH
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIH 125
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K NIL+ + ++ DFG A+LL + VA T Y +P
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSP 171
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 1e-19
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 13/128 (10%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
+ K L L + L++ ++P L + ELQ L++ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 135 --------SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAI 184
+ + + + N+L + P S L K+ +L + +N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 185 PSDGVLTK 192
+ G K
Sbjct: 589 EAFGTNVK 596
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 29/213 (13%), Positives = 62/213 (29%), Gaps = 42/213 (19%)
Query: 21 IIINKSRAINSDGEALLSFRTAVVSSD-GFLNQWRPEDPDPCNWK------------GVK 67
I + ++ D +AL + A+ + + + NW GV
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
D N RV LSL G + +G+L +LK L+ +++
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSLSD---------------------------- 158
+ + + L L D+ ++++
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
+I ++ +L +L +N+ +
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWED 471
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 20/126 (15%), Positives = 36/126 (28%), Gaps = 15/126 (11%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ N + A + N Y N +L + L +
Sbjct: 452 IIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 136 IPSELGNLSNLLNLDISSNSLSDY---------IPPSLGKLQRLITFNVSNNFLVGAIPS 186
+P L +L L +L+I+ N + ++ F + N L P+
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPA 565
Query: 187 DGVLTK 192
L K
Sbjct: 566 SASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 23/132 (17%), Positives = 44/132 (33%), Gaps = 17/132 (12%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-------YGEIPSELGNCTEL 122
K T++L+ +++ + + + L +N N L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 123 QGLSLQSNYLSGSIPSEL--GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN------ 174
+ L+ N L+ S+ + L L N+D+S N S P +L F
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 175 VSNNFLVGAIPS 186
N ++ P+
Sbjct: 789 AEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 16/120 (13%), Positives = 47/120 (39%), Gaps = 6/120 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
+ ++++ IS + +L +L+ + ++ F + + + + +
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENE 483
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
NL +L ++++ + +P L L L + N++ N + A T+ ++
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-16
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
+ + L P SA L K+ +L L+ N G +L L L N +
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE- 608
Query: 135 SIPSELG-NLSNLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPS 186
IP + + L S N L IP + + + + + S N + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 17/126 (13%)
Query: 70 KNKRVITLSLTNHKLS-------GPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCT 120
+ T+ L+N+ ++ P + L ++L N + +
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLP 753
Query: 121 ELQGLSLQSNYLSGSIPSELGNLSNL------LNLDISSNSLSDYIPPSLGKLQRLITFN 174
L + + N S S P++ N S L D N + P + LI
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 175 VSNNFL 180
+ +N +
Sbjct: 813 IGSNDI 818
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 17/132 (12%), Positives = 40/132 (30%), Gaps = 14/132 (10%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPS-----ELGNCTELQGLSLQS 129
L +++KL P + + + ++ N E + + ++L
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSD-------YIPPSLGKLQRLITFNVSNNFLVG 182
N + S + + +S+N ++ + L T ++ N L
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 183 AIPSDGVLTKFS 194
+ D T
Sbjct: 743 -LSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 18/109 (16%), Positives = 35/109 (32%), Gaps = 10/109 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNL------HSNNFYGEIPSELGNCTELQGLSLQS 129
+ ++ + S QLK + N + P+ + C L L + S
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
N + + +L L LDI+ N S+ + + +
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 11/82 (13%), Positives = 26/82 (31%), Gaps = 5/82 (6%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL-SGS 135
+++ + L L + SN+ ++ +L +L L + N S
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISID 843
Query: 136 IPSELGNL-SNLLNLDISSNSL 156
+ S + + + L
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQD 865
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 19/174 (10%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
I+G G F TV LA +A+K ++K + E + RE +++ + H + V L
Sbjct: 37 ILGEGSFSTVV-LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
+ G L + + + D R I+ L YLH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSA----LEYLH--- 147
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI-VAGTFGYLAP 477
IIHRD+K NILL+ ++ +++DFG AK+L E GT Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 17/172 (9%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + V+A+K + K + FF E +I+ ++V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCS 425
Y L ++ +++PGG L + W AR +++ L +H S
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFYTAEVVLA----LDAIH---S 186
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IHRD+K N+LLD + +++DFG + E GT Y++P
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 9/166 (5%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK A D G + ALKRI D +EG RE+ +L + H +V+L
Sbjct: 29 VGEGTYGVVYK-AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+S L+++F+ L + L E L + +G+A+ H RI+HR
Sbjct: 88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K N+L++ + +++DFGLA+ T V T Y AP
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V K + G + A+K+ ++ + RE+++L ++H LVNL
Sbjct: 33 VGEGSYGMVMK-CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C L+++F+ ++ + L LD+ + G+ + H S IIH
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIH 147
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RDIK NIL+ + ++ DFG A+ L VA T Y AP
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAP 193
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK A ++ G FALK+I +K +EG RE+ IL +KH +V L
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ +L+++ L L + L L+ + ++ G+AY H R++HR
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K N+L++ E +++DFGLA+ T + T Y AP
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G VYK A+D A+KRI + EG RE+ +L ++HR ++ L+
Sbjct: 42 LGEGTYGEVYK-AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 371 YCNSPTSKLLIYDFLPGGSLD-EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ LI+++ D + +++ + + + G+ + H S R +
Sbjct: 101 VIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCL 154
Query: 430 HRDIKSSNILLDGNLEAR-----VSDFGLAK 455
HRD+K N+LL + + + DFGLA+
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 32/192 (16%)
Query: 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILG 358
II + ++G G G V + + FALK + + RE+E+
Sbjct: 58 AIIDDYKVTSQ--VLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPK-----ARREVELHW 109
Query: 359 SI-KHRYLVNLRG-YCNSPTSKLLIY---DFLPGGSLDEALHER-----SEQLDWDARLN 408
+ ++V + Y N + + + L GG L + +R +E+ +A
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER---EAS-E 165
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHIT 465
I+ + + YLH S I HRD+K N+L N +++DFG AK S +T
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221
Query: 466 TIVAGTFGYLAP 477
T T Y+AP
Sbjct: 222 TPC-YTPYYVAP 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 42/146 (28%), Positives = 63/146 (43%), Gaps = 10/146 (6%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF-DRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V GN A+K + + F E ++ ++H LV L G
Sbjct: 27 QTIGKGEFGDVML-GDYRGNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 372 CNSPTSKLLI-YDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L I +++ GSL + L R L D L + + + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAK 455
HRD+ + N+L+ + A+VSDFGL K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 4e-19
Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A + G V ALK+I D EG RE+ +L + H +V L
Sbjct: 11 IGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 371 YCNSPTSKLLIYDFLPGGSLD-EALHERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPR 427
++ L+++FL D + + S L + + +GLA+ H R
Sbjct: 70 VIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K N+L++ +++DFGLA+ T V T Y AP
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 172
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 55/216 (25%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYL 365
IG G +G V +A++ + A+K ++K +N + E+ ++ + H +
Sbjct: 32 GAIGQGSYGVVR-VAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG------------- 412
L L+ + GG L + L+ + ++++
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 413 -------------------AAK-------GLAYLHHDCSPRIIHRDIKSSNILL--DGNL 444
+ L YLH + I HRDIK N L + +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207
Query: 445 EARVSDFGLAKLL---EDEESHITTIVAGTFGYLAP 477
E ++ DFGL+K + E + T AGT ++AP
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 8/145 (5%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V GN A+K I K + F E ++ ++H LV L G
Sbjct: 199 QTIGKGEFGDVML-GDYRGNKVAVKCI-KNDATAQAFLA-EASVMTQLRHSNLVQLLGVI 255
Query: 373 -NSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ +++ GSL + L R L D L + + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 431 RDIKSSNILLDGNLEARVSDFGLAK 455
RD+ + N+L+ + A+VSDFGL K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI-----DKLNEGFDRFFERELEILGSIKHRYLVN 367
+G G F TVYK A D + A+K+I + +G +R RE+++L + H ++
Sbjct: 18 LGEGQFATVYK-ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG-AAKGLAYLHHDCSP 426
L ++ L++DF+ L+ + + S L + + M +GL YLH
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEYLHQH--- 131
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAK 455
I+HRD+K +N+LLD N +++DFGLAK
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 43/189 (22%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEI---LGSIKHRYLV 366
+ G G FGTV + G A+K++ RF REL+I L + H +V
Sbjct: 30 MAGQGTFGTVQL-GKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 367 NLRGYCNSPTSK-------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----- 414
L+ Y + + ++ +++P + LH R +
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRC---CRNYYRRQVAPPPILIKVF 134
Query: 415 -----KGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIV 468
+ + LH S + HRDIK N+L++ + ++ DFG AK L E ++ I
Sbjct: 135 LFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 469 AGTFGYLAP 477
+ Y AP
Sbjct: 194 --SRYYRAP 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-19
Identities = 40/151 (26%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRG 370
+G+G + TVYK ++ G ALK + KL+ EG RE+ ++ +KH +V L
Sbjct: 13 LGNGTYATVYK-GLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 371 YCNSPTSKLLIYDFLPGGSLD-EALHERSEQLDWDARLNIIMGAA------KGLAYLHHD 423
++ L+++F+ D + + + L + + +GLA+ H +
Sbjct: 71 VIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
+I+HRD+K N+L++ + ++ DFGLA
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 39/185 (21%), Positives = 74/185 (40%), Gaps = 19/185 (10%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALK--RIDKLNEGF 346
+L +D++ L I+G G FG+V + + A+K ++D ++
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 347 DRFFERELEILGSIKHRYLVNLRGYC-----NSPTSKLLIYDFLPGGSLDEAL-----HE 396
F E + H ++ L G C ++I F+ G L L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
+ + L ++ A G+ YL + +HRD+ + N +L ++ V+DFGL+K
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 457 LEDEE 461
+ +
Sbjct: 197 IYSGD 201
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 36/178 (20%), Positives = 68/178 (38%), Gaps = 21/178 (11%)
Query: 315 IGSG--GFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G TV A G ++RI+ + F + EL + H +V
Sbjct: 33 IGKGFEDLMTVNL-ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 369 RG-YCNSPTSKL-LIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
R + ++L ++ F+ GS + + + ++ A I+ G K L Y+HH
Sbjct: 92 RATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-- 147
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI------VAGTFGYLAP 477
+HR +K+S+IL+ + + +S + + +L+P
Sbjct: 148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 31/185 (16%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK D +ALK+I+ G RE+ +L +KH +++L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 86
Query: 372 CNSPTSKL--LIYDFLPGGSLD--EALHERSEQLDWDARLNIIMGAAK--------GLAY 419
S + L++D+ D + + + G K G+ Y
Sbjct: 87 FLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEE---SHITTIVAGTF 472
LH + ++HRD+K +NIL+ G R ++D G A+L + + +V TF
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 473 GYLAP 477
Y AP
Sbjct: 200 WYRAP 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 9/166 (5%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G + TVYK + N+ ALK I +L EG RE+ +L +KH +V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ S L++++L L + L + ++ + +GLAY H +++HR
Sbjct: 69 IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K N+L++ E +++DFGLA+ V T Y P
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 41/164 (25%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG V+K A G ALK++ + EGF RE++IL +KH +VNL
Sbjct: 25 IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 371 YCNSPTSKL--------LIYDFL----------PGGSLDEALHERS--EQLDWDARLNII 410
C + S L++DF + + + L
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQML--------- 133
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
GL Y+H + +I+HRD+K++N+L+ + +++DFGLA
Sbjct: 134 ---LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 33/168 (19%), Positives = 68/168 (40%), Gaps = 25/168 (14%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
+G G FG VY+ + D+ A+K +NE F E ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERIEFLNEASVMKEFNC 87
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------LNIIMGA 413
++V L G + L+I + + G L L + + + +
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
A G+AYL+ + + +HRD+ + N ++ + ++ DFG+ + + + +
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 40/185 (21%), Positives = 73/185 (39%), Gaps = 20/185 (10%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALK--RIDKLNEGFD 347
+L +D++ + ++G G FG+V + + F A+K + D +
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 348 RFFERELEILGSIKHRYLVNLRGYC------NSPTSKLLIYDFLPGGSLDEAL-----HE 396
F RE + H ++ L G ++I F+ G L L E
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
L + ++ A G+ YL S IHRD+ + N +L ++ V+DFGL++
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 457 LEDEE 461
+ +
Sbjct: 187 IYSGD 191
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 45/207 (21%), Positives = 72/207 (34%), Gaps = 53/207 (25%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V + D G FALK++ + R+ REL+I+ + H ++ L Y
Sbjct: 14 TLGTGSFGIVCE-VFDIESGKRFALKKVLQ----DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------LNIIMG---------- 412
+ + P + LN+IM
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 413 ---------------------AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSD 450
+ + ++H S I HRDIK N+L++ ++ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 451 FGLAKLLEDEESHITTIVAGTFGYLAP 477
FG AK L E + I + Y AP
Sbjct: 186 FGSAKKLIPSEPSVAYIC--SRFYRAP 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 47/198 (23%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK--------------------------LNEGF 346
IG G +G V KLA +D +A+K + K G
Sbjct: 21 IGKGSYGVV-KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 347 DRFFERELEILGSIKHRYLVNLRGYCNSPT-SKL-LIYDFLPGGSL-DEALHER-SEQLD 402
+E+ IL + H +V L + P L ++++ + G + + + SE
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 403 WDARL---NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
AR ++I G + YLH +IIHRDIK SN+L+ + +++DFG++ +
Sbjct: 138 -QARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 460 EESHITTIVAGTFGYLAP 477
++ ++ GT ++AP
Sbjct: 190 SDALLSN-TVGTPAFMAP 206
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 42/168 (25%), Positives = 63/168 (37%), Gaps = 25/168 (14%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGF---DRF-FERELEILGSIKH 362
+G G FG VY+ + D + A+K L E D F E I+ H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNH 92
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL------NIIMGAAKG 416
+ +V G + ++ + + GG L L E + + L ++ A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAKLLEDEE 461
YL IHRDI + N LL RV DFG+A+ +
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 41/168 (24%), Positives = 62/168 (36%), Gaps = 25/168 (14%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
+G G FG VY+ + D + A+K L E F E I+ H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNH 133
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL------NIIMGAAKG 416
+ +V G + ++ + + GG L L E + + L ++ A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAKLLEDEE 461
YL IHRDI + N LL RV DFG+A+ +
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 29/172 (16%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF---FERELEILGSIKHR 363
+G G FG V+ L + + A+K L E + F+RE E+L ++H+
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEASESARQDFQREAELLTMLQHQ 103
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR--------------LNI 409
++V G C L++++++ G L+ L A L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
A G+ YL +HRD+ + N L+ L ++ DFG+++ + +
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 21/109 (19%), Positives = 42/109 (38%), Gaps = 1/109 (0%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ + +L + N LS + + L +L+ L+L P G L+ L L+
Sbjct: 206 QNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++P ++ L+ L LD+ +P + +L V +
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 20/111 (18%), Positives = 44/111 (39%), Gaps = 2/111 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L L + + A + L LK L + ++ + + + +L+ L L+ +
Sbjct: 187 SLRLEWTGIRS-LPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRN 244
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
P G + L L + S +P + +L +L ++ + +PS
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 22/127 (17%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ L L + L +L L+ + + + E+P + L+ L+L
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLAR 136
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK---------LQRLITFNVSNNFL 180
N L ++P+ + +L+ L L I + +P L L L + + +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 181 VGAIPSD 187
++P+
Sbjct: 196 R-SLPAS 201
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 29/121 (23%), Positives = 56/121 (46%), Gaps = 12/121 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC---------TELQGLS 126
TL+L + L + A + L++L+ L++ + E+P L + LQ L
Sbjct: 131 TLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ + S+P+ + NL NL +L I ++ LS + P++ L +L ++ + P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 187 D 187
Sbjct: 248 I 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 5/111 (4%)
Query: 78 SLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTE--LQGLSLQSNYLSGS 135
N + SA + + L + T+ L L+S L
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
P + LS+L ++ I + L + +P ++ + L T ++ N L A+P+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L G LK L L + +P ++ T+L+ L L+
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 136 IPSELGNLSNLLNLDISSNSLS---DYIPPSLGKL 167
+PS + L + + + + + P +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 10/104 (9%), Positives = 22/104 (21%), Gaps = 22/104 (21%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG-------------------SIPS 138
+ L + L + + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 139 ELGNLS--NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + + + L++ S L P +L L + L
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 23/112 (20%), Positives = 37/112 (33%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L LT ++ +L L L +N + L L+ L +S
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
L N L +L + SN +S P ++L + NN + D
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 20/111 (18%), Positives = 35/111 (31%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + + L + +L L FL+L Y + L L L +N L
Sbjct: 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ L L +L +S L + L + + +N +
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 25/124 (20%), Positives = 48/124 (38%), Gaps = 2/124 (1%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
V +++L H S L+ L+L + + E+PS L + L+ L L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDG 188
N N +L +L I N+ + L L+ L ++S++ + + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 189 VLTK 192
L
Sbjct: 371 QLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 2/129 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL LT + L L LK L L N L+ L L SN++S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL--ITFNVSNNFLVGAIPSDGVLTKF 193
+ L LD +N++ + LQ+ ++ N++ N + G P F
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 194 SESSFFGNR 202
+F G +
Sbjct: 205 QSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 18/120 (15%), Positives = 33/120 (27%), Gaps = 3/120 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLS 126
KC + + T + N L+ I L + + L N + L L
Sbjct: 7 KCIEKEVNKTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L + + L L +++N L +L + L +
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---PSELGNCTELQGLSLQSNYL 132
L+L++ L L L+ LNL N+F + L L+ L L L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S +L + ++D+S N L+ +L L+ + N+++N + +PS
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 24/115 (20%), Positives = 41/115 (35%), Gaps = 4/115 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+L+L+ ++ + + QL+ L+L + S N L+ L+L + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYI---PPSLGKLQRLITFNVSNNFLVGAIPS 186
S L L +L++ N SL L RL +S L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 24/119 (20%), Positives = 42/119 (35%), Gaps = 4/119 (3%)
Query: 72 KRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFY--GEIPSELGNCTELQGLSLQ 128
+ LS+ + + L L+ L+ L+L ++ +L N + LQ L+L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
N L LD++ L S L L N+S++ L +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPI---SADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
L+L + + L L +L+ L L + + + + L N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ S L +L + L+++SN +S +P L L + T N+ N
Sbjct: 513 TSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 1/82 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ LS L + ++L N L + + L+L SN++S
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISII 538
Query: 136 IPSELGNLSNLLNLDISSNSLS 157
+PS L LS +++ N L
Sbjct: 539 LPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 23/142 (16%), Positives = 46/142 (32%), Gaps = 13/142 (9%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K + +L L ++ +S ++LK L+ +N + ++ + + LSL N
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 132 LS-GSIPSELGNLSNLLNLDISSNSLSDYIPPSLG--KLQRLITFNVSNNFLVGAIPSDG 188
I + + +L+ I L +Q L +
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM---------- 238
Query: 189 VLTKFSESSFFGNRGLCGKQIN 210
S + F G + + IN
Sbjct: 239 DDEDISPAVFEGLCEMSVESIN 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF---FERELEILGSIKHR 363
+G G FG V+ L+ + A+K L + F+RE E+L +++H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKDFQREAELLTNLQHE 77
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------LN 408
++V G C +++++++ G L++ L L+
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
I A G+ YL S +HRD+ + N L+ NL ++ DFG+++ + +
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 31/174 (17%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEG---FDRF-FERELEILGSIKH 362
+G FG VYK A + A+K L + R F E + ++H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------L 407
+V L G +I+ + G L E L RS D + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+++ A G+ YL S ++H+D+ + N+L+ L ++SD GL + + +
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSI-KHR 363
+IG G FG V K + D + A+KR + E R F ELE+L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLN 408
++NL G C L ++ P G+L + L + + L L+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 30/176 (17%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER 352
L II + ++G G G V + FALK + + R
Sbjct: 8 LQIKKNAIIDDYKVTS--QVLGLGINGKVL-QIFNKRTQEKFALKMLQDCPK-----ARR 59
Query: 353 ELEILGSI-KHRYLVNLRG-YCNSPTSKLLIY---DFLPGGSLDEALHER-----SEQLD 402
E+E+ + ++V + Y N + + + L GG L + +R +E+
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-- 117
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAK 455
+A I+ + + YLH S I HRD+K N+L N +++DFG AK
Sbjct: 118 -EAS-EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 27/183 (14%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDK-----LNEGFDRFFERELEIL 357
LD +G+G FG V L + GN +A+K +DK L + E+ IL
Sbjct: 39 QLDQFDRIKTLGTGSFGRVM-LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR--IL 95
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAA 414
++ +LV L ++ ++ +++ GG + L + AR I++
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-- 153
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
YLH S +I+RD+K N+L+D +V+DFG AK ++ T + GT
Sbjct: 154 --FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEA 204
Query: 475 LAP 477
LAP
Sbjct: 205 LAP 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 34/197 (17%), Positives = 68/197 (34%), Gaps = 28/197 (14%)
Query: 303 IKKLETLDDDHII------GSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI 356
+K L L+ I+ + + + ++
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIY---DFLPGGSLDEALHER--SEQLDWDARLNIIM 411
+ + V + K+ +Y +L + ++ R E + L+I +
Sbjct: 115 MDPFSTKNTVG---QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA-- 469
A+ + +LH S ++HRD+K SNI + +V DFGL ++ +E T +
Sbjct: 172 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 470 ---------GTFGYLAP 477
GT Y++P
Sbjct: 229 AYATHTGQVGTKLYMSP 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVNLRG 370
+G GGFG V++ D +A+KRI N R RE++ L ++H +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 35/181 (19%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFER-------ELEILGSIKHR 363
+G G FG V+ D ++A+K + K R E +IL + H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKVRDRVRTKMERDILVEVNHP 86
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
++V L Y KL LI DFL GG L L + +E+ D + + +
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALA---- 138
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L +LH S II+RD+K NILLD +++DFGL+K D E + GT Y+A
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 194
Query: 477 P 477
P
Sbjct: 195 P 195
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 37/188 (19%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
+L D I +G+G FG V+ L +G +A+K + K + E
Sbjct: 4 SLQDFQILRTLGTGSFGRVH-LIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDER 57
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL--DWDARL---NI 409
+L + H +++ + G +I D++ GG L R Q + A+ +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEV 115
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ L YLH S II+RD+K NILLD N +++DFG AK + D +T +
Sbjct: 116 CLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLC 164
Query: 470 GTFGYLAP 477
GT Y+AP
Sbjct: 165 GTPDYIAP 172
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 31/187 (16%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
T+++ +G G FG V L G +A+K + K + + E
Sbjct: 146 TMNEFEYLKLLGKGTFGKVI-LVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTEN 199
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NII 410
+L + +H +L L+ Y +L + ++ GG L L + AR I+
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
L YLH + + +++RD+K N++LD + +++DFGL K + + + T G
Sbjct: 259 SA----LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CG 311
Query: 471 TFGYLAP 477
T YLAP
Sbjct: 312 TPEYLAP 318
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 23/112 (20%), Positives = 39/112 (34%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ + L S +L++L+L L L L N +
Sbjct: 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P L++L NL L+ +G+L L NV++NF+
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 24/106 (22%), Positives = 34/106 (32%), Gaps = 1/106 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ L L L + N+F S N T L L L L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L L L++S N+L +L L T + S N +
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 25/104 (24%), Positives = 35/104 (33%), Gaps = 1/104 (0%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL + N +S L FL+L LQ L++ N L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
S L +L LD S N + + L FN++NN
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + L L++L +L++ N + T L L + N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ S N +NL LD+S L L RL N+S+N L+ S
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 6/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
L KL+ S +G+L LK LN+ N + ++P+ N T L + L NY+
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 135 SIPSELGNLSNL----LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
++L L L+LD+S N + +I + +L + NF I
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 19/113 (16%), Positives = 38/113 (33%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L L+ + +SA+ L++L+ L+ + S + +L L +
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
L++L L ++ NS D + L ++S L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 26/120 (21%), Positives = 39/120 (32%), Gaps = 3/120 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLS 126
C + IT + KLS + D+ K ++L N N +ELQ L
Sbjct: 6 PCIEVVPNITYQCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLD 62
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L + L +L NL ++ N + + P S L L L
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 17/82 (20%), Positives = 30/82 (36%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ +L L +L+ LN+ NN S L L N + S
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 136 IPSELGNLSNLLNLDISSNSLS 157
+L ++++NS++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 28/114 (24%), Positives = 44/114 (38%), Gaps = 8/114 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+LS+ +L + DL LK L L N G I + L L L N LS S
Sbjct: 311 SLSIIRCQLKQFPTLDLP---FLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFS 365
Query: 136 IPSELGNL--SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+L ++L +LD+S N + + L+ L + ++ L
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 7/108 (6%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ LT L + ++L + + ++ + Q LS+ L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P+ +L L +L ++ N S I L L ++S N L
Sbjct: 320 K-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNAL 362
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 18/114 (15%), Positives = 37/114 (32%), Gaps = 11/114 (9%)
Query: 76 TLSLTNHKLSGPISADLGK-LDQLKFLNLHSNNFYGEIPSELGNCTELQGL--------S 126
L+L + S I + L L L F E E+ + ++GL
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L+N+ + ++ S+ + K + + ++ L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 12/123 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH---SNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ L+ + + DL L + +NL S N I + +L L+L+ N+
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN 216
Query: 133 SGSIPSE-LGNLSNLLNLDISSNSLSDYI------PPSLGKLQRL--ITFNVSNNFLVGA 183
S +I L NL+ L + D P + L + F ++
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 184 IPS 186
Sbjct: 277 DIV 279
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 19/172 (11%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V +LA++ A+K +D + + ++E+ I + H +V G
Sbjct: 15 LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYG 72
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + L ++ GG L + + + DA+ ++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLED--EESHITTIVAGTFGYLAP 477
I HRDIK N+LLD ++SDFGLA + E + + GT Y+AP
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 52/183 (28%), Positives = 77/183 (42%), Gaps = 37/183 (20%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFERELE---------ILGSIK 361
+G GG+G V+ + G +FA+K + K + IL +K
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-----AMIVRNAKDTAHTKAERNILEEVK 79
Query: 362 HRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAA 414
H ++V+L Y KL LI ++L GG L L E A I M
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISM--- 132
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
L +LH II+RD+K NI+L+ +++DFGL K + + T GT Y
Sbjct: 133 -ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEY 187
Query: 475 LAP 477
+AP
Sbjct: 188 MAP 190
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 33/162 (20%)
Query: 315 IGSGGFGTVYKLAMDD---GNVFALKRI--DKLNEGFDRFFERELEILGSIK---HRYLV 366
IG G +G V+K A D G ALKR+ EG RE+ +L ++ H +V
Sbjct: 19 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 367 NLR----GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK------ 415
L +KL L+++ + + + LD + K
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 416 --GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
GL +LH R++HRD+K NIL+ + + +++DFGLA+
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 24/173 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG +L D + A+K I++ D +RE+ S++H +V +
Sbjct: 28 IGSGNFGVA-RLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 373 NSPTSKLLIYDFLPGGSLDE--ALHER-SEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
+PT +I ++ GG L E R SE +AR ++ G ++Y H S
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLSG----VSYCH---SM 135
Query: 427 RIIHRDIKSSNILLDGNLEAR--VSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+I HRD+K N LLDG+ R + DFG +K +T+ GT Y+AP
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAP 186
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 45/186 (24%), Positives = 72/186 (38%), Gaps = 41/186 (22%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDR 348
G L + + + IG G +GTVYK A D G+ ALK + G
Sbjct: 1 GPLGSMATSRYEPVA------EIGVGAYGTVYK-ARDPHSGHFVALKSVRVPNGGGGGGG 53
Query: 349 FFE---RELEILGSIK---HRYLVNLR----GYCNSPTSKL-LIYDFLPGGSLDEALHER 397
RE+ +L ++ H +V L K+ L+++ + +
Sbjct: 54 LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL 105
Query: 398 SEQLDWDARLNIIMGAAK--------GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
LD + K GL +LH + I+HRD+K NIL+ +++
Sbjct: 106 RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162
Query: 450 DFGLAK 455
DFGLA+
Sbjct: 163 DFGLAR 168
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 40/179 (22%), Positives = 71/179 (39%), Gaps = 27/179 (15%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK----LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G +G V K +D A+K + K + ++E+++L ++H+ ++ L
Sbjct: 13 LGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 369 RG--YCNSPTSKLLIYDFLPGGS---LDEALHER-SEQLDWDAR---LNIIMGAAKGLAY 419
Y ++ ++ G LD +R A +I GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLI----DGLEY 124
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAP 477
LH S I+H+DIK N+LL ++S G+A+ L G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 35/183 (19%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFER---------ELEILGSIK 361
+G+G +G V+ D G ++A+K + K ++ E ++L I+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-----ATIVQKAKTTEHTRTERQVLEHIR 116
Query: 362 HR-YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAA 414
+LV L Y +KL LI D++ GG L H + E+ ++ I++
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL--- 170
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
L +LH II+RDIK NILLD N ++DFGL+K +E+ GT Y
Sbjct: 171 -ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 475 LAP 477
+AP
Sbjct: 227 MAP 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 19/172 (11%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V +LA++ A+K +D + + ++E+ I + H +V G
Sbjct: 15 LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYG 72
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + L ++ GG L + + + DA+ ++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLED--EESHITTIVAGTFGYLAP 477
I HRDIK N+LLD ++SDFGLA + E + + GT Y+AP
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 264 CFLYKKLGKNESK-GLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
+ YK+ K + + + G + + LPY+ K + L +G+G FG
Sbjct: 3 DYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPR-NNLQFGKTLGAGAFGK 61
Query: 323 VYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI-KHRYLVNLRGY 371
V + L +D + A+K L EL+I+ + +H +VNL G
Sbjct: 62 VVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN-----------IIMGA--AKG 416
C P L+I ++ G L L +S L+ D + + A+G
Sbjct: 119 CTHGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+A+L S IHRD+ + N+LL A++ DFGLA+ + ++
Sbjct: 177 MAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 41/182 (22%), Positives = 70/182 (38%), Gaps = 39/182 (21%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
IG G FG V++ L + A+K L E F+RE ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDN 109
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------- 406
+V L G C L+++++ G L+E L S
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 407 -------LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
L I A G+AYL + +HRD+ + N L+ N+ +++DFGL++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 460 EE 461
+
Sbjct: 227 AD 228
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G F V KLA + G A+K IDK LN + RE+ I+ + H +V L
Sbjct: 23 IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + LI ++ GG + + L + +AR I+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR--- 134
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRD+K+ N+LLD ++ +++DFG + G Y AP
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAP 182
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 34/178 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI- 360
+G+G FG V + L D + A+K L EL++L +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLG 84
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------------ 408
H +VNL G C L+I ++ G L L + +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 409 ---IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ AKG+A+L S IHRD+ + NILL ++ DFGLA+ ++++
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 39/183 (21%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIK 361
+G G FG V K L G A+K L E E +L +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVN 84
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA-------- 413
H +++ L G C+ LLI ++ GSL L E + +
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 414 ---------------AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
++G+ YL +++HRD+ + NIL+ + ++SDFGL++ +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 459 DEE 461
+E+
Sbjct: 202 EED 204
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
+G G FG V L G +A+K + K + + E +L + +H +
Sbjct: 13 LGKGTFGKVI-LVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 365 LVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAAKGLA 418
L L+ Y +L + ++ GG L H R + AR I+ L
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVS----ALE 119
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLH S +++RDIK N++LD + +++DFGL K + + + T GT YLAP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 46/179 (25%), Positives = 68/179 (37%), Gaps = 37/179 (20%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI- 360
+G G FG V + + A+K L EG EL+IL I
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIG 88
Query: 361 KHRYLVNLRGYC---NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--------- 408
H +VNL G C P ++I +F G+L L + +
Sbjct: 89 HHLNVVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 409 ----IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
I AKG+ +L S + IHRD+ + NILL ++ DFGLA+ + +
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 34/178 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V + D A+K L + E+E++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKM 96
Query: 360 I-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSL---------------DEALHERSEQLDW 403
I KH+ ++NL G C +I ++ G+L + EQ+ +
Sbjct: 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+ + + +
Sbjct: 157 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 34/178 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V + D A+K L + E+E++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKM 142
Query: 360 I-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDW 403
I KH+ ++NL G C +I ++ G+L E L R EQ+ +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+ + + +
Sbjct: 203 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 44/171 (25%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V K+ G+ A+K +++ + +RE++ L +H +++ L
Sbjct: 19 LGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
++PT ++ +++ GG L + + + + +AR I+ + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCH---RH 130
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K N+LLD ++ A+++DFGL+ ++ D E T+ G+ Y AP
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 179
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRG 370
IG G +G V A D + A+K+I R RE++IL +H ++ +
Sbjct: 35 IGEGAYGMVCS-AYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIND 92
Query: 371 YCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHD 423
+PT + ++ D + + L++ +++ L D + +GL Y+H
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIVAGTFGYLAP 477
S ++HRD+K SN+LL+ + ++ DFGLA++ + + H +T VA T Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAP 200
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 38/180 (21%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V L D N A+K L E+E++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKM 130
Query: 360 I-KHRYLVNLRGYC--NSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGA-- 413
I KH+ ++NL G C + P +I ++ G+L E L R L++ +
Sbjct: 131 IGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 414 ------------AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 17/103 (16%), Positives = 37/103 (35%), Gaps = 3/103 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + ++ +L L L L++ + I +++ ++ + L N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
I L L L +L+I + + DY + +L +
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-14
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L++ N + + + L L+ L + + + L T L L + + S
Sbjct: 70 DLTINNIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
I +++ L + ++D+S N I P L L L + N+ +
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 17/95 (17%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ +K L +++ + + + + L+ L + ++ L L++L LDI
Sbjct: 62 IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S ++ D I + L ++ + ++S N + I
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 19/111 (17%), Positives = 51/111 (45%), Gaps = 6/111 (5%)
Query: 78 SLTNHKLSGPISADL--GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ N L +A++ +++ L ++ L + N ++ + + ++ L++ + + +
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIHATNY 81
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ + LSNL L I ++ P+L L L ++S++ +I +
Sbjct: 82 --NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 14/83 (16%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L +++ I + L ++ ++L N +I L EL+ L++Q + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174
Query: 136 IPSELGNLSNLLNLDISSNSLSD 158
+ + L L S ++
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGG 195
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 49/234 (20%)
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLE----TLDDDHIIGSGGFGT 322
YKK + ES+ V G + F+ D D K E L+ ++GSG FG
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGK 60
Query: 323 VYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI-KHRYLVNLRGY 371
V ++ ++ A+K L E D EL+++ + H +VNL G
Sbjct: 61 VMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--------------------I 409
C + P LI+++ G L L + E+ D +
Sbjct: 118 CTLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 410 IMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
AKG+ +L +HRD+ + N+L+ ++ DFGLA+ + +
Sbjct: 176 CFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 28/180 (15%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFF---ERELEIL----GSIKH 362
+G GGFGTV + D A+K I + L E+ +L H
Sbjct: 39 LGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 363 RYLVNLRGYCNSPTSKLLIYDF-LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLA 418
++ L + + +L+ + LP L + + E+ E +R +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SR-CFFGQVVAAIQ 153
Query: 419 YLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ H S ++HRDIK NIL+D A++ DFG LL DE GT Y P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DF--DGTRVYSPP 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 22/171 (12%), Positives = 42/171 (24%), Gaps = 33/171 (19%)
Query: 312 DHIIGSGGFGTVYKLAMDD--GNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLV 366
G ++ A+D AL +D L + + L I +
Sbjct: 36 LIFHGGVPPLQFWQ-ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ L++ +++ GGSL E + + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ S + VS G L +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD 178
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 40/186 (21%), Positives = 68/186 (36%), Gaps = 32/186 (17%)
Query: 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFE---------RELEILGSI 360
I SG +G V +D +G A+KR+ + RE+ +L
Sbjct: 28 RFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 361 KHRYLVNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDW-DARLNIIM- 411
H ++ LR L+ + + L + +++ + M
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
GL LH ++HRD+ NILL N + + DF LA+ + +++ T V
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-H 196
Query: 472 FGYLAP 477
Y AP
Sbjct: 197 RWYRAP 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 41/187 (21%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRY 364
H+IG+G +G V + A D + V A+K+I ++ F+ R RE+ IL + H +
Sbjct: 59 HLIGTGSYGHVCE-AYDKLEKRVVAIKKILRV---FEDLIDCKRIL-REIAILNRLNHDH 113
Query: 365 LVNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQ-LDWDARLNIIMGAAKG 416
+V + + ++ + D + R+ L ++ G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
+ Y+H S I+HRD+K +N L++ + +V DFGLA+ ++ E+ + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 477 PGKDCTN 483
+
Sbjct: 226 NLVTFPH 232
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + +++S + + L +LK LN+ SN S L N ++L L L +N L
Sbjct: 247 WLEIGTNQISDINA--VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNE 302
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+G L+NL L +S N ++D P L L ++ + + +N +
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 6/110 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L + N+K++ L L QL +L + +N + + + T+L+ L++ SN +S
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD- 279
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S L NLS L +L +++N L + +G L L T +S N + P
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L++T K+ + L L L+L+ N P L + T L + N ++
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P + N++ L +L I +N ++D P L L +L + N +
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 28/121 (23%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ + L + K++ + L L++LNL+ N P L N +L L + +N
Sbjct: 44 ESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
++ S L NL+NL L ++ +++SD L L ++ + N+ N + + +T
Sbjct: 100 IT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMT 155
Query: 192 K 192
Sbjct: 156 G 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 7/114 (6%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
++ L + +K++ + L L L+ L L+ +N S L N T++ L+L +N+
Sbjct: 88 VKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH 143
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S S L N++ L L ++ + + D P + L L + +++ N + P
Sbjct: 144 NL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ L++ ++++S L L QL L L++N E +G T L L L
Sbjct: 263 DLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLS 157
N+++ P L +LS + + D ++ +
Sbjct: 321 NHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + L + + + L + ++ SI + L+NL L++
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ N ++D P L L +L + N +
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI 100
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 47/177 (26%), Positives = 68/177 (38%), Gaps = 24/177 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHRY 364
+GSG FG V A+D +K I K + + E+ IL ++H
Sbjct: 32 LGSGAFGFV-WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 365 LVNLRGYCNSPTSKLLIYDF-LPGGSLDE--ALHER-SEQLDWDARLNIIMGAAKGLAYL 420
++ + + L+ + G L H R E L A I + YL
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---AS-YIFRQLVSAVGYL 146
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
IIHRDIK NI++ + ++ DFG A LE + T GT Y AP
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAP 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFE---RELEILGSIKHR--Y 364
+GSGGFG+V + D A+K ++K + G E+ +L +
Sbjct: 51 LGSGGFGSV-YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 365 LVNLRGYCNSPTSKLLI----------YDFLPG-GSLDEALHERSEQLDWDARLNIIMGA 413
++ L + P S +LI +DF+ G+L E L AR +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----------AR-SFFWQV 158
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTF 472
+ + + H + ++HRDIK NIL+D N E ++ DFG LL+D + T GT
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFD-GTR 212
Query: 473 GYLAP 477
Y P
Sbjct: 213 VYSPP 217
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 24/104 (23%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L +++ + D L+ LNL N Y ++ ++ +L+ L L SN L+
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ E + + + + + +N L I +L Q L F++ N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
++ K + ++ + S + ++ L L N LS ++L + L L++SSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L L L T +++NN++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 24/106 (22%), Positives = 48/106 (45%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+ L N+K++ D G ++++L+L N + L+ L+LQ N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ ++ + L LD+SSN L+ + P + ++ NN L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 26/109 (23%), Positives = 48/109 (44%), Gaps = 7/109 (6%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
R +T+ L +++ +K L+L N ++L T+L+ L+L SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L +L +LS L LD+++N + L + T + +NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L N+ + +L ++ L+ +NN + G + + L +N ++
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITML 135
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ G S + LD+ N + L L N+ NF+ + V K
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L + + + + +LK L+L SN + E + + +SL++N L
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNN 178
I L NL + D+ N + K QR+ T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 17/69 (24%), Positives = 28/69 (40%)
Query: 112 IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
I N + + + L ++ S + N+ LD+S N LS L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 172 TFNVSNNFL 180
N+S+N L
Sbjct: 62 LLNLSSNVL 70
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVN 367
+GSG +G V A+D G A+K KL F REL +L ++H ++
Sbjct: 33 VGSGAYGAVCS-AVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 368 LRGYCNSPTSKL------LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAY 419
L + L+ F+ L + + E+L D ++ KGL Y
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+H + IIHRD+K N+ ++ + E ++ DFGLA+ + E +T V T Y AP
Sbjct: 144 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVV-TRWYRAP 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 43/171 (25%), Positives = 88/171 (51%), Gaps = 18/171 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V K+ + G+ A+K +++ + RE++ L +H +++ L
Sbjct: 24 LGVGTFGKV-KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
++P+ ++ +++ GG L + + + + ++R I+ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCH---RH 135
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K N+LLD ++ A+++DFGL+ ++ D E T+ G+ Y AP
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G+V A D G A+K KL+ F R + REL +L +KH ++
Sbjct: 37 VGSGAYGSVCA-AFDTKTGLRVAVK---KLSRPFQSIIHAKRTY-RELRLLKHMKHENVI 91
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLA 418
L S L+ + L+ + ++L D +I +GL
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
Y+H S IIHRD+K SN+ ++ + E ++ DFGLA+ DE +T VA T Y AP
Sbjct: 147 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVA-TRWYRAP 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 56/181 (30%), Positives = 77/181 (42%), Gaps = 36/181 (19%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILG-SIKHR 363
IG G FG V LA + +A+K + K ++ E +L ++KH
Sbjct: 46 IGKGSFGKVL-LARHKAEEVFYAVKVLQK-----KAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
+LV L + KL + D++ GG L L E AR I
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA---- 151
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH S I++RD+K NILLD ++DFGL K + S +T GT YLA
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLA 207
Query: 477 P 477
P
Sbjct: 208 P 208
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 30/178 (16%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
IGSG G V A D A+K KL+ F R + REL ++ + H+ ++
Sbjct: 70 IGSGAQGIVCA-AYDAVLDRNVAIK---KLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 124
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLAY 419
+L + L+ + + D L + + R++ ++ G+ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH S IIHRD+K SNI++ + ++ DFGLA+ +T V T Y AP
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRYYRAP 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 27/187 (14%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYL 365
H+IG G +G VY A D A+K+++++ F+ + RE+ IL +K Y+
Sbjct: 32 HLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRM---FEDLIDCKRILREITILNRLKSDYI 87
Query: 366 VNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMG-AAKGL 417
+ L ++ + D L + ++ + + I+ G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++H IIHRD+K +N LL+ + +V DFGLA+ + E+ P
Sbjct: 143 NFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 478 GKDCTNG 484
Sbjct: 200 HNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNL 368
++G G +G V A G + A+K+I+ ++ R RE++IL KH ++ +
Sbjct: 17 SLLGEGAYGVVCS-ATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITI 74
Query: 369 RGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLH 421
+ + +I + + LH ++ L D I + + LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
+IHRD+K SN+L++ N + +V DFGLA+++++ +
Sbjct: 130 ---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KH 362
+IG G + V L ++A+K + K + + E + H
Sbjct: 16 VIGRGSYAKVL-LVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 363 RYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
+LV L C S+L + +++ GG L + + + + AR I + L
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 124
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLH II+RD+K N+LLD +++D+G+ K +T GT Y+AP
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAP 179
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 33/188 (17%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
L D + +G G FG V L+ ++A+K + K D + E
Sbjct: 339 KLTDFNFLMVLGKGSFGKVM-LSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEK 392
Query: 355 EILGSI-KHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NI 409
+L K +L L C +L + +++ GG L + + + A I
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+G L +L S II+RD+K N++LD +++DFG+ K + T
Sbjct: 452 AIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-C 503
Query: 470 GTFGYLAP 477
GT Y+AP
Sbjct: 504 GTPDYIAP 511
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
IGSG G V A D A+K KL+ F R + REL ++ + H+ +
Sbjct: 32 PIGSGAQGIVCA-AYDAILERNVAIK---KLSRPFQNQTHAKRAY-RELVLMKCVNHKNI 86
Query: 366 VNLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLA 418
+ L S ++ + + D L + + R++ ++ G+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+LH S IIHRD+K SNI++ + ++ DFGLA+ +T V T Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRYYRAP 195
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KH 362
+IG G + V L ++A++ + K + + E + H
Sbjct: 59 VIGRGSYAKVL-LVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 363 RYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
+LV L C S+L + +++ GG L + + + + AR I + L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 167
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLH II+RD+K N+LLD +++D+G+ K +T GT Y+AP
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAP 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 36/188 (19%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
+G GG G V+ A+D A+K+I RE++I+ + H +
Sbjct: 18 PLGCGGNGLVFS-AVDNDCDKRVAIKKI-----VLTDPQSVKHAL-REIKIIRRLDHDNI 70
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEA----------LHE--RSEQLDWDARLNIIMGA 413
V + P+ L D L+ L L + +
Sbjct: 71 VKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESH---ITTIVA 469
+GL Y+H S ++HRD+K +N+ ++ +L ++ DFGLA++++ SH ++ +
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 470 GTFGYLAP 477
T Y +P
Sbjct: 187 -TKWYRSP 193
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 5/106 (4%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L +++ + D L+ LNL N Y ++ ++ +L+ L L SN L+
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ E + + + + + +N L I +L Q L F++ N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+T+ L +++ +K L+L N ++L T+L+ L+L SN L
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE- 72
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+L +LS L LD+++N + L + T + +NN +
Sbjct: 73 -TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
++ K + ++ + S + ++ L L N LS ++L + L L++SSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L L L T +++NN++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+ L N+K++ D G ++++L+L N + L+ L+LQ N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ ++ + L LD+SSN L+ ++ P + ++ NN L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L N+ + +L ++ L+ +NN + G + + L +N ++
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITML 135
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ G S + LD+ N + L L N+ NF+ + V K
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK 192
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L + + + + +LK L+L SN + E + + +SL++N L
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNN 178
I L NL + D+ N + K QR+ T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 17/69 (24%), Positives = 28/69 (40%)
Query: 112 IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
I N + + + L ++ S + N+ LD+S N LS L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 172 TFNVSNNFL 180
N+S+N L
Sbjct: 62 LLNLSSNVL 70
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 12/106 (11%), Positives = 26/106 (24%), Gaps = 3/106 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGEIPSELGNCTELQG 124
+C + L P + L L + L+ + + E N +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQRE 340
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
+ I + L+ +L + + L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 30/178 (16%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KHR 363
+G G FG V LA + G+++A+K + K D + E IL H
Sbjct: 31 LGKGSFGKVM-LARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRILSLARNHP 84
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAY 419
+L L C +L + +F+ GG L + + + AR II L +
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMF 139
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH II+RD+K N+LLD +++DFG+ K T GT Y+AP
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAP 193
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V KLA ALK I + ERE+ L ++H +++ L
Sbjct: 17 LGEGSFGKV-KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
+PT +++ ++ GG L + + E+ + + R II + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCH---RH 127
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+I+HRD+K N+LLD NL +++DFGL+ ++ D T+ G+ Y AP
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 176
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 36/181 (19%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KHR 363
+G G FG V L+ ++A+K + K D + E +L K
Sbjct: 28 LGKGSFGKVM-LSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAAKGL 417
+L L C +L + +++ GG L H ++ + A I +G L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG----L 134
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLA 476
+L S II+RD+K N++LD +++DFG+ K E+ + T GT Y+A
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189
Query: 477 P 477
P
Sbjct: 190 P 190
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 9/127 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++++K+S L KL L+ L +N P LG T L LSL N L
Sbjct: 181 RLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
L +L+NL +LD+++N +S+ P L L +L + N + I LT +
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTN 291
Query: 196 SSFFGNR 202
N+
Sbjct: 292 LELNENQ 298
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
++ +N++L+ L L +L + +++N + L N T L GL+L +N ++
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITDI 127
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P L NL+NL L++SSN++SD +L L L + N
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT 168
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 37/127 (29%), Positives = 52/127 (40%), Gaps = 9/127 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+++S L L +L L L +N P L T L L L N L
Sbjct: 247 DLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
P + NL NL L + N++SD P + L +L NN + + S LT +
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINW 357
Query: 196 SSFFGNR 202
S N+
Sbjct: 358 LSAGHNQ 364
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 23/114 (20%), Positives = 45/114 (39%), Gaps = 8/114 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ L ++ +S LDQ+ L + + L ++ +N
Sbjct: 24 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ 79
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L+ P L NL+ L+++ +++N ++D P L L L + NN + P
Sbjct: 80 LTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+++ +S + L L L+ L+ N P L N T L+ L + SN +S
Sbjct: 138 RLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD- 191
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
S L L+NL +L ++N +SD P LG L L +++ N L I + LT
Sbjct: 192 -ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTN 244
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
K + L+L + +S + L +L+ L ++N S L N T + LS
Sbjct: 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAG 361
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N +S P L NL+ + L ++ + ++ + T L+
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 6/94 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + L N + + ++ L + + L+NL ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S+N L+D P L L +L+ ++NN + P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 17/110 (15%), Positives = 37/110 (33%), Gaps = 5/110 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
LS ++++S L L ++ L L+ + + N + + + L
Sbjct: 357 WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI-- 412
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
P+ + + + DI+ N S Y + +T G +
Sbjct: 413 APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 38/182 (20%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILG-SIKHR 363
+G G FG V+ LA FA+K + K D E +L + +H
Sbjct: 25 LGKGSFGKVF-LAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
+L ++ L + ++L GG L + A II+G
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG---- 130
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYL 475
L +LH S I++RD+K NILLD + +++DFG+ K + + T GT Y+
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYI 185
Query: 476 AP 477
AP
Sbjct: 186 AP 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 21/106 (19%), Positives = 37/106 (34%), Gaps = 1/106 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ ++ L L L L N + LQ L L+
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 136 IPSELGNLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFL 180
+G+L L L+++ N + +P L L ++S+N +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 22/105 (20%), Positives = 38/105 (36%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L + + L L L N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
LS+L L +L+ +G L+ L NV++N +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 26/117 (22%), Positives = 38/117 (32%), Gaps = 4/117 (3%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ LS G S LK+L+L S N + S +L+ L Q + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 133 SGSIPSE--LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ +L NL+ LDIS L L ++ N D
Sbjct: 409 K-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 27/110 (24%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL-SG 134
TL LT + + L L+ L N +G+ L+ L++ N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL----ITFNVSNNFL 180
+P NL+NL +LD+SSN + L L ++ ++ ++S N +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQGLSLQSNYLSG 134
L L+ + +G L LK LN+ N ++P N T L+ L L SN +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 135 SIPSELGNLSNL----LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
++L L + L+LD+S N ++ +I P K RL + NNF +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ + L L+ L + N+F + L L L L
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
P+ +LS+L L+++SN L +P +L L + N
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 4/108 (3%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + L + L L +L++ + + L+ L + N
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
+ + L NL LD+S L + P+ L L N+++N L
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 21/108 (19%), Positives = 45/108 (41%), Gaps = 5/108 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYLS 133
L L+ + + +S++ L+QL+ L+ +N ++ + L L + +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ LS+L L ++ NS + P +L+ L ++S L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 22/113 (19%), Positives = 33/113 (29%), Gaps = 3/113 (2%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C + IT I +L K L+L N + ELQ L L
Sbjct: 3 CVEVVPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ +LS+L L ++ N + + L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 1/90 (1%)
Query: 69 DKNKRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
+ + L + + D +L L FL+L P+ + + LQ L++
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
SN L L++L + + +N
Sbjct: 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 26/119 (21%), Positives = 45/119 (37%), Gaps = 10/119 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLH---SNNFYGEIPSELGNCTELQGLSLQ 128
+ L L+++K+ DL L Q+ LNL S N I L L+L+
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 129 SNYLSGSIPSE-LGNLSNL------LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+N+ S ++ + L+ L L + +L + +L L L +L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G+V A+D G A+K KL+ F R + REL +L ++H ++
Sbjct: 32 VGSGAYGSVCS-AIDKRSGEKVAIK---KLSRPFQSEIFAKRAY-RELLLLKHMQHENVI 86
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLAY 419
L +S L+ F+ L + + ++ ++ KGL Y
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+H S ++HRD+K N+ ++ + E ++ DFGLA+ + E +T V T Y AP
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVV-TRWYRAP 192
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 25/137 (18%)
Query: 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130
+++ L L N LS + L+ L N+ E+P + L +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNLK 124
Query: 131 YLSGSIPS---------------ELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175
LS P EL N S L +D+ +NSL +P L+ +
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI---AA 180
Query: 176 SNNFLVGAIPSDGVLTK 192
NN L +P L
Sbjct: 181 GNNQLE-ELPELQNLPF 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 8/86 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+F+ +N E EL N L + +N L +P +L ++ +N
Sbjct: 172 PPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNN 225
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + P L L L T NN L
Sbjct: 226 ILEE--LPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150
+L L L + +N+ ++P + L+ + +N L EL NL L +
Sbjct: 190 ELQNLPFLTAIYADNNSL-KKLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIY 243
Query: 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+N L +P L+ L + L S
Sbjct: 244 ADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 18/112 (16%)
Query: 88 ISADLGKLDQLKFLNLHSNNFYGEIPSELGN-------------CTELQGLSLQSNYLSG 134
+ + + + + P G + L L + LS
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S+P +L +L S NSL++ +P L+ L+ N + L P
Sbjct: 85 SLPELPPHLE---SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 19/99 (19%), Positives = 30/99 (30%), Gaps = 18/99 (18%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS---------- 144
L+ HS+N E+P E N + + P G
Sbjct: 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 145 ---NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L++++ LS +P L+ L S N L
Sbjct: 69 LDRQAHELELNNLGLSS-LPELPPHLESL---VASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L +LN SN + + L+ L++ +N L +P+ L L S N
Sbjct: 296 PPNLYYLNASSNEI-RSLCDLPPS---LEELNVSNNKLI-ELPALPPRLERL---IASFN 347
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L++ +P L++L +V N L
Sbjct: 348 HLAE-VPELPQNLKQL---HVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 18/99 (18%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS------------EL-G 141
L+ LN+ +N+ ++P + T L + LS P+ L
Sbjct: 256 PPSLEALNV-RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCD 314
Query: 142 NLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+L L++S+N L + +P +L+RL S N L
Sbjct: 315 LPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 14/77 (18%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP 161
+L N+ E+P N L+ L +++N L P ++ +L ++S + D
Sbjct: 381 DLRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYE 433
Query: 162 PSLGKLQRLITFNVSNN 178
+ +L ++
Sbjct: 434 FAHETTDKLEDDVFEHH 450
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 3/108 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + + ++ L+QL+ L L S I E N L+ L L S+ +
Sbjct: 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF 87
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
P L +L L + LSD + L+ L ++S N +
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 18/112 (16%), Positives = 40/112 (35%), Gaps = 2/112 (1%)
Query: 71 NKRVITLSLTNHKLSGPISADLGKLDQ--LKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ H + P L + ++ L+L + +L+ L+L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++ L NL L++S N L + + L ++ ++ N +
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 17/133 (12%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQGLSLQSNYLS 133
+ L+ ++L I L ++ L+ L L+ N F L+ L L N L
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 134 GSIPSEL-----GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDG 188
+ +EL LS+L L ++ N L+ P L L ++++N
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR--------- 515
Query: 189 VLTKFSESSFFGN 201
LT S + N
Sbjct: 516 -LTVLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 27/98 (27%), Positives = 38/98 (38%), Gaps = 3/98 (3%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISS 153
L+ + L L N S +LQ L L S Y +I E NL NL LD+ S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 154 NSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPSDGVL 190
+ + ++ P L L + L A+ DG
Sbjct: 83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 45/203 (22%), Positives = 72/203 (35%), Gaps = 17/203 (8%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADL-----GKLDQLKFLNLHSNNFYGEIPSELGNCTEL 122
+N + L L + L +L L L+ L L+ N P + T L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506
Query: 123 QGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG 182
+GLSL SN L+ + +NL LDIS N L P+ L ++++N +
Sbjct: 507 RGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFIC 561
Query: 183 AIPSDGVLTKFSESSFFGNRGLCGKQINVTCKND---SGGSTTDSQSPNSAQNQGGKKNS 239
L+ F N + G ++ C SG S + + + K
Sbjct: 562 ECE----LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
Query: 240 GRLLISASATVGALLLVALMCFW 262
L I + T+ L+ L
Sbjct: 618 FSLFIVCTVTLTLFLMTILTVTK 640
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 5/121 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI--PSELGNCTELQGLSLQS 129
+ L L + K+ L L L L+ + N L L L
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 130 NYLSG-SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVGAIPS 186
N + + G L++L ++D SSN + L LQ L F+++ N L +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 187 D 187
D
Sbjct: 193 D 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 26/111 (23%), Positives = 41/111 (36%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
V L L++ + S L LK LNL N LQ L+L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L S L + +D+ N ++ + L++L T ++ +N L
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 31/148 (20%), Positives = 46/148 (31%), Gaps = 13/148 (8%)
Query: 76 TLSLTNHKLSGPISAD--LGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYL 132
L L LS + D L L L+L N + G L+ + SN +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 133 SGSIPSELGNLS--NLLNLDISSNSLSDYIPPSLGKLQ------RLITFNVSNNFLVGAI 184
EL L L +++NSL + GK L +VS N I
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 185 PSD--GVLTKFSESSFFGNRGLCGKQIN 210
+ ++K S + G
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 18/107 (16%), Positives = 32/107 (29%), Gaps = 15/107 (14%)
Query: 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSD 158
+ N ++P L + L L NY+ S L L L++ S
Sbjct: 7 RIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 159 YIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
I + L L ++ ++ + +F G L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSK----------IYFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K + L+L +K++ LD L+ LNL N S ++ + LQ N+
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ L L LD+ N+L+ + + + +S N L
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 16/110 (14%), Positives = 36/110 (32%), Gaps = 2/110 (1%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGN--CTELQGLSLQSN 130
V ++ +S + L + +N + + ++ L L
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ L +L L+++ N ++ + L L N+S N L
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 26/181 (14%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIK-HR 363
+G G +G V+K ++D G V A+K K+ + F R F RE+ IL + H
Sbjct: 15 KKLGKGAYGIVWK-SIDRRTGEVVAVK---KIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 364 YLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAY 419
+VNL + + L++D++ + LH R+ L+ + ++ K + Y
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGK 479
LH S ++HRD+K SNILL+ +V+DFGL++ + I
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 480 D 480
D
Sbjct: 182 D 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 36/147 (24%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGY 371
+G G + V++ A++ + +K + + + + RE++IL +++ ++ L
Sbjct: 44 LGRGKYSEVFE-AINITNNEKVVVKILKPVKK--KKIK-REIKILENLRGGPNIITLADI 99
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNI--IMGAAKGLAYLHHDCSPRI 428
P S+ F + D + + L D+D R + I+ K L Y H S I
Sbjct: 100 VKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYDIRFYMYEIL---KALDYCH---SMGI 151
Query: 429 IHRDIKSSNILLDG-NLEARVSDFGLA 454
+HRD+K N+++D + + R+ D+GLA
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 15/105 (14%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L LS + +L Q+ L + N +P + L+ L N LS +
Sbjct: 63 ELQLNRLNLSS-LPDNLPP--QITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-T 114
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+P +L +LD+ +N L+ +P L+ + N NN L
Sbjct: 115 LPELPASLK---HLDVDNNQLT-MLPELPALLEYI---NADNNQL 152
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L++L+ N +P + L + +N L+ +P L ++ +N
Sbjct: 99 PASLEYLDACDNRL-STLPELPASLKHLD---VDNNQLT-MLPELPALLE---YINADNN 150
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ +P L+ L +V NN L
Sbjct: 151 QLTM-LPELPTSLEVL---SVRNNQL 172
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 13/90 (14%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+++N +N +P + L+ LS+++N L+ +P +L L D+S+N
Sbjct: 139 PALLEYINADNNQL-TMLPELPTS---LEVLSVRNNQLT-FLPELPESLEAL---DVSTN 190
Query: 155 SLSDYIPPSLGKLQRL----ITFNVSNNFL 180
L +P + I F N +
Sbjct: 191 LLES-LPAVPVRNHHSEETEIFFRCRENRI 219
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 16/116 (13%), Positives = 30/116 (25%), Gaps = 8/116 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLK----FLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
L ++ + L + A + + F N IP + + + L+ N
Sbjct: 184 ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNP 241
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LS I L + + S + + SD
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 95 LDQLKFLNLHSNNFYG---EIPSELGNC----TELQGLSLQSNYLSGSIPSELGNLSNLL 147
L +L N+FY ++ + + N + L ++
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 148 NLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L ++ +LS +P +L ++ ++ N L
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNAL 92
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 27/113 (23%), Positives = 38/113 (33%), Gaps = 8/113 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC----TELQGLSLQSNY 131
LS+ + L L+L N GE C LQ L+L++
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 132 ---LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFL 180
SG + L LD+S NSL D +L + N+S L
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 76 TLSLTN---HKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNY 131
L+L N SG SA QL+ L+L N+ + ++L L+L
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA 183
L +P L + L LD+S N L PS +L ++ ++ N + +
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 35/136 (25%), Positives = 52/136 (38%), Gaps = 14/136 (10%)
Query: 76 TLSLTNHKLSGPI----SADLGKLDQLKFLNLHSNNF---YGEIPSELGNCTELQGLSLQ 128
TL L+++ G + K L+ L L + G + +LQGL L
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236
Query: 129 SNYLSGSIPSEL-GNLSNLLNLDISSNSLSDYIPPSLG-KLQRLITFNVSNNFLVGAIPS 186
N L + + S L +L++S L +P L KL L ++S N L PS
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVL---DLSYNRLDR-NPS 291
Query: 187 DGVLTKFSESSFFGNR 202
L + S GN
Sbjct: 292 PDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 23/126 (18%), Positives = 47/126 (37%), Gaps = 11/126 (8%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLD---QLKFLNLHSNNFYGEIPSELGNCT--ELQG 124
K+ + L++ ++ I ++ L+ L L + G P L T +L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 125 LSLQSNYLSGSIPSELGNLSNLLN-----LDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
L+L++ + + L L L L I+ ++ + L T ++S+N
Sbjct: 126 LNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 180 LVGAIP 185
+G
Sbjct: 185 ELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 22/118 (18%), Positives = 40/118 (33%), Gaps = 10/118 (8%)
Query: 73 RVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGE--IPSELGNC--TELQGLS 126
+ L+L N +++G L + L LNL + ++ +EL L+ LS
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS----LGKLQRLITFNVSNNFL 180
+ + ++ L LD+S N K L + N +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 21/129 (16%), Positives = 41/129 (31%), Gaps = 11/129 (8%)
Query: 71 NKRVITLSLTNHKLSGPIS--ADLGKLDQ--LKFLNLHSNNFYGEIPSELGNCTELQGLS 126
+ L+L N + + A+L + + LK L++ + ++ L L
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 127 LQSNYLSGSIPSE----LGNLSNLLNLDISSN---SLSDYIPPSLGKLQRLITFNVSNNF 179
L N G L L + + + S +L ++S+N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 180 LVGAIPSDG 188
L A +
Sbjct: 240 LRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 23/147 (15%), Positives = 48/147 (32%), Gaps = 11/147 (7%)
Query: 56 EDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE 115
E+ CN+ K D + L + +L G G L ++
Sbjct: 10 EESCSCNFSDPKPDWSSAFNCLGAADVELYG------GGRSLEYLLKRVDTEADLGQFTD 63
Query: 116 LGNCTELQGLSLQSNYLSGSIPS---ELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RL 170
+ L+ L++++ + I + +S L L + + ++ PP L + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 171 ITFNVSNNFLVGAIPSDGVLTKFSESS 197
N+ N L ++ +
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPG 150
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 1e-10
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 6/104 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L + L+ L +L + L+L S+N +P L L+ L N L +
Sbjct: 445 VLHLAHKDLTVLCH--LEQLLLVTHLDL-SHNRLRALPPALAALRCLEVLQASDNALE-N 500
Query: 136 IPSELGNLSNLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNN 178
+ + NL L L + +N L L RL+ N+ N
Sbjct: 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 7e-10
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
++ L+L + + L + L L N L ++P L L L L S N+L
Sbjct: 442 DVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
Query: 157 SDYIPPSLGKLQRLITFNVSNNFL 180
+ + L RL + NN L
Sbjct: 499 ENV--DGVANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 4e-08
Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 8/98 (8%)
Query: 88 ISADLGKLDQLKFLNLH-----SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
L + + + F E +++ L L L+ + L
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQ 461
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + +LD+S N L +PP+L L+ L S+N L
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 5/97 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
L L++++L + L L L+ L S+N + + N LQ L L +N L
Sbjct: 467 HLDLSHNRLRA-LPPALAALRCLEVLQA-SDNALENVD-GVANLPRLQELLLCNNRLQQS 523
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
+ L + L+ L++ NSL +L ++
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 559
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 19/92 (20%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
+ LN+ + +P L + L + N L+ S+P+ L L ++S N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ +P L L F+ L
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+ L++ N +P+ L L +N L+ S+P+ L L +S N
Sbjct: 180 PSGLQELSVSDNQL-ASLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK---ELIVSGN 231
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ +P +L+ L VS N L
Sbjct: 232 RLTS-LPVLPSELKEL---MVSGNRL 253
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 16/109 (14%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ TL + ++ L+ + A +L+ L + N +P EL S +
Sbjct: 61 AHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L S L L I N L+ +P LQ L +VS+N L
Sbjct: 116 LPAL-------PSGLCKLWIFGNQLTS-LPVLPPGLQEL---SVSDNQL 153
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+ L++ N +P+ L L +N L+ S+P L L +S N
Sbjct: 140 PPGLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDN 191
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ +P +L +L +N L
Sbjct: 192 QLAS-LPTLPSELYKLWAYNNRLTSLPALPSG 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 5/92 (5%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
+LK L + N +P L S+ N L+ +P L +LS+ +++ N
Sbjct: 240 PSELKELMVSGNRL-TSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
LS+ +L ++ ++ A S
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L L+++ N +P L + + ++L+ N LS +
Sbjct: 260 PSGLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
D S + R + ++ +
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLV 343
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 4/107 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
++ N + +A L Q++ LNL+ EI + +Q L + N +
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+P N+ L L + N LS +L T ++SNN L
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ ++L + K+ +L+ L + +N + L+ L L N+L
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-H 309
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ L NL + NS+ + S L +S+N
Sbjct: 310 VERNQPQFDRLENLYLDHNSIVT-LKLST--HHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L +++ ++ + + +L L L NN + L N L + L N L
Sbjct: 209 ELDASHNSINV-VRGPV--NVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLSYNELE-K 262
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I + L L IS+N L + + L ++S+N L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 6/120 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++N++L ++ + LK L+L N+ + L+ L L N + +
Sbjct: 276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFS 194
+ L L NL +S N + + + R + + + G+ K S
Sbjct: 333 LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNL 149
+ L L L N+ +P + N +L LS+ +N L I + ++L NL
Sbjct: 113 FQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 170
Query: 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+SSN L+ + SL + L NVS N L
Sbjct: 171 QLSSNRLTH-VDLSL--IPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGS 135
+ + + L+ K + ++ ++P+ L + +++ L+L +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
I + + L + N++ Y+PP + L + N L
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 9/103 (8%), Positives = 35/103 (33%), Gaps = 6/103 (5%)
Query: 82 HKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSE 139
+ D F ++H + ++ E + ++ +++ + +P+
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 140 -LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
L + + L+++ + + I + + + N +
Sbjct: 64 LLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAI 105
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 21/106 (19%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN----------------YLSG 134
+L L++ +NN I + T LQ L L SN +S
Sbjct: 137 FHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSY 195
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ S L + LD S NS++ + + L + +N L
Sbjct: 196 NLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNL 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 5/115 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+L L+ +K++ DL L+ L L S+ I + + L+ L L N+LS
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS- 87
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
S+ S G LS+L L++ N SL L L T + N I
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---PSELGNCTELQGLSLQSNYL 132
+++ N K+ + L L+FL+L N E + G LQ L L N+L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 133 S--GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L L NL +LDIS N+ +P S +++ N+S+ +
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L+L + +++ L L+ L + + + EI T L L +++ L
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L ++ ++ +L + + + + L + + + L
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 2/107 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
L L + +++ L L+ L+L N+ S G + L+ L+L N
Sbjct: 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL 113
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ S NL+NL L I + I L L + L
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 24/95 (25%), Positives = 38/95 (40%), Gaps = 1/95 (1%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
+K L+L N +L C LQ L L+S+ ++ +L +L +LD+S N LS
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
G L L N+ N + +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 9/118 (7%)
Query: 68 CDKNKRVITLSLTNHKLS---GPISADLGKLDQLKFLNLHSNNFY--GEIPSELGNCTEL 122
K + L L+ + + SA G L+ L L N+ + L L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 123 QGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + N +P + L++SS + + + Q L +VSNN L
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 14/90 (15%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
+ ++ L++ + ++ + +++ ++++++ + S +L +L LD+S
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 154 NSLSDYIPPS---LGKLQRLITFNVSNNFL 180
N + + + G L T +S N L
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
D + S +F IPS L ++ L L N ++ +L +NL L + S+
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 156 LSDYIPPSLGKLQRLITFNVSNNFL 180
++ + L L ++S+N L
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHL 86
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 11/112 (9%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C +++ L+L++ + L+ L++ +NN L LQ L +
Sbjct: 406 CQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNL-DSFSLFLPR---LQELYI 458
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
N L ++P LL + IS N L +P +L L + N
Sbjct: 459 SRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 15/104 (14%), Positives = 34/104 (32%), Gaps = 1/104 (0%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL + S D L L L + + + L + ++ L+L + +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ LS++ L++ +L+ + L +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 16/105 (15%), Positives = 35/105 (33%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + L S L + + L LH + + + ++ L L+ L+
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
S L + + S S +L +L+ + + + +
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 9/95 (9%), Positives = 36/95 (37%), Gaps = 8/95 (8%)
Query: 94 KLDQLKFLNLHSNN---FYGEIPSELGNCTELQGLSLQSNYLSG-----SIPSELGNLSN 145
+L +++F + N F + +++ ++++ ++ + + L
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 146 LLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ + + ++ + L+ L ++S N +
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 11/62 (17%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L +L+ L + N +P L + + N L L++L + + +N
Sbjct: 450 LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 155 SL 156
Sbjct: 508 PW 509
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
++ N + +A L Q++ LNL+ EI + +Q L + N +
Sbjct: 55 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR- 112
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+P + N+ L L + N LS +L T ++SNN L
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 24/174 (13%), Positives = 55/174 (31%), Gaps = 6/174 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++N++L ++ + LK L+L N+ + L+ L L N + +
Sbjct: 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFS 194
+ L L NL +S N + + + R + + + G+ K S
Sbjct: 339 LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 396
Query: 195 ESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASA 248
+ + +V K + ++ + + +
Sbjct: 397 DKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ ++L + K+ +L+ L + +N + L+ L L N+L
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ L NL + NS+ + S L +S+N
Sbjct: 316 VERNQPQFDRLENLYLDHNSIVT-LKLST--HHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 8/113 (7%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
V L +++ ++ +L L L NN + L N L + L
Sbjct: 208 AIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLS 262
Query: 129 SNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L I + L L IS+N L + + L ++S+N L
Sbjct: 263 YNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNL 149
+ L L L N+ +P + N +L LS+ +N L I + ++L NL
Sbjct: 119 FQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176
Query: 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+SSN L+ + SL + L NVS N L
Sbjct: 177 QLSSNRLTH-VDLSL--IPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGS 135
+ + + L+ K + ++ ++P+ L + +++ L+L +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
I + + L + N++ Y+PP + L + N L
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 8/88 (9%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 97 QLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISS 153
F ++H + ++ E + ++ +++ + +P+ L + + L+++
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 84
Query: 154 NSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ + I + + + N +
Sbjct: 85 LQIEE-IDTYAFAYAHTIQKLYMGFNAI 111
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/107 (23%), Positives = 38/107 (35%), Gaps = 23/107 (21%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIP------------- 137
+L L++ +NN I + T LQ L L SN L+ +
Sbjct: 143 FHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVS 200
Query: 138 ----SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
S L + LD S NS++ P +L L + +N L
Sbjct: 201 YNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNL 244
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 19/107 (17%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
I ++ ++ ++ LD + L+ + L GL L+ N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
++ + + L NL+ + L++S N L + + + LQ + T ++++
Sbjct: 75 IT-DL-APLKNLTKITELELSGNPLKN-VSA-IAGLQSIKTLDLTST 117
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L +SA + L +K L+L S P L + LQ L L N ++ +
Sbjct: 89 ELELSGNPLKN-VSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-N 143
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I S L L+NL L I + +SD + P L L +L T +N +
Sbjct: 144 I-SPLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 23/106 (21%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
LS+ N ++S ++ L L +L L +N +I S L + L + L++N +S
Sbjct: 155 YLSIGNAQVSD-LTP-LANLSKLTTLKA-DDNKISDI-SPLASLPNLIEVHLKNNQIS-D 209
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
+ S L N SNL + +++ ++++ L + +
Sbjct: 210 V-SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 17/89 (19%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + +N + + LS ++ +I + L+NL+ L++
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++D + P L L ++ +S N L
Sbjct: 71 KDNQITD-LAP-LKNLTKITELELSGNPL 97
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
N ++ L +K + D+ QL L+ N E+ + L L+ +
Sbjct: 146 HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDT 200
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++ + L L LD SSN L++ + L +L F+ S N L
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 18/111 (16%), Positives = 42/111 (37%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ TL L DL QL + E+ ++ + T+L L Q+
Sbjct: 252 TLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQA 306
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ + L L+ L +++ L++ + + +L + + N +
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 10/112 (8%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
D N + + + I +L L L+ H+++ + + T L L
Sbjct: 17 DDNFASEVAAAFEMQATDTI--SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICT 72
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
SN ++ ++ L +NL L SN L++ + L +L N N L
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ + +L N ++ + KL L L SNN + L T L L+ S
Sbjct: 40 QLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDS 94
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L+ ++ + L+ L L+ +N L+ + + L N + N L
Sbjct: 95 NKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ L+ +KL+ D+ + L +LN N EI + + T+L L
Sbjct: 103 TPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCH 156
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + + + L LD S N +++ + + + L N N +
Sbjct: 157 LNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 17/111 (15%), Positives = 39/111 (35%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+N ++ L +++KL+ D+ L QL + + N E+ + ++L L
Sbjct: 210 QNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQ 263
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L I L + + L+ + + +L + +
Sbjct: 264 TDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 21/111 (18%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
N ++ L ++ DL + +L +L L++ E+ + + T+L+ LS +
Sbjct: 295 HNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ +G + L N + +P L T VS + L
Sbjct: 349 AHIQ-DFS-SVGKIPALNNNFEAEGQTIT-MPKETLTNNSL-TIAVSPDLL 395
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 9e-09
Identities = 35/229 (15%), Positives = 59/229 (25%), Gaps = 61/229 (26%)
Query: 287 SIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI------- 339
V F LP +K IG G FG V++ + D A+K I
Sbjct: 9 GPVPFSHCLPTEKLQRCEK---------IGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDL 58
Query: 340 -DKLNEGFDRFFERELEIL---------GSIKHRYLVNLRGYC----------------- 372
+ ++ E+ I + + L
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 373 -------------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++ +F GG E R++ +I+ LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE--QMRTKLSSLATAKSILHQLTASLAV 176
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
S R HRD+ N+LL ++ K + +
Sbjct: 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 5/108 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ + L L+ L + N+F + L L L L
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
+ +LS+L L++S N+ + L L + S N +
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 26/118 (22%), Positives = 39/118 (33%), Gaps = 6/118 (5%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
++LS G S LK+L+L S N + S +L+ L Q + L
Sbjct: 55 TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNL 113
Query: 133 SGSIPSE--LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ +L NL+ LDIS L L ++ N D
Sbjct: 114 K-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 5/115 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNN--FYGEIPSELGNCTELQGLSLQSNYLS 133
L L ++KL KL QL L+L SN F G T L+ L L N +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
++ S L L +LD ++L S+ L+ LI ++S+ +
Sbjct: 92 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYLS 133
L L+ + + +S++ L+QL+ L+ +N ++ + L L + +
Sbjct: 82 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ LS+L L ++ NS + P +L+ L ++S L
Sbjct: 140 -VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDI 151
L L +L++ + + + L+ L + N + + L NL LD+
Sbjct: 124 SLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 152 SSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
S L + P + L L N+S+N
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 20/107 (18%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L + N + +L L FL+L ++ + + LQ L++ N
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFF 212
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSL--GKLQRLITFNVSNN 178
L++L LD S N + L N++ N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS- 157
+ +S +P+ + + L L+SN L L+ L L +SSN LS
Sbjct: 10 TEIRCNSKGL-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 158 -DYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
S L ++S N ++ + S+
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 96
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
+ T K+ L+ +N + G+ TEL+ L LQ N L +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 137 PSELG---NLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFL 180
+ +L LDIS NS+S + L++ N+S+N L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+++ + +S ++D+ L +L+ L + N S EL+ L L N L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
I NL +LD+S N+ +P G + +L +S L
Sbjct: 84 ISC--HPTVNLKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHL 127
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 4/95 (4%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
LN+ N S++ + ++L+ L + N + S L LD+S N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
L+ L ++S N A+P
Sbjct: 83 KISCHPTVNLKHL---DLSFNAF-DALPICKEFGN 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 27/111 (24%), Positives = 41/111 (36%), Gaps = 4/111 (3%)
Query: 69 DKNKRVITLSL-TNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
+ K + L + N D L LN+ SN I L ++ L L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
SN + SIP ++ L L L+++SN L +L L + N
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 5/128 (3%)
Query: 58 PDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLG-----KLDQLKFLNLHSNNFYGEI 112
+ ++ + V S++N KL G + L L + S+ F
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 113 PSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLIT 172
+ + + + +S L+LD S+N L+D + + G L L T
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 173 FNVSNNFL 180
+ N L
Sbjct: 353 LILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 6/116 (5%)
Query: 68 CDKNKRVITLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQG 124
C + TL L ++L I+ ++ L+ L++ N+ Y E + L
Sbjct: 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L++ SN L+ +I L + LD+ SN + IP + KL+ L NV++N L
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 34/194 (17%), Positives = 67/194 (34%), Gaps = 13/194 (6%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--SELGNCTELQGL 125
N+ + L L+++KL LK L+L N F +P E GN ++L+ L
Sbjct: 65 FKFNQELEYLDLSHNKLV---KISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFL 120
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L + +L S + +L+ L + + + P LQ T ++ F P
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVF-----P 173
Query: 186 SDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLIS 245
++ + S L I +++ + + + +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 246 ASATVGALLLVALM 259
++ + L LV
Sbjct: 234 WNSFIRILQLVWHT 247
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159
++ N +P +L + L++ NY+S S++ +LS L L IS N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDG 188
Q L ++S+N L I
Sbjct: 61 DISVFKFNQELEYLDLSHNKL-VKISCHP 88
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C K +++L+++++ L+ I L ++K L+LHSN IP ++ LQ L++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNV 451
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
SN L S+P L++L + + +N
Sbjct: 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L +KL+ I L L L +L L N ++ S L + +L+ LSL+ N +S
Sbjct: 69 KLFLNGNKLTD-IK-PLTNLKNLGWLFLDENKI-KDL-SSLKDLKKLKSLSLEHNGIS-D 123
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I L +L L +L + +N ++D L +L +L T ++ +N +
Sbjct: 124 ING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ L + L L+ N +I L N L L L N + + S L +L L +L +
Sbjct: 61 IQYLPNVTKLFLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
N +SD I L L +L + + NN
Sbjct: 117 EHNGISD-ING-LVHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 6/103 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L L N+K++ I+ L +L +L L+L N L T+LQ L L N++S
Sbjct: 135 SLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHIS-D 189
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ L L NL L++ S + L T ++
Sbjct: 190 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ NL + + + + ++ + S+ + L N+ L +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N L+D I P L L+ L + N
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDEN 97
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 23/110 (20%), Positives = 44/110 (40%), Gaps = 6/110 (5%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN 130
K++ + + + ++ I L L L+L N ++ + L L L L N
Sbjct: 171 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFN 226
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+S L N +L L +++N L +P L + + + NN +
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 28/143 (19%), Positives = 50/143 (34%), Gaps = 17/143 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+K++ D L L L L +N
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-S 89
Query: 111 EIPSE-LGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQ 168
+I +L+ L L N L +P ++ L L + N ++ + L
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 169 RLITFNVSNNFLVGAIPSDGVLT 191
++I + N L + +G
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 22/113 (19%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L+ + +S + L L+ L+L++N ++P L + +Q + L +N +S
Sbjct: 220 KLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276
Query: 135 SIPSE-------LGNLSNLLNLDISSNSLSDY-IPPSL-GKLQRLITFNVSNN 178
+I S ++ + + SN + + I PS + + N
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 19/110 (17%), Positives = 43/110 (39%), Gaps = 10/110 (9%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN 130
++ L L+ ++L + + L+ L +H N ++ ++ + L +N
Sbjct: 100 VKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN 155
Query: 131 YL-SGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
L S I + + L + I+ +++ IP L L ++ N
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 8/110 (7%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNY 131
++ L ++ KL+G I DL + L L+L N I E L ++L L L N
Sbjct: 173 KLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQ 228
Query: 132 LSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ I + L L L L + +N LS +P L L+ L + N +
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 17/143 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+ +S D L L L L +N
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-S 91
Query: 111 EIPSE-LGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQ 168
+I + +LQ L + N+L IP L S+L+ L I N + +P L+
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLR 147
Query: 169 RLITFNVSNNFLVGAIPSDGVLT 191
+ + N L + G
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 18/113 (15%), Positives = 43/113 (38%), Gaps = 13/113 (11%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L ++++ I L L L+ L+L +N +P+ L + LQ + L +N ++
Sbjct: 221 RLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 135 SIPSE-------LGNLSNLLNLDISSNSLSDY-IPPSL-GKLQRLITFNVSNN 178
+ + + + +N + + + P+ + + N
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 9/115 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N+K+S I L +L+ L + N+ EIP L + L L + N +
Sbjct: 82 ALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR- 136
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+P L N+ +++ N L + P +L +S L IP D
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKD 190
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 29/108 (26%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ L + + A L L K L L +NN +I S L L+ LSL N +
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I + L L IS N ++ + + KL L +SNN +
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 94 KLDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152
+ + + LH ++ + L + L+L +N + I S L + NL L +
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78
Query: 153 SNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + I L +S N +
Sbjct: 79 RNLIKK-IENLDAVADTLEELWISYNQI 105
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L ++ L+ L+L N +I + L+ L + N ++ S+ S + L NL L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122
Query: 152 SSNSLSDYIP-PSLGKLQRLITFNVSNN 178
S+N ++++ L L +L ++ N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 6/115 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+ L +++S +A L L LHSN I + L+ L L N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
S+ L L L + L + + P L L + +N L A+P D
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDD 147
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 8/109 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
TL L L + L L++L L N +P + + L L L N +S
Sbjct: 109 TLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
S+P L +L L + N ++ ++ P + L RL+T + N L
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNL 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 8/107 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L L ++ L + D L L L LH N +P L L L N ++
Sbjct: 133 YLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
+ +L L+ L + +N+LS +P L L+ L +++N
Sbjct: 191 -HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+ + LH N + C L L L SN L+ I + L+ L LD+S N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 157 SDYIPPS-LGKLQRLITFNVSNNFLVGAIPSD 187
+ P+ L RL T ++ L +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ ++ + L L++ N +P + + L+ L+L N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+I L L L + + L+ + P + L L NVS N L
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+LS+T+ L+ + L L+FLNL N I L LQ + L L+
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA- 285
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLV 181
+ L+ L L++S N L+ + S+ + L T + +N L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 5/114 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L L+ + L L L L L N I L+ L +
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
++ NL +L I+ +L+ +P ++ L L N+S N + I
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 4/114 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ +K+ + L LK L + N+ I L+ L+L+ L+
Sbjct: 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
SIP+E L +L L+ L + +++ S +L RL +S+ + + +
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 12/92 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDIS 152
L L+ L L SN IP + L L + N + + + +L NL +L++
Sbjct: 79 LFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 153 SNSLSDYIPP----SLGKLQRLITFNVSNNFL 180
N L YI L L++L + L
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQL---TLEKCNL 164
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 11/95 (11%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+ L+L N E + L+ L L N +S ++ NL NL L + SN L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL 92
Query: 157 SDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
IP L L +L ++S N +V +
Sbjct: 93 KL-IPLGVFTGLSNLTKL---DISENKIV-ILLDY 122
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 105 SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL 164
+ +P + TE + L L N + E + +L L+++ N +S P +
Sbjct: 19 HRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 165 GKLQRLITFNVSNNFLVGAIPSD 187
L L T + +N L IP
Sbjct: 77 NNLFNLRTLGLRSNRLK-LIPLG 98
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L + + + L L+ L L N+ +I L L L N+L+
Sbjct: 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT- 136
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS----LGKLQRL 170
IPS LS L L + +N + IP + L RL
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRL 176
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 8/115 (6%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L K IS L LK+LNL N ++P+ L L+ L + N+
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP- 231
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
I LS+L L + ++ +S I + L L+ N+++N L ++P D
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L + +L L L+ L + N+F EI + L+ L + ++ +S
Sbjct: 200 YLNLGMCNIKDM--PNLTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS- 255
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
I L++L+ L+++ N+LS +P L+ L+ ++ +N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 8/131 (6%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L L + + I L L L L N IPS ++L+ L L++N +
Sbjct: 103 VLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE 160
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
SIPS + +L+ LD+ +YI + L L N+ + +P+ L
Sbjct: 161 -SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV 218
Query: 192 KFSESSFFGNR 202
E GN
Sbjct: 219 GLEELEMSGNH 229
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/83 (21%), Positives = 29/83 (34%), Gaps = 4/83 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ + L LK L + ++ I L L+L N LS
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS- 279
Query: 135 SIPSE-LGNLSNLLNLDISSNSL 156
S+P + L L+ L + N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+Q + E+P + + + L+L N + +L +L L + NS
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 156 LSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ I + L L T + +N+L IPS
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSG 141
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLD 150
L L++LNL N EIP+ L +L L L N+LS +I L +L L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 151 ISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ + + I + LQ L+ N+++N L
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 25/101 (24%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L +++ L L+ L L N+ I L L L N L+
Sbjct: 68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT- 125
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS----LGKLQRL 170
+IP+ LS L L + +N + IP + L+RL
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L L +L L +L L+L N+ I LQ L + + +
Sbjct: 189 YLNLAMCNLREI--PNLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ- 244
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
I NL +L+ ++++ N+L+ +P L L ++ +N
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 33/130 (25%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + + L L L L N IP+ ++L+ L L++N +
Sbjct: 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
SIPS + +L LD+ YI + L L N++ L IP+ L K
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208
Query: 193 FSESSFFGNR 202
E GN
Sbjct: 209 LDELDLSGNH 218
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + LS L L+ L + + I N L ++L N L+
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 135 SIPSE-LGNLSNLLNLDISSNSL 156
+P + L +L + + N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+Q + N E+P + T + L+L N + + +L +L L +S N
Sbjct: 43 NQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 156 LSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ I + L L T + +N L IP+
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG 130
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 7/116 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
+L L+N++++ ++DL + L+ L L SN I + + L+ L L NYLS
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS- 113
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIPSD 187
++ S LS+L L++ N + + L +L V N I
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/134 (12%), Positives = 39/134 (29%), Gaps = 12/134 (8%)
Query: 79 LTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIP 137
+ D L L+ L + +++ + L + + L L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 138 SEL-GNLSNLLNLDISSNSLSD----YIPP----SLGKLQRLITFNVSNNFLVGAIPSDG 188
S++ L++ L + SL K +++ L +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
Query: 189 VLTKFSESSFFGNR 202
++ E F N+
Sbjct: 275 QISGLLELEFSRNQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 11/112 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG----EIPS----ELGNCTELQGLSL 127
L L + + + ++ L L + E+ + L + + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
L + L +S LL L+ S N L +P +L L + N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 11/97 (11%)
Query: 69 DKNKRVITLSLTNHKLSGP--------ISADLGKLDQLKFLNLHSNNFYGEIPSELGNCT 120
D V L L + L + L K + + + + + ++ L +
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 121 ELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
L L N L S+P L++L + + +N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 18/141 (12%), Positives = 51/141 (36%), Gaps = 9/141 (6%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L+L + ++ L +L+ L + + + + +I + T L+ L + ++ L
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG----AIPSDG 188
S + L ++ N+ +L + + + + + + L + + G
Sbjct: 188 -SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-G 245
Query: 189 VLTKFSESSFFGNRGLCGKQI 209
+ F N + + +
Sbjct: 246 ETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
D+ S + IPS L ++ L L +N ++ S+L NL L ++SN
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 155 SLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
++ I S L L ++S N+L + S
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSS 118
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 8/112 (7%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
V L L +KL+ I L L L +L L N ++ S L + +L+ LSL+
Sbjct: 65 QYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKV-KDL-SSLKDLKKLKSLSLE 120
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N +S I L +L L +L + +N ++D L +L +L T ++ +N +
Sbjct: 121 HNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 29/113 (25%), Positives = 48/113 (42%), Gaps = 6/113 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ +L L N+K++ I+ L +L +L L+L N L T+LQ L L
Sbjct: 131 VHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLS 186
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N++S + L L NL L++ S + L T ++ LV
Sbjct: 187 KNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ NL + + + + ++ + S+ + L N+ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N L+D I P L L+ L + N
Sbjct: 76 NGNKLTD-IKP-LANLKNLGWLFLDEN 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-07
Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N + + G + + ++L+FL+ N I + L +L+ L L N +SG
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSI-ANLPKLNKLKKLELSDNRVSG 78
Query: 135 SIPSELGNLSNLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNN 178
+ NL +L++S N + D L KL+ L + ++ N
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 3e-07
Identities = 36/245 (14%), Positives = 65/245 (26%), Gaps = 81/245 (33%)
Query: 265 FLYKKLGKNESKGLARDVGGGASIV-MFHGDLPYSSKD----------IIKKLETLDDDH 313
FL + K E + + + D +K + + L L
Sbjct: 93 FLMSPI-KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 314 II---GSGGFG-TVYKLAMD-----------DGNVF------------ALKRIDKLNEGF 346
+ G G G T +A+D D +F L+ + KL
Sbjct: 152 NVLIDGVLGSGKTW--VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 347 DRFFERELEILGSIKH---------RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER 397
D + + +IK R L+ + Y N LL+ L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LLV--------LLNV---- 253
Query: 398 SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
+A+ + C + R + ++ L +S + L
Sbjct: 254 -----QNAKA---------WNAFNLSCKILLTTRFKQVTDF-LSAATTTHISLDHHSMTL 298
Query: 458 EDEES 462
+E
Sbjct: 299 TPDEV 303
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 8/108 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
LSL+ + +S D+ L +L+ L L N + + +L+ L + N L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ- 113
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
+I +++L +LD+S N +P G L +L +S
Sbjct: 114 NISC--CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 23/137 (16%), Positives = 52/137 (37%), Gaps = 7/137 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--SELGNCTELQGLS 126
N+ + L +++++L + + L+ L+L N+F +P E GN T+L L
Sbjct: 97 LFNQDLEYLDVSHNRLQ---NISCCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLG 152
Query: 127 LQSNYLSGSIPSELGNLS-NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L + + +L + + LD+ S + SL + V + + ++
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 186 SDGVLTKFSESSFFGNR 202
+ + +
Sbjct: 213 VNMSVNALGHLQLSNIK 229
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 25/99 (25%), Positives = 43/99 (43%), Gaps = 10/99 (10%)
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144
S + + LNL SN G + L +++ L L +N + SIP ++ +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 145 NLLNLDISSNSLSDYIPP----SLGKLQRLITFNVSNNF 179
L L+++SN L +P L LQ + + N +
Sbjct: 474 ALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHD--NPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 21/127 (16%), Positives = 43/127 (33%), Gaps = 5/127 (3%)
Query: 59 DPCNWKGVKCDKNKRVITLSLTNHKLSGPI-----SADLGKLDQLKFLNLHSNNFYGEIP 113
C+ K + + V L++ N ++ I + L L ++ + F
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 114 SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITF 173
+ E+ L + + S+ L+ + N +D + L+RL T
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 174 NVSNNFL 180
+ N L
Sbjct: 383 ILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 6/116 (5%)
Query: 68 CDKNKRVITLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQG 124
C KR+ TL L + L ++ + L+ L++ N+ +
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L+L SN L+GS+ L + LD+ +N + IP + LQ L NV++N L
Sbjct: 433 LNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 18/112 (16%), Positives = 34/112 (30%), Gaps = 4/112 (3%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K ++ + N A ++ L ++ + + L+ N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPP---SLGKLQRLITFNVSNNFL 180
+ S+ L L L + N L + + L T +VS N L
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSL 415
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+ ++ + N +P +L + LSL N +S ++ LS L L +S N
Sbjct: 31 ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 156 LSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
+ + + Q L +VS+N L I
Sbjct: 88 IR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC 118
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 35/184 (19%), Positives = 76/184 (41%), Gaps = 42/184 (22%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK---------- 361
+G G F TV+ A D + A+K + + ++ + E E+++L +
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 362 -HRYLVNLRG---YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNI--IMGAA 414
+++ L + + ++++ L G +L + + + + + + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-----GIPLIYVKQIS 137
Query: 415 K----GLAYLHHDCSPRIIHRDIKSSNILLD------GNLEARVSDFGLAKLLEDEESHI 464
K GL Y+H C IIH DIK N+L++ ++ +++D G A + H
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHY 192
Query: 465 TTIV 468
T +
Sbjct: 193 TNSI 196
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y + G A+K + E + +++ + +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRWCG 74
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+++ + L G SL++ + S + L + + Y+H S IHRD
Sbjct: 75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130
Query: 433 IKSSNILL----DGNLEARVSDFGLAKLLEDEESH 463
+K N L+ GNL + DFGLAK D +H
Sbjct: 131 VKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDARTH 164
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 1e-06
Identities = 20/126 (15%), Positives = 39/126 (30%), Gaps = 13/126 (10%)
Query: 58 PDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-L 116
PD C + + + L + L L + + + L
Sbjct: 2 PDAC-----CPHGSSGL----RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDL 52
Query: 117 GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175
EL+ L++ + L + + L L++S N+L + + L +
Sbjct: 53 RGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110
Query: 176 SNNFLV 181
S N L
Sbjct: 111 SGNPLH 116
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 9/107 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ +L ++ +S +L ++ N ++N + + + T L+ L L N
Sbjct: 19 ANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQ 74
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+S + S L +L+ L L ++ N L + L RL + NN
Sbjct: 75 IS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNN 116
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 20/112 (17%), Positives = 43/112 (38%), Gaps = 6/112 (5%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ + L L N++L L L L+ L++ +N + LG ++L+ L L
Sbjct: 104 PSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHG 159
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N ++ + L L + +D++ + +L T + +
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 15/113 (13%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
+ L L+++++S +S L L +L+ L+++ N L N + L
Sbjct: 60 QFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNR--------LKNLNGIPSACLS 109
Query: 129 SNYLSGSIPSELGNLSNLLNL---DISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+L + + +L +L NL I +N L I LG L +L ++ N
Sbjct: 110 RLFLDNNELRDTDSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGN 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 30/98 (30%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L+ + L A L +L LNL ++ + G L L L N L S+
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SL 92
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
P L L LD+S N L+ +P LG+LQ L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQEL 129
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L ++ ++L+ + L +L+ L L N +P L +L+ LSL +N L+
Sbjct: 104 VLDVSFNRLTS-LPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT 161
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+P+ L L NL L + NSL IP L + N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 18/48 (37%), Positives = 28/48 (58%), Gaps = 3/48 (6%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
AKG+ +L S + IHRD+ + NILL ++ DFGLA+ + +
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 39/161 (24%), Positives = 55/161 (34%), Gaps = 17/161 (10%)
Query: 312 DHIIGSGGFGTVYK---LAMDDGNVFALKRIDKLNEGFDRF----FERELEILGSI-KHR 363
+G G FG V + +D + L EG EL+IL I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+VNL G C P L +I +F G+L L + R + KG +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGARFRQG 138
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
I D+K + + + S F K L D E
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 18/109 (16%), Positives = 38/109 (34%), Gaps = 5/109 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
+ L+ + ++ +L L+FL + I + + L L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 135 SIPSE-LGNLSNLLNLDISSNSL-SDYIPP-SLGKLQRLITFNVSNNFL 180
+ + L+NL L ++ +L + L L + +N +
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDI 151
L L LNL N G I S + N +L+ L L N++ ++ + L NL L +
Sbjct: 321 GLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELAL 378
Query: 152 SSNSLSDYIPP----SLGKLQRL 170
+N L +P L LQ++
Sbjct: 379 DTNQLKS-VPDGIFDRLTSLQKI 400
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 98 LKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNS 155
+ +++L N+ E+ +LQ L ++ I + LS+L+ L + N
Sbjct: 32 VNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 156 LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ L L ++ L GA+ S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 29/161 (18%)
Query: 50 LNQWRPEDPDPCNWKGVKC---DKNKRVITLSLTNHKLSG-PISADLGKLDQLKFLNLHS 105
L+ +D + KC KN + TL L+ + + K +L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 106 NNFYGEIPSELGNC--------------TELQGLSLQSNYLSGSIPSEL-GNLSNLLNLD 150
+N Y S + ++ L + + ++ + + ++L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 151 ISSNSLSDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
++ N ++ I L L +L N+S NFL G+I S
Sbjct: 306 LAQNEINK-IDDNAFWGLTHLLKL---NLSQNFL-GSIDSR 341
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 13/97 (13%)
Query: 97 QLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSN 154
+K +L + + + + T+L+ L+L N ++ I L++LL L++S N
Sbjct: 276 GVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 155 SLSDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
L I +L KL+ L ++S N + A+
Sbjct: 334 FLGS-IDSRMFENLDKLEVL---DLSYNHI-RALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 20/90 (22%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSL 127
++ L+L+ + L S LD+L+ L+L N+ + + L+ L+L
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELAL 378
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+N L S+P L++L + + +N
Sbjct: 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N K + G I + L+FL+L N + + L +L+ L L N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISVSN-LPKLPKLKKLELSENRIFG 85
Query: 135 SIPSELGNLSNLLNLDISSNSLSDY--IPPSLGKLQRLITFNVSNN 178
+ L NL +L++S N L D + P L KL+ L + ++ N
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 95 LDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
++ L L + G+I L+ LSL + L S+ + L L L L++S
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + + KL L N+S N L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 36/159 (22%), Positives = 59/159 (37%), Gaps = 13/159 (8%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLR 369
IG G FG + + A+K + E R + LGS + +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG--IPQVY 71
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ ++ + L G SL++ L I + + Y+H S +I
Sbjct: 72 YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLI 127
Query: 430 HRDIKSSNILL--DGNLEAR---VSDFGLAKLLEDEESH 463
+RD+K N L+ GN + + DF LAK D E+
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y + A+K + + +E + IL + N+R +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG--IPNVRWFG 72
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+L+ D L G SL++ + S +L L + + ++H S +HRD
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 433 IKSSNILLDGNLEAR---VSDFGLAKLLEDEESH 463
IK N L+ A + DFGLAK D +H
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 41/150 (27%), Positives = 61/150 (40%), Gaps = 34/150 (22%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK--------H 362
+G G F TV+ L+ D A+K + K E + E+ +L S++
Sbjct: 43 RKLGWGHFSTVW-LSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 363 RYLVNLRGY-----------CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNII 410
+V L C ++++ L G L + + + + Q L II
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440
+GL YLH C RIIH DIK NILL
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILL 180
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 7/118 (5%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYL 132
L + N L P + D L + N + IP G C E L L +N
Sbjct: 109 FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITF-NVSNNFLVGAIPSDG 188
+ S+ N + L + ++ N I + G + + +VS + A+PS G
Sbjct: 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 95 LDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSE--LGNLSNLLNLDI 151
L ++ + + + I + L L+ L + + L P + + L+I
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 152 SSNSLSDYIPPSL--GKLQRLITFNVSNN 178
+ N IP + G +T + NN
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 22/81 (27%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL--GNLSNLLNLDISSN 154
+ L L++N F + N T+L + L N I + G S LD+S
Sbjct: 157 ETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 155 SLSDYIPP-SLGKLQRLITFN 174
S++ +P L L+ LI N
Sbjct: 216 SVTA-LPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 98 LKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNS 155
+ L L + IPS N + + + + + S NLS + +++I +
Sbjct: 33 TQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 156 LSDYIPPS-LGKLQRLITFNVSNNFLVGAIPSDGVL 190
YI P L +L L + N L P +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 28/156 (17%), Positives = 54/156 (34%), Gaps = 13/156 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYC 372
IG G FG +++ + + A+K + E + + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+L+ D L G SL++ L + + +H +++RD
Sbjct: 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 433 IKSSNILL---DGNLEARVS--DFGLAKLLEDEESH 463
IK N L+ + + DFG+ K D +
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 25/121 (20%), Positives = 43/121 (35%), Gaps = 11/121 (9%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L I + + L L L N + S
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-S 90
Query: 136 IPSEL-GNLSNLLNLDISSN---SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
+ LS+L L SL ++ L L+ L NV++N + + +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL---NVAHNLIQ-SFKLPEYFS 146
Query: 192 K 192
Sbjct: 147 N 147
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 10/102 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
TL LT + + L L+ L N + + G+ L+ L++ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQ- 137
Query: 135 SIPSE--LGNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
S NL+NL +LD+SSN + I L ++ L
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 29/174 (16%)
Query: 315 IGSGGFGTVYK---------LAMDDGNVFALKRIDKLN---EGFDRFFERELEILGSIKH 362
G +Y+ + F+LK +D + FF+R + L K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 363 RYLVNLRG-------YCNSPTSK--LLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMG 412
+ L + K L+ L G SL AL + L + L +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L +LH +H ++ + NI +D +++V + +G A H+
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 25/134 (18%), Positives = 51/134 (38%), Gaps = 17/134 (12%)
Query: 61 CNWKGVKCDKNKR-----------VITLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNF 108
C V C N++ L L N++ + + KL QL+ +N +N
Sbjct: 11 CEGTTVDCS-NQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 109 YGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGK 166
+ + + L SN L ++ ++ L +L L + SN ++ + S
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIG 127
Query: 167 LQRLITFNVSNNFL 180
L + ++ +N +
Sbjct: 128 LSSVRLLSLYDNQI 141
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 35/171 (20%), Positives = 59/171 (34%), Gaps = 26/171 (15%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEIL---------GSIKHRY 364
IGSGGFG +Y + A + K+ + EL+ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 365 LVNLRG-----YCNSPTSKLLIYDF----LPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ G K Y F G L + + ++ L + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-QKISGQNGTFKKSTVLQLGIRMLD 162
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L Y+H +H DIK++N+LL +V +D+GL+ +H
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 22/116 (18%), Positives = 41/116 (35%), Gaps = 5/116 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYLS 133
L ++N + Q L++ N I G E L L N +
Sbjct: 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDG 188
I + N + L L++S N+ + +P + ++S + ++PS G
Sbjct: 168 -EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSL-QSNYLSGSIPSE-LGNLSNLLNLDISSN 154
+ L L+ N EI + N T+L L+L +N L +P++ S + LDIS
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212
Query: 155 SLSDYIPPSLGKLQRLITFNVSNN 178
+ L L++L + N
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 26/141 (18%), Positives = 51/141 (36%), Gaps = 16/141 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + C ++K I L KL L+ + + N+
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 111 EIPSE-LGNCTELQGLSLQ-SNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGK 166
I ++ N +L + ++ +N L I E NL NL L IS+ + +P
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIH 126
Query: 167 LQRLITFNVSNNFLVGAIPSD 187
+ + ++ +N + I +
Sbjct: 127 SLQKVLLDIQDNINIHTIERN 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 13/89 (14%), Positives = 27/89 (30%), Gaps = 3/89 (3%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ + L+L I + + + N + + L L L +
Sbjct: 15 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++N + L L ++NN L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 9e-05
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 10/107 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLS 133
L L +K+ I LDQ ++ N EI L+ L + +N +
Sbjct: 23 ELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNNRIC 77
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDY--IPPSLGKLQRLITFNVSNN 178
L +L L +++NSL + + P L L+ L + N
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 11/102 (10%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L L ++KL + A + +L L+ L + N +P + L L L N L
Sbjct: 65 LLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK 122
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
S+P + +L+ L L + N L +P L L+ L
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKEL 162
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 36/173 (20%), Positives = 57/173 (32%), Gaps = 27/173 (15%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKR-----IDKLNEGFDRF---FERELEILGSIKHRYLV 366
IG GGFG +Y M+ ++ + G F + I+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 367 NLRGYCNSPTSK-------------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
Y P +I D G L + +++ L + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L Y+H +H DIK+SN+LL+ +V D+GLA E H
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 53/212 (25%), Positives = 81/212 (38%), Gaps = 53/212 (25%)
Query: 292 HGDLPYSSKDII-KKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR 348
G D + + E L +IG G FG V K A D ALK + + + F R
Sbjct: 84 QGSYVQVPHDHVAYRYEVLK---VIGKGSFGQVVK-AYDHKVHQHVALKMV-RNEKRFHR 138
Query: 349 FFERELEILGSIKHR------YLVNLRGY-------CNSPTSKLL---IYDFL-----PG 387
E+ IL ++ + ++++ C T +LL +Y+ + G
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYELIKKNKFQG 196
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLE 445
SL + + + + + L LH RIIH D+K NILL G
Sbjct: 197 FSLP-LVRKFAHSI------------LQCLDALH---KNRIIHCDLKPENILLKQQGRSG 240
Query: 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+V DFG + E + T + F Y AP
Sbjct: 241 IKVIDFGSSC---YEHQRVYTYIQSRF-YRAP 268
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 27/85 (31%), Positives = 37/85 (43%), Gaps = 13/85 (15%)
Query: 101 LNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSLS 157
L+L NN + +E T L L L N+L+ I SE + NL LD+SSN L
Sbjct: 44 LDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 158 DYIPP----SLGKLQRLITFNVSNN 178
+ L L+ L + NN
Sbjct: 102 T-LDEFLFSDLQALEVL---LLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 9/110 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+++ L L L+ L L++N+ + + +LQ L L N +S
Sbjct: 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS- 149
Query: 135 SIPSE----LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS--NN 178
P E L L+ LD+SSN L L KL + + NN
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
+ L+N+++S ++ D L L L L+ N E+P L LQ L L +N ++
Sbjct: 60 RIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN 117
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
+ + +L NL L + N L I L +Q +
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 22/111 (19%), Positives = 44/111 (39%), Gaps = 12/111 (10%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS----ELGNCTELQGLSLQSNY 131
+ L + + +L+ ++L SNN E+ L L L L N
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDL-SNNQISELAPDAFQGL---RSLNSLVLYGNK 91
Query: 132 LSGSIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
++ +P L L +L L +++N ++ + + L L ++ +N L
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 51/212 (24%)
Query: 292 HGDLPYSSKDIIK-KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR 348
+ D + + + E +IG G FG V K A D + A+K I K + F
Sbjct: 41 NYDYIVKNGEKWMDRYEIDS---LIGKGSFGQVVK-AYDRVEQEWVAIKII-KNKKAFLN 95
Query: 349 FFERELEILGSIKHR------YLVNLRGY-------CNSPTSKLL---IYDFL-----PG 387
+ E+ +L + Y+V+L+ + C ++L +YD L G
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC--LVFEMLSYNLYDLLRNTNFRG 153
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLE 445
SL+ + ++Q+ L +L IIH D+K NILL
Sbjct: 154 VSLN-LTRKFAQQM------------CTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199
Query: 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++ DFG + I + F Y +P
Sbjct: 200 IKIVDFGSSC---QLGQRIYQYIQSRF-YRSP 227
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.92 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.9 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.89 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.89 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.83 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.82 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.82 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.81 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.8 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.8 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.8 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.79 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.78 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.77 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.76 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.75 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.73 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.72 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.72 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.71 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.7 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.7 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.7 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.68 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.68 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.68 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.68 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.67 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.67 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.67 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.67 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.66 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.65 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.65 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.65 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.64 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.64 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.64 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.64 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.64 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.62 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.61 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.61 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.61 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.61 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.61 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.6 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.6 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.6 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.6 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.59 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.59 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.58 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.58 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.57 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.56 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.56 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.56 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.56 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.54 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.53 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.52 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.46 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.46 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.43 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.42 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.4 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.39 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.38 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.36 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.35 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.33 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.32 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.85 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.8 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.73 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.53 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.46 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.42 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.23 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.14 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.84 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.68 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.61 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.29 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.24 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.8 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.33 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.5 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=321.78 Aligned_cols=174 Identities=22% Similarity=0.420 Sum_probs=150.3
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999864 477899999988777677889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 381 IYDFLPGGSLDEALHER------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
|||||++|+|.++++.. ...++|.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 2359999999999999999999995 59999999999999999999999
Q ss_pred EecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 449 SDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
+|||+|+......... .....||+.|||||++.++
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~ 205 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 205 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCC
Confidence 9999998775543322 2335699999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=320.39 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=152.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 68999999997532 234577999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.++++.. +.+++..+..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999765 569999999999999999999995 5999999999999999999999999999998764332
Q ss_pred -ceeecccccccccCCcccCC
Q 011486 463 -HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 -~~~~~~~Gt~~Y~APE~~~~ 482 (484)
......+||+.|||||++.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcC
Confidence 23445789999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=321.96 Aligned_cols=174 Identities=22% Similarity=0.424 Sum_probs=144.3
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666789999999999999864 478899999988777777899999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcE
Q 011486 381 IYDFLPGGSLDEALHERS--------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~ 446 (484)
|||||++|+|.++++... ..++|.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997532 348999999999999999999995 599999999999999999999
Q ss_pred EEEecCCCcccCCCCc-ceeecccccccccCCcccCCC
Q 011486 447 RVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 447 kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
||+|||+|+.+..... .......||+.|||||++.++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~ 235 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 235 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCC
Confidence 9999999997754332 223446799999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=323.63 Aligned_cols=171 Identities=25% Similarity=0.387 Sum_probs=152.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+.|+..+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999875 69999999997655445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++|+|.+++.. ..+++.++..|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.+...... .
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence 99999999975 459999999999999999999995 59999999999999999999999999999987654332 3
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
...+||+.|||||++...
T Consensus 228 ~~~~GTp~YmAPEvl~~~ 245 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRL 245 (346)
T ss_dssp CCCCSCGGGCCHHHHTTC
T ss_pred cccccCcCcCCHHHHCCC
Confidence 456799999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=325.02 Aligned_cols=174 Identities=26% Similarity=0.413 Sum_probs=146.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999865 6899999999754 3445678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||++|+|.+++..+. ..+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999997643 347999999999999999999995 599999999999999999999999999999775432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .....+||+.|||||++.+.
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~ 200 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENK 200 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTC
T ss_pred c-cccccCCCccccCHHHHCCC
Confidence 1 23446799999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.95 Aligned_cols=170 Identities=29% Similarity=0.430 Sum_probs=143.4
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++++..+.||+|+||+||+|++.+ .||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4677888999999999999998753 58999987533 4456789999999999999999999998854 56899999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC-c
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-S 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~ 462 (484)
||++|+|.++++.....++|.++..|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999998777789999999999999999999995 599999999999999999999999999998765432 2
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
......+||+.|||||++.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp -----CCCCTTSCCHHHHH
T ss_pred eeecccccCCCccCHHHhh
Confidence 2234567999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=316.03 Aligned_cols=174 Identities=21% Similarity=0.339 Sum_probs=147.7
Q ss_pred cCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
.+++..+.||+|+||+||+|.+. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556789999999999999863 46789999997543 334678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 380 LIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
+|||||++|+|.++++.+. ..++|.++++|+.||+.||+|||+ .+||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 9999999999999996532 348999999999999999999995 5999999999999999999
Q ss_pred cEEEEecCCCcccCCCCc-ceeecccccccccCCcccCCC
Q 011486 445 EARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+||+|||+|+....... .......||++|||||++.++
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~ 222 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG 222 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC
Confidence 999999999987754332 223446799999999998654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=325.21 Aligned_cols=171 Identities=25% Similarity=0.387 Sum_probs=152.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+.|+..+.||+|+||.||+|... +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999875 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++|+|.++++. ..+++.++..|+.||+.||+|||+ .+||||||||+||||+.+|.+||+|||+|+.+...... .
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 99999999965 459999999999999999999995 59999999999999999999999999999987654332 3
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
...+||+.|||||++...
T Consensus 305 ~~~~GTp~YmAPEvl~~~ 322 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRL 322 (423)
T ss_dssp CCCEECTTTCCHHHHTTC
T ss_pred cccccCcCcCCHHHHCCC
Confidence 456799999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.27 Aligned_cols=171 Identities=25% Similarity=0.439 Sum_probs=136.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||+||+|... +++.||+|++++.. ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999865 68999999997532 23456799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+ +|+|.+++..+ +.+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...+..
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9999 67999999764 569999999999999999999995 599999999999999999999999999998765433
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....+||+.|||||++.+.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~ 186 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGK 186 (275)
T ss_dssp ----------CTTSCHHHHSSS
T ss_pred --ccCCeeECcccCChhhhcCC
Confidence 23346799999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.52 Aligned_cols=168 Identities=27% Similarity=0.379 Sum_probs=142.8
Q ss_pred CccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEEEE
Q 011486 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIY 382 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 382 (484)
+..+.||+|+||+||+|... ++..||+|++... .....+.|.+|++++++++|||||++++++.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999875 5889999999653 34456789999999999999999999999865 34579999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~ 461 (484)
|||++|+|.++++.. ..+++..+..|+.||+.||+|||++ .++||||||||+|||++ +++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999765 5699999999999999999999954 23499999999999998 4899999999999865432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+||+.|||||++.+
T Consensus 186 --~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT
T ss_pred --ccCCcccCccccCHHHcCC
Confidence 2345679999999998853
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.02 Aligned_cols=175 Identities=26% Similarity=0.389 Sum_probs=138.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------- 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 376 (484)
.++|++.+.||+|+||+||+|+.. +++.||||+++... +...+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356889999999999999999865 68999999997543 445678999999999999999999999987544
Q ss_pred -----ceEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEE
Q 011486 377 -----SKLLIYDFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (484)
Q Consensus 377 -----~~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~ 449 (484)
..|+||||+++|+|.+++..+.. ..++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999976432 25677788999999999999995 599999999999999999999999
Q ss_pred ecCCCcccCCCCcc-----------eeecccccccccCCcccCCC
Q 011486 450 DFGLAKLLEDEESH-----------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 450 DFGla~~~~~~~~~-----------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|||+|+.+...... ..+..+||+.|||||++.+.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence 99999987543221 11235799999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.52 Aligned_cols=169 Identities=27% Similarity=0.355 Sum_probs=144.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.+.|+..+.||+|+||+||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456777889999999999999875 689999999975432 24699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 463 (484)
|++|+|.++++.. +.+++..+..|+.||+.||+||| +.+||||||||+|||++.+| .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999765 56999999999999999999999 56999999999999999988 6999999999987643221
Q ss_pred ----eeecccccccccCCcccCCC
Q 011486 464 ----ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ----~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....++||+.|||||++.+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~ 231 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGK 231 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTC
T ss_pred cceecCCccccCccccCHHHHCCC
Confidence 12345799999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.51 Aligned_cols=172 Identities=28% Similarity=0.375 Sum_probs=142.1
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|++.+.||+|+||+||+|+.. +++.||+|++++.. .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999753 47899999997532 2233468899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... +.+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999765 569999999999999999999995 59999999999999999999999999999876543
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ....+||+.|||||++.+.
T Consensus 180 ~~~-~~~~~GT~~YmAPE~~~~~ 201 (304)
T 3ubd_A 180 EKK-AYSFCGTVEYMAPEVVNRR 201 (304)
T ss_dssp -CC-CCSCCCCGGGCCHHHHHTS
T ss_pred Ccc-ccccccCcccCCHHHhccC
Confidence 322 3446799999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=305.29 Aligned_cols=172 Identities=28% Similarity=0.381 Sum_probs=140.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----ceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 382 (484)
++|...+.||+|+||+||+|++ +|+.||||+++.... ....+++|+..+.+++|||||++++++.+++ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3566788999999999999987 588999999976432 2233455666677899999999999998664 469999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
|||++|+|.++++.. .++|+.+.+++.|++.||+|||+++ .++||||||||+|||+++++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999763 5899999999999999999999641 359999999999999999999999999999877
Q ss_pred CCCCcce---eecccccccccCCcccCC
Q 011486 458 EDEESHI---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~---~~~~~Gt~~Y~APE~~~~ 482 (484)
....... ....+||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred cCCCCceeeecccccccccccCHHHhcc
Confidence 5543322 234579999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.20 Aligned_cols=186 Identities=26% Similarity=0.379 Sum_probs=157.2
Q ss_pred CCCCHHHHHHHhcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCC-Ccee
Q 011486 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKH-RYLV 366 (484)
Q Consensus 295 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv 366 (484)
.|++.++++...++|++.+.||+|+||+||+|.... ++.||||+++... ....+.|.+|++++++++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 456777777778899999999999999999998653 3689999997644 4456789999999999975 8999
Q ss_pred eeEEEEEcC-CceEEEEEcCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 011486 367 NLRGYCNSP-TSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (484)
Q Consensus 367 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH 430 (484)
+++|+|.++ +..++|||||++|+|.++|+.. ...+++..++.|+.|||.||+|||+ ++|||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeec
Confidence 999999765 5689999999999999999753 2348999999999999999999995 59999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 431 rDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|||||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.++
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~ 262 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 262 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC
Confidence 999999999999999999999999977554333 23456799999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.79 Aligned_cols=171 Identities=26% Similarity=0.414 Sum_probs=145.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 377 (484)
++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 47899999999999999999875 69999999997543 34456788999999999999999999997643 56
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+|||||+ |+|.+++... +.+++..+..|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999995 6899999754 579999999999999999999995 59999999999999999999999999999876
Q ss_pred CCCC---cceeecccccccccCCcccCC
Q 011486 458 EDEE---SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~---~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .......+||+.|||||++.+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTT
T ss_pred ccCccccccccccceeChHhcCHHHhcC
Confidence 4322 122345689999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.63 Aligned_cols=171 Identities=27% Similarity=0.416 Sum_probs=147.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHH---HHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFF---ERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ......+ .+++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999876 68999999996432 1112223 3446777888999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||++||+|.+++... +.+++..+..|+.||+.||+||| +.+||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999765 56999999999999999999999 5699999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ....+||+.|||||++..|
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~ 365 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKG 365 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTT
T ss_pred CCC---CCCccCCcCccCHHHHhCC
Confidence 543 3446899999999998643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=291.95 Aligned_cols=168 Identities=23% Similarity=0.311 Sum_probs=143.2
Q ss_pred hcCCCccceeeeccceeEEEEEec----CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.+.|++.+.||+|+||+||+|+.+ +++.||+|++..... ..++.+|+++++.+ +||||+++++++.+++..|+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 467999999999999999999753 467899999876443 45688999999998 69999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~~~~~ 459 (484)
||||+++|+|.++++ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999999983 48999999999999999999995 599999999999999876 7999999999986543
Q ss_pred CCc---------------------------ceeecccccccccCCcccCC
Q 011486 460 EES---------------------------HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~---------------------------~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ......+||+.|||||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 211 11233579999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.50 Aligned_cols=173 Identities=27% Similarity=0.479 Sum_probs=155.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999875 6899999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC--CcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN--LEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~--~~~kl~DFGla~~~~~~~~ 462 (484)
|++|+|.+++......+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.+.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 99999999997766779999999999999999999995 599999999999999854 8999999999998865432
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+||+.|||||++.+.
T Consensus 313 --~~~~~GT~~y~APEv~~~~ 331 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGK 331 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTC
T ss_pred --eeeeEECccccCHHHhCCC
Confidence 3446799999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=266.00 Aligned_cols=175 Identities=29% Similarity=0.508 Sum_probs=153.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|+..+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999875 5899999999876677788899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.++++.....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999998866779999999999999999999995 499999999999999999999999999998765432211
Q ss_pred -------------eecccccccccCCcccCCC
Q 011486 465 -------------TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 -------------~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCC
Confidence 1145699999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=271.70 Aligned_cols=187 Identities=44% Similarity=0.829 Sum_probs=163.1
Q ss_pred CCCHHHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 296 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
.++..++....++|+..+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 478899999999999999999999999999998889999999997643 2223468999999999999999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
++..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999998643 23999999999999999999999654459999999999999999999999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++..............||+.|+|||++.+
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred ccccccCcccccccccccCCcCccCHHHhcc
Confidence 9999876555444555679999999998743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=283.44 Aligned_cols=180 Identities=24% Similarity=0.379 Sum_probs=155.9
Q ss_pred HHHHHHHhcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 299 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
..++....++|++.+.||+|+||+||+|+..+ ++.||+|++++.. ......+.+|.+++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34444556889999999999999999998774 7889999997532 1122348899999999999999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
++..|+||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999998756679999999999999999999995 59999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+.............+||+.|+|||++.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHh
Confidence 877655444444567999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=278.82 Aligned_cols=179 Identities=25% Similarity=0.376 Sum_probs=155.5
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 375 (484)
++.....++|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|.+++..++||||+++++++.++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445688999999999999999999875 68999999997532 12234588999999999999999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
+..|+||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999998765679999999999999999999995 599999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCCcccC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.............+||+.|+|||++.
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred eccCCCccccceeccccCcCCHHHHh
Confidence 87654443334567999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=261.01 Aligned_cols=171 Identities=25% Similarity=0.384 Sum_probs=151.7
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999986 46899999999765555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999999764 58999999999999999999995 49999999999999999999999999999877654332
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC
T ss_pred cCCccCCcCccChhhhcC
Confidence 334569999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=265.72 Aligned_cols=171 Identities=25% Similarity=0.351 Sum_probs=151.7
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56899999999999999999987 57999999999754 3445677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 999999999999765 569999999999999999999995 4999999999999999999999999999987765432
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 170 --~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHT
T ss_pred --cccccCCcceeCcccccC
Confidence 234579999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=278.87 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=152.7
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
++....++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|+++++.++||||+++++++.+++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999876 58899999996522 112345789999999999999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..|+||||+++|+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 99999999999999999975 358999999999999999999995 5999999999999999999999999999988
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
............+||+.|+|||++..
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHT
T ss_pred eccCCcccccCCcCCccccCHHHhhc
Confidence 76544333445679999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=264.79 Aligned_cols=173 Identities=24% Similarity=0.337 Sum_probs=150.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|+++++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467889999999999999999876 68999999997532 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999999764 568999999999999999999995 499999999999999999999999999998654322
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ......||+.|+|||++.++
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~ 180 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSS
T ss_pred C-cccccccChhhCChhhhcCC
Confidence 2 23446799999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=261.25 Aligned_cols=183 Identities=25% Similarity=0.345 Sum_probs=158.6
Q ss_pred CCCCHHHHHHHhcC----------CCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC
Q 011486 295 LPYSSKDIIKKLET----------LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHR 363 (484)
Q Consensus 295 ~~~~~~el~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 363 (484)
.+++.+++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888877764 566779999999999999876 6999999999866555667899999999999999
Q ss_pred ceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC
Q 011486 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443 (484)
Q Consensus 364 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~ 443 (484)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999999864 459999999999999999999995 499999999999999999
Q ss_pred CcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 444 LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 444 ~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+.+||+|||+++........ .....||+.|+|||++.++
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRS 216 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTC
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCC
Confidence 99999999999877543322 2345799999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=259.24 Aligned_cols=172 Identities=29% Similarity=0.409 Sum_probs=144.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56888999999999999999865 6889999998542 2345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999765 468999999999999999999995 4999999999999999999999999999987765433
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......||+.|+|||++.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp --------CCSSCCHHHHHT
T ss_pred cccCccccCccccCHhHhcC
Confidence 33445679999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=266.48 Aligned_cols=181 Identities=39% Similarity=0.662 Sum_probs=156.9
Q ss_pred HHHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 299 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
..++....++|+..+.||+|+||.||+|...+++.||+|++........+.+.+|+++++.++||||+++++++...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34445567899999999999999999999888999999999876666678899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 379 LLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999996543 248999999999999999999995 499999999999999999999999999998
Q ss_pred ccCCCCc-ceeecccccccccCCcccCC
Q 011486 456 LLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .......||+.|+|||++.+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcC
Confidence 7543222 22234568999999998743
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=259.62 Aligned_cols=172 Identities=28% Similarity=0.415 Sum_probs=148.4
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788999999999999999999889999999997532 3345778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9974 8999888766679999999999999999999995 49999999999999999999999999999877543322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 176 -~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 176 -YTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp ---CCCCCCTTCCHHHHTT
T ss_pred -ccCCcccCCcCCHHHhcC
Confidence 233468999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=256.50 Aligned_cols=172 Identities=26% Similarity=0.380 Sum_probs=151.5
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|+..+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357888999999999999999998899999999986443 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999998776779999999999999999999995 4999999999999999999999999999987654332223
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....||+.|+|||++.
T Consensus 165 ~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFS 180 (269)
T ss_dssp TSTTCCGGGCCHHHHH
T ss_pred cCcccccccCCHHHhc
Confidence 3345788999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=264.12 Aligned_cols=172 Identities=25% Similarity=0.371 Sum_probs=144.7
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 379 (484)
..++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999876 58999999997532 23456688999999988 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999765 569999999999999999999995 4999999999999999999999999999986443
Q ss_pred CCcceeecccccccccCCcccC
Q 011486 460 EESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
... .....+||+.|+|||++.
T Consensus 177 ~~~-~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 177 NGV-TTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp ----------CCGGGCCHHHHH
T ss_pred CCc-cccccCCCcCeEChhhcC
Confidence 222 234567999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=259.34 Aligned_cols=170 Identities=29% Similarity=0.442 Sum_probs=149.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467889999999999999999876 68999999997532 22356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999754 56899999999999999999999 559999999999999999999999999999876542
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~ 178 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTK 178 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTC
T ss_pred ---cccccCCccccCHhHhcCC
Confidence 2345799999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=259.42 Aligned_cols=174 Identities=25% Similarity=0.393 Sum_probs=144.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------ 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 377 (484)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467888999999999999999876 78999999997533 4456789999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEEcCCCCCHHHHHhhcCC--CCCHH
Q 011486 378 ---------------------------------------------------KLLIYDFLPGGSLDEALHERSE--QLDWD 404 (484)
Q Consensus 378 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~--~l~~~ 404 (484)
.++||||+++++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 7899999999999999976432 26677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-----------eeeccccccc
Q 011486 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-----------ITTIVAGTFG 473 (484)
Q Consensus 405 ~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-----------~~~~~~Gt~~ 473 (484)
.+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 889999999999999995 49999999999999999999999999999987654211 1223569999
Q ss_pred ccCCcccCC
Q 011486 474 YLAPGKDCT 482 (484)
Q Consensus 474 Y~APE~~~~ 482 (484)
|+|||++.+
T Consensus 242 y~aPE~~~~ 250 (332)
T 3qd2_B 242 YMSPEQIHG 250 (332)
T ss_dssp GSCHHHHHC
T ss_pred ccChHHhcC
Confidence 999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=252.11 Aligned_cols=172 Identities=24% Similarity=0.341 Sum_probs=152.0
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||+|...++..||+|+++.... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999998888999999976442 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999998766669999999999999999999995 4999999999999999999999999999987765443333
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....||+.|+|||++.
T Consensus 163 ~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFH 178 (268)
T ss_dssp CSCCCCGGGCCHHHHH
T ss_pred cCCCcCcccCCHHHHh
Confidence 3445778899999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=262.83 Aligned_cols=176 Identities=24% Similarity=0.364 Sum_probs=150.1
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
....++|++.+.||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999876 58899999997532 22356678899999876 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999764 468999999999999999999995 49999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... ......||+.|+|||++.+.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~ 193 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEILLGQ 193 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTC
T ss_pred ccCCC-cccCCCCCcccCChhhhcCC
Confidence 43222 23456799999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=257.98 Aligned_cols=172 Identities=20% Similarity=0.335 Sum_probs=151.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367889999999999999999876 58889999987543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC--CCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~~ 462 (484)
+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999998765679999999999999999999995 49999999999999987 78999999999998765432
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTC
T ss_pred --cccccCChhhcCcHHhcCC
Confidence 3345699999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=268.03 Aligned_cols=173 Identities=23% Similarity=0.380 Sum_probs=148.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+++..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 568999999999999999999876 57889999997542 22234578899999887 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999765 569999999999999999999995 49999999999999999999999999999864332
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. .....+||+.|+|||++.+.
T Consensus 207 ~~-~~~~~~gt~~Y~aPE~l~~~ 228 (396)
T 4dc2_A 207 GD-TTSTFCGTPNYIAPEILRGE 228 (396)
T ss_dssp TC-CBCCCCBCGGGCCHHHHTTC
T ss_pred CC-ccccccCCcccCCchhhcCC
Confidence 22 23456799999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=260.01 Aligned_cols=173 Identities=28% Similarity=0.438 Sum_probs=147.0
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|++.+.||+|+||.||+|... .+..||||.++.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999875 3456999999864 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.++++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999998766779999999999999999999995 499999999999999999999999999999875432
Q ss_pred cc--eeecccccccccCCcccCC
Q 011486 462 SH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ......||+.|+|||++.+
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~ 228 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAF 228 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHH
T ss_pred cceeeccCCCCcccccCHhHhcC
Confidence 22 1223346889999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=261.46 Aligned_cols=173 Identities=23% Similarity=0.381 Sum_probs=149.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|.++++++ +||||+++++++.+++..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467888999999999999999876 58899999997542 33456788999999988 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999764 469999999999999999999995 49999999999999999999999999999864332
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. ......||+.|+|||++.+.
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTC
T ss_pred CC-cccccCCCccccCccccCCC
Confidence 22 23446799999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=264.36 Aligned_cols=174 Identities=26% Similarity=0.394 Sum_probs=148.4
Q ss_pred hcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|++.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999753 35579999997643 34567899999999999 899999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..|+||||+++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997643 248999999999999999999995 499999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 99999999999999876543321 1233457899999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.41 Aligned_cols=171 Identities=30% Similarity=0.402 Sum_probs=149.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.+.|++.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357889999999999999999876 689999999975432 1357799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla 454 (484)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999654 569999999999999999999995 4999999999999998877 7999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+....... .....||+.|+|||++..
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTT
T ss_pred eEcCCCCc--cccCCCCccEECchHHcC
Confidence 88765332 234569999999999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=264.48 Aligned_cols=171 Identities=30% Similarity=0.477 Sum_probs=150.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467899999999999999999876 58899999986532 23356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999999754 569999999999999999999995 499999999999999999999999999998775433
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++..
T Consensus 170 ~--~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 170 Q--ITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp C--BCCCCSCGGGCCGGGTCC
T ss_pred c--eeccCCCccccCCeeecc
Confidence 2 344679999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=253.22 Aligned_cols=171 Identities=26% Similarity=0.409 Sum_probs=148.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999876 58899999997433 3445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++ ++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9975 7777776666779999999999999999999995 49999999999999999999999999999877543322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 158 -~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTT
T ss_pred -ccCCccccCCcChHHHcC
Confidence 234568999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.23 Aligned_cols=171 Identities=30% Similarity=0.444 Sum_probs=146.2
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788899999999999999998889999999997543 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 975 9999998766779999999999999999999995 49999999999999999999999999999876533222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 157 ~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp -----CCCTTCCHHHHTT
T ss_pred cccccccccccCchheeC
Confidence 233468999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=262.53 Aligned_cols=173 Identities=27% Similarity=0.399 Sum_probs=152.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.+.|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999875 6889999999876655567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC--CCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~~ 462 (484)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999998765679999999999999999999995 49999999999999974 57899999999998765432
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++...
T Consensus 207 --~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTC
T ss_pred --eeeeccCCCccCchhccCC
Confidence 2334699999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=260.84 Aligned_cols=170 Identities=26% Similarity=0.368 Sum_probs=150.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467889999999999999999876 68999999997532 22356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999765 468999999999999999999995 49999999999999999999999999999877543
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~ 213 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSK 213 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTC
T ss_pred ---cccccCCccccCHHHhcCC
Confidence 2345699999999998653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=263.64 Aligned_cols=172 Identities=19% Similarity=0.235 Sum_probs=146.3
Q ss_pred hcCCCccceeeeccceeEEEEE------ecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC---CCceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLA------MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 376 (484)
.++|.+.+.||+|+||.||+|. ..+++.||+|+++... ...+.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4678889999999999999993 4568899999997653 456788888888887 999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC----------
Q 011486 377 SKLLIYDFLPGGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---------- 442 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---------- 442 (484)
..++||||+++|+|.+++.. ....+++..+..|+.||+.||+||| +.+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999975 2456999999999999999999999 459999999999999998
Q ss_pred -CCcEEEEecCCCcccCCC-CcceeecccccccccCCcccCCC
Q 011486 443 -NLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 443 -~~~~kl~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.+||+|||+|+.+... .........||+.|||||++.+.
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 260 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC
Confidence 899999999999765421 22233456799999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=259.13 Aligned_cols=173 Identities=28% Similarity=0.432 Sum_probs=140.1
Q ss_pred hcCCCccceeeeccceeEEEEEe----cCCCEEEEEEecccC----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
.++|++.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999987 478999999997642 2234568899999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999764 468999999999999999999995 49999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCCcccCCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... ......||+.|+|||++.++
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~ 196 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRS 196 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTS
T ss_pred ccCCc-cccccCCCcCccCHhhCcCC
Confidence 43222 23345799999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=264.40 Aligned_cols=173 Identities=27% Similarity=0.458 Sum_probs=138.9
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|++.+.||+|+||.||+|+.. ++..||||.++.. .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999865 5778999999764 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999998776679999999999999999999995 499999999999999999999999999998775432
Q ss_pred cce--eecccccccccCCcccCC
Q 011486 462 SHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....+|+.|+|||++.+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~ 224 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAY 224 (373)
T ss_dssp ------------CTTSCHHHHHH
T ss_pred ccceeccCCCcCCCccChhhhcc
Confidence 211 122345788999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=256.96 Aligned_cols=178 Identities=31% Similarity=0.474 Sum_probs=142.2
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
++....++|++.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334467889999999999999999987 58889999997543 34456799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999976432 28999999999999999999995 47 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+....... ......||+.|+|||++.+.
T Consensus 187 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 214 (309)
T 3p86_A 187 RLKASTFL-SSKSAAGTPEWMAPEVLRDE 214 (309)
T ss_dssp ----------------CCTTSCHHHHTTC
T ss_pred cccccccc-ccccCCCCccccChhhhcCC
Confidence 86544321 22345699999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=255.10 Aligned_cols=173 Identities=23% Similarity=0.326 Sum_probs=148.6
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|+..+.||+|+||.||++...++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888999999999999999998888999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999998755679999999999999999999995 4999999999999999999999999999987654332222
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|+|||++..
T Consensus 179 ~~~~~~~~y~aPE~~~~ 195 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMY 195 (283)
T ss_dssp TSTTSCGGGCCHHHHHH
T ss_pred cCCccCcccCCHHHhcc
Confidence 33457889999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.38 Aligned_cols=175 Identities=23% Similarity=0.309 Sum_probs=150.0
Q ss_pred HHhcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCce
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 378 (484)
...++|++.+.||+|+||.||+|+... ++.||+|++++.. ....+.+.+|.+++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 346789999999999999999998764 7889999997532 23356788999999988 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999999764 469999999999999999999995 499999999999999999999999999998643
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......||+.|+|||++.+.
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~ 196 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQ 196 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTC
T ss_pred cCCc-ccccccCCccccChhhhcCC
Confidence 3222 23456799999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=256.14 Aligned_cols=173 Identities=32% Similarity=0.530 Sum_probs=145.3
Q ss_pred cCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 379 (484)
++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788899999999999999974 36889999999877666678899999999999999999999998654 5589
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999998765669999999999999999999995 4999999999999999999999999999987754
Q ss_pred CCcc--eeecccccccccCCcccCC
Q 011486 460 EESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......||..|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC
Confidence 3221 1223457888999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-30 Score=249.10 Aligned_cols=182 Identities=35% Similarity=0.627 Sum_probs=158.5
Q ss_pred CCCHHHHHHHhcCCCcc------ceeeeccceeEEEEEecCCCEEEEEEeccc----ChhHHHHHHHHHHHHhcCCCCce
Q 011486 296 PYSSKDIIKKLETLDDD------HIIGSGGFGTVYKLAMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYL 365 (484)
Q Consensus 296 ~~~~~el~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~ni 365 (484)
.|+..++...+++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|++++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 48899999999998877 8999999999999987 5889999998653 23456789999999999999999
Q ss_pred eeeEEEEEcCCceEEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC
Q 011486 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443 (484)
Q Consensus 366 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~ 443 (484)
+++++++...+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999999743 3459999999999999999999995 499999999999999999
Q ss_pred CcEEEEecCCCcccCCCCcc-eeecccccccccCCcccC
Q 011486 444 LEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 444 ~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~ 481 (484)
+.+||+|||+++........ ......||+.|+|||++.
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhc
Confidence 99999999999876543222 223456999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=260.22 Aligned_cols=173 Identities=25% Similarity=0.371 Sum_probs=147.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468899999999999999999876 78999999986433 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc-
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~- 462 (484)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999998654 459999999999999999999995 5999999999999999999999999999987643221
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......||+.|+|||++..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHC
T ss_pred cccCCCccCcCccCcHHhcc
Confidence 12234579999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.52 Aligned_cols=173 Identities=24% Similarity=0.324 Sum_probs=147.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999865 68999999986421 1235779999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc---EEEEecCCC
Q 011486 381 IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLA 454 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~---~kl~DFGla 454 (484)
||||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 2348999999999999999999995 49999999999999986654 999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+....... ......||+.|+|||++..+
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 208 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKRE 208 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCC
Confidence 88765432 22345699999999998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=257.09 Aligned_cols=170 Identities=34% Similarity=0.404 Sum_probs=146.0
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc----eEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----KLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv 381 (484)
.++|++.+.||+|+||.||+|+.. ++.||||+++... .....+.+|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999875 7899999997643 234556779999999999999999999987553 6999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP----------RIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~----------~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
|||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999763 4899999999999999999999 55 9999999999999999999999999
Q ss_pred CCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++........ ......||+.|+|||++.+
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred CcccccccccCccccccCccCccccCHhhccc
Confidence 999877543322 1233569999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=265.38 Aligned_cols=174 Identities=25% Similarity=0.372 Sum_probs=149.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999886 68999999997543 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++|+|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999998766669999999999999999999995 49999999999999999999999999999875443211
Q ss_pred ee-ecccccccccCCcccCC
Q 011486 464 IT-TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~-~~~~Gt~~Y~APE~~~~ 482 (484)
.. ....+++.|+|||++..
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~ 289 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNY 289 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhcc
Confidence 11 11235788999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=253.05 Aligned_cols=171 Identities=25% Similarity=0.394 Sum_probs=142.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh--------------------------hHHHHHHHHHHHHh
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--------------------------GFDRFFERELEILG 358 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 358 (484)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467899999999999999999865 688999999865321 11356889999999
Q ss_pred cCCCCceeeeEEEEEc--CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 011486 359 SIKHRYLVNLRGYCNS--PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (484)
Q Consensus 359 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~ 436 (484)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 9999999999999987 4578999999999999887543 469999999999999999999995 49999999999
Q ss_pred cEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 437 NILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 437 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||++.++.+||+|||+++........ .....||+.|+|||++..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCT
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhcc
Confidence 999999999999999999877654322 334569999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=265.35 Aligned_cols=173 Identities=27% Similarity=0.355 Sum_probs=148.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467889999999999999999764 68899999997543 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~~~~~ 459 (484)
||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 90 E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999765 569999999999999999999995 4999999999999998 567899999999987765
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....||+.|+|||++...
T Consensus 166 ~~~~-~~~~~gt~~Y~APE~l~~~ 188 (444)
T 3soa_A 166 EQQA-WFGFAGTPGYLSPEVLRKD 188 (444)
T ss_dssp TCCB-CCCSCSCGGGCCHHHHTTC
T ss_pred CCce-eecccCCcccCCHHHhcCC
Confidence 4322 2345799999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=258.29 Aligned_cols=172 Identities=29% Similarity=0.415 Sum_probs=149.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457899999999999999999875 68999999997532 344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~~~~ 459 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999754 568999999999999999999995 4999999999999998654 599999999987764
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .....||+.|+|||++.++
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~ 205 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKD 205 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTC
T ss_pred Ccc--cccCCCCccccCHHHHccC
Confidence 332 2345799999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=254.21 Aligned_cols=172 Identities=25% Similarity=0.386 Sum_probs=134.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999875 58999999997543 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 384 FLPGGSLDEALHERS-----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999987532 348999999999999999999995 499999999999999999999999999998775
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||+.|+|||++.+
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTT
T ss_pred CCccc-CCCCcccccccCchHhhC
Confidence 43222 233468999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=254.22 Aligned_cols=170 Identities=29% Similarity=0.401 Sum_probs=148.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
+.|++.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999876 589999999875321 13578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCCc
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla~ 455 (484)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999654 569999999999999999999995 4999999999999999887 89999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .....||+.|+|||++..
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTT
T ss_pred ECCCCCc--cccccCCcCcCCceeecC
Confidence 7754332 234569999999998864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=260.82 Aligned_cols=167 Identities=25% Similarity=0.372 Sum_probs=142.3
Q ss_pred ccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 311 DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
..+.||+|+||.||+|... +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999865 689999999987665667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE--cCCCcEEEEecCCCcccCCCCcceeec
Q 011486 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLEARVSDFGLAKLLEDEESHITTI 467 (484)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 467 (484)
|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.+..... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 999997665669999999999999999999995 499999999999999 5678999999999998765432 233
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..||+.|+|||++..
T Consensus 248 ~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNY 262 (373)
T ss_dssp CCSSCTTCCHHHHTT
T ss_pred ccCCCcEeChhhccC
Confidence 469999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=252.47 Aligned_cols=170 Identities=22% Similarity=0.275 Sum_probs=142.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|+..+.||+|+||+||+|... +++.||||++.... ......+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999876 78999999986532 33344555666666555 8999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+ +++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999 679999998877779999999999999999999995 4999999999999999999999999999987754322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 213 --~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 213 --GEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT
T ss_pred --CcccCCCccccCHhHhcC
Confidence 334569999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=262.29 Aligned_cols=185 Identities=26% Similarity=0.388 Sum_probs=154.8
Q ss_pred CCCCHHHHHHHhcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCcee
Q 011486 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLV 366 (484)
Q Consensus 295 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv 366 (484)
.++...++....++|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++++++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 4566777777788999999999999999999973 246789999998643 34457799999999999 799999
Q ss_pred eeEEEEEcCCc-eEEEEEcCCCCCHHHHHhhcCC----------------------------------------------
Q 011486 367 NLRGYCNSPTS-KLLIYDFLPGGSLDEALHERSE---------------------------------------------- 399 (484)
Q Consensus 367 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 399 (484)
++++++.+.+. .++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999988655 8999999999999999976432
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 400 -------------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 400 -------------------~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
.+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 18899999999999999999995 49999999999999999999999999999876543
Q ss_pred Cc-ceeecccccccccCCcccCC
Q 011486 461 ES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .......||+.|+|||++.+
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcC
Confidence 32 22334568999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=255.65 Aligned_cols=170 Identities=26% Similarity=0.439 Sum_probs=148.1
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46788999999999999999986 478999999986532 12245789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+ +|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78999998765 569999999999999999999995 499999999999999999999999999998776543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVING 181 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCC
T ss_pred c--cccccCCcCcCCHHHHcC
Confidence 2 234569999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=260.81 Aligned_cols=173 Identities=28% Similarity=0.373 Sum_probs=140.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHH-HhcCCCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999876 58889999997543 2234456677776 577899999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999764 468999999999999999999995 59999999999999999999999999999864332
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. .....+||+.|+|||++.+.
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~ 214 (373)
T 2r5t_A 193 NS-TTSTFCGTPEYLAPEVLHKQ 214 (373)
T ss_dssp CC-CCCSBSCCCCCCCHHHHTTC
T ss_pred CC-ccccccCCccccCHHHhCCC
Confidence 22 23456799999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=250.05 Aligned_cols=172 Identities=24% Similarity=0.341 Sum_probs=135.9
Q ss_pred hcCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4578889999999999999998753 4569999987643 44567899999999999999999999997 4567899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999998766679999999999999999999995 49999999999999999999999999999877654
Q ss_pred CcceeecccccccccCCcccC
Q 011486 461 ESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.........||+.|+|||++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp ---------CCGGGCCHHHHH
T ss_pred cccccccCCCcccccChhhcc
Confidence 333333445788999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=248.36 Aligned_cols=172 Identities=26% Similarity=0.367 Sum_probs=150.8
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|+..+.||+|+||.||++...+++.||+|.+..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999998889999999986543 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999998776679999999999999999999995 4999999999999999999999999999987654322222
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....||+.|+|||++.
T Consensus 163 ~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFS 178 (267)
T ss_dssp TSTTCCGGGCCHHHHH
T ss_pred ccccccccccChhhhc
Confidence 3345788999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=256.86 Aligned_cols=175 Identities=23% Similarity=0.413 Sum_probs=149.2
Q ss_pred HhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
..++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999875 34789999998643 4456789999999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 011486 378 KLLIYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDik 434 (484)
.++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999997632 458999999999999999999995 499999999
Q ss_pred CCcEEEcCCCcEEEEecCCCcccCCCCc-ceeecccccccccCCcccCC
Q 011486 435 SSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 435 p~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 9999999999999999999987654322 11233568999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.32 Aligned_cols=172 Identities=25% Similarity=0.410 Sum_probs=139.9
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK---- 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 378 (484)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|++++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788999999999999999986 468899999997542 33456789999999999999999999998776544
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++++|.++++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999765 468999999999999999999995 499999999999999999999999999998775
Q ss_pred CCCcc--eeecccccccccCCcccCC
Q 011486 459 DEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... ......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp --------------CCTTCCHHHHHT
T ss_pred ccccccccccccCcCcccCCHHHhcC
Confidence 43221 1234569999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=270.49 Aligned_cols=173 Identities=27% Similarity=0.419 Sum_probs=150.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999875 68999999996532 22356688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 382 YDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997643 349999999999999999999995 49999999999999999999999999999887654
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. ....+||+.|+|||++.++
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~ 360 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNE 360 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTC
T ss_pred cc--ccccCCCccccCHHHHcCC
Confidence 32 2345799999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=250.90 Aligned_cols=169 Identities=22% Similarity=0.355 Sum_probs=148.6
Q ss_pred hcCCCccceeeeccceeEEEEEecC-C-------CEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-G-------NVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 377 (484)
.++|++.+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999997653 3 4799999987666667889999999999999999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc--------EEEE
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--------ARVS 449 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~--------~kl~ 449 (484)
.++||||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999998765569999999999999999999995 49999999999999998887 9999
Q ss_pred ecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||++...... ....||+.|+|||++.+
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIEN 191 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHC
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCC
Confidence 99999765432 23458999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=265.50 Aligned_cols=166 Identities=21% Similarity=0.212 Sum_probs=138.7
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--------hhHHHHHHHHHHHHhcCC---------CCceeee
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--------EGFDRFFERELEILGSIK---------HRYLVNL 368 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 368 (484)
.++|++.+.||+|+||+||+|+. +++.||||+++... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999988 68999999997542 223477889999988885 7888877
Q ss_pred EEEEE------------------------------cCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Q 011486 369 RGYCN------------------------------SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418 (484)
Q Consensus 369 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~ 418 (484)
.+.+. ..+..|+||||+++|++.+.+.. ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 77643 26788999999999977666643 45899999999999999999
Q ss_pred HHH-hCCCCCeEEcCCCCCcEEEcCCC--------------------cEEEEecCCCcccCCCCcceeecccccccccCC
Q 011486 419 YLH-HDCSPRIIHRDIKSSNILLDGNL--------------------EARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477 (484)
Q Consensus 419 ~LH-~~~~~~ivHrDikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~AP 477 (484)
||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.||||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 65 999999999999999887 9999999999876542 23699999999
Q ss_pred cccCCC
Q 011486 478 GKDCTN 483 (484)
Q Consensus 478 E~~~~~ 483 (484)
|++.+.
T Consensus 247 E~~~g~ 252 (336)
T 2vuw_A 247 DLFTGD 252 (336)
T ss_dssp GGGCCC
T ss_pred hhhcCC
Confidence 998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.06 Aligned_cols=173 Identities=23% Similarity=0.335 Sum_probs=139.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|+++.. .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999865 6899999999753 233345678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999765 4689999999999999999999951 499999999999999999999999999998654332
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. ......||+.|+|||++.+
T Consensus 304 ~-~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 304 A-TMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT
T ss_pred c-ccccccCCccccCHhhcCC
Confidence 2 2334679999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=249.70 Aligned_cols=173 Identities=26% Similarity=0.462 Sum_probs=146.8
Q ss_pred cCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 378 (484)
+.|+..+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 368899999997543 33457899999999999999999999999877 668
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 99999999999999997776779999999999999999999995 499999999999999999999999999998876
Q ss_pred CCCcc--eeecccccccccCCcccCC
Q 011486 459 DEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... ......||..|+|||++.+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC
Confidence 54332 1234568899999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=266.73 Aligned_cols=171 Identities=23% Similarity=0.323 Sum_probs=133.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 378 (484)
++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57899999999999999999765 6899999999753 234567899999999999999999999998543 568
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 57999999654 569999999999999999999995 499999999999999999999999999998765
Q ss_pred CCCc--------------------------ceeecccccccccCCcccCC
Q 011486 459 DEES--------------------------HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~--------------------------~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......+||+.|+|||++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 257 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhC
Confidence 3221 11234578999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=250.78 Aligned_cols=170 Identities=31% Similarity=0.445 Sum_probs=146.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--ceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999876 48999999997543 334577889999999999999999999998765 679999
Q ss_pred EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE----cCCCcEEEEecCCCcc
Q 011486 383 DFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKL 456 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla~~ 456 (484)
||+++++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976432 38999999999999999999995 499999999999999 7888899999999988
Q ss_pred cCCCCcceeecccccccccCCcccC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
...... .....||+.|+|||++.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhh
Confidence 765432 23356999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=246.17 Aligned_cols=174 Identities=27% Similarity=0.484 Sum_probs=136.4
Q ss_pred HhcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 356789999999999999999987 478999999996532 2234678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999999998766779999999999999999999995 49999999999999999999999999999876543
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++..
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATR 186 (278)
T ss_dssp ----------------------
T ss_pred CCc-ceeccCCCCcCCcchhcC
Confidence 221 223568999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=258.09 Aligned_cols=174 Identities=26% Similarity=0.367 Sum_probs=148.7
Q ss_pred hcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888999999999999999853 23579999997643 44557899999999999 899999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999998643 348999999999999999999995 499999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCc-ceeecccccccccCCcccCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++++.+||+|||+++....... .......||+.|+|||++.+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 9999999999999987754322 12233457899999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=255.27 Aligned_cols=171 Identities=19% Similarity=0.252 Sum_probs=147.3
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688899999999999999986 4788999999875432 24588999999999 899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc-----EEEEecCCCcccCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~-----~kl~DFGla~~~~~ 459 (484)
+ +++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 999999998766679999999999999999999995 49999999999999999887 99999999997654
Q ss_pred CCcc------eeecccccccccCCcccCCC
Q 011486 460 EESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGK 192 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred CCCCccccccccCCcCCCccccChHHHcCC
Confidence 3321 12346799999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=267.54 Aligned_cols=174 Identities=28% Similarity=0.405 Sum_probs=150.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999876 68999999997532 22346788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 382 YDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999753 2359999999999999999999995 499999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... .....||+.|+|||++.+.
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~ 364 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGE 364 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTC
T ss_pred CCCcc-cccccCCccccChhhhcCC
Confidence 54322 2345799999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=248.36 Aligned_cols=172 Identities=28% Similarity=0.410 Sum_probs=141.7
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhc--CCCCceeeeEEEEEcC----CceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSP----TSKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 379 (484)
.++|++.+.||+|+||.||+|.. +++.||||++.... .+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788999999999999999987 68899999987542 3455666676665 7999999999987543 4578
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+||||+++|+|.++++. ..+++..+..++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999954 46999999999999999999999211 359999999999999999999999999999
Q ss_pred cccCCCCcce---eecccccccccCCcccCCC
Q 011486 455 KLLEDEESHI---TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~---~~~~~Gt~~Y~APE~~~~~ 483 (484)
+......... .....||+.|+|||++.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred eecccccccccccccccccccceeChhhhcCc
Confidence 8765433322 1234699999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=244.28 Aligned_cols=171 Identities=24% Similarity=0.310 Sum_probs=150.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356888999999999999999876 4778999999875555577899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~~~ 461 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998765 458999999999999999999995 499999999999999 788999999999998776543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTT
T ss_pred c--hhccCCCCCccChHHhcc
Confidence 2 234569999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=264.62 Aligned_cols=172 Identities=24% Similarity=0.435 Sum_probs=150.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999876 78999999997532 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999653 56999999999999999999999 5599999999999999999999999999999876533
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .....||+.|+|||++.+.
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~ 190 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGR 190 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTC
T ss_pred c--ccccCCCcCeEChhhccCC
Confidence 2 2345699999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=260.73 Aligned_cols=173 Identities=30% Similarity=0.438 Sum_probs=150.0
Q ss_pred hcCCCccceeeeccceeEEEEEe----cCCCEEEEEEecccC----hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999987 368999999987532 22345677899999999 6999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999765 468999999999999999999995 4999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+............||+.|+|||++.+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred cccCCCCcccCcccCcCccChhhhcC
Confidence 65443333445679999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=257.16 Aligned_cols=170 Identities=27% Similarity=0.384 Sum_probs=140.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999876 689999999976432 246688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc--EEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~--~kl~DFGla~~~~~~~~ 462 (484)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.......
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999764 469999999999999999999995 59999999999999987765 99999999985433221
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 174 --~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 174 --PKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp ---------CTTSCHHHHHC
T ss_pred --CCCCcCCCCcCChhhhcC
Confidence 234569999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=252.00 Aligned_cols=173 Identities=28% Similarity=0.466 Sum_probs=150.1
Q ss_pred cCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 379 (484)
++|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 3688999999987776667889999999999999999999999874 45588
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999998765679999999999999999999995 4999999999999999999999999999997754
Q ss_pred CCcce--eecccccccccCCcccCC
Q 011486 460 EESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhcc
Confidence 43221 223458899999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=267.90 Aligned_cols=173 Identities=24% Similarity=0.394 Sum_probs=148.1
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..++|+..+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346788899999999999999999888999999998644 34678999999999999999999999986 5678999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.++++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999997542 358999999999999999999995 49999999999999999999999999999877543222
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......+|+.|+|||++..
T Consensus 341 ~~~~~~~~~~y~aPE~~~~ 359 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINF 359 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHH
T ss_pred ccCCCcccccccCHHHhcc
Confidence 2223446889999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=268.63 Aligned_cols=173 Identities=24% Similarity=0.363 Sum_probs=149.7
Q ss_pred hcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|+..+.||+|+||.||+|.... +..||||.++.... ..+.|.+|++++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999998875 78999999976433 367899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.++++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999864 3458999999999999999999995 49999999999999999999999999999987544322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......+|+.|+|||++..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~ 393 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAY 393 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHH
T ss_pred ecCCCcCCcceeCHhHHhc
Confidence 2233456789999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=260.66 Aligned_cols=171 Identities=25% Similarity=0.353 Sum_probs=143.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----Cce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 378 (484)
++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 57889999999999999999875 5788999999753 234567899999999999999999999999776 568
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||++ ++|.++++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 99999996 5999999754 569999999999999999999995 499999999999999999999999999999775
Q ss_pred CCCcc---------------------eeecccccccccCCcccCC
Q 011486 459 DEESH---------------------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~---------------------~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....+||+.|+|||++..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 43211 1245679999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=255.49 Aligned_cols=174 Identities=20% Similarity=0.266 Sum_probs=149.7
Q ss_pred hcCCCccceeeec--cceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSG--GFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+| +||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999876 68999999997543 3445778899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999764 2459999999999999999999995 4999999999999999999999999999876532
Q ss_pred CCc------ceeecccccccccCCcccCC
Q 011486 460 EES------HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~------~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .......||+.|+|||++..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccccCHHHHhc
Confidence 211 11122468999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=260.06 Aligned_cols=174 Identities=23% Similarity=0.320 Sum_probs=146.0
Q ss_pred hcCCCccceeeeccceeEEEEEec------CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999843 4678999999754 344566789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEE
Q 011486 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVS 449 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~ 449 (484)
++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998643 348999999999999999999995 4999999999999999555 59999
Q ss_pred ecCCCcccCCCC-cceeecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEE-SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++.+.... ........||+.|+|||++.+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 260 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC
Confidence 999998653221 112233568999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=247.42 Aligned_cols=165 Identities=24% Similarity=0.394 Sum_probs=126.7
Q ss_pred ccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEEEcCCCC
Q 011486 311 DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 388 (484)
..+.||+|+||.||+|... +++.||+|++... ....+.+|+++++.+. ||||+++++++.+++..++||||+++|
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp TSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 3578999999999999875 6899999999653 3467889999999997 999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecCCCcccCCCCccee
Q 011486 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 465 (484)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 92 ELFERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp BHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999999764 569999999999999999999995 4999999999999998766 8999999999876543322 2
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
....||+.|+|||++.+.
T Consensus 167 ~~~~~t~~y~aPE~~~~~ 184 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN 184 (325)
T ss_dssp -----------------C
T ss_pred cccCCCcCccCHHHhcCC
Confidence 345689999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=248.29 Aligned_cols=173 Identities=24% Similarity=0.368 Sum_probs=148.2
Q ss_pred hcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|.+.+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788899999999999999975 245789999997643 44567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 011486 379 LLIYDFLPGGSLDEALHERSE-----------------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~-----------------------~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp 435 (484)
++||||+++++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999976432 38899999999999999999995 4999999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccC
Q 011486 436 SNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 436 ~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~ 481 (484)
+||++++++.+||+|||+++......... .....||+.|+|||++.
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 99999999999999999998775443222 22345788999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=247.90 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=147.8
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 3467888999999999999999988888999999976432 3578999999999999999999999986 4568999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999997532 258999999999999999999995 49999999999999999999999999999987654333
Q ss_pred eeecccccccccCCcccC
Q 011486 464 ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~ 481 (484)
......||+.|+|||++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp CCTTCCCCTTTSCHHHHH
T ss_pred cccCCCCccCccChhhhc
Confidence 233445788999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=254.06 Aligned_cols=175 Identities=28% Similarity=0.412 Sum_probs=143.4
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-----hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
....++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999876 589999999975321 11246889999999999999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..++||||+++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999976 8999998766679999999999999999999995 4999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .....||+.|+|||++.+
T Consensus 162 ~~~~~~~-~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 162 FGSPNRA-YTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp TTSCCCC-CCCSCCCCTTCCHHHHTT
T ss_pred ccCCccc-CCcccccccccCchHhhC
Confidence 7543322 234568999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=246.96 Aligned_cols=175 Identities=23% Similarity=0.329 Sum_probs=142.9
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34678999999999999999999875 68899999997542 334578999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999999765 468999999999999999999995 4999999999999999999999999999987755
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..........||+.|+|||++.+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp ----------CCGGGCCGGGTCC
T ss_pred cccccccccCCCcCccCHHHHcC
Confidence 43333334569999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=253.12 Aligned_cols=166 Identities=28% Similarity=0.415 Sum_probs=145.8
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477889999999999999986 478899999997532 233467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||++ |+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 689998876667799999999999999999999954 9999999999999999999999999999876542
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
....||+.|+|||++.
T Consensus 208 ---~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp ---CCCCSCGGGCCHHHHH
T ss_pred ---CcccCCcceeCHhhhc
Confidence 2356999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=247.50 Aligned_cols=172 Identities=24% Similarity=0.339 Sum_probs=143.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367889999999999999999876 58999999986543 334577889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999888643 568999999999999999999995 4999999999999999999999999999987764332
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 158 Y-YDDEVATRWYRSPELLVG 176 (311)
T ss_dssp ---------GGGCCHHHHHT
T ss_pred c-cCCCcCCccccChHHHhc
Confidence 2 234568999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=253.58 Aligned_cols=171 Identities=27% Similarity=0.397 Sum_probs=140.5
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999876 689999999975432 1122456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++ ++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 97 59999998776779999999999999999999995 49999999999999999999999999999866543222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 157 ~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp ------CGGGCCHHHHTT
T ss_pred cccccCcccccChhhhcC
Confidence 233468999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.30 Aligned_cols=176 Identities=24% Similarity=0.384 Sum_probs=147.3
Q ss_pred HHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
...++|++.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578899999999999999999862 45689999997543 33457799999999999 899999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSE----------------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDi 433 (484)
+..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999976432 27899999999999999999995 49999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 434 KSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 434 kp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+||+++.++.+||+|||++......... ......||+.|+|||++.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 999999999999999999999877543322 2234557899999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=252.28 Aligned_cols=172 Identities=28% Similarity=0.433 Sum_probs=140.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCC----EEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||.||+|... +++ .||+|.+.... ....+.+.+|++++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999864 344 35888876432 345678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|+||+++|+|.+++......+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999999998877779999999999999999999995 49999999999999999999999999999877543
Q ss_pred Ccce-eecccccccccCCcccCC
Q 011486 461 ESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp CC-------CCCGGGSCHHHHHH
T ss_pred cccccccCCCccccccChHHhcc
Confidence 3222 233457889999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=264.72 Aligned_cols=172 Identities=26% Similarity=0.408 Sum_probs=141.8
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|+..+.||+|+||.||+|...++..||||.++.... ..+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 456788899999999999999998888899999986442 35679999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++|+|.++++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999753 3458999999999999999999995 599999999999999999999999999998775433222
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+|+.|+|||++..
T Consensus 338 ~~~~~~~~~y~aPE~~~~ 355 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALY 355 (452)
T ss_dssp -----CCGGGSCHHHHHH
T ss_pred ccCCcccccccCHhHHhc
Confidence 233457889999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=242.39 Aligned_cols=172 Identities=26% Similarity=0.423 Sum_probs=149.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999876 5788999998653 234567789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998764 468999999999999999999995 499999999999999999999999999998775433
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....||+.|+|||++.+
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTT
T ss_pred cc-cccccCCCCcCCcchhcc
Confidence 22 234568999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=253.24 Aligned_cols=170 Identities=25% Similarity=0.440 Sum_probs=132.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.+.|++.+.||+|+||.||+|... +++.||+|+++... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 357888999999999999999886 57899999997643 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~~~~~~ 461 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999754 558999999999999999999995 49999999999999975 8899999999998765432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||++.++
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~ 225 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGC 225 (349)
T ss_dssp ---------CGGGSCHHHHTTC
T ss_pred --ccccccCCCCccCHHHhcCC
Confidence 22345699999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=253.98 Aligned_cols=178 Identities=24% Similarity=0.337 Sum_probs=149.6
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEE
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCN 373 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 373 (484)
.....++|+..+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 33445788999999999999999998643 2479999997643 34567799999999999 8999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHER-------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
..+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence 999999999999999999999753 2357999999999999999999995 499999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 240 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence 99999999999999876543322 2233457889999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=241.76 Aligned_cols=170 Identities=25% Similarity=0.394 Sum_probs=146.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999876 7899999998753 234567788999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC---------------
Q 011486 382 YDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN--------------- 443 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~--------------- 443 (484)
|||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753 2558999999999999999999995 499999999999999844
Q ss_pred ----CcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 444 ----LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 444 ----~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..+||+|||.+....... ...||+.|+|||++.++
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQEN 205 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTC
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCC
Confidence 479999999998775432 23489999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=241.88 Aligned_cols=166 Identities=30% Similarity=0.567 Sum_probs=142.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChh--H-----HHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG--F-----DRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
++|+..+.||+|+||.||+|... +++.||+|++...... . .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888999999999999999875 7899999998643211 1 167899999999999999999999986554
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCcEEEcCCCc-----EEEEec
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLE-----ARVSDF 451 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDikp~NILl~~~~~-----~kl~DF 451 (484)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 79999999999999998776779999999999999999999995 47 999999999999988776 999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
|+++..... .....||+.|+|||++.
T Consensus 174 g~~~~~~~~----~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 174 GLSQQSVHS----VSGLLGNFQWMAPETIG 199 (287)
T ss_dssp TTCBCCSSC----EECCCCCCTTSCGGGSS
T ss_pred Ccccccccc----ccccCCCccccCchhhc
Confidence 999855432 23456999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=247.73 Aligned_cols=174 Identities=26% Similarity=0.403 Sum_probs=149.5
Q ss_pred hcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
.++|+..+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999974 346789999998644 34567899999999999 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 378 KLLIYDFLPGGSLDEALHERSE-----------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999976432 38999999999999999999995 499999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
+.++.+||+|||+++......... .....||+.|+|||++.+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence 999999999999998776543322 233457889999998643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=246.18 Aligned_cols=174 Identities=24% Similarity=0.365 Sum_probs=151.8
Q ss_pred HhcCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999998764 7889999997643 346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999763 3448999999999999999999995 4999999999999999999999999999988765544
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~ 186 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY 186 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH
T ss_pred ccccCCccccCcCChhhhcc
Confidence 44444567899999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=273.20 Aligned_cols=175 Identities=23% Similarity=0.309 Sum_probs=150.0
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCce
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 378 (484)
...++|++.+.||+|+||.||+|... +++.||||++++.. ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 35678999999999999999999876 58889999997532 23346688899999988 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++|+|.++++.. ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999765 469999999999999999999995 599999999999999999999999999998654
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......||+.|+|||++...
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~ 517 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQ 517 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCC
T ss_pred cCCc-ccccccCCCcccCHhhhcCC
Confidence 3322 23456799999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=243.71 Aligned_cols=172 Identities=25% Similarity=0.353 Sum_probs=143.7
Q ss_pred hcCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998653 3369999997643 4456789999999999999999999999765 45689
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999998776779999999999999999999995 49999999999999999999999999999877654
Q ss_pred CcceeecccccccccCCcccC
Q 011486 461 ESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.........||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp ------CCCCCGGGCCHHHHH
T ss_pred cccccccCCCCcceeCchhhc
Confidence 333333455789999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=247.74 Aligned_cols=171 Identities=26% Similarity=0.430 Sum_probs=149.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57888999999999999999876 4788999998653 2345677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999998764 568999999999999999999995 4999999999999999999999999999987754332
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 197 ~-~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 197 R-KKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp C-BCCCCSCCSSCCHHHHHT
T ss_pred c-ccccCCCccccCHHHhcc
Confidence 2 234569999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=253.99 Aligned_cols=172 Identities=28% Similarity=0.393 Sum_probs=136.8
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCC--ce
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPT--SK 378 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 378 (484)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999865 6899999998643 3445667889999999997 999999999997654 67
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||++ ++|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 599999975 468999999999999999999995 499999999999999999999999999998764
Q ss_pred CCC--------------------cceeecccccccccCCcccCC
Q 011486 459 DEE--------------------SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~--------------------~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .......+||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 311 111234579999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=240.25 Aligned_cols=172 Identities=29% Similarity=0.417 Sum_probs=148.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 367889999999999999999875 58899999986532 344577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc---EEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~---~kl~DFGla~~~~~ 459 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999998765 568999999999999999999995 49999999999999986655 99999999987764
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .....||+.|+|||++.++
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~ 182 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKD 182 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTC
T ss_pred Ccc--ccCCCCCcCCcCchhhcCC
Confidence 332 2345699999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=258.86 Aligned_cols=168 Identities=26% Similarity=0.386 Sum_probs=144.1
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-ceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 384 (484)
.++|+..+.||+|+||.||+|... ++.||||.++... ..+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888999999999999999885 7799999998643 3567999999999999999999999987765 68999999
Q ss_pred CCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.++++..... +++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999999876443 7999999999999999999995 499999999999999999999999999998654321
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+|+.|+|||++.++
T Consensus 344 --~~~~~~~~y~aPE~~~~~ 361 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREK 361 (450)
T ss_dssp -----CCCTTTSCHHHHHSS
T ss_pred --cCCCCCcceeCHHHhcCC
Confidence 223578999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=242.48 Aligned_cols=170 Identities=32% Similarity=0.505 Sum_probs=145.0
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 567889999999999999999766 57789999986532 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999765 45899999999999999999999 5599999999999999999999999999986554322
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||++.+
T Consensus 164 ---~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp -------CCCCTTCCHHHHTT
T ss_pred ---ccccCCCCCccCHhHhcc
Confidence 234568999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=248.36 Aligned_cols=173 Identities=27% Similarity=0.401 Sum_probs=147.1
Q ss_pred hcCCCccceeeeccceeEEEEEec--------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|++.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468889999999999999999863 46789999997643 34567799999999999 899999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999997643 238999999999999999999995 499999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~ 481 (484)
+.++.+||+|||+++......... .....||+.|+|||++.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 999999999999998776533221 22345788999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=247.07 Aligned_cols=171 Identities=30% Similarity=0.399 Sum_probs=148.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.+.|++.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999876 689999999875331 1367899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla 454 (484)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999753 568999999999999999999995 4999999999999999888 7999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+....... .....||+.|+|||++.+
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTT
T ss_pred eecCcccc--ccccCCCCCccCcccccC
Confidence 87765332 234569999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=252.21 Aligned_cols=173 Identities=24% Similarity=0.293 Sum_probs=148.6
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh--------hHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--------GFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 375 (484)
..++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467899999999999999999864 688999999875321 1234577899999999999999999999999
Q ss_pred CceEEEEEcCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 376 TSKLLIYDFLPGG-SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 376 ~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+..++||||+.+| +|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 999999754 469999999999999999999995 49999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+....... .....||+.|+|||++.+.
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 204 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGN 204 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTC
T ss_pred eECCCCCc--eeccCCCccccChhhhcCC
Confidence 87765432 2335699999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=247.97 Aligned_cols=174 Identities=32% Similarity=0.509 Sum_probs=149.5
Q ss_pred hcCCCccceeeeccceeEEEEEe-----cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--ce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 378 (484)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999983 368899999998766666788999999999999999999999987654 68
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999998776679999999999999999999995 499999999999999999999999999998876
Q ss_pred CCCcce--eecccccccccCCcccCC
Q 011486 459 DEESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
...... .....|+..|+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcC
Confidence 543321 123457888999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=244.04 Aligned_cols=171 Identities=27% Similarity=0.393 Sum_probs=143.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999875 58899999987543 33467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccC
Q 011486 385 LPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 385 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~ 458 (484)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999864 23569999999999999999999995 499999999999999 456789999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....||+.|+|||++..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ----------CTTGGGCCHHHHTT
T ss_pred Cccc--CcCcccccCcCChHHhcc
Confidence 4322 234568999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=239.74 Aligned_cols=169 Identities=23% Similarity=0.334 Sum_probs=145.8
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 381 (484)
.++|+..+.||+|+||.||+|+.. ++.+|+|+++... ....+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467889999999999999999985 8889999997543 44567899999999999999999999999887 778999
Q ss_pred EEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 382 YDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+. ..+|+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999999986543 489999999999999999999954 122999999999999999999999999987654332
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...||+.|+|||++.+
T Consensus 167 ------~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQK 182 (271)
T ss_dssp ------TCBSCGGGSCHHHHHS
T ss_pred ------CccCCccccChhhhcc
Confidence 2458999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=243.58 Aligned_cols=171 Identities=19% Similarity=0.245 Sum_probs=147.4
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+++++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4688899999999999999986 578999999986533 234588899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc-----EEEEecCCCcccCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~-----~kl~DFGla~~~~~ 459 (484)
+ +++|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+++....
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 99999999876667999999999999999999999 559999999999999987776 99999999987754
Q ss_pred CCcc------eeecccccccccCCcccCCC
Q 011486 460 EESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......||+.|+|||++.+.
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 193 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGR 193 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred ccccccccccCccCCCCCcccCCchhhcCC
Confidence 3321 12345699999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=245.53 Aligned_cols=171 Identities=23% Similarity=0.344 Sum_probs=141.6
Q ss_pred cCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467764 78999999999999865 6899999999766555567899999999985 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc---EEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~---~kl~DFGla~~~~~~ 460 (484)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999765 468999999999999999999995 49999999999999998776 999999999876432
Q ss_pred Cc------ceeecccccccccCCcccC
Q 011486 461 ES------HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 461 ~~------~~~~~~~Gt~~Y~APE~~~ 481 (484)
.. .......||+.|+|||++.
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp --------------CCSGGGCCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhh
Confidence 11 1112345999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=240.81 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=150.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999876 68999999987433 3456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc-
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~- 462 (484)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998643 458999999999999999999995 4999999999999999999999999999987643221
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.......||+.|+|||++.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~ 182 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRR 182 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCS
T ss_pred hcccCCccccCccChHHHhcC
Confidence 112345689999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=250.25 Aligned_cols=179 Identities=18% Similarity=0.298 Sum_probs=150.3
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEE
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 373 (484)
++....++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999998764 36789999997543 344567999999999999999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
..+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence 9999999999999999999997532 347899999999999999999995 4999999999999999999
Q ss_pred cEEEEecCCCcccCCCCcce-eecccccccccCCcccCC
Q 011486 445 EARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~ 482 (484)
.+||+|||+++......... .....||+.|+|||++.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 214 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence 99999999998765432211 123457899999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=247.98 Aligned_cols=175 Identities=21% Similarity=0.312 Sum_probs=131.8
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCC----EEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN----VFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
..++|++.+.||+|+||.||+|...... .||+|.++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3467999999999999999999876432 7999999754 344567899999999999999999999999887665
Q ss_pred ------EEEEEcCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEE
Q 011486 379 ------LLIYDFLPGGSLDEALHERS-----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447 (484)
Q Consensus 379 ------~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~k 447 (484)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999996432 248999999999999999999995 4999999999999999999999
Q ss_pred EEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 448 VSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 448 l~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+|||+++........ ......||+.|+|||++.+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC
Confidence 9999999876543321 1223457889999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.77 Aligned_cols=179 Identities=25% Similarity=0.291 Sum_probs=145.6
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-----ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
++....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34555677899999999999999999875 6889999998643 23456789999999999999999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 011486 375 PTSKLLIYDFLPGGSLDEALHER---------------------------------------SEQLDWDARLNIIMGAAK 415 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~ 415 (484)
.+..++||||+++|+|.+++... ...+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 111367788899999999
Q ss_pred HHHHHHhCCCCCeEEcCCCCCcEEEcCCC--cEEEEecCCCcccCCCCc---ceeecccccccccCCcccCC
Q 011486 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNL--EARVSDFGLAKLLEDEES---HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 416 aL~~LH~~~~~~ivHrDikp~NILl~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+|||+ .+|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999995 4999999999999998776 899999999987643221 12234569999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=247.74 Aligned_cols=173 Identities=28% Similarity=0.468 Sum_probs=140.8
Q ss_pred cCCCccceeeeccceeEEEEEecC-----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||.||+|.... +..||+|.++... ......+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678899999999999997653 2359999997543 3455679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999998766779999999999999999999995 49999999999999999999999999999877543
Q ss_pred Ccc--eeecccccccccCCcccCC
Q 011486 461 ESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ......||+.|+|||++.+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~ 224 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISY 224 (333)
T ss_dssp ----------CCCGGGSCHHHHHS
T ss_pred cccccccCCCCccccccCchhccc
Confidence 221 1122346889999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=245.69 Aligned_cols=174 Identities=25% Similarity=0.313 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 380 (484)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788999999999999999987 5789999999977666667889999999999999999999999873 346789
Q ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 381 IYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999975 345699999999999999999999954 9999999999999999999999999998865
Q ss_pred CCCCcce--------eecccccccccCCcccCC
Q 011486 458 EDEESHI--------TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~--------~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .....||+.|+|||++..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSC
T ss_pred ccccccccccccccccccccCCcccCCHhHhcc
Confidence 4311100 122457999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=245.55 Aligned_cols=173 Identities=27% Similarity=0.380 Sum_probs=140.8
Q ss_pred HHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcC--CCCceeeeEEEEEcC----Cc
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI--KHRYLVNLRGYCNSP----TS 377 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 377 (484)
...++|++.+.||+|+||.||+|+.. ++.||+|++.... ...+.+|.+++... +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34568999999999999999999875 8899999986533 33455566666554 899999999999877 67
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
.++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 89999999999999999653 5899999999999999999999421 1299999999999999999999999999
Q ss_pred CCcccCCCCcce---eecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHI---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~---~~~~~Gt~~Y~APE~~~~ 482 (484)
+++.+....... .....||+.|+|||++..
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccc
Confidence 998765433221 123569999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=244.26 Aligned_cols=173 Identities=25% Similarity=0.383 Sum_probs=144.0
Q ss_pred cCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 380 (484)
..|+..+.||+|+||.||+|...+ ...+|+|.+.... ....+.+.+|++++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998643 2358999987643 4456789999999999999999999999654 567899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.++++.....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999998766779999999999999999999995 49999999999999999999999999999876543
Q ss_pred Ccc---eeecccccccccCCcccCC
Q 011486 461 ESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ......||+.|+|||.+.+
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT 206 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH
T ss_pred chhccccccCCCCCccccChHHhcC
Confidence 221 1233457899999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=248.70 Aligned_cols=186 Identities=26% Similarity=0.392 Sum_probs=154.9
Q ss_pred CCCCCHHHHHHHhcCCCccceeeeccceeEEEEEe------cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCce
Q 011486 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYL 365 (484)
Q Consensus 294 ~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni 365 (484)
..++...+.....++|++.+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|+++++++ +||||
T Consensus 14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 34566666666678999999999999999999974 356889999997643 34456799999999999 69999
Q ss_pred eeeEEEEEcCC-ceEEEEEcCCCCCHHHHHhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011486 366 VNLRGYCNSPT-SKLLIYDFLPGGSLDEALHERSEQ---------------LDWDARLNIIMGAAKGLAYLHHDCSPRII 429 (484)
Q Consensus 366 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 429 (484)
+++++++...+ ..++||||+++++|.+++...... +++..+..++.|++.||+|||+ .+|+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 99999988765 489999999999999999765332 7899999999999999999995 4999
Q ss_pred EcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 430 HrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 224 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc
Confidence 9999999999999999999999999876543322 2234568999999998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=243.51 Aligned_cols=173 Identities=26% Similarity=0.405 Sum_probs=142.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS---------- 374 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 374 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999875 7899999999653 3345778999999999999999999998865
Q ss_pred ---CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 375 ---PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 375 ---~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
.+..++||||+++++|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 3457899999999999999987656688999999999999999999954 9999999999999999999999999
Q ss_pred CCCcccCCCC-------------cceeecccccccccCCcccCC
Q 011486 452 GLAKLLEDEE-------------SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 452 Gla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|+++...... ........||+.|+|||++.+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 9998765321 111234568999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=242.99 Aligned_cols=170 Identities=29% Similarity=0.443 Sum_probs=134.8
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
-++|++.+.||+|+||.||+|... ..+|+|+++... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 357889999999999999999864 359999987543 44567899999999999999999999965 5566899999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC-c
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-S 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~ 462 (484)
|+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999999999998766779999999999999999999995 499999999999999999999999999998665322 1
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
.......||+.|+|||++.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -------CCCTTCCHHHHC
T ss_pred ccccccCCCccccCchhhc
Confidence 2223456999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=243.57 Aligned_cols=171 Identities=31% Similarity=0.471 Sum_probs=146.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|.+.+.||+|+||.||++... +++.||+|.++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888999999999999999876 6899999999865544556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~~~ 461 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999999999765 468999999999999999999995 499999999999999 788999999999997654322
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~ 182 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQK 182 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSC
T ss_pred ---cccccCCCCccChHHhccC
Confidence 2334689999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=260.20 Aligned_cols=169 Identities=24% Similarity=0.334 Sum_probs=138.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 376 (484)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999765 6889999999754 3445678899999999999999999999997654
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 46999999976 57777643 48999999999999999999995 4999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... .....+||+.|+|||++.+.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 238 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGM 238 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCC
Confidence 65432 23446799999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=249.97 Aligned_cols=169 Identities=18% Similarity=0.320 Sum_probs=142.0
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCC--CceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKH--RYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ 382 (484)
+.|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|++++++++| |||+++++++..++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468889999999999999999988999999998743 34445789999999999986 99999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|| .+++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 89 e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred eC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 95 588999999764 568999999999999999999995 4999999999999997 67899999999987754332
Q ss_pred c-eeecccccccccCCcccC
Q 011486 463 H-ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~-~~~~~~Gt~~Y~APE~~~ 481 (484)
. ......||+.|+|||++.
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp -------CCCCSSCCHHHHH
T ss_pred cccCCCCcCCcCcCCHHHHh
Confidence 2 223457999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=250.86 Aligned_cols=178 Identities=21% Similarity=0.283 Sum_probs=144.2
Q ss_pred HHHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC-----------hhHHHHHHHHHHHHhcCCCCceee
Q 011486 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-----------EGFDRFFERELEILGSIKHRYLVN 367 (484)
Q Consensus 299 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 367 (484)
..++....++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677789999999999999999999998889999999986422 122478999999999999999999
Q ss_pred eEEEEEcC-----CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC
Q 011486 368 LRGYCNSP-----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (484)
Q Consensus 368 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~ 442 (484)
+++++... ...++||||++ |+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcC
Confidence 99998543 35799999997 69999998766679999999999999999999995 49999999999999999
Q ss_pred CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 443 ~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++.+||+|||+++....... .....||+.|+|||++.+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTT
T ss_pred CCCEEEEecCcccccccccc--cceecccceecCcHHhcC
Confidence 99999999999986543322 234568999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=249.16 Aligned_cols=173 Identities=29% Similarity=0.429 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP------- 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 375 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999874 68999999986533 23345788999999999999999999998774
Q ss_pred -CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 376 -TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 376 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+..++||||+++ +|.+.+......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 457999999975 8888887766679999999999999999999995 49999999999999999999999999999
Q ss_pred cccCCCCc---ceeecccccccccCCcccCC
Q 011486 455 KLLEDEES---HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~---~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.+..... .......||+.|+|||++.+
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred ccccccccccccccCCcccccCccCchhhcC
Confidence 87653221 11234568999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=254.49 Aligned_cols=170 Identities=31% Similarity=0.445 Sum_probs=146.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--ceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999876 48999999997543 334577889999999999999999999998765 679999
Q ss_pred EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE----cCCCcEEEEecCCCcc
Q 011486 383 DFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKL 456 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----~~~~~~kl~DFGla~~ 456 (484)
||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 38999999999999999999995 499999999999999 7788899999999987
Q ss_pred cCCCCcceeecccccccccCCcccC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
...... .....||+.|+|||++.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHH
T ss_pred ccCCCc--cccccCCccccCHHHhh
Confidence 755332 23356999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=249.88 Aligned_cols=174 Identities=23% Similarity=0.369 Sum_probs=139.1
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
....++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999765 68899999997543 223466889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-----CCCcEEEEecCCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-----GNLEARVSDFGLA 454 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-----~~~~~kl~DFGla 454 (484)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||++
T Consensus 110 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999997 5999999764 459999999999999999999995 4999999999999994 5556999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+........ .....||+.|+|||++.+
T Consensus 185 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 185 RAFGIPIRQ-FTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHC------------CCTTCCHHHHTT
T ss_pred cccCCcccc-cCCCcCCccccCHHHhcC
Confidence 877543222 233468999999999865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=238.99 Aligned_cols=171 Identities=30% Similarity=0.429 Sum_probs=145.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
++|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999876 68999999986532 113678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCCc
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla~ 455 (484)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999764 468999999999999999999995 4999999999999999877 89999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....... .....||+.|+|||++..+
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~ 186 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYE 186 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTC
T ss_pred eccCCCc--ccccCCCcCccCcceecCC
Confidence 7754322 2335689999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=241.68 Aligned_cols=173 Identities=23% Similarity=0.352 Sum_probs=145.6
Q ss_pred CCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce-EEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK-LLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 381 (484)
.|+..+.||+|+||.||+|...+ +..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999997543 2379999997644 34567899999999999999999999999877665 999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+.+++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999987667799999999999999999999954 99999999999999999999999999998765432
Q ss_pred c---ceeecccccccccCCcccCCC
Q 011486 462 S---HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~---~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .......||+.|+|||.+.+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred ccccccCcCCCCCccccChhhhccC
Confidence 1 112335689999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=251.70 Aligned_cols=172 Identities=27% Similarity=0.413 Sum_probs=141.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCE----EEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNV----FALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|+..+.||+|+||.||+|... +++. +|+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999865 3443 7888775432 223356788999999999999999999886 466899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999998765679999999999999999999995 49999999999999999999999999999987554
Q ss_pred Ccc-eeecccccccccCCcccCC
Q 011486 461 ESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ......||+.|+|||++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~ 191 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHF 191 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHH
T ss_pred cccccccCCCCcccccChHHhcc
Confidence 322 2234568889999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=240.16 Aligned_cols=171 Identities=25% Similarity=0.403 Sum_probs=145.4
Q ss_pred cCCCccc-eeeeccceeEEEEEec---CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDH-IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|.+.+ .||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999754 57789999998643 44567899999999999999999999999 45668999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 99999999999997766679999999999999999999995 499999999999999999999999999998875443
Q ss_pred ccee--ecccccccccCCcccC
Q 011486 462 SHIT--TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 462 ~~~~--~~~~Gt~~Y~APE~~~ 481 (484)
.... ....||+.|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHH
T ss_pred ceeeccccccccccccCHHHhc
Confidence 3221 2334689999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=239.94 Aligned_cols=171 Identities=27% Similarity=0.477 Sum_probs=148.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467889999999999999999876 57789999986532 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999765 46899999999999999999999 5599999999999999999999999999997665422
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~ 187 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGK 187 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTC
T ss_pred ---cccccCCCCcCCHHHhccC
Confidence 2345689999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-29 Score=247.89 Aligned_cols=173 Identities=31% Similarity=0.452 Sum_probs=150.2
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--------hhHHHHHHHHHHHHhcC-CCCceeeeEEEE
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--------EGFDRFFERELEILGSI-KHRYLVNLRGYC 372 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 372 (484)
....++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567999999999999999999886 69999999986532 12246788999999999 799999999999
Q ss_pred EcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 373 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999999764 469999999999999999999995 499999999999999999999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
++..+..... .....||+.|+|||++.
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILK 272 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred cccccCCCcc--cccCCCCCCccChhhcc
Confidence 9987765432 23456999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=238.06 Aligned_cols=171 Identities=23% Similarity=0.411 Sum_probs=141.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888999999999999999876 68999999986532 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999765 458999999999999999999995 499999999999999999999999999998775432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp -------------CCTGGGTT
T ss_pred c--eecccCCccccCHHHHcC
Confidence 2 233468999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=252.46 Aligned_cols=174 Identities=21% Similarity=0.247 Sum_probs=141.0
Q ss_pred hcCCCccceeeeccceeEEEEEecC------CCEEEEEEecccChhHH-----------HHHHHHHHHHhcCCCCceeee
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLNEGFD-----------RFFERELEILGSIKHRYLVNL 368 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 368 (484)
.++|++.+.||+|+||.||+|.... ++.||+|++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3578899999999999999998764 47899999875432111 123445667778899999999
Q ss_pred EEEEEcC----CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--C
Q 011486 369 RGYCNSP----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--G 442 (484)
Q Consensus 369 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~ 442 (484)
++++... ...++||||+ +++|.+++......+++..+..|+.||+.||+|||+ .+|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 9998765 3479999999 999999998766779999999999999999999995 4999999999999999 8
Q ss_pred CCcEEEEecCCCcccCCCCcce------eecccccccccCCcccCCC
Q 011486 443 NLEARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 443 ~~~~kl~DFGla~~~~~~~~~~------~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.+||+|||+++.+....... .....||+.|+|||++.+.
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC
Confidence 8999999999998765432211 1234599999999998653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=252.65 Aligned_cols=169 Identities=18% Similarity=0.310 Sum_probs=143.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 382 (484)
+.|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 3445678999999999996 599999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
| +.+++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5688999999765 46899999999999999999999 45999999999999996 58999999999987754332
Q ss_pred c-eeecccccccccCCcccC
Q 011486 463 H-ITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~-~~~~~~Gt~~Y~APE~~~ 481 (484)
. ......||+.|+|||++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~ 229 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIK 229 (390)
T ss_dssp ----CCSCCCGGGCCHHHHH
T ss_pred cccCCCCCcCCCccChHHhh
Confidence 2 223457999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=267.66 Aligned_cols=174 Identities=25% Similarity=0.398 Sum_probs=148.3
Q ss_pred HHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
...++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34567888999999999999999998888899999986442 35679999999999999999999999876 67899999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
|+++|+|.++++.. ...+++.+++.|+.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999753 3458999999999999999999995 5999999999999999999999999999987754322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......++..|+|||++..
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~ 438 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY 438 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH
T ss_pred ecccCCcCcccccCHHHhcc
Confidence 22223456889999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=252.41 Aligned_cols=168 Identities=24% Similarity=0.350 Sum_probs=134.0
Q ss_pred hcCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHh-cCCCCceeeeEEEEEc----CCce
Q 011486 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILG-SIKHRYLVNLRGYCNS----PTSK 378 (484)
Q Consensus 306 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 378 (484)
.++|.+. +.||+|+||+||++... +++.||||+++.. ..+.+|++++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456655 68999999999999875 6889999999642 34678888874 4589999999999865 5568
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla 454 (484)
|+||||+++|+|.+++.... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999997643 359999999999999999999995 49999999999999997 789999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+....... .....||+.|+|||++.++
T Consensus 212 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 238 (400)
T 1nxk_A 212 KETTSHNS--LTTPCYTPYYVAPEVLGPE 238 (400)
T ss_dssp EECC-------------CTTCCGGGSCCC
T ss_pred cccCCCCc--cccCCCCCCccCHhhcCCC
Confidence 87654322 2345689999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=246.60 Aligned_cols=172 Identities=26% Similarity=0.426 Sum_probs=143.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999876 48999999986533 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999998888876543 569999999999999999999995 4999999999999999999999999999987654332
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 180 ~-~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 180 V-YDDEVATRWYRAPELLVG 198 (331)
T ss_dssp -----CCCCCTTCCHHHHTT
T ss_pred c-cCCCcCCccccCcccccC
Confidence 2 233568999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=246.97 Aligned_cols=175 Identities=25% Similarity=0.301 Sum_probs=149.0
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-----CCceeeeEEEEE
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-----HRYLVNLRGYCN 373 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~ 373 (484)
++.....++|++.+.||+|+||.||+|... +++.||+|+++.. ....+.+..|+++++.++ ||||+++++++.
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 333334578999999999999999999874 6889999999753 334567888999999986 999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC----------
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---------- 442 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---------- 442 (484)
..+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 999999999999 899999997643 348999999999999999999995 59999999999999975
Q ss_pred ---------------CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 443 ---------------NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 443 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.+||+|||+++...... ....||+.|+|||++.++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~ 234 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL 234 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCC
Confidence 7899999999998654422 245689999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=239.38 Aligned_cols=171 Identities=32% Similarity=0.510 Sum_probs=134.5
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC----hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|+..+.||+|+||.||+|... ++.+|+|+++... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888999999999999999875 8889999987532 22346789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC--------CCcEEEEecCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------NLEARVSDFGL 453 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--------~~~~kl~DFGl 453 (484)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999854 46999999999999999999999651122999999999999986 77899999999
Q ss_pred CcccCCCCcceeecccccccccCCcccCC
Q 011486 454 AKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 454 a~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++....... ....||+.|+|||++.+
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp ----------------CCGGGSCHHHHHH
T ss_pred ccccccccc---cCCCCccceeCHHHhcc
Confidence 987654322 23468999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=251.50 Aligned_cols=171 Identities=28% Similarity=0.447 Sum_probs=147.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999876 6889999999764 344567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999999999765 4689999999999999999999951 289999999999999999999999999997654321
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.+.
T Consensus 187 ~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp ----CCCCTTCCHHHHTTC
T ss_pred ccCCCCCCCeECHHHHcCC
Confidence 2345699999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=252.79 Aligned_cols=172 Identities=25% Similarity=0.389 Sum_probs=134.7
Q ss_pred CCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCceEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLI 381 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 381 (484)
.|+..+.||+|+||.||+|...+ +..+|+|.++... ....+.+.+|++++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35567899999999999998642 2368999987543 4456789999999999999999999999765 4578999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998766678999999999999999999995 499999999999999999999999999998765432
Q ss_pred cc---eeecccccccccCCcccCC
Q 011486 462 SH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ......||+.|+|||++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~ 270 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT 270 (373)
T ss_dssp -----------CCGGGSCHHHHHH
T ss_pred cccccccCCCCCcccccChHHhcC
Confidence 11 1223457889999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=242.66 Aligned_cols=173 Identities=29% Similarity=0.421 Sum_probs=145.9
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
..+.|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467889999999999999999876 58999999997643 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999998666779999999999999999999995 49999999999999999999999999999876543222
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 182 -~~~~~~~~~y~aPE~~~~~ 200 (314)
T 3com_A 182 -RNTVIGTPFWMAPEVIQEI 200 (314)
T ss_dssp -BCCCCSCGGGCCHHHHSSS
T ss_pred -cCccCCCCCccChhhcCCC
Confidence 2345689999999997653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=259.86 Aligned_cols=171 Identities=26% Similarity=0.422 Sum_probs=146.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999876 68999999986432 234577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999998765 569999999999999999999995 4999999999999995 566799999999987754
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 177 ~~~--~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 177 NTK--MKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS
T ss_pred CCc--cCCCcCCCCCCCHHHhCC
Confidence 332 234569999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=245.98 Aligned_cols=171 Identities=29% Similarity=0.392 Sum_probs=144.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.+.|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999876 5889999999876555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 99999999998766779999999999999999999995 499999999999999999999999999876432211 11
Q ss_pred eecccccccccCCccc
Q 011486 465 TTIVAGTFGYLAPGKD 480 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~ 480 (484)
.....||+.|+|||++
T Consensus 174 ~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVV 189 (302)
T ss_dssp -----CCGGGCCHHHH
T ss_pred cccccCChhhcCCeee
Confidence 2234689999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=242.81 Aligned_cols=171 Identities=28% Similarity=0.425 Sum_probs=141.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-----hhHHHHHHHHHHHHhcCC---CCceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIK---HRYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 376 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 468999999999999999999864 68999999986422 112345677888777664 999999999998765
Q ss_pred -----ceEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEe
Q 011486 377 -----SKLLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (484)
Q Consensus 377 -----~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~D 450 (484)
..++||||++ ++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999996 599999976533 38999999999999999999995 4999999999999999999999999
Q ss_pred cCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+++....... .....||+.|+|||++.+
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHT
T ss_pred CccccccCCCcc--cCCccccccccCchHHcC
Confidence 999987654322 244679999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=247.62 Aligned_cols=167 Identities=25% Similarity=0.359 Sum_probs=142.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|... +++.||+|.++.... ...+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467889999999999999999876 588999999976432 245688888887 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC----CcEEEEecCCCcccCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKLLED 459 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~----~~~kl~DFGla~~~~~ 459 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999754 569999999999999999999995 499999999999998533 3599999999987754
Q ss_pred CCcceeecccccccccCCcccC
Q 011486 460 EESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.... .....||+.|+|||++.
T Consensus 173 ~~~~-~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 173 ENGL-LMTPCYTANFVAPEVLE 193 (342)
T ss_dssp TTCC-BCCSSCCSSCCCHHHHH
T ss_pred CCCc-eeccCCCccccCHHHhc
Confidence 4322 23456899999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=255.57 Aligned_cols=170 Identities=24% Similarity=0.381 Sum_probs=136.4
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 375 (484)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999765 58899999986532 1122358899999999999999999999865
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEEEecC
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFG 452 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl~DFG 452 (484)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 4579999999999999988654 569999999999999999999995 4999999999999997544 59999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+++...... ......||+.|+|||++.
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC
T ss_pred cceecCCCc--cccccCCCCCccCceeee
Confidence 998775432 233467999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=240.87 Aligned_cols=174 Identities=20% Similarity=0.375 Sum_probs=138.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457889999999999999999864 7899999999752 244567799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999964 34558999999999999999999995 499999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... .....||+.|+|||++..+
T Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~~ 211 (310)
T 2wqm_A 188 SKTTA-AHSLVGTPYYMSPERIHEN 211 (310)
T ss_dssp ------------CCSSCCHHHHTTC
T ss_pred CCCcc-ccccCCCeeEeChHHhCCC
Confidence 43221 2335689999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=243.06 Aligned_cols=169 Identities=27% Similarity=0.434 Sum_probs=137.2
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||.||++... ++.||+|.+... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999875 788999999753 34578999999999999999999999876 4579999999
Q ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc-EEEEecCCCcccCCCCc
Q 011486 386 PGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAKLLEDEES 462 (484)
Q Consensus 386 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~-~kl~DFGla~~~~~~~~ 462 (484)
++++|.+++..... .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 99999999976432 3789999999999999999999642269999999999999998886 7999999998664321
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....||+.|+|||++.++
T Consensus 161 ---~~~~gt~~y~aPE~~~~~ 178 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGS 178 (307)
T ss_dssp -------CCTTSSCHHHHTCC
T ss_pred ---ccCCCCCceEChhhhCCC
Confidence 234589999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=239.66 Aligned_cols=171 Identities=32% Similarity=0.431 Sum_probs=149.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888999999999999999865 68899999997543 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 999999999964 468999999999999999999995 49999999999999999999999999999877543322
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++.++
T Consensus 176 ~~~~~~~~~y~aPE~~~~~ 194 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQS 194 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTC
T ss_pred cCccCCCcCccCHHHHhcC
Confidence 2345689999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=238.02 Aligned_cols=171 Identities=26% Similarity=0.399 Sum_probs=144.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555679999999999999864 68899999998766556778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCcccCCCCc
Q 011486 386 PGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 386 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~ 462 (484)
++++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999986533 36788999999999999999995 49999999999999987 89999999999987654322
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
......||+.|+|||++.
T Consensus 179 -~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIID 196 (295)
T ss_dssp ---CCCCCCGGGCCHHHHH
T ss_pred -cccccCCCccccChhhhc
Confidence 123456899999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=258.42 Aligned_cols=170 Identities=25% Similarity=0.392 Sum_probs=143.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
+.|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++......++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999876 68899999997543 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~~~~~ 460 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999998765 568999999999999999999995 49999999999999976 455999999999877643
Q ss_pred CcceeecccccccccCCcccCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....||+.|+|||++..
T Consensus 193 ~~--~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 193 KK--MKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp BC--BCCCCSCTTTCCHHHHTT
T ss_pred cc--ccccCCCcCeeCHHHHcc
Confidence 32 234569999999998753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=245.79 Aligned_cols=175 Identities=35% Similarity=0.597 Sum_probs=163.1
Q ss_pred CCCcchHHHHHHHHHhccCCCCCCCCCCCCCCCCCC--cceeeeCCC---CcEEEEeeCCCcccc--ccCcCcCCCCCCC
Q 011486 27 RAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCN--WKGVKCDKN---KRVITLSLTNHKLSG--PISADLGKLDQLK 99 (484)
Q Consensus 27 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~--w~gv~C~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~ 99 (484)
.|.+.|++||++||+++.+|. .+.+|+. +.+||. |.||.|+.. ++|+.|+|++|+++| .+|+.|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 477789999999999998776 7899975 458998 999999853 799999999999999 8999999999999
Q ss_pred EEEccc-CcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCC
Q 011486 100 FLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (484)
Q Consensus 100 ~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N 178 (484)
+|+|++ |++.+.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CCCccc-ccCcccccCCcC
Q 011486 179 FLVGAIP-SDGVLT-KFSESSFFGNRG 203 (484)
Q Consensus 179 ~l~~~~p-~~~~l~-~l~~l~l~~N~~ 203 (484)
++++.+| .+..+. +|+.+++++|..
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCee
Confidence 9998888 778887 899999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=249.47 Aligned_cols=172 Identities=24% Similarity=0.389 Sum_probs=149.6
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChh-----------------HHHHHHHHHHHHhcCCCCceeee
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-----------------FDRFFERELEILGSIKHRYLVNL 368 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 368 (484)
.++|++.+.||+|+||.||+|.. +++.||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999998 8999999998643211 12789999999999999999999
Q ss_pred EEEEEcCCceEEEEEcCCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc
Q 011486 369 RGYCNSPTSKLLIYDFLPGGSLDEA------LHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (484)
Q Consensus 369 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~ 441 (484)
++++...+..++||||+++++|.++ +... ...+++..+..++.|++.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5442 4569999999999999999999995 15999999999999999
Q ss_pred CCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 442 ~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.++.+||+|||.+...... ......||+.|+|||++.++
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSC
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCC
Confidence 9999999999999876543 23445699999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=256.90 Aligned_cols=171 Identities=29% Similarity=0.397 Sum_probs=145.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh-------------hHHHHHHHHHHHHhcCCCCceeeeEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-------------GFDRFFERELEILGSIKHRYLVNLRGY 371 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 371 (484)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999876 578999999875321 235678999999999999999999999
Q ss_pred EEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC---cEEE
Q 011486 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARV 448 (484)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~---~~kl 448 (484)
+.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999765 569999999999999999999995 4999999999999998776 6999
Q ss_pred EecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|||+++....... .....||+.|+|||++..
T Consensus 191 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp CCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT
T ss_pred EECCCCEEcCCCCc--cccccCCcCCCCHHHhcc
Confidence 99999987765432 234569999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=248.55 Aligned_cols=166 Identities=29% Similarity=0.432 Sum_probs=138.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------c
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------S 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 377 (484)
++|+..+.||+|+||.||+|... +++.||+|++... .....+++.+|+++++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 57888999999999999999874 6899999999653 2344677899999999999999999999997763 4
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 8899999975 458999999999999999999995 49999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHT
T ss_pred ccc----cCcCcCCCCcCCHHHHhC
Confidence 542 234568999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=242.14 Aligned_cols=175 Identities=29% Similarity=0.388 Sum_probs=147.6
Q ss_pred HHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhc--CCCCceeeeEEEEEcCC----
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSPT---- 376 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 376 (484)
....++|++.+.||+|+||.||+|.. +++.||+|.+... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34456899999999999999999987 5889999999753 24567888888887 78999999999998876
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||... +.+|+||||||+|||++.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 78999999999999999975 35899999999999999999999310 249999999999999999999999999
Q ss_pred CCCcccCCCCcce---eecccccccccCCcccCCC
Q 011486 452 GLAKLLEDEESHI---TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 452 Gla~~~~~~~~~~---~~~~~Gt~~Y~APE~~~~~ 483 (484)
|+++......... .....||+.|+|||++..+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 9998775543221 2345699999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=241.01 Aligned_cols=169 Identities=27% Similarity=0.444 Sum_probs=143.9
Q ss_pred CCccceeeeccceeEEEEEec-----CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CceEE
Q 011486 309 LDDDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 380 (484)
|++.+.||+|+||.||++.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988643 57889999998643 34567899999999999999999999999874 56789
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999754 48999999999999999999995 49999999999999999999999999999987654
Q ss_pred Ccce--eecccccccccCCcccCC
Q 011486 461 ESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....||+.|+|||++.+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcC
Confidence 3221 233458899999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=266.20 Aligned_cols=165 Identities=25% Similarity=0.412 Sum_probs=137.6
Q ss_pred eeeeccceeEEEEEec---CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 314 IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 314 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 45679999998643 3456789999999999999999999999976 56899999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee--ec
Q 011486 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--TI 467 (484)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~~ 467 (484)
|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+........ ..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999998766679999999999999999999995 5999999999999999999999999999997754332222 22
Q ss_pred ccccccccCCcccCC
Q 011486 468 VAGTFGYLAPGKDCT 482 (484)
Q Consensus 468 ~~Gt~~Y~APE~~~~ 482 (484)
..+|+.|+|||++.+
T Consensus 499 ~~~~~~y~APE~~~~ 513 (613)
T 2ozo_A 499 GKWPLKWYAPECINF 513 (613)
T ss_dssp ---CCTTSCHHHHHH
T ss_pred CCCccceeCHhhhcC
Confidence 345789999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=236.15 Aligned_cols=169 Identities=27% Similarity=0.370 Sum_probs=142.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 380 (484)
.|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999875 5788999998753 34456789999999999999999999999865 345799
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~ 459 (484)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. ..+|+||||||+||+++ +++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999999764 5589999999999999999999954 12299999999999998 889999999999976544
Q ss_pred CCcceeecccccccccCCcccC
Q 011486 460 EESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.. .....||+.|+|||++.
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGG
T ss_pred cc---cccccCCcCcCCHHHHh
Confidence 32 23456999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=237.66 Aligned_cols=170 Identities=28% Similarity=0.424 Sum_probs=148.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---------hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---------EGFDRFFERELEILGSIK-HRYLVNLRGYCNS 374 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 374 (484)
.++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999876 58899999986432 223567889999999996 9999999999999
Q ss_pred CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999764 568999999999999999999995 49999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
........ .....||+.|+|||++.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIE 196 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhc
Confidence 87764332 23456899999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=239.24 Aligned_cols=167 Identities=31% Similarity=0.571 Sum_probs=144.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----------
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----------- 374 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------- 374 (484)
.+|++.+.||+|+||.||+|... +++.||+|.++... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 56888999999999999999876 78999999997644 346789999999999999999998854
Q ss_pred -----CCceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEE
Q 011486 375 -----PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (484)
Q Consensus 375 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl 448 (484)
....++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEE
Confidence 34478999999999999999754 3469999999999999999999995 49999999999999999999999
Q ss_pred EecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|||+++....... .....||+.|+|||++.+
T Consensus 164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHC
T ss_pred Ccchhheecccccc--ccccCCcccccChhhhcc
Confidence 99999987765432 233468999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=245.19 Aligned_cols=173 Identities=28% Similarity=0.424 Sum_probs=138.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCE----EEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNV----FALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
.++|++.+.||+|+||.||+|... +++. ||+|.+... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999864 3443 577777543 2445678999999999999999999999998765 78
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+|+||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999998877779999999999999999999995 4999999999999999999999999999987754
Q ss_pred CCcc-eeecccccccccCCcccCC
Q 011486 460 EESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......||+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp ----------CCCGGGSCHHHHHH
T ss_pred ccccccccCCCccccccCHHHHcC
Confidence 3222 1223457889999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=245.94 Aligned_cols=171 Identities=30% Similarity=0.464 Sum_probs=136.2
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHH--HhcCCCCceeeeEEEEEc-----CCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI--LGSIKHRYLVNLRGYCNS-----PTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 378 (484)
.++|++.+.||+|+||.||+|+. +++.||+|++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 56889999999999999999976 68899999997543 2334444444 556899999999986532 2246
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC------SPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
++||||+++|+|.+++... ..++..+..++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 8999999999999999754 3589999999999999999999421 1199999999999999999999999999
Q ss_pred CCcccCCCCc-------ceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEES-------HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~-------~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+++.+..... .......||+.|+|||++.+
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9987654221 11223569999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=259.21 Aligned_cols=170 Identities=26% Similarity=0.425 Sum_probs=148.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999876 78999999986432 334678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~ 459 (484)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 106 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999999754 569999999999999999999995 499999999999999 5678999999999987765
Q ss_pred CCcceeecccccccccCCcccCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 182 SKK--MKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp CCS--HHHHTTGGGTCCHHHHHT
T ss_pred ccc--cccCCCCccccCceeecC
Confidence 432 234569999999998753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=239.72 Aligned_cols=172 Identities=27% Similarity=0.427 Sum_probs=144.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 467889999999999999999876 68999999987533 223467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 9997 69999997643 458999999999999999999995 499999999999999999999999999998765432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .....||+.|+|||++.+
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 158 RT-YTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp BC-TTSCBCCCTTCCHHHHTT
T ss_pred cc-cCcccccccccCcHHhhc
Confidence 21 223458999999998765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=251.48 Aligned_cols=168 Identities=17% Similarity=0.199 Sum_probs=136.8
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc---ChhHHHHHHHHHH---HHhcCCCCceeeeE-------EE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELE---ILGSIKHRYLVNLR-------GY 371 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 371 (484)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++ .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 357888999999999999999864 6899999999742 3445678999994 55566899999998 77
Q ss_pred EEcCCc-----------------eEEEEEcCCCCCHHHHHhhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011486 372 CNSPTS-----------------KLLIYDFLPGGSLDEALHERSE------QLDWDARLNIIMGAAKGLAYLHHDCSPRI 428 (484)
Q Consensus 372 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~aL~~LH~~~~~~i 428 (484)
+..++. .|+||||+ +|+|.+++..... .+++..+..|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 766543 78999999 6899999975421 13358888999999999999995 499
Q ss_pred EEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 429 vHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++..
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcc
Confidence 9999999999999999999999999986433 2344568 99999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=245.08 Aligned_cols=170 Identities=25% Similarity=0.431 Sum_probs=144.8
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 379 (484)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 47889999999999999999865 68889999997543 34457899999999999999999999999765 3579
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9999997 599999965 359999999999999999999995 4999999999999999999999999999987754
Q ss_pred CCcce--eecccccccccCCcccCC
Q 011486 460 EESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||+.|+|||++..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~ 205 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLN 205 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred CCCccccccccccccCCCCCHHhcC
Confidence 32221 234579999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=242.64 Aligned_cols=174 Identities=25% Similarity=0.363 Sum_probs=130.5
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999865 68899999987533 334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 383 DFLPGGSLDEALHE-------RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 383 e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
||+++++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999974 23458999999999999999999995 499999999999999999999999999998
Q ss_pred ccCCCCc----ceeecccccccccCCcccC
Q 011486 456 LLEDEES----HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 456 ~~~~~~~----~~~~~~~Gt~~Y~APE~~~ 481 (484)
....... .......||+.|+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HCC---------------CCCTTCCHHHHH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhc
Confidence 7654321 1123356899999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-29 Score=240.04 Aligned_cols=173 Identities=25% Similarity=0.459 Sum_probs=145.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 380 (484)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468889999999999999999876 6899999999753 24456789999999999999999999998754 567899
Q ss_pred EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 381 IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPR-----IIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999753 23489999999999999999999965 5 9999999999999999999999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+++........ .....||+.|+|||++.+
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 162 LARILNHDTSF-AKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp HHHHC---CHH-HHHHHSCCTTCCHHHHHC
T ss_pred hheeecccccc-ccccCCCccccChHHhcc
Confidence 99876543221 223568999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.81 Aligned_cols=170 Identities=25% Similarity=0.388 Sum_probs=139.2
Q ss_pred HHHhcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 375 (484)
....++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999976 4789999999865432 234799999999999999999998543
Q ss_pred --------------------------------CceEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 011486 376 --------------------------------TSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYL 420 (484)
Q Consensus 376 --------------------------------~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~L 420 (484)
...++||||++ ++|.+.+.. ....+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999997 588877763 345699999999999999999999
Q ss_pred HhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 421 HHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 421 H~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
| +.+|+||||||+|||++ +++.+||+|||+++....... .....||+.|+|||++.+
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLG 215 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTT
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcC
Confidence 9 56999999999999998 689999999999997755432 234568999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=242.01 Aligned_cols=171 Identities=29% Similarity=0.457 Sum_probs=141.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCE--EEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNV--FALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|... ++.. +|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368899999999999999999865 4554 4899887532 33456789999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
||||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997643 358999999999999999999995 49999999999999999999
Q ss_pred EEEEecCCCcccCCCCcceeecccccccccCCcccC
Q 011486 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
+||+|||+++....... .....+|+.|+|||++.
T Consensus 181 ~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLN 214 (327)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHH
T ss_pred EEEcccCcCcccccccc--ccCCCCCccccChhhhc
Confidence 99999999975432211 22345788999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=263.55 Aligned_cols=160 Identities=19% Similarity=0.151 Sum_probs=123.7
Q ss_pred eeeccceeEEEEE-ecCCCEEEEEEecccC----------hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEE
Q 011486 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLN----------EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 315 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.|+.|.+..++ ...|+.+++|.+.... +...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555444432 3358889999986421 23456799999999999 6999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||++|++|.+++... +.+++. +|+.||+.||+|+|+ .|||||||||+|||++++|.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 999999999999764 556654 489999999999995 4999999999999999999999999999997765432
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. ....+||+.|||||++.+
T Consensus 395 ~-~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 395 W-PTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp C-SHHHHHHHHHHHHHHC--
T ss_pred c-ccCceechhhccHHHhCC
Confidence 2 344679999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=263.60 Aligned_cols=175 Identities=24% Similarity=0.327 Sum_probs=144.7
Q ss_pred HHhcCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
...++|++.+.||+|+||.||+|.... +..+|+|.++... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 334678888999999999999998742 4579999987543 445578999999999999999999999984 5668
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999998766679999999999999999999995 499999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...........||+.|+|||++..
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~ 566 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF 566 (656)
T ss_dssp C----------CCGGGCCHHHHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcC
Confidence 544333334557889999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=237.93 Aligned_cols=164 Identities=17% Similarity=0.326 Sum_probs=143.0
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEc--CCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNS--PTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|.. .+++.||+|+++... .+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5788899999999999999976 468999999997543 467899999999997 9999999999988 56689999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~ 461 (484)
||+++++|.+++.. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999843 8899999999999999999995 4999999999999999776 89999999998775543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||++.+
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTT
T ss_pred c--cccccccccccChhhhcC
Confidence 2 233568999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=239.38 Aligned_cols=179 Identities=23% Similarity=0.345 Sum_probs=136.6
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec----CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 374 (484)
++....++|.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33344567888999999999999999764 24579999987542 3445779999999999999999999999987
Q ss_pred CCc-----eEEEEEcCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC
Q 011486 375 PTS-----KLLIYDFLPGGSLDEALHE-----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (484)
Q Consensus 375 ~~~-----~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~ 444 (484)
.+. .++||||+++++|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence 653 4999999999999999853 2345999999999999999999999 55999999999999999999
Q ss_pred cEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 445 EARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+||+|||+++........ ......|++.|+|||.+.+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence 9999999999876543221 1233457889999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=244.65 Aligned_cols=169 Identities=24% Similarity=0.329 Sum_probs=135.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 376 (484)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999865 6889999999753 3445677889999999999999999999997765
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 57999999964 88888853 48999999999999999999995 4999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..... ......||+.|+|||++.+.
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 201 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGM 201 (371)
T ss_dssp ---------------CTTCCHHHHTTC
T ss_pred ccccc--ccCCceecCCccCHHHhcCC
Confidence 65432 22345699999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=236.98 Aligned_cols=170 Identities=25% Similarity=0.379 Sum_probs=131.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-h-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-E-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|++.+.||+|+||.||+|... +++.||+|+++... . ...+.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999874 68899999997543 2 22334455555688889999999999999999999999
Q ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||++ |+|.+++.. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588888764 345699999999999999999999942 2999999999999999999999999999987654
Q ss_pred CCcceeecccccccccCCccc
Q 011486 460 EESHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~ 480 (484)
... .....||+.|+|||++
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERI 181 (290)
T ss_dssp ---------CCCCCCSCHHHH
T ss_pred ccc--ccccCCCccccChhhc
Confidence 332 2334689999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=234.77 Aligned_cols=173 Identities=19% Similarity=0.312 Sum_probs=143.7
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC----hhHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCN--SPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 378 (484)
.++|++.+.||+|+||.||++... +++.+|+|.++... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999875 68899999997532 234678999999999999999999999985 34578
Q ss_pred EEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 379 LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
++||||++++ |.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77777653 3459999999999999999999995 49999999999999999999999999999876
Q ss_pred CCCC-cceeecccccccccCCcccCC
Q 011486 458 EDEE-SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~-~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ........||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred CccccccccccCCCCCCCcChhhccC
Confidence 5422 122234568999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=241.14 Aligned_cols=171 Identities=25% Similarity=0.345 Sum_probs=131.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEc--------CC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNS--------PT 376 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~~ 376 (484)
.+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47888999999999999999865 68999999997766666778999999999996 9999999999842 33
Q ss_pred ceEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 377 SKLLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
..++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4789999995 799999865 34569999999999999999999995 46 9999999999999999999999999
Q ss_pred CCcccCCCCcce-----------eecccccccccCCcccC
Q 011486 453 LAKLLEDEESHI-----------TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 453 la~~~~~~~~~~-----------~~~~~Gt~~Y~APE~~~ 481 (484)
+++......... .....||+.|+|||++.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp TCBCCSSCC-------------------------------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 998775432211 11345899999999973
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=242.07 Aligned_cols=174 Identities=23% Similarity=0.326 Sum_probs=142.4
Q ss_pred hcCCCccceeeeccceeEEEEEe------cCCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||+|.. .++..||+|.+... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788999999999999999974 35778999999754 344567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEE
Q 011486 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVS 449 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~ 449 (484)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998643 348999999999999999999995 49999999999999984 4469999
Q ss_pred ecCCCcccCCCCc-ceeecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEES-HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++....... .......||+.|+|||++.+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 219 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME 219 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence 9999986543221 11233568999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=236.78 Aligned_cols=172 Identities=27% Similarity=0.398 Sum_probs=136.9
Q ss_pred hcCCCccceeeeccceeEEEEEec--CCC--EEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD--DGN--VFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||+|... +++ .||+|+++.. .....+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999753 233 6899998753 2345678999999999999999999999998765 8
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999998766679999999999999999999995 499999999999999999999999999998876
Q ss_pred CCCcce--eecccccccccCCcccC
Q 011486 459 DEESHI--TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 459 ~~~~~~--~~~~~Gt~~Y~APE~~~ 481 (484)
...... .....||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHH
T ss_pred ccccchhhhccCCCCceeeCchhhc
Confidence 543321 22345788999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=240.55 Aligned_cols=168 Identities=26% Similarity=0.401 Sum_probs=140.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
.++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357889999999999999999875 57899999986532 112345889999999999999999999987665
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc---EEEEecCC
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGL 453 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~---~kl~DFGl 453 (484)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999998654 568999999999999999999995 49999999999999987664 99999999
Q ss_pred CcccCCCCcceeecccccccccCCccc
Q 011486 454 AKLLEDEESHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 454 a~~~~~~~~~~~~~~~Gt~~Y~APE~~ 480 (484)
++...... ......||+.|+|||++
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHH
T ss_pred ceeccccc--ccccccCCcCccCchhh
Confidence 98775432 12345689999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=237.93 Aligned_cols=170 Identities=23% Similarity=0.367 Sum_probs=137.4
Q ss_pred cCCCccceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEE------------
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN------------ 373 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------ 373 (484)
++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578889999999999999998764 8899999998766666788999999999999999999999874
Q ss_pred --cCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEe
Q 011486 374 --SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSD 450 (484)
Q Consensus 374 --~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~D 450 (484)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3356799999997 699999964 458999999999999999999995 4999999999999997 567999999
Q ss_pred cCCCcccCCCCcc--eeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+++........ ......||+.|+|||++..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcC
Confidence 9999876532211 1233457999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=246.64 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=126.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 377 (484)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 57888999999999999999864 6889999999753 234567788999999999999999999999764 55
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 7899999865 469999999999999999999995 49999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp ------------CCCTTCCHHHHTT
T ss_pred ccc----CCCcCcCcCccChHHHcC
Confidence 432 234568999999998765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=240.99 Aligned_cols=171 Identities=25% Similarity=0.419 Sum_probs=143.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----Cce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 378 (484)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888999999999999999876 68899999997543 34456788999999999999999999998654 568
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999996 699999875 458999999999999999999995 499999999999999999999999999998775
Q ss_pred CCCcc---------eeecccccccccCCcccCC
Q 011486 459 DEESH---------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~---------~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... ......||+.|+|||++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHS
T ss_pred cccccccCccccccchhhccccccccCCeeecc
Confidence 32211 1123468999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=245.11 Aligned_cols=171 Identities=18% Similarity=0.198 Sum_probs=136.9
Q ss_pred cCCCccceeeeccceeEEEEEec----CCCEEEEEEecccChh-----------HHHHHHHHHHHHhcCCCCceeeeEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEG-----------FDRFFERELEILGSIKHRYLVNLRGY 371 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~ 371 (484)
++|++.+.||+|+||.||+|... ++..+|+|++...... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999875 5778999998754321 12246678889999999999999999
Q ss_pred EEc----CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC--c
Q 011486 372 CNS----PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL--E 445 (484)
Q Consensus 372 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~--~ 445 (484)
+.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 987 67789999999 999999997653 79999999999999999999995 4999999999999999887 9
Q ss_pred EEEEecCCCcccCCCCcc------eeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESH------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 999999999877543211 1133569999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=234.11 Aligned_cols=172 Identities=24% Similarity=0.378 Sum_probs=142.6
Q ss_pred hcCCCccc-eeeeccceeEEEEEec---CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 306 LETLDDDH-IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 306 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
.++|++.+ .||+|+||.||+|... +++.||+|+++... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999543 46789999997543 33467899999999999999999999999 566789
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999764 569999999999999999999995 4999999999999999999999999999987765
Q ss_pred CCccee--ecccccccccCCcccCC
Q 011486 460 EESHIT--TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~~--~~~~Gt~~Y~APE~~~~ 482 (484)
...... ....||+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH
T ss_pred CCCcccccccCCCCceeeChHHhcc
Confidence 433222 22346789999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=247.02 Aligned_cols=167 Identities=19% Similarity=0.233 Sum_probs=141.1
Q ss_pred cCCCccceeeeccceeEEEEEecC---------CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceee----------
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD---------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN---------- 367 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 367 (484)
++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999998764 788999998754 35889999999999999987
Q ss_pred -----eEEEEEc-CCceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 368 -----LRGYCNS-PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 368 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+++++.. .+..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 6777766 67789999999 99999999764 3569999999999999999999995 499999999999999
Q ss_pred cCCC--cEEEEecCCCcccCCCCcc------eeecccccccccCCcccCC
Q 011486 441 DGNL--EARVSDFGLAKLLEDEESH------ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 441 ~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.++ .+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9998 9999999999877543221 1133479999999998865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=264.55 Aligned_cols=164 Identities=20% Similarity=0.339 Sum_probs=140.8
Q ss_pred cCCCccceeeeccceeEEEEEec--CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc-----e
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-----K 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 378 (484)
++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57889999999999999999875 58999999986533 4456678999999999999999999999987765 6
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++++|.+++.. .+++..++.|+.||+.||+|||+ .+|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999998754 59999999999999999999995 499999999999999986 89999999998775
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. ....||+.|+|||++.+
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHH
T ss_pred cC-----CccCCCccccCHHHHcC
Confidence 43 23569999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=235.20 Aligned_cols=172 Identities=23% Similarity=0.314 Sum_probs=141.2
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46899999999999999999986 4688999998754322 23588899999999988877777666 55667899999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~~ 460 (484)
|+ +++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 999999998666679999999999999999999995 499999999999999 78899999999999877553
Q ss_pred Ccc------eeecccccccccCCcccCCC
Q 011486 461 ESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ......||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTC
T ss_pred ccCccCCCCcccccCCCccccchHHhcCC
Confidence 321 12345699999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=236.20 Aligned_cols=167 Identities=26% Similarity=0.381 Sum_probs=136.5
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-CceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-TSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||++... ++.||+|.++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999874 8899999997643 456799999999999999999999997655 468999999
Q ss_pred CCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999976432 27899999999999999999995 499999999999999999999999999998654322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
....+++.|+|||++.+
T Consensus 172 --~~~~~~~~y~aPE~~~~ 188 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALRE 188 (278)
T ss_dssp ------CCTTTSCHHHHHH
T ss_pred --cCCCccccccCHHHhCC
Confidence 22357899999998743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=234.18 Aligned_cols=172 Identities=23% Similarity=0.314 Sum_probs=144.0
Q ss_pred hcCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35788999999999999999986 5789999999865432 24588999999999988877766665 55567799999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCCC
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~~ 460 (484)
|+ +++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 899999998666679999999999999999999995 499999999999999 48889999999999877654
Q ss_pred Ccc------eeecccccccccCCcccCCC
Q 011486 461 ESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ......||+.|+|||++.++
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTC
T ss_pred ccccccccccccccccccccCChhhhcCC
Confidence 321 12345699999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=246.79 Aligned_cols=167 Identities=27% Similarity=0.400 Sum_probs=136.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc------eEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------KLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 380 (484)
.+|+..+.||+|+||.||+|+..++..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999998777799998865332 23469999999999999999999965433 789
Q ss_pred EEEcCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCccc
Q 011486 381 IYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLL 457 (484)
Q Consensus 381 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~ 457 (484)
||||++++.+..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997744333322 224569999999999999999999995 4999999999999999 7999999999999877
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||+.|+|||++.+
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFG 215 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTT
T ss_pred cCCCC--CcccccCcCccCHHHHcC
Confidence 54432 234568999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=239.63 Aligned_cols=173 Identities=23% Similarity=0.339 Sum_probs=143.3
Q ss_pred hcCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 380 (484)
.+.|.+. +.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++ ||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3456655 88999999999999876 58999999987532 334678899999999995 6999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCcc
Q 011486 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKL 456 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~ 456 (484)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999998643 3459999999999999999999995 49999999999999997 78999999999987
Q ss_pred cCCCCcceeecccccccccCCcccCCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... .....||+.|+|||++..+
T Consensus 184 ~~~~~~--~~~~~gt~~y~aPE~~~~~ 208 (327)
T 3lm5_A 184 IGHACE--LREIMGTPEYLAPEILNYD 208 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTC
T ss_pred cCCccc--cccccCCcCccCCeeecCC
Confidence 754322 2345699999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=238.09 Aligned_cols=173 Identities=25% Similarity=0.402 Sum_probs=142.2
Q ss_pred HHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEc------C
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS------P 375 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~ 375 (484)
...++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34678889999999999999999874 688999999875432 356788999999998 79999999999976 4
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 57899999999999999997642 458999999999999999999995 49999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCCcccC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
........ ......||+.|+|||++.
T Consensus 177 ~~~~~~~~-~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 177 AQLDRTVG-RRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp C--------------CCGGGCCHHHHC
T ss_pred eecCcCcc-ccccccCCccccChhhhc
Confidence 87654321 123456899999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=247.28 Aligned_cols=166 Identities=30% Similarity=0.426 Sum_probs=136.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------ceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------SKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 379 (484)
..|+..+.||+|+||.||+|... +++.||||++..... ...+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999886 589999999865332 2457999999999999999999985421 257
Q ss_pred EEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-CcEEEEecCCCc
Q 011486 380 LIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAK 455 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-~~~kl~DFGla~ 455 (484)
+||||+++ ++.+.+.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 67666643 3456999999999999999999999 5599999999999999965 678999999999
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+..... .....||+.|+|||++.+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFG 230 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTT
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcC
Confidence 7654332 234568999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=260.28 Aligned_cols=165 Identities=25% Similarity=0.396 Sum_probs=136.1
Q ss_pred ceeeeccceeEEEEEec---CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMD---DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997643 3346789999999999999999999999964 558899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc--ee
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH--IT 465 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~ 465 (484)
|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999754 569999999999999999999995 49999999999999999999999999999877544322 12
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|+|||++..
T Consensus 530 ~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 530 THGKWPVKWYAPECINY 546 (635)
T ss_dssp -----CGGGSCHHHHHH
T ss_pred cCCCCceeeeChhhhcC
Confidence 23457889999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=245.25 Aligned_cols=167 Identities=11% Similarity=-0.023 Sum_probs=126.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHH---HHhcCCCCceeeeE-------EEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE---ILGSIKHRYLVNLR-------GYC 372 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~~ 372 (484)
.+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++ .++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888999999999999999865 78899999998643 234566778854 4555 799988755 455
Q ss_pred EcCC-----------------ceEEEEEcCCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 011486 373 NSPT-----------------SKLLIYDFLPGGSLDEALHERSEQLDWDAR------LNIIMGAAKGLAYLHHDCSPRII 429 (484)
Q Consensus 373 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~~iv 429 (484)
..++ ..++||||++ |+|.+++......+++..+ ..++.||+.||+|||+ .+|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 4332 2799999998 8999999875444566666 7888999999999995 4999
Q ss_pred EcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 430 HrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||++..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccC
Confidence 9999999999999999999999999876432 223457899999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=240.26 Aligned_cols=180 Identities=22% Similarity=0.290 Sum_probs=136.7
Q ss_pred CHHHHHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 298 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
...+.....++|++.+.||+|+||.||+|... +++.||||++.... .....+.+|++.++.++||||+++++++...+
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34567788899999999999999999999875 68999999986533 22345677888889999999999999996644
Q ss_pred c-------eEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCc
Q 011486 377 S-------KLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLE 445 (484)
Q Consensus 377 ~-------~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~ 445 (484)
. .++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 3 7899999976 55554442 345689999999999999999999943 459999999999999996 899
Q ss_pred EEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||+|||+++....... .....||+.|+|||++.+
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFG 205 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTT
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcC
Confidence 99999999987765432 234568999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=245.48 Aligned_cols=168 Identities=26% Similarity=0.386 Sum_probs=126.6
Q ss_pred CCc-cceeeeccceeEEEEEec---CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCceEEEE
Q 011486 309 LDD-DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLLIY 382 (484)
Q Consensus 309 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 382 (484)
|+. .++||+|+||.||+|... +++.||+|++..... ...+.+|++++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999865 578899999976432 3468899999999999999999999954 56789999
Q ss_pred EcCCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE----cCCCcEEEEe
Q 011486 383 DFLPGGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSD 450 (484)
Q Consensus 383 e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----~~~~~~kl~D 450 (484)
||++ ++|.+++... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5888887632 1248999999999999999999995 499999999999999 6788999999
Q ss_pred cCCCcccCCCCc--ceeecccccccccCCcccCC
Q 011486 451 FGLAKLLEDEES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 451 FGla~~~~~~~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
||+++.+..... .......||+.|+|||++.+
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTT
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 999987754321 12234679999999998865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=241.02 Aligned_cols=165 Identities=26% Similarity=0.413 Sum_probs=139.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce-----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK----- 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----- 378 (484)
++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57888999999999999999865 6889999999753 234467889999999999999999999999887654
Q ss_pred -EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 379 -LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 379 -~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 68888874 348999999999999999999995 49999999999999999999999999999866
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSC
T ss_pred ccC----cCCcccCccccCHHHhcC
Confidence 432 234568999999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=231.62 Aligned_cols=172 Identities=26% Similarity=0.413 Sum_probs=147.6
Q ss_pred HhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467899999999999999999876 68999999986532 33467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC---CcEEEEecCCCcccC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFGLAKLLE 458 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~---~~~kl~DFGla~~~~ 458 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999998765 468999999999999999999995 499999999999999754 479999999998765
Q ss_pred CCCcceeecccccccccCCcccCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....||+.|+|||++.+
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT
T ss_pred CCCc--cccccCcccccChHHhcC
Confidence 4332 223458999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=244.40 Aligned_cols=167 Identities=23% Similarity=0.258 Sum_probs=142.8
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcC------CCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI------KHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~ 379 (484)
.+|++.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46888999999999999999765 5889999999763 33456788888888876 5779999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc--EEEEecCCCcc
Q 011486 380 LIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKL 456 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~--~kl~DFGla~~ 456 (484)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 69999997654 349999999999999999999995 49999999999999999887 99999999976
Q ss_pred cCCCCcceeecccccccccCCcccCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... .....||+.|+|||++.+
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHT
T ss_pred cCCc----ccccCCCCCccChHHHhC
Confidence 5432 223568999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=236.72 Aligned_cols=173 Identities=27% Similarity=0.431 Sum_probs=142.2
Q ss_pred HhcCCCccceeeeccceeEEEEEe--cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcC---CCCceeeeEEEEE----
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAM--DDGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCN---- 373 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 373 (484)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346899999999999999999987 367889999986432 11223566777777666 8999999999987
Q ss_pred -cCCceEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 374 -SPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 374 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 4566899999997 69999997643 348999999999999999999995 49999999999999999999999999
Q ss_pred CCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 452 GLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 452 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
|+++...... ......||+.|+|||++.++
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 194 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQS 194 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTC
T ss_pred cccccccCCC--CccccccccceeCHHHHhcC
Confidence 9998765432 12345689999999988653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=234.47 Aligned_cols=168 Identities=21% Similarity=0.337 Sum_probs=143.6
Q ss_pred cCCCccceeeeccceeEEEEEe--cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC------ceeeeEEEEEcCCce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR------YLVNLRGYCNSPTSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~ 378 (484)
++|++.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+.+|+++++.++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788999999999999999986 36889999999754 33467788999999988655 599999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---------------
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------------- 442 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~--------------- 442 (484)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999997653 358999999999999999999995 49999999999999987
Q ss_pred ----CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 443 ----NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 443 ----~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.+||+|||+++...... ....||+.|+|||++.+.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILAL 209 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTS
T ss_pred ccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCC
Confidence 6689999999998754322 235689999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=243.93 Aligned_cols=168 Identities=26% Similarity=0.290 Sum_probs=140.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC--------CCceeeeEEEEE----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK--------HRYLVNLRGYCN---- 373 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---- 373 (484)
++|++.+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|+++++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 57899999999999999999765 6889999999754 344677899999999885 788999999987
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCcEEEcCCC-------
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSP-RIIHRDIKSSNILLDGNL------- 444 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDikp~NILl~~~~------- 444 (484)
.....++||||+ ++++.+++... ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 556789999999 55666666543 3569999999999999999999995 4 999999999999999775
Q ss_pred ------------------------------------------cEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 445 ------------------------------------------EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 445 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876543 223468999999998765
Q ss_pred C
Q 011486 483 N 483 (484)
Q Consensus 483 ~ 483 (484)
+
T Consensus 268 ~ 268 (397)
T 1wak_A 268 S 268 (397)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=236.77 Aligned_cols=173 Identities=25% Similarity=0.289 Sum_probs=138.6
Q ss_pred HHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh------hHHHHHHHHHHHHhcC----CCCceeeeEEE
Q 011486 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSI----KHRYLVNLRGY 371 (484)
Q Consensus 303 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~ 371 (484)
..-.++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344568999999999999999999864 688999999975432 1233466799999888 89999999999
Q ss_pred EEcCCceEEEEEc-CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEE
Q 011486 372 CNSPTSKLLIYDF-LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVS 449 (484)
Q Consensus 372 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~ 449 (484)
+...+..++|||| +++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 7899999999765 468999999999999999999995 4999999999999999 89999999
Q ss_pred ecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 450 DFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 450 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||+++...... .....||+.|+|||++.+
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 212 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISR 212 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHH
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeec
Confidence 999998776432 234568999999998653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=245.46 Aligned_cols=171 Identities=24% Similarity=0.333 Sum_probs=143.5
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5788999999999999999986 4689999998765332 2357889999999987 5566666667777888999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE---cCCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl---~~~~~~kl~DFGla~~~~~~~ 461 (484)
+ +++|.+++......+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 999999998766779999999999999999999995 499999999999999 688999999999998776543
Q ss_pred cce------eecccccccccCCcccCCC
Q 011486 462 SHI------TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~------~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .....||+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 188 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGI 188 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred cccccccccccccCCCccccCHHHhcCC
Confidence 211 2246799999999998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=237.71 Aligned_cols=165 Identities=26% Similarity=0.399 Sum_probs=138.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc------
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------ 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 377 (484)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888999999999999999875 68899999997532 3345778999999999999999999999987754
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 588887743 489999999999999999999954 9999999999999999999999999999875
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||++.+
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp -----------CCSBCCSCHHHHSC
T ss_pred CCC----ccccccCcCcCCHHHHhC
Confidence 432 233568999999998765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=237.66 Aligned_cols=171 Identities=23% Similarity=0.298 Sum_probs=144.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CC-----ceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HR-----YLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 468999999999999999999866 5788999999753 334567888999988875 44 499999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCCcEEEEecCCCc
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAK 455 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~~~kl~DFGla~ 455 (484)
++||||++ ++|.+++.... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 59999997653 4589999999999999999999954 46999999999999994 57889999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
...... ....||+.|+|||++.+.
T Consensus 210 ~~~~~~----~~~~~t~~y~aPE~~~~~ 233 (382)
T 2vx3_A 210 QLGQRI----YQYIQSRFYRSPEVLLGM 233 (382)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHTTC
T ss_pred eccccc----ccccCCccccChHHHcCC
Confidence 775432 235689999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=239.68 Aligned_cols=176 Identities=28% Similarity=0.396 Sum_probs=143.2
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
+.....++|++.+.||+|+||.||+|...+ .+|+|.++... ....+.+.+|++++++++||||+++++++..++..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 333445788999999999999999998754 48999987432 22345678899999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
++||||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999998766679999999999999999999995 4999999999999998 6799999999987653
Q ss_pred CCC----cceeecccccccccCCcccCC
Q 011486 459 DEE----SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 459 ~~~----~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ........||+.|+|||++..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccCCCcccccChHHhhh
Confidence 211 111223458999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=232.60 Aligned_cols=172 Identities=19% Similarity=0.304 Sum_probs=142.0
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCCceEE
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 380 (484)
..++|++.+.||+|+||.||++...+++.||+|.+... .....+.+.+|++++++++ ||||+++++++..++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34678899999999999999999988999999998643 3445678999999999997 5999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||| +.+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||+++.....
T Consensus 106 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 999 5588999999764 568999999999999999999995 49999999999999974 89999999999877543
Q ss_pred Ccc-eeecccccccccCCcccCC
Q 011486 461 ESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
... ......||+.|+|||++..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp ----------CCGGGCCHHHHTT
T ss_pred cccccccCCCCCCCcCCHHHHhh
Confidence 321 1234568999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=232.13 Aligned_cols=170 Identities=29% Similarity=0.410 Sum_probs=126.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHH-HHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|+..+.||+|+||.||+|... +++.||+|+++... .....++.+|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999875 68899999997643 334455666666 677889999999999999999999999
Q ss_pred EcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 383 DFLPGGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSP-RIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88888763 24568999999999999999999994 4 9999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCCcccC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
..... .....||+.|+|||++.
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERID 198 (327)
T ss_dssp ------------------------
T ss_pred ccccc--cccCCCCccccCceeec
Confidence 54322 22346999999999983
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=243.77 Aligned_cols=169 Identities=26% Similarity=0.341 Sum_probs=135.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+....|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 35777899999999997665566899999999975432 2356899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-----CCcEEEEecCCCcccCCC
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-----~~~~kl~DFGla~~~~~~ 460 (484)
+ |+|.+++.......++..+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999998765556666778999999999999995 49999999999999953 236889999999877543
Q ss_pred Cc--ceeecccccccccCCcccCC
Q 011486 461 ES--HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~--~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.. .......||+.|+|||++..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ---------CCSCTTSCCGGGTSC
T ss_pred CcceeeccccCCCcCccChhhhhc
Confidence 22 12234679999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=235.70 Aligned_cols=170 Identities=26% Similarity=0.316 Sum_probs=145.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh------hHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIK--HRYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 376 (484)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++ ||||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 467899999999999999999764 688999999865321 12345778999999996 599999999999999
Q ss_pred ceEEEEEcCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCC
Q 011486 377 SKLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLA 454 (484)
Q Consensus 377 ~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla 454 (484)
..++||||+.+ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 99999999976 8999999764 568999999999999999999995 4999999999999999 7899999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+...... .....||+.|+|||++..
T Consensus 198 ~~~~~~~---~~~~~gt~~y~aPE~~~~ 222 (320)
T 3a99_A 198 ALLKDTV---YTDFDGTRVYSPPEWIRY 222 (320)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHH
T ss_pred ccccccc---ccCCCCCccCCChHHhcc
Confidence 8776432 233569999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=231.06 Aligned_cols=167 Identities=21% Similarity=0.268 Sum_probs=119.6
Q ss_pred hcCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceE
Q 011486 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKL 379 (484)
Q Consensus 306 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 379 (484)
.++|.+. +.||+|+||.||+|... +++.||+|++..... ...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3577774 46999999999999876 689999999965321 12222334567799999999999876 34579
Q ss_pred EEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCc
Q 011486 380 LIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAK 455 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~ 455 (484)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998653 359999999999999999999995 49999999999999976 4559999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... .....||+.|+|||++..
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp EC-------------------------
T ss_pred eccccc---cccCCCCcCccChhhhCC
Confidence 765432 233568999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=242.55 Aligned_cols=167 Identities=25% Similarity=0.304 Sum_probs=129.9
Q ss_pred CCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 44467899999999987777789999999986532 45678899999876 89999999999999999999999995
Q ss_pred CCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC-------------CcEEE
Q 011486 388 GSLDEALHERSEQ------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-------------LEARV 448 (484)
Q Consensus 388 gsL~~~l~~~~~~------l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~-------------~~~kl 448 (484)
|+|.+++...... .++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999754321 1233457899999999999995 499999999999999754 48999
Q ss_pred EecCCCcccCCCCcce---eecccccccccCCcccCC
Q 011486 449 SDFGLAKLLEDEESHI---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 449 ~DFGla~~~~~~~~~~---~~~~~Gt~~Y~APE~~~~ 482 (484)
+|||+++......... .....||+.|+|||++.+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 9999999876543221 224569999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=230.05 Aligned_cols=171 Identities=26% Similarity=0.401 Sum_probs=129.1
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-h-hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-E-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
.++|+..+.||+|+||.||+|... +++.||+|++.... . ...+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 567888999999999999999876 68999999997543 2 22334455556788889999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+ ++.+..+.......+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 999 5567666655556799999999999999999999951 2899999999999999999999999999987654322
Q ss_pred ceeecccccccccCCcccC
Q 011486 463 HITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~ 481 (484)
.....||+.|+|||++.
T Consensus 181 --~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERID 197 (318)
T ss_dssp --------CCTTCCHHHHC
T ss_pred --ccccCCCccccChhhcc
Confidence 23346899999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=231.20 Aligned_cols=168 Identities=25% Similarity=0.338 Sum_probs=141.9
Q ss_pred cCCCccceeeeccceeEEEEEec-CC-CEEEEEEecccChhHHHHHHHHHHHHhcCCCCc------eeeeEEEEEcCCce
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DG-NVFALKRIDKLNEGFDRFFERELEILGSIKHRY------LVNLRGYCNSPTSK 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~ 378 (484)
++|++.+.||+|+||.||+|... ++ ..||+|+++.. ....+.+.+|++++++++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57889999999999999999875 34 68999999754 334677889999999987665 99999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE-----------------
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----------------- 440 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl----------------- 440 (484)
++||||+ ++++.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 667777776543 46999999999999999999999 5599999999999999
Q ss_pred --cCCCcEEEEecCCCcccCCCCcceeecccccccccCCcccCCC
Q 011486 441 --DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 441 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+.++.+||+|||+++...... ....||+.|+|||++.++
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILEL 214 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTC
T ss_pred cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecC
Confidence 567899999999998754332 335699999999998653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=249.30 Aligned_cols=173 Identities=28% Similarity=0.420 Sum_probs=145.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc------CCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS------PTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 377 (484)
.++|++.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999874 6889999998754 34456789999999999999999999999765 667
Q ss_pred eEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc---EEEEecC
Q 011486 378 KLLIYDFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFG 452 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~---~kl~DFG 452 (484)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976432 58999999999999999999995 49999999999999997765 9999999
Q ss_pred CCcccCCCCcceeecccccccccCCcccCCC
Q 011486 453 LAKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 453 la~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+++....... .....||+.|+|||++.++
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~ 198 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQK 198 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCS
T ss_pred cccccccccc--cccccCCcccCChHHhccC
Confidence 9987755432 2345699999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-27 Score=233.99 Aligned_cols=167 Identities=21% Similarity=0.273 Sum_probs=141.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-----------CCceeeeEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-----------HRYLVNLRGYCNS 374 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 374 (484)
++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57889999999999999999864 6889999999753 334567889999998886 8999999999876
Q ss_pred CC----ceEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCcEEEc------C
Q 011486 375 PT----SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSP-RIIHRDIKSSNILLD------G 442 (484)
Q Consensus 375 ~~----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivHrDikp~NILl~------~ 442 (484)
.+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ . +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 54 678999999 88999999764 3459999999999999999999995 4 999999999999994 4
Q ss_pred CCcEEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 443 ~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
++.+||+|||+++...... ....||+.|+|||++.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLG 209 (373)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHT
T ss_pred cceEEEcccccccccCCCC----CCCCCCccccCcHHHhC
Confidence 4589999999998765432 23468999999998764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=244.43 Aligned_cols=157 Identities=19% Similarity=0.202 Sum_probs=122.9
Q ss_pred CccceeeeccceeEEEEEecCCCEEEEEEecccC--------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
...+.||+|+||.||++.. .++.+++|+..... ....+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 56788888764321 11245689999999999999999777777778888999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++++|.++++. +..++.|+++||+|||+ .+|+||||||+|||+++ .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999865 56899999999999995 49999999999999998 99999999999876533
Q ss_pred cce------eecccccccccCCcccC
Q 011486 462 SHI------TTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 462 ~~~------~~~~~Gt~~Y~APE~~~ 481 (484)
... .....||+.|||||++.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHH
Confidence 221 13567999999999875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=251.13 Aligned_cols=177 Identities=23% Similarity=0.362 Sum_probs=118.8
Q ss_pred hhccCCCcchHHHHHHHHHhccCCCCCCCCCCCCCCCCCCcceeeeCCCCcEEEEeeCCCccccc---cCc---------
Q 011486 23 INKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGP---ISA--------- 90 (484)
Q Consensus 23 ~~~~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~C~~~~~l~~L~L~~n~l~~~---~~~--------- 90 (484)
++++.+.+.|++||++||+++.||. .+++|+. +.|||+|+||+|+ .++|+.|+|+++.++|. +|+
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3444556789999999999999888 8999974 4689999999998 78999999999999987 665
Q ss_pred --------------CcCCCCCCCEEEcccCcccccCCc--ccCCccccceecccccccCCCCChhh-hcccccccccccc
Q 011486 91 --------------DLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISS 153 (484)
Q Consensus 91 --------------~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~ls~ 153 (484)
.++++++|++|||++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|||++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 455555555555555555555555 55555555555555555555555544 4555555555555
Q ss_pred cccCCCCCCc---cccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 154 NSLSDYIPPS---LGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 154 N~l~~~~p~~---~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
|++++..|.. +.++++|++|++++|.+++.+|. ..+++|+.|++++|..
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~l 212 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNF 212 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSCC
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCcC
Confidence 5555555444 45556666666666666655443 5566666666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=212.03 Aligned_cols=144 Identities=10% Similarity=-0.007 Sum_probs=127.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46888999999999999999876 48999999997543 334578999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
||+++++|.++++.. ....++.+|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++|....
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~~~~ 178 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATMPD 178 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCCCTT
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEeccccCC
Confidence 999999999999542 4566788999999999999995 4999999999999999999999998877653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=249.56 Aligned_cols=171 Identities=24% Similarity=0.276 Sum_probs=151.8
Q ss_pred CcchHHHHHHHHHhccCCCCCCCCCCCCC----CCC--CCc------------ceeeeCCCCcEEEEeeCCCccccccCc
Q 011486 29 INSDGEALLSFRTAVVSSDGFLNQWRPED----PDP--CNW------------KGVKCDKNKRVITLSLTNHKLSGPISA 90 (484)
Q Consensus 29 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~C~~~~~l~~L~L~~n~l~~~~~~ 90 (484)
...|+.||++||+++.+| +|+.++ .+| |+| .||+|+..++|+.|+|++|+|+|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 346899999999999766 787554 456 999 999999888999999999999999999
Q ss_pred CcCCCCCCCEEEc-ccCccccc----------------------------------------------------------
Q 011486 91 DLGKLDQLKFLNL-HSNNFYGE---------------------------------------------------------- 111 (484)
Q Consensus 91 ~~~~l~~L~~L~L-s~N~l~~~---------------------------------------------------------- 111 (484)
.|++|++|++|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 77866555
Q ss_pred ------------------CCcccCCccccceecccccccCC-----------------CCChhhh--ccccccccccccc
Q 011486 112 ------------------IPSELGNCTELQGLSLQSNYLSG-----------------SIPSELG--NLSNLLNLDISSN 154 (484)
Q Consensus 112 ------------------~p~~~~~l~~L~~L~Ls~N~l~g-----------------~~p~~~~--~l~~L~~L~ls~N 154 (484)
+|..|+++++|++|+|++|+|+| .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 88899999999999999999998 3999987 9999999999999
Q ss_pred ccCCCCCCccccccccceeeccCCc-ccc-cCC-CCCccc-------ccCcccccCCcCC
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNF-LVG-AIP-SDGVLT-------KFSESSFFGNRGL 204 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~-l~~-~~p-~~~~l~-------~l~~l~l~~N~~~ 204 (484)
++.+.+|..|.++++|+.|+|++|+ ++| .+| .++.++ +|+.|++++|...
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 9999999999999999999999998 998 666 455554 8999999988765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=209.29 Aligned_cols=146 Identities=24% Similarity=0.396 Sum_probs=126.5
Q ss_pred hcCCCcc-ceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHH-hcCCCCceeeeEEEEEc----CCce
Q 011486 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEIL-GSIKHRYLVNLRGYCNS----PTSK 378 (484)
Q Consensus 306 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 378 (484)
.++|.+. +.||+|+||.||++... +++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456666 78999999999999874 6889999999652 3567888887 56689999999999876 5678
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla 454 (484)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998653 359999999999999999999995 49999999999999998 789999999999
Q ss_pred cccCC
Q 011486 455 KLLED 459 (484)
Q Consensus 455 ~~~~~ 459 (484)
.....
T Consensus 168 ~~~~~ 172 (299)
T 3m2w_A 168 KETTG 172 (299)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 87654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=225.76 Aligned_cols=165 Identities=16% Similarity=0.178 Sum_probs=125.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccCh---hHHHHHHHHHHHHhcCCC-Cce---------ee-----
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKH-RYL---------VN----- 367 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v~----- 367 (484)
..|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35667789999999999999854 689999999874322 235679999999999987 211 11
Q ss_pred -------eEEEEEc-----CCceEEEEEcCCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011486 368 -------LRGYCNS-----PTSKLLIYDFLPGGSLDEALHE------RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429 (484)
Q Consensus 368 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv 429 (484)
+..++.. ....+++|+++ +++|.+++.. ....+++..+..++.||+.||+|||+ .+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 1111111 12356777765 6899999852 23347888999999999999999995 5999
Q ss_pred EcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceeecccccccccCCccc
Q 011486 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKD 480 (484)
Q Consensus 430 HrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~ 480 (484)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhh
Confidence 9999999999999999999999999875432 334568 999999987
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=238.71 Aligned_cols=173 Identities=23% Similarity=0.247 Sum_probs=154.1
Q ss_pred cchHHHHHHHHHhccCCCC--------CCCCCCCCCCCCCCc---ceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCC
Q 011486 30 NSDGEALLSFRTAVVSSDG--------FLNQWRPEDPDPCNW---KGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQL 98 (484)
Q Consensus 30 ~~~~~~l~~~k~~~~~~~~--------~l~~w~~~~~~~c~w---~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L 98 (484)
..|+.||.++++++.+++- ...+|+. +.+||.| .||+|+..++|+.|+|++++++|.+|++|++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 3589999999999875531 1237985 4689999 99999977899999999999999999999999999
Q ss_pred CEEEcccC------------------------------------------------------------------------
Q 011486 99 KFLNLHSN------------------------------------------------------------------------ 106 (484)
Q Consensus 99 ~~L~Ls~N------------------------------------------------------------------------ 106 (484)
++|+|++|
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 99999998
Q ss_pred ------cccccCCcccCCccccceecccccccCCC-----------------CChhhh--cccccccccccccccCCCCC
Q 011486 107 ------NFYGEIPSELGNCTELQGLSLQSNYLSGS-----------------IPSELG--NLSNLLNLDISSNSLSDYIP 161 (484)
Q Consensus 107 ------~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-----------------~p~~~~--~l~~L~~L~ls~N~l~~~~p 161 (484)
+|+| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.+.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 4455 899999999999999999999986 999999 99999999999999999999
Q ss_pred CccccccccceeeccCCc-ccc-cCC-CCCcc------cccCcccccCCcCC
Q 011486 162 PSLGKLQRLITFNVSNNF-LVG-AIP-SDGVL------TKFSESSFFGNRGL 204 (484)
Q Consensus 162 ~~~~~l~~L~~L~ls~N~-l~~-~~p-~~~~l------~~l~~l~l~~N~~~ 204 (484)
..|+++++|++|+|++|+ ++| .+| .++.+ ++|+.|++++|...
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 999999999999999998 998 677 56665 89999999999765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=207.15 Aligned_cols=142 Identities=12% Similarity=0.130 Sum_probs=114.1
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccCh------------------hHHHHHHHHHHHHhcCC
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE------------------GFDRFFERELEILGSIK 361 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 361 (484)
..+......|.+.+.||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 444555566777899999999999999987799999999964321 13567899999999999
Q ss_pred CCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc
Q 011486 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (484)
Q Consensus 362 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~ 441 (484)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+ .+|+||||||+|||++
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS 227 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE
Confidence 4 555554433 56799999999999988 421 2244699999999999995 5999999999999999
Q ss_pred CCCcEEEEecCCCccc
Q 011486 442 GNLEARVSDFGLAKLL 457 (484)
Q Consensus 442 ~~~~~kl~DFGla~~~ 457 (484)
++.+||+|||+|+..
T Consensus 228 -~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEV 242 (282)
T ss_dssp -TTEEEECCCTTCEET
T ss_pred -CCcEEEEECCCCeEC
Confidence 999999999999743
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=214.50 Aligned_cols=176 Identities=17% Similarity=0.269 Sum_probs=153.8
Q ss_pred cCCCcchHHHHHHHHHhc-cCCCCCCCCCC---CCCCCCCCcceeeeC---------CCCcEEEEeeCCCccccccCcCc
Q 011486 26 SRAINSDGEALLSFRTAV-VSSDGFLNQWR---PEDPDPCNWKGVKCD---------KNKRVITLSLTNHKLSGPISADL 92 (484)
Q Consensus 26 ~~~~~~~~~~l~~~k~~~-~~~~~~l~~w~---~~~~~~c~w~gv~C~---------~~~~l~~L~L~~n~l~~~~~~~~ 92 (484)
+.+...|++||++||+.+ .++.+++.+|. ....++|.|.|+.|+ ...+|+.|+|++|+++ .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999998 47778889994 345689999999995 2478999999999999 888889
Q ss_pred CCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCcccc------
Q 011486 93 GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK------ 166 (484)
Q Consensus 93 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~------ 166 (484)
+++++|++|+|++|.|+ .+|..++++++|++|+|++|+++ .+|..+..+++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 89999999999999999999998889988765
Q ss_pred ---ccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 167 ---LQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 167 ---l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+++|++|+|++|+++..++.+..+++|+.|++++|...
T Consensus 179 ~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC
T ss_pred hccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC
Confidence 89999999999999844447888889999999988754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=194.00 Aligned_cols=150 Identities=22% Similarity=0.256 Sum_probs=137.1
Q ss_pred CCCCCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecc
Q 011486 58 PDPCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127 (484)
Q Consensus 58 ~~~c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 127 (484)
.+.|+|.+|.|+. ..+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 4689999999974 257999999999999988999999999999999999998666667899999999999
Q ss_pred cccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCC
Q 011486 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 128 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~ 206 (484)
++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++.++ .+..+++|+.+++.+|++.|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999666667899999999999999999 689999999999999999999998887 688899999999999999998
Q ss_pred Cc
Q 011486 207 KQ 208 (484)
Q Consensus 207 ~~ 208 (484)
++
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 75
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=191.68 Aligned_cols=149 Identities=16% Similarity=0.203 Sum_probs=136.8
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
|.|..|.|+. ..+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 6899999973 247999999999999888889999999999999999999888999999999999999999
Q ss_pred ccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 131 ~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++ .+..+++|+.+++++|++.|.+.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 9994444457899999999999999999889999999999999999999999988 688899999999999999998775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=189.21 Aligned_cols=149 Identities=19% Similarity=0.236 Sum_probs=136.6
Q ss_pred CCcceeeeCCC----------CcEEEEeeCCCccccccC-cCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 61 CNWKGVKCDKN----------KRVITLSLTNHKLSGPIS-ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 61 c~w~gv~C~~~----------~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
|.|..+.|+.. ..++.|+|++|+|++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 68999999732 367899999999998755 4589999999999999999988888999999999999999
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+| .+..+++|+.+++++|++.|.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99997777789999999999999999999889999999999999999999999977 78899999999999999999877
Q ss_pred c
Q 011486 209 I 209 (484)
Q Consensus 209 ~ 209 (484)
+
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 5
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=182.32 Aligned_cols=149 Identities=21% Similarity=0.207 Sum_probs=133.9
Q ss_pred CCCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 60 ~c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
.|.|.+|.|+. ..+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 47899999974 24699999999999977777789999999999999999977666789999999999999
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++.++ .+..+++|+.+++++|++.|..+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99996666668999999999999999998777778999999999999999998887 47889999999999999998765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-22 Score=217.75 Aligned_cols=141 Identities=35% Similarity=0.581 Sum_probs=133.8
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 155 (484)
.+++..|.++|.+|..++++++|++|||++|+|+|.+|..|+++++|+.|||++|+++|.+|..++++++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 45667799999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcccccccCCC
Q 011486 156 LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDS 217 (484)
Q Consensus 156 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~~~~c~~~~ 217 (484)
++|.+|..+.++++|++|||++|+|+|.+|..+.+..+....+.||+.+||.|+. .|....
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~ 752 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSN 752 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCc
Confidence 9999999999999999999999999999998888999999999999999999987 886543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.83 E-value=3.2e-21 Score=188.98 Aligned_cols=138 Identities=30% Similarity=0.528 Sum_probs=115.3
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
.++.|+|++|++++.+|..+..++ |++|+|++|.+++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 566666666666666666666665 77777777777777777778888888888888888866555 7788999999999
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcccccc
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTC 213 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~~~~c 213 (484)
+|++++.+|..+..+++|+.|+|++|+++|.+|....+++|+.+++.+|+++||.|+. .|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9999989999999999999999999999999997789999999999999999998775 45
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=179.11 Aligned_cols=132 Identities=23% Similarity=0.229 Sum_probs=93.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 35677777777777766667777777777777777777666666777777777777777777555556677777777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
++|+|++..+..|..+++|+.|+|++|+|++.++ .+..+++|+.|++++|+.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 167 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQL 167 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcC
Confidence 7777776555556677777777777777776666 466677777777777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-21 Score=182.91 Aligned_cols=139 Identities=20% Similarity=0.193 Sum_probs=108.8
Q ss_pred CCCccceeeeccceeEEEEEe-cCCCE--EEEEEecccCh------------------------hHHHHHHHHHHHHhcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAM-DDGNV--FALKRIDKLNE------------------------GFDRFFERELEILGSI 360 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 360 (484)
-|++.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999988 67888 99998754311 1123688999999999
Q ss_pred CCCce--eeeEEEEEcCCceEEEEEcCCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcC
Q 011486 361 KHRYL--VNLRGYCNSPTSKLLIYDFLPG-G----SLDEALHERSEQLDWDARLNIIMGAAKGLAYLH-HDCSPRIIHRD 432 (484)
Q Consensus 361 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~~ivHrD 432 (484)
.|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 88754 444432 357899999942 3 77776533 234567789999999999999 54 999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 433 IKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 433 ikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
|||+|||+++ .++|+|||+|.....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCHHHEEEcC--cEEEEECcccccCCC
Confidence 9999999998 999999999987654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.82 E-value=6e-21 Score=173.37 Aligned_cols=131 Identities=22% Similarity=0.274 Sum_probs=97.8
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCc-ccCCccccceecccccccCCCCChhhhccccccccccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS-ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 154 (484)
.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4556666775 56655543 778888888888755553 3777888888888888888777777888888888888888
Q ss_pred ccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|++..|..|..+++|++|+|++|+|++.+| .+..+++|+.+++++|++.|.+++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 8887777777778888888888888887766 667777888888888888777664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.2e-20 Score=175.07 Aligned_cols=136 Identities=24% Similarity=0.267 Sum_probs=126.5
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999998888899999999999999999987778899999999999999999966666689999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~ 206 (484)
|++|+|++..|..|..+++|++|+|++|+|++.++ .+..+++|+.+++++|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999998777789999999999999999999888 788999999999999999987
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.81 E-value=4.4e-20 Score=167.63 Aligned_cols=149 Identities=23% Similarity=0.308 Sum_probs=127.8
Q ss_pred CCcceeeeCCC----------CcEEEEeeCCCccccccCc-CcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 61 CNWKGVKCDKN----------KRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 61 c~w~gv~C~~~----------~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
|.|..+.|+.. .+++.|+|++|++++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 68999999742 3799999999999976664 489999999999999999999999999999999999999
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcc
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|++|+|++|++++..+...-...++...+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 99998888889999999999999999999999999999999999999999998876322222344446667777777653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=9e-20 Score=165.72 Aligned_cols=130 Identities=22% Similarity=0.269 Sum_probs=118.4
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 155 (484)
.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 5677888888 6776554 68999999999999 888999999999999999999997777889999999999999999
Q ss_pred cCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 156 LSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 156 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|++..|..|..+++|+.|+|++|+|++.++ .+..+++|+.+++++|++.|++.+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 999888899999999999999999998887 588899999999999999998775
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=173.96 Aligned_cols=139 Identities=24% Similarity=0.196 Sum_probs=121.3
Q ss_pred CCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...++++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 34678999999999997777778999999999999999997777778999999999999999996666667889999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
+|++|++++..|..|..+++|++|++++|++++.+| .+..+++|+.+++++|++.|.++
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999998777778899999999999999998887 47889999999999999988765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=173.76 Aligned_cols=131 Identities=23% Similarity=0.254 Sum_probs=97.8
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
.++.|+|++|++++..+..|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46777777777776666677788888888888888875555556778888888888888875555556777888888888
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
+|++++..|..|..+++|++|+|++|++++.++ .+..+++|+.|++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 888877666677778888888888888877666 467777788888877754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-19 Score=173.07 Aligned_cols=138 Identities=24% Similarity=0.187 Sum_probs=116.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 457888888888888 6777888899999999999999977777899999999999999999966666678889999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcc
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|++|+|++..+..|..+++|+.|+|++|+|+..++.+..+.+|+.+++.+|+|.|.+.+
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCcc
Confidence 99999987666667889999999999999997666777778899999999999998754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=169.97 Aligned_cols=137 Identities=26% Similarity=0.216 Sum_probs=89.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 45666666666666555555666666666666666666555555666666777777777666443444666777777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
++|++++..+..|..+++|++|+|++|++++.++ .+..+++|+.+++++|++.|+++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7777776555556677777777777777776655 45666777777777777777643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=191.11 Aligned_cols=160 Identities=19% Similarity=0.185 Sum_probs=128.3
Q ss_pred CCCCCCCCCCCCC---CCCCCcc----eeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCc
Q 011486 45 SSDGFLNQWRPED---PDPCNWK----GVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN 107 (484)
Q Consensus 45 ~~~~~l~~w~~~~---~~~c~w~----gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 107 (484)
+++..+++|+.+- .+||.+. .|.|.. +..+++|||++|+|++..+..|.++++|++|||++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 3444556665332 2456442 467863 2479999999999998888899999999999999999
Q ss_pred ccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCccccc-CC-
Q 011486 108 FYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA-IP- 185 (484)
Q Consensus 108 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p- 185 (484)
|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+++. +|
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9987788899999999999999999965556799999999999999999987778899999999999999999874 45
Q ss_pred CCCcccccCcccccCCcCC
Q 011486 186 SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 186 ~~~~l~~l~~l~l~~N~~~ 204 (484)
.++.+++|+.|++++|+..
T Consensus 168 ~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp GGGGCTTCCEEECCSSCCC
T ss_pred hhccchhhhhhcccCcccc
Confidence 6688999999999999764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=158.07 Aligned_cols=134 Identities=20% Similarity=0.240 Sum_probs=100.5
Q ss_pred CCcceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhh
Q 011486 61 CNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL 140 (484)
Q Consensus 61 c~w~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 140 (484)
|+|.++.|+ +++++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..+
T Consensus 7 C~~~~l~~~-----------~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCN-----------SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECC-----------SSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEec-----------CCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 578777775 34555 344433 3678888888888886666667888888888888888885555557
Q ss_pred hcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 141 GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 141 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
..+++|++|+|++|+|++..+..+..+++|++|+|++|++++.++ .+..+++|+.+++++|++.|.++
T Consensus 73 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 788888888888888887666667888888888888888887766 35677888888888888887654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.1e-19 Score=172.18 Aligned_cols=138 Identities=21% Similarity=0.204 Sum_probs=83.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|+|++|++++..|..+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 105 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 184 (285)
T 1ozn_A 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (285)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEEC
Confidence 35555666666665555555566666666666666666444444566666666666666666333334566666666666
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
++|++++..|..|..+++|+.|++++|++++.++ .+..+++|+.+++++|++.|.+++
T Consensus 185 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 6666666556666666666666666666666554 355666666666777766666543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.5e-19 Score=181.30 Aligned_cols=137 Identities=22% Similarity=0.180 Sum_probs=130.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|.+++.+|..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 57999999999999999999999999999999999999988999999999999999999999877889999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
++|++++..|..|..+++|++|+|++|++++.++ .+..+++|+.+++++|++.|.++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999889999999999999999999999877 56889999999999999999887
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=8.3e-19 Score=155.44 Aligned_cols=130 Identities=25% Similarity=0.271 Sum_probs=119.5
Q ss_pred CcEEEEeeCCCccc-cccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 67999999999998 88999999999999999999999965 7899999999999999999977999898999999999
Q ss_pred ccccccCCCC-CCccccccccceeeccCCcccccCC----CCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYI-PPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~l~~l~~l~l~~N~~ 203 (484)
|++|++++.. +..+..+++|++|++++|++++.++ .+..+++|+.+++.+|..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 9999999742 2789999999999999999999887 678899999999999874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=169.84 Aligned_cols=137 Identities=18% Similarity=0.211 Sum_probs=89.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccc-cCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++.|+|++|.+++..+..+.++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+..+++|++|+
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 456666666666666666666666666666666666665 4566666666666666666666655566666666677777
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC-CCCcc-cccCcccccCCcCCCCCc
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVL-TKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l-~~l~~l~l~~N~~~c~~~ 208 (484)
|++|++++..+..+..+++|+.|+|++|++++.+| .+..+ ++|+.+++++|++.|.++
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 77776666555566666677777777777766665 45555 366677777777666544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7.1e-19 Score=152.63 Aligned_cols=127 Identities=21% Similarity=0.278 Sum_probs=115.7
Q ss_pred CcEEEEeeCCCccc-cccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++.|++++|+++ +.+|+.+..+++|++|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999999 88999999999999999999999966 7899999999999999999977999899999999999
Q ss_pred ccccccCCC-CCCccccccccceeeccCCcccccCC----CCCcccccCcccccC
Q 011486 151 ISSNSLSDY-IPPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSFFG 200 (484)
Q Consensus 151 ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~l~~l~~l~l~~ 200 (484)
|++|++++. .|..+..+++|++|++++|++++.++ .+..+++|+.+++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999973 34889999999999999999999877 477888999888763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-19 Score=177.25 Aligned_cols=125 Identities=20% Similarity=0.140 Sum_probs=83.4
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcC-CCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
|.|..+.|+. ...++.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 4566677752 13466777777777766666665 677777777777777766666677777777777777
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 153 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV 153 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCG
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCH
Confidence 77775444556667777777777777766666666666666666666666665444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=173.27 Aligned_cols=139 Identities=19% Similarity=0.183 Sum_probs=121.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 46899999999999988888999999999999999999987777899999999999999999977788999999999999
Q ss_pred ccccccCCCCCCcc---ccccccceeeccCCcccccCC-CCCcccc--cCcccccCCcCCCCCcc
Q 011486 151 ISSNSLSDYIPPSL---GKLQRLITFNVSNNFLVGAIP-SDGVLTK--FSESSFFGNRGLCGKQI 209 (484)
Q Consensus 151 ls~N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~~~p-~~~~l~~--l~~l~l~~N~~~c~~~~ 209 (484)
|++|+|++..+..| ..+++|+.|+|++|+|++.++ .+..++. ++.+++.+|++.|++.+
T Consensus 143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 99999997444444 679999999999999998765 4566665 47899999999999864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=157.34 Aligned_cols=124 Identities=22% Similarity=0.293 Sum_probs=112.1
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
|.|..+.|+. ..+++.|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 5788888863 247999999999999 78889999999999999999999888888999999999999999
Q ss_pred ccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 131 ~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.....
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9997777789999999999999999998666679999999999999999987543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-18 Score=183.01 Aligned_cols=139 Identities=18% Similarity=0.196 Sum_probs=128.3
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcc-cccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...++.++++.|.+++..+..+..++.|+.|+|++|++ .+.+|..|..+++|++|||++|+|++..|..|.++++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 35788899999999999999999999999999999985 45688899999999999999999998889999999999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCcc-cccCcccccCCcCCCCCcc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVL-TKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l-~~l~~l~l~~N~~~c~~~~ 209 (484)
+|++|+|++..|..|..+++|++|||++|+|++.+| .+..+ ++|+.+++++|||.|+|.+
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 999999999888899999999999999999999998 67777 6899999999999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=180.29 Aligned_cols=144 Identities=24% Similarity=0.277 Sum_probs=117.2
Q ss_pred CCcceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccC-CccccceecccccccCCCCChh
Q 011486 61 CNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSNYLSGSIPSE 139 (484)
Q Consensus 61 c~w~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~ 139 (484)
|.+.++.|...++++.|+|++|.+++..|..++++++|++|+|++|.|++.+|..+. .+++|++|+|++|.|++. |.
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 456677777667788888888888888888888888888888888888888887776 788888888888888854 33
Q ss_pred hhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCC
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGK 207 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~ 207 (484)
+..+++|++|+|++|+|++ +|..+..+++|+.|+|++|+|++.++.+..+++|+.+++++|++.|+.
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcc
Confidence 3458888999999999887 555588888899999999999886667788888888899998888764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.1e-18 Score=162.35 Aligned_cols=137 Identities=23% Similarity=0.258 Sum_probs=86.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCC-CCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG-SIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~ 150 (484)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++ .+|..+..+++|++|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 456666666666665555666666666666666666665555456666666666666666664 2566666666666666
Q ss_pred ccccccCCCCCCcccccc---------------------------ccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 151 ISSNSLSDYIPPSLGKLQ---------------------------RLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~---------------------------~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
|++|++++..+..+..++ +|+.|+|++|++++.++ .+..+++|+.+++++|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 666666654443333222 56666666666666655 34667777777777777
Q ss_pred CCCCCc
Q 011486 203 GLCGKQ 208 (484)
Q Consensus 203 ~~c~~~ 208 (484)
+.|+++
T Consensus 236 ~~c~c~ 241 (276)
T 2z62_A 236 WDCSCP 241 (276)
T ss_dssp BCCCTT
T ss_pred ccccCC
Confidence 777654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-18 Score=180.38 Aligned_cols=146 Identities=21% Similarity=0.243 Sum_probs=130.1
Q ss_pred CCCCc----ceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccce
Q 011486 59 DPCNW----KGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQG 124 (484)
Q Consensus 59 ~~c~w----~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 124 (484)
+||.| ..+.|+. ..++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 56755 2577752 357999999999999888889999999999999999999888989999999999
Q ss_pred ecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccc-cCC-CCCcccccCcccccCCc
Q 011486 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG-AIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 125 L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p-~~~~l~~l~~l~l~~N~ 202 (484)
|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++ .+| .++.+++|+.|++++|.
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 9999999998889999999999999999999998777899999999999999999987 456 78899999999999997
Q ss_pred CC
Q 011486 203 GL 204 (484)
Q Consensus 203 ~~ 204 (484)
..
T Consensus 165 l~ 166 (606)
T 3vq2_A 165 IQ 166 (606)
T ss_dssp CC
T ss_pred ce
Confidence 53
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.9e-18 Score=161.19 Aligned_cols=132 Identities=20% Similarity=0.187 Sum_probs=117.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46899999999999877778999999999999999999777778999999999999999999777788999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCccccc-CC-CCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA-IP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p-~~~~l~~l~~l~l~~N~~ 203 (484)
++|++++..+..+..+++|++|++++|++++. +| .+..+++|+.+++++|+.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 99999987777899999999999999999884 45 788889999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3e-18 Score=180.65 Aligned_cols=143 Identities=24% Similarity=0.241 Sum_probs=127.4
Q ss_pred CCCcceeeeCC------------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecc
Q 011486 60 PCNWKGVKCDK------------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127 (484)
Q Consensus 60 ~c~w~gv~C~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 127 (484)
.|.|.|+ |+. ..++++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 862 247999999999999888999999999999999999999888899999999999999
Q ss_pred cccccCCCCChhhhcccccccccccccccCC-CCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcC
Q 011486 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 128 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~ 203 (484)
++|++++..|..|+.+++|++|+|++|++++ .+|..+.++++|++|++++|++.+.+| .+..+++|+.+++++|..
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 9999997777779999999999999999986 367889999999999999999555554 688899999999998875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=161.10 Aligned_cols=133 Identities=21% Similarity=0.195 Sum_probs=114.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccc-cCCCCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY-LSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L 149 (484)
..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..+..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 3578899999999997777788999999999999999998778889999999999999997 775557788889999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
+|++|++++..|..+.++++|++|++++|++++.++ .+..+++|+.+++++|..
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 999999988778888889999999999999988777 478888999999998864
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=176.81 Aligned_cols=146 Identities=17% Similarity=0.183 Sum_probs=129.3
Q ss_pred CCCCcce--eeeCC---------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccC-CcccCCccccceec
Q 011486 59 DPCNWKG--VKCDK---------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLS 126 (484)
Q Consensus 59 ~~c~w~g--v~C~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ 126 (484)
+.|.|.+ |.|+. ..++++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3566655 88873 257999999999999988999999999999999999998666 56799999999999
Q ss_pred ccccccCCCCChhhhcccccccccccccccCCCCCCc--cccccccceeeccCCcccccCCC--CCcccccCcccccCCc
Q 011486 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIPS--DGVLTKFSESSFFGNR 202 (484)
Q Consensus 127 Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~~~~p~--~~~l~~l~~l~l~~N~ 202 (484)
|++|++++..|..|.++++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|. +..+++|+.+++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999865554 89999999999999999999883 7899999999999997
Q ss_pred CC
Q 011486 203 GL 204 (484)
Q Consensus 203 ~~ 204 (484)
..
T Consensus 166 l~ 167 (455)
T 3v47_A 166 VK 167 (455)
T ss_dssp BS
T ss_pred cc
Confidence 53
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-18 Score=183.10 Aligned_cols=139 Identities=18% Similarity=0.125 Sum_probs=118.3
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccc-cCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
..+++.|+|++|.+++..|..+.++++|++|+|++|.+++ .+|..|..+++|++|+|++|++++..|..+..+++|++|
T Consensus 423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 3578888888888888888888888888888888888887 478888888999999999999988888888889999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCCCCCccc-ccCcccccCCcCCCCCcc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT-KFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~-~l~~l~l~~N~~~c~~~~ 209 (484)
+|++|++++.+|..|.++++|+.|+|++|+|+..++.+..++ +|+.+++++|++.|++++
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999988888888889999999999999986666677776 589999999999998775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=159.63 Aligned_cols=115 Identities=17% Similarity=0.166 Sum_probs=109.1
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 46899999999999988888999999999999999999988888899999999999999999988899999999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999999889999999999999999999998765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.2e-18 Score=168.85 Aligned_cols=144 Identities=24% Similarity=0.280 Sum_probs=125.3
Q ss_pred CCCCCcceeeeCC------------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCcccccee
Q 011486 58 PDPCNWKGVKCDK------------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (484)
Q Consensus 58 ~~~c~w~gv~C~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 125 (484)
..+|.|.|+ |+. ..++++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 357889887 641 2479999999999998777789999999999999999998888899999999999
Q ss_pred cccccccCCCCChh-hhcccccccccccccccCCCCC-CccccccccceeeccCC-cccccCC-CCCcccccCcccccCC
Q 011486 126 SLQSNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIP-PSLGKLQRLITFNVSNN-FLVGAIP-SDGVLTKFSESSFFGN 201 (484)
Q Consensus 126 ~Ls~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N-~l~~~~p-~~~~l~~l~~l~l~~N 201 (484)
+|++|+++ .+|.. +..+++|++|+|++|++++..+ ..+..+++|++|++++| .+++.+| .+..+++|+.+++++|
T Consensus 106 ~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 99999999 55554 8999999999999999996433 47899999999999999 4777666 7889999999999998
Q ss_pred cC
Q 011486 202 RG 203 (484)
Q Consensus 202 ~~ 203 (484)
..
T Consensus 185 ~l 186 (353)
T 2z80_A 185 DL 186 (353)
T ss_dssp TC
T ss_pred Cc
Confidence 74
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=166.42 Aligned_cols=131 Identities=24% Similarity=0.350 Sum_probs=118.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCC---------ccccceecccccccCCCCChhhhc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGN---------CTELQGLSLQSNYLSGSIPSELGN 142 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~g~~p~~~~~ 142 (484)
.++++|+|++|.++ .+|+.++++++|++|+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..++.
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 57999999999999 88989999999999999999998899988765 999999999999999 89999999
Q ss_pred ccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCC
Q 011486 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 143 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c 205 (484)
+++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+| .++.+++|+.|++++|+..-
T Consensus 205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence 9999999999999996 77789999999999999999999888 68889999999999987643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=158.60 Aligned_cols=132 Identities=25% Similarity=0.272 Sum_probs=120.1
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.++++.|+|++|.+++ + +.+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 3689999999999996 3 4799999999999999999988887899999999999999999977777789999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
|++|++++..|..|..+++|+.|++++|++++.++ .+..+++|+.+++++|+..
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 99999998777788999999999999999998888 4688999999999999754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=172.59 Aligned_cols=143 Identities=22% Similarity=0.215 Sum_probs=127.7
Q ss_pred CcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccc
Q 011486 62 NWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131 (484)
Q Consensus 62 ~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 131 (484)
.|..|.|.. ..+++.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 467888863 2478999999999998888899999999999999999998889999999999999999999
Q ss_pred cCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 132 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..| .+..+++|+.|++++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 995444568999999999999999999889999999999999999999999887 7888999999999998653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=171.44 Aligned_cols=136 Identities=25% Similarity=0.277 Sum_probs=109.8
Q ss_pred CcEEEEeeCCCccccccCcC-------------------------cCCCCCCCEEEcccCcccccCCcccCCccccceec
Q 011486 72 KRVITLSLTNHKLSGPISAD-------------------------LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLS 126 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 126 (484)
.+++.|+|++|.++...+.. |.++++|++|+|++|+|+ .+| .+..+++|++|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEE
Confidence 56778888888777544433 455666666666666666 444 467777888888
Q ss_pred ccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCC
Q 011486 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 127 Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c 205 (484)
|++|+|++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++ .+..+++|+.+++++|++.|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 88888887778888899999999999999998888889999999999999999998887 57889999999999999999
Q ss_pred CCcc
Q 011486 206 GKQI 209 (484)
Q Consensus 206 ~~~~ 209 (484)
++.+
T Consensus 294 dC~l 297 (440)
T 3zyj_A 294 NCDI 297 (440)
T ss_dssp SSTT
T ss_pred CCCc
Confidence 9875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=1e-17 Score=182.01 Aligned_cols=173 Identities=20% Similarity=0.198 Sum_probs=114.2
Q ss_pred CCcchHHHHHHHHHhccCC-CCCCCCCCCCCCCCCCcceeeeCCCCcEEEE------------------eeCCCcccc--
Q 011486 28 AINSDGEALLSFRTAVVSS-DGFLNQWRPEDPDPCNWKGVKCDKNKRVITL------------------SLTNHKLSG-- 86 (484)
Q Consensus 28 ~~~~~~~~l~~~k~~~~~~-~~~l~~w~~~~~~~c~w~gv~C~~~~~l~~L------------------~L~~n~l~~-- 86 (484)
..+.++++|+++....... ...-..|......++.|.++.++. ++++.| +|++|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 4557889999998777422 122345654444556888877763 334444 344444433
Q ss_pred -------ccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCC
Q 011486 87 -------PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159 (484)
Q Consensus 87 -------~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~ 159 (484)
..+..+..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 33667889999999999999999 88888889999999999999999 99999999999999999999999 6
Q ss_pred CCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 160 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+|..|+.|++|++|+|++|.|+..++.++.+++|+.|++++|+..
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCC
T ss_pred cChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccC
Confidence 899999999999999999999866558999999999999999865
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=169.24 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=120.1
Q ss_pred CcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccc
Q 011486 62 NWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131 (484)
Q Consensus 62 ~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 131 (484)
.|..|.|.. ..+++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 366788863 2568899999999998888999999999999999999998888899999999999999999
Q ss_pred cCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCC
Q 011486 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 132 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~ 204 (484)
|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+..+.++ .+..+++|+.|++++|...
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 995555579999999999999999998777788888889999988854444443 5777888888888888653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=152.35 Aligned_cols=127 Identities=17% Similarity=0.183 Sum_probs=115.7
Q ss_pred EEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccccc
Q 011486 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (484)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 154 (484)
..+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46899999999 6777665 79999999999999877778999999999999999999888999999999999999999
Q ss_pred ccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+|++..+..|..+++|+.|+|++|+|++.+| .+..+++|+.|++++|+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 9998666678999999999999999999988 7889999999999999753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=185.62 Aligned_cols=135 Identities=23% Similarity=0.253 Sum_probs=113.7
Q ss_pred CCcEEEEeeCCCccccccCc-CcCCCCCCCEEEcccCccc-----ccCCcccCCccccceecccccccCCCCChhhhccc
Q 011486 71 NKRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFY-----GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 144 (484)
.++++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|..++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 35678888888888865443 4566888899999999887 44556788999999999999999988888899999
Q ss_pred ccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcc
Q 011486 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 145 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|. .+.+|+.+++++|++.|+|++
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSSC
T ss_pred hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCccccccc
Confidence 999999999999987666665 8999999999999999883 356899999999999998875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=177.47 Aligned_cols=154 Identities=19% Similarity=0.139 Sum_probs=119.2
Q ss_pred CCCCCCCCCCCCCC----cceeeeCC-----------------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCc
Q 011486 49 FLNQWRPEDPDPCN----WKGVKCDK-----------------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN 107 (484)
Q Consensus 49 ~l~~w~~~~~~~c~----w~gv~C~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 107 (484)
.+++|.+. .+||. |.++.|+. ..+++.|++++|.++...+..|.++++|++|+|++|.
T Consensus 8 ~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 8 NVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ---CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred cccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence 45788754 34552 76665541 1356778888888886555567888888888888888
Q ss_pred ccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-C
Q 011486 108 FYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-S 186 (484)
Q Consensus 108 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~ 186 (484)
|++..|..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..+..|.++++|++|+|++|.+++.+| .
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 887777788888888888888888887777778888888888888888887555557888888888888888888877 6
Q ss_pred CCcccccCcccccCCcC
Q 011486 187 DGVLTKFSESSFFGNRG 203 (484)
Q Consensus 187 ~~~l~~l~~l~l~~N~~ 203 (484)
+..+++|+.|++++|..
T Consensus 167 ~~~l~~L~~L~L~~N~l 183 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRL 183 (597)
T ss_dssp TTTCTTCCEEECTTSCC
T ss_pred hhcCCcCcEEECcCCCC
Confidence 78888888888888864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-17 Score=155.93 Aligned_cols=131 Identities=16% Similarity=0.147 Sum_probs=117.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCc-ccccCCcccCCccccceecccc-cccCCCCChhhhcccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN-FYGEIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L 149 (484)
.+++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..|..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998777789999999999999997 8866667899999999999999 99996556778999999999
Q ss_pred cccccccCCCCCCccccccccc---eeeccCC-cccccCC-CCCcccccC-cccccCCcCC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLI---TFNVSNN-FLVGAIP-SDGVLTKFS-ESSFFGNRGL 204 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~---~L~ls~N-~l~~~~p-~~~~l~~l~-~l~l~~N~~~ 204 (484)
+|++|++++ +|. |..+++|+ +|++++| ++++.++ .+..+++|+ .+++++|...
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999997 776 88888888 9999999 9998887 588899999 9999998753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.9e-18 Score=164.39 Aligned_cols=143 Identities=23% Similarity=0.235 Sum_probs=118.1
Q ss_pred CCCcceeeeCCC----------CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccc--cCCcccCCccccceecc
Q 011486 60 PCNWKGVKCDKN----------KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSL 127 (484)
Q Consensus 60 ~c~w~gv~C~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 127 (484)
.|.|.+|.|+.. .++++|+|++|+++...+..|.++++|++|+|++|.++. .+|..+..+++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 379999999842 479999999999995555568999999999999999983 33667778888999999
Q ss_pred cccccCCCCChhhhcccccccccccccccCCCCC-CccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 128 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+| .+..+++|+.|++++|..
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 999888 678778888888899998888887544 578888888888888888888777 577788888888888864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-17 Score=157.66 Aligned_cols=129 Identities=26% Similarity=0.177 Sum_probs=78.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|.+++..+..|.++++|++|+|++|.|++. |. ...+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 4566677777777666666666666666666666666633 22 255666666666666665 55655666666666666
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
++|+|++..|..|..+++|++|+|++|+|++.++ .+..+++|+.|++++|+.
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 6666665445556666666666666666665554 345556666666666553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=168.07 Aligned_cols=133 Identities=20% Similarity=0.137 Sum_probs=117.8
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|++++|.++...+..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 56888999999999655555789999999999999999877789999999999999999999777888999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
++|+++...+..|.++++|++|++++|++++.+| .+..+++|+.|++++|...
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 9999997555557899999999999999999887 6889999999999999753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.6e-17 Score=169.39 Aligned_cols=137 Identities=23% Similarity=0.229 Sum_probs=113.9
Q ss_pred CCcEEEEeeCCCccccccCcC-------------------------cCCCCCCCEEEcccCcccccCCcccCCcccccee
Q 011486 71 NKRVITLSLTNHKLSGPISAD-------------------------LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 125 (484)
..+++.|+|++|.++...+.. |.++++|++|+|++|+|++ +| .+..+++|++|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEE
Confidence 357888888888887544433 5556667777777777763 44 47778888888
Q ss_pred cccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 126 ~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++ .+..+++|+.+++++|++.
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 888888887778889999999999999999999889999999999999999999998887 5788999999999999999
Q ss_pred CCCcc
Q 011486 205 CGKQI 209 (484)
Q Consensus 205 c~~~~ 209 (484)
|++.+
T Consensus 304 CdC~~ 308 (452)
T 3zyi_A 304 CDCDI 308 (452)
T ss_dssp CSTTT
T ss_pred CCCCc
Confidence 99875
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.3e-17 Score=167.82 Aligned_cols=142 Identities=15% Similarity=0.149 Sum_probs=121.3
Q ss_pred cceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccccc
Q 011486 63 WKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132 (484)
Q Consensus 63 w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 132 (484)
|..|.|.. ..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788863 24799999999999998899999999999999999999988889999999999999999999
Q ss_pred CCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCC
Q 011486 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 133 ~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~ 204 (484)
++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|+..+.+| .+..+++|+.|++++|...
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 96555668999999999999999998777788888888889888844444444 5778888888888888653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=162.03 Aligned_cols=147 Identities=11% Similarity=0.078 Sum_probs=106.3
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccCh--------------h--------HHHHHHHHHHHH
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE--------------G--------FDRFFERELEIL 357 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~--------~~~~~~~E~~~l 357 (484)
..+...-.-|++...||+|++|.||+|...+|+.||||+++.... . ......+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444445889999999999999999999999999998753100 0 011234677777
Q ss_pred hcCCCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCc
Q 011486 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (484)
Q Consensus 358 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~N 437 (484)
.++.+..+....-+.. ...++||||+++++|.++.. .+....++.|++.+|.|||+. +||||||||.|
T Consensus 168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 7776554432222222 23479999999988865432 123456889999999999964 99999999999
Q ss_pred EEEcCCC----------cEEEEecCCCcccC
Q 011486 438 ILLDGNL----------EARVSDFGLAKLLE 458 (484)
Q Consensus 438 ILl~~~~----------~~kl~DFGla~~~~ 458 (484)
||+++++ .+.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998876 38999999887654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=174.34 Aligned_cols=138 Identities=19% Similarity=0.220 Sum_probs=110.8
Q ss_pred CcEEEEeeCCCccccccC-cCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccC-CCCChhhhcccccccc
Q 011486 72 KRVITLSLTNHKLSGPIS-ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS-GSIPSELGNLSNLLNL 149 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L 149 (484)
.+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ +.+|..+..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 355666666666665544 35777888888888888888777888888888888888888887 5788888888888888
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|++|++++..|..|..+++|++|++++|++++.+| .+..+++|+.+++++|++.|.++.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 888888888778888888888999999888888877 577888888889999988887653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4e-17 Score=174.16 Aligned_cols=142 Identities=18% Similarity=0.162 Sum_probs=128.9
Q ss_pred cceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccccc
Q 011486 63 WKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132 (484)
Q Consensus 63 w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 132 (484)
+..+.|.. ...++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 44577863 35799999999999988899999999999999999999998899999999999999999999
Q ss_pred CCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCccccc-CCCCCcccccCcccccCCcCC
Q 011486 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA-IPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 133 ~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~l~~l~~l~l~~N~~~ 204 (484)
++..|..|+.+++|++|+|++|++++..|..+.++++|++|++++|++++. +|.+..+++|+.+++++|+..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 988899999999999999999999987788899999999999999999984 466666999999999999754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.68 E-value=9.7e-17 Score=149.71 Aligned_cols=135 Identities=20% Similarity=0.207 Sum_probs=118.1
Q ss_pred cceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhc
Q 011486 63 WKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142 (484)
Q Consensus 63 w~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 142 (484)
|..-.|+. +.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..
T Consensus 14 ~~~~~Cs~----~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 86 (229)
T 3e6j_A 14 PSQCSCSG----TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS 86 (229)
T ss_dssp CTTCEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCEEeC----CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhccc
Confidence 45566753 45999999998 6776554 89999999999999988999999999999999999998554566899
Q ss_pred ccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 143 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+..++.+..+++|+.|++++|+..
T Consensus 87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCC
T ss_pred CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCC
Confidence 99999999999999987777789999999999999999966558889999999999999754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.3e-17 Score=181.51 Aligned_cols=142 Identities=23% Similarity=0.221 Sum_probs=123.1
Q ss_pred CCcceeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccC-CcccCCccccceecccccccCCCCChh
Q 011486 61 CNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSGSIPSE 139 (484)
Q Consensus 61 c~w~gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 139 (484)
|+|..|.+ -..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56888877 6688999999999999888889999999999999999766666 778999999999999999999888889
Q ss_pred hhcccccccccccccccCCCCCCc--cccccccceeeccCCcccccCC--CCCcccccCcccccCCcC
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~ 203 (484)
|.++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ .++.+++|+.|++++|..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i 160 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence 999999999999999998866665 8899999999999999988755 578888999999988865
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=178.66 Aligned_cols=134 Identities=21% Similarity=0.268 Sum_probs=124.0
Q ss_pred CCCcEEEEeeCCCccccc-----------------cCcCcC--CCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 70 KNKRVITLSLTNHKLSGP-----------------ISADLG--KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
...++++|+|++|.++|. +|+.++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|
T Consensus 204 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 356899999999999986 999999 9999999999999999999999999999999999999
Q ss_pred c-cCC-CCChhhhcc------cccccccccccccCCCCCC--ccccccccceeeccCCcccccCCCCCcccccCcccccC
Q 011486 131 Y-LSG-SIPSELGNL------SNLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFG 200 (484)
Q Consensus 131 ~-l~g-~~p~~~~~l------~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~ 200 (484)
+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .++++++|++|++++|+++|.+|.++.+++|+.|++++
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 8 998 899999887 99999999999999 6998 89999999999999999998888888889999999999
Q ss_pred CcCC
Q 011486 201 NRGL 204 (484)
Q Consensus 201 N~~~ 204 (484)
|...
T Consensus 363 N~l~ 366 (636)
T 4eco_A 363 NQIT 366 (636)
T ss_dssp SEEE
T ss_pred Cccc
Confidence 8653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=177.14 Aligned_cols=137 Identities=21% Similarity=0.197 Sum_probs=100.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccccc---CCcccCCccccceecccccccCCCCChhhhccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE---IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLN 148 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 148 (484)
.+++.|+|++|.+++..|..+..+++|++|+|++|.+++. .+..+..+++|++|+|++|++++..|..|..+++|++
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 504 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE
Confidence 4566667777777666666677777777777777777652 2245667777777777777777666777777777777
Q ss_pred ccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 149 L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|+|++|++++..|..+.++++| .|+|++|++++.+| .+..+++|+.+++++|++.|.++.
T Consensus 505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 7777777777777777777777 78888888877777 456778888888888888887663
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.4e-17 Score=161.61 Aligned_cols=139 Identities=24% Similarity=0.296 Sum_probs=91.9
Q ss_pred eeeeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCccc-CCccccceecccccccCCCCChhhhcc
Q 011486 65 GVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSELGNL 143 (484)
Q Consensus 65 gv~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l 143 (484)
++.+....+++.|+|++|++++..+..++.+++|++|+|++|.+++..|..+ ..+++|++|+|++|+++ .+|. ...+
T Consensus 113 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l 190 (317)
T 3o53_A 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVF 190 (317)
T ss_dssp EEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCC
T ss_pred CcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-cccc
Confidence 3333334456667777777776666666777777777777777776555555 35677777777777776 3333 2346
Q ss_pred cccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCC
Q 011486 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 144 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~ 206 (484)
++|++|+|++|++++ +|..+..+++|+.|+|++|++++.++.+..+++|+.+++++|++.|+
T Consensus 191 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 777777777777775 44557777777777777777776555666677777777777777665
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.5e-17 Score=170.50 Aligned_cols=138 Identities=23% Similarity=0.241 Sum_probs=95.0
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccc--cCCcccCCccccceecccccccCCCCChh-hhcc----
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNL---- 143 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l---- 143 (484)
..+++.|+|++|++++.+|..++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3456666666666666566666666666666666666654 34445555555666666665555434432 2222
Q ss_pred ------------------cccccccccccccCCCCCCccccccccceeeccCCcccccCCC-CCcccccCcccccCCcCC
Q 011486 144 ------------------SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 144 ------------------~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~l~~l~~l~l~~N~~~ 204 (484)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++.++. +..+++|+.+++++|++.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 57777888888887 5787778899999999999999976654 788899999999999999
Q ss_pred CCCcc
Q 011486 205 CGKQI 209 (484)
Q Consensus 205 c~~~~ 209 (484)
|.+++
T Consensus 482 c~c~~ 486 (520)
T 2z7x_B 482 CSCPR 486 (520)
T ss_dssp CCHHH
T ss_pred ccCCc
Confidence 98764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.7e-17 Score=171.00 Aligned_cols=138 Identities=21% Similarity=0.209 Sum_probs=94.6
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccc--cCCcccCCccccceecccccccCCCCChh-hhc-----
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSGSIPSE-LGN----- 142 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~----- 142 (484)
..+++.|+|++|++++.+|..++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 3456666666666665555556666666666666666654 22344555555555555555555434432 222
Q ss_pred ----------------c-cccccccccccccCCCCCCccccccccceeeccCCcccccCCC-CCcccccCcccccCCcCC
Q 011486 143 ----------------L-SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 143 ----------------l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~l~~l~~l~l~~N~~~ 204 (484)
+ ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +..+++|+.+++++|++.
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 2 57888888888887 4777777899999999999999976664 888999999999999999
Q ss_pred CCCcc
Q 011486 205 CGKQI 209 (484)
Q Consensus 205 c~~~~ 209 (484)
|.+++
T Consensus 511 c~c~~ 515 (562)
T 3a79_B 511 CTCPG 515 (562)
T ss_dssp CCHHH
T ss_pred CCcch
Confidence 98764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=8.5e-17 Score=174.01 Aligned_cols=132 Identities=25% Similarity=0.233 Sum_probs=115.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 57899999999999877778999999999999999999888888999999999999999999444446899999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
++|++++..|..|.++++|++|+|++|++++.+| .+..+++|+.+++++|..
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc
Confidence 9999988777889999999999999999998877 677888999999988864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.9e-17 Score=147.45 Aligned_cols=127 Identities=18% Similarity=0.222 Sum_probs=94.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|.++ .++.+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 46778888888665 2336777888888888888887777777888888888888888887767777888888888888
Q ss_pred cccc-cCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNS-LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|. ++. +| .+..+++|+.|++++|++++.. .+..+++|+.+++++|+.
T Consensus 144 ~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 144 SYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC--
T ss_pred cCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCccc
Confidence 8887 553 55 5777888888888888887643 566777788888887763
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=141.46 Aligned_cols=110 Identities=20% Similarity=0.218 Sum_probs=96.3
Q ss_pred EEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccccc
Q 011486 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (484)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 154 (484)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 46777888998 5776663 89999999999999888999999999999999999999666666899999999999999
Q ss_pred ccCCCCCCccccccccceeeccCCcccccCCCC
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 187 (484)
+|++..|..|..+++|+.|+|++|+++...+.+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l 121 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI 121 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence 999877777999999999999999999876633
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=143.26 Aligned_cols=116 Identities=22% Similarity=0.208 Sum_probs=104.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 35799999999999987777889999999999999999977777789999999999999999976666789999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 186 (484)
|++|++++..+..+..+++|++|+|++|++++..|.
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999999986666678999999999999999988763
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=156.75 Aligned_cols=140 Identities=23% Similarity=0.265 Sum_probs=123.7
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
|.|+.+.|+. ..+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 6899999973 247999999999999888889999999999999999999888999999999999999999
Q ss_pred ccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccc--cCC-CCCcccccCcccccCCcCC
Q 011486 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG--AIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 131 ~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++. ..| .+..+ +|+.+++++|...
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 999 8888766 899999999999998666779999999999999999974 555 56666 8999999988753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.2e-17 Score=148.09 Aligned_cols=128 Identities=22% Similarity=0.219 Sum_probs=112.2
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..++++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999977777789999999999999999977777789999999999999999966666689999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
|++|++++..+..+..+++|+.|++++|++.+..| +++.+++.+|...
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHS 178 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCT
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCC
Confidence 99999998777778999999999999999987655 5667777777643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=8.4e-17 Score=174.06 Aligned_cols=137 Identities=22% Similarity=0.264 Sum_probs=113.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCC--------cccCCccccceecccccccCCCCCh-hhhc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--------SELGNCTELQGLSLQSNYLSGSIPS-ELGN 142 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~ 142 (484)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+++ .+|. .|..
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~ 558 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKD 558 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHccc
Confidence 568888888888887777778888888888888888885421 23788888999999999998 5665 5889
Q ss_pred ccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCC-cccccCcccccCCcCCCCCcc
Q 011486 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDG-VLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 143 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~-~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+++|++|+|++|++++..+..|..+++|+.|+|++|+|++.+| .+. .+++|+.+++++|+|.|+++.
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9999999999999998666778899999999999999998877 344 688999999999999998764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=156.14 Aligned_cols=141 Identities=21% Similarity=0.288 Sum_probs=123.6
Q ss_pred CCCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 60 ~c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
.|.|+.+.|+. ...++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 36899999973 24789999999999987777899999999999999999988899999999999999999
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccc--cCC-CCCcccccCcccccCCcC
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG--AIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++. ..+ .+..+++|+.+++++|..
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999 7887765 789999999999998777778999999999999999964 444 677888999999988864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=139.52 Aligned_cols=108 Identities=19% Similarity=0.238 Sum_probs=93.9
Q ss_pred CCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccC
Q 011486 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177 (484)
Q Consensus 98 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~ 177 (484)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999998 6787664 7899999999999977788899999999999999999987777788999999999999
Q ss_pred CcccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 178 NFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 178 N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
|+|++.++ .+..+++|+.+++++|++.|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99998887 58889999999999999998875
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=142.86 Aligned_cols=127 Identities=18% Similarity=0.134 Sum_probs=109.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCC-CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++.|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..|..+..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 57999999999999 4554 55555 999999999999965 6899999999999999999954444559999999999
Q ss_pred ccccccCCCCCC--ccccccccceeeccCCcccccCCC----CCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPS----DGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~----~~~l~~l~~l~l~~N~~ 203 (484)
|++|+|+. +|. .+..+++|+.|++++|+++..++. +..+++|+.+++++|..
T Consensus 95 L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 95 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 99999975 676 889999999999999999976553 78889999999998864
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=141.68 Aligned_cols=113 Identities=21% Similarity=0.215 Sum_probs=97.9
Q ss_pred EEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccccc
Q 011486 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (484)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 154 (484)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999997 7777665 89999999999999888999999999999999999999654555789999999999999
Q ss_pred ccCCCCCCccccccccceeeccCCcccccCCCCCcc
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVL 190 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l 190 (484)
+|++..+..|..+++|++|+|++|++....+.+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l 127 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYL 127 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHH
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccHHHH
Confidence 999866666999999999999999999776544333
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=139.85 Aligned_cols=107 Identities=21% Similarity=0.293 Sum_probs=98.2
Q ss_pred CEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCC
Q 011486 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (484)
Q Consensus 99 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N 178 (484)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 78999999997 7888775 89999999999999888899999999999999999999866667899999999999999
Q ss_pred cccccCC-CCCcccccCcccccCCcCCCCCc
Q 011486 179 FLVGAIP-SDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 179 ~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
+|++.++ .+..+++|+.+++++|++.|.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9999888 48999999999999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.7e-17 Score=166.19 Aligned_cols=138 Identities=20% Similarity=0.141 Sum_probs=108.9
Q ss_pred CcEEEEeeCCCccccccCcCcCCCC------------------------CCCEEEcccCcccccCCcccCCccccceecc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLD------------------------QLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~------------------------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 127 (484)
.+++.|+|++|.+++..+..|..++ +|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 176 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 255 (477)
T 2id5_A 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255 (477)
T ss_dssp TTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeEC
Confidence 4566666666666655555555554 5555555566666333346788888999999
Q ss_pred cccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCC
Q 011486 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 128 s~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~ 206 (484)
++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++ .+..+++|+.+++++|++.|.
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp CSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred CCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 9999987667778889999999999999998889999999999999999999998877 578899999999999999998
Q ss_pred Ccc
Q 011486 207 KQI 209 (484)
Q Consensus 207 ~~~ 209 (484)
+++
T Consensus 336 c~~ 338 (477)
T 2id5_A 336 CRL 338 (477)
T ss_dssp GGG
T ss_pred cch
Confidence 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.2e-17 Score=177.04 Aligned_cols=133 Identities=19% Similarity=0.226 Sum_probs=122.2
Q ss_pred CCCcEEEEeeCCCcccc-----------------ccCcCcC--CCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 70 KNKRVITLSLTNHKLSG-----------------PISADLG--KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
...+++.|+|++|.|+| .+|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 34689999999999998 4899988 9999999999999999999999999999999999999
Q ss_pred c-cCC-CCChhhhccc-------ccccccccccccCCCCCC--ccccccccceeeccCCcccccCCCCCcccccCccccc
Q 011486 131 Y-LSG-SIPSELGNLS-------NLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFF 199 (484)
Q Consensus 131 ~-l~g-~~p~~~~~l~-------~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~ 199 (484)
+ ++| .+|..++.++ +|++|+|++|+++ .+|. .|.++++|+.|+|++|+++ .+|.++.+++|+.|+++
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 8 998 8999888887 9999999999999 7998 8999999999999999999 66788899999999999
Q ss_pred CCcCC
Q 011486 200 GNRGL 204 (484)
Q Consensus 200 ~N~~~ 204 (484)
+|...
T Consensus 604 ~N~l~ 608 (876)
T 4ecn_A 604 YNQIE 608 (876)
T ss_dssp SSCCS
T ss_pred CCccc
Confidence 99754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=166.96 Aligned_cols=120 Identities=24% Similarity=0.271 Sum_probs=105.2
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
.++.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999996 666 999999999999999999 889999999999999999999995 78 89999999999999
Q ss_pred ccccCCCC-CCccccccccceeeccCCcccccCCCCCc----ccccCccc
Q 011486 153 SNSLSDYI-PPSLGKLQRLITFNVSNNFLVGAIPSDGV----LTKFSESS 197 (484)
Q Consensus 153 ~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~----l~~l~~l~ 197 (484)
+|+|++.+ |..|..+++|+.|+|++|+|++.+|.... +++|+.|+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 99999876 99999999999999999999998885433 55666553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.1e-16 Score=165.84 Aligned_cols=134 Identities=19% Similarity=0.182 Sum_probs=117.3
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 35789999999999988888899999999999999999987788899999999999999999977778899999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccc-cCC-CCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG-AIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
|++|++++..+..++++++|++|++++|.+++ .+| .++.+++|+.|++++|...
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 99999997666678999999999999999987 346 6888999999999998753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.8e-17 Score=146.02 Aligned_cols=128 Identities=16% Similarity=0.190 Sum_probs=115.6
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .++.+..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 57999999999999 666 6999999999999999776 3457999999999999999999888999999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|++++..|..+..+++|++|++++|++.+.+|.+..+++|+.+++++|+.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCC
Confidence 9999998888999999999999999999444556788999999999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=2.6e-16 Score=156.13 Aligned_cols=135 Identities=18% Similarity=0.142 Sum_probs=109.1
Q ss_pred CCcceeeeCCCCcEEEEeeCCC-ccccccCcCcCCCCCCCEEEccc-CcccccCCcccCCccccceecccccccCCCCCh
Q 011486 61 CNWKGVKCDKNKRVITLSLTNH-KLSGPISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS 138 (484)
Q Consensus 61 c~w~gv~C~~~~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 138 (484)
|.|..|.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 777777765 34 788 4787 99999999999996 999988888999999999999999999988888
Q ss_pred hhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCCCCCcc
Q 011486 139 ELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 139 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
.|.+|++|++|||++|+|++..|..|..++ |+.|+|++|+|..... .+..+.+.....+..+...|..+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999999999999999999986666666665 9999999999987644 222233334445556677776553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2e-16 Score=157.41 Aligned_cols=132 Identities=17% Similarity=0.144 Sum_probs=119.4
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCCh--hhhccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS--ELGNLSNLLN 148 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~ 148 (484)
..+++.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+..+++|++
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468999999999999888889999999999999999999655555999999999999999999 6666 7899999999
Q ss_pred cccccc-ccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 149 LDISSN-SLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 149 L~ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
|++++| .+++..|..|.++++|++|++++|++++.+| .+..+++|+.+++++|..
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 999999 5777677889999999999999999999877 788999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=8.2e-16 Score=163.84 Aligned_cols=129 Identities=19% Similarity=0.137 Sum_probs=114.1
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+.+++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 57999999999999888889999999999999999999988888999999999999999999444445799999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~ 202 (484)
++|.+++..|..|..+++|++|+|++|.+++..+ +.+++|+.+++++|.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNL 203 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCc
Confidence 9999999888899999999999999999998643 456666666666664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-16 Score=152.09 Aligned_cols=131 Identities=20% Similarity=0.140 Sum_probs=97.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccccc--C--CcccCCccccceecccccccCCCCChh----hhc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE--I--PSELGNCTELQGLSLQSNYLSGSIPSE----LGN 142 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~----~~~ 142 (484)
.++++.|+|++|++++..+..|+.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .+|.. +..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 35788888888888877777888888888888888887642 2 223467888888888888887 45542 467
Q ss_pred ccccccccccccccCCCCCCccccc---cccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 143 LSNLLNLDISSNSLSDYIPPSLGKL---QRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 143 l~~L~~L~ls~N~l~~~~p~~~~~l---~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+++|++|||++|+|++..|..+..+ ++|++|+|++|+|+..++.+ .++|+.|++++|+..
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~--~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGL--PAKLRVLDLSSNRLN 285 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCC--CSCCSCEECCSCCCC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhh--cCCCCEEECCCCcCC
Confidence 7888888888888888777777766 58888888888888543333 268888888888653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.9e-16 Score=163.74 Aligned_cols=128 Identities=20% Similarity=0.147 Sum_probs=114.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 368999999999999888889999999999999999999888999999999999999999999 78887 899999999
Q ss_pred ccccccCC-CCCCccccccccceeeccCCcccccCCCCCccccc--CcccccCCcC
Q 011486 151 ISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF--SESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l--~~l~l~~N~~ 203 (484)
|++|++++ .+|..|.++++|++|+|++|++++. .+..++++ +.+++++|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccc
Confidence 99999987 3468999999999999999999873 34566666 9999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.2e-17 Score=158.30 Aligned_cols=131 Identities=18% Similarity=0.185 Sum_probs=97.4
Q ss_pred cEEEEeeCCCcc-ccccCcCcC-------CCCCCCEEEcccCcccccCCccc--CCccccceecccccccCCCCChhhhc
Q 011486 73 RVITLSLTNHKL-SGPISADLG-------KLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYLSGSIPSELGN 142 (484)
Q Consensus 73 ~l~~L~L~~n~l-~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~g~~p~~~~~ 142 (484)
.++.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.
T Consensus 64 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 377778888887 355666555 67888888888888887777775 7788888888888888855 777777
Q ss_pred c-----cccccccccccccCCCCCCccccccccceeeccCCccccc---CCCC--CcccccCcccccCCcCC
Q 011486 143 L-----SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA---IPSD--GVLTKFSESSFFGNRGL 204 (484)
Q Consensus 143 l-----~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---~p~~--~~l~~l~~l~l~~N~~~ 204 (484)
+ ++|++|+|++|++++..|..|..+++|++|+|++|++++. ++.+ ..+++|+.|++++|...
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 7 7888888888888877777788888888888888887764 2222 67777888888877643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=9.3e-17 Score=157.01 Aligned_cols=131 Identities=18% Similarity=0.132 Sum_probs=72.2
Q ss_pred CcEEEEeeCCCccccccCcCc--CCCCCCCEEEcccCcccccCCcccCCc-----cccceecccccccCCCCChhhhccc
Q 011486 72 KRVITLSLTNHKLSGPISADL--GKLDQLKFLNLHSNNFYGEIPSELGNC-----TELQGLSLQSNYLSGSIPSELGNLS 144 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~l~ 144 (484)
.++++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 355666666666665555554 5566666666666666644 5555554 5666666666666655555566666
Q ss_pred ccccccccccccCCC--CCCcc--ccccccceeeccCCcccccC--C--CCCcccccCcccccCCcC
Q 011486 145 NLLNLDISSNSLSDY--IPPSL--GKLQRLITFNVSNNFLVGAI--P--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 145 ~L~~L~ls~N~l~~~--~p~~~--~~l~~L~~L~ls~N~l~~~~--p--~~~~l~~l~~l~l~~N~~ 203 (484)
+|++|+|++|++.+. +|..+ ..+++|++|+|++|++++.. + .+..+++|+.|++++|..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 240 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcC
Confidence 666666666665443 12222 55566666666666665321 1 112345566666666543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=153.07 Aligned_cols=129 Identities=20% Similarity=0.171 Sum_probs=117.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChh-hhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ 150 (484)
++++.|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|.. |..+++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 57999999999999888889999999999999999999888888999999999999999999 66665 68999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
|++|++++..|..|..+++|++|++++|++++.. +..+++|+.+++++|..
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccc
Confidence 9999999988888999999999999999999864 46678888888888864
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=4e-16 Score=152.35 Aligned_cols=129 Identities=21% Similarity=0.231 Sum_probs=110.1
Q ss_pred CCcEEEEeeCCCccccc--cC--cCcCCCCCCCEEEcccCcccccCCc----ccCCccccceecccccccCCCCChhhhc
Q 011486 71 NKRVITLSLTNHKLSGP--IS--ADLGKLDQLKFLNLHSNNFYGEIPS----ELGNCTELQGLSLQSNYLSGSIPSELGN 142 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~--~~--~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 142 (484)
..++++|+|++|++.+. ++ ..++.+++|++|+|++|+|+ .+|. .+.++++|++|||++|+|++.+|..+..
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 246 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR 246 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence 46899999999998763 32 33578999999999999997 3443 2578899999999999999888988877
Q ss_pred c---cccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 143 L---SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 143 l---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |.+..+++|+.+++++|++.
T Consensus 247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 247 CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence 7 69999999999999 5888774 7999999999999986 44678899999999999864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-16 Score=145.05 Aligned_cols=130 Identities=16% Similarity=0.104 Sum_probs=112.4
Q ss_pred CCcEEEEeeCCCc-cccccCcCcCCCCCCCEEEccc-CcccccCCcccCCccccceecccccccCCCCChhhhcccccc-
Q 011486 71 NKRVITLSLTNHK-LSGPISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLL- 147 (484)
Q Consensus 71 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~- 147 (484)
..+++.|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|+++ .+|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-ccccccccc
Confidence 4689999999997 8877777899999999999998 9999777778999999999999999999 4887 88888888
Q ss_pred --ccccccc-ccCCCCCCccccccccc-eeeccCCcccccCCCCCcccccCcccccCCc
Q 011486 148 --NLDISSN-SLSDYIPPSLGKLQRLI-TFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (484)
Q Consensus 148 --~L~ls~N-~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~ 202 (484)
+|++++| ++++..+..|..+++|+ .|++++|+++..++.....++|+.+++++|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99987777799999999 9999999999655533333789999999995
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.3e-15 Score=148.33 Aligned_cols=126 Identities=17% Similarity=0.255 Sum_probs=63.8
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccc--ccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFY--GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
++++|+|++|++++..+..|.++++|++|+|++|.++ +..|..+..+ +|++|++++|+++ .+|..+. ++|++|+
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELH 199 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCB
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEE
Confidence 4555555555555444444666666666666666664 2445555544 3444444444333 2332221 3455555
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
|++|++++..|..|..+++|+.|+|++|++++.+| .+..+++|+.+++++|+
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCc
Confidence 55555554444455555555555555555555444 34445555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=145.38 Aligned_cols=125 Identities=24% Similarity=0.282 Sum_probs=98.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|+|++..+ +.++++|++|+|++|+|++ +|. +.. ++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 578888888888885444 8888888888888888884 443 333 788888888888884 44 5888888888888
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~ 206 (484)
++|++++ +| .+..+++|+.|+|++|++++. +.+..+++|+.+++++|+..+.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 8888886 44 678888888888888888877 6677888888888888876554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=145.47 Aligned_cols=124 Identities=28% Similarity=0.361 Sum_probs=102.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++..+ +.++++|++|+|++|.+++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 3678899999999986544 8889999999999999885 44 48888999999999999884 4 4688888999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
|++|++++. ..+..+++|+.|++++|++++.+| +..+++|+.|++++|..
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 999998874 578888899999999999988776 77888888899988865
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.5e-16 Score=162.71 Aligned_cols=132 Identities=19% Similarity=0.164 Sum_probs=117.9
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCC-CCChhhhcccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG-SIPSELGNLSNLLNL 149 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L 149 (484)
..++++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4689999999999999888999999999999999999998877779999999999999999996 467889999999999
Q ss_pred cccccccCCCCC-CccccccccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 150 DISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 150 ~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
++++|++.+.+| ..|.++++|++|++++|++++.+| .+..+++|+.+++.+|.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 999999544555 689999999999999999999877 77778888888877775
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-17 Score=151.36 Aligned_cols=129 Identities=27% Similarity=0.271 Sum_probs=104.5
Q ss_pred CcEEEEeeCCCccccccCc------CcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccc
Q 011486 72 KRVITLSLTNHKLSGPISA------DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSN 145 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 145 (484)
.+++.++|+.+.++|.+|. .+..+++|++|+|++|.|++ +| .+.++++|++|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3566677777777777766 78888889999999998885 67 8888888999999999888 78888888888
Q ss_pred cccccccccccCCCCCCccccccccceeeccCCcccccCC--CCCcccccCcccccCCcCCC
Q 011486 146 LLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 146 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~~c 205 (484)
|++|+|++|++++ +| .+..+++|++|++++|++++..+ .+..+++|+.+++++|+..|
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 9999999998886 55 67888889999999998887543 56778888888888887644
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-16 Score=162.41 Aligned_cols=127 Identities=22% Similarity=0.222 Sum_probs=114.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 68999999999999888889999999999999999999888999999999999999999999 78877 8999999999
Q ss_pred cccccCC-CCCCccccccccceeeccCCcccccCCCCCccccc--CcccccCCcC
Q 011486 152 SSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF--SESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l--~~l~l~~N~~ 203 (484)
++|++++ .+|..|+++++|++|++++|++++. .+..+++| +.+++++|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--GGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh--hccccccceeeEEEeecccc
Confidence 9999987 4789999999999999999999873 45667777 9999999876
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.3e-16 Score=170.15 Aligned_cols=130 Identities=28% Similarity=0.283 Sum_probs=114.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
...++.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|||++|+|+ .+|..|+.|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 467999999999999 78888889999999999999999 89999999999999999999999 8999999999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCC-CCCccc-ccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLT-KFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~-~l~~l~l~~N~~~ 204 (484)
|++|.|+ .+|..|+.+++|+.|+|++|+|++.+| .+..+. ....+++.+|...
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence 9999998 689999999999999999999999988 332221 1223667777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-15 Score=147.24 Aligned_cols=128 Identities=18% Similarity=0.243 Sum_probs=75.6
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccc--ccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFY--GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
.++++|+|++|.+++..+..+.++++|++|+|++|.++ +..|..+.++++|++|+|++|+++ .+|..+. ++|++|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 46777777777777666666777777777777777774 255666666666666666666665 4444332 455555
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
+|++|++++..|..|..+++|+.|+|++|++++.++ .+..+++|+.+++++|+
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 251 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence 555555555444555555555555555555555444 34445555555555554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-15 Score=158.96 Aligned_cols=127 Identities=20% Similarity=0.117 Sum_probs=100.0
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhh-cccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELG-NLSNLLNLDI 151 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l 151 (484)
+++.|+|++|.+++..+. .+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++.+|..+. .+++|++|+|
T Consensus 100 ~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence 344455555555543332 457888899999999888888888899999999999999987888776 7889999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
++|.|++. |. +..+++|+.|+|++|+|++.+|.+..+++|+.|++++|...
T Consensus 177 s~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCc
Confidence 99999875 33 34588999999999999988888888889999999988753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=147.19 Aligned_cols=127 Identities=27% Similarity=0.379 Sum_probs=105.0
Q ss_pred CCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...+++.|+|++|.+++. + .+..+++|++|+|++|++++ +|. +..+++|++|+|++|++++ +|. +..+++|++|
T Consensus 83 ~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEE
Confidence 346899999999999853 3 68899999999999999985 443 8899999999999999984 444 8888999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
+|++|++++ +|. +..+++|+.|++++|++++.++ +..+++|+.|++++|+...
T Consensus 157 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 157 SIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCB
T ss_pred EccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCc
Confidence 999999987 444 8888999999999999987665 6778888899998887643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.56 E-value=9.7e-16 Score=161.18 Aligned_cols=133 Identities=26% Similarity=0.345 Sum_probs=92.5
Q ss_pred CCCCCCCCCCCC-----Cccee-eeCCCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccc
Q 011486 50 LNQWRPEDPDPC-----NWKGV-KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ 123 (484)
Q Consensus 50 l~~w~~~~~~~c-----~w~gv-~C~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 123 (484)
+.+|.. +.+|| .|.|+ .|.. .+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 445654 34678 69999 7863 478899999999986 676553 77888888888887 666 4467788
Q ss_pred eecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCc
Q 011486 124 GLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (484)
Q Consensus 124 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~ 202 (484)
+|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|++|+|++. |. .+++|+.|++++|+
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~--~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE--LPTSLEVLSVRNNQ 171 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC--cCCCcCEEECCCCC
Confidence 88888888874 666 554 77777777777776 555 456667777777776663 32 45566666666665
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.7e-15 Score=142.00 Aligned_cols=124 Identities=26% Similarity=0.286 Sum_probs=108.9
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|+++ .++ .+..+++|++|+|++|+|++..| +.++++|++|+|++|+++ .+|.... ++|++|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC-CcCcccc--CcccEEEc
Confidence 57999999999999 566 79999999999999999996544 999999999999999999 5665433 99999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
++|++++ +| .+..+++|+.|+|++|++++. |.+..+++|+.|++++|+...
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCB
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcc
Confidence 9999997 44 689999999999999999986 467889999999999997643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.56 E-value=4.3e-15 Score=144.91 Aligned_cols=125 Identities=22% Similarity=0.315 Sum_probs=106.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++..+ +..+++|++|+|++|.+++ +| .+..+++|++|+|++|++++ +|. +..+++|++|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 4689999999999995444 8999999999999999985 44 68999999999999999984 554 88999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|...
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccC
Confidence 99999987433 8899999999999999998666 788899999999998753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.6e-15 Score=132.80 Aligned_cols=112 Identities=25% Similarity=0.237 Sum_probs=100.6
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCC--hhhhccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP--SELGNLSNLLN 148 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~ 148 (484)
..+++.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|+++ .+| ..+..+++|++
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKS 124 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCSCCCE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCCCCCE
Confidence 36899999999999966 78999999999999999999888888888999999999999999 554 78999999999
Q ss_pred ccccccccCCCCC---CccccccccceeeccCCcccccCC
Q 011486 149 LDISSNSLSDYIP---PSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 149 L~ls~N~l~~~~p---~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
|+|++|.+++..+ ..+..+++|++|++++|.+...+.
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 9999999997544 388999999999999999987654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2e-15 Score=130.73 Aligned_cols=108 Identities=21% Similarity=0.186 Sum_probs=99.1
Q ss_pred CCCCCCEEEcccCccc-ccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccce
Q 011486 94 KLDQLKFLNLHSNNFY-GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLIT 172 (484)
Q Consensus 94 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 172 (484)
..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999999 88999999999999999999999955 77899999999999999999888888888999999
Q ss_pred eeccCCcccccC--CCCCcccccCcccccCCcC
Q 011486 173 FNVSNNFLVGAI--PSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 173 L~ls~N~l~~~~--p~~~~l~~l~~l~l~~N~~ 203 (484)
|++++|++++.. +.+..+++|+.+++++|+.
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 999999999854 5788999999999999974
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6.5e-15 Score=142.45 Aligned_cols=127 Identities=28% Similarity=0.371 Sum_probs=112.5
Q ss_pred CCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...+++.|+|++|.+++ ++ .+..+++|++|+|++|++++ + +.+..+++|++|+|++|++++ + ..+..+++|++|
T Consensus 88 ~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEE
Confidence 45789999999999996 44 49999999999999999995 4 469999999999999999995 4 679999999999
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
+|++|++++..| +..+++|+.|+|++|++++. |.+..+++|+.+++++|+..+
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 999999998554 89999999999999999985 557889999999999998644
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=5.8e-15 Score=146.33 Aligned_cols=108 Identities=22% Similarity=0.187 Sum_probs=97.3
Q ss_pred CEEEcccC-cccccCCcccCCccccceecccc-cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeecc
Q 011486 99 KFLNLHSN-NFYGEIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (484)
Q Consensus 99 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls 176 (484)
..+++++| +|+ .+|. |..+++|++|+|++ |+|++..|..|..|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 899 6888 99999999999996 99997777889999999999999999999899999999999999999
Q ss_pred CCcccccCCC-CCcccccCcccccCCcCCCCCcc
Q 011486 177 NNFLVGAIPS-DGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 177 ~N~l~~~~p~-~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|+|++.++. +..+. |+.|++.+|++.|.+.+
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l 121 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCAL 121 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGG
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCcc
Confidence 9999998884 44444 99999999999998874
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.2e-15 Score=145.93 Aligned_cols=125 Identities=22% Similarity=0.261 Sum_probs=72.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|++++|.+++..+ +..+++|++|+|++|.+++. |. +..+++|++|+|++|.+++ + +.+..+++|++|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 456666666666664333 55666666666666666633 22 5566666666666666653 3 34555666666666
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
++|++++. +.+..+++|+.|++++|++++..| .+..+++|+.+++++|+..
T Consensus 273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 324 (347)
T 4fmz_A 273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324 (347)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccc
Confidence 66666542 235556666666666666665554 3455566666666666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-14 Score=154.38 Aligned_cols=124 Identities=28% Similarity=0.359 Sum_probs=93.1
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+|+.|+|++|+|++..+ +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ + ..+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 3578888888888886544 7788888888888888874 34 67788888888888888874 4 3477778888888
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
|++|+|++. ..+..+++|+.|+|++|+|++.+| +..+++|+.|++++|+.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 888888764 567777788888888888877766 67777777777777754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.1e-15 Score=144.97 Aligned_cols=127 Identities=20% Similarity=0.117 Sum_probs=98.0
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhh-hcccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDI 151 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~l 151 (484)
+++.|+|++|++++..+. .+++|++|+|++|++++..|..+..+++|++|+|++|.+++..|..+ ..+++|++|+|
T Consensus 100 ~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 445555555555544333 35778888888888887777788888999999999999987666666 47888999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
++|++++. |. ...+++|++|+|++|++++.++.+..+++|+.+++++|+..
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 99998864 33 33588899999999999988777888889999999988754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=153.45 Aligned_cols=125 Identities=28% Similarity=0.382 Sum_probs=112.5
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+|+.|+|++|.|++ +| .+..+++|+.|+|++|.|++ + +.+..|++|+.|+|++|+|++ + ..+..+++|+.|+
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLS 159 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEE
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEE
Confidence 4689999999999995 44 79999999999999999995 4 469999999999999999995 4 6799999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
|++|+|++..| +..+++|+.|+|++|+|++. |.+..+++|+.|++++|+..
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEE
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCc
Confidence 99999998666 89999999999999999986 67888999999999999864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-16 Score=144.51 Aligned_cols=125 Identities=22% Similarity=0.274 Sum_probs=108.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++ +| .+.++++|++|+|++|.|+ .+|..+..+++|++|+|++|++++ +| .+..+++|++|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4689999999999996 67 8999999999999999999 788888889999999999999994 66 699999999999
Q ss_pred ccccccCCCCC-CccccccccceeeccCCcccccCCC-----------CCcccccCcccccCCc
Q 011486 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPS-----------DGVLTKFSESSFFGNR 202 (484)
Q Consensus 151 ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~-----------~~~l~~l~~l~l~~N~ 202 (484)
|++|++++..+ ..+..+++|++|++++|++++.+|. +..+++|+.++ +|+
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~ 183 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMP 183 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGG
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--Ccc
Confidence 99999986322 4788999999999999999998774 56677777765 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=8.2e-15 Score=154.60 Aligned_cols=103 Identities=22% Similarity=0.248 Sum_probs=96.6
Q ss_pred CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeecc
Q 011486 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (484)
Q Consensus 97 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls 176 (484)
.|+.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58999999999995 776 999999999999999999 999999999999999999999997 77 89999999999999
Q ss_pred CCcccccC-C-CCCcccccCcccccCCcCC
Q 011486 177 NNFLVGAI-P-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 177 ~N~l~~~~-p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+|+|++.+ | .++.+++|+.|++++|+..
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 99999995 6 8899999999999999853
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-14 Score=147.46 Aligned_cols=123 Identities=29% Similarity=0.311 Sum_probs=80.9
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|+|++|.+++..+ +..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++. +. +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEEC
Confidence 467777777777775544 6777777777777777774433 66677777777777777643 32 666677777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|++++..| +..+++|+.|++++|++++. +.+..+++|+.+++++|+.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 7777766444 56666666666666666664 4455666666666666654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-14 Score=128.91 Aligned_cols=108 Identities=17% Similarity=0.163 Sum_probs=96.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCCh--hhhcccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS--ELGNLSNLLNL 149 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L 149 (484)
++++.|+|++|.|++. +.+..+++|++|+|++|.|++..|..|..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999975 68999999999999999999654455699999999999999997 7887 79999999999
Q ss_pred cccccccCCCCCCc----cccccccceeeccCCccccc
Q 011486 150 DISSNSLSDYIPPS----LGKLQRLITFNVSNNFLVGA 183 (484)
Q Consensus 150 ~ls~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~~ 183 (484)
+|++|.++. +|.. +..+++|+.||+++|.+...
T Consensus 119 ~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 119 CILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred EecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 999999985 6775 89999999999999988754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.2e-14 Score=147.98 Aligned_cols=118 Identities=23% Similarity=0.229 Sum_probs=62.8
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCC-----------------
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG----------------- 134 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g----------------- 134 (484)
.+++.|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPELPTSLEVLSVRNNQ 171 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCCcCCCcCEEECCCCC
Confidence 566777777777775 555 443 56666666666654 443 34455555555555542
Q ss_pred --CCChhhhcccccccccccccccCCCCCCcccccccc-------ceeeccCCcccccCCCCCcccccCcccccCCcCC
Q 011486 135 --SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL-------ITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 135 --~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L-------~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
.+|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+..++.+..+++|+.+++++|+..
T Consensus 172 L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 172 LTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp CSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCC
T ss_pred CCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCC
Confidence 2444 33 45555555555555 2444 332 44 5566666666543334455666666666666553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.46 E-value=4.9e-14 Score=139.93 Aligned_cols=143 Identities=17% Similarity=0.116 Sum_probs=108.4
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCc-ccCCccccce-eccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS-ELGNCTELQG-LSLQ 128 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~-L~Ls 128 (484)
|+|..|.|+. ..++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++|++ ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 6899999963 24689999999999965566899999999999999998776664 5788988765 6777
Q ss_pred ccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccC-CcccccCC-CCCccc-ccCcccccCCcC
Q 011486 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN-NFLVGAIP-SDGVLT-KFSESSFFGNRG 203 (484)
Q Consensus 129 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p-~~~~l~-~l~~l~l~~N~~ 203 (484)
.|+|++..|..|..+++|++|++++|++++..+..+....++..|++++ |+++...+ .+..+. .++.+++++|..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 8999966677889999999999999999876666666666677777754 45554444 344433 456667776653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.45 E-value=7.7e-14 Score=143.99 Aligned_cols=126 Identities=29% Similarity=0.390 Sum_probs=105.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
..+++.|+|++|++++. +.+..+++|++|+|++|.+++..| +..+++|++|+|++|++++ +|. +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEE
Confidence 35789999999999853 358889999999999999986555 8889999999999999985 444 88899999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c 205 (484)
|++|++++..| +..+++|+.|+|++|++++.+| +..+++|+.+++++|+...
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence 99999987544 7889999999999999998877 6788899999999987543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=141.52 Aligned_cols=118 Identities=24% Similarity=0.266 Sum_probs=68.9
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|+|++|++++. | .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++ +| ++.+++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 3566666666666643 3 46666666666666666664 23 5666666666666666663 33 556666666666
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~ 202 (484)
++|++++ +| ++.+++|++|++++|++++. + ++.+++|+.+++++|+
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~-l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D-VSHNTQLTELDCHLNK 159 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C-CTTCTTCCEEECTTCS
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c-cccCCcCCEEECCCCC
Confidence 6666665 33 55666666666666666653 2 4455555555555553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=129.27 Aligned_cols=150 Identities=19% Similarity=0.117 Sum_probs=117.7
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceE
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 379 (484)
.+....+.|+....++.|+.+.||++... ++.+++|............+.+|.++++.+. +..++++++++...+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34556778888888888889999998754 6889999987532222346889999999884 678889999998888899
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD------------------------------------ 423 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------ 423 (484)
+||||++|.+|.+.+. +......++.+++++|+.||..
T Consensus 87 lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999987642 1122346889999999999971
Q ss_pred --------------------CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 424 --------------------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 424 --------------------~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
....++|+|++|.||+++++..+.|+||+.+..-
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 0145899999999999987666779999988643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.4e-13 Score=136.21 Aligned_cols=123 Identities=25% Similarity=0.364 Sum_probs=84.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.+++.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|+++ .+|. +..+++|++|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC-CCcc-hhcCCCCCEEEC
Confidence 467777777777774333 6777777777777777774433 667777777777777777 3444 677777777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|.+++ + +.+..+++|+.|++++|++++. |.+..+++|+.+++++|+.
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 7777765 3 3566777777777777777764 4566677777777777764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=139.64 Aligned_cols=122 Identities=25% Similarity=0.225 Sum_probs=87.0
Q ss_pred CCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccc
Q 011486 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (484)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 149 (484)
...+++.|++++|...+.+ .++.+++|++|+|++|+|++ +| +..+++|+.|+|++|++++. + ++.+++|++|
T Consensus 146 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L 217 (457)
T 3bz5_A 146 HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFL 217 (457)
T ss_dssp TCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEE
T ss_pred cCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEE
Confidence 3457888888888665555 37778888888888888885 45 77788888888888888743 3 7777888888
Q ss_pred cccccccCCCCCCccccccccceeeccCCcccccCC-CCCccc-------ccCcccccCCc
Q 011486 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLT-------KFSESSFFGNR 202 (484)
Q Consensus 150 ~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~-------~l~~l~l~~N~ 202 (484)
+|++|++++ +| +..+++|+.|++++|++++.++ .+..+. +|+.+++++|+
T Consensus 218 ~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~ 275 (457)
T 3bz5_A 218 DCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNT 275 (457)
T ss_dssp ECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred ECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCc
Confidence 888888887 55 6777888888888888887654 333332 34455555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.7e-14 Score=150.89 Aligned_cols=135 Identities=24% Similarity=0.284 Sum_probs=79.9
Q ss_pred CCCCCCCCCCCCCCcceeeeC-------CCCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccc
Q 011486 49 FLNQWRPEDPDPCNWKGVKCD-------KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTE 121 (484)
Q Consensus 49 ~l~~w~~~~~~~c~w~gv~C~-------~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 121 (484)
..++|.. +.+||.|+|..|. ...+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 4456754 3467888764321 1234777788888777 6666554 67777777777777 4554 4567
Q ss_pred cceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCC
Q 011486 122 LQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (484)
Q Consensus 122 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N 201 (484)
|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|+|++.++. +++|+.|++++|
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCC
Confidence 777777777776 5665 55666666776666665 343 334455555555555543221 244444444444
Q ss_pred c
Q 011486 202 R 202 (484)
Q Consensus 202 ~ 202 (484)
.
T Consensus 152 ~ 152 (622)
T 3g06_A 152 Q 152 (622)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.41 E-value=4.3e-15 Score=146.35 Aligned_cols=130 Identities=22% Similarity=0.304 Sum_probs=85.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCccccc-CCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++.|++++|.+++..+. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4566677777777655444 55677777777777777654 666667777777777777777666666676777777777
Q ss_pred cccc-ccCCC-CCCccccccccceeeccCC-ccccc-CC-CCCccc-ccCcccccCCc
Q 011486 151 ISSN-SLSDY-IPPSLGKLQRLITFNVSNN-FLVGA-IP-SDGVLT-KFSESSFFGNR 202 (484)
Q Consensus 151 ls~N-~l~~~-~p~~~~~l~~L~~L~ls~N-~l~~~-~p-~~~~l~-~l~~l~l~~N~ 202 (484)
|++| .+++. +|..+..+++|++|++++| .+++. ++ .+..++ +|+.|++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 7777 56542 4555666677777777777 66653 23 345566 67777776664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.40 E-value=6.1e-13 Score=136.75 Aligned_cols=118 Identities=24% Similarity=0.281 Sum_probs=58.9
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
++++|+|++|++++ +| .++++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .++.+++|++|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 44555555555553 33 35555555555555555553 33322 245555555555552 44 35555555555555
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
+|++++ +|... ++|++|++++|+++ .+|.++.+++|+.+++++|+.
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l 249 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLL 249 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCC
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcC
Confidence 555554 33321 34555555555555 334455556666666666543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.8e-14 Score=144.38 Aligned_cols=123 Identities=17% Similarity=0.105 Sum_probs=52.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCcccc-------------ceecccccccCC----
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTEL-------------QGLSLQSNYLSG---- 134 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~g---- 134 (484)
.++++|++++|++ |.+|++++++++|++|+|++|.++|.+|..++++++| ++|++++|.+++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 4566677777777 5667667777777777777777776677666665543 445555554442
Q ss_pred ---------------CCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCccccc
Q 011486 135 ---------------SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFF 199 (484)
Q Consensus 135 ---------------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~ 199 (484)
.+|..+ ++|++|++++|++++ +|.. .++|++|++++|++++ +|.++.+++|+.++++
T Consensus 90 ~~~L~~L~l~~n~l~~lp~~~---~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVD 161 (454)
T ss_dssp CTTCSEEECCSSCCSSCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCcccccc---CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-CcccCCCCCCCEEECC
Confidence 133321 333444444443332 2211 1355666666666665 3455566666666666
Q ss_pred CCcC
Q 011486 200 GNRG 203 (484)
Q Consensus 200 ~N~~ 203 (484)
+|..
T Consensus 162 ~N~l 165 (454)
T 1jl5_A 162 NNSL 165 (454)
T ss_dssp SSCC
T ss_pred CCcC
Confidence 6643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-14 Score=142.70 Aligned_cols=133 Identities=17% Similarity=0.181 Sum_probs=104.4
Q ss_pred CCcEEEEeeCCCccccc-cCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc-ccCC-CCChhhhcccccc
Q 011486 71 NKRVITLSLTNHKLSGP-ISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN-YLSG-SIPSELGNLSNLL 147 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g-~~p~~~~~l~~L~ 147 (484)
..++++|+|++|.+++. ++..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++ .+|..+..+++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 36788899999988866 7778888899999999999888888888888888999999988 6775 3666778888888
Q ss_pred ccccccc-ccCCC-CCCcccccc-ccceeeccCC--ccc-ccCC-CCCcccccCcccccCCcC
Q 011486 148 NLDISSN-SLSDY-IPPSLGKLQ-RLITFNVSNN--FLV-GAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 148 ~L~ls~N-~l~~~-~p~~~~~l~-~L~~L~ls~N--~l~-~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
+|+|++| .+++. +|..+..++ +|++|++++| .++ +.+| .+..+++|+.|++++|..
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 8888888 88754 566677788 8888888888 454 3333 456677888888888874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-14 Score=145.29 Aligned_cols=130 Identities=19% Similarity=0.247 Sum_probs=61.7
Q ss_pred cEEEEeeCCCccc-cccC---cCcCCCCCCCEEEcccCccc--c---cCCcccCCccccceecccccccC----CCCChh
Q 011486 73 RVITLSLTNHKLS-GPIS---ADLGKLDQLKFLNLHSNNFY--G---EIPSELGNCTELQGLSLQSNYLS----GSIPSE 139 (484)
Q Consensus 73 ~l~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----g~~p~~ 139 (484)
+++.|+|++|+++ +.++ ..+..+++|++|+|++|+|+ | .+|..+..+++|++|+|++|.++ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4445555555544 2222 23444455555555555554 1 23334455555555555555553 344555
Q ss_pred hhcccccccccccccccCCC----CCCccc--cccccceeeccCCcccc----cCC-CC-CcccccCcccccCCc
Q 011486 140 LGNLSNLLNLDISSNSLSDY----IPPSLG--KLQRLITFNVSNNFLVG----AIP-SD-GVLTKFSESSFFGNR 202 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~----~p~~~~--~l~~L~~L~ls~N~l~~----~~p-~~-~~l~~l~~l~l~~N~ 202 (484)
+..+++|++|+|++|.+++. +|..+. .+++|+.|+|++|++++ .+| .+ ..+++|+.|++++|+
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 55555555555555555443 233332 24555555555555555 233 22 334555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-14 Score=144.24 Aligned_cols=131 Identities=18% Similarity=0.248 Sum_probs=76.7
Q ss_pred CcEEEEeeCCCcccc----ccCcCcCCCCCCCEEEcccCcccccCCcccC----Cc---------cccceecccccccC-
Q 011486 72 KRVITLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGEIPSELG----NC---------TELQGLSLQSNYLS- 133 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~- 133 (484)
+++++|+|++|.+++ .+|..+..+++|++|+|++|.|++..+..+. .+ ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 456666666666665 3555566666666666666666533333222 22 56666666666665
Q ss_pred CCCC---hhhhcccccccccccccccC--C---CCCCccccccccceeeccCCccc----ccCC-CCCcccccCcccccC
Q 011486 134 GSIP---SELGNLSNLLNLDISSNSLS--D---YIPPSLGKLQRLITFNVSNNFLV----GAIP-SDGVLTKFSESSFFG 200 (484)
Q Consensus 134 g~~p---~~~~~l~~L~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p-~~~~l~~l~~l~l~~ 200 (484)
+.+| ..+..+++|++|+|++|+++ | .+|..+..+++|+.|+|++|.++ +.+| .+..+++|+.|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 3444 34556666666666666665 2 23445666666666666666664 3333 445566666666666
Q ss_pred Cc
Q 011486 201 NR 202 (484)
Q Consensus 201 N~ 202 (484)
|.
T Consensus 254 n~ 255 (386)
T 2ca6_A 254 CL 255 (386)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.34 E-value=6.5e-14 Score=139.69 Aligned_cols=132 Identities=20% Similarity=0.186 Sum_probs=84.8
Q ss_pred CcEEEEeeCCCccccccC----cCcCCCC-CCCEEEcccCcccccCCcccCCc-----cccceecccccccCCCCChhhh
Q 011486 72 KRVITLSLTNHKLSGPIS----ADLGKLD-QLKFLNLHSNNFYGEIPSELGNC-----TELQGLSLQSNYLSGSIPSELG 141 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~ 141 (484)
.++++|+|++|.+++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 347777777777775555 5566676 77777777777776666666554 7777777777777765555444
Q ss_pred cc-----cccccccccccccCCCCCCcccc-----ccccceeeccCCcccccCC-----CCCccc-ccCcccccCCcC
Q 011486 142 NL-----SNLLNLDISSNSLSDYIPPSLGK-----LQRLITFNVSNNFLVGAIP-----SDGVLT-KFSESSFFGNRG 203 (484)
Q Consensus 142 ~l-----~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~~p-----~~~~l~-~l~~l~l~~N~~ 203 (484)
.. ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+ .+..++ +|+.|++++|..
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 43 67777777777777654444332 2477777777777774322 112233 677777777654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=138.24 Aligned_cols=77 Identities=27% Similarity=0.241 Sum_probs=51.7
Q ss_pred cccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCccccc
Q 011486 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFF 199 (484)
Q Consensus 120 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~ 199 (484)
++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+..++.+..+++|+.++++
T Consensus 221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEec
Confidence 44566666666666 355 344667777777777764 554 4567788888888888544467778888888888
Q ss_pred CCcCC
Q 011486 200 GNRGL 204 (484)
Q Consensus 200 ~N~~~ 204 (484)
+|+..
T Consensus 293 ~N~l~ 297 (622)
T 3g06_A 293 GNPLS 297 (622)
T ss_dssp SCCCC
T ss_pred CCCCC
Confidence 88754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-13 Score=137.25 Aligned_cols=129 Identities=22% Similarity=0.182 Sum_probs=110.1
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCC----cccCCcc-ccceecccccccCCCCChhhhcc-----cc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP----SELGNCT-ELQGLSLQSNYLSGSIPSELGNL-----SN 145 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l-----~~ 145 (484)
.++|++|+++|.+|..+...++|++|||++|.|++..+ ..|..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999997666 6788888 89999999999998888888886 99
Q ss_pred cccccccccccCCCCCCccccc-----cccceeeccCCcccccCC-CC----Cc-ccccCcccccCCcCC
Q 011486 146 LLNLDISSNSLSDYIPPSLGKL-----QRLITFNVSNNFLVGAIP-SD----GV-LTKFSESSFFGNRGL 204 (484)
Q Consensus 146 L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~ls~N~l~~~~p-~~----~~-l~~l~~l~l~~N~~~ 204 (484)
|++|+|++|++++..+..+... ++|++|+|++|++++..+ .+ .. ..+|+.|++++|...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 9999999999998777655544 899999999999998765 22 22 258999999999754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.30 E-value=2e-12 Score=128.34 Aligned_cols=125 Identities=15% Similarity=0.070 Sum_probs=104.0
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCCh-hhhccccccc-ccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS-ELGNLSNLLN-LDISS 153 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~-L~ls~ 153 (484)
+++.++++|+ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++|+. +++++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 5788999999 778766 46899999999999955556799999999999999999877775 5788988775 67788
Q ss_pred cccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
|+++...|..|..+++|++|++++|++++.++ .+....++..+++.+|..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~ 140 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTT
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccc
Confidence 99998888999999999999999999998877 445555666777766543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=9.3e-12 Score=117.54 Aligned_cols=139 Identities=15% Similarity=0.057 Sum_probs=102.5
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCc--eeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY--LVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 384 (484)
..+......+.|..+.||++...+|..+++|...... ...+.+|+++++.+.+.+ +++++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3444333334555699999987778889999976531 245788999998886444 66788888888888999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC---------------------------------------- 424 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------------- 424 (484)
++|.++. ... .+ ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 22 2357788888888888531
Q ss_pred ---------------CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 425 ---------------SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ---------------~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...++|+|++|.||++++++.+.|+|||.+...
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999988766779999998754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.19 E-value=2.2e-13 Score=140.04 Aligned_cols=131 Identities=20% Similarity=0.096 Sum_probs=78.5
Q ss_pred CcEEEEeeCCCcccccc-----CcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccCCCCChhhhc
Q 011486 72 KRVITLSLTNHKLSGPI-----SADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGSIPSELGN 142 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 142 (484)
++++.|+|++|.+++.- +..+..+++|++|+|++|.+++. ++..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 56777777777776432 22233567777777777777643 5556666777777777777766443333433
Q ss_pred c-----cccccccccccccCCC----CCCccccccccceeeccCCcccccCC-CCCc-----ccccCcccccCCc
Q 011486 143 L-----SNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-SDGV-----LTKFSESSFFGNR 202 (484)
Q Consensus 143 l-----~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~-----l~~l~~l~l~~N~ 202 (484)
. ++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+ .+.. .++|+.|++++|.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 2 4677777777766653 34455556666777777766665432 1111 3466666666664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=7.9e-11 Score=117.06 Aligned_cols=143 Identities=17% Similarity=0.237 Sum_probs=108.0
Q ss_pred ccceeeeccceeEEEEEecCCCEEEEEEec--ccC-hhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcC---CceEEEE
Q 011486 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRID--KLN-EGFDRFFERELEILGSIK--HRYLVNLRGYCNSP---TSKLLIY 382 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 382 (484)
..+.++.|.+..||++...+ ..+++|+.. ... ......+.+|.++++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 678888876 322 122456888999999887 45688999988776 4489999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-------------------------------------- 424 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-------------------------------------- 424 (484)
||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998774421 123678888999999999999999720
Q ss_pred -----------------CCCeEEcCCCCCcEEEcCCCc--EEEEecCCCccc
Q 011486 425 -----------------SPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKLL 457 (484)
Q Consensus 425 -----------------~~~ivHrDikp~NILl~~~~~--~kl~DFGla~~~ 457 (484)
...++|||+++.||+++.++. +.|+||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999998743
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.09 E-value=2.4e-12 Score=121.75 Aligned_cols=124 Identities=21% Similarity=0.207 Sum_probs=75.0
Q ss_pred CCCcceeeeCC-CCcEEEEeeCC---CccccccCc------------------------CcCCCCCCCE--EEcccCccc
Q 011486 60 PCNWKGVKCDK-NKRVITLSLTN---HKLSGPISA------------------------DLGKLDQLKF--LNLHSNNFY 109 (484)
Q Consensus 60 ~c~w~gv~C~~-~~~l~~L~L~~---n~l~~~~~~------------------------~~~~l~~L~~--L~Ls~N~l~ 109 (484)
.|+|.|+.|+. ..+++.+...+ ..+.+.+++ .|...+.|.. ++++.|+..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 57999999984 44666665544 233333321 1222333333 555666333
Q ss_pred ---ccCCcccCCccccceecccccccCC--CCChhhhcccccccccccccccCCCCCCcccccc--ccceeeccCCcccc
Q 011486 110 ---GEIPSELGNCTELQGLSLQSNYLSG--SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVG 182 (484)
Q Consensus 110 ---~~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~ 182 (484)
+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|++++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 1122222456778888888888876 4556677778888888888888764 3345555 77788888888877
Q ss_pred cCC
Q 011486 183 AIP 185 (484)
Q Consensus 183 ~~p 185 (484)
.+|
T Consensus 235 ~~~ 237 (267)
T 3rw6_A 235 TFR 237 (267)
T ss_dssp GCS
T ss_pred ccC
Confidence 555
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-12 Score=132.78 Aligned_cols=130 Identities=22% Similarity=0.193 Sum_probs=89.0
Q ss_pred cEEEEeeCCCcccc----ccCcCcCCCCCCCEEEcccCcccccCCcccC-----CccccceecccccccCCC----CChh
Q 011486 73 RVITLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGEIPSELG-----NCTELQGLSLQSNYLSGS----IPSE 139 (484)
Q Consensus 73 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~----~p~~ 139 (484)
++++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 58888888888873 5677788888888888888887754443332 245688888888887753 3555
Q ss_pred hhcccccccccccccccCCCCCCcccc-----ccccceeeccCCccccc----CC-CCCcccccCcccccCCc
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPPSLGK-----LQRLITFNVSNNFLVGA----IP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~----~p-~~~~l~~l~~l~l~~N~ 202 (484)
+..+++|++|+|++|.+++..+..+.. +++|++|++++|.+++. ++ .+..+++|+.+++++|+
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 238 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence 666778888888888876543333322 45778888888877763 23 44556777778887775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=5.5e-12 Score=126.06 Aligned_cols=132 Identities=17% Similarity=0.155 Sum_probs=94.5
Q ss_pred CcEEEEeeCCCccccccCcCc-CCCCCCCEEEcccCcccccCCccc-----CCccccceecccccccCC----CCChhhh
Q 011486 72 KRVITLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-----GNCTELQGLSLQSNYLSG----SIPSELG 141 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~g----~~p~~~~ 141 (484)
.++++|+|++|.|+..-...+ ..+++|+.|+|++|.|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 578899999998874433333 346788899999998875443333 346789999999998863 2444556
Q ss_pred cccccccccccccccCCC----CCCccccccccceeeccCCcccccCC-----CCCcccccCcccccCCcC
Q 011486 142 NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-----SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 142 ~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p-----~~~~l~~l~~l~l~~N~~ 203 (484)
.+++|++|||++|.|++. ++..+...++|+.|+|++|.|+.... .+...++|+.|++++|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 778899999999988742 24556677889999999998876422 233457788899998864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.3e-10 Score=115.96 Aligned_cols=113 Identities=21% Similarity=0.188 Sum_probs=89.8
Q ss_pred CcEEEEeeCCCccccccCcCc-----CCCCCCCEEEcccCcccc----cCCcccCCccccceecccccccCC----CCCh
Q 011486 72 KRVITLSLTNHKLSGPISADL-----GKLDQLKFLNLHSNNFYG----EIPSELGNCTELQGLSLQSNYLSG----SIPS 138 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~~p~ 138 (484)
.+++.|+|++|+|+..-...+ ...++|++|+|++|.|+. .++..+..+++|++|||++|.|+. .++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 479999999999985544433 356899999999999974 345556788999999999999984 2355
Q ss_pred hhhcccccccccccccccCCC----CCCccccccccceeeccCCcccccC
Q 011486 139 ELGNLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAI 184 (484)
Q Consensus 139 ~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~ 184 (484)
.+...++|++|+|++|.|++. ++..+...++|++|||++|.|+...
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g 255 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEG 255 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence 677788999999999999753 3344556789999999999998653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.4e-09 Score=103.90 Aligned_cols=57 Identities=18% Similarity=0.213 Sum_probs=40.8
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
.+++.|+|++ +++..-+..|.++++|+.|+|++|.+....+..|.++.++..+.++.
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 5788999999 88866667899999999999999987644444555554444444433
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.9e-08 Score=97.43 Aligned_cols=137 Identities=23% Similarity=0.205 Sum_probs=102.0
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCc--eeeeEEEEEcCC---ceEEEEEcC
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRY--LVNLRGYCNSPT---SKLLIYDFL 385 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 385 (484)
.+.++.|.+..||++. ..+++|..... .....+.+|.++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999853 45788886542 34567899999998873 332 445555543333 348999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD------------------------------------------ 423 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------------ 423 (484)
+|.++.+... ..++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988876433 2367888889999999999999961
Q ss_pred -------------CCCCeEEcCCCCCcEEEcC--CCcEEEEecCCCccc
Q 011486 424 -------------CSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLL 457 (484)
Q Consensus 424 -------------~~~~ivHrDikp~NILl~~--~~~~kl~DFGla~~~ 457 (484)
....++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 0135899999999999998 556889999998754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.80 E-value=7e-09 Score=101.63 Aligned_cols=99 Identities=13% Similarity=-0.014 Sum_probs=45.4
Q ss_pred CCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccc-cccccccccCCCCCCccccccccceee
Q 011486 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLL-NLDISSNSLSDYIPPSLGKLQRLITFN 174 (484)
Q Consensus 96 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~ 174 (484)
++|+.|+|++|+++...+..|.++++|+.|+|++| ++..-+..|.++++|+ .|++++ +++.+-+..|.++++|+.|+
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 44555555555454333334455555555555544 4322222344555554 555544 44433344455555555555
Q ss_pred ccCCcccccCC-CCCcccccCcc
Q 011486 175 VSNNFLVGAIP-SDGVLTKFSES 196 (484)
Q Consensus 175 ls~N~l~~~~p-~~~~l~~l~~l 196 (484)
+++|+++...+ .|..+++|+.+
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEE
T ss_pred eCCCccCccchhhhcCCcchhhh
Confidence 55555544444 34444444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7.3e-10 Score=104.64 Aligned_cols=80 Identities=26% Similarity=0.397 Sum_probs=66.7
Q ss_pred CCCCCCCEEEcccCcccc--cCCcccCCccccceecccccccCCCCChhhhccc--ccccccccccccCCCCCC------
Q 011486 93 GKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS--NLLNLDISSNSLSDYIPP------ 162 (484)
Q Consensus 93 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~--~L~~L~ls~N~l~~~~p~------ 162 (484)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999997 5567778999999999999999954 4456666 999999999999987774
Q ss_pred -ccccccccceee
Q 011486 163 -SLGKLQRLITFN 174 (484)
Q Consensus 163 -~~~~l~~L~~L~ 174 (484)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 256777887776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-10 Score=123.04 Aligned_cols=130 Identities=15% Similarity=0.088 Sum_probs=68.0
Q ss_pred cEEEEeeCCCccccccCcCcCC-CCCCCEEEcc----cCccccc-----CCcccCCccccceeccccc--ccCCCCChhh
Q 011486 73 RVITLSLTNHKLSGPISADLGK-LDQLKFLNLH----SNNFYGE-----IPSELGNCTELQGLSLQSN--YLSGSIPSEL 140 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~g~~p~~~ 140 (484)
+++.|+|..|++++..+..++. +++|+.|+|+ .|.+++. ++..+.++++|++|+|++| .+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 4555555555555444444433 5555555554 4455532 2222444555666666532 2443333333
Q ss_pred hc-ccccccccccccccCC-CCCCccccccccceeeccCCccccc-CC-CCCcccccCcccccCCc
Q 011486 141 GN-LSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGA-IP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 141 ~~-l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~p-~~~~l~~l~~l~l~~N~ 202 (484)
.. +++|++|+|++|++++ .++..+..+++|+.|+|++|++++. ++ ....+++|+.|++++|+
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 33 5666666666666654 2334445566677777777766543 22 22345666667776665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.7e-09 Score=114.57 Aligned_cols=104 Identities=13% Similarity=0.152 Sum_probs=64.8
Q ss_pred cEEEEeeCCCc-cc-cccCcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccCC----CCChhhhc
Q 011486 73 RVITLSLTNHK-LS-GPISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSG----SIPSELGN 142 (484)
Q Consensus 73 ~l~~L~L~~n~-l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~ 142 (484)
++++|+|++|. ++ ..++....++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 37777777765 22 11222334677777777777777654 33344566777777777777762 33344556
Q ss_pred ccccccccccccccCCCCCCccccccccceeeccC
Q 011486 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177 (484)
Q Consensus 143 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~ 177 (484)
+++|++|+|++|.+++ +|..+..+++|+.|+++.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7777777777777765 555566666666666653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.9e-07 Score=90.40 Aligned_cols=138 Identities=17% Similarity=0.169 Sum_probs=99.6
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC---ceeeeEEEEE-cCCceEEEEEcCCC
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR---YLVNLRGYCN-SPTSKLLIYDFLPG 387 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 387 (484)
.+.++.|....||+. +..+++|.... ......+.+|.++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 56678887532 23456789999999998742 4667777775 44567899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-------------------------------------------- 423 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-------------------------------------------- 423 (484)
.++.+... ..++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876422 1245556666666666666666642
Q ss_pred -------------CCCCeEEcCCCCCcEEEcC---CCc-EEEEecCCCcccC
Q 011486 424 -------------CSPRIIHRDIKSSNILLDG---NLE-ARVSDFGLAKLLE 458 (484)
Q Consensus 424 -------------~~~~ivHrDikp~NILl~~---~~~-~kl~DFGla~~~~ 458 (484)
....++|+|++|.||+++. ++. +.|+||+.+..-.
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1235699999999999987 455 5899999887543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.64 E-value=1.1e-09 Score=98.20 Aligned_cols=111 Identities=22% Similarity=0.284 Sum_probs=71.5
Q ss_pred CCcEEEEeeCCC-ccccc----cCcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccCCC----CC
Q 011486 71 NKRVITLSLTNH-KLSGP----ISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IP 137 (484)
Q Consensus 71 ~~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p 137 (484)
...+++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 356778888887 77632 344566667788888888877632 333444556788888888877632 34
Q ss_pred hhhhcccccccccc--cccccCCC----CCCccccccccceeeccCCccc
Q 011486 138 SELGNLSNLLNLDI--SSNSLSDY----IPPSLGKLQRLITFNVSNNFLV 181 (484)
Q Consensus 138 ~~~~~l~~L~~L~l--s~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 181 (484)
..+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 44556667788888 67777642 2233444567777777777764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.9e-07 Score=84.53 Aligned_cols=147 Identities=20% Similarity=0.185 Sum_probs=105.0
Q ss_pred HHHHhcCCCccceeeeccce-eEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCce
Q 011486 302 IIKKLETLDDDHIIGSGGFG-TVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 378 (484)
+......|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|.+.++.+. +--+.++++++...+..
T Consensus 20 l~~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 20 LDADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp HHHHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 3344445542 456666665 68987665 4567888876542 3456888999988774 44477889999888899
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC---------------------------------- 424 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------- 424 (484)
++|||++++.++.+..... ......+..+++..|..||...
T Consensus 96 ~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 9999999998887765431 1233456677777777777420
Q ss_pred ---------------------CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 425 ---------------------SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ---------------------~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...++|+|+.+.|||+++++.+-|+||+.+..-
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998877789999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=2.3e-09 Score=96.07 Aligned_cols=117 Identities=15% Similarity=0.105 Sum_probs=89.5
Q ss_pred cccCcCcCCCCCCCEEEcccC-ccccc----CCcccCCccccceecccccccCCC----CChhhhccccccccccccccc
Q 011486 86 GPISADLGKLDQLKFLNLHSN-NFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPSELGNLSNLLNLDISSNSL 156 (484)
Q Consensus 86 ~~~~~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l 156 (484)
..+...+...+.|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345556788899999999999 88742 445567789999999999999732 334455668999999999999
Q ss_pred CCC----CCCccccccccceeec--cCCcccccCC-----CCCcccccCcccccCCc
Q 011486 157 SDY----IPPSLGKLQRLITFNV--SNNFLVGAIP-----SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 157 ~~~----~p~~~~~l~~L~~L~l--s~N~l~~~~p-----~~~~l~~l~~l~l~~N~ 202 (484)
++. +...+...++|++|+| ++|.++..-. .+...+.|+.|++++|.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 753 4556777889999999 8899986421 23344678899998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.3e-09 Score=115.41 Aligned_cols=85 Identities=14% Similarity=0.147 Sum_probs=38.6
Q ss_pred CCccccceecccccccCCCCChhhhc-ccccccccccccccCCCCCCcc-ccccccceeeccCCcccccCC--CCCcccc
Q 011486 117 GNCTELQGLSLQSNYLSGSIPSELGN-LSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIP--SDGVLTK 192 (484)
Q Consensus 117 ~~l~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p--~~~~l~~ 192 (484)
..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++... ....+++
T Consensus 429 ~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~ 507 (594)
T 2p1m_B 429 EHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET 507 (594)
T ss_dssp HHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGG
T ss_pred hhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCC
Confidence 3444455555544 333332333333 4555555555555543322222 345555555555555543222 2233455
Q ss_pred cCcccccCCc
Q 011486 193 FSESSFFGNR 202 (484)
Q Consensus 193 l~~l~l~~N~ 202 (484)
|+.|++++|+
T Consensus 508 L~~L~l~~~~ 517 (594)
T 2p1m_B 508 MRSLWMSSCS 517 (594)
T ss_dssp SSEEEEESSC
T ss_pred CCEEeeeCCC
Confidence 5555555543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.4e-07 Score=93.35 Aligned_cols=80 Identities=8% Similarity=0.039 Sum_probs=55.5
Q ss_pred ccee-eeccceeEEEEEec-------CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCC-C--CceeeeEEEEEcC--
Q 011486 312 DHII-GSGGFGTVYKLAMD-------DGNVFALKRIDKLN---EGFDRFFERELEILGSIK-H--RYLVNLRGYCNSP-- 375 (484)
Q Consensus 312 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 375 (484)
.+.| +.|....+|+.... ++..+++|...... ......+.+|.++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998764 26678888765432 001245778888888774 2 3577888887665
Q ss_pred -CceEEEEEcCCCCCHH
Q 011486 376 -TSKLLIYDFLPGGSLD 391 (484)
Q Consensus 376 -~~~~lv~e~~~~gsL~ 391 (484)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.42 E-value=8.6e-09 Score=109.06 Aligned_cols=128 Identities=16% Similarity=0.186 Sum_probs=83.0
Q ss_pred CcEEEEeeCCCccccccCcCcC-CCCCCCEEEcccC-ccccc-CCcccCCccccceecccccccCCCCChhhh----ccc
Q 011486 72 KRVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSN-NFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELG----NLS 144 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~----~l~ 144 (484)
+++++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688888888888776666665 6788888888887 55432 444445778888888888887765554443 456
Q ss_pred ccccccccccccCCCCC-Cc----cccccccceeeccCC-cccccCCCCCcccccCcccccCC
Q 011486 145 NLLNLDISSNSLSDYIP-PS----LGKLQRLITFNVSNN-FLVGAIPSDGVLTKFSESSFFGN 201 (484)
Q Consensus 145 ~L~~L~ls~N~l~~~~p-~~----~~~l~~L~~L~ls~N-~l~~~~p~~~~l~~l~~l~l~~N 201 (484)
+|+.|+|++|. . .++ .. +..+++|++|+|++| .+++....+..+++|+.+++.++
T Consensus 185 ~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred cCcEEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence 88888888876 1 121 22 234578888888877 44442224455666666665443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.4e-07 Score=93.52 Aligned_cols=127 Identities=16% Similarity=0.128 Sum_probs=63.0
Q ss_pred CcEEEEeeCCCc-cccccCcCcCCCCCCCEEEcccCcccccCCcccC--Cccccceecccc--cccCCC-----CChhh-
Q 011486 72 KRVITLSLTNHK-LSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG--NCTELQGLSLQS--NYLSGS-----IPSEL- 140 (484)
Q Consensus 72 ~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~g~-----~p~~~- 140 (484)
++++.|+|++|. + .+++ + .+++|+.|+|..+.+.......+. .+++|+.|+|+. |...|. +...+
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 456666666552 2 1222 2 256666666666655432222232 566666666642 221111 11111
Q ss_pred -hcccccccccccccccCCCCCCccc---cccccceeeccCCccccc----CC-CCCcccccCcccccCCc
Q 011486 141 -GNLSNLLNLDISSNSLSDYIPPSLG---KLQRLITFNVSNNFLVGA----IP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 141 -~~l~~L~~L~ls~N~l~~~~p~~~~---~l~~L~~L~ls~N~l~~~----~p-~~~~l~~l~~l~l~~N~ 202 (484)
..+++|++|+|++|.+.+..+..+. .+++|++|+|+.|.|++. ++ .+..+++|+.|++++|.
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 2356666666666666532222221 356667777777666653 12 22345666666666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.3e-07 Score=93.62 Aligned_cols=129 Identities=18% Similarity=0.219 Sum_probs=89.7
Q ss_pred CcEEEEeeCCCccccccCcCcC--CCCCCCEEEccc--Cccccc-----CCccc--CCccccceecccccccCCCCChhh
Q 011486 72 KRVITLSLTNHKLSGPISADLG--KLDQLKFLNLHS--NNFYGE-----IPSEL--GNCTELQGLSLQSNYLSGSIPSEL 140 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~g~~p~~~ 140 (484)
.+++.|+|..++++...-..+. .+++|++|+|+. |...|. +...+ ..+++|++|+|++|.++...+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 5799999999988754444444 799999999963 332211 11122 357899999999999885444444
Q ss_pred h---cccccccccccccccCCC----CCCccccccccceeeccCCcccccCCCCCcccc-c-CcccccCCc
Q 011486 141 G---NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK-F-SESSFFGNR 202 (484)
Q Consensus 141 ~---~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~-l-~~l~l~~N~ 202 (484)
. .+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.++...- ..+.. + ..+++++|+
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~--~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK--KELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH--HHHHHHCCSEEECCSBC
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH--HHHHHHcCCEEEecCCc
Confidence 3 478999999999999863 45566778999999999999875421 12222 2 345666654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.7e-06 Score=80.31 Aligned_cols=139 Identities=20% Similarity=0.306 Sum_probs=79.9
Q ss_pred ceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC--CCceeeeEE------EEEcCCceEEEEEc
Q 011486 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK--HRYLVNLRG------YCNSPTSKLLIYDF 384 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~ 384 (484)
+.|+.|....||++...++ .+++|+.... ...+..|.++++.+. .-.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4465677889999877554 5899998752 123344555554442 112333332 11235567899999
Q ss_pred CCCCCHH--------------HHHhhcCC----C---------CCHHHH-------------------------------
Q 011486 385 LPGGSLD--------------EALHERSE----Q---------LDWDAR------------------------------- 406 (484)
Q Consensus 385 ~~~gsL~--------------~~l~~~~~----~---------l~~~~~------------------------------- 406 (484)
++|..+. ..+|.... . -.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221100 0 122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 407 LNIIMGAAKGLAYLHH----------DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 407 ~~i~~~i~~aL~~LH~----------~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..+..++..++++|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111234456667763 0156899999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.1e-06 Score=83.33 Aligned_cols=75 Identities=11% Similarity=0.001 Sum_probs=49.8
Q ss_pred cceeeeccceeEEEEEec-CCCEEEEEEecccCh-------hHHHHHHHHHHHHhcCCC---CceeeeEEEEEcCCceEE
Q 011486 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-------GFDRFFERELEILGSIKH---RYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~l 380 (484)
.+.+|.|..+.||++... +++.+++|....... ....++..|.++++.+.. ..+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 467899998653211 123456778888887642 345566644 3455689
Q ss_pred EEEcCCCC
Q 011486 381 IYDFLPGG 388 (484)
Q Consensus 381 v~e~~~~g 388 (484)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.14 E-value=2.6e-06 Score=85.64 Aligned_cols=125 Identities=14% Similarity=0.077 Sum_probs=69.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.+.|.++ ++..-...|.++++|+.++|.+| ++..-...|.+ .+|+.++| .|.++..-+..|.++++|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 35677777643 66455566777777777777764 44333344554 55666666 33344222344566666666666
Q ss_pred cccccC-----CCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCC
Q 011486 152 SSNSLS-----DYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGN 201 (484)
Q Consensus 152 s~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N 201 (484)
.+|.+. ..-+..|.++++|+.++|.+ .++.... .|..+.+|+.+.+..|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence 665543 23344555666666666652 3443333 4555555555555444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.11 E-value=3.5e-06 Score=84.67 Aligned_cols=126 Identities=13% Similarity=0.136 Sum_probs=98.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccC-----CCCChhhhccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS-----GSIPSELGNLSNL 146 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~~L 146 (484)
.+++.|+|.++ ++..-...|.+ .+|+.++| .|.++..-+..|.++++|+.++|.+|.+. ..-+..|.+|++|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 46888888874 66455566777 89999999 45677566778999999999999998775 2334568899999
Q ss_pred ccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 147 LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 147 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
+.++|. |.++..-...|.++++|+.|+|.+| ++...+ .|..+ +|+.+.+.+|..
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 999999 4577666778999999999999665 665545 67778 899999998853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.9e-05 Score=74.15 Aligned_cols=137 Identities=16% Similarity=0.199 Sum_probs=93.1
Q ss_pred ccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC---CCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
..+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.+. ...+++++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999876 4678888887543 3567889999888874 36788999998888889999999998
Q ss_pred CCHH--------H---HHhhcCC--C-------------------CCHHHHH---HHH----------------HHHHHH
Q 011486 388 GSLD--------E---ALHERSE--Q-------------------LDWDARL---NII----------------MGAAKG 416 (484)
Q Consensus 388 gsL~--------~---~l~~~~~--~-------------------l~~~~~~---~i~----------------~~i~~a 416 (484)
..+. + .+|.... . -+|.... ++. .+++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 2222111 0 1454321 111 111212
Q ss_pred H-HHHHh-CCCCCeEEcCCCCCcEEEcCCCcEEEEecC
Q 011486 417 L-AYLHH-DCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (484)
Q Consensus 417 L-~~LH~-~~~~~ivHrDikp~NILl~~~~~~kl~DFG 452 (484)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23421 2257899999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.92 E-value=7.6e-05 Score=71.17 Aligned_cols=77 Identities=14% Similarity=0.193 Sum_probs=56.8
Q ss_pred CccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-C--CceeeeEEEEEcCCceEEEEEcCC
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-H--RYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
...+.+|.|..+.||+.+..+|+.+.+|+...........|..|.+.|+.+. . --+++++++. ..++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 3456789999999999999999999999876544333456889999888774 2 2355555542 3478999998
Q ss_pred CCCH
Q 011486 387 GGSL 390 (484)
Q Consensus 387 ~gsL 390 (484)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=5e-05 Score=76.67 Aligned_cols=73 Identities=15% Similarity=0.195 Sum_probs=46.5
Q ss_pred cceeeeccceeEEEEEecCCCEEEEEEeccc----Ch-----hHHHHHHHHHHHHh-cCCCCceeeeEEEEEcCCceEEE
Q 011486 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKL----NE-----GFDRFFERELEILG-SIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~-----~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.+.+|.|....||++.. +++.++||..... .. .....++.|+..+. ......+++++.+. ++..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 56789999999999865 4678999943211 11 12334444544332 22335677777765 5667999
Q ss_pred EEcC-CC
Q 011486 382 YDFL-PG 387 (484)
Q Consensus 382 ~e~~-~~ 387 (484)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.2e-05 Score=67.20 Aligned_cols=60 Identities=15% Similarity=0.195 Sum_probs=41.1
Q ss_pred cccccccccC-CCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 148 NLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 148 ~L~ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+ .+..+++|+.++|.+|+|.|++.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence 5666677665 23554432 357777777777776666 556677788888888888888765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.68 E-value=5.4e-06 Score=72.69 Aligned_cols=82 Identities=12% Similarity=0.065 Sum_probs=36.6
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCc-ccccCCcccCCc----cccceecccccc-cCCCCChhhhccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN-FYGEIPSELGNC----TELQGLSLQSNY-LSGSIPSELGNLSNL 146 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~L 146 (484)
++++|||+++.++..--..+.++++|++|+|+++. |+..--..+..+ ++|++|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46666666665553322334555555555555553 443222223332 245555555542 331111123344444
Q ss_pred cccccccc
Q 011486 147 LNLDISSN 154 (484)
Q Consensus 147 ~~L~ls~N 154 (484)
++|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.61 E-value=1.2e-05 Score=70.53 Aligned_cols=84 Identities=12% Similarity=0.103 Sum_probs=64.5
Q ss_pred CCCCEEEcccCcccccCCcccCCccccceecccccc-cCCCCChhhhcc----cccccccccccc-cCCCCCCccccccc
Q 011486 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY-LSGSIPSELGNL----SNLLNLDISSNS-LSDYIPPSLGKLQR 169 (484)
Q Consensus 96 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~ls~N~-l~~~~p~~~~~l~~ 169 (484)
-+|+.|||+++.++..--..+.++++|++|+|+++. ++..--..+..+ ++|++|+|+++. +++.=-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999986655668899999999999995 663222234443 479999999974 77532334678899
Q ss_pred cceeeccCCc
Q 011486 170 LITFNVSNNF 179 (484)
Q Consensus 170 L~~L~ls~N~ 179 (484)
|++|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00024 Score=68.72 Aligned_cols=157 Identities=18% Similarity=0.166 Sum_probs=88.9
Q ss_pred CCHHHHHHHhcCCCc-----cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCC--ceeeeE
Q 011486 297 YSSKDIIKKLETLDD-----DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR--YLVNLR 369 (484)
Q Consensus 297 ~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 369 (484)
++.+++......|.. .+.|+.|....+|++...++ .+++|...... ....+..|.+++..+... .+.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556677777766764 23456688889999887655 57889887521 123455677777665321 133333
Q ss_pred EE------EEcCCceEEEEEcCCCCCHHH--------------HHhhcCCC--------C---CHHHHHH----------
Q 011486 370 GY------CNSPTSKLLIYDFLPGGSLDE--------------ALHERSEQ--------L---DWDARLN---------- 408 (484)
Q Consensus 370 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~--------l---~~~~~~~---------- 408 (484)
.. ....+..+++++|++|..+.. .+|..... . .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999998865311 12211000 1 1222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 409 --IIMGAAKGLAYLHHD----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 409 --i~~~i~~aL~~LH~~----~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
+...+...++++++. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455555532 135799999999999999876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0002 Score=68.72 Aligned_cols=140 Identities=11% Similarity=0.064 Sum_probs=76.3
Q ss_pred CCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCce-eeeEEEEEcCCceEEEEEcC-C
Q 011486 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYDFL-P 386 (484)
Q Consensus 309 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~ 386 (484)
+...+.|+.|....+|++ +.+++|........ .....+|..+++.+....+ .+++++ .++.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 334678999999999998 45788877643211 1123457777766642222 455544 344457899999 6
Q ss_pred CCCHHHH------------------HhhcCCC----CCH-HHHHHHHHH--------------HHHHHH----HHHh-CC
Q 011486 387 GGSLDEA------------------LHERSEQ----LDW-DARLNIIMG--------------AAKGLA----YLHH-DC 424 (484)
Q Consensus 387 ~gsL~~~------------------l~~~~~~----l~~-~~~~~i~~~--------------i~~aL~----~LH~-~~ 424 (484)
+.++... +|..... .+. .....+... +...+. .+.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 5544210 1111110 111 111111100 111111 1111 11
Q ss_pred CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 345899999999999 56678899999988743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0006 Score=66.27 Aligned_cols=140 Identities=15% Similarity=0.103 Sum_probs=74.5
Q ss_pred ceeeecccee-EEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCCceEEEEEcCCCCC
Q 011486 313 HIIGSGGFGT-VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 313 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
+.|+.|.... +|+....+++.+++|....... ..+..|+++++.+. .-.+.+++.+.... -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665544 6677654467777876544220 23455666666553 23456677664333 378999997766
Q ss_pred HHHHHhhcC-------------------------CCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 011486 390 LDEALHERS-------------------------EQLDWDARL-------N-------------IIMGAAKGLAYLHH-- 422 (484)
Q Consensus 390 L~~~l~~~~-------------------------~~l~~~~~~-------~-------------i~~~i~~aL~~LH~-- 422 (484)
+.+++.... ..++..... . ....+...++.+.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655442110 012211100 0 00111222223311
Q ss_pred -CCCCCeEEcCCCCCcEEEcCC----CcEEEEecCCCccc
Q 011486 423 -DCSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKLL 457 (484)
Q Consensus 423 -~~~~~ivHrDikp~NILl~~~----~~~kl~DFGla~~~ 457 (484)
.....++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 114689999999999999875 68999999988754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00058 Score=66.14 Aligned_cols=157 Identities=12% Similarity=0.104 Sum_probs=88.8
Q ss_pred CCHHHHHHHhcCCCc-----cceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCC--CceeeeE
Q 011486 297 YSSKDIIKKLETLDD-----DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH--RYLVNLR 369 (484)
Q Consensus 297 ~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~ 369 (484)
.+.+++....+.|.. ...++ |....||++...+|+.+++|...... .....+..|..++..+.. -.+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344555555544432 23466 77889999887777789999986431 124456778888776642 1244444
Q ss_pred EE-----EEcCCceEEEEEcCCCCCHH-----HH---------Hhhc--------CCCCCHHHH----HHH---------
Q 011486 370 GY-----CNSPTSKLLIYDFLPGGSLD-----EA---------LHER--------SEQLDWDAR----LNI--------- 409 (484)
Q Consensus 370 ~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~--------~~~l~~~~~----~~i--------- 409 (484)
.. ....+..+++|||++|..+. .+ +|.. ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 33 11234567899999875431 11 1110 011222211 001
Q ss_pred ------HHHHHHHHHHHHhC----CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 410 ------IMGAAKGLAYLHHD----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 410 ------~~~i~~aL~~LH~~----~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...+...++.+.+. ....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 11111223333211 245689999999999999 5 8999999887643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00017 Score=60.08 Aligned_cols=56 Identities=18% Similarity=0.303 Sum_probs=33.2
Q ss_pred EEEcccCccc-ccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccC
Q 011486 100 FLNLHSNNFY-GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157 (484)
Q Consensus 100 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 157 (484)
.++.+++.|+ ..+|..+. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777777775 34554432 35667777777776322333566666666666666553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00036 Score=70.58 Aligned_cols=73 Identities=14% Similarity=0.134 Sum_probs=48.9
Q ss_pred cceeeeccceeEEEEEecC--------CCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 312 DHIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.|+.|....+|++...+ ++.+++|+..... ....+.+|..+++.+. +.-.+++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999988653 5788999884421 1134557888888774 3334667766532 3899
Q ss_pred EcCCCCCH
Q 011486 383 DFLPGGSL 390 (484)
Q Consensus 383 e~~~~gsL 390 (484)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.27 E-value=1.6e-05 Score=70.95 Aligned_cols=62 Identities=13% Similarity=0.253 Sum_probs=28.5
Q ss_pred CcEEEEeeCCC-cccc----ccCcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccC
Q 011486 72 KRVITLSLTNH-KLSG----PISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLS 133 (484)
Q Consensus 72 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 133 (484)
..+++|+|++| +|.. .+...+..=+.|+.|+|++|.|... +...+..-+.|++|+|++|.|+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34555555553 4431 1223344445555555555555522 1122223344555555555554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00089 Score=66.36 Aligned_cols=140 Identities=13% Similarity=0.140 Sum_probs=83.9
Q ss_pred cceeeeccceeEEEEEec--------CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 312 DHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899998864 24788888864322 22455668999888774 3334667766543 3899
Q ss_pred EcCCCCCHHH--------------H---HhhcC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 011486 383 DFLPGGSLDE--------------A---LHERS----EQLD--WDARLNIIMGAAK-------------------GLAYL 420 (484)
Q Consensus 383 e~~~~gsL~~--------------~---l~~~~----~~l~--~~~~~~i~~~i~~-------------------aL~~L 420 (484)
||++|.++.. . +|.-. .... +.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765431 1 11111 1122 4555555544422 23333
Q ss_pred H----hC-CCCCeEEcCCCCCcEEEcCC----CcEEEEecCCCcc
Q 011486 421 H----HD-CSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKL 456 (484)
Q Consensus 421 H----~~-~~~~ivHrDikp~NILl~~~----~~~kl~DFGla~~ 456 (484)
. .. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 11 13468999999999999876 7899999999874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00046 Score=68.85 Aligned_cols=115 Identities=12% Similarity=0.216 Sum_probs=83.1
Q ss_pred cccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCC-hhhhcccccccccccccccCCCCCC
Q 011486 84 LSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP-SELGNLSNLLNLDISSNSLSDYIPP 162 (484)
Q Consensus 84 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~~~~p~ 162 (484)
++..-...|.++..|+.+.+.++..+ .-...|.++++|+.+++. +.++ .|+ ..|.++.+|+.++|..| ++.+-..
T Consensus 253 v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 253 VARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp EEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred ceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 34334456888889999998776554 555678888999999886 4555 444 45788889999988765 5544456
Q ss_pred ccccccccceeeccCCcccccCC-CCCcccccCcccccCCcC
Q 011486 163 SLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 163 ~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~ 203 (484)
.|.++.+|+.+.+..+ ++..-. .|..+.+|+.+.+.+|..
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 7888889999988654 554433 677788888888888753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0024 Score=64.99 Aligned_cols=74 Identities=16% Similarity=0.148 Sum_probs=46.9
Q ss_pred cceeeeccceeEEEEEecC-CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCce-eeeEEEEEcCCceEEEEEcCCCCC
Q 011486 312 DHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYDFLPGGS 389 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 389 (484)
.+.|+.|-...+|++...+ +..+++|+........ -.-.+|..+++.+...++ +++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999988765 4778888875422111 112578888888864333 56777662 2 35999998754
Q ss_pred H
Q 011486 390 L 390 (484)
Q Consensus 390 L 390 (484)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0025 Score=62.13 Aligned_cols=33 Identities=21% Similarity=0.313 Sum_probs=28.9
Q ss_pred CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999887654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00091 Score=66.66 Aligned_cols=121 Identities=8% Similarity=0.102 Sum_probs=70.5
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
.++.+.+.++-.+ .-...|.+++.|+.+.+. +.++..-...|.++++|+.++|..| ++..-...|.++.+|+.+.|.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 3444555444332 334567777888888885 4455344556778888888888754 552223457778888888886
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCccccc
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFF 199 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~ 199 (484)
.+ ++..-...|.++++|+.+++.+|.... ..+.....|+.+.+.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~ 386 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVA 386 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeC
Confidence 54 554445667788888888887765432 123334445544443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0015 Score=64.64 Aligned_cols=111 Identities=14% Similarity=0.092 Sum_probs=74.8
Q ss_pred cCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccc
Q 011486 88 ISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKL 167 (484)
Q Consensus 88 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 167 (484)
-...+.+...|+.+.+..+ ++..-...|.++.+|+.+++..+ ++..-...|.++++|+.+++.+|.++..-+..|.++
T Consensus 232 ~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c 309 (379)
T 4h09_A 232 GDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDC 309 (379)
T ss_dssp CTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTC
T ss_pred ccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCC
Confidence 3445667777777777665 45344556777788888887654 442223457778888888888887776556778888
Q ss_pred cccceeeccCCcccccCC-CCCcccccCcccccCC
Q 011486 168 QRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGN 201 (484)
Q Consensus 168 ~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N 201 (484)
.+|+.++|.++ ++..-. .|..+.+|+.+.+..|
T Consensus 310 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 310 VKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred CCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 88888888654 544333 5667777777777544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00089 Score=66.11 Aligned_cols=139 Identities=16% Similarity=0.179 Sum_probs=75.6
Q ss_pred cceeeeccceeEEEEEecC---------CCEEEEEEecccChhHHHHHHHHHHHHhcCCCCc-eeeeEEEEEcCCceEEE
Q 011486 312 DHIIGSGGFGTVYKLAMDD---------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 381 (484)
.+.++.|..-.+|++...+ ++.+++|+....... ......|.++++.+.... ++++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457778888999987654 267888887543221 112356777777774222 45666554 2 3789
Q ss_pred EEcCCCCCHH-------H-------H---Hhh---cC---CCCC-----HHHHHHHHH--------------------HH
Q 011486 382 YDFLPGGSLD-------E-------A---LHE---RS---EQLD-----WDARLNIIM--------------------GA 413 (484)
Q Consensus 382 ~e~~~~gsL~-------~-------~---l~~---~~---~~l~-----~~~~~~i~~--------------------~i 413 (484)
|||++|..+. + . +|. .. ..++ +.....+.. .+
T Consensus 113 ~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (369)
T 3c5i_A 113 EEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKES 192 (369)
T ss_dssp EECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHH
T ss_pred EEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHH
Confidence 9999875431 1 1 111 00 0111 111111111 11
Q ss_pred HHHHHHHHh-------CCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 414 AKGLAYLHH-------DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 414 ~~aL~~LH~-------~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
...++++.+ .....++|+|+++.|||++++. +.|+||..+..
T Consensus 193 ~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 193 DKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp HHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred HHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 222334432 1135689999999999998654 89999998864
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0019 Score=64.28 Aligned_cols=84 Identities=11% Similarity=0.070 Sum_probs=47.6
Q ss_pred ccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCC-CCCccccc
Q 011486 115 ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKF 193 (484)
Q Consensus 115 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l 193 (484)
.|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-...|.++++|+.+++..| ++.... .|..+.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 3555666666666544 44122334666677777777543 54434456666777777777655 443333 55666666
Q ss_pred CcccccCC
Q 011486 194 SESSFFGN 201 (484)
Q Consensus 194 ~~l~l~~N 201 (484)
+.+.+..|
T Consensus 369 ~~i~lp~~ 376 (394)
T 4fs7_A 369 KKVELPKR 376 (394)
T ss_dssp CEEEEEGG
T ss_pred CEEEECCC
Confidence 66666543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0031 Score=62.72 Aligned_cols=57 Identities=11% Similarity=0.174 Sum_probs=33.4
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
.+++++.|.+ .++..-..+|.++++|+.++|.+| ++..-...|.++++|+.+.+..+
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~ 127 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM 127 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc
Confidence 3566777653 355344455677777777777644 44333445666666666666543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00022 Score=63.57 Aligned_cols=89 Identities=18% Similarity=0.169 Sum_probs=62.7
Q ss_pred cCcCCCCCCCEEEcccC-cccc----cCCcccCCccccceecccccccCC----CCChhhhcccccccccccccccCCC-
Q 011486 90 ADLGKLDQLKFLNLHSN-NFYG----EIPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY- 159 (484)
Q Consensus 90 ~~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~- 159 (484)
..+.+-+.|++|+|++| .|.. .+-..+..-+.|+.|+|++|+|.. .|...+..-+.|+.|+|++|.|.+.
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34556688999999986 7763 234456667889999999999973 2333444557899999999999642
Q ss_pred ---CCCccccccccceeeccCC
Q 011486 160 ---IPPSLGKLQRLITFNVSNN 178 (484)
Q Consensus 160 ---~p~~~~~l~~L~~L~ls~N 178 (484)
+-..+..-+.|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 2223444567888888865
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0019 Score=63.78 Aligned_cols=104 Identities=13% Similarity=0.130 Sum_probs=80.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.+.+..+ ++..-...|.+..+|+.+.+..+ +...-...|.++++|+.+++.+|.++..-+..|.++.+|+.++|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 35667777655 55455567889999999999765 55355567999999999999999998333456899999999999
Q ss_pred cccccCCCCCCccccccccceeeccCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N 178 (484)
.+| ++.+-...|.++++|+.+.+..|
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 865 66545678999999999988544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.016 Score=58.09 Aligned_cols=139 Identities=15% Similarity=0.148 Sum_probs=83.3
Q ss_pred cceeeeccceeEEEEEecC--------CCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 312 DHIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.+..|-...+|++...+ ++.+++|+....... .-.-.+|.++++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999987653 578888886543211 112356777777764 333456665432 37899
Q ss_pred EcCCCCCHHH--------------HH---hh--c-----C---C-C-CCHHHHHHHHHHH-------------------H
Q 011486 383 DFLPGGSLDE--------------AL---HE--R-----S---E-Q-LDWDARLNIIMGA-------------------A 414 (484)
Q Consensus 383 e~~~~gsL~~--------------~l---~~--~-----~---~-~-l~~~~~~~i~~~i-------------------~ 414 (484)
||++|..|.. .+ |. . . . . .-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865321 11 11 0 0 1 1 1244444443322 2
Q ss_pred HHHHHHHh---------------------CCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 415 KGLAYLHH---------------------DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 415 ~aL~~LH~---------------------~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..+.+|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11346899999999999 8888999999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.33 E-value=0.081 Score=52.60 Aligned_cols=30 Identities=27% Similarity=0.390 Sum_probs=25.6
Q ss_pred CeEEcCCCCCcEEE------cCCCcEEEEecCCCcc
Q 011486 427 RIIHRDIKSSNILL------DGNLEARVSDFGLAKL 456 (484)
Q Consensus 427 ~ivHrDikp~NILl------~~~~~~kl~DFGla~~ 456 (484)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566799999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.50 E-value=0.62 Score=41.79 Aligned_cols=88 Identities=11% Similarity=0.044 Sum_probs=64.3
Q ss_pred CCCceeeeEEEEEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEcCCCCCcEE
Q 011486 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA-YLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 361 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~-~LH~~~~~~ivHrDikp~NIL 439 (484)
.||++ -..+-.+++...+.++.-+++-=...++ ..+...+++++..|+.... +++ .-+|--+.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 58888 4445566777777777554433233342 2688999999999888766 555 5688899999999
Q ss_pred EcCCCcEEEEecCCCcccCC
Q 011486 440 LDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~~ 459 (484)
+|.++.+++.-.|+-..+.+
T Consensus 117 f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp ECTTCCEEESCCEETTTBSS
T ss_pred EeCCCcEEEEEcCCcccCCC
Confidence 99999999999998665544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.50 E-value=0.73 Score=41.17 Aligned_cols=88 Identities=9% Similarity=0.145 Sum_probs=63.9
Q ss_pred CCCceeeeEEEEEcCCceEEEEEcCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEE
Q 011486 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGG-SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 361 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NIL 439 (484)
.||+++.. .+-.+++...+.|+.-+.+ ++.. + ...+...+++++..|+....+++ .-+|=-+.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 68888865 4556666555555543321 2322 3 23688999999999999887766 4588899999999
Q ss_pred EcCCCcEEEEecCCCcccCC
Q 011486 440 LDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~~ 459 (484)
++.++.+++.-.|+-..+.+
T Consensus 112 f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp ECTTSCEEESCCEETTTBSC
T ss_pred EcCCCCEEEEEccCccCCCC
Confidence 99999999999987665544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 484 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-47
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 9/168 (5%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IGSG FGTVYK G+V A+K ++ + F+ E+ +L +H ++ G
Sbjct: 14 QRIGSGSFGTVYK-GKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
Y +P ++ + G SL LH + + ++I A+G+ YLH IIH
Sbjct: 72 YSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
RD+KS+NI L +L ++ DFGLA + SH ++G+ ++AP
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 5e-46
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 12/178 (6%)
Query: 306 LETLDDD----HIIGSGGFGTVYK-LAMDDGNVFALKRIDK-LNEGFDRFFERELEILGS 359
+E DDD +G+G G V+K G V A K I + REL++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
Y+V G S + + + GGSLD+ L + ++ + + KGL Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 119
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L +I+HRD+K SNIL++ E ++ DFG++ L D + GT Y++P
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSP 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-44
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 5/164 (3%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + + A K ID +E + E++IL S H +V L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+ ++ +F GG++D + E L + L YLH +IIHRD+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
K+ NIL + + +++DFG++ + + GT ++AP
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAP 179
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-44
Identities = 45/185 (24%), Positives = 89/185 (48%), Gaps = 15/185 (8%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P + ++++ +G+G FG V+ + A+K + + + D F E
Sbjct: 9 EVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-LAE 58
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMG 412
++ ++H+ LV L +I +++ GSL + L S +L + L++
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
A+G+A++ IHRD++++NIL+ L +++DFGLA+L+ED E
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 473 GYLAP 477
+ AP
Sbjct: 175 KWTAP 179
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-44
Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 300 KDIIKKLETLD-DDHIIGSGGFGTVYK---LAMDDGNVFALKRIDK-LNEGFDRFFEREL 354
K + K + L D +G G FG+V + A+K + + + RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA 414
+I+ + + Y+V L G C + + +L+ + GG L + L + E++ ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--TIVAGTF 472
G+ YL +HRD+ + N+LL A++SDFGL+K L ++S+ T +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 473 GYLAP 477
+ AP
Sbjct: 177 KWYAP 181
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-43
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 4/163 (2%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+G+G FG V A+K I + + D F E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434
+I +++ G L L E + L + + + YL + +HRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLA 127
Query: 435 SSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ N L++ +VSDFGL++ + D+E + + P
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-43
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG+G +G K DG + K +D + E + E+ +L +KH +V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 371 YCNSPTSKLL--IYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLH--HD 423
T+ L + ++ GG L + + +++ LD + L ++ L H D
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++HRD+K +N+ LDG ++ DFGLA++L + S GT Y++P
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-42
Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 16/175 (9%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
IG G FG V++ G A+K E F E E+ ++H ++ N
Sbjct: 11 IGKGRFGEVWR-GKWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 375 PTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----S 425
L+ D+ GSL + L+ + + + + + + A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI---TTIVAGTFGYLAP 477
P I HRD+KS NIL+ N ++D GLA + I GT Y+AP
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 4/163 (2%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
IGSG FG V+ + + A+K I + + F E E++ + H LV L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434
L+++F+ G L + L + + L + + +G+ + +IHRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRDLA 128
Query: 435 SSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ N L+ N +VSDFG+ + + D++ +T + +P
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 4e-42
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 296 PYSSKDIIK---------KLETLDDDHIIGSGGFGTVYK----LAMDDGNVFALKRIDK- 341
P++ +D + + + + +IG+G FG V L A+K +
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL 401
E R F E I+G H +++L G T ++I +F+ GSLD L + Q
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ ++ G A G+ YL +HRD+ + NIL++ NL +VSDFGL++ LED+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 462 SHITTIVA----GTFGYLAP 477
S T A + AP
Sbjct: 183 SDPTYTSALGGKIPIRWTAP 202
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 6e-42
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 16/185 (8%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFER 352
+ D K L IG G FG VY + + V A+K++ + + +
Sbjct: 8 FFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E+ L ++H + RG + L+ ++ G + D + + L + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHG 123
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
A +GLAYLH S +IHRD+K+ NILL ++ DFG A ++ GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTP 175
Query: 473 GYLAP 477
++AP
Sbjct: 176 YWMAP 180
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 55/177 (31%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
L+D I +G G FG VY + ALK + K G + RE+EI +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H ++ L GY + T LI ++ P G++ L + S + D I A L+Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 122
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H S R+IHRDIK N+LL E +++DFG + + GT YL P
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPP 173
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 6/172 (3%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G G FG V+ + A+K + + F +E +++ ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMKKLRHEKLV 75
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +++ GSL + L E + L +++ A G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+HRD++++NIL+ NL +V+DFGLA+L+ED E + AP
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (372), Expect = 9e-41
Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 303 IKKLETLDDDHI---IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEIL 357
IK LD I +G+G FG V++ + GN FA K + +E +E++ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGL 417
++H LVNL ++IY+F+ GG L E + + ++ D + + KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 418 AYLHHDCSPRIIHRDIKSSNILL--DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
++H +H D+K NI+ + E ++ DFGL L+ ++S T GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFA 192
Query: 476 AP 477
AP
Sbjct: 193 AP 194
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-41
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 13/174 (7%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
D IG G F TVYK L + A + L + + F+ E E+L ++H +V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 369 RGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S +L+ + + G+L L R + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 425 SPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
P IIHRD+K NI + G ++ D GLA L V GT ++AP
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAP 182
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-40
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 9/168 (5%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V A++ A+K +D ++E+ I + H +V G
Sbjct: 12 TLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ + L ++ GG L + + + G+ YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
RDIK N+LLD ++SDFGLA + + + + GT Y+AP
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-40
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK---LAMDDGNVFALKRIDK--LNEGFDRFFERELEILG 358
+KL TL+D +GSG FGTV K A+K + + E ++
Sbjct: 5 RKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ + Y+V + G C + S +L+ + G L++ L + + + ++ + G+
Sbjct: 64 QLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMK 121
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--IVAGTFGYLA 476
YL +HRD+ + N+LL A++SDFGL+K L +E++ + A
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 477 P 477
P
Sbjct: 179 P 179
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-39
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 12/182 (6%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELE 355
S D KK + IG G GTVY AMD G A+++++ + E+
Sbjct: 14 SVGDPKKKYTRFE---KIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ K+ +VN ++ ++L GGSL + + E D + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQ 127
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
L +LH S ++IHRDIKS NILL + +++DFG + E+S +T+V GT ++
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183
Query: 476 AP 477
AP
Sbjct: 184 AP 185
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-39
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 30/209 (14%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
LPY K + L +G+G FG V + + D A+K + +
Sbjct: 12 LPYDHKWEFPR-NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 348 RFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------ 400
EL++L + H +VNL G C L+I ++ G L L + +
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 401 -----------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
LD + L+ AKG+A+L S IHRD+ + NILL ++
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKIC 187
Query: 450 DFGLAKLLEDEESH-ITTIVAGTFGYLAP 477
DFGLA+ ++++ ++ + ++AP
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAP 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 12/167 (7%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V GN A+K I + + F E ++ ++H LV L G
Sbjct: 13 QTIGKGEFGDVML-GDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 373 NSPTSKL-LIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L ++ +++ GSL + L R L D L + + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+ + N+L+ + A+VSDFGL K + + AP
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAP 169
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 4e-39
Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 6/182 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR 363
+ + H +G G +G VY+ + A+K + + + F +E ++ IKH
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHP 73
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHH 422
LV L G C +I +F+ G+L + L E + Q + L + + + YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482
IHRD+ + N L+ N +V+DFGL++L+ + + AP
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 483 NG 484
N
Sbjct: 191 NK 192
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 1e-38
Identities = 42/194 (21%), Positives = 78/194 (40%), Gaps = 34/194 (17%)
Query: 315 IGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVN 367
IG G FG V++ L + + A+K + + + F+RE ++ + +V
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-----------------------LDWD 404
L G C L+++++ G L+E L S L
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESH 463
+L I A G+AYL + +HRD+ + N L+ N+ +++DFGL++ + +
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 464 ITTIVAGTFGYLAP 477
A ++ P
Sbjct: 198 ADGNDAIPIRWMPP 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (357), Expect = 1e-38
Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 303 IKKLETLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
+K+ D I +GSG FG V++ + G VF K I+ + E+ I+
Sbjct: 22 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ H L+NL +LI +FL GG L + + ++ +N + A +GL
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLA 476
++H I+H DIK NI+ + + V DFGLA L +E T T + A
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAA 196
Query: 477 P 477
P
Sbjct: 197 P 197
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-38
Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 291 FHGDLPYSSKDIIKKLE---------TLDDDHIIGSGGFGTVYKLAMDDGN----VFALK 337
H DL + ++++ ++ + + +IG G FG VY + D + A+K
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 338 RIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALH 395
++++ + G F E I+ H +++L G C S S L++ ++ G L +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 396 ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ + + AKG+ S + +HRD+ + N +LD +V+DFGLA+
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 456 LLEDEE---SHITTIVAGTFGYLAP 477
+ D+E H T ++A
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMAL 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-38
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 9/168 (5%)
Query: 314 IIGSGGFGTVYK----LAMDDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG V++ + A+K ++ F +E + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G + +I + G L L R LD + + + LAYL S R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
+HRDI + N+L+ N ++ DFGL++ +ED + + ++A
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 35/214 (16%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
Y K + E L+ ++GSG FG V A+K + + +
Sbjct: 26 YEYDLKWEFPR-ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 348 RFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------ 400
EL+++ + H +VNL G C LI+++ G L L + E+
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 401 ----------------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444
L ++ L AKG+ +L +HRD+ + N+L+
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGK 201
Query: 445 EARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
++ DFGLA+ + D + ++AP
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 11/179 (6%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGN-----VFALKRIDK-LNEGFDRFFERELEILGSI 360
+ +IG+G FG VYK + + A+K + E F E I+G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H ++ L G + ++I +++ G+LD+ L E+ + + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--GTFGYLAP 477
+ + +HRD+ + NIL++ NL +VSDFGL+++LED+ T + AP
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-37
Identities = 42/179 (23%), Positives = 76/179 (42%), Gaps = 9/179 (5%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGS 359
K+ E I+G G F TV + +A+K ++K + E + RE +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
+ H + V L + G L + + + D A+ ++
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYT---AEIVSA 120
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
L + IIHRD+K NILL+ ++ +++DFG AK+L + + GT Y++P
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 13/172 (7%)
Query: 315 IGSGGFGTVYKLAMD----DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVN 367
+G G FG V + D A+K + F RE+ + S+ HR L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L G +P K+ + + P GSL + L + + A+G+ YL S R
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH--ITTIVAGTFGYLAP 477
IHRD+ + N+LL ++ DFGL + L + H + F + AP
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK-----LNEGFDRFFERELEI 356
I K ++GSG FGTVYK L + +G + K + ++ E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
+ S+ + ++ L G C + T LI +P G L + + E + + LN + AKG
Sbjct: 65 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYL 475
+ YL R++HRD+ + N+L+ +++DFGLAKLL EE + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 476 AP 477
A
Sbjct: 181 AL 182
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 38/181 (20%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
K++ +K + +G G FG V++ + + K + K+ ++E+ IL
Sbjct: 1 KELYEKYMIAE---DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILN 56
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+HR +++L S ++I++F+ G + E ++ + +L+ ++ + + L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 419 YLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
+LH S I H DI+ NI+ + ++ +FG A+ L+ ++ Y A
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYA 171
Query: 477 P 477
P
Sbjct: 172 P 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 130 bits (327), Expect = 2e-34
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 308 TLDD---DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK------LNEGFDRFFERELEIL 357
T++D IIG GGFG VY D G ++A+K +DK E L ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGL 417
+ ++V + ++P I D + GG L L + + D R GL
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGL 120
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
++H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 3e-34
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 304 KKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEI 356
K+ E + D ++G+G F V A D + A+K I K EG + E E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
L IKH +V L S LI + GG L + + E+ +I
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDA 119
Query: 417 LAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
+ YLH I+HRD+K N+L D + + +SDFGL+K+ + + + GT G
Sbjct: 120 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 174
Query: 474 YLAP 477
Y+AP
Sbjct: 175 YVAP 178
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-34
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 314 IIGSGGFGTVYKLAMDDGN---VFALKRIDK-LNEGFDRFFERELEILGSI-KHRYLVNL 368
+IG G FG V K + A+KR+ + ++ R F ELE+L + H ++NL
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGA 413
G C L ++ P G+L + L + + L L+
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++ E T+
Sbjct: 137 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVR 191
Query: 474 YLAP 477
++A
Sbjct: 192 WMAI 195
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (317), Expect = 1e-33
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK---------LNEGFDRFFERELEILGSIK-H 362
I+G G V + + +A+K ID + +E++IL + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++ L+ + T L++D + G L + L E+ L I+ + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH- 127
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
I+HRD+K NILLD ++ +++DFG + L+ E V GT YLAP
Sbjct: 128 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAP 178
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-33
Identities = 50/208 (24%), Positives = 81/208 (38%), Gaps = 28/208 (13%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
LPY + + L +G G FG V + A+K + +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 348 RFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLI-YDFLPGGSLDEALHERSEQ----- 400
R EL+IL I H +VNL G C P L++ +F G+L L + +
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 401 ----------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450
L + + AKG+ +L S + IHRD+ + NILL ++ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICD 177
Query: 451 FGLAKLLEDEESHI-TTIVAGTFGYLAP 477
FGLA+ + + ++ ++AP
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAP 205
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-33
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G V A D + A+K+I ++ + + RE++IL +H ++ +
Sbjct: 15 YIGEGAYGMVCS-AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 371 YCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+PT + + + L G L + L + L D + +GL Y+H S
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SA 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAP 477
++HRD+K SN+LL+ + ++ DFGLA++ + + H + T Y AP
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 2e-32
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 15/177 (8%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
+L D I +G+G FG V+ + +G +A+K + K + E +L +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H +++ + G +I D++ GG L L + + A+ A+ L
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ S II+RD+K NILLD N +++DFG AK + D + GT Y+AP
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 35/204 (17%), Positives = 76/204 (37%), Gaps = 26/204 (12%)
Query: 297 YSSKDIIK------KLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LN 343
+S+ D+ E + +G G FG VY+ + + A+K +++ +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 344 EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH-------- 395
F E ++ ++V L G + L+I + + G L L
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 396 -ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
+ + A G+AYL + + +HRD+ + N ++ + ++ DFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 455 KLL-EDEESHITTIVAGTFGYLAP 477
+ + E + +++P
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSP 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 5e-32
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G +G VYK + G FALK+I +K +EG RE+ IL +KH +V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ +L+++ L L L+ + ++ G+AY H R++HRD
Sbjct: 70 HTKKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+K N+L++ E +++DFGLA+ T + +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-32
Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK-----LNEGFDRFFERELEILGSI 360
E LD +G G F TVYK + + A+K+I +G +R RE+++L +
Sbjct: 1 EKLD---FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H ++ L ++ L++DF+ + + S L ++ +GL YL
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H I+HRD+K +N+LLD N +++DFGLAK T V T Y AP
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAP 169
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 8e-32
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--------LAMDDGNVFALKRIDK-LNE 344
+LP + + + + L +G G FG V + A+K + E
Sbjct: 1 ELPEDPRWELPR-DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 345 GFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER------ 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 398 ---------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448
EQL ++ A+G+ YL S + IHRD+ + N+L+ + ++
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKI 176
Query: 449 SDFGLAKLLEDEESHITTIV-AGTFGYLAP 477
+DFGLA+ + + + T ++AP
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (301), Expect = 1e-31
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 16/175 (9%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
I+G GG V+ A D A+K + + F F RE + ++ H +V +
Sbjct: 14 ILGFGGMSEVHL-ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 369 RGYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ T ++ +++ G +L + +H + + +I A + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFS---H 128
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAP 477
IIHRD+K +NI++ +V DFG+A+ + D + + T V GT YL+P
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 310 DDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
D +IG+G FG VY+ D G + A+K++ + RF REL+I+ + H +V L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL 78
Query: 369 RGYCNSPTSK------LLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYL 420
R + S K L+ D++P A H + L + + LAY+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 421 HHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H S I HRDIK N+LLD + ++ DFG AK L E +++ I + Y AP
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAP 191
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-31
Identities = 40/177 (22%), Positives = 77/177 (43%), Gaps = 13/177 (7%)
Query: 309 LDD---DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK----LNEGFDRFFERELEILGSI 360
++D ++G G FG V+ FA+K + K +++ + + + +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H +L ++ + + + ++L GG L + + D GL +L
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFL 119
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S I++RD+K NILLD + +++DFG+ K ++ T GT Y+AP
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAP 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-31
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A + G V ALK+I D EG RE+ +L + H +V L
Sbjct: 10 IGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ L+++FL + + + +GLA+ S R++H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLH 125
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
RD+K N+L++ +++DFGLA+ T V T Y AP
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAP 171
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 26/190 (13%)
Query: 303 IKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEI 356
IKK +DD ++G G G V + + FALK + + RE+E+
Sbjct: 4 IKKNAIIDDYKVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPK-----ARREVEL 57
Query: 357 LGSI-KHRYLVNLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQ-LDWDARLNII 410
+ ++V + + + L++ + L GG L + +R +Q I+
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEESHITTI 467
+ + YLH S I HRD+K N+L N +++DFG AK S T
Sbjct: 118 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 468 VAGTFGYLAP 477
T Y+AP
Sbjct: 175 Y--TPYYVAP 182
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 7e-30
Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 12/177 (6%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
T++D +G G FG V G +A+K + K + + E +L +
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H +L L+ + + ++ GG L L + AR A+ ++ L
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSAL 118
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ S +++RDIK N++LD + +++DFGL K + + + T GT YLAP
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 17/175 (9%)
Query: 315 IGSGGFGTVYK--LAMDDGNVFALKRIDK--LNEGFDRFFERELEI---LGSIKHRYLVN 367
IG G +G V+K + G ALKR+ EG RE+ + L + +H +V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 368 LRGYCNSPTSK-----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
L C + L+++ + + + +++ +GL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
S R++HRD+K NIL+ + + +++DFGLA++ + + + + T Y AP
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAP 184
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-29
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V+K G ALK++ EGF RE++IL +KH +VNL
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 372 CNSPTSK--------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
C + S L++DF + + + + + M L L++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML----LNGLYYI 133
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES---HITTIVAGTFGYLAP 477
+I+HRD+K++N+L+ + +++DFGLA+ ++ + T T Y P
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 7e-29
Identities = 41/174 (23%), Positives = 64/174 (36%), Gaps = 17/174 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y D G A+K + E +I ++ + +C
Sbjct: 15 IGSGSFGDIYL-GTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+ ++ L G SL++ + S + L + + Y+H S IHRD
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 433 IKSSNIL---LDGNLEARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAP 477
+K N L + DFGLAK D +H + GT Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-28
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 21/190 (11%)
Query: 303 IKKLETLDDD----HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF------FE 351
+ + E +DD +GSG F V K G +A K I K R E
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 352 RELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
RE+ IL I+H ++ L + T +LI + + GG L + L E+ E L + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLK 120
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLD----GNLEARVSDFGLAKLLEDEESHITTI 467
G +++ S +I H D+K NI+L ++ DFGLA ++
Sbjct: 121 QILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKN 175
Query: 468 VAGTFGYLAP 477
+ GT ++AP
Sbjct: 176 IFGTPEFVAP 185
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 16/174 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF------FERELEILGSIK--HRY 364
++GSGGFG+VY + + D A+K ++K E+ +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
++ L + P S +LI + L + + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 425 SPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ ++HRDIK NIL+D N E ++ DFG LL+D + T GT Y P
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (272), Expect = 2e-27
Identities = 30/176 (17%), Positives = 58/176 (32%), Gaps = 19/176 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG +++ + + A+K + ++ E + + Y
Sbjct: 13 IGEGSFGVIFE-GTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ L G SL++ L + + +H +++RD
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 433 IKSSNILLDGNL-----EARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAP 477
IK N L+ V DFG+ K D + ++GT Y++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 314 IIGSGGFGTVYK----LAMDDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ D G ++A+K + K E ++L I+ +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
LV L + T LI D++ GG L L +R + + ++ + + + L H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV----GEIVLALEHLH 146
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
II+RDIK NILLD N ++DFGL+K +E+ GT Y+A
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-27
Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 7/166 (4%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +GTV+K + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+S L+++F + + + L L S ++HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----FLFQLLKGLGFCHSRNVLHR 125
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
D+K N+L++ N E ++++FGLA+ + V +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (269), Expect = 1e-26
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 15/186 (8%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFE 351
P + + + + + +G+G FG V + GN +A+K +DK +
Sbjct: 33 PSQNTAQLDQFDRIK---TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 352 RELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
E IL ++ +LV L ++ ++ +++ GG + L +
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAA 148
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
YLH S +I+RD+K N+L+D +V+DFG AK T + GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGT 201
Query: 472 FGYLAP 477
LAP
Sbjct: 202 PEALAP 207
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-26
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 297 YSSKDIIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDR 348
+ +++ K + +GSG +G V A+D G A+K++ + +E F +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE---RSEQLDWDA 405
REL +L ++H ++ L + DF + E+L D
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
++ KGL Y+H + IIHRD+K N+ ++ + E ++ DFGLA+ +S +T
Sbjct: 123 IQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMT 176
Query: 466 TIVAGTFGYLAP 477
V +
Sbjct: 177 GYVVTRWYRAPE 188
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 6e-25
Identities = 32/189 (16%), Positives = 79/189 (41%), Gaps = 20/189 (10%)
Query: 297 YSSKDIIKKLETLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFER 352
+ + + + DD + +G G + V++ + + + +K + + + + +R
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKR 78
Query: 353 ELEILGSIK-HRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEALHERSEQLDWDARLNI 409
E++IL +++ ++ L P S+ L+++ + + L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFY 134
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIV 468
+ K L Y H I+HRD+K N+++D + + R+ D+GLA+ + + +
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 189
Query: 469 AGTFGYLAP 477
+ + P
Sbjct: 190 VASRYFKGP 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 23/190 (12%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A D A+K++ + N+ + RE
Sbjct: 11 STFTVLKRYQNLK---PIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK------LLIYDFLPGGSLDEALHERSEQLDWDARL 407
L ++ + H+ +++L + L+ + + E D +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMS 122
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467
++ G+ +LH IIHRD+K SNI++ + ++ DFGLA+ S + T
Sbjct: 123 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 177
Query: 468 VAGTFGYLAP 477
T Y AP
Sbjct: 178 YVVTRYYRAP 187
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 4e-22
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 297 YSSKDIIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDR 348
+ +++ K + + + +GSG +G+V A D G A+K++ + + +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDW 403
REL +L +KH ++ L S + + L G L+ + ++L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTD 120
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
D +I +GL Y+H S IIHRD+K SN+ ++ + E ++ DFGLA+ +DE +
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 464 ITTIVAGTFGYLAP 477
T Y AP
Sbjct: 178 YVA----TRWYRAP 187
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 1e-17
Identities = 37/184 (20%), Positives = 60/184 (32%), Gaps = 23/184 (12%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G F TV+ A D + A+K + ++ + E E+++L +
Sbjct: 19 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 371 YCNSPTSKLLIY---------------DFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
+ KLL + + L L + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHIT-TIVAGTFG 473
GL Y+H C IIH DIK N+L++ + +A L T T
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 474 YLAP 477
Y +P
Sbjct: 195 YRSP 198
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 3e-17
Identities = 24/160 (15%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----------DRFFERELEILGSIKHR 363
++G G V+ + +K + F D F + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDE-ALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
L L+G +Y + L E + ++ + ++ + +A +H
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
I+H D+ N+L+ + DF + + +E
Sbjct: 122 RG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.9 bits (177), Expect = 8e-15
Identities = 54/163 (33%), Positives = 75/163 (46%), Gaps = 8/163 (4%)
Query: 31 SDGEALLSFRTAVVSSDGFLNQWRPE-DPDPCNWKGVKCDKN---KRVITLSLTNHKLSG 86
D +ALL + + + L+ W P D W GV CD + RV L L+ L
Sbjct: 6 QDKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 --PISADLGKLDQLKFLNLHSN-NFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNL 143
PI + L L L FL + N G IP + T+L L + +SG+IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ LD S N+LS +PPS+ L L+ N + GAIP
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.2 bits (165), Expect = 3e-13
Identities = 25/66 (37%), Positives = 37/66 (56%)
Query: 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203
NL LD+ +N + +P L +L+ L + NVS N L G IP G L +F S++ N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 204 LCGKQI 209
LCG +
Sbjct: 304 LCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 7e-11
Identities = 17/55 (30%), Positives = 25/55 (45%), Gaps = 1/55 (1%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
+L +N YG +P L L L++ N L G IP + GNL ++N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 4e-09
Identities = 22/87 (25%), Positives = 35/87 (40%), Gaps = 1/87 (1%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
Q + + K +K + L L N+++ G + L +L L LN+ NN G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIP 137
EIP + GN + +N P
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.6 bits (169), Expect = 2e-13
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L L +L L+ NN P + + T+LQ L +N +S S L NL+N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 155 SLSDYIPPSLGKLQRLITFNVSNN 178
+SD P L L R+ +++
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.2 bits (147), Expect = 1e-10
Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 26/134 (19%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP------------------ 113
+ L L N+++S L L +L L L +N P
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 114 --SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
S + N L L+L N +S P + +L+ L L ++N +SD SL L +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 172 TFNVSNNFLVGAIP 185
+ +N + P
Sbjct: 355 WLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 6/111 (5%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
R + K + +L TN+++S + L L+L+ N
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD 233
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP 161
L + T L L L +N +S P L L+ L L + +N +S+ P
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
L + L N + ++L T LQ L + G + L+NL ++ S+
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNF 179
N L+D P L L +L+ ++NN
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.1 bits (139), Expect = 6e-10
Identities = 24/152 (15%), Positives = 41/152 (26%), Gaps = 10/152 (6%)
Query: 61 CNWKGVKCDKN----------KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+K++ D L L L L +N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
P +L+ L L N L L L + + + L ++ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 171 ITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
+ + K S
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 18/112 (16%), Positives = 32/112 (28%), Gaps = 3/112 (2%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
+ L + G +L + + ++ +IP G +L L +
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 180
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205
N ++ SL L L +S N + T N L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 3/135 (2%)
Query: 48 GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADL--GKLDQLKFLNLHS 105
LNQ + K + L+ +++ + G L L+L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 180
Query: 106 NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLG 165
N + L L L L N +S L N +L L +++N L +P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLA 239
Query: 166 KLQRLITFNVSNNFL 180
+ + + NN +
Sbjct: 240 DHKYIQVVYLHNNNI 254
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 3e-08
Identities = 21/120 (17%), Positives = 39/120 (32%), Gaps = 9/120 (7%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
P+ + + + S I + L+ LN+ +N
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-I 297
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
E+P+ L+ L N+L+ +P NL L + N L + P ++ L
Sbjct: 298 ELPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDL 349
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 3e-07
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 5/106 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL LT L + G+L + +F + +E + +Q + L ++ +
Sbjct: 4 TLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 135 -SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++ L S L NL + LSD I +L K L+ N+S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 5e-07
Identities = 15/82 (18%), Positives = 28/82 (34%), Gaps = 9/82 (10%)
Query: 97 QLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGSIPSELG-----NLSNLL 147
L+ L L + + + L L+ L L +N L + +L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 148 NLDISSNSLSDYIPPSLGKLQR 169
L + S+ + L L++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 3e-06
Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 98 LKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDIS 152
++ L++ +EL + Q + L L+ I S L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 153 SNSLSDYIPPSLGKL 167
SN L D + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 1e-05
Identities = 19/89 (21%), Positives = 30/89 (33%), Gaps = 5/89 (5%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSN 130
+L + +LS + L L Q + + L I S L L L+L+SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDY 159
L + + I SL +
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 2e-05
Identities = 22/116 (18%), Positives = 38/116 (32%), Gaps = 10/116 (8%)
Query: 48 GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSG----PISADLGKLDQLKFLNL 103
++ R ED + L L + +S ++A L L+ L+L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 104 HSNNFYGEIPSELG-----NCTELQGLSLQSNYLSGSIPSELGNLS-NLLNLDISS 153
+N +L L+ L L Y S + L L + +L + S
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 5/65 (7%)
Query: 121 ELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNSLSD----YIPPSLGKLQRLITFNV 175
++Q L +Q LS + +EL L + + L++ I +L L N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 176 SNNFL 180
+N L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 9/78 (11%)
Query: 118 NCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR---- 169
+ L+ L L +S S+ + L +L LD+S+N L D L + R
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 170 -LITFNVSNNFLVGAIPS 186
L + + + +
Sbjct: 427 LLEQLVLYDIYWSEEMED 444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 4e-06
Identities = 23/126 (18%), Positives = 40/126 (31%), Gaps = 32/126 (25%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQG----------- 124
L L + L+ L +L + L+L N P+ L L+
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 125 -----------LSLQSNYL-SGSIPSELGNLSNLLNLDISSNSLSD------YIPPSLGK 166
L L +N L + L + L+ L++ NSL + L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 167 LQRLIT 172
+ ++T
Sbjct: 119 VSSILT 124
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 6e-06
Identities = 19/74 (25%), Positives = 31/74 (41%), Gaps = 4/74 (5%)
Query: 104 HSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS 163
N + L N ++L L N +S P L +L NL+ + + +N +SD P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 164 LGKLQRLITFNVSN 177
L L ++N
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 25/111 (22%), Positives = 38/111 (34%), Gaps = 1/111 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L +++S L L L LH N P + L L L +N LS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L L L L ++ N + L F S++ + ++P
Sbjct: 217 PTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
L++L L+ N + + + LQ S+ + S+P L +++N L
Sbjct: 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDL 281
Query: 157 S 157
Sbjct: 282 Q 282
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 2e-05
Identities = 22/99 (22%), Positives = 34/99 (34%), Gaps = 3/99 (3%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG--SIPSELGNLSNLLN 148
DL + LN ++ + N EL L+L +N L + S + NL
Sbjct: 37 DLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
L++S N L K +L + N L
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 1e-04
Identities = 14/79 (17%), Positives = 22/79 (27%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159
L L+ N + +N L S + LDIS +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 160 IPPSLGKLQRLITFNVSNN 178
L L++L + N
Sbjct: 217 PSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 6e-04
Identities = 10/112 (8%), Positives = 24/112 (21%), Gaps = 3/112 (2%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
+ + + + L L + + + + +NN
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP 162
+ L + + L NL L + +P
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 10/87 (11%), Positives = 26/87 (29%), Gaps = 5/87 (5%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISS 153
LK + + + + L ++ + L N + + + + +L + S
Sbjct: 10 LKLDAI-TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ L+ + L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 115 ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN 174
E+ ++ L+ ++P +L + L +S N L + +L RL N
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 175 VSNNF 179
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 3e-04
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150
++ K+ +N N +P +L + L L N L + L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 151 ISSNS 155
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 8e-04
Identities = 21/75 (28%), Positives = 27/75 (36%), Gaps = 1/75 (1%)
Query: 104 HSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS 163
N P L +L+ LSL +N L+ L L NL L + NSL IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 164 LGKLQRLITFNVSNN 178
L + N
Sbjct: 191 FFGSHLLPFAFLHGN 205
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 3e-04
Identities = 15/81 (18%), Positives = 26/81 (32%), Gaps = 4/81 (4%)
Query: 105 SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL 164
+ + N + L L+ + I + L +D S N +
Sbjct: 4 TAELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 165 GKLQRLITFNVSNNFLVGAIP 185
L+RL T V+NN +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGE 80
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.001
Identities = 21/115 (18%), Positives = 31/115 (26%), Gaps = 2/115 (1%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSN 154
L + + L L L +++ + L L NL I +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
L P + RL N+S N L E GN C +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.71 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.6 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.5 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.49 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.47 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.42 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.4 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.33 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.3 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.14 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.02 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.95 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.76 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.26 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.19 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=307.17 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=149.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999875 68999999997543 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc-
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~- 462 (484)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999653 569999999999999999999995 5999999999999999999999999999997754332
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......+||+.|||||++.+.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~ 180 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRR 180 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCS
T ss_pred ccccceeeCcCccCHhHhcCC
Confidence 223456799999999998653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-39 Score=303.77 Aligned_cols=173 Identities=26% Similarity=0.377 Sum_probs=143.6
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888999999998643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+|+|.+++......+++..+..|+.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999999998776779999999999999999999995 49999999999999999999999999999887654444344
Q ss_pred cccccccccCCcccCCC
Q 011486 467 IVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~~ 483 (484)
...||+.|||||++.++
T Consensus 161 ~~~gt~~y~aPE~l~~~ 177 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFS 177 (263)
T ss_dssp ----CTTSCCHHHHTTC
T ss_pred ceecCcccCChHHhcCC
Confidence 46799999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=304.10 Aligned_cols=171 Identities=25% Similarity=0.385 Sum_probs=152.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
++|+..+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999864 68999999998655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++|+|.+++.. ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+...... .
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence 99999998865 359999999999999999999995 59999999999999999999999999999987654332 3
Q ss_pred ecccccccccCCcccCCC
Q 011486 466 TIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~~ 483 (484)
...+||+.|||||++.++
T Consensus 174 ~~~~gt~~Y~aPE~~~~~ 191 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRK 191 (293)
T ss_dssp CCCCSCGGGCCHHHHSSS
T ss_pred cccccCCCccChhhhcCC
Confidence 445799999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=298.47 Aligned_cols=171 Identities=31% Similarity=0.505 Sum_probs=151.3
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 367899999999999999999875 68899999987432 33467789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999999764 569999999999999999999995 599999999999999999999999999998765432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|||||++.+.
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~ 179 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGR 179 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTC
T ss_pred ---ccccCCCCcccCHHHHcCC
Confidence 2346799999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=303.17 Aligned_cols=171 Identities=29% Similarity=0.439 Sum_probs=144.0
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||+||+|+.+ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999864 36999999753 34456789999999999999999999998754 56899999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc-
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~- 462 (484)
|+++|+|.++++.....+++..+..|+.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999998776779999999999999999999995 5999999999999999999999999999987754322
Q ss_pred ceeecccccccccCCcccCC
Q 011486 463 HITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.......||+.|||||++..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp -----CCCCGGGCCHHHHTT
T ss_pred ccccccccCcccCCHHHHhc
Confidence 22345679999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=304.28 Aligned_cols=171 Identities=26% Similarity=0.344 Sum_probs=151.8
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
+.|++.+.||+|+||+||+|+.. +++.||+|+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999875 68899999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCccee
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 465 (484)
++|+|.+++.+....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 9999999988776779999999999999999999995 4999999999999999999999999999986543211 12
Q ss_pred ecccccccccCCcccC
Q 011486 466 TIVAGTFGYLAPGKDC 481 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~ 481 (484)
....||+.|||||++.
T Consensus 168 ~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVM 183 (288)
T ss_dssp TCCCSCCTTCCHHHHT
T ss_pred cccccccccCCHHHHh
Confidence 3457999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-38 Score=305.56 Aligned_cols=178 Identities=24% Similarity=0.350 Sum_probs=154.9
Q ss_pred HHHHhcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 302 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++...++|+..+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|++++++++|||||++++++.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567888999999999999999876 588899999976433 45679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
||||+++|+|.+++... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999753 3458999999999999999999995 4999999999999999999999999999998766
Q ss_pred CCcceeecccccccccCCcccCCC
Q 011486 460 EESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
..........||+.|||||++.++
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~ 191 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYN 191 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHC
T ss_pred CCceeeccccccccccChHHHcCC
Confidence 554444455689999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=302.36 Aligned_cols=173 Identities=27% Similarity=0.404 Sum_probs=150.6
Q ss_pred HhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 3467888999999999999999998888999999976443 35679999999999999999999998754 567999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.+++.... ..+++..+++|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+.+....
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999999886532 348999999999999999999995 49999999999999999999999999999988765444
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
......||+.|||||++.+
T Consensus 166 ~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHH
T ss_pred cccccCCcccccChHHHhC
Confidence 4445679999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-38 Score=307.27 Aligned_cols=172 Identities=28% Similarity=0.437 Sum_probs=150.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.++|++.+.||+|+||+||+|... +++.||+|+++.. .....+++.+|++++++++|||||+++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999875 6899999999754 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++|+|.+++.+. +.+++..+..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+|+.+.+..
T Consensus 85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999999999765 5699999999999999999999951 389999999999999999999999999999765322
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+||+.|||||++.+.
T Consensus 160 -~~~~~GT~~Y~APEvl~~~ 178 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGT 178 (322)
T ss_dssp -C---CCSSCCCCHHHHHCS
T ss_pred -cccccCCccccCchHHcCC
Confidence 2346799999999998653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-37 Score=301.27 Aligned_cols=174 Identities=30% Similarity=0.467 Sum_probs=138.3
Q ss_pred cCCCccceeeeccceeEEEEEecC-C---CEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|+..+.||+|+||+||+|..+. + ..||||++... .....++|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345667899999999999998753 2 25889988754 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++......+++.++..|+.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999999998776779999999999999999999995 599999999999999999999999999999876433
Q ss_pred cce----eecccccccccCCcccCCC
Q 011486 462 SHI----TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~----~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .....||+.|||||++.++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 208 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYR 208 (299)
T ss_dssp -------------CGGGSCHHHHHSC
T ss_pred CcceeeecccccCCccccCHHHHhcC
Confidence 221 1224579999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=298.47 Aligned_cols=173 Identities=25% Similarity=0.383 Sum_probs=148.6
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 382 (484)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 68999999997532 234567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~ 462 (484)
||+++|+|.+++... +.+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999998765 569999999999999999999995 5999999999999999999999999999998764332
Q ss_pred -ceeecccccccccCCcccCCC
Q 011486 463 -HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 -~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......+||+.|||||++.+.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~ 185 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEK 185 (288)
T ss_dssp ------CCCCGGGCCHHHHHTC
T ss_pred ccccccccCCccccCceeeccC
Confidence 223446799999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=296.18 Aligned_cols=177 Identities=25% Similarity=0.448 Sum_probs=138.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 380 (484)
.++|++.+.||+|+||+||+|+.. +|+.||+|.++... +...+.+.+|++++++++||||+++++++.+ ++..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999865 68999999997543 4456779999999999999999999999865 456799
Q ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 381 IYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 3456999999999999999999999641 1359999999999999999999999999999
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.+..... ......||+.|||||++.++
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~ 189 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRM 189 (269)
T ss_dssp HC------------CCCSCCCHHHHTTC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCC
Confidence 8765432 23456799999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=291.05 Aligned_cols=172 Identities=23% Similarity=0.333 Sum_probs=154.7
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 386 (484)
++|+..+.||+|+||+||+|+.++++.||||+++.... ..+.|.+|++++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999986443 35789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcceee
Q 011486 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (484)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 466 (484)
+|+|.+++......+++..+.+++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999988777779999999999999999999995 59999999999999999999999999999877655444444
Q ss_pred cccccccccCCcccCC
Q 011486 467 IVAGTFGYLAPGKDCT 482 (484)
Q Consensus 467 ~~~Gt~~Y~APE~~~~ 482 (484)
...||+.|+|||++..
T Consensus 160 ~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMY 175 (258)
T ss_dssp CSCCCGGGCCHHHHHH
T ss_pred ccCCCCCcCCcHHhcC
Confidence 5679999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-37 Score=301.98 Aligned_cols=173 Identities=27% Similarity=0.480 Sum_probs=154.4
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999875 6899999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~~~kl~DFGla~~~~~~~~ 462 (484)
+++|+|.+++....+.+++..+..|+.||+.||+|||+ .+||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999999997666679999999999999999999995 5999999999999996 467899999999998765433
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|||||++.+.
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTC
T ss_pred --cceecCcccccCHHHHcCC
Confidence 3345799999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=298.24 Aligned_cols=173 Identities=24% Similarity=0.337 Sum_probs=152.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999874 79999999997532 23457789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999999765 568999999999999999999995 599999999999999999999999999999765433
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. .....+||+.|||||++.+.
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~ 180 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSS
T ss_pred c-ccccceeCHHHhhhhhccCC
Confidence 2 23456799999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-36 Score=298.98 Aligned_cols=173 Identities=27% Similarity=0.399 Sum_probs=154.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999864 6999999999876655677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc--CCCcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~--~~~~~kl~DFGla~~~~~~~~ 462 (484)
+++|+|.+++......+++.++..|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999987766679999999999999999999995 4999999999999998 678999999999998865433
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|||||++.+.
T Consensus 185 --~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTC
T ss_pred --eeeccCcccccCHHHHcCC
Confidence 3345699999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-36 Score=286.90 Aligned_cols=168 Identities=27% Similarity=0.369 Sum_probs=142.4
Q ss_pred CccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCceEEEE
Q 011486 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIY 382 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 382 (484)
+..+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999876 5889999998753 34456789999999999999999999999865 34578999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc-CCCcEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~ 461 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+......
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 999999999999765 5699999999999999999999964 23499999999999996 58899999999998654432
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
....+||+.|||||++.+
T Consensus 170 ---~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 170 ---AKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp ---BEESCSSCCCCCGGGGGT
T ss_pred ---cCCcccCccccCHHHhCC
Confidence 335679999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-36 Score=295.16 Aligned_cols=166 Identities=27% Similarity=0.384 Sum_probs=145.7
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
.|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999865 68899999997543 2344678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+++|++..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999998766654 4679999999999999999999995 49999999999999999999999999999876542
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|||||++.+
T Consensus 169 --~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp --CCCCSCGGGCCHHHHTT
T ss_pred --CccccCccccCHHHHhc
Confidence 23569999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=291.43 Aligned_cols=174 Identities=28% Similarity=0.468 Sum_probs=142.8
Q ss_pred cCCCccceeeeccceeEEEEEecCC-----CEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDG-----NVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
+.|+..++||+|+||.||+|.+++. ..||||+++... +....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999987642 369999997543 4455679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||++++++.+++......+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999998777789999999999999999999995 59999999999999999999999999999977543
Q ss_pred Ccc--eeecccccccccCCcccCCC
Q 011486 461 ESH--ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~--~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... ......||+.|||||++..+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~ 188 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYR 188 (283)
T ss_dssp ----------CCCGGGSCHHHHHSC
T ss_pred CccceEeccCCCCccccCHHHHccC
Confidence 222 22335689999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-36 Score=293.84 Aligned_cols=170 Identities=28% Similarity=0.437 Sum_probs=150.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 467999999999999999999875 68999999997532 23457799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999999988654 56899999999999999999999 5699999999999999999999999999999875432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....||+.|||||++.+.
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~ 176 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTK 176 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTC
T ss_pred ----ccccCcccccCHHHHcCC
Confidence 346799999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-36 Score=290.71 Aligned_cols=172 Identities=25% Similarity=0.407 Sum_probs=146.4
Q ss_pred cCCCccce-eeeccceeEEEEEec---CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHI-IGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|...+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45555664 999999999999764 34579999997643 4456789999999999999999999999875 468999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999999987766779999999999999999999995 599999999999999999999999999999876543
Q ss_pred cce--eecccccccccCCcccCC
Q 011486 462 SHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|||||++.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~ 186 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINF 186 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHH
T ss_pred cccccccccccCccccChHHHhC
Confidence 322 224568999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-36 Score=295.61 Aligned_cols=171 Identities=29% Similarity=0.435 Sum_probs=133.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
+.|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56889999999999999999875 68999999997543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEc---CCCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~---~~~~~kl~DFGla~~~~~~~ 461 (484)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+. +++.+||+|||+|+......
T Consensus 89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999754 569999999999999999999995 5999999999999994 57899999999998765433
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
. ....+||+.|||||++.++
T Consensus 165 ~--~~~~~GT~~y~APE~~~~~ 184 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVLAQK 184 (307)
T ss_dssp ----------CTTSCHHHHTTC
T ss_pred e--eeeeeeCccccCcHHHcCC
Confidence 2 2346799999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=292.43 Aligned_cols=173 Identities=25% Similarity=0.404 Sum_probs=143.5
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 385 (484)
.++|++.+.||+|+||+||+|..++++.||||+++.... ..+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 467999999999999999999999888999999976543 3578999999999999999999999985 45689999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++|+|.+++... ...++|.+++.|+.||+.||+|||++ +|+||||||+||||++++++||+|||+|+.+.+.....
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999998753 34599999999999999999999964 99999999999999999999999999999876544433
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||++..+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~ 189 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYG 189 (285)
T ss_dssp -----CCGGGSCHHHHHHC
T ss_pred eccccccccccChHHHhCC
Confidence 4446699999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=284.55 Aligned_cols=171 Identities=29% Similarity=0.399 Sum_probs=149.7
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC------hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
+.|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999875 68999999986432 223678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC----cEEEEecCCCc
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~----~~kl~DFGla~ 455 (484)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999765 469999999999999999999995 4999999999999998776 49999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....... .....||+.|||||++.+.
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~ 191 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYE 191 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTC
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCC
Confidence 8765432 2345689999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-36 Score=292.52 Aligned_cols=175 Identities=23% Similarity=0.395 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEecC-C-----CEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-G-----NVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 377 (484)
.++|++.+.||+|+||+||+|+... + ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678889999999999999998653 2 368999986533 34456789999999998 89999999999999999
Q ss_pred eEEEEEcCCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 011486 378 KLLIYDFLPGGSLDEALHERS----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp 435 (484)
.++||||+++|+|.++++.+. ..+++..++.|+.||+.||+|||+ .+||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 999999999999999997643 238999999999999999999995 5999999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 436 SNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 436 ~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
+|||++.++.+||+|||+|+......... .....||+.|||||++.++
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 241 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC
Confidence 99999999999999999998776543322 2345689999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=282.87 Aligned_cols=165 Identities=25% Similarity=0.401 Sum_probs=138.5
Q ss_pred ceeeeccceeEEEEEecC---CCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEcCCC
Q 011486 313 HIIGSGGFGTVYKLAMDD---GNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (484)
Q Consensus 313 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 387 (484)
+.||+|+||+||+|.+++ ++.||||+++.. .....++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999997653 467999999753 23446789999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce--e
Q 011486 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI--T 465 (484)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~ 465 (484)
|+|.++++.. ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999754 569999999999999999999995 499999999999999999999999999999876543322 2
Q ss_pred ecccccccccCCcccCC
Q 011486 466 TIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 466 ~~~~Gt~~Y~APE~~~~ 482 (484)
....||+.|||||++..
T Consensus 168 ~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 168 THGKWPVKWYAPECINY 184 (277)
T ss_dssp ---CCCGGGCCHHHHHH
T ss_pred cccCCCceecCchhhcC
Confidence 33568999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-35 Score=291.44 Aligned_cols=170 Identities=25% Similarity=0.362 Sum_probs=150.9
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 381 (484)
.++|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 367999999999999999999875 69999999986432 23456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+.+|+|.+++... +.+++..+..|+.||+.||.|||+ .+||||||||+|||++.++.+||+|||+|+.+....
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999999765 469999999999999999999995 499999999999999999999999999999876432
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....||+.|||||++.+.
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~ 213 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSK 213 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTC
T ss_pred ----ccccCccccCCHHHHcCC
Confidence 345799999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-35 Score=290.12 Aligned_cols=171 Identities=27% Similarity=0.410 Sum_probs=146.2
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHH---HHHHHHhcCCCCceeeeEEEEEcCCce
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFE---RELEILGSIKHRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 378 (484)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+. +|+++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999875 68999999986422 11223333 457778888999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999765 568999999999999999999995 599999999999999999999999999999776
Q ss_pred CCCcceeecccccccccCCcccCCC
Q 011486 459 DEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
... .....||+.|||||++..+
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~ 180 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKG 180 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTT
T ss_pred CCc---ccccccccccchhHHhhcC
Confidence 543 2345799999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-35 Score=278.72 Aligned_cols=169 Identities=28% Similarity=0.423 Sum_probs=149.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---------hhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcC
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---------EGFDRFFERELEILGSIK-HRYLVNLRGYCNSP 375 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 375 (484)
++|++.+.||+|+||+||+|+.. +++.||||+++... +...+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68899999999999999999874 68899999986532 123456889999999997 99999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCc
Q 011486 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~ 455 (484)
+..|+||||+++|+|.++++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999765 5699999999999999999999954 99999999999999999999999999999
Q ss_pred ccCCCCcceeecccccccccCCcccC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDC 481 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~ 481 (484)
.+.+... .....||+.|+|||++.
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIE 182 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhh
Confidence 8765432 23467999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=282.23 Aligned_cols=174 Identities=24% Similarity=0.331 Sum_probs=137.6
Q ss_pred hcCCCccceeeeccceeEEEEEecC----CCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
.++|++.+.||+|+||.||+|.... +..||||.++... ....+.|.+|++++++++||||+++++++. ++..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998653 3468999987543 445678999999999999999999999985 567899
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
||||+++|+|.+++......+++..++.++.||++||+|||+ .+|+||||||+||++++++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 999999999999988777779999999999999999999995 59999999999999999999999999999987654
Q ss_pred CcceeecccccccccCCcccCCC
Q 011486 461 ESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.........||+.|+|||++..+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~ 184 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFR 184 (273)
T ss_dssp ---------CCGGGCCHHHHHHC
T ss_pred cceeccceecCcccchhhHhccC
Confidence 44444556789999999997643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=282.33 Aligned_cols=172 Identities=20% Similarity=0.336 Sum_probs=150.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
.++|++.+.||+|+||+||+|... +++.||+|.++.... ....+.+|++++++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999875 688999999986543 356688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCC--CcEEEEecCCCcccCCCCc
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN--LEARVSDFGLAKLLEDEES 462 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~--~~~kl~DFGla~~~~~~~~ 462 (484)
+++|+|.+++......+++.++..|+.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999998766679999999999999999999995 599999999999999854 4899999999988755432
Q ss_pred ceeecccccccccCCcccCCC
Q 011486 463 HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 463 ~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.....||+.|+|||.+.+.
T Consensus 160 --~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTC
T ss_pred --ccccccccccccchhccCC
Confidence 3345689999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-35 Score=283.36 Aligned_cols=172 Identities=24% Similarity=0.378 Sum_probs=148.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHh-cCCCCceeeeEEEEEcCCceEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILG-SIKHRYLVNLRGYCNSPTSKLLI 381 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 381 (484)
++|++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999876 68999999997532 233456677777765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCC
Q 011486 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~ 461 (484)
|||+++|+|.++++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999765 568999999999999999999995 499999999999999999999999999998765433
Q ss_pred cceeecccccccccCCcccCCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. .....||+.|+|||++.++
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 158 AK-TNTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTC
T ss_pred cc-ccccCCCCCcCCHHHHcCC
Confidence 32 3445799999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=284.55 Aligned_cols=173 Identities=27% Similarity=0.430 Sum_probs=143.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCC----EEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 380 (484)
++|++.+.||+|+||+||+|... +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46889999999999999999865 343 5889988753 344567899999999999999999999999875 5678
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
++||+.+|+|.+++......+++..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 899999999999998877789999999999999999999995 59999999999999999999999999999987654
Q ss_pred Ccce-eecccccccccCCcccCCC
Q 011486 461 ESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 461 ~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....||+.|||||++.++
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~ 188 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHR 188 (317)
T ss_dssp CC--------CCTTTSCHHHHHHC
T ss_pred cccccccccccCccccChHHHhcC
Confidence 3322 2345689999999987643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-35 Score=282.09 Aligned_cols=185 Identities=26% Similarity=0.376 Sum_probs=143.6
Q ss_pred CCCHHHHHHHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceee
Q 011486 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVN 367 (484)
Q Consensus 296 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~ 367 (484)
|++..+++...++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|.+.+.++ +|+||+.
T Consensus 2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 4555555555678999999999999999999864 34689999997543 44566788888888877 6899999
Q ss_pred eEEEEEcCC-ceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 011486 368 LRGYCNSPT-SKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431 (484)
Q Consensus 368 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHr 431 (484)
+++++.+++ ..++||||+++|+|.++++... ..+++..+..++.||+.||+|||+ ++|+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCC
Confidence 999987654 5799999999999999997532 248899999999999999999995 599999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 432 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
||||+|||+++++.+||+|||+|+........ ......||+.|||||++.++
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 211 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC
Confidence 99999999999999999999999876543322 23346799999999987643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-35 Score=282.88 Aligned_cols=179 Identities=23% Similarity=0.396 Sum_probs=150.8
Q ss_pred HHHHHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEE
Q 011486 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (484)
Q Consensus 301 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 373 (484)
+++...++|++.+.||+|+||+||+|+.+ +++.||||+++... ....++|.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33444678999999999999999999864 35789999997643 445678999999999999999999999999
Q ss_pred cCCceEEEEEcCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 011486 374 SPTSKLLIYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (484)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH 430 (484)
..+..++||||+++|+|.++++... ..+++..++.|+.|++.||+|||+ .+|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 9999999999999999999996432 238899999999999999999995 59999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCC
Q 011486 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 431 rDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~ 482 (484)
|||||+|||++.++.+||+|||+|+.+.+.... ......||+.|||||++..
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 999999999999999999999999876543322 2334568999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-34 Score=274.93 Aligned_cols=173 Identities=24% Similarity=0.388 Sum_probs=141.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC---hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCc----e
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----K 378 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 378 (484)
++|++.+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56899999999999999999864 78999999997532 3445679999999999999999999999876543 7
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccC
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~ 458 (484)
|+||||+++++|.+++... +.+++.++..++.||+.||+|||+ .+|+||||||+|||++.++..+|+|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 8999999999999998765 569999999999999999999995 499999999999999999999999999988664
Q ss_pred CCCc--ceeecccccccccCCcccCCC
Q 011486 459 DEES--HITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 459 ~~~~--~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... ......+||+.|||||++.++
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 189 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGD 189 (277)
T ss_dssp ----------------TTCCHHHHTTC
T ss_pred cccccccccccccCcccccCHHHHcCC
Confidence 3222 223446799999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=279.33 Aligned_cols=172 Identities=27% Similarity=0.367 Sum_probs=144.2
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|++.+.||+|+||+||+|.. .+++.||||+++... +...+++.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 468999999996533 2235678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+.++.+..........+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 997644443334445669999999999999999999995 49999999999999999999999999999877543322
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....||+.|+|||.+..
T Consensus 159 -~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTT
T ss_pred -ceeecccceeeehhhhcc
Confidence 234569999999998654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=278.73 Aligned_cols=168 Identities=29% Similarity=0.380 Sum_probs=139.9
Q ss_pred ccceeeeccceeEEEEEec-CCCEEEEEEecccCh-----hHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 311 DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 311 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
..++||+|+||+||+|... +++.||||+++.... ...+.+.+|++++++++|||||++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 689999999975321 1234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
++++++..+. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 9887666555 444669999999999999999999995 59999999999999999999999999999877654322
Q ss_pred eecccccccccCCcccCCC
Q 011486 465 TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+||+.|||||++..+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGA 175 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTC
T ss_pred ccceecChhhccHHHHccC
Confidence 2345699999999997643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=276.71 Aligned_cols=172 Identities=28% Similarity=0.380 Sum_probs=140.1
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----ceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 382 (484)
.+|...+.||+|+||.||+|+. +|+.||||+++.... .....+.|+..+..++||||+++++++.+++ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566788999999999999986 588999999975432 2223344555667789999999999997654 478999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
||+++|+|.++++.. .++|..+.+++.|++.||+|+|+. ..++|+||||||+||||++++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999764 589999999999999999999953 1369999999999999999999999999999987
Q ss_pred CCCCcce---eecccccccccCCcccCC
Q 011486 458 EDEESHI---TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~---~~~~~Gt~~Y~APE~~~~ 482 (484)
....... .....||+.|||||++..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred cCCCcceeccccceecccCcCChhhccc
Confidence 5543322 234679999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=272.81 Aligned_cols=168 Identities=26% Similarity=0.380 Sum_probs=137.1
Q ss_pred hcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCceEEEEEc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYDF 384 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 384 (484)
.++|+..+.||+|+||.||+|+.+ |..||||+++... ..+.|.+|++++++++||||++++|++.+ ++..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456788899999999999999985 7789999997643 45779999999999999999999999865 4568999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
+++|+|.+++..+. ..+++..+++|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 99999999997542 348999999999999999999995 599999999999999999999999999998765432
Q ss_pred eeecccccccccCCcccCCC
Q 011486 464 ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~~ 483 (484)
....+|+.|+|||++.++
T Consensus 158 --~~~~~~~~y~aPE~l~~~ 175 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREK 175 (262)
T ss_dssp ------CCTTTSCHHHHHHC
T ss_pred --ccccccccCCChHHHhCC
Confidence 234589999999987643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=272.88 Aligned_cols=172 Identities=27% Similarity=0.387 Sum_probs=137.4
Q ss_pred cCCCccceeeeccceeEEEEEecC--C--CEEEEEEeccc---ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDD--G--NVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 379 (484)
++|++.+.||+|+||.||+|+... + ..||||++++. .....++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999997642 2 36899998753 23445789999999999999999999999965 4678
Q ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCC
Q 011486 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (484)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~ 459 (484)
+||||+++|++.+++..+...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.+..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999988776779999999999999999999995 5999999999999999999999999999998765
Q ss_pred CCcce--eecccccccccCCcccCC
Q 011486 460 EESHI--TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 460 ~~~~~--~~~~~Gt~~Y~APE~~~~ 482 (484)
..... .....||..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH
T ss_pred CCCcceecCccccCcccCCHHHHhC
Confidence 43322 223468899999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-33 Score=274.66 Aligned_cols=169 Identities=25% Similarity=0.409 Sum_probs=143.9
Q ss_pred cceeeeccceeEEEEEecCC----CEEEEEEeccc-ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCceEEEEEcC
Q 011486 312 DHIIGSGGFGTVYKLAMDDG----NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYDFL 385 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 385 (484)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987542 25899999753 45556889999999999999999999999875 45789999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc--
Q 011486 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-- 463 (484)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 463 (484)
++|+|.++++......++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998777778999999999999999999995 59999999999999999999999999999977543322
Q ss_pred -eeecccccccccCCcccCCC
Q 011486 464 -ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 464 -~~~~~~Gt~~Y~APE~~~~~ 483 (484)
......||+.|+|||.+.++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~ 209 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQ 209 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHC
T ss_pred eecccccccccccChHHHhcC
Confidence 12235689999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-34 Score=278.38 Aligned_cols=167 Identities=25% Similarity=0.343 Sum_probs=140.9
Q ss_pred hcCCCccc-eeeeccceeEEEEEe-cCCCEEEEEEecccChhHHHHHHHHHHHHhc-CCCCceeeeEEEEEc----CCce
Q 011486 306 LETLDDDH-IIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGS-IKHRYLVNLRGYCNS----PTSK 378 (484)
Q Consensus 306 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 378 (484)
.++|.+.+ +||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46787764 699999999999986 46899999999653 457789998765 489999999999865 3568
Q ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCC
Q 011486 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLA 454 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla 454 (484)
|+|||||++|+|.+++..+. ..+++.++..|+.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 99999999999999997653 459999999999999999999995 59999999999999985 567999999999
Q ss_pred cccCCCCcceeecccccccccCCcccCC
Q 011486 455 KLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+....... .....||+.|||||++.+
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCG
T ss_pred eeccCCCc--cccccCCcccCCcHHHcC
Confidence 97765432 234579999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-33 Score=271.12 Aligned_cols=171 Identities=29% Similarity=0.403 Sum_probs=145.0
Q ss_pred cCCCccceeeeccceeEEEEEecCCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|+..+.||+|+||+||+|+.++++.||||+++... +...+++.+|+.++++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6889999999999999999999999999999997543 33357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcce
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 464 (484)
+.++.+..+. .....+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||.|.........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence 9776555554 445679999999999999999999995 49999999999999999999999999999877543322
Q ss_pred eecccccccccCCcccCC
Q 011486 465 TTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 465 ~~~~~Gt~~Y~APE~~~~ 482 (484)
.....|++.|+|||.+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMG 174 (286)
T ss_dssp -----CCCTTCCHHHHTT
T ss_pred cceecccchhhhHHHHhC
Confidence 234468999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=274.35 Aligned_cols=177 Identities=18% Similarity=0.306 Sum_probs=150.0
Q ss_pred HHhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Q 011486 304 KKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (484)
Q Consensus 304 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 376 (484)
...++|+..+.||+|+||.||+|.+. ++..||||+++... ......|.+|++++++++||||+++++++..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33578888999999999999999763 35789999997543 445567999999999999999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEE
Q 011486 377 SKLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~k 447 (484)
..++||||+++|+|.+++.... ..+++..+.+++.|+++||.|||+ .+|+||||||+|||+++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEE
Confidence 9999999999999999986421 237899999999999999999995 4999999999999999999999
Q ss_pred EEecCCCcccCCCCcce-eecccccccccCCcccCCC
Q 011486 448 VSDFGLAKLLEDEESHI-TTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 448 l~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~ 483 (484)
|+|||+|+......... .....||+.|+|||.+.++
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~ 210 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence 99999998775433222 2334689999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-34 Score=275.50 Aligned_cols=172 Identities=28% Similarity=0.446 Sum_probs=143.0
Q ss_pred hcCCCccceeeeccceeEEEEEecC-CC--EEEEEEeccc-ChhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCCceEE
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD-GN--VFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 380 (484)
.++|+..+.||+|+||.||+|.+++ +. .||||+++.. .....+.|.+|+++++++ +||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 4688889999999999999998764 33 4778887643 233456799999999999 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCc
Q 011486 381 IYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~ 445 (484)
||||+++|+|.++++.. ...+++..+.+++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 99999999999999743 2459999999999999999999995 59999999999999999999
Q ss_pred EEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+||+|||+|+....... .....||..|+|||.+..
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHH
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhcc
Confidence 99999999986654322 234568999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=273.18 Aligned_cols=176 Identities=26% Similarity=0.372 Sum_probs=151.3
Q ss_pred HhcCCCccceeeeccceeEEEEEec------CCCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcCC
Q 011486 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (484)
Q Consensus 305 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 376 (484)
..++|+..+.||+|+||.||+|+.. +++.||||+++... ......|.+|+++++++ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468888999999999999999752 45789999998643 44566799999999999 6999999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEE
Q 011486 377 SKLLIYDFLPGGSLDEALHERS-----------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NIL 439 (484)
..++||||+++|+|.++++... ..+++..+..++.||+.||+|||++ +||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 9999999999999999997532 2489999999999999999999954 9999999999999
Q ss_pred EcCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 440 LDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 440 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
++.++.+||+|||+++........ ......||+.|+|||++.++
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 222 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence 999999999999999987654332 23456799999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-34 Score=271.40 Aligned_cols=169 Identities=27% Similarity=0.314 Sum_probs=143.2
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC------hhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCCc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN------EGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 377 (484)
++|++.+.||+|+||+||+|... +++.||||+++... .....++.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 47889999999999999999875 68999999986432 112234678999999986 8999999999999999
Q ss_pred eEEEEEcCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-CCcEEEEecCCCc
Q 011486 378 KLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAK 455 (484)
Q Consensus 378 ~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-~~~~kl~DFGla~ 455 (484)
.++||||+++ +++.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 6788888654 569999999999999999999995 59999999999999985 4799999999998
Q ss_pred ccCCCCcceeecccccccccCCcccCC
Q 011486 456 LLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 456 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... .....||+.|||||++.+
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHH
T ss_pred eccccc---ccccccCCCcCCHHHHcC
Confidence 765432 234679999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-33 Score=270.10 Aligned_cols=175 Identities=26% Similarity=0.361 Sum_probs=144.3
Q ss_pred hcCCCccceeeeccceeEEEEEecC--------CCEEEEEEecccC-hhHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 375 (484)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999997542 2479999997644 34567888999999888 799999999999999
Q ss_pred CceEEEEEcCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEE
Q 011486 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (484)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl 440 (484)
+..++||||+++|+|.+++..+. ..+++.++++++.||+.||+|||+ .+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 348999999999999999999995 599999999999999
Q ss_pred cCCCcEEEEecCCCcccCCCCcc-eeecccccccccCCcccCCC
Q 011486 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 441 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+.++.+||+|||+++........ ......||+.|+|||++.++
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~ 212 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC
Confidence 99999999999999977543322 23446789999999988653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-32 Score=268.47 Aligned_cols=171 Identities=26% Similarity=0.428 Sum_probs=141.4
Q ss_pred cCCCccceeeeccceeEEEEEe-cCCCEEEEEEecccC-hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC----ceEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLL 380 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 380 (484)
++|++.+.||+|+||+||+|.. .+++.||||++++.. ....+++.+|+++|++++||||+++++++..+. ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688899999999999999976 479999999997643 445678999999999999999999999997653 2355
Q ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCC
Q 011486 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (484)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~ 460 (484)
+++|+.+|+|.+++..+ .+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 56677799999999653 599999999999999999999954 9999999999999999999999999999876543
Q ss_pred Ccc--eeecccccccccCCcccCC
Q 011486 461 ESH--ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 461 ~~~--~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....+||+.|+|||++..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred CccceeeccccccceechHHHhhc
Confidence 221 1234569999999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.1e-32 Score=268.29 Aligned_cols=184 Identities=35% Similarity=0.606 Sum_probs=159.6
Q ss_pred CCCcchHHHHHHHHHhccCCCCCCCCCCCCCCCCC--CcceeeeCCC---CcEEEEeeCCCcccc--ccCcCcCCCCCCC
Q 011486 27 RAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPC--NWKGVKCDKN---KRVITLSLTNHKLSG--PISADLGKLDQLK 99 (484)
Q Consensus 27 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c--~w~gv~C~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~ 99 (484)
-|.+.|++||++||+++.+|. .+++|.. +.||| .|+||+|+.. .||+.|+|++|+++| .+|+++++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 377899999999999998875 6899985 46999 5999999843 379999999999998 5889999999999
Q ss_pred EEEccc-CcccccCCcccCCccccceecccccccCCC-------------------------------------------
Q 011486 100 FLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGS------------------------------------------- 135 (484)
Q Consensus 100 ~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~------------------------------------------- 135 (484)
+|+|++ |+++|.+|..|++|++|++|||++|+|++.
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 899999999999999999999988876421
Q ss_pred -----C-----------------------------------------------------------------------Chh
Q 011486 136 -----I-----------------------------------------------------------------------PSE 139 (484)
Q Consensus 136 -----~-----------------------------------------------------------------------p~~ 139 (484)
+ +..
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0 122
Q ss_pred hhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcccccc
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTC 213 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~~~~c 213 (484)
++.+++|+.|+|++|+|+|.+|.+|+++++|++|||++|+|+|.+|.++.+++|+.+++.+|+.+||.|++ .|
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 34456788889999999999999999999999999999999999998889999999999999999998875 55
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=266.01 Aligned_cols=173 Identities=26% Similarity=0.385 Sum_probs=140.5
Q ss_pred hcCCCccceeeeccceeEEEEEec-C-CCEEEEEEecccC--hhHHHHHHHHHHHHhcC---CCCceeeeEEEEEc----
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-D-GNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNS---- 374 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 374 (484)
.++|++.+.||+|+||+||+|+.. + ++.||||+++... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999864 4 5678999986432 22233466777776655 79999999999853
Q ss_pred -CCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCC
Q 011486 375 -PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (484)
Q Consensus 375 -~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGl 453 (484)
....+++|||++++++..........+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 245789999998887766665566679999999999999999999995 4999999999999999999999999999
Q ss_pred CcccCCCCcceeecccccccccCCcccCCC
Q 011486 454 AKLLEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 454 a~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
++...... ......||+.|||||++.+.
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~ 190 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQS 190 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTC
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCC
Confidence 98665432 23446799999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=7.5e-32 Score=259.86 Aligned_cols=171 Identities=19% Similarity=0.257 Sum_probs=145.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+|++.++.++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46889999999999999999865 688999998865332 2457789999999975 8999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC-----CCcEEEEecCCCcccCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLED 459 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~-----~~~~kl~DFGla~~~~~ 459 (484)
+ +++|.+++......+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 78999999877677999999999999999999999 569999999999999974 57899999999997754
Q ss_pred CCcc------eeecccccccccCCcccCCC
Q 011486 460 EESH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 460 ~~~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.... .....+||+.|||||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~ 188 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGR 188 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred CccccceeecccCceEEchhhcCHHHhcCC
Confidence 3211 12346799999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-32 Score=265.72 Aligned_cols=166 Identities=29% Similarity=0.429 Sum_probs=138.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------c
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------S 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 377 (484)
++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57888999999999999999865 6999999999753 3445678899999999999999999999997765 4
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||+ +.+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+|+..
T Consensus 98 ~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 6688887754 459999999999999999999995 49999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... +...||+.|+|||++.+
T Consensus 172 ~~~~----~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 172 DSEM----TGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CSSC----CSSCSCGGGCCTHHHHT
T ss_pred CCcc----ccccccccccCHHHHcC
Confidence 5432 34569999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1.2e-31 Score=262.82 Aligned_cols=164 Identities=18% Similarity=0.335 Sum_probs=141.1
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcC--CceEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSP--TSKLLIY 382 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 382 (484)
++|++.+.||+|+||+||+|+.. +++.||||+++... .+++.+|+++|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999874 68999999997643 467889999999995 99999999999754 4689999
Q ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCcccCCCC
Q 011486 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (484)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~ 461 (484)
||+++++|.++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+...+..
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999987764 358999999999999999999995 5999999999999998655 69999999998776543
Q ss_pred cceeecccccccccCCcccCC
Q 011486 462 SHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 462 ~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
. .....||+.|+|||.+..
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVD 203 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTT
T ss_pred c--ccccccCccccCcccccC
Confidence 2 234568999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=256.09 Aligned_cols=171 Identities=26% Similarity=0.369 Sum_probs=149.0
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCceEEEEE
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 383 (484)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+++.++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 67999999999999999999875 6889999998643 24456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcccCCCCcc
Q 011486 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (484)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 463 (484)
|+.++++..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.|+........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999888887754 4668999999999999999999995 49999999999999999999999999999987654332
Q ss_pred eeecccccccccCCcccCC
Q 011486 464 ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 464 ~~~~~~Gt~~Y~APE~~~~ 482 (484)
.....+++.|+|||.+..
T Consensus 158 -~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTT
T ss_pred -ceeeccccchhhhhHhcc
Confidence 233457899999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=265.25 Aligned_cols=166 Identities=31% Similarity=0.436 Sum_probs=136.2
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------CceEE
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TSKLL 380 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 380 (484)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|++++++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999876 689999999976432 235799999999999999999998543 23689
Q ss_pred EEEcCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC-cEEEEecCCCccc
Q 011486 381 IYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLL 457 (484)
Q Consensus 381 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~-~~kl~DFGla~~~ 457 (484)
||||++++.+..+.+ .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998654443332 23456999999999999999999999 56999999999999999775 8999999999887
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
...... ....||+.|+|||.+..
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~ 196 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFG 196 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTT
T ss_pred cCCccc--ccccccccccChHHhhc
Confidence 654322 33569999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-31 Score=258.87 Aligned_cols=173 Identities=28% Similarity=0.395 Sum_probs=140.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-------
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------- 375 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 375 (484)
.++|++.+.||+|+||+||+|+.. +|+.||||++... .+...+++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999874 7999999998643 233456789999999999999999999998653
Q ss_pred -CceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCC
Q 011486 376 -TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (484)
Q Consensus 376 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla 454 (484)
+..++||||++++.+..+ ......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 457899999987655544 4445668999999999999999999995 49999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccCCcccCC
Q 011486 455 KLLEDEESH---ITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 455 ~~~~~~~~~---~~~~~~Gt~~Y~APE~~~~ 482 (484)
+.+...... ......||+.|+|||++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcC
Confidence 876543221 1223569999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-32 Score=264.71 Aligned_cols=174 Identities=29% Similarity=0.425 Sum_probs=150.3
Q ss_pred hcCCCccceeeeccceeEEEEEec----CCCEEEEEEecccC----hhHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCC
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN----EGFDRFFERELEILGSIKH-RYLVNLRGYCNSPT 376 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 376 (484)
.++|++.+.||+|+||+||+|... +|+.||||.+++.. ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999752 47899999987532 2234668899999999976 89999999999999
Q ss_pred ceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
..+++|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999999765 457889999999999999999995 5999999999999999999999999999988
Q ss_pred cCCCCcceeecccccccccCCcccCCC
Q 011486 457 LEDEESHITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 457 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 483 (484)
+............||+.|+|||.++.+
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred hcccccccccccccccccchhHHhhcC
Confidence 765444444556799999999998653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6.6e-31 Score=254.06 Aligned_cols=171 Identities=23% Similarity=0.284 Sum_probs=139.3
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCceeee-EEEEEcCCceEEEEEc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL-RGYCNSPTSKLLIYDF 384 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~ 384 (484)
++|++.+.||+|+||.||+|+.. +++.||||.+..... .+++.+|+++++.++|+|++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46889999999999999999864 688999998875432 2457889999999987765554 5555677788899999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcC---CCcEEEEecCCCcccCCCC
Q 011486 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDEE 461 (484)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~---~~~~kl~DFGla~~~~~~~ 461 (484)
+ ++++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+|||++. +..+||+|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 568888877766779999999999999999999995 59999999999999863 5579999999999876433
Q ss_pred cc------eeecccccccccCCcccCCC
Q 011486 462 SH------ITTIVAGTFGYLAPGKDCTN 483 (484)
Q Consensus 462 ~~------~~~~~~Gt~~Y~APE~~~~~ 483 (484)
.. ......||+.|||||++.+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 188 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGI 188 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTB
T ss_pred cccceeccccCCcCCCccccCHHHHhCC
Confidence 21 12345799999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=256.94 Aligned_cols=168 Identities=28% Similarity=0.385 Sum_probs=139.6
Q ss_pred hcCCCccceeeeccceeEEEEEec-CCCEEEEEEecccC--hhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----Cc
Q 011486 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TS 377 (484)
Q Consensus 306 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 377 (484)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 357999999999999999999864 79999999997543 34456789999999999999999999998643 33
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 4677788889999999964 459999999999999999999995 49999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
... .....||+.|+|||.+..
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTT
T ss_pred Ccc----cccccccccccCchhhcC
Confidence 432 233568999999998654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-30 Score=254.62 Aligned_cols=167 Identities=24% Similarity=0.334 Sum_probs=131.4
Q ss_pred cCCCccceeeeccceeEEEEEec-CCCEEEEEEeccc--ChhHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------Cc
Q 011486 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (484)
Q Consensus 307 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 377 (484)
++|++.+.||+|+||+||+|... +|+.||||+++.. .....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999876 6999999999753 234456789999999999999999999999644 56
Q ss_pred eEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
.|+||||+.+ ++.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 7999999966 4545543 358999999999999999999995 49999999999999999999999999998876
Q ss_pred CCCCcceeecccccccccCCcccCC
Q 011486 458 EDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 458 ~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
.... ......||+.|+|||++.+
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp -------------CCTTCCHHHHTT
T ss_pred cccc--ccccccccccccChhhhcC
Confidence 5433 2334568999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=1.6e-25 Score=221.76 Aligned_cols=168 Identities=20% Similarity=0.190 Sum_probs=131.8
Q ss_pred CCCccceeeeccceeEEEEEec-CCCEEEEEEecccChhHHHHHHHHHHHHhcCC-----------CCceeeeEEEEEcC
Q 011486 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-----------HRYLVNLRGYCNSP 375 (484)
Q Consensus 308 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 375 (484)
+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4889999999999999999874 78999999997643 34567888999988775 57899999987653
Q ss_pred --CceEEEEEcCCCCCHH-HHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCC------c
Q 011486 376 --TSKLLIYDFLPGGSLD-EAL-HERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL------E 445 (484)
Q Consensus 376 --~~~~lv~e~~~~gsL~-~~l-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~------~ 445 (484)
...+++++++..+... ... ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 4456666666554332 222 23345589999999999999999999962 5999999999999998665 4
Q ss_pred EEEEecCCCcccCCCCcceeecccccccccCCcccCC
Q 011486 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPGKDCT 482 (484)
Q Consensus 446 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 482 (484)
+|++|||.+...... .....||+.|+|||++..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT
T ss_pred eeEeecccccccccc----cccccccccccChhhccc
Confidence 999999999865432 234569999999998764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6.2e-23 Score=184.22 Aligned_cols=134 Identities=13% Similarity=0.140 Sum_probs=107.2
Q ss_pred CccceeeeccceeEEEEEecCCCEEEEEEecccC------------------hhHHHHHHHHHHHHhcCCCCceeeeEEE
Q 011486 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN------------------EGFDRFFERELEILGSIKHRYLVNLRGY 371 (484)
Q Consensus 310 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 371 (484)
.+.+.||+|+||+||+|...+|+.||||+++... ........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3568999999999999998899999999875311 0112345678899999999999998866
Q ss_pred EEcCCceEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCcEEEcCCCcEEEEec
Q 011486 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (484)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivHrDikp~NILl~~~~~~kl~DF 451 (484)
. ..+++|||+++..+.+ +++.....++.|++.|++|||+ .+|+||||||+|||++++ .++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 2479999998765432 3445567899999999999995 499999999999999965 5899999
Q ss_pred CCCcccCC
Q 011486 452 GLAKLLED 459 (484)
Q Consensus 452 Gla~~~~~ 459 (484)
|.|.....
T Consensus 147 G~a~~~~~ 154 (191)
T d1zara2 147 PQSVEVGE 154 (191)
T ss_dssp TTCEETTS
T ss_pred CCcccCCC
Confidence 99987654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=1.1e-19 Score=162.82 Aligned_cols=131 Identities=22% Similarity=0.266 Sum_probs=107.3
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccC-CcccCCccccceecccccccCCCCChhhhccccccccccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 154 (484)
.++.++++|+ .+|+.+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++++..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3455667777 6776653 68889999999997644 556788899999999999998888888888899999999999
Q ss_pred ccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|+...|..|.++++|++|+|++|+|++.+| .+..+++|+.+++++|++.|.+++
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch
Confidence 9988777888889999999999999988877 678888899999999998887654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=2.7e-20 Score=166.85 Aligned_cols=148 Identities=22% Similarity=0.310 Sum_probs=126.4
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCcccccc-CcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPI-SADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
|.|..|.|+. ..++++|+|++|+|++.+ +..|.++++|++|+|++|++.+..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6799999973 247899999999998755 56789999999999999999999999999999999999999
Q ss_pred cccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCc
Q 011486 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQ 208 (484)
Q Consensus 130 N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~ 208 (484)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+.......+..+.+..|...|..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 9999767778999999999999999999988889999999999999999998765522223345666777777777654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3.8e-18 Score=160.75 Aligned_cols=136 Identities=24% Similarity=0.198 Sum_probs=96.5
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
+++.|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 3444444444444 223344444555555555555444444445555555666666666664444556778999999999
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCCcc
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
+|+|++..+..|..+++|++|+|++|+|+..++.+..+.+|+.++++||||.|+|.+
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 999999888889999999999999999996555778899999999999999999764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=3.8e-18 Score=162.28 Aligned_cols=138 Identities=21% Similarity=0.204 Sum_probs=128.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
+++++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 67999999999999777888999999999999999999777788999999999999999999777788999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCcCCCCCcc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
++|++++..|..|..+++|++||+++|++++.+| .++.+.+|+.+++++|++.|.+++
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 9999999999999999999999999999999887 678899999999999999998764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=4.4e-17 Score=134.64 Aligned_cols=104 Identities=25% Similarity=0.338 Sum_probs=87.6
Q ss_pred EEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccc
Q 011486 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155 (484)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 155 (484)
.|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 6899999998 555 4889999999999999998 67878999999999999999998 566 48889999999999999
Q ss_pred cCCCCC-CccccccccceeeccCCcccccC
Q 011486 156 LSDYIP-PSLGKLQRLITFNVSNNFLVGAI 184 (484)
Q Consensus 156 l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~ 184 (484)
|++..+ ..+..+++|+.|++++|+++...
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 986432 46788899999999999998654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=5.1e-16 Score=145.90 Aligned_cols=128 Identities=27% Similarity=0.208 Sum_probs=91.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
++++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46888999999998776778889999999999999988 455 3677888888888888888 56667777777777777
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-CCCcccccCcccccCCc
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNR 202 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~ 202 (484)
++|.+.+..+..+..+.+|+.|++++|.++..++ .+..+++++.+++++|.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 7777766555555555555555555555555444 33445555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=5.2e-16 Score=128.08 Aligned_cols=101 Identities=23% Similarity=0.260 Sum_probs=91.0
Q ss_pred CEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCC
Q 011486 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (484)
Q Consensus 99 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N 178 (484)
|+|||++|+|+ .+| .+..+++|++|||++|+|+ .+|..++.+++|+.|++++|+|++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 68999999999 566 5999999999999999999 889999999999999999999996 55 5899999999999999
Q ss_pred cccccCC--CCCcccccCcccccCCcCC
Q 011486 179 FLVGAIP--SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 179 ~l~~~~p--~~~~l~~l~~l~l~~N~~~ 204 (484)
+++.... .+..+++|+.+++++|+..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 9997654 5788899999999999864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.60 E-value=1e-15 Score=146.67 Aligned_cols=73 Identities=26% Similarity=0.385 Sum_probs=64.3
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceeccccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (484)
|.|.+|.|++ ...++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 6899999974 257899999999999655668999999999999999999777888999999999999998
Q ss_pred ccC
Q 011486 131 YLS 133 (484)
Q Consensus 131 ~l~ 133 (484)
+++
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.6e-16 Score=135.41 Aligned_cols=123 Identities=19% Similarity=0.168 Sum_probs=101.1
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|+|++|+|+ .++..+..+++|++|||++|.|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 47899999999999 56776788999999999999999 554 5899999999999999999444445678999999999
Q ss_pred cccccCCCCC--CccccccccceeeccCCcccccCC----CCCcccccCcccc
Q 011486 152 SSNSLSDYIP--PSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSF 198 (484)
Q Consensus 152 s~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~p----~~~~l~~l~~l~l 198 (484)
++|+|+. ++ ..+..+++|++|++++|+++..+. .+..+++|+.|+.
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 9999986 44 467889999999999999987643 2456677776653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=8.9e-16 Score=145.62 Aligned_cols=137 Identities=19% Similarity=0.192 Sum_probs=118.7
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
...++.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|++++|++++..|..|..+++|++||
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 46789999999999977778899999999999999999988888999999999999999999988899999999999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcCCCCC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGK 207 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~ 207 (484)
+++|++++..|..|..+++|++|+|++|++.+..+...-...++.+....+...|..
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~ 264 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence 999999998888999999999999999999987652222234555556666666643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.7e-15 Score=131.05 Aligned_cols=111 Identities=15% Similarity=0.091 Sum_probs=96.7
Q ss_pred cCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccc
Q 011486 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR 169 (484)
Q Consensus 90 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 169 (484)
+.+.+..+|++|||++|+|+ .+|..+..+++|+.|||++|+|+ .++ .+..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34778889999999999999 67777788999999999999999 675 4889999999999999999755555678999
Q ss_pred cceeeccCCcccccCC--CCCcccccCcccccCCcC
Q 011486 170 LITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 170 L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~ 203 (484)
|+.|++++|+++.... .+..+++|+.+++++|+.
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCcc
Confidence 9999999999987543 567889999999999975
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.2e-15 Score=125.56 Aligned_cols=102 Identities=19% Similarity=0.104 Sum_probs=77.7
Q ss_pred eeCCCccccccCcCcCCCCCCCEEEcccC-cccccCCcccCCccccceecccccccCCCCChhhhccccccccccccccc
Q 011486 78 SLTNHKLSGPISADLGKLDQLKFLNLHSN-NFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156 (484)
Q Consensus 78 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 156 (484)
+++++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|
T Consensus 14 ~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l 92 (156)
T d2ifga3 14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (156)
T ss_dssp ECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred EecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCC
Confidence 33445555 56777888899999999766 48866666789999999999999999865577788899999999999999
Q ss_pred CCCCCCccccccccceeeccCCccc
Q 011486 157 SDYIPPSLGKLQRLITFNVSNNFLV 181 (484)
Q Consensus 157 ~~~~p~~~~~l~~L~~L~ls~N~l~ 181 (484)
+. +|.......+|+.|+|++|++.
T Consensus 93 ~~-l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 93 ES-LSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred cc-cChhhhccccccccccCCCccc
Confidence 85 4444333446888888888775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.8e-14 Score=123.68 Aligned_cols=113 Identities=20% Similarity=0.135 Sum_probs=93.5
Q ss_pred CCCCEEEcccCcccccCCcccCCccccceeccccc-ccCCCCChhhhcccccccccccccccCCCCCCccccccccceee
Q 011486 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN-YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN 174 (484)
Q Consensus 96 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 174 (484)
...+.++.+++.+. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556889999888 67888999999999999766 48844445689999999999999999987788899999999999
Q ss_pred ccCCcccccCCCCCcccccCcccccCCcCCCCCcc
Q 011486 175 VSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (484)
Q Consensus 175 ls~N~l~~~~p~~~~l~~l~~l~l~~N~~~c~~~~ 209 (484)
|++|+|+..++......+++.+++++|++.|.+.+
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred ccCCCCcccChhhhccccccccccCCCcccCCchH
Confidence 99999997777443444789999999999998764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.49 E-value=6.4e-15 Score=141.55 Aligned_cols=111 Identities=32% Similarity=0.429 Sum_probs=103.5
Q ss_pred CCCCCCEEEcccCcccc--cCCcccCCccccceecccc-cccCCCCChhhhcccccccccccccccCCCCCCcccccccc
Q 011486 94 KLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170 (484)
Q Consensus 94 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 170 (484)
.-.+++.|+|++|.++| .+|+++++|++|++|||++ |+++|.+|..|++|++|++|+|++|++++..|..+..+..|
T Consensus 48 ~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L 127 (313)
T d1ogqa_ 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp SCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred CcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhh
Confidence 34578999999999998 5899999999999999997 89999999999999999999999999999999999999999
Q ss_pred ceeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 171 ITFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 171 ~~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
+.+++++|.+.+.+| .+..+++++.+++++|...
T Consensus 128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred cccccccccccccCchhhccCcccceeeccccccc
Confidence 999999999999988 7899999999999999753
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.47 E-value=4.4e-14 Score=134.97 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=113.8
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.+++++|+++ .+|..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..|..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 56889999999998 566543 689999999999999999999999999999999999999777888999999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCC-C------CCcccccCcccccCCcCCCC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP-S------DGVLTKFSESSFFGNRGLCG 206 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~------~~~l~~l~~l~l~~N~~~c~ 206 (484)
++|+|+ .+|.+|..+++|++|+|++|+|+.... . ...+.+|+.+++.+|++.+.
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999998 478899999999999999999997643 2 23467789999999998653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.44 E-value=9.6e-14 Score=124.20 Aligned_cols=124 Identities=30% Similarity=0.404 Sum_probs=97.8
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++++|+|++|++++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhh
Confidence 3578888888888885443 888888888888888887 444 47888888888888888873 3 3477888899999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
+++|++.. +| .+..+++|+.|++++|++++.. .+..+++|+.|++++|+.
T Consensus 135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCC
T ss_pred hhhhhhcc-cc-cccccccccccccccccccCCc-cccCCCCCCEEECCCCCC
Confidence 99998874 43 5788888999999999888754 367788889999988863
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=1.3e-15 Score=136.46 Aligned_cols=112 Identities=28% Similarity=0.277 Sum_probs=89.0
Q ss_pred ccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCcccc
Q 011486 87 PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK 166 (484)
Q Consensus 87 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 166 (484)
.++..+..|++|++|+|++|+|+ .++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. ++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence 44566888888999999998888 455 5888888999999999888 777766777788889999998885 33 4778
Q ss_pred ccccceeeccCCcccccCC--CCCcccccCcccccCCcC
Q 011486 167 LQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 167 l~~L~~L~ls~N~l~~~~p--~~~~l~~l~~l~l~~N~~ 203 (484)
+++|+.|++++|+++.... .+..+++|+.+++++|+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCcc
Confidence 8888899999988876532 567788888888888874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.42 E-value=1.7e-13 Score=123.68 Aligned_cols=124 Identities=28% Similarity=0.362 Sum_probs=102.2
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
.+++++|+|++|++++. + .++.+++|++|++++|+|+ .+| .+.++++|+.|++++|.+. .++ .+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 35799999999999864 3 3788999999999999998 455 5888999999999999887 444 578888999999
Q ss_pred ccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 151 ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
+++|.+++ +..+..+++|+.+++++|++++..+ +..+++|+.|++++|+.
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred cccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCCC
Confidence 99999875 3457788999999999999987544 67889999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.40 E-value=1.4e-13 Score=135.22 Aligned_cols=125 Identities=30% Similarity=0.295 Sum_probs=78.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCC---------------
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI--------------- 136 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~--------------- 136 (484)
.+++.|++++|.++. ++ .+..+++|+.|++++|.+++..| +..+++|++|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 456667777776663 22 45666666666666666664332 555666666666666555321
Q ss_pred -----ChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 137 -----PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 137 -----p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
+..+..+++|+.|++++|++++.. .+..+++|+.|++++|+|++. +.+..+++|+.+++++|+.
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCC
T ss_pred cccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcC
Confidence 123555667777777777777642 266777777777777777753 3566777777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=2.7e-13 Score=121.25 Aligned_cols=123 Identities=26% Similarity=0.371 Sum_probs=106.5
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
.++++|++++|+++ .++ .+..+++|++|+|++|+|++..| +.++++|++|++++|.+. .+|. +.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-cccccccccccc
Confidence 57899999999998 444 48899999999999999996443 999999999999999998 6664 889999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|.+... ..+..+++|+.|++++|+++.. +.+..+++++.+++.+|..
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccc
Confidence 99999853 3578899999999999999854 5677889999999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=2.9e-15 Score=134.10 Aligned_cols=110 Identities=24% Similarity=0.298 Sum_probs=95.5
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccc
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 150 (484)
-.+++.|+|++|+|+ .++ .|..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++ .++ .+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence 468999999999999 555 5999999999999999998 67766667789999999999999 554 588999999999
Q ss_pred ccccccCCCCC--CccccccccceeeccCCcccccCCC
Q 011486 151 ISSNSLSDYIP--PSLGKLQRLITFNVSNNFLVGAIPS 186 (484)
Q Consensus 151 ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~p~ 186 (484)
|++|+|+. ++ ..+..+++|+.|+|++|+++...+.
T Consensus 122 L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 122 MSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence 99999986 44 4688999999999999999887663
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.33 E-value=1.1e-12 Score=118.32 Aligned_cols=123 Identities=24% Similarity=0.295 Sum_probs=106.2
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 151 (484)
..++.|++++|.++. ++ .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++ .+| .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccc
Confidence 468999999999985 43 38899999999999999996 44 4789999999999999999 566 5889999999999
Q ss_pred cccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 152 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
++|.+.. + ..+..++.|+.+++++|.+++.. .+..+++|+.+++++|..
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCC
T ss_pred ccccccc-c-ccccccccccccccccccccccc-cccccccccccccccccc
Confidence 9999974 3 46889999999999999998644 457789999999999975
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=1.5e-12 Score=119.72 Aligned_cols=144 Identities=19% Similarity=0.130 Sum_probs=92.6
Q ss_pred CCcceeeeCC----------CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCC-cccCCccccceecccc
Q 011486 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQS 129 (484)
Q Consensus 61 c~w~gv~C~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~ 129 (484)
|.+..|.|.. ..++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5677788862 2468999999999996566678999999999999998875443 3455566666665543
Q ss_pred -cccCCCCChhhhcccccccccccccccCCC-------------------------------------------------
Q 011486 130 -NYLSGSIPSELGNLSNLLNLDISSNSLSDY------------------------------------------------- 159 (484)
Q Consensus 130 -N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~------------------------------------------------- 159 (484)
|.+....+..|.++++|++|++++|+++..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 445444444455555555555555555422
Q ss_pred CCCccccccccc-eeeccCCcccccCC-CCCcccccCcccccCCcCC
Q 011486 160 IPPSLGKLQRLI-TFNVSNNFLVGAIP-SDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 160 ~p~~~~~l~~L~-~L~ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~ 204 (484)
++.......++. .+++++|+++..++ .+..+++|+.|++++|+..
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 111111222322 33556677776555 4788899999999999754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=4.4e-12 Score=124.29 Aligned_cols=123 Identities=26% Similarity=0.346 Sum_probs=78.7
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCC--------------------cccCCccccceecccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--------------------SELGNCTELQGLSLQSNY 131 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------------------~~~~~l~~L~~L~Ls~N~ 131 (484)
.+++.|++++|.+++..+ ++.+++|++|++++|.+++..| ..+..++++++|+|++|+
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 456677777777765433 6666777777777776664321 124455666777777777
Q ss_pred cCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCC
Q 011486 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (484)
Q Consensus 132 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N 201 (484)
+++ ++ .+..+++|++|+|++|+|++ +| .+.++++|++|++++|+|++.+| +..+++|+.|++++|
T Consensus 319 l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 764 33 26667777777777777764 33 46677777777777777776655 566667777777665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=9.8e-12 Score=113.13 Aligned_cols=126 Identities=23% Similarity=0.352 Sum_probs=94.5
Q ss_pred CCcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCC-------------
Q 011486 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP------------- 137 (484)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p------------- 137 (484)
.++++.|+|++|.+++..| +..+++|++|++++|.++ .++ .+.++++|+.|++++|...+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 4678888888888885443 788888888888888887 444 57788888888888887663211
Q ss_pred -------hhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCcccccCCcC
Q 011486 138 -------SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 138 -------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~~N~~ 203 (484)
..+..+++|+.|++++|.+++. ..+.++++|+.|+|++|++++. +.+..+++|+.|++++|+.
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQI 207 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCC
T ss_pred hhhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 2355667788888888888753 2377888888899988888864 4467788888888888863
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.14 E-value=2.7e-11 Score=110.11 Aligned_cols=121 Identities=28% Similarity=0.369 Sum_probs=91.3
Q ss_pred CcEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccC--------------------CcccCCccccceecccccc
Q 011486 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI--------------------PSELGNCTELQGLSLQSNY 131 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------------------p~~~~~l~~L~~L~Ls~N~ 131 (484)
.+++.+++++|.++ .++ .+.++++|+.+++++|...+.. ...+.++++|++|++++|.
T Consensus 85 ~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 85 TKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 45666677766665 333 3566666666666666554321 1235678889999999999
Q ss_pred cCCCCChhhhcccccccccccccccCCCCCCccccccccceeeccCCcccccCCCCCcccccCccccc
Q 011486 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFF 199 (484)
Q Consensus 132 l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~l~~l~~l~l~ 199 (484)
+++ ++ .+.++++|+.|||++|++++ +| .+.++++|++|+|++|++++..| +..+++|+.++++
T Consensus 163 ~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 163 VSD-LT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp CCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred ccc-ch-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 983 33 38899999999999999997 44 38999999999999999997654 6788999998886
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.8e-10 Score=105.41 Aligned_cols=108 Identities=18% Similarity=0.173 Sum_probs=91.6
Q ss_pred EEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCCh-hhhccccccccccc-
Q 011486 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS-ELGNLSNLLNLDIS- 152 (484)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~ls- 152 (484)
+.++.++.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|. .|..++++++|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 36788899999 7887663 5899999999999955556799999999999999999866654 57889999999986
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 185 (484)
.|++....+..|.++++|++|++++|.++...+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred cccccccccccccccccccccccchhhhccccc
Confidence 578888888889999999999999999986544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.95 E-value=9.4e-10 Score=105.68 Aligned_cols=101 Identities=26% Similarity=0.263 Sum_probs=82.7
Q ss_pred cEEEEeeCCCccccccCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhccccccccccc
Q 011486 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 152 (484)
++++|||++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5789999999998 57753 578999999999999 788764 57889999999998 66642 1469999999
Q ss_pred ccccCCCCCCccccccccceeeccCCcccccCCCC
Q 011486 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187 (484)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 187 (484)
+|.++. +|. +..+++|+.|++++|.++..++..
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred cccccc-ccc-hhhhccceeecccccccccccccc
Confidence 999985 665 578999999999999998766543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=1.6e-10 Score=99.15 Aligned_cols=92 Identities=24% Similarity=0.111 Sum_probs=47.9
Q ss_pred cCCCCCCCEEEcccCcccccCCcccCCccccceecccccccCCC--CChhhhcccccccccccccccCCCCCCccccccc
Q 011486 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS--IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR 169 (484)
Q Consensus 92 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 169 (484)
+..+..+..+++.+|... .++..+.++++|++|||++|+|+.. ++..+..+++|+.|||++|.|+...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 334444444444444433 3333344566666666666666621 1233556666666666666666422212223345
Q ss_pred cceeeccCCcccccC
Q 011486 170 LITFNVSNNFLVGAI 184 (484)
Q Consensus 170 L~~L~ls~N~l~~~~ 184 (484)
|+.|++++|+++...
T Consensus 117 L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 117 LEELWLDGNSLSDTF 131 (162)
T ss_dssp CSSCCCTTSTTSSSS
T ss_pred cceeecCCCCcCcCc
Confidence 666666666666543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=7.6e-10 Score=103.96 Aligned_cols=57 Identities=23% Similarity=0.302 Sum_probs=26.8
Q ss_pred cEEEEeeCCCccccc-cCcCcCCCCCCCEEEcccCcccccCCcccCCccccceecccc
Q 011486 73 RVITLSLTNHKLSGP-ISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (484)
Q Consensus 73 ~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (484)
++++|||+++.++.. +...+.++++|++|+|+++.+++..+..+..+++|++|+|++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 445555555544422 223344445555555555554444444444444555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.70 E-value=1.3e-08 Score=97.55 Aligned_cols=96 Identities=22% Similarity=0.161 Sum_probs=79.7
Q ss_pred CCCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCCCCccccccccceeec
Q 011486 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175 (484)
Q Consensus 96 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 175 (484)
.+|+.|||++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence 47899999999998 68864 468999999999999 899764 578999999999984 5532 246999999
Q ss_pred cCCcccccCCCCCcccccCcccccCCcCC
Q 011486 176 SNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (484)
Q Consensus 176 s~N~l~~~~p~~~~l~~l~~l~l~~N~~~ 204 (484)
++|.++.. |.++.+++|+.+++.+|...
T Consensus 106 ~~n~l~~l-p~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLEKL-PELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCSSC-CCCTTCTTCCEEECCSSCCS
T ss_pred cccccccc-cchhhhccceeecccccccc
Confidence 99999865 55678999999999988754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=3.7e-08 Score=90.67 Aligned_cols=151 Identities=18% Similarity=0.121 Sum_probs=104.8
Q ss_pred HHHHHHhcCCCccceeeeccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCce
Q 011486 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (484)
Q Consensus 300 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 378 (484)
.++.+..+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46667777777655544444578999765 46667888876544333445778888877664 44467888888888889
Q ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 011486 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC---------------------------------- 424 (484)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------- 424 (484)
++||+++++.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999998886654221 112335566666666666321
Q ss_pred ----------------------CCCeEEcCCCCCcEEEcCCCcEEEEecCCCccc
Q 011486 425 ----------------------SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (484)
Q Consensus 425 ----------------------~~~ivHrDikp~NILl~~~~~~kl~DFGla~~~ 457 (484)
...++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123799999999999998777779999988743
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4.6e-09 Score=89.78 Aligned_cols=104 Identities=21% Similarity=0.090 Sum_probs=78.6
Q ss_pred CCCEEEcccCcccccCCcccCCccccceecccccccCCCCChhhhcccccccccccccccCCCC--CCccccccccceee
Q 011486 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYI--PPSLGKLQRLITFN 174 (484)
Q Consensus 97 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~--p~~~~~l~~L~~L~ 174 (484)
..+.||++++... ..+..+..+..|++.+|... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777765532 24666677778888887776 66666778999999999999998642 35567899999999
Q ss_pred ccCCcccccCC-CCCcccccCcccccCCcCCC
Q 011486 175 VSNNFLVGAIP-SDGVLTKFSESSFFGNRGLC 205 (484)
Q Consensus 175 ls~N~l~~~~p-~~~~l~~l~~l~l~~N~~~c 205 (484)
|++|+++...+ ......+++.+++.||+..+
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 99999998655 22334578999999998643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=2.1e-09 Score=106.89 Aligned_cols=112 Identities=23% Similarity=0.288 Sum_probs=86.3
Q ss_pred CcEEEEeeCCCccccc-cCcCcCCCCCCCEEEcccCcccc----cCCcccCCccccceecccccccCCC----CChhhh-
Q 011486 72 KRVITLSLTNHKLSGP-ISADLGKLDQLKFLNLHSNNFYG----EIPSELGNCTELQGLSLQSNYLSGS----IPSELG- 141 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~- 141 (484)
.+|+.||+++|++++. +...+..+++|+.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999853 24456778999999999999883 3455678899999999999998621 111221
Q ss_pred cccccccccccccccCCC----CCCccccccccceeeccCCccccc
Q 011486 142 NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGA 183 (484)
Q Consensus 142 ~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~ 183 (484)
...+|++|+|++|++++. ++..+..+++|++|+|++|.++..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 224799999999999753 355677889999999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.41 E-value=3.7e-09 Score=101.85 Aligned_cols=131 Identities=18% Similarity=0.165 Sum_probs=77.0
Q ss_pred cEEEEeeCCCcccc----ccCcCcCCCCCCCEEEcccCccccc-----CCcccCCccccceecccccccCCC----CChh
Q 011486 73 RVITLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGE-----IPSELGNCTELQGLSLQSNYLSGS----IPSE 139 (484)
Q Consensus 73 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~ 139 (484)
.++.|++++|.++. .+...+...+.|+.|+|++|.++.. +...+..+++|+.|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 45555555555541 1223345567777788877777631 334466677778888887776522 3344
Q ss_pred hhcccccccccccccccCCCCCC----ccc--cccccceeeccCCcccccC----C-CC-CcccccCcccccCCcC
Q 011486 140 LGNLSNLLNLDISSNSLSDYIPP----SLG--KLQRLITFNVSNNFLVGAI----P-SD-GVLTKFSESSFFGNRG 203 (484)
Q Consensus 140 ~~~l~~L~~L~ls~N~l~~~~p~----~~~--~l~~L~~L~ls~N~l~~~~----p-~~-~~l~~l~~l~l~~N~~ 203 (484)
+..+++|++|+|++|.|++.-.. .+. ..+.|++|++++|+++..- . .+ ..+++|+.+++++|..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 56677778888888877643111 121 1246777888888776421 1 11 1345677777777765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.26 E-value=1.6e-08 Score=97.24 Aligned_cols=131 Identities=15% Similarity=0.169 Sum_probs=65.7
Q ss_pred CcEEEEeeCCCccccc----cCcCcCCCCCCCEEEcccCcccccCCcc-------------cCCccccceecccccccCC
Q 011486 72 KRVITLSLTNHKLSGP----ISADLGKLDQLKFLNLHSNNFYGEIPSE-------------LGNCTELQGLSLQSNYLSG 134 (484)
Q Consensus 72 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~g 134 (484)
++++.|+|++|.++.. +...+...++|++|+|++|.+...-... ....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 3466666666655532 2233344556666666666553110000 1233455666666665541
Q ss_pred C----CChhhhcccccccccccccccCCC-----CCCccccccccceeeccCCccccc----C-CCCCcccccCcccccC
Q 011486 135 S----IPSELGNLSNLLNLDISSNSLSDY-----IPPSLGKLQRLITFNVSNNFLVGA----I-PSDGVLTKFSESSFFG 200 (484)
Q Consensus 135 ~----~p~~~~~l~~L~~L~ls~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~----~-p~~~~l~~l~~l~l~~ 200 (484)
. +...+...++|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. + ..+...++|+.|++++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 1 122234455666666666666421 223345566666666666666432 1 1334455666666665
Q ss_pred Cc
Q 011486 201 NR 202 (484)
Q Consensus 201 N~ 202 (484)
|.
T Consensus 253 n~ 254 (344)
T d2ca6a1 253 CL 254 (344)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=1.4e-08 Score=100.64 Aligned_cols=108 Identities=20% Similarity=0.208 Sum_probs=82.0
Q ss_pred CCCCEEEcccCcccccC-CcccCCccccceecccccccCC----CCChhhhcccccccccccccccCCC----CCCccc-
Q 011486 96 DQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY----IPPSLG- 165 (484)
Q Consensus 96 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~- 165 (484)
.+|+.||+++|++++.. ..-+..+++|+.|+|++|.++. .++..+..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998532 3346678999999999999872 3445577889999999999998631 122222
Q ss_pred cccccceeeccCCccccc----CC-CCCcccccCcccccCCcC
Q 011486 166 KLQRLITFNVSNNFLVGA----IP-SDGVLTKFSESSFFGNRG 203 (484)
Q Consensus 166 ~l~~L~~L~ls~N~l~~~----~p-~~~~l~~l~~l~l~~N~~ 203 (484)
...+|++|+|++|+++.. ++ .+..+++|+.+++++|+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 235799999999999864 23 456788999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=6.5e-08 Score=90.41 Aligned_cols=125 Identities=22% Similarity=0.293 Sum_probs=73.9
Q ss_pred EEEeeCCCccccccCcCcCCCCCCCEEEcccCccccc-CCcccCCccccceecccccccCCCCChhhhcccccccccccc
Q 011486 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153 (484)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~ 153 (484)
..+.++...+...+ .......+|++|||+++.+++. ++..+..+++|++|+|++|.+++..+..++.+++|++|+|++
T Consensus 26 ~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 34444444444222 2234556788888888777643 344467778888888888887766677777778888888877
Q ss_pred c-ccCCC-CCCccccccccceeeccCC-ccccc-CC-CCCc-ccccCcccccC
Q 011486 154 N-SLSDY-IPPSLGKLQRLITFNVSNN-FLVGA-IP-SDGV-LTKFSESSFFG 200 (484)
Q Consensus 154 N-~l~~~-~p~~~~~l~~L~~L~ls~N-~l~~~-~p-~~~~-l~~l~~l~l~~ 200 (484)
+ .+++. +..-...+++|++|+++++ .++.. ++ .+.. .++|+.++++|
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~ 157 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 157 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcc
Confidence 3 55421 1122345677888888774 44321 11 1111 24566666654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=5.5e-06 Score=75.18 Aligned_cols=131 Identities=16% Similarity=0.100 Sum_probs=86.8
Q ss_pred eeeeccc-eeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCC--CCceeeeEEEEEcCCceEEEEEcCCCCCH
Q 011486 314 IIGSGGF-GTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (484)
Q Consensus 314 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 390 (484)
.+..|.. +.||+....++..+++|....... ..+..|.+.++.+. .-.+.+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 678999888888889998765432 24667777777663 33467788888888889999999987655
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 011486 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLH------------------------------------------------- 421 (484)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~i~~aL~~LH------------------------------------------------- 421 (484)
.+.. .+. ...+.++++.|+-||
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3210 110 011222222233333
Q ss_pred --hCC----CCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 422 --HDC----SPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 422 --~~~----~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
+.. ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 23489999999999999877778999998875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.85 E-value=7.3e-07 Score=76.05 Aligned_cols=108 Identities=10% Similarity=0.158 Sum_probs=61.4
Q ss_pred CcEEEEeeCCC-ccccc----cCcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccCCC----CCh
Q 011486 72 KRVITLSLTNH-KLSGP----ISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (484)
Q Consensus 72 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~ 138 (484)
+++++|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|++|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56777888764 45421 233466667788888888777632 222334456677777777777631 111
Q ss_pred hhhcccccccccccccccCCC-------CCCccccccccceeeccCCc
Q 011486 139 ELGNLSNLLNLDISSNSLSDY-------IPPSLGKLQRLITFNVSNNF 179 (484)
Q Consensus 139 ~~~~l~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~L~ls~N~ 179 (484)
.+...++|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 234446677777777765431 12223334566666665554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=3.8e-05 Score=74.48 Aligned_cols=76 Identities=12% Similarity=0.014 Sum_probs=49.0
Q ss_pred cceeeeccceeEEEEEecC-CCEEEEEEeccc-------ChhHHHHHHHHHHHHhcCC-C--CceeeeEEEEEcCCceEE
Q 011486 312 DHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL-------NEGFDRFFERELEILGSIK-H--RYLVNLRGYCNSPTSKLL 380 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 380 (484)
.+.||.|..-.||++...+ ++.+++|.-... .+....+...|.+.++.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998764 678899965421 1112234556887776652 2 456666654 4556789
Q ss_pred EEEcCCCCC
Q 011486 381 IYDFLPGGS 389 (484)
Q Consensus 381 v~e~~~~gs 389 (484)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.48 E-value=9.3e-06 Score=68.89 Aligned_cols=90 Identities=19% Similarity=0.172 Sum_probs=63.9
Q ss_pred CCCCCCCEEEcccC-ccccc----CCcccCCccccceecccccccCC----CCChhhhcccccccccccccccCCC----
Q 011486 93 GKLDQLKFLNLHSN-NFYGE----IPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY---- 159 (484)
Q Consensus 93 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~---- 159 (484)
.+.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.|++.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999974 56532 33456677889999999998872 2223455668899999999998742
Q ss_pred CCCccccccccceeeccCCcccc
Q 011486 160 IPPSLGKLQRLITFNVSNNFLVG 182 (484)
Q Consensus 160 ~p~~~~~l~~L~~L~ls~N~l~~ 182 (484)
+-..+...++|++|+|++|.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCC
Confidence 12235566789999998887653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.28 E-value=6.9e-06 Score=69.58 Aligned_cols=109 Identities=21% Similarity=0.282 Sum_probs=56.1
Q ss_pred CcEEEEeeCC-Cccccc----cCcCcCCCCCCCEEEcccCccccc----CCcccCCccccceecccccccCCC----CCh
Q 011486 72 KRVITLSLTN-HKLSGP----ISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (484)
Q Consensus 72 ~~l~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~ 138 (484)
+.+++|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4566777765 345411 233455666777777777766532 222334456677777776666521 112
Q ss_pred hhhccccccc--ccccccccCC----CCCCccccccccceeeccCCcc
Q 011486 139 ELGNLSNLLN--LDISSNSLSD----YIPPSLGKLQRLITFNVSNNFL 180 (484)
Q Consensus 139 ~~~~l~~L~~--L~ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l 180 (484)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3344455654 3334555532 1223344555666666655543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00031 Score=65.90 Aligned_cols=133 Identities=14% Similarity=0.166 Sum_probs=76.9
Q ss_pred eeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCce--eeeEE-----EEEcCCceEEEEEcCCCCCH---
Q 011486 321 GTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL--VNLRG-----YCNSPTSKLLIYDFLPGGSL--- 390 (484)
Q Consensus 321 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL--- 390 (484)
-.||++..++|..|++|..+... ...+++..|.+.+..|....+ +..+. .....+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999987542 235667788888877642222 11111 12334567889999876432
Q ss_pred --HHH---------Hhh----c----CCCCCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCCe
Q 011486 391 --DEA---------LHE----R----SEQLDW-------------------DARLNIIMGAAKGLAYLHH----DCSPRI 428 (484)
Q Consensus 391 --~~~---------l~~----~----~~~l~~-------------------~~~~~i~~~i~~aL~~LH~----~~~~~i 428 (484)
..+ +|. . ....++ ..+..+...+...++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 110 0 011111 1111222222333333322 224679
Q ss_pred EEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 429 IHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 429 vHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.0027 Score=58.70 Aligned_cols=157 Identities=18% Similarity=0.115 Sum_probs=84.3
Q ss_pred CCHHHHHHHhcCCCccceee-----eccceeEEEEEecCCCEEEEEEecccChhHHHHHHHHHHHHhcCCCCc--eeeeE
Q 011486 297 YSSKDIIKKLETLDDDHIIG-----SGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY--LVNLR 369 (484)
Q Consensus 297 ~~~~el~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 369 (484)
.+.+|+.....+|...+... .|---+.|+.+..+|+ +++|++..... .+++..|++++..+...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 46678888888898755543 4555678998876654 89998865321 234555666666653221 22211
Q ss_pred EE------EEcCCceEEEEEcCCCCCHHH--------------HHhhcC--------CCC------------------CH
Q 011486 370 GY------CNSPTSKLLIYDFLPGGSLDE--------------ALHERS--------EQL------------------DW 403 (484)
Q Consensus 370 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~--------~~l------------------~~ 403 (484)
.. .........++.+..+..... .++... ... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 122334556677665532210 011000 000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCcEEEcCCCcEEEEecCCCcc
Q 011486 404 DARLNIIMGAAKGLAYLHH-DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (484)
Q Consensus 404 ~~~~~i~~~i~~aL~~LH~-~~~~~ivHrDikp~NILl~~~~~~kl~DFGla~~ 456 (484)
......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111222223333333321 1356899999999999999988778999998863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=2.8e-05 Score=65.67 Aligned_cols=112 Identities=16% Similarity=0.090 Sum_probs=75.7
Q ss_pred cCcCCCCCCCEEEccc-Cccccc----CCcccCCccccceecccccccCCCC----ChhhhcccccccccccccccCCC-
Q 011486 90 ADLGKLDQLKFLNLHS-NNFYGE----IPSELGNCTELQGLSLQSNYLSGSI----PSELGNLSNLLNLDISSNSLSDY- 159 (484)
Q Consensus 90 ~~~~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~ls~N~l~~~- 159 (484)
....+.+.|++|+|++ |.++.. +-..+...++|++|+|++|.++..- -..+...++|+.|++++|.++..
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3345678999999998 567532 3345667899999999999987322 22355678999999999998642
Q ss_pred ---CCCcccccccccee--eccCCcccccC-----CCCCcccccCcccccCC
Q 011486 160 ---IPPSLGKLQRLITF--NVSNNFLVGAI-----PSDGVLTKFSESSFFGN 201 (484)
Q Consensus 160 ---~p~~~~~l~~L~~L--~ls~N~l~~~~-----p~~~~l~~l~~l~l~~N 201 (484)
+-..+...++|+.+ ++++|.+.... ..+...+.|+.+++..|
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 22456677888864 55677775421 12344566777777654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.0019 Score=62.05 Aligned_cols=73 Identities=15% Similarity=0.158 Sum_probs=48.3
Q ss_pred cceeeeccceeEEEEEecC--------CCEEEEEEecccChhHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCceEEEE
Q 011486 312 DHIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (484)
Q Consensus 312 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 382 (484)
.+.|+.|-.=.+|++...+ .+.|.+++.-. ... .....+|.++++.+. +.-.+++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567888888999987653 34566666543 222 234567888888774 4445577877642 6899
Q ss_pred EcCCCCCH
Q 011486 383 DFLPGGSL 390 (484)
Q Consensus 383 e~~~~gsL 390 (484)
||+++.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|